Structure Search

List Search MOL Search Structure Search

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (162)
Other Achiral Nitrogen Ligands (53)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (90)
Mono-phosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (133)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (69)
Chiral Oxazoline Ligands
BOX Ligands (510)
Chiral Mono Oxazoline Ligands (363)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (218)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (137)
BIDIME and BIBOP Ligands (78)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (50)
Chiral Ferrocenyl Phosphine Ligands (96)
Chiral Phosphoramidite Ligands (98)
Duphos and BPE Ligands (28)
PHOX Ligands (218)
Sadphos Ligands (110)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (79)
Chiral Phosphoric Acids (161)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (15)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (61)
Chiral Phase-Transfer Catalysts (25)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (10)
Photoredox Iridiums Catalysts (104)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (92)
Copper (108)
Gold (70)
Iridium (60)
Iron (101)
Manganese (45)
Molybdenum (11)
Nickel (95)
Osmium (2)
Palladium (240)
Platinum (75)
Rhenium (6)
Rhodium (166)
Ruthenium (199)
Silver (33)
Tantalum (1)
Titanium (10)
Tungsten (6)
Vanadium (6)
Zinc (48)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18939)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Bcat (11)
Boronic Acids (13202)
MIDA Boronates (363)
Pinacol Boronates (16140)
Pinane Boronates (96)
Potassium Organotrifluoroborate Salts (1076)
Other Boronates (132)
Heterocyclic Building Blocks
Acridines (640)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (18)
Aliphatic Heterocycles (103)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (6)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (8)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2997)
1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)3-Phenylazetidine (5)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)
Benzimidazoles (4428)
Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)
Benzisoxazoles (508)
3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)
Benzodioxans (697)
(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3713)
Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (6)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)
Benzothiazoles (2422)
Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)
Benzothiophenes (1116)
Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2804)
Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (482)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (11)
Dioxolanes (1580)
(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (24)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)
Dioxoles (13)
Epoxides (407)
Epoxy (7)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)
Furans (7000)
Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (37)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (31)Furan-2-Ylmethanol (5)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)
Imidazoles (833)
Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (19)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1145)
Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (695)
Indazoles (3081)
Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (7)1-Ethyl-1H-Indazole (7)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7683)
Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (28)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Indolecarboxylic (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (4)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (10)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (85)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (4)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (21)
Indolines (4489)
Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Indoline-Carboxylate (1)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)
Isoquinolines (2729)
Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (343)
Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (24)
Isoxazoles (3403)
Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4988)
Benzylmorpholine (25)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)2-Phenylmorpholine (8)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)
Naphthyridines (939)
1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3559)
1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2026)
Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1298)
Dimethyloxazolidin (6)Dioxooxazolidin (2)Oxazolidinone (5)Phenyloxazolidin (9)Propionyloxazolidin (5)(R)-4-Benzyloxazolidin-2-One (5)(S)-4-Benzyloxazolidin-2-One (11)3-(4-Morpholinophenyl)Oxazolidin-2-One (4)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)
Oxazolines (1577)
(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Methyloxetane (11)
Phthalazines (423)
Dihydrophthalazine (15)Phthalazine (16)
Piperazines (7427)
Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(R)-2-Benzylpiperazine (5)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (5)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (17)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)
Piperidines (21889)
Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (8)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)3-Phenylpiperidine (6)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2020)
(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1095)
Chromene-Carboxylic Acid (1)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (10)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3359)
Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16157)
Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (23)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)
Pyridazines (2753)
Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (10)Pyridazinecarboxylic (1)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)
Pyridines (70617)
Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (202)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (28)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (288)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (342)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (393)Oxopyridin (2)Phenoxypyridin (1)Picolinate (42)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (12)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (436)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (8)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (12)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (52)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (50)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (4)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (153)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14557)
Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (8)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4953)
Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (5)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (5)3-Phenylpyrrolidine (26)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)
Pyrrolidines (14879)
Acetylpyrrolidine (9)Benzylpyrrolidine (33)Bipyrrolidine (9)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (129)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylpyrrolidine (8)(S)-3-Phenylpyrrolidine (14)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenylpyrrolidine (26)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4-Phenylpyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Pyrrolines (1763)
1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3143)
Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11910)
Iodoquinoline (32)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (18)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1411)
Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Spiroes (4763)
Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)
Tetrahydrofurans (2265)
Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (9)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (30)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (46)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (27)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (19)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (2)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (7)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (7)
Tetrahydroisoquinolines (1291)
Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3359)
Chroman-Amine (1)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)
Tetrahydroquinolines (1464)
Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (82)
1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2122)
1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (15)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)
Thiazines (62)
Thiazoles (6687)
Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)
Thiazolidines (1260)
Thioxothiazolidin (23)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (16)
Thiomorpholines (454)
Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (960)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (58)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (11)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1387)
1,2,4-Triazine (9)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7749)
(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenethyl-1H-1,2,4-Triazole (6)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)
Other Aliphatic Heterocycles (6209)
1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)
Other Aromatic Heterocycles (37751)
Indolizine (15)Phenazine (8)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3025)
2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45771)
Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (18)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Hydroxynaphthalene (29)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (3)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (39)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (21)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (102)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (77)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18914)
Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1094)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (153)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12579)
Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (2)Carbonylbis (2)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (306)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dinonyl (1)Dinonyl (1)Dioctyl (1)Dioxide (451)Dioxide (451)Ethoxy (711)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (16)Ethoxyethyl (16)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (69)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11046)
Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (292)Azabicyclo (292)Azatricyclo (5)Azatricyclo (5)Azetidine (185)Azetidine (185)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclodextrin (1)Cyclodextrin (1)Cyclohexa (176)Cyclohexa (176)Cyclohexane (127)Cyclohexane (127)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (92)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (12)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (94)Cyclohexylpropanoic (9)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (16)Cyclopentyloxy (16)Cyclopentylpropanoic (1)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (355)Cyclopropyl (355)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (22)Cyclopropylmethyl (22)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (7)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (175)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (12)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)Trimethylcyclohexane (1)Trimethylcyclohexane (1)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (19)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (72)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)
Alkenyls (16078)
Acrylaldehyde (11)Acryloyl (9)Acryloyl (9)Annulene (2)Cyclohexene (88)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (9)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (19)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (4)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (36)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (81)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)
Alkyls (195)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (11)
Alkynyls (2698)
(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (13)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (90371)
Acetamide (651)Acetamide (651)Acetamido (156)Carboxamide (929)Carboxamide (929)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (2)Propanamido (5)Propanamido (5)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-3-Phenylpropanamide (8)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)
Amidines (1564)
Carbamimidoyl (16)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139951)
Amino-Carboxylate (2)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (157)Aminoethyl (157)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (403)Aminomethyl (403)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (8)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Chroman-Amine (1)Diamino (90)Diamino (90)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (490)Dimethylamino (490)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (3)Hydroxyamino (3)Imidazol-Amine (1)Methoxyethanamine (1)Methoxyethanamine (1)Methoxyimino (2)Methylamino (241)Methylamino (241)Methylcarbamoyl (19)Methylcarbamoyl (19)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrol-Amine (1)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2-Diphenylethan-1-Amine (15)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (6)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (19)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (289)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (4)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (29)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Methyl L-Phenylalaninate (20)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (17)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1,2-Diphenylethan-1-Amine (7)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)
Anhydrides (659)
Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (187653)
Acetylbenzonitrile (3)Aminobenzyl (7)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1061)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (132)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (176)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (33)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (17)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (10)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (17)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (39)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (28)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (13)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (17)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)
Azides (42)
Azoes (112)
(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (19035)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (13)Acetylphenyl (13)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (239)Anisole (4)Anthracenes (142)Benzaldehyde (1601)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1393)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (989)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (44)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (3)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (345)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (403)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (189)Dihydrobenzo (189)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (257)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (32)Diphenylamino (27)Diphenylaniline (9)Diphenylethane (19)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (7)Diphenylethyl (7)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (204)Diphenylphosphine (204)Diphenylpropane (22)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (46)Ethoxyphenyl (46)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (338)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (18)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (461)Hydroxyphenyl (461)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (6)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (41)Isopropoxyphenyl (41)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1749)Methoxybenzene (1749)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (116)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (56)Methoxynaphthalene (56)Methoxyphenethyl (1)Methoxyphenethyl (1)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (81)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (7)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (529)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (465)Naphthalene (465)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (727)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (2)Phenylacetyl (2)Phenylacrylamide (3)Phenylalaninol (4)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (12)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (4)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (169)Phenylene (169)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (14)Phenylethane (14)Phenylethanol (10)Phenylethanone (20)Phenylethoxy (2)Phenylethyl (70)Phenylethyl (70)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethanone (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (15)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (9)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (239)Terphenyl (239)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (418)Tolyl (418)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (19)Tolyloxy (19)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (20)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (56)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-4-Benzyloxazolidin-2-One (5)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (7)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (7)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (19)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (5)3-Phenylazetidine (5)3-Phenyloxazolidin-2-One (4)3-Phenylpiperidine (6)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (8)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (5)Ethylbenzene (198)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (251)Triphenyl Phosphate (6)
Benzyl Bromides (1065)
1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (646)
Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52859)
Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (36)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromocyclopropanecarboxylate (1)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (760)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (698)Dibromo (698)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Dibromopropoxy (1)Dibromopropoxy (1)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (21)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (4)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (11)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7957)
Carboxylic Acid Salts (668)
Carboxylic Acids (58191)
Aceticacid (1249)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (11)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (75)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (124)Chlorobenzoic (35)Chloromandelic Acid (3)Chromene-Carboxylic Acid (1)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (8)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Indolecarboxylic (2)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (11)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (175)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (108)Methylpentanoic (108)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (57)Oxobutanoic (57)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (18)Pentanedioic (18)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (47)Phenylpentanoic (11)Phenylpropanoic (45)Propanoic (1167)Propenoic (6)Pyridazinecarboxylic (1)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (27)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (32)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (19)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3,3-Diphenylpropanoic Acid (4)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (39)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3519)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (31)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (11)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (21)
Chlorides (77875)
Chloroacetamide (17)Chloroacetyl (12)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (479)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (39)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (10)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (7)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (9)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32566)
(Difluoromethyl)Benzene (63)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (51168)
Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (53)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Amino-Carboxylate (2)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (10)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromocyclopropanecarboxylate (1)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1675)Butoxycarbonyl (1675)Carbamate (1539)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (6)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (56)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (70)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Indoline-Carboxylate (1)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (169)Methoxycarbonyl (169)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (42)Propanoate (296)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Thiophenecarboxylate (2)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (16)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (70)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (36)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl L-Phenylalaninate (20)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (5)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (12)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82526)
Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (19)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (13)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (223)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Dimethoxybenzene (235)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (8)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (126)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (17)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (19)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (197)2-Methoxypyrazine (45)2-Methoxypyridine (436)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (6)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (52)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (285)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (85)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (70)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (17)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (19)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)
Fluorinated Building Blocks (99063)
Dichlorofluorobenzene (23)Difluoro (901)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (27)Difluoroethyl (27)Difluoromethoxy (200)Difluoromethoxy (200)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (271)Trifluoro (271)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (63)Trifluoromethanesulfonamide (4)Trifluoromethanesulfonyl (22)Trifluoromethoxy (480)Trifluoromethoxy (480)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (51)1,2,3,4-Tetrafluorobenzene (73)1,2,3-Trifluorobenzene (156)1,2,4-Trifluorobenzene (210)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (658)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (361)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (255)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (24)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-(2-Fluorophenyl)Propanoic Acid (16)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-((Tert-Butoxycarbonyl)Amino)-4-(2-Fluorophenyl)Butanoic Acid (9)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (289)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (180)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (51)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9967)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (776)
Biguanide (2)Biguanide (2)
Hydrazides (3103)
Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6277)
Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (2)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2042)
1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (623)
N-Hydroxybenzamide (8)
Iodides (14083)
Diiodo (19)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (3)1,3-Diiodobenzene (59)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (77)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (16)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (63)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (237)
Isocyanate (4)Isocyanate (4)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (69)
Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (40074)
Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1793)Dioxobutanoate (2)Enone (21)Ethanone (1026)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (48)Tetraone (48)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (10)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (33)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (11)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (5)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (14)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)4-Phenylpyrrolidin-2-One (7)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (10)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1120)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (7)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (11)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28529)
Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (434)Cyanide (434)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (64)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1312)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)
Nitroes (23714)
Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2309)
Oximes (561)
Phenols (1786)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (98)Dihydroxystyryl (4)Diiodophenol (7)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (73)1-(3-Hydroxyphenyl)Ethan-1-One (19)1-Hydroxyanthracene-9,10-Dione (11)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (21)2,6-Dichlorophenol (16)2,6-Difluorophenol (24)2,6-Diiodophenol (16)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (7)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (63)2-Isopropylphenol (28)2-Methoxyphenol (197)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (180)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (147)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (131)Resorcinol (146)
Phosphoruses (827)
Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)
Polycyclic Aromatic Hydrocarbons (6)
Protective Groups (23)
Saturated Aliphatic Fused Rings (2)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (2)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10218)
Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (54)Methanesulfonamide (54)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (4)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10123)
Methylthio (432)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1160)
4-Methylbenzenesulfonate (9)
Sulfones (3927)
(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (51)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1261)
Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (144)Propanesulfonic Acid (2)Trifluoromethanesulfonic (4)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4029)
Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (333)
(Methylsulfinyl)Benzene (7)
Thioesters (625)
Thiols (468)
Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3045)
Thioureas (1128)
Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28951)
Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (21)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1336)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (126)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (11)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (52)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1841)
Other Function Groups (5)
Organometallic Reagents
Organoborons (34729)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (31)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (22)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1286)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (73)
Organotins (5)
Other Organometallic Reagents (1)
Specialty Synthesis
Ionic Liquids (738)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (25506)
Phase Transfer Catalysts (29)
Other Synthetic Reagents (106)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (77)
Liquid Crystal (LC) Materials (413)
Molecular Conductors (80)
Organic Field-Effect Transistors (OFETs) (86)
Organic Light-Emitting Diode (OLED) Materials (22)
4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)
Photoresist Materials (249)
Silane Coupling Agents (176)
Energy and Battery Materials
Battery Additives (75)
Battery Electrolytes Materials (16)
Battery Solvent Materials (24)
Electrode Active Materials (4)
Ionic Liquids (738)
Organic Redox Flow Battery Materials (26)
Solution & Vapor Deposition Precursors (31)
Material Building Blocks
Alkyl Chain Building Blocks (93)
Ligands for Functional Metal Complexes (198)
Liquid Crystal (LC) Building Blocks (558)
Phthalocyanine Building Blocks (71)
Small Molecule Semiconductor Building Blocks (1878)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1087)
Metal Organic Framework (MOF) Linkers (1693)
Metal Organic Frameworks (MOFs) (85)
Organic Framework Building Blocks (218)
Supramolecular Host Materials  (185)
Polymer Additives
Antioxidants (81)
Crosslinking Agents (75)
Flame Retardants (35)
Light Stabilizers (67)
Plasticizers (84)
Polymerization Catalysts (156)
Polymerization Initiators (141)
Polymerization Reagents (170)
Surfactants (340)
Other Additives (34)
Polymer Reagents
Dendrimer Materials (59)
Ion Exchange Resins (7)
Monomers (3050)
Photopolymer Monomers (180)
Polybenzoxazole and Polyimide Raw Materials (240)
Polymer Semiconductor Monomers (269)
Polymers (375)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (45)
Quantum Dots (QD) Capping Agents (178)
Quantum Dots (QD) Synthetic Reagents (13)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1029)
Dye-Sensitized Solar Cell (DSSC) Materials (130)
Dyes and Pigments (392)
Organic Non-Linear Optical (NLO) Materials (39)
Organic Phto-Voltaics (OPV) Materials (185)
Perovskite Solar Cell (PSC) Materials (278)
Visible Light Photoredox Catalysts (29)
Other Functional Materials
Aggregation-Induced Emission Materials (169)
Inorganic Compounds and Ceramic Materials (33)
Magnetic Materials (50)
Life Science
Inhibitors/Agonists
ADC (371)
ADC Linker (371)
Angiogenesis (1714)
ALK (86)Bcr-Abl (105)BTK (149)EGFR (403)FAK (56)FGFR (136)FLT3 (134)HER2 (31)HIF (112)JAK (245)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (271)
Anti-Infection (4763)
3CLpro (41)Antibacterial (2101)Antifungal (525)Antiparasitic (648)Antiprotozoal (2)Antiviral (48)Arenavirus (5)BVDV (3)CMV (30)Dengue Virus (36)EBV (14)Enterovirus (33)FCoV (3)Filovirus (14)Flavivirus (64)GraR (1)HBV (151)HCV (222)HHV (1)HIV (447)HIV Integrase (39)HIV Protease (68)HPV (10)HRV (3)HSV (75)Influenza Virus (251)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (28)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (4)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (298)SQLE (5)TMV (12)Viral MTase (3)Virus Protease (62)VSV (1)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (647)
ADC Linker (371)ADC Toxins (123)Payload-Linker Conjugate (165)
Apoptosis (2443)
Apoptosis (2143)Apoptosis Inducer (1407)Bcl-2 (195)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (109)FKBP (15)GDNF Receptor (1)IAP (48)IDO (70)MDM2 (143)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (13)RIP Kinase (84)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (117)TNF-alpha (30)
Autophagy (745)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (730)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (27)TFEB (1)ULK (17)
Cell Cycle (4595)
Antifolate (31)APC (6)Aurora Kinase (87)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (336)HGF (1)HSF (4)HSP (161)IRE1 (27)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (305)MKLP (1)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1441)p21 (1)PAK (30)PDI (1)PKMYT1 (2)PLK (50)PPAR (193)PTEN (5)RAD51 (18)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (90)Separase (1)Sirtuin (129)SRPK (51)STK33 (2)TACC (3)Telomerase (21)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (728)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (14)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (305)MLCK (5)Mps1 (21)Myosin (25)PAK (30)ROCK (90)Spastin (1)
DNA Damage (3023)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (87)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (75)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (161)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1441)OGG (3)p97 (15)PARP (175)RAD51 (18)RAD52 (3)Telomerase (21)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (826)
5 Alpha Reductase (2)ACE (76)Adrenergic Receptor (184)Androgen Receptor (96)Aromatase (8)ERR (218)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (54)Progesterone Receptor (9)PTHR (1)Renin (18)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (7)TPO (4)TRHR (1)TSH Receptor (17)TTR (7)
Endoplasmic Reticulum Stress (567)
Antioxidant (33)IRE1 (27)JNK (79)PDI (1)PERK (35)ROS (398)
Epigenetics (2366)
AMPK (105)Aurora Kinase (87)DNA Methyltransferase (43)Epigenetic Reader Domain (396)FTO (15)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)JAK (245)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)SF3B1 (3)Sirtuin (129)TET (8)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (25)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3483)
5-HT Receptor (402)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (184)Amylin receptor (1)Angiotensin Receptor (72)Apelin Receptor (22)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (34)Cannabinoid Receptor (65)CaSR (23)CCR (89)CGRP Receptor (14)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (170)Endothelin Receptor (47)Epac (9)G protein (2)GHSR (21)GLP Receptor (25)Glucagon Receptor (50)GNRH Receptor (19)GPCR (203)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (10)Guanylate Cyclase (31)HCAR (2)Histamine Receptor (239)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (118)Melanocortin Receptor (31)mGluR (226)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (54)OXTR (10)P2Y Receptor (77)PACAP Receptor (3)PAFR (38)PAR (55)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)Sigma Receptor (53)SOS (7)SRPK (51)SSTR (28)SUCNR1 (4)TAAR (8)TSH Receptor (17)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (832)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (126)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2700)
AIM2 (5)AP-1 (14)Arginase (15)Calcineurin (8)CCR (89)CD19 (1)CD20 (2)CD22 (2)CD28 (2)CD28-B7 (1)CD3 (3)CD38 (10)CD47 (6)CD6 (1)CD73 (26)CD80 (1)cGAS (8)Complement System (45)COX (344)CRTH2 (9)CTLA-4 (2)CXCR (112)CYPA (1)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (239)HMGB (1)IFNAR (24)IL (172)IL Receptor (9)Immunology & Inflammation Related (75)IRAK (71)IRF3 (1)LAG-3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (71)MALT1 (24)MIF (18)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (186)NOT (1)Nrf2 (99)PD-1/PD-L1 (80)PG Synthase (30)PSMA (13)Pyroptosis (13)ROS (398)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (27)STING (98)TENT (1)Thrombopoietin Receptor (11)Tim3 (4)TLR (163)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (837)
EGFR (403)JAK (245)Pim (58)STAT (160)
MAPK/ERK Pathway (712)
AP-1 (14)ERK (166)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (99)MK2 (11)MLK (14)MNK (11)p38 MAPK (163)Raf (106)RSK (33)TAOK (1)
Membrane Transporter/Ion Channel (1711)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (41)BCRP (23)Calcium Channel (269)CFTR (61)Chloride Channel (30)CRAC Channel (14)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (188)GLUT (32)Glutamate transporter (21)Glycine transporter (23)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (15)Na+/K+ ATPase (16)Na/HCO3 cotransporter (1)NKCC (1)Oct (11)OCTN (1)Organic Anion Transporter (1)P-gp (53)P2X Receptor (79)Piezo (4)Potassium Channel (287)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (195)SV2 (2)TRP Channel (182)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3492)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (2)ACAT (38)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (49)AKR (15)ALDH (30)Aldose Reductase (54)Aminopeptidase (28)Antifolate (31)AO (1)ApoE (1)Arginase (15)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (121)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (98)Ceramidase (4)CETP (15)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (8)Factor Xa (45)Farnesyl Transferase (4)FAS (35)FBPase (4)Ferroptosis (109)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (71)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (26)Glucosidase (131)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (25)GSNOR (3)GST (16)Hexokinase (8)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (24)IDH (37)IDO (70)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (109)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (98)MPC (3)NAMPT (33)Neprilysin (20)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (261)PAI-1 (25)PARG (12)PDE (366)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (86)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (43)Thymidylate Synthase (24)Transferase (80)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3852)
5-HT Receptor (402)AAK1 (17)AChE (43)AChR (348)Adenosine Kinase (5)Adrenergic Receptor (184)AMPAR (54)Amylin receptor (1)Amyloid-β (172)Calcium Channel (269)CaMK (54)Cannabinoid Receptor (65)CGRP Receptor (14)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (16)DAT (21)Dopamine Receptor (170)Endorphin (1)Enkephalinase (3)FAAH (45)GABA Receptor (188)Glucosylceramide Synthase (13)GluR (208)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (239)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (195)Melanocortin Receptor (31)mGluR (226)MT Receptor (12)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (57)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (54)OX Receptor (50)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (112)SERT (27)Sigma Receptor (53)SMS (4)SSRIs (5)Substance P (2)TAAR (8)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (182)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (540)
IKK (74)MALT1 (24)NF-κB (419)Nrf2 (99)Pirin (3)RANKL (1)RANKL/RANK (3)RIP Kinase (84)TAK1 (3)
Notch Signaling Pathway (763)
ERK (166)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (90)TGF-beta/Smad (381)β-catenin (71)
PI3K/AKT/mTOR (1044)
Akt (207)AMPK (105)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (126)MELK (9)mTOR (187)PDK (22)PDK-1 (3)PI3K (340)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (33)
PPAR Signaling Pathway (2131)
ACS (3)Akt (207)AMPK (105)AQP (5)Bcl-6 (6)FABP (8)FATP (3)IL (172)LXR (27)MMP (179)NF-κB (419)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (193)RAR/RXR (86)RGS (6)ROS (398)SCD (18)SGK (15)Sirtuin (129)STAT (160)TNF-alpha (30)
Protease (697)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (24)Dipeptidase 1 (2)DP-IV (2)DPP1 (2)DPP2 (2)DPP4 (72)Glutaminase (25)MMP (179)NEP (4)PE (2)Proteasome (122)Ser/Thr Protease (164)SPP (1)Tyrosinase (100)
Protein Tyrosine Kinase/RTK (2741)
Ack1 (5)ALK (86)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (403)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (624)HER2 (31)IGF-1R (28)Insulin Receptor (26)ITK (18)JAK (245)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (271)
Pyroptosis (993)
Caspase (170)Cathepsin (98)IL (172)MyD88 (6)NF-κB (419)TLR (163)
Stem Cells (1527)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (166)Frizzled (2)Gli (6)GSK-3 (126)Hedgehog (32)JAK (245)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (90)sFRP-1 (1)Smo (36)SOD1 (2)STAT (160)TGF-beta/Smad (381)Wnt (104)YAP (28)β-catenin (71)
TGF-beta/Smad (458)
Bcr-Abl (105)PKC (157)ROCK (90)TGF-beta/Smad (381)
Toll-Like Receptor (TLR) (549)
CREB (5)IKK (74)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (163)TAK1 (3)TLR (163)
Ubiquitin (370)
DUB (83)E1/E2/E3 Enzyme (142)FBXO (2)NAE (8)p97 (15)Proteasome (122)SUMO (4)
Vitamin D Related/Nuclear Receptor (587)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (193)Progesterone Receptor (9)RAR/RXR (86)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (7)VD/VDR (47)
Wnt Signaling Pathway (2371)
AP-1 (14)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (126)JNK (79)MMP (179)NF-κB (419)NFAT (11)p300/CBP/PROTAC (2)PDE (366)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (90)ROR (67)Wnt (104)β-catenin (71)
Other Inhibitors/Agonists (3218)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (126)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (30)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (33)Antispasmodic Agent (3)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD20 (2)CD52 (1)CD73 (26)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (286)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1247)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (60)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (24)IgE (2)IMP1 (1)Importin β (1)Insecticide (27)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (5)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (15)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (7)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (248)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (4)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (61)VPS (3)XOR (1)α-amylase (15)Others (2611)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (62)
Amyloid-β/monoclonal antibody (2)CA Ⅸ/monoclonal antibody (1)CCR/monoclonal antibody (1)CD19/monoclonal antibody (1)CD20/monoclonal antibody (2)CD22/monoclonal antibody (1)CD25/monoclonal antibody (1)CD3/monoclonal antibody (1)CD38/monoclonal antibody (1)CD4/monoclonal antibody (1)CD40/monoclonal antibody (1)CD47/monoclonal antibody (1)CD52/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (1)CD73/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (2)Complement System/monoclonal antibody (1)CTLA-4/monoclonal antibody (1)EGFR/monoclonal antibody (2)HER2/monoclonal antibody (2)IFNAR/monoclonal antibody (1)IgE/monoclonal antibody (2)IGF-1R/monoclonal antibody (1)IL-13/monoclonal antibody (1)IL-17a/monoclonal antibody (1)IL-1β/monoclonal antibody (1)IL-23/monoclonal antibody (2)IL-4Ra/monoclonal antibody (1)IL-5/monoclonal antibody (1)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (3)Integrin/monoclonal antibody (1)KIR/monoclonal antibody (1)LAG-3/monoclonal antibody (1)PCSK9/monoclonal antibody (2)PD-1/PD-L1/monoclonal antibody (4)RANKL /monoclonal antibody (1)Sclerostin/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)TIGIT/monoclonal antibody (1)Tim3/monoclonal antibody (1)TNF Receptor/monoclonal antibody (3)TNF-alpha/monoclonal antibody (2)TROP2/monoclonal antibody (1)VEGFR/monoclonal antibody (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Skin Disease Models (1)
Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (133)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (62)Cell Culture Antibiotic (2)Insect Repellent (42)Plant Tissue Culture Antibiotic (2)Preservative and Disinfectant (20)
Structure (8762)
Amino Acid Derivative (3)Aminoglycoside (9)Ansamycin (2)Cephalosporin (7)Chloramphenicol (1)Imidazole (6042)Macrolide (8)Nucleoside (5)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (19)Sulfonamide (17)Tetracycline (6)β-Lactam (4)Other Antibiotics (35)Others (2611)
Biochemical Reagents
Amino Acids (799)
Amino Acid Amide (17)Biologically Modified Amino Acid (29)C-protective Amino Acid (194)N-protective Amino Acid (438)Non-protein Amino Acid (115)Protein Amino Acid (55)Side Chain Protected Amino Acid (25)
Biological Buffers (2643)
Good's Buffer (19)Other Buffers (13)Others (2611)
Cross-Linking Agents (33)
Amino-amino Crosslinker (7)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (18)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (2)Nonionic Surfactant (6)Sulfonated Betaine (3)
Lipids (219)
Aliphatic Acyl (210)Glycerol Lipid (7)Sphingolipid (2)
Polypeptides (39)
Dipeptide and Tripeptide (36)Oligopeptide (3)
Steroids (2675)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (3)Other Steroids (2)Others (2611)
Sugar and Derivatives (151)
Sugar (137)Sugar Alcohol (15)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2475)
Cathepsin (98)CXCR (112)Hedgehog (32)IL (172)IL Receptor (9)Integrin (134)MIF (18)MMP (179)NF-κB (419)NOS (186)Notch (26)PDGFR (127)PPAR (193)STAT (160)TGF-beta/Smad (381)VEGFR (271)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1825)
ALK (86)AP-1 (14)CAR (5)CCR (89)Complement System (45)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (188)GSK-3 (126)IFNAR (24)IRAK (71)JAK (245)LAG-3 (1)NLR (73)Nrf2 (99)PD-1/PD-L1 (80)STING (98)Syk (40)TLR (163)TNF-alpha (30)TNK (4)
Tumor Epigenetics and Gene Regulation (2861)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (43)DNA/RNA Synthesis (620)Epigenetic Reader Domain (396)HDAC (336)HIF (112)Histone Acetyltransferase (95)Histone Demethylase (147)Histone Methyltransferase (294)METTL3 (10)MicroRNA (16)PAD (24)PARP (175)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (129)TET (8)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2213)
Akt (207)Aurora Kinase (87)Bcl-2 (195)c-Met/HGFR (131)c-Myc (47)EGFR (403)ERK (166)HER2 (31)MEK (99)MLKL (4)mTOR (187)p53 (41)PI3K (340)PTEN (5)Raf (106)Ras (275)ROR (67)Telomerase (21)
Tumor Metabolism (1274)
ACC (22)ALDH (30)AMPK (105)Arginase (15)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (25)Hexokinase (8)IDH (37)IDO (70)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (261)PDHK (12)PHGDH (5)PKM2 (6)ROS (398)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1419)
Apoptosis Inducer (1407)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (292)
Additive and Auxiliary Reagent (130)Cell Assay Reagents (9)Cell Staining (3)Organoid Culture Additive (90)Stem Cell Induction (83)
Enzymology
Enzyme Inhibitors (206)
Acetaldehyde Dehydrogenase Inhibitor (1)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (7)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (47)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (20)Protease Inhibitor (20)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (2)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (63)
Cyclooxygenase (COX) (46)E3 Ubiquitin Ligase (2)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (4)
Peroxidase Substrate (2)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (61)
Apoptosis Dyes (6)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (12)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (2)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (4)Mitochondrial Dyes (5)NOS Dyes (6)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (18)ROS Dyes (27)
Fluorescence Labeling Reagents (2848)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (7)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (213)Others (2611)
Fluorescent Dyes (2797)
Acridine Dye (8)Blood Dyes (2)Cancer Analysis Dyes (8)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (7)Others (2611)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (21)
Buffer (21)
Nucleic Acid Electrophoresis (5)
Electrophoretic Buffer (3)Gelatin (2)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (76)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (3)Oplopanax (1)Panax (53)
Alismataceae (2)
Alisma (2)
Amaranthaceae (5)
Achyranthes (3)Celosia (1)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (15)
Aristolochia (11)Asarum (3)Holostylis (1)
Asclepiadaceae (19)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (4)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (25)Aster (2)Atractylodes (9)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (37)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (26)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (11)
Boswellia (3)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5433)
Alkaloids (149)Coumarins (21)Lignans (36)Phenols (1786)Phenylpropanane (54)Quinones (35)Natural Products-Other Structure (3377)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (11)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (2)Maytenus (1)Tripterygium (10)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (94)
Alliaria (1)Brassica (6)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (2)
Cornus (2)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (44)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (2)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (11)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (2)
Dipsacus (2)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (46)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (10)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (348)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (26)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (22)Glycyrrhiza (41)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (8)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pterolobium (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (9)
Ginkgo (9)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (129)
Ammi (2)Angelica (32)Bupleurum (13)Centella (4)Cnidium (9)Cuminum (1)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (7)
Illicium (7)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (140)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (5)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (22)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (3)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (78)
Aloe (4)Anemarrhena (9)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (3)Liriope (3)Ophiopogon (28)Paris (8)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (6)
Morella (6)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (1)
Ardisia (1)
Myrtaceae (27)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (3)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (33)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Solanum (6)Withania (1)
Nyssaceae (52)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (5)Vaccinium (38)
Oleaceae (37)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Olax (1)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (1)
Pittosporum (1)
Plantaginaceae (2)
Picrorhiza (1)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (14)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (2)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (45)
Aconitum (2)Anemone (6)Cimicifuga (9)Clematis (3)Coptis (7)Delphinium (2)Hydrastis (2)Pulsatilla (10)Semiaquilegia (1)Thalictrum (3)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (31)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (1)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (3)Sanguisorba (1)Sorbus (1)Spiraea (1)
Rubiaceae (69)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (11)Hedyotis (8)Knoxia (2)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (14)Uncaria (6)
Rutaceae (162)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (20)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (11)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (5)Penthorum (1)
Schisandraceae (18)
Kadsura (5)Schisandra (13)
Scrophulariaceae (33)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (12)Scrophularia (4)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (19)
Nardostachys (4)Patrinia (5)Valeriana (10)
Verbenaceae (39)
Callicarpa (10)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (79)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (33)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (61)
Cardiovascular System (20)Diabete (30)Digestive System (11)
Drug Analysis (663)
Drug Standard (208)Plant Standard (457)
Drug Delivery (560)
Cationic Lipids (119)Cholesterol (10)Fluorescent Lipids (1)Pegylated Lipids (11)Phospholipids (175)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (12)Medicinal Excipient (14)
Small Molecule Positive Drugs (2843)
Anti-allergy (5)Anti-inflammation (30)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (62)Depressurization (18)Diabete (30)Neurotransmitter (32)Reduce Blood Lipid (6)Other Compounds (66)Others (2611)
PROTACS
E3 Ligand-Linker Conjugate (166)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (49)
E3 Ligands (72)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (2)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2591)
ApoE (1)ARF (2)Calcium Channel (269)Ceramidase (4)FGF (2)HBV (151)HIV (447)HSP (161)HSV (75)Integrin (134)LPL Receptor (118)MicroRNA (16)mTOR (187)Neurotransmitter (32)p53 (41)PD-1/PD-L1 (80)Phospholipase (108)Ras (275)STAT (160)TGF-beta/Smad (381)
Parkinson'S Disease and Alzheimer'S Disease (5789)
Akt (207)AMPAR (54)Apoptosis (2143)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (170)Dopamine β-hydroxylase (8)ERK (166)Glucagon Receptor (50)GPCR (203)GSK-3 (126)IL (172)JAK (245)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (419)Notch (26)p53 (41)PI3K (340)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (90)ROS (398)Secretase (112)STAT (160)STING (98)Tau Protein (28)TLR (163)TNF (22)Tyrosinase (100)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (71)
Zoology and Botany
Pesticide Composition (103)
Fungicide (60)Herbicide (17)Insecticide (27)
Home Cart Sign in  
/
Chemistry
/
Organic Building Blocks
/
Chlorides
/
Chloroethyl
/
Cyclophosphamide hydrate
/
Chemistry
Pharmaceutical Research Animal Modeling Reagents
/
Organic Building Blocks
Animal Modeling Agents Small Molecule Positive Drugs Urinary System Disease Models Immune and Inflammatory Disease Models
/
Chlorides
Inflammation Model Nervous System Model Other Modeling Agents Anti-rheumatoid Arthritis Other Urinary System Disease Model Myocarditis Model Cystitis Model
/
Chloroethyl
/
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 6055-19-2 Chemical Structure| 6055-19-2

Structure of Cyclophosphamide hydrate
CAS No.: 6055-19-2

Chemical Structure| 6055-19-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Cyclophosphamide is a nitrogen mustard alkylating agent used in the treatment of cancers and autoimmune disorders.

Synonyms: Cyclophosphamide monohydrate; Cyclophosphamide (hydrate); NSC-26271 Monohydrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

Quality Control of Cyclophosphamide hydrate Purity: 98% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Cyclophosphamide hydrate

CAS No. :6055-19-2
Formula : C7H17Cl2N2O3P
M.W : 279.10
SMILES Code : ClCCN(P1(OCCCN1)=O)CCCl.[H]O[H]
Synonyms :
Cyclophosphamide monohydrate; Cyclophosphamide (hydrate); NSC-26271 Monohydrate
MDL No. :MFCD00149395
InChI Key :PWOQRKCAHTVFLB-UHFFFAOYSA-N
Pubchem ID :22420

Safety of Cyclophosphamide hydrate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301-H315-H362-H340-H350
Precautionary Statements:P263-P260-P201-P280-P308+P313-P301+P310+P330
Class:6.1
UN#:3464
Packing Group:Ⅲ

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03218852 IgA Nephropathy Phase 4 Active, not recruiting December 2021 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT01670500 Breast Cancer Phase 2 Recruiting October 2021 United States, Colorado ... More >> University of Colorado Cancer Center Recruiting Aurora, Colorado, United States, 80045 Contact: Virginia Borges, MD    303-724-0186    virginia.borges@ucdenver.edu    United States, Connecticut Smilow Cancer Hospital Care Center at Derby Recruiting Derby, Connecticut, United States, 06418 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    Smilow Cancer Hospital Care Center at Guilford Recruiting Guilford, Connecticut, United States, 06437 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    St. Francis Hospital and Medical Center Recruiting Hartford, Connecticut, United States, 06105 Contact: Erin Hofstatter, MD       erin.hofstatter@yale.edu    Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06520 Contact: Erin Hofstatter, MD    203-737-1600    erin.hofstatter@yale.edu    United States, District of Columbia Georgetown University Medical Center Recruiting Washington, District of Columbia, United States, 20007 Contact: Claudine Isaacs, MD       isaacsc@georgetown.edu    Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016-2698 Contact: Antonio Wolff, MD       awolff@jhmi.edu    United States, Maryland Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Antonio Wolff, MD       awolff@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Steven Isakoff, MD, PhD    617-726-4920    sisakoff@partners.org    Principal Investigator: Steven Isakoff, MD, PhD          Dana-Farber Cancer Institute at Faulkner Hospital Withdrawn Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Nadine Tung, MD    617-667-7081    ntung@bidmc.harvard.edu    Principal Investigator: Nadine Tung, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Judy Garber, MD, MPH    617-632-2282    jegarber@partners.org    Principal Investigator: Judy Garber, MD, MPH          United States, New Hampshire New Hampshire Oncology-Hematology Withdrawn Hooksett, New Hampshire, United States, 03106 United States, New Jersey Rutgers Cancer Institute of New Jersey Active, not recruiting New Brunswick, New Jersey, United States, 08901 United States, New York Memorial Sloan-Kettering Cancer Center Withdrawn New York, New York, United States, 10065 United States, North Carolina Duke University Recruiting Durham, North Carolina, United States, 27708 Contact: P. Kelly Marcom       kelly.marcom@dm.duke.edu    United States, Rhode Island Women and Infants Hospital Recruiting Providence, Rhode Island, United States, 02905 Contact: Robert Legare, MD    401-453-7540    rlegare@wihri.org    United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Banu Arun, MD    713-792-2817    barun@mdanderson.org    MD Anderson in Katy Withdrawn Houston, Texas, United States, 77094 MD Anderson in the Bay Area Withdrawn Nassau Bay, Texas, United States, 77058 MD Anderson - Sugar Land Withdrawn Sugar Land, Texas, United States, 77478 MD Anderson - The Woodlands Withdrawn The Woodlands, Texas, United States, 77384 Less <<
NCT00296205 Multiple Sclerosis Phase 2 Withdrawn(I am changing locati... More >>ons to Johns Hopkins Medical Center) Less << February 2006 United States, New York ... More >> Stony Brook University Hospital Stony Brook, New York, United States, 11794-8174 Less <<
NCT01301040 Breast Cancer Phase 2 Terminated(Slow recruitment) March 2016 Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT01681563 Chronic Lymphocytic Leukemia Phase 2 Completed - Italy ... More >> Azienda Ospedaliera San Gerardo di Monza U.O. Ematologia Monza, MB, Italy, 20052 IRCCS Istituto clinico Humanitas di Rozzano Dipartimento di Ematologia Rozzano, Milano, Italy, 20089 Azienda Ospedaliera Ospedale Civile di Legnano U.O. Medicina Interna Legnano, MI, Italy, 20025 A.O. Papa Giovanni XXIII U.S.C. Ematologia Bergamo, Italy, 24128 Presidi Ospedalieri Spedali Civili di Brescia Divisione di Ematologia Brescia, Italy, 25125 Ospedale Valduce S.C. Medicina Interna Sez. Ematologia Como, Italy, 22100 Ospedale Maggiore Policlinico Università di Milano Istituto di Ematologia Milano, Italy, 20122 IRCCS Fondazione Centro S. Raffaele del Monte Tabor Università Vita-Salute Dipartimento di Medicina Interna Milano, Italy, 20132 Ospedale Cà Granda - Niguarda S.C: Ematologia Milano, Italy, 20162 Azienda ospedaliera-universitaria Maggiore della Carità SCDU Ematologia Novara, Italy, 28100 IRCCS Policlinico San Matteo Pavia Istituto di Ematologia Pavia, Italy, 27100 A.O.U. Città della Salute e della Scienza Ospedale Molinette Divisione di Ematologia Torino, Italy, 10126 Less <<
NCT01306032 Ovarian Cancer ... More >> Primary Peritoneal Cancer Serous Carcinoma Cancer Triple-Negative Breast Cancer Fallopian Tube Cancer Less << Phase 2 Completed - United States, California ... More >> University of California, Davis Davis, California, United States, 95616 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Minnesota Mayo Clinic, Rochester Rochester, Minnesota, United States, 55905 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4096 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00866905 Breast Cancer Phase 2 Completed - United States, Florida ... More >> Aventura Medical Center Aventura, Florida, United States, 33180 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas South Texas Oncology and Hematology San Antonio, Texas, United States, 78258 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT01306032 - Completed - -
NCT00866905 - Completed - -
NCT01005979 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic Less << Phase 1 Terminated(Slow Accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT01339988 Acute Leukemias ... More >> Chronic Leukemias Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia Less << Phase 4 Not yet recruiting June 2019 -
NCT01445522 Neoplasms Lym... More >>phoma Less << Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03417154 Acute Myeloid Leukemia ... More >> Higher Risk Myelodysplastic Syndrome Less << Phase 2 Recruiting February 2023 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org Less <<
NCT01093183 - Terminated(study sponsors with... More >>drew support for the study drug.) Less << - -
NCT01001780 Active Chronic Graft Versus Ho... More >>st Disease Less << Phase 2 Withdrawn(Study stopped early ... More >>due to poor accrual.) Less << - United States, New York ... More >> University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00939549 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 2 Withdrawn(Study revised to ret... More >>rospective chart review) Less << - United States, Maryland ... More >> Johns Hopkins Hospital Multiple Sclerosis Center Baltimore, Maryland, United States, 21287 Less <<
NCT00976300 Systemic Lupus Erythematosus ... More >> Lupus Nephritis Less << Phase 2 Completed - Czech Republic ... More >> Department of Rheumatology, Faculty of Medicine, Charles University in Prague Hradec Kralove, Czech Republic Department of Rheumatology, Faculty of Medicine, Palacky University Olomouc, Czech Republic Department of Nephrology, General Teaching Hospital and First faculty of Medicine, Charles University in Prague Prague, Czech Republic, 12800 Institute of Rheumatology Prague, Czech Republic, 12850 Less <<
NCT01093183 Adenocarcinoma of the Prostate... More >> Hormone-resistant Prostate Cancer Recurrent Prostate Cancer Less << Phase 1 Phase 2 Terminated(study sponsors with... More >>drew support for the study drug.) Less << - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT01236456 Chronic Inflammatory Demyelina... More >>ting Polyneuropathy Less << Phase 2 Withdrawn(I am relocating to J... More >>ohns Hopkins Medical Center) Less << November 2006 -
NCT02969980 Myelodysplastic Syndromes Phase 2 Recruiting November 2020 Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Recruiting Seoul, Korea, Republic of, 05505 Contact: Je-Hwan Lee, M.D. Prof.    82-2-3010-3218    jhlee3@amc.seoul.kr    Contact: Eun-Ji Choi, M.D. Fellow    82-2-3010-0458    imeunjeee@gmail.com Less <<
NCT00258206 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00882323 Aplastic Anemia Phase 2 Unknown October 2012 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D    82 2 2072 3625    hsahn@snu.ac.kr Less <<
NCT00258206 - Completed - -
NCT02790580 Breast Cancer Phase 2 Recruiting November 2020 Singapore ... More >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119228 Contact: Soo Chin Lee    (65) 6779 5555    soo_chin_lee@nuhs.edu.sg Less <<
NCT02206503 Multiple Myeloma Phase 2 Completed - Italy ... More >> Policlinico Umberto I Rome, Italy, 00161 Less <<
NCT01976182 Large Granular Lymphocytes Leu... More >>kemia Less << Phase 2 Recruiting November 2019 -
NCT02512926 Relapsed Solid Tumors ... More >> Refractory Solid Tumors Leukemias Less << Phase 1 Recruiting September 2018 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Lauree Deublein    602-933-5004    ldeublein@phoenixchildrens.com    Contact: Sam Chimienti    602-933-0188    schimienti@phoenixchildrens.com    Principal Investigator: Jessica Boklan, MD          United States, Arkansas Arkansas Children's Hospital Recruiting Little Rock, Arkansas, United States, 72202 Contact: Kathleen Neville, MD, MS    501-364-4405    KANeville@uams.edu    Principal Investigator: Kathleen Neville, MD, MS          United States, California Stanford University School of Medicine and Stanford Cancer Institute Recruiting Palo Alto, California, United States, 94304 Contact: Norman Lacayo, MD    650-723-5533    lacayon@stanford.edu    Principal Investigator: Norman Lacayo, MD          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Steven DuBois, MD    617-632-5460    steven_dubois@dfci.harvard.edu    Principal Investigator: Steven DuBois, MD          United States, New York Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Tanya Trippett, MD    212-639-8267    trippet1@mskcc.org    Principal Investigator: Tanya Trippett, MD          United States, Pennsylvania Penn State Hershey Children's Hospital Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Valerie Brown, MD, PhD    717-531-6012    vbrown1@hmc.psu.edu    Principal Investigator: Valerie Brown, MD, PhD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Anne Franklin, MD    713-792-3497    afranklin@mdanderson.org    Principal Investigator: Anne Franklin, MD          University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Anne-Marie Langevin, MD    210-567-7460    langevin@uthscsa.edu    Principal Investigator: Anne-Marie Langevin, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3B 6A8 Contact: Aru Narendran, MD, PhD    403-210-6418    a.narendran@ucalgary.ca    Principal Investigator: Aru Narendran, MD, PhD Less <<
NCT01696877 - Active, not recruiting - -
NCT01696877 Prostate Cancer Adenocarcinoma... More >> in Situ Less << Phase 1 Phase 2 Active, not recruiting December 2019 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT02360111 - Terminated(Lack of accrual) - -
NCT01955434 - Completed - -
NCT02650635 Colorectal Adenocarcinoma ... More >> Metastatic Pancreatic Adenocarcinoma Recurrent Breast Carcinoma Recurrent Colorectal Carcinoma Recurrent Melanoma of the Skin Recurrent Non-Small Cell Lung Carcinoma Recurrent Pancreatic Carcinoma Recurrent Renal Cell Carcinoma Solid Neoplasm Stage IV Breast Cancer Stage IV Non-Small Cell Lung Cancer Stage IV Renal Cell Cancer Stage IV Skin Melanoma Stage IVA Colorectal Cancer Stage IVA Pancreatic Cancer Stage IVB Colorectal Cancer Stage IVB Pancreatic Cancer Less << Phase 1 Terminated(permanently closed ... More >>per sponsor's request) Less << - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 Less <<
NCT02360111 Leukemia Myel... More >>odysplastic Syndrome Non-Hodgkin's Lymphoma Less << Not Applicable Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02805725 Soft-tissue Sarcomas Phase 1 Phase 2 Recruiting December 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD          Principal Investigator: Antoine ITALIANO, MD,PhD          Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY          Principal Investigator: Jean-Yves BLAY, MD,PhD          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Sarah DUMONT, MD          Principal Investigator: Sarah DUMONT, MD Less <<
NCT01435499 Melanoma Phase 1 Completed - United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT01346787 Multiple Myeloma Phase 2 Active, not recruiting October 2019 Italy ... More >> IRCCS CROB UOC di Ematologia e trapianto cellule staminali Ospedale Oncologico Regionale Rionero In Vulture, PZ, Italy, 85100 azienda ospedaliero-universitaria umberto I Clinica di Ematologia Ancona, Italy, 60020 Policlinico S. Orsola Istituto di Ematologia e Oncologia Medica Bologna, Italy, 40138 Ospedale Ferrarotto_Reparto di Ematologia Catania, Italy, 95124 Az.Osp. Di Careggi_Dh ematologia Firenze, Italy, 50134 Istituto Nazionale per lo Studio e la Cura dei Tumori_UO Ematologia_Trapianto di Midollo Osseo Allogenico Milano, Italy, 20133 Divisione di Ematologia Dipartimento di Medicina Clinica e Sperimentale Università Amedeo Avogadro Novara, Italy, 28100 Cattedra di ematologia Università La Sapienza Roma, Italy Divisione di ematologia ospedale s.eugenio Roma, Italy S.C.di Oncoematologia, Azienda Ospedaliera S. Maria di Terni Terni, Italy Az. Osp. San Giovanni Battista - Molinette_Ematologia 2 Torino, Italy, 10126 Division of Hematology, A.O.U. San Giovanni Battista Torino, Italy, 10126 Netherlands Erasmus MC Rotterdam, Netherlands Less <<
NCT01758120 IgA Nephropathy Phase 4 Active, not recruiting December 2019 China, Guangdong ... More >> Guangdong General Hospital Guangzhou, Guangdong, China, 510080 Less <<
NCT02441270 Radiotherapy ... More >>Immunology Less << Early Phase 1 Unknown - Belgium ... More >> University Hospital - Radiotherapy Department Recruiting Ghent, Belgium, 9000 Contact: Liv Veldeman, MD, PhD       liv.veldeman@uzgent.be    Principal Investigator: Liv Veldeman, MD, PhD          Sub-Investigator: Katrien De Wolf, MD Less <<
NCT01955434 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT03295383 Severe Forms of Mucous Membran... More >>e Pemphigoid Less << Phase 3 Not yet recruiting November 2, 2023 France ... More >> CHU Amiens Not yet recruiting Amiens, France Contact: Catherine Lok          Principal Investigator: Catherine Lok          CHU Angers Angers, France CH Argenteuil Not yet recruiting Argenteuil, France Contact: Emmanuel Mahe          Principal Investigator: Emmanuel Mahe          CHU Bordeaux Not yet recruiting Bordeaux, France Contact: Marie Beylot Barry          Principal Investigator: Marie Beylot Barry          Brest University Hospital Brest, France CHU Caen Not yet recruiting Caen, France Contact: Laurence Verneuil          Principal Investigator: Laurence Verneuil          CHU Clermont Ferrand Clermont Ferrand, France CHU Dijon Not yet recruiting Dijon, France Contact: Pierre Vabres          Principal Investigator: Pierre Vabres          CH Le Mans Not yet recruiting Le Mans, France Contact: Hervé Maillard          Principal Investigator: Hervé Maillard          CHU Lille Not yet recruiting Lille, France Contact: Emmanuel Delaporte          Principal Investigator: Emmanuel Delaporte          CHU de Limoges Not yet recruiting Limoges, France Contact: Christophe Bedane          Principal Investigator: Christophe Bedane          HCL Not yet recruiting Lyon, France Contact: Sébastien Debarbieux          Principal Investigator: Sébastien Debarbieux          Principal Investigator: Denis Jullien          APHM La Timone Not yet recruiting Marseille, France Contact: Marie-Aleth Richard          Principal Investigator: Marie-Aleth Richard          CHU Montpellier Montpellier, France CHU Nantes Not yet recruiting Nantes, France Contact: Gaelle Querreux          Principal Investigator: Gaelle Querreux          CHU Nice Not yet recruiting Nice, France Contact: Jean-Philippe Lacour          Principal Investigator: Jean-Philippe Lacour          APHP Avicennes Not yet recruiting Paris, France Contact: Catherine Prost          Principal Investigator: Catherine Prost          APHP Bichat Not yet recruiting Paris, France Contact: Catherine Picard-Dahan          Principal Investigator: Catherine Picard-Dahan          APHP Cochin Not yet recruiting Paris, France Contact: Nicolas Dupin          Principal Investigator: Nicolas Dupin          APHP Henri Mondor Not yet recruiting Paris, France Contact: Oro Saskia          Principal Investigator: Oro Saskia          APHP Pitié Salpétrière Not yet recruiting Paris, France Contact: Stéphane Barete          Principal Investigator: Stéphane Barete          APHP Saint-Louis Not yet recruiting Paris, France Contact: Jean-David Bouaziz          Principal Investigator: Jean-David Bouaziz          CH Quimper Not yet recruiting Quimper, France Contact: Patrice Plantin          Principal Investigator: Patrice Plantin          CHU de Reims Not yet recruiting Reims, France Contact: Bernard Philippe          Principal Investigator: Bernard Philippe          CHU Rennes Not yet recruiting Rennes, France Contact: Alain Dupuy          Principal Investigator: Alain Dupuy          CHU saint-Etienne Not yet recruiting Saint-Étienne, France Contact: Bruno Labeille          Principal Investigator: Bruno Labeille          CHU Tours Not yet recruiting Tours, France Contact: Laurent Machet          Principal Investigator: Laurent Machet Less <<
NCT00201708 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01253460 Leukemia Phase 2 Terminated(Accrual not met) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01238770 Epithelial Ovarian Cancer Phase 1 Phase 2 Completed - Germany ... More >> Marienkrankenhaus Hamburg Hamburg, Germany, 22087 Universitäts-Frauenklinik Heidelberg, Germany, 69120 Klinikum Konstanz Gynäkologie und Geburtshilfe Konstanz, Germany, 78464 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Klinik und Poliklinik für Geburtshilfe und Frauenheilkunde Mainz, Germany, 55131 Universitätsfrauenklinik Tübingen Klinik für Gynäkologie und Geburtshilfe Tübingen, Germany, 72076 Less <<
NCT01229605 Breast Cancer Phase 2 Withdrawn(Study was not a good... More >> fit for the patient population seen at this hospital.) Less << - -
NCT00999986 Genital Wart Phase 3 Completed - China, Hubei ... More >> Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT03187756 Hematopoietic Malignancies Phase 2 Recruiting December 2018 United States, New York ... More >> New York University School of Medicine Recruiting New York, New York, United States, 10016 Contact: Ankeeta Joshi    212-263-4431    ankeeta.joshi@nyumc.org    Principal Investigator: David Kaminetzky, MD Less <<
NCT00334646 Nausea and Vomiting, Chemother... More >>apy-Induced Less << Phase 1 Terminated(compound terminated... More >>) Less << - United States, Delaware ... More >> GSK Investigational Site Newark, Delaware, United States, 19713 United States, New Mexico GSK Investigational Site Albuquerque, New Mexico, United States, 87131 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 New Zealand GSK Investigational Site Christchurch, New Zealand, 8011 Sweden GSK Investigational Site Lund, Sweden, SE-221 85 Less <<
NCT01885013 Human Epidermal Growth Factor ... More >>2 Negative Carcinoma of Breast Less << Phase 2 Completed - Italy ... More >> P.O. M. Bufalini Cesena, FC, Italy UO Oncologia Medica IRCCS IRST Meldola (FC), FC, Italy, 47014 Ospedale Civile degli Infermi Faenza, RA, Italy Ospedale Umberto I Lugo, RA, Italy Ospedale Civile Santa Maria delle Croci Ravenna, RA, Italy ULSS n.8 Asolo Ospedale di Castelfranco Asolo, Italy Centro di Riferimento Oncologico CRO Aviano, Italy Ospedale S.Martino Belluno, Italy Azienda Ospedaliera "Antonio Cardarelli" Campobasso, Italy P.O. "SS. Annunziata" Chieti, Italy Presidio Ospedaliero E. Profili Fabriano, Italy E.O. Galliera Genova, Italy Ospedale di Guastalla Guastalla, Italy Azienda per i Servizi Sanitari n.5 "Bassa Friulana" Latisana, Italy Presidio Ospedaliero "Vito Fazzi" Lecce, Italy ULSS n.13 di Mirano Mirano, Italy Arcispedale S. Maria Nuova Modena, Italy Azienda Ospedaliera S. Salvatore di Pesaro Pesaro, Italy Ospedale S. Spirito Pescara, Italy Ospedale Civile di Piacenza Piacenza, Italy Azienda Ospedaliera Santa Maria degli Angeli Pordenone, Italy Arcispedale S. Maria Nuova Reggio Emilia, Italy Ospedale Civile degli Infermi Rimini, Italy IRCCS Centro di riferimento Oncologico di Basilicata di Rionero in Vulture Rionero in Vulture, Italy Ospedale Nuovo Regina Margherita Roma, Italy Less <<
NCT03099356 Metastatic Thyroid Cancer Phase 2 Recruiting May 12, 2023 United States, Michigan ... More >> University of Michigan Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Francis P Worden, MD    734-936-0453    fworden@umich.edu    Contact: Cancer AnswerLine    1-800-865-1125    canceranswerline@umich.edu Less <<
NCT00381173 Breast Cancer ... More >> Ovarian Cancer Prostate Cancer Colon Cancer Renal Cancer Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00852709 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Myeloproliferative Disorders Acute Lymphocytic Leukemia Acute Promyelocytic Leukemia Acute Leukemia Chronic Myelogenous Leukemia Myelofibrosis Chronic Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia Less << Phase 1 Terminated(Lack of accrual) - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016-7710 United States, Colorado University of Colorado Health Sciences Center and The Children's Hospital Aurora, Colorado, United States, 80045 United States, Florida Pediatrix Hematology/Oncology University of Florida College of Medicine Gainesville, Florida, United States, 32610-0296 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States, 37232-6310 United States, Texas M.D. Anderson Comprehensive Cancer Center Houston, Texas, United States, 77030 Canada, Alberta Southern Alberta Children's Cancer Program Calgary, Alberta, Canada, T3B6A8 Less <<
NCT00743509 - Completed - -
NCT01492673 Neuroblastoma ... More >> Sarcoma Less << Phase 2 Completed - United States, Arizona ... More >> Phoenix Children'S Hospital Phoenix, Arizona, United States, 85016 United States, Colorado University of Colorado Health Sciences Center and The Children's Hospital Denver, Colorado, United States, 80045 United States, Florida MD Anderson Cancer Center Orlando at Arnold Palmer Hospital for Children Orlando, Florida, United States, 32806 United States, Missouri Children's Mercy Hospital & Clinics Kansas City, Missouri, United States, 64108 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania Pennsylvania State University College of Medicine Hershey, Pennsylvania, United States, 17110 Canada, Alberta Alberta Children'S Hospital Calgary, Alberta, Canada, T2N 1N4 Less <<
NCT01543152 HIV Phase 1 Phase 2 Completed - United States, California ... More >> UCLA Care Center Los Angeles, California, United States, 90035 Quest Clinical Research San Francisco, California, United States, 94115 United States, Connecticut Circle CARE Center, LLC Norwalk, Connecticut, United States, 06850 United States, Florida Orlando Immunology Center Orlando, Florida, United States, 32803 United States, Missouri Central West Clinical Research, Inc. Saint Louis, Missouri, United States, 63108 United States, New Mexico Southwest CARE Center Santa Fe, New Mexico, United States, 87505 United States, New York Ricky K Hsu, MD, PC New York, New York, United States, 10011 United States, Texas Central Texas Clinical Research Austin, Texas, United States, 78705 North Texas Infectious Diseases Consultants Dallas, Texas, United States, 75246 Gordon Crofoot, MD, PA Houston, Texas, United States, 77098 Puerto Rico Clinical Research Puerto Rico San Juan, Puerto Rico, 00909 Less <<
NCT02755844 Recurrent Endometrial Cancer Phase 1 Phase 2 Not yet recruiting November 2019 France ... More >> Centre Hospitalier Lyon Sud Not yet recruiting Pierre Benite, France, 69495 Contact: Benoit YOU          Contact: Marine DUPUIS          Principal Investigator: Benoit YOU, MD Less <<
NCT00954135 Breast Cancer Phase 2 Unknown December 2010 Italy ... More >> Breast Unit Azienda Ospedaliera Istituti Ospitalieri Cremona, Italy Azienda Ospedaliera S.Luigi Orbassano Orbassano, Italy Less <<
NCT00743509 Osteosarcoma Phase 2 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT03184194 Myeloma Phase 2 Recruiting March 1, 2021 Netherlands ... More >> Rijnstate ziekenhuis Not yet recruiting Arnhem, Ge, Netherlands Contact: Ellen van der Spek, MD PhD          Radboud MC Not yet recruiting Nijmegen, Ge, Netherlands Contact: Sandra Croockewit, MD PhD          UMC Groningen Not yet recruiting Groningen, Gr, Netherlands Contact: Goda Choi, MD PhD          MUMC Recruiting Maastricht, Li, Netherlands Contact: Gerard Bos, MD PhD          VU University Medical Center Recruiting Amsterdam, NH, Netherlands, 1081HV Contact: Niels van de Donk, MD PhD       n.vandedonk@vumc.nl    Contact: Christie Verkleij, MD       c.verkleij@vumc.nl    Isala Klinieken Not yet recruiting Zwolle, Ov, Netherlands Contact: Juleon Coenen, MD PhD          Meander MC Recruiting Amersfoort, Ut, Netherlands Contact: Saskia Klein, MD PhD          St. Antonius Ziekenhuis Recruiting Nieuwegein, Ut, Netherlands Contact: Okke de Weerdt, MD PhD          UMC Utrecht Recruiting Utrecht, Ut, Netherlands Contact: Monique Minnema, MD PhD          Albert Schweitzer Ziekenhuis Recruiting Dordrecht, ZH, Netherlands Contact: MD Levin, MD PhD          Erasmus MC Not yet recruiting Rotterdam, ZH, Netherlands Contact: Pieter Sonneveld, MD PhD          Contact: Annemiek Broyl, MD PhD Less <<
NCT01092962 Idiopathic Nephrotic Syndrome Phase 3 Completed - France ... More >> Robert Debre Hospital, AP-HP Paris, France, 75019 Less <<
NCT02876679 Graft vs Host Disease Phase 2 Recruiting February 2020 France ... More >> Saint Antoine Hospital - Hematology Department Recruiting Paris, France, 75012 Contact: Mohamad MOHTY, PU-PH    01.49.28.26.20 ext +33    mohamad.mohty@inserm.fr    Contact: Florent MALARD, CCU-AH    01.49.28.26.20 ext +33    malardf@yahoo.fr Less <<
NCT00605566 Neuroendocrine Tumors Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT01861561 Renal Insufficiency ... More >> Infection Less << Phase 4 Recruiting November 2019 Thailand ... More >> Nephrology division, Department of Pediatrics, Siriraj Hospital Recruiting Bangkoknoi, Bangkok, Thailand, 10700 Contact: Nuntawan Piyaphanee, MD    +662-419-7000 ext 5660    nuntawan.piy@mahidol.ac.th    Contact: Anirut Pattaragarn, MD    +662-419-7000 ext 5660    Apattaragarn@gmail.com    Principal Investigator: Nuntawan Piyaphanee, MD          Sub-Investigator: Anirut Pattaragarn, MD          Sub-Investigator: Achra Sumboonnanonda, MD          Sub-Investigator: Suroj Supavekin, MD          Sub-Investigator: Kraisoon Lomjansook, MD Less <<
NCT02996773 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma Less << Phase 1 Phase 2 Recruiting April 2022 United States, Arizona ... More >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz    (520) 694-4767    oambriz@email.arizona.edu    Principal Investigator: Emmanuel Katsanis, MD          Sub-Investigator: Faiz Anwer, MD          Sub-Investigator: Daniel Persky, MD          Sub-Investigator: Soham Puvvada, MD          Sub-Investigator: Ali McBride, PharmD, MS, BCPS          Sub-Investigator: Denise J. Roe, DrPH          Sub-Investigator: Murali Kodali, MD          Sub-Investigator: Lisa Kopp, DO          Sub-Investigator: Ravitharan Krishnadasan, MD          Sub-Investigator: Sandra Kurtin, NPC          Sub-Investigator: Laura McPheeters, NP          Sub-Investigator: Jana Montez, NP          Sub-Investigator: Lauren Nichols, MD          Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP          Sub-Investigator: Lauren Sapp, NP          Sub-Investigator: Katherine Whitney, NP          Sub-Investigator: Andrew Yeager, MD          Sub-Investigator: Yi Zeng, MD Less <<
NCT03088293 Idiopathic Refractory Scleriti... More >>s Less << Phase 3 Not yet recruiting June 2021 France ... More >> Hospices Civils de Lyon - Hopital de la Croix Rousse Not yet recruiting Lyon, France, 69004 Contact: Pascal SEVE    + 33 4 26 73 26 27    pascal.seve@chu-lyon.fr    Contact: Mahé RAFFIN    04 26 73 27 38    mahe.raffin@chu-lyon.fr    Principal Investigator: Pascal SEVE          Sub-Investigator: Laurent KODJIKIAN Less <<
NCT01322776 Mantle Cell Lymphoma Recurrent Phase 1 Phase 2 Unknown October 2013 China, Guang Dong ... More >> SunYat-sen University Cancer Centre Recruiting Guang Zhou, Guang Dong, China Contact: Huiqiang Huang       huanghq@sysucc.org.cn    Principal Investigator: Huiqiang Huang          Sub-Investigator: Xiaoxiao Wang Less <<
NCT01351909 HER2/Neu Negative ... More >> Recurrent Breast Carcinoma Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Less << Phase 1 Active, not recruiting - United States, New York ... More >> Montefiore Medical Center-Einstein Campus Bronx, New York, United States, 10461 Montefiore Medical Center-Weiler Hospital Bronx, New York, United States, 10461 Montefiore Medical Center - Moses Campus Bronx, New York, United States, 10467 Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, New York, United States, 10016 Columbia University/Herbert Irving Cancer Center New York, New York, United States, 10032 Less <<
NCT00176605 Prostate Cancer Phase 2 Completed - United States, New Jersey ... More >> Central Jersey Oncology Center East Brunswick, New Jersey, United States, 08816 Robert Wood Johnson University Hospital/CINJ at Hamilton Hamilton, New Jersey, United States, 08690 Morristown Memorial Hospital Morristown, New Jersey, United States, 07962 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 Saint Peter's University Hospital New Brunswick, New Jersey, United States, 08903 UMDNJ/Robert Wood Johnson Medical School Newark, New Jersey, United States, 07103 Overlook Hospital Summit, New Jersey, United States, 070901 Less <<
NCT00176605 - Completed - -
NCT03139851 Metastatic Breast Cancer Phase 2 Recruiting February 2020 France ... More >> ICO - Paul Papin Recruiting Angers, France, 49055 Contact: Jean-Sébastien FRENEL    0240679900    jean-sebastien.frenel@ico.unicancer.fr    Principal Investigator: Jean-Sébastien FRENEL          Sub-Investigator: Sophie ABADIE-LACOURTOISIE          Sub-Investigator: Paule AUGEREAU          Sub-Investigator: Elouen BOUGHALEM          Sub-Investigator: Mario CAMPONE          Sub-Investigator: Caroline FONSEGRIVE          Sub-Investigator: Anne PATSOURIS          Sub-Investigator: Patrick SOULIE          Centre Léon Bérard Recruiting Lyon, France, 69003 Contact: Olivier TREDAN, MD    +33478782828    olivier.tredan@lyon.unicancer.fr    Principal Investigator: Olivier TREDAN, MD          Sub-Investigator: Thomas BACHELOT, MD          Sub-Investigator: Olivia BALLY, MD          Sub-Investigator: Alice BONNEVILLE-LEVARD, MD          Sub-Investigator: Armelle DUFRESNE, MD          Sub-Investigator: Pierre-Etienne HEUDEL, MD          Sub-Investigator: Isabelle RAY-COQUARD, MD          Sub-Investigator: Mehdi BRAHMI, MD          Sub-Investigator: Olfa DERBEL MILED, MD          Sub-Investigator: Pauline ROCHEFORT, MD          Sub-Investigator: Philippe TOUSSAINT, MD          Hôpital Privé Jean Mermoz Recruiting Lyon, France, 69008 Contact: Olfa DERBEL    0437538725    olfa.derbel@lyon.unicancer.fr    Principal Investigator: Olfa DERBEL          Sub-Investigator: Olivia BALLY          Sub-Investigator: Dominique BEAL-ARDISSON          ICO - René Gauducheau Recruiting Saint-Herblain, France, 44805 Contact: Jean-Sébastien FRENEL    0240679900    jean-sebastien.frenel@ico.unicancer.fr    Principal Investigator: Jean-Sébastien FRENEL          Sub-Investigator: Dominique BERTON-RIGAUD          Sub-Investigator: Emmanuelle BOURBOULOUX          Sub-Investigator: Mario CAMPIONE          Sub-Investigator: Carole GOURMELON          Sub-Investigator: Marie ROBERT          Sub-Investigator: Audrey ROLLOT          Institut de cancérologie Lucien Neuwirth Not yet recruiting Saint-Priest-en-Jarez, France, 42270 Contact: Jean-Philippe JACQUIN    0477917026    jean-philippe.jacquin@icloire.fr    Principal Investigator: Jean-Philippe JACQUIN          Sub-Investigator: Claire BOSACKI          Sub-Investigator: Olivier COLLARD          Sub-Investigator: Romain RIVOIRARD Less <<
NCT01570764 Systemic Sclerosis ... More >> Scleroderma Interstitial Lung Disease Lung Fibrosis Less << Phase 3 Active, not recruiting October 2018 France ... More >> Cochin Hospital Paris, France, 75014 Less <<
NCT03149679 Colorectal Cancer Metastatic ... More >> Colorectal Cancer Stage IV TP53 Gene Mutation Less << Phase 2 Recruiting June 2025 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Norway, 5021 Contact: Inger Marie Løes, MD PhD    +47 55975000    inger.marie.loees@helse-bergen.no    Contact: Per Eystein Lønning, MD PhD    +47 55975000    per.eystein.lonning@helse-bergen.no Less <<
NCT03371095 Behcet's Disease ... More >> Vasculitis Less << Phase 3 Not yet recruiting January 1, 2022 -
NCT00667615 Hodgkin's Disease ... More >> Lymphoma Less << Phase 1 Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan Kettering Cancer Center @ BaskingRidge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States Memorial Sloan Kettering Cancer Center @ Phelps Sleepy Hollow, New York, United States, 10591 Less <<
NCT00844506 Ovarian Cancer Phase 2 Completed - Netherlands ... More >> University Medical Centre Groningen Groningen, Netherlands, 9700 RB Less <<
NCT01910870 Metastatic Breast Cancer Phase 2 Terminated(Because of difficul... More >>ties in recruiting) Less << - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Less <<
NCT00890955 Lung Cancer Phase 1 Completed - United States, Arkansas ... More >> Highlands Oncology Group Springdale, Arkansas, United States, 72764 United States, Delaware Helen F. Graham Cancer Center Newark, Delaware, United States, 19713 United States, Illinois Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Missouri Siteman Cancer Center St. Louis, Missouri, United States, 63110 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania Fox Chase Cancer Center Extramural Research Program Rockledge, Pennsylvania, United States, 19046 Less <<
NCT02645565 Lupus Nephritis Phase 4 Completed - India ... More >> Department of Clinical Immunology , Jawaharlal Institute of Post graduate Medical Educationa and Research Pondicherry, India, 605006 Less <<
NCT02768701 Triple Negative Breast Cancer Phase 2 Active, not recruiting December 2022 United States, District of Col... More >>umbia George Washington University-Medical Faculty Associates Washington, District of Columbia, United States, 20037 United States, North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Cone Health Cancer Center Greensboro, North Carolina, United States, 27403 Rex Cancer Center Raleigh, North Carolina, United States, 27607 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01554371 Malignant Solid Tumour ... More >> Breast Cancer Nos Metastatic Recurrent Neuropathy Less << Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Principal Investigator: Hope S Rugo, MD          Principal Investigator: Amy P Moore, MD          Sub-Investigator: Pamela N Munster, MD          Sub-Investigator: John W Park, MD          Sub-Investigator: Mark JM Magbanua, phD          Sub-Investigator: Leslie Floren, PhD          Sub-Investigator: Deanna Kroetz, PhD          Sub-Investigator: Michelle Melisko, MD          Sub-Investigator: Mark Moasser, MD          Sub-Investigator: Andrei Goga, MD Less <<
NCT02406781 Sarcoma Phase 2 Recruiting March 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD          Principal Investigator: Antoine ITALIANO          Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Nicolas Penel          Principal Investigator: Nicolas Penel          Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Jean-Yves BLAY, MD-PHD          Principal Investigator: Jean-Yves BLAY, MD-PHD          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: François BERTUCCI          Principal Investigator: François BERTUCCI          Institut Curie Recruiting Paris, France, 75005 Contact: Sophie Piperno-Neumann          Principal Investigator: Sophie Piperno-Neumann          Institut de Cancérologie de l'Ouest Recruiting Saint-Herblain, France, 44805 Contact: Emmanuelle BOMPAS, MD          Principal Investigator: Emmanuelle BOMPAS, MD          Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine CHEVREAU          Principal Investigator: Christine CHEVREAU          Institut Gustave Roussy Recruiting Villejuif, France, 94800 Contact: Axel LE CESNE          Principal Investigator: Axel Le CESNE Less <<
NCT00667615 - Completed - -
NCT00492921 Graft Versus Host Disease Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT03132584 Non Hodgkin Lymphoma ... More >> High-grade B-cell Lymphoma CD52 Positive Non-Hodgkin Lymphoma DLBCL or High-grade B-cell Lymphoma NOS Less << Phase 1 Active, not recruiting May 1, 2023 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03733587 Solid Tumor Phase 1 Phase 2 Recruiting May 1, 2020 Korea, Republic of ... More >> Seoul National University Bundang Hospital Recruiting Seongnam-si, Korea, Republic of Contact: Keun-Wook Lee, MD    +82 31 787 7009    hmodoctor@hanmail.net    Principal Investigator: Keun-Wook Lee, MD          Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Yung-Jue Bang, MD    +82 2 2072 2390    bangyj@snu.ac.kr    Principal Investigator: Yung-Jue Bang, MD Less <<
NCT00412243 Burkitt's Lymphoma ... More >> Lymphoblastic Lymphoma Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02298348 Neuroblastoma Phase 1 Active, not recruiting May 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago, Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Texas Cook Children's Healthcare System Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT01207297 SLE Lupus Nep... More >>hritis Renal Insufficiency End-stage Renal Disease Less << Phase 1 Completed - -
NCT01910844 Metastatic Breast Cancer Phase 2 Terminated(Because of difficul... More >>ties in recruting) Less << - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Less <<
NCT01670175 Malignant Solid Tumor ... More >> Childhood Solid Tumor Less << Phase 1 Completed - United States, California ... More >> UCSF Benioff Children's Hospital San Francisco, California, United States, 94143 Less <<
NCT00492921 - Completed - -
NCT01537029 - Completed - -
NCT01537029 Breast Cancer ... More >> Obesity Less << Phase 4 Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT02013336 Recurrent or Refractory Solid ... More >>Tumors Ewing Sarcoma Rhabdomyosarcoma Neuroblastoma Osteosarcoma Less << Phase 1 Recruiting December 2020 United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact    513-636-4200       Principal Investigator: Joseph Pressey, MD          United States, Oklahoma University Of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States Contact: Susan Heavner          United States, Texas UT Southwestern Recruiting Dallas, Texas, United States Contact: Alison Patterson          Not yet recruiting Houston, Texas, United States Texas Tech University Health Sciences Center Not yet recruiting Lubbock, Texas, United States, 79430 United States, Wisconsin Midwest Children's Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Adam Fiebelkorn Less <<
NCT00412243 - Completed - -
NCT02441491 ROHHAD Syndrome Not Applicable Recruiting March 2023 United States, Maryland ... More >> Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Allen Chen, MD    410-502-4997    chenal@jhmi.edu    Contact: Tammy Scott, RN    4140-614-5990    scottta@jhmi.edu Less <<
NCT00981708 Amyloidosis Phase 1 Phase 2 Unknown February 2015 Greece ... More >> Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece, 115 28 Less <<
NCT01740401 - Terminated(Primary Endpoint no... More >>t met) Less << - -
NCT01740401 Melanoma Phase 2 Terminated(Primary Endpoint no... More >>t met) Less << - United States, New York ... More >> New York University Langone Clinical Cancer Center New York, New York, United States, 10016 Less <<
NCT01540110 Breast Cancer Phase 2 Completed - Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT00501995 - Completed - -
NCT00501995 Scleroderma Phase 3 Completed - -
NCT01995331 Aplastic Anemia Phase 4 Unknown March 2015 China, Tianjin ... More >> Department of Pediatrics,Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, Tianjin, China, 300020 Less <<
NCT01630538 Antibody Mediated Rejection Phase 2 Terminated(After March 2015, u... More >>nable to enroll due to patients meeting exclusion criteria.) Less << - Canada, Manitoba ... More >> Transplant Manitoba Adult Kidney Transplant Program, Health Sciences Centre Winnipeg, Manitoba, Canada Less <<
NCT02444091 Chronic Fatigue Syndrome (CFS)... More >> Myalgic Encephalomyelitis (ME) Less << Phase 2 Unknown January 2017 Norway ... More >> Dept. of Oncology, Haukeland University Hospital Bergen, Norway, N-5021 Less <<
NCT01974518 Pemphigus Phase 3 Unknown June 2015 India ... More >> PGIMER Chandigarh, India, 160012 Post-graduate Institute of Medical Education and Research Chandigarh, India, 160012 Less <<
NCT01352338 Multiple Myeloma Phase 1 Phase 2 Completed - Netherlands ... More >> Antonius Ziekenhuis Nieuwegein Nieuwegein, Utrecht, Netherlands, 3435 CM VU Medical Center Amsterdam, Netherlands UMC Utrecht Utrecht, Netherlands, 3584CX Less <<
NCT03700450 Multiple Myeloma Phase 2 Recruiting June 2022 Germany ... More >> University Medical Center Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Nicolaus Kroeger, Prof. Dr.    +49-40-7410-55864    nkroeger@uke.de    Contact: Marion Heinzelmann    +49-40-7410-54188    mheinzel@uke.de    Principal Investigator: Nicolaus Kröger, Prof. Dr.          Sub-Investigator: Christine Wolschke, Dr.          Universitätsklinikum Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Ute Hegenbart, PD Dr.       Ute.Hegenbart@med.uni-heidelberg.de    Principal Investigator: Ute Hegenbart, PD Dr.          Sub-Investigator: Stefan Schönland, Prof. Dr.          Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, 55131 Contact: Eva Wagner-Drouet, Dr.       eva.wagner@unimedizin-mainz.de    Principal Investigator: Eva Wagner-Drouet, Dr.          Sub-Investigator: Markus Munder, PD Dr. Less <<
NCT02821507 Conventional Chondrosarcoma ... More >> Myxoid Liposarcoma Mesenchymal Chondrosarcoma Dedifferentiated Chondrosarcoma Less << Phase 2 Recruiting June 2020 Netherlands ... More >> LUMC Recruiting Leiden, Netherlands, 2333ZA Contact: Hans Gelderblom, Prof       a.j.gelderblom@lumc.nl    Spain Hospital de Sant Pau Recruiting Barcelona, Spain Contact: A López Pousa          Hospital Val d'Hebron Recruiting Barcelona, Spain Contact: C Valverde          CIO Clara Campal Recruiting Madrid, Spain Contact: J Rodriguez          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Contact: J Martin Broto          Hospital Universitario y Politécnico de La Fe Recruiting Valencia, Spain Contact: R Diaz-Beveridge          Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: J Lavernia Less <<
NCT02794077 Recurrent Nasopharyngeal Undif... More >>ferentiated Carcinoma Stage IV Nasopharyngeal Undifferentiated Carcinoma Less << Phase 2 Unknown June 2016 -
NCT03336073 Multiple Myeloma Phase 2 Recruiting December 2021 Spain ... More >> H.Universitari Germans Trias I Pujol de Badalona Recruiting Barcelona, Spain Contact: Albert Oriol, Dr       aoriol@iconcologia.net    Ico L'Hospitalet Recruiting Barcelona, Spain Contact: Anna Sureda, Dr       asureda@iconcologia.net    Complejo Hospitalario Regional Virgen Del Rocío Recruiting Sevilla, Spain Contact: Jesús Martín, Dr       jesusms79@gmail.com Less <<
NCT01836289 Crohn's Disease ... More >> Crohn Disease Less << Phase 1 Phase 2 Withdrawn(Too difficult to rec... More >>ruit given new Crohn's medications approved) Less << March 2018 -
NCT03318016 Acute Myeloid Leukemia ... More >> Relapsed/Refractory Acute Myeloid Leukemia Less << Phase 1 Recruiting November 2019 United States, Colorado ... More >> University of Colorado Denver Recruiting Aurora, Colorado, United States, 80045 Contact: Derek Schatz    720-848-0628    DEREK.SCHATZ@UCDENVER.EDU    Principal Investigator: Daniel Pollyea, MD Less <<
NCT02139280 Hematologic Malignancies Phase 2 Recruiting December 2018 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Principal Investigator: Kenneth Meehan, MD Less <<
NCT02389309 Solid Tumors Phase 1 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03200002 To Compare the Effects of Myco... More >>phenolate Mofetil With Cyclophosphamide in Neplaese Lupus Nephritis Patients Less << Phase 2 Completed - -
NCT01971658 Multiple Myeloma Phase 3 Completed - -
NCT02502864 Breast Cancer ... More >> Breast Cancer Female Less << Phase 4 Active, not recruiting September 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02502864 - Active, not recruiting - -
NCT01427881 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Myeloid Leukemia in Remission Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Multiple Myeloma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00441220 - Unknown October 2010 New Zealand ... More >> Auckland City Hospital Recruiting Auckland, North Island, New Zealand Principal Investigator: Janak R de Zoysa, MBChB          University Of Auckland Recruiting Auckland, New Zealand Contact: Nuala Helsby, PhD          Principal Investigator: Nuala Helsby, PhD          Middlemore Hospital Recruiting Manakau City, New Zealand, Private Bag 93311 Contact: Peter Gow, MBChB, FRACP    649276 0000    PGow@middlemore.co.nz    Principal Investigator: Peter Gow, MBChB          Sub-Investigator: May C Soh, MBChB Less <<
NCT00201721 B-Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT03043105 Multicentric Castleman Disease Phase 2 Recruiting January 1, 2021 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Jian Li, M.D.    +86-18610852525    lijian@pumch.cn    Contact: Lu Zhang, M.D.    +86-18610728815    pumczhanglu@163.com Less <<
NCT01416974 Leukemia Phase 1 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03192397 Acute Myeloid Leukemia in Remi... More >>ssion Adult Acute Lymphoblastic Leukemia in Complete Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission Chronic Myelomonocytic Leukemia in Remission Graft Versus Host Disease Hodgkin Lymphoma Minimal Residual Disease Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Plasma Cell Myeloma Severe Aplastic Anemia Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting July 1, 2022 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Christine M. Ho Less <<
NCT00727441 Pancreatic Cancer Not Applicable Active, not recruiting March 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00958854 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Cancer Research UK and University College London Cancer Trials Centre Recruiting Exeter, England, United Kingdom, EX2 5DW Contact: Claudius Rudin, MD    44-1392-402-850 Less <<
NCT00066469 - Unknown - -
NCT00066469 Lymphoproliferative Disorder Phase 2 Unknown - -
NCT01947062 Lung Cancer S... More >>quamous Cell Carcinoma of the Lung Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung Less << Phase 3 Unknown October 2014 India ... More >> Swami Rama Cancer Hospital & Research Institute Not yet recruiting Haldwani, Nainital, Uttarakhand, India, 263139 Contact: Swaroop Revannasiddaiah, MD    91 ext 8971862565    swarooptheone@gmail.com    Principal Investigator: Swaroop Revannasiddaiah, MD          Sub-Investigator: Kailash C Pandey, MD          Sub-Investigator: Sridhar P Susheela, MD Less <<
NCT01427881 - Completed - -
NCT02225665 Human Immunodeficiency Virus (... More >>HIV) Less << Phase 1 Phase 2 Active, not recruiting June 2018 United States, California ... More >> Long Beach, California, United States, 90813 Palm Springs, California, United States, 92262 San Francisco, California, United States, 94115 United States, Connecticut Norwalk, Connecticut, United States, 06850 United States, District of Columbia Washington, District of Columbia, United States, 20009 United States, Florida Orlando, Florida, United States, 32803 United States, New York New York, New York, United States, 10011 United States, Texas Austin, Texas, United States, 78705 Dallas, Texas, United States, 75246 Less <<
NCT01082939 - Completed - -
NCT03252600 Recurrent Primary Amyloidosis Phase 2 Recruiting December 31, 2020 United States, Michigan ... More >> Wayne State University/Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Silva Pregja    313-576-8673    Pregjas@karmanos.org    Contact: Christiane Houde    313-576-9381    Houdec@karmanos.org    Principal Investigator: Jeffrey A. Zonder Less <<
NCT01082939 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00676949 Metastatic Tumors Phase 1 Completed - Japan ... More >> Kyushu University Hospital Fukuoka, Japan, 812-8582 Less <<
NCT00589901 Breast Cancer Phase 2 Unknown December 2008 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, +86200032 Sub-Investigator: Xichun Hu, MD, PhD Less <<
NCT03466801 Idiopathic Membranous Nephropa... More >>thy Less << Not Applicable Not yet recruiting June 30, 2019 -
NCT00331552 - Completed - -
NCT00816595 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00049114 Inflammatory Breast Cancer ... More >> Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 2 Completed - United States, New York ... More >> Albert Einstein College of Medicine Bronx, New York, United States, 10461 Less <<
NCT00331552 HER2-positive Breast Cancer ... More >> Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01057225 Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-6350 Less <<
NCT01187017 Aplastic Anemia ... More >> Neutropenia Pancytopenia Severe Aplastic Anemia Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00816595 - Completed - -
NCT03242460 Relapsed and/or refractorY Mul... More >>tiple Myeloma Less << Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Catholic university of korea, Seoul ST. Mary's Hospital. Recruiting Seoul, Korea, Republic of Contact: Chang-Ki Min, MD, PhD.       ckmin@catholic.ac.kr    Contact: Ho-Sup Lee, MD, PhD.       hs3667@hanmail.net    Principal Investigator: Chang-Ki Min, MD, PhD.          Sub-Investigator: Sung-su Yoon, MD, PhD. Less <<
NCT01210768 Breast Cancer Phase 2 Recruiting August 2018 Taiwan ... More >> Changhua Christian Hospital Not yet recruiting Changhua, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital Active, not recruiting Kaohsiung, Taiwan Kaohsiung Veterans General Hospital Not yet recruiting Kaohsiung, Taiwan Chang-Gung Memorial Hospital, Linkou Not yet recruiting Linkou, Taiwan China Medical University Hospital Recruiting Taichung, Taiwan Contact: Hwei-Chung Wang, MD    +886-4-22052121 ext 1639    whcym64@yahoo.com.tw    Taichung Veterans General Hospital Not yet recruiting Taichung, Taiwan National Taiwan University Hospital Not yet recruiting Taipei, Taiwan Shin Kong Wu Ho-Su Memorial Hospital Not yet recruiting Taipei, Taiwan Taipei Veterans General Hospital Not yet recruiting Taipei, Taiwan Less <<
NCT01057225 - Completed - -
NCT02629809 Chronic Lymphocytic Leukemia ... More >> Immunoglobulin Heavy Chain Locus Variable Region Mutation Small Lymphocytic Lymphoma Less << Phase 2 Recruiting March 31, 2022 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nitin Jain    713-745-6080       Principal Investigator: Nitin Jain Less <<
NCT01432600 Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94143 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, New York Mount Sinai School of Medicine, The Tisch Cancer Institute New York, New York, United States, 10029-6574 Less <<
NCT01432600 - Completed - -
NCT02412228 Multiple Myeloma Phase 2 Recruiting September 2019 United States, Rhode Island ... More >> Memorial Hospital of Rhode Island Withdrawn Pawtucket, Rhode Island, United States, 02860 Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: John Reagan, MD          The Miriam Hospital Recruiting Providence, Rhode Island, United States, 02906 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: John Reagan, MD Less <<
NCT00352378 Breast Cancer Phase 3 Completed - -
NCT01187017 - Completed - -
NCT00190229 Henoch-Schoenlein Purpura Not Applicable Completed - France ... More >> Hôpital LARIBOISIERE Paris, France, 75015 Less <<
NCT00774527 Bone Marrow Failure Syndromes Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00278161 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00847171 - Completed - -
NCT01222715 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Pleomorphic Rhabdomyosarcoma Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features Previously Treated Childhood Rhabdomyosarcoma Recurrent Adult Soft Tissue Sarcoma Recurrent Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT00278161 - Completed - -
NCT01581970 Head and Neck Cancer ... More >> Head and Neck Squamous Cell Carcinoma Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01222715 - Completed - -
NCT01614197 Lymphoblastic Leukemia, Acute,... More >> Childhood Lymphoblastic Lymphoma Peripheral T-cell Lymphoma Less << Phase 1 Recruiting December 2019 -
NCT02030964 Neuroblastoma Phase 1 Active, not recruiting April 2019 United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Colorado Children Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Boston, Massachusetts, United States, 02115 United States, Michigan C.S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 United States, Texas Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Australia Sydney Childrens Hospital KCC Randwick, Australia, 2031 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00616122 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00305760 Pancreatic Cancer Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00847171 Breast Cancer Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00002943 Extragonadal Germ Cell Tumor ... More >> Ovarian Cancer Testicular Germ Cell Tumor Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT02838992 Aplastic Anemia Phase 4 Not yet recruiting July 2019 China, Shandong ... More >> The General Hospital Of Jinan Military Command Not yet recruiting Jinan, Shandong, China, 250031 Contact: Fang Zhou, MD    86-0531-51665316    zhoufang1@medmail.com.cn    Contact: Zhe Yu, MD    86-0531-51665781    doctoryu1120@163.com Less <<
NCT02027220 Myeloma Borte... More >>zomib Cyclophosphamide Dexamethasone Granulocyte Colony-Stimulating Factor Less << Phase 2 Unknown December 2015 China, Jiangsu ... More >> The Second Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215004 Contact: jinxiang fu, doctor    86-512-67784066    lbzwz0907@hotmail.com    Principal Investigator: jinxiang fu, doctor Less <<
NCT00616122 - Completed - -
NCT03301350 Breast Cancer ... More >> Triple Negative Breast Cancer Less << Phase 2 Suspended(Toxicity) October 2022 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01862926 Interstitial Lung Disease ... More >> Scleroderma Idiopathic Inflammatory Myositis Mixed Connective Tissue Disease Less << Phase 2 Phase 3 Recruiting November 2020 United Kingdom ... More >> Royal Brompton Hospital Recruiting London, United Kingdom, SW3 6NP Contact: Toby M Maher, MD PhD    0207 3518018    t.maher@rbht.nhs.uk    Principal Investigator: Toby M Maher, MD PhD          Sub-Investigator: Greg Keir, MD Less <<
NCT01677949 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 2 Withdrawn(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02224599 Progressive Solid Malignancies... More >> Refractory Solid Malignancies Cancer Less << Phase 1 Phase 2 Active, not recruiting March 31, 2019 United States, Texas ... More >> San Antonio, Texas, United States, 78240 Less <<
NCT00305760 - Completed - -
NCT00295932 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, New Jersey Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT02953340 Neutropenia B... More >>reastcancer Less << Phase 3 Recruiting April 2019 United States, Mississippi ... More >> Jackson Oncology Associates, PLLC Recruiting Jackson, Mississippi, United States, 39202 Contact: Tammy Young Less <<
NCT00482911 Intraocular Melanoma ... More >> Malignant Conjunctival Neoplasm Less << Phase 2 Terminated(Investigator left t... More >>he institute.) Less << - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT02498912 Solid Tumors Phase 1 Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roisin O'Cearbhaill, MD    646-888-4227       Contact: Jae Park, MD    212-639-4048       Principal Investigator: Roisin O'Cearbhaill, MD Less <<
NCT00295932 - Completed - -
NCT00564512 Leukemia Phase 3 Completed - France ... More >> Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT03601624 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Progression Refractory Multiple Myeloma Less << Phase 2 Recruiting July 30, 2020 Mexico ... More >> ISSSTE Recruiting Ciudad de Mexico, Mexico, 03229 Contact: MARTHA A ALVARADO, MD    15525600960    normoblasto@gmail.com Less <<
NCT00482911 - Terminated(Investigator left t... More >>he institute.) Less << - -
NCT00540644 Multiple Myeloma Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT03029403 Advanced Cancer ... More >> Ovarian Cancer Primary Peritoneal Carcinoma Fallopian Tube Cancer Less << Phase 2 Recruiting February 12, 2024 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Amit Oza, M.D.          Principal Investigator: Amit Oza, M.D. Less <<
NCT00540644 - Completed - -
NCT00641095 Lymphoma Phase 2 Phase 3 Completed - -
NCT00478218 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT02549677 Breast Neoplasms Phase 4 Recruiting September 2019 China, Shanghai ... More >> Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Yan Fang, doctor    64370045 ext 602215    fangyan4743@163.com Less <<
NCT01328249 Her2normal Phase 2 Completed - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center ,Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02903524 Breast Cancer Phase 4 Unknown December 2018 China, Hebei ... More >> Fourth Hospital of Hebei Medical University Recruiting Shi Jiazhuang, Hebei, China, 050019 Contact: Geng Cuizhi, archiater    0311-66696310    gengcuizhi@hotmail.com Less <<
NCT01328249 - Completed - -
NCT00794820 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00794820 - Completed - -
NCT01723839 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Active, not recruiting August 2018 United States, New Jersey ... More >> John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States, 07601 Less <<
NCT02354547 Neoplasm Phase 1 Recruiting November 2020 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Renee Klenke    832-824-4570    RAKLENKE@txch.org Less <<
NCT03201965 Amyloidosis Phase 3 Recruiting October 30, 2025 -
NCT02664103 Breast Cancer Metastatic Phase 2 Completed - India ... More >> Investigational Site Number 356009 Kollkata, India, 700053 Investigational Site Number 356002 Mumbai, India, 400012 Investigational Site Number 356007 New Delhi, India, 110085 Investigational Site Number 356008 Trivandrum, India, 695011 Investigational Site Number 356001 Vellore, India, 632004 Less <<
NCT00276848 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT01074060 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Less <<
NCT00779129 Breast Neoplasm Phase 2 Completed - -
NCT00038142 Ewing's Sarcoma Phase 2 Terminated(Low Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01881789 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting February 28, 2019 United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States United States, California Providence St. Joseph's Hospital Burbank, California, United States David Geffen School of Medicine at UCLA Los Angeles, California, United States Monterey Bay Oncology Corp DBA Pacific Cancer Care Salinas, California, United States United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States United States, Florida H. Lee Moffit Cancer Center & Research Institute Tampa, Florida, United States United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States United States, Indiana Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States United States, Maryland Center for Cancer & Blood Disorders Bethesda, Maryland, United States United States, North Carolina The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States United States, Wisconsin Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT00478218 - Completed - -
NCT00313235 Malignant Melanoma Stage IV Phase 1 Phase 2 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT00824265 - Completed - -
NCT00824265 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT02461888 Multiple Myeloma Phase 2 Recruiting May 2019 United Kingdom ... More >> Queen Elizabeth Medical Centre Recruiting Birmingham, United Kingdom, B15 2TH Heart of England NHS Foundation Trust Recruiting Birmingham, United Kingdom, B9 5ST Royal Bournemouth General Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW University Hospital Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU North Tees and Hartlepool NHS Foundation Trust Recruiting Hartlepool, United Kingdom, TS24 9AH Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Royal Liverpool and Broadgreen University Hospital NHS Trust Recruiting Liverpool, United Kingdom, L7 8XP Barts and the London NHS Trust Recruiting London, United Kingdom, E1 1BB University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG Guy's and St Thomas's NHS Foundation Trust Recruiting London, United Kingdom, SE1 9RT Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W2 1NY The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Nottingham University Hospital NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Sheffield, United Kingdom, S5 7AU Southampton University Hospital NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD The Royal Wolverhampton Hospital NHS Trust Recruiting Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT02684071 Recurrent Childhood Medullobla... More >>stoma Recurrent Childhood Ependymoma Childhood Atypical Teratoid/Rhabdoid Tumor Embryonal Tumor With Abundant Neuropil and True Rosettes Metastatic Malignant Neoplasm to the Leptomeninges Less << Phase 2 Recruiting February 2020 United States, Florida ... More >> Nicklaus Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Ziad A Khatib, MD    305-662-8386    ziad.khatib@mch.com    Contact: Matthew Bittle, Supervisor    786-624-2838    matthew.bittle@nicklaushealth.org    Sub-Investigator: John Ragheb, MD          Sub-Investigator: Guillermo De Angulo, MD          Sub-Investigator: Sanjiv Bhatia, MD          Sub-Investigator: Toba Niazi, MD          Sub-Investigator: David Sandberg, MD          Sub-Investigator: Ana Diaz, ARNP          Principal Investigator: Ziad A Khatib, MD Less <<
NCT02244125 Multiple Myeloma ... More >> First Relapse Less << Phase 2 Active, not recruiting December 2020 France ... More >> CHRU Hopital Sud Amiens, France, 80054 Centre Hospitalier de la côte Basque Bayonne, France, 64109 Hôpital Avicenne Bobigny, France, 93009 ICH - Hôpital A. Morvan Brest, France, 29609 Institut d'Hématologie de Basse Normandie - IHBN Caen, France, 14033 Chu Estaing Clermont Ferrand, France, 63003 CHU Henri Mondor Creteil, France, 94010 CHRU Dijon Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59385 Chru Grenoble Grenoble, France, 38043 Centre Hospitalier départemental de Vendée La Roche sur Yon, France, 85925 Clinique Victor Hugo Le Mans, France, 72000 CHRU - Hôpital Claude Huriez Lille, France, 59037 CHU de Limoges Limoges, France, 87042 Institut Paoli Calmette Marseille, France, 13273 Hopital Emile Muller Mulhouse, France, 68100 CHU de Nantes Nantes, France, 44093 CHU Carémeau Nimes, France, 30029 Institut Curie Paris, France, 750005 CHRU Hopital Saint Antoine Paris, France, 75012 CHRU Hôpital Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier Annecy Genevois Pringy, France, 74374 CHRU Hopital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Centre Hospitalier Yves Le Foll Saint Brieuc, France, 22027 Centre René Huguenin Saint Cloud, France, 92210 Institut Universitaire du Cancer Toulouse-Oncopôle (IUCT-O) Toulouse, France, 31059 CHRU Hopital Bretonneau Tours, France, 37044 CHRU Hopitaux de Brabois Vandoeuvre les Nancy, France, 54511 Less <<
NCT01263704 Lymphocytic Leukemia, Chronic Phase 2 Completed - Israel ... More >> Haemek Medical Center; Hematology Department Afula, Israel, 18101 Soroka Medical Center; Hematology Deptartment Beer Sheva, Israel, 8410101 Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel, 3109601 Bnei-Zion Medical Center; Hematology Dept Haifa, Israel, 3339419 Shaare Zedek Medical Center; Hematology Dept. Jerusalem, Israel, 9103102 Hadassah Ein Karem Hospital; Haematology Jerusalem, Israel, 9112001 Meir Medical Center; Internal Dept A Kfar Saba, Israel, 44281 Western Galilee Hospital - Nahariya Nahariya, Israel, 22100 Beilinson Medical Center; Haematology Petach Tikva, Israel, 49100 Kaplan Medical Center Rehovot, Israel, 7661041 ASSAF Harofe; Department of Hematology Rishon Lezion, Israel, 70300 Ichilov Sourasky Medical Center; Heamatology Tel Aviv, Israel, 6423906 Less <<
NCT01193283 Aplastic Anemia ... More >> Neutropenia Pancytopenia Severe Aplastic Anemia Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01193283 - Completed - -
NCT00184002 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033 Less <<
NCT01263704 - Completed - -
NCT03467386 Acute Myeloid Leukemia in Remi... More >>ssion Hematopoietic Cell Transplantation Recipient Less << Phase 1 Recruiting June 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Anthony S. Stein, MD    626-256-4673    astein@coh.org    Principal Investigator: Anthony S. Stein, MD Less <<
NCT00538031 Fallopian Tube Cancer ... More >> Peritoneal Cavity Cancer Recurrent Ovarian Epithelial Cancer Less << Phase 2 Active, not recruiting June 2019 United States, California ... More >> City of Hope Duarte, California, United States, 91010 City of Hope Medical Group Inc Pasadena, California, United States, 91105 Less <<
NCT00774280 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00184002 - Completed - -
NCT02082405 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Withdrawn(Funding unavailable) - -
NCT00293384 Breast Cancer ... More >> Chronic Myeloproliferative Disorders Gestational Trophoblastic Tumor Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Nausea and Vomiting Neuroblastoma Ovarian Cancer Testicular Germ Cell Tumor Less << Not Applicable Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00072566 - Completed - -
NCT00306670 - Terminated(Sponsor no longer f... More >>unding study.) Less << - -
NCT00306670 Hemophilia A Phase 2 Phase 3 Terminated(Sponsor no longer f... More >>unding study.) Less << - -
NCT02965950 Locally Advanced Breast Cancer... More >> Metastatic Breast Carcinoma Less << Phase 2 Recruiting May 2030 Norway ... More >> Haukeland University Hospital Recruiting Bergen, Hordaland, Norway, 5021 Contact: Hans Petter Eikesdal, MD PhD    +4755972010       Contact: Per Eystein Lønning, MD PhD    +4755972010       Sub-Investigator: Sindre Molvær, MD          Principal Investigator: Hans Petter Eikesdal, MD PhD          Sub-Investigator: Stian Knappskog, PhD          Sub-Investigator: Turid Aas, MD PhD          St. Olavs Hospital Not yet recruiting Trondheim, Sør Trøndelag, Norway Contact: Steinar Lundgren, Professor          Principal Investigator: Steinar Lundgren, MD PhD Less <<
NCT00072566 Primary Peritoneal Carcinoma ... More >> Recurrent Ovarian Carcinoma Stage IV Ovarian Cancer Less << Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Less <<
NCT01716689 Sarcoma Phase 2 Completed - Singapore ... More >> National Cancer Centre Singapore Singapore, Singapore, 169610 Less <<
NCT00740805 Ann Arbor Stage III Non-Hodgki... More >>n Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma Solid Neoplasm Less << Phase 1 Active, not recruiting - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00795899 Breast Cancer Phase 2 Completed - Germany ... More >> Ludwig Maximillian University Munich, Department of Gynecology and Obstetrics Munich, Bavaria, Germany, D-81377 Less <<
NCT00241254 Multiple Sclerosis, Chronic Pr... More >>ogressive Less << Phase 3 Completed - France ... More >> CH de la Cote Basque Bayonne, France, 64109 CHU Besançon Besançon, France, 25030 Hôpital Pellegrin, Département de neurologie Bordeaux, France, 33076 CHU Caen Caen, France, 14033 Hôpital Gabriel Montpied Clermont Ferrand, France, 63003 AP HP Henri Mondor Créteil, France, 94010 CHU Dijon Dijon, France, 21033 CHU Lille Hôpital Salengro Lille, France, 59037 CHU Limoges Limoges, France, 87042 GHICL Hôpital St. Philibert Lomme, France, 59462 (CHU Lyon) Hôpital neurologique Lyon, France, 69394 Hôpital La Timone Marseille, France, 13385 (CHR Metz-Thionville) Hôpital Notre Dame de Bon Secours Metz, France, 57038 (CHU Montpellier), Hôpital de Gui de Chauliac Montpellier, France, 34295 CHU Nancy Hôpital central Nancy, France, 54035 Hôpital Guillaume et René Laënnec Nantes, France, 44093 CHU Nice Hôpital Pasteur Nice, France, 06002 (CHU Nîmes) Hôpital Caremeau Nîmes, France, 30029 Fondation Rothschild Paris, France, 75019 (AP HP) Hôpital Tenon Paris, France, 75970 Centre Hospitalier de Pau Pau, France, 64046 CHU de POISSY Poissy, France, 78300 (CHU Reims) Hôpital Robert Debré Reims, France, 51092 CHU Ponchaillou Rennes, France, 35033 CH d'Angoulême Girac Saint Michel, France, 16470 (CHRU Starsbourg) Hôpital civil Strasbourg, France, 67091 Less <<
NCT00719173 Breast Cancer ... More >> Nausea and Vomiting Less << Phase 1 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01660750 Multiple Myeloma Phase 1 Completed - United States, California ... More >> Samuel Oschin Comprehensive Cancer Center at Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 United States, Massachusetts University of Massachusettes Memorial Worcester, Massachusetts, United States, 01655 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00293384 - Completed - -
NCT00083161 Lung Cancer Phase 2 Completed - United States, Wisconsin ... More >> Gundersen Lutheran Center for Cancer and Blood La Crosse, Wisconsin, United States, 54601 Less <<
NCT00721747 Breast Cancer Phase 2 Unknown January 2015 Spain ... More >> Hospital de Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain, 08906 Hospital Juan Canalejo La Coruña, Galicia, Spain, 15006 Centro Oncológico de Galicia La Coruña, Galicia, Spain, 15009 Complejo Hospitalario de Ourense Ourense, Galicia, Spain, 32005 Hospital Clínico Universitario de Santiago Santiago de Compostela, Galicia, Spain, 15706 Hospital Xeral Cies Vigo, Galicia, Spain, 36204 Less <<
NCT00849251 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Terminated(One of the study dr... More >>ugs is not available.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00813150 Multiple Myeloma Phase 3 Completed - Germany ... More >> Augsburg, Germany Berlin, Germany Bielefeld, Germany Bremerhaven, Germany Darmstadt, Germany Donauwörth, Germany Dresden, Germany Frankfurt, Germany Halle, Germany Hamburg, Germany Hamm, Germany Hannover, Germany Hildesheim, Germany Hof, Germany Koblenz, Germany Köln, Germany Lebach, Germany Leer, Germany Lübeck, Germany Magdeburg, Germany Mannheim, Germany Moers, Germany München, Germany Münster, Germany Neunkirchen, Germany Offenburg, Germany Oldenburg, Germany Osnabrück, Germany Passau, Germany Porta Westfalica, Germany Ravensburg, Germany Rostock, Germany Saarbrücken, Germany Singen, Germany Stuttgart, Germany Velbert, Germany Weiden, Germany Wiesbaden, Germany Würselen, Germany Würzburg, Germany Less <<
NCT01610869 Ovarian Cancer ... More >> Fallopian Tube Cancer Less << Phase 2 Active, not recruiting January 2019 United Kingdom ... More >> Kent Oncology Centre Maidstone, Kent, United Kingdom Beatson West of Scotland Cancer Centre Glasgow, Scotland, United Kingdom Velindre Hospital Cardiff, Wales, United Kingdom Royal United Hospital Bath, United Kingdom Addenbrookes Hospital Cambridge, United Kingdom Royal Derby Hospital Derby, United Kingdom Royal Surrey County Hospital Guildford, United Kingdom St James's University Hospital Leeds, United Kingdom Clatterbridge Centre for Oncology Liverpool, United Kingdom Mount Vernon Hospital London, United Kingdom Royal Marsden Hospital London, United Kingdom St Bartholomew's Hospital London, United Kingdom University College London Hospital (UCLH) London, United Kingdom Christie Hospital Manchester, United Kingdom Churchill Hospital Oxford, United Kingdom Wexham Park Hospital Slough, United Kingdom Less <<
NCT00849251 - Terminated(One of the study dr... More >>ugs is not available.) Less << - -
NCT01303705 Metastatic Prostate Cancer ... More >> Cancer of the Prostate Prostate Cancer Less << Phase 1 Completed - United States, Oregon ... More >> Providence Portland Medical Center Portland, Oregon, United States, 97213 Less <<
NCT00002501 Lymphoma Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, Missouri Ellis Fischel Cancer Center - Columbia Columbia, Missouri, United States, 65203 Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, Nevada CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States, 89106 United States, New Hampshire Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, New York CCOP - North Shore University Hospital Manhasset, New York, United States, 11030 Mount Sinai Medical Center, NY New York, New York, United States, 10029 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, North Carolina CCOP - Southeast Cancer Control Consortium Winston-Salem, North Carolina, United States, 27104-4241 Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 United States, Tennessee University of Tennessee, Memphis Cancer Center Memphis, Tennessee, United States, 38103 Less <<
NCT01321775 Breast Cancer Phase 2 Unknown November 2013 Spain ... More >> Complejo Hospital Costa Del Recruiting Marbella, Malaga, Spain, 29600 Contact: Diego Perez, MD    0034951 97 66 69    dipema2026@gmail.com    Principal Investigator: Diego Perez, MD          Hospital Ramón Y Cajal Recruiting Madrid, Spain, 28034 Contact: Noelia Martinez, MD    003491 336 80 00    mjnoelia@hotmail.com    Principal Investigator: Noelia Martinez, MD          Hospital Universitario Recruiting Madrid, Spain, 28050 Contact: Laura Garcia, MD    003491 756 78 50    lauraestevez@hospitaldemadrid.com    Principal Investigator: Laura Garcia, MD Less <<
NCT03191981 Myeloma Multiple Phase 1 Phase 2 Withdrawn(Withdrawal of pharma... More >> support prior to opening to recruitment) Less << - United Kingdom ... More >> Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH University College Hospital London, United Kingdom, NW1 2BU Guys and St Thomas NHS Foundation Trust London, United Kingdom, SE1 9RT Southampton General Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT00813150 - Completed - -
NCT00727415 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Italy ... More >> Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Divisione di Ematologia Ospedale "Santa Maria Goretti" Latina, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy (SA) U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani Nocera Inferiore, Italy Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S. M. delle Croci Ravenna, Italy, I-48100 Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Ospedale "Infermi" Rimini, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia - Ospedale S.Eugenio Rome, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Less <<
NCT00089726 Lung Cancer C... More >>arcinoma, Non-Small-Cell Lung Less << Phase 2 Completed - -
NCT01493154 Head and Neck Cancer Phase 1 Terminated(Study Funding Termi... More >>nated) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 Less <<
NCT01689987 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01907529 Stage III Breast Cancer Phase 2 Phase 3 Not yet recruiting December 2021 -
NCT00093834 Breast Cancer Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01857115 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting April 2019 Italy ... More >> FO.NE.SA.Onlus Torino, Italy, 10126 Less <<
NCT00004474 Aplastic Anemia Phase 3 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03602898 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Blasts 5 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Minimal Residual Disease Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Not yet recruiting September 17, 2023 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda    206-667-4546       Principal Investigator: Masumi Ueda Less <<
NCT00590785 High Risk Bre... More >>ast Cancer Positive Nodes Cyclophosphamide Doxorubicin Less << Phase 3 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01396200 Myeloma Early Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00005778 Lupus Erythematosus, Systemic Phase 3 Completed - United States, Maryland ... More >> Johns Hopkins University Division of Rheumatology Baltimore, Maryland, United States, 21205 United States, Pennsylvania Drexel University School of Medicine, Division of Hematology/Oncology Philadelphia, Pennsylvania, United States, 19102 United States, Wisconsin Medical College of Wisconsin, Division of Rheumatology Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03154749 Triple-Negative Breast Cancer Phase 2 Recruiting September 1, 2019 China, Guangdong ... More >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Liming Yao    00862083827812 ext 20984    13149395530@163.com Less <<
NCT01462214 Metastatic Renal Cell Cancer Phase 1 Phase 2 Completed - Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands VU University Medical Center Amsterdam, Netherlands, 1081 HV NKI-AVL Amsterdam, Netherlands Haga Ziekenhuis Den Haag, Netherlands Medisch Centrum Haaglanden Den Haag, Netherlands Universitair Medisch Centrum Groningen Groningen, Netherlands Spaarne Ziekenhuis Hoofddorp Hoofddorp, Netherlands Medisch Centrum Leeuwarden Leeuwarden, Netherlands University Hospital Maastricht Maastricht, Netherlands St. Antonius Ziekenhuis Nieuwegein, Netherlands UMC St Radboud Nijmegen Nijmegen, Netherlands Sint Franciscus Gasthuis Rotterdam Rotterdam, Netherlands Isala Klinieken Zwolle Zwolle, Netherlands Less <<
NCT00131963 - Completed - United States, North Carolina ... More >> Duke Cancer Institute Durham, North Carolina, United States, 27710 Less <<
NCT01329627 Locally Advanced HER2-negative... More >> Breast Cancer Less << Phase 2 Terminated(Toxicity) - Brazil ... More >> State of Sao Paulo Cancer Institute Sao Paulo, Brazil, 01246-000 Less <<
NCT00883129 Scleroderma I... More >>nterstitial Lung Disease Less << Phase 2 Completed - United States, California ... More >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado National Jewish Health Denver, Colorado, United States, 80206 United States, District of Columbia Georgetown University School of Medicine Washington, District of Columbia, United States, 20057 United States, Illinois Feinberg School of Medicine, Northwestern University Chicago, Illinois, United States, 60611 University of Illinois at Chicago, College of Medicine Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 United States, Massachusetts Boston University School of Medicine Boston, Massachusetts, United States, 02118 United States, Michigan University of Michigan Medical School Ann Arbor, Michigan, United States, 48109 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55454 United States, New Jersey University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08854 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Medical School at Houston Houston, Texas, United States, 77225 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00881933 Aplastic Anemia Phase 1 Phase 2 Unknown September 2012 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D    82 2 2072 3625    hsahn@snu.ac.kr Less <<
NCT03339804 Breast Cancer ... More >> Chemotherapeutic Toxicity Less << Not Applicable Completed - Brazil ... More >> Heart Institute São Paulo, Cerqueira Cesar, Brazil Less <<
NCT00602836 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT00293410 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01592981 Waldenstrom's Macroglobulinaem... More >>ia Less << Phase 2 Active, not recruiting July 2021 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom Royal United Hospital Bath, United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS City Hospital Birmingham, United Kingdom Pilgrim Hospital Boston, United Kingdom Colchester General Hospital Colchester, United Kingdom Darent Valley Hospital Dartford, United Kingdom Derriford Hospital Derriford, United Kingdom Dewsbury and District Hospital Dewsbury, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Grantham and District Hospital Grantham, United Kingdom St James University Hospital Leeds, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartolomew's Hospital London, United Kingdom, EC1A 7BE University College Hospital London, United Kingdom, NW1 2BU King's College Hospital London, United Kingdom Northwick Park Hospital London, United Kingdom Royal Free Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom Pontefract Hospital Pontefract, United Kingdom Queen's Hospital Romford, United Kingdom Salisbury District Hospital Salisbury, United Kingdom Musgrove Park Hospital Taunton, United Kingdom Torbay Hospital Torbay, United Kingdom Tunbridge Wells Hospital Tunbridge Wells, United Kingdom Pinderfields Hospital Wakefield, United Kingdom Sandwell Hospital West Bromwich, United Kingdom Royal Hampshire County Hospital Winchester, United Kingdom Less <<
NCT00602836 - Completed - -
NCT02533401 Lymphocytic Leukemia, Chronic Phase 2 Completed - Argentina ... More >> Buenos Aires, Argentina, 1406 Buenos Aires, Argentina, C1114AAN Buenos Aires, Argentina, C1280AEB Buenos Aires, Argentina, C1431FWO Córdoba, Argentina, 5016 La Plata, Argentina, B1897GOL Pilar, Argentina, B1629ODT Rosario, Argentina, S2000DSV Venezuela Caracas, Venezuela, 2122 Less <<
NCT02533401 - Completed - -
NCT02861417 Other Diseases of Blood and Bl... More >>ood-forming Organs Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndrome Myeloproliferative Syndrome Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Less << Phase 2 Recruiting August 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01288131 Anti-r-HuEpo Associated PRCA S... More >>ubjects Less << Phase 3 Terminated(We observed >90 % e... More >>fficacy in cyclophosphamide and Prednisolone group for treatment of anti-i-HuEpo associated PRCA) Less << - Thailand ... More >> Kearkiat Praditpornsilpa Bangkok, Thailand, 10330 Less <<
NCT00883129 - Completed - -
NCT02029638 Kidney Transplantation Phase 2 Terminated(Slow accrual) - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT02586038 Multiple Myeloma Phase 2 Recruiting October 2023 Italy ... More >> AO SS Antonio e Biagio e Cesare Arrigo di Alessandria Recruiting Alessandria, Italy, 15121 Contact: Marco Ladetto, MD    +390131206129    mladetto@ospedale.al.it Less <<
NCT02029638 - Terminated(Slow accrual) - -
NCT00629499 Breast Cancer Phase 2 Completed - United States, Florida ... More >> Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Maine Mercy Hospital Portland, Maine, United States, 04101 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, North Carolina Cancer Care of Western North Carolina Asheville, North Carolina, United States, 28801 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT00981799 Relapsed T-Cell Acute Lymphobl... More >>astic Leukemia Relapsed T-Cell Lymphoblastic Lymphoma Less << Phase 1 Phase 2 Terminated(Slow accrual rate) - -
NCT00002556 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT02323230 Diffuse Large B-Cell Lymphoma Phase 2 Unknown February 2018 Canada, Ontario ... More >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT02193880 Hematologic Neoplasms ... More >> Graft-Versus-Host Disease Less << Not Applicable Active, not recruiting March 2019 United States, Alabama ... More >> UAB Medical Center (University of Alabama at Birmingham) Birmingham, Alabama, United States, 35233 Less <<
NCT00629499 - Completed - -
NCT00759798 Chronic Lymphocytic Leukemia ... More >> Leukemia Less << Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01093196 Multiple Myeloma Phase 3 Active, not recruiting November 2021 Italy ... More >> Division Of Hematology, A.O.U. San Giovanni Battista Torino, TO, Italy, 10126 Less <<
NCT02488967 Breast Adenocarcinoma ... More >> Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIC Breast Cancer Triple-Negative Breast Carcinoma Less << Phase 3 Recruiting - -
NCT00577122 Estrogen Receptor-negative Bre... More >>ast Cancer Progesterone Receptor-negative Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Texas The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00577122 - Completed - -
NCT01244906 - Completed - -
NCT01244906 Hematologic Neoplasms Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT01435447 Lymphoid Malignancies Phase 2 Completed - China, Shanghai ... More >> Blood and Marrow Transplantation Center, Rui Jin Hospital Shanghai, Shanghai, China, 200025 Less <<
NCT02270307 Leukemia Mult... More >>iple Myeloma Less << Phase 2 Phase 3 Unknown January 2016 Russian Federation ... More >> BMT department Recruiting Moscow, Russian Federation Contact: Elena Parovichnikova, Prof MD PhD    +79161487131    kuzlara@rambler.ru    Principal Investigator: Elena Parovichnikova Less <<
NCT01421017 Breast Cancer ... More >> Metastatic Breast Cancer Recurrent Breast Cancer Less << Phase 1 Phase 2 Active, not recruiting February 2019 United States, New York ... More >> New York University Medical Center New York, New York, United States, 10016 Less <<
NCT00129376 Breast Cancer Phase 2 Completed - Spain ... More >> Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Corporació Sanitaria Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital de la Ribera Alcira, Valencia, Spain, 46600 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Hospital General Universitario de Alicante Alicante, Spain, 03010 Fundación Jiménez Díaz Madrid, Spain, 28040 Less <<
NCT00564889 - Completed - -
NCT02955810 Multiple Myeloma Phase 1 Active, not recruiting November 2020 Ireland ... More >> Galway University Hospital Galway, Ireland Less <<
NCT00908232 Multiple Myeloma Phase 2 Completed - -
NCT00626626 Leukemia Myel... More >>odysplastic Syndrome Chronic Myelogenous Leukemia Lymphoma Hodgkin's Lymphoma Multiple Myeloma Less << Phase 1 Phase 2 Terminated(Investigator decisi... More >>on) Less << - United States, Pennsylvania ... More >> Penn State College of Medicine, Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033 Less <<
NCT00626626 - Terminated(Investigator decisi... More >>on) Less << - -
NCT00586560 Solid Tumors Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00564889 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01024010 Chronic Lymphocytic Leukemia ... More >> Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT03285607 Breast Cancer ... More >> Cancer of Breast Less << Phase 1 Withdrawn(Drug provider decide... More >>d not to move forward with the study.) Less << February 28, 2021 -
NCT01860170 Hematological Malignancy Phase 1 Phase 2 Active, not recruiting March 2018 United States, Michigan ... More >> Spectrum Health Grand Rapids, Michigan, United States, 49503 Less <<
NCT01024010 - Completed - -
NCT01860170 - Active, not recruiting - -
NCT01873833 HER2-positive Breast Cancer ... More >> Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 2 Active, not recruiting July 27, 2020 United States, California ... More >> USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT01046487 Cancer Phase 1 Completed - France ... More >> Institut Bergonié Bordeaux, France, 33076 Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69008 Less <<
NCT00908232 - Completed - -
NCT00784927 Lymphoma Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01526499 Breast Cancer Phase 2 Unknown July 2013 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Leiping Wang, MD    +862164175590 ext 8908    leipingwang@163.com Less <<
NCT02693210 Rheumatoid Arthritis Phase 2 Completed - -
NCT01194791 Primary Systemic Amyloidosis Phase 2 Completed - Spain ... More >> Hospital Universitario de Canarias Tenerife, Islas Canarias, Spain Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospitalm Clínico de Salamanca Salamanca, Spain Hospital La Fe Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT03012100 Bilateral Breast Carcinoma ... More >> Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Stage IB Breast Cancer AJCC v7 Stage II Breast Cancer AJCC v6 and v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7 Triple-Negative Breast Carcinoma Unilateral Breast Carcinoma Less << Phase 2 Recruiting July 31, 2023 United States, Arizona ... More >> Mayo Clinic in Arizona Recruiting Scottsdale, Arizona, United States, 85259 Contact: Nicole Ritacca    480-301-4161    Ritacca.Nicole@mayo.edu    Principal Investigator: Donald W. Northfelt          United States, District of Columbia MedStar Georgetown University Hospital Withdrawn Washington, District of Columbia, United States, 20007 United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Pulkit Mathur    904-953-3803    Mathur.Pulkit@mayo.edu    Principal Investigator: Alvaro Moreno-Aspitia          University of Miami Miller School of Medicine-Sylvester Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Onaidy T. Torres    305-243-3379    OTorres@med.miami.edu    Principal Investigator: Carmen J. Calfa          United States, Illinois University of Chicago Comprehensive Cancer Center Recruiting Chicago, Illinois, United States, 60637 Contact: Simona Olberkyte    773-702-4848    solberkyte@medicine.bsd.uchicago.edu    Principal Investigator: Rita Nanda          Carle Cancer Center NCI Community Oncology Research Program Recruiting Urbana, Illinois, United States, 61801 Contact: MaryEllen Sherwood    217-326-1881    MaryEllen.Sherwood@Carle.com    Principal Investigator: Kendrith M. Rowland          United States, Louisiana Ochsner Medical Center Jefferson Recruiting New Orleans, Louisiana, United States, 70121 Contact: Socea A. May    504-842-2373    Socea.may@ochsner.org    Principal Investigator: John T. Cole          United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Steven J. Isakoff    617-726-6500    sisakoff@partners.org    Principal Investigator: Steven J. Isakoff          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Lori L. Henrichs    507-538-7665    Henrichs.lori@mayo.edu    Principal Investigator: Kathryn J. Ruddy          United States, Virginia Inova Fairfax Hospital Withdrawn Falls Church, Virginia, United States, 22042 United States, Wisconsin Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Brenda K. Maronde    715-389-7542    maronde.brenda@marshfieldresearch.org    Principal Investigator: Arlene A. Gayle Less <<
NCT03349450 Adult Diffuse Large Cell Lymph... More >>oma Recurrent Adult Refractory Diffuse Large B-Cell Lymphoma Less << Phase 2 Recruiting May 2021 Canada, Alberta ... More >> Tom Baker Cancer Centre - Alberta Health Services Recruiting Calgary, Alberta, Canada Contact: Douglas Stewart, MD       Douglas.Stewart@albertahealthservices.ca    Contact: Asongna Folefoc    403-521-3035    Asongna.Folefoc@albertahealthservices.ca    Canada, Ontario Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada Contact: Isabelle Bence-Bruckler, MD    613-737-8899 ext 72414    ibence-bruckler@toh.ca    Contact: Priscila Ogawa-Vedder    613-737-8899 ext 73952    pogawavedder@ohri.ca    Sunnybrook Health Sciences Centre, Odette Cancer Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Neil Berinstein    416-480-5248    neil.berinstein@sunnybrook.ca    Contact: Lindsay McCaw    416-480-5000 ext 7937    lindsay.mccaw@sunnybrook.ca    Principal Investigator: Neil L Berinstein, MD, FRCP(C)          Canada, Quebec McGill University Health Centre Recruiting Montréal, Quebec, Canada Contact: Pierre Laneuville, MD    5149341934 ext 34091    pierre.laneuville@mcgill.ca Less <<
NCT00281918 Leukemia Phase 3 Completed - -
NCT01985724 Breast Cancer Phase 3 Completed - Greece ... More >> University Hospital of Crete Heraklion, Crete, Greece, 71110 University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece "Marika Iliadis" Hospital of Athens, Dep of Medical Oncology Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece State General Hospital of Larissa, Dep of Medical Oncology Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT00784927 - Completed - -
NCT00551265 Fallopian Tube Carcinoma ... More >> Primary Peritoneal Carcinoma Recurrent Ovarian Carcinoma Stage III Ovarian Cancer Stage IV Ovarian Cancer Less << Not Applicable Withdrawn - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT02048813 Anemia Chroni... More >>c Lymphocytic Leukemia Fatigue Fever, Sweat, and Hot Flashes Hepatomegaly Lymphadenopathy Lymphocytosis Small Lymphocytic Lymphoma Splenomegaly Thrombocytopenia Weight Change Less << Phase 3 Active, not recruiting - -
NCT02879526 Relapse/Refratory Peripheral T... More >> Cell Lymphoma Less << Phase 2 Recruiting August 2019 China, Jiangsu ... More >> HuaiAn First People's Hospital Recruiting HuaiAn, Jiangsu, China, 223300 Contact: Liang Yu, M.D., Ph.D.          WuXi People's Hospital Recruiting WuXi, Jiangsu, China, 214023 Contact: Yun Zhuang, M.D.          Contact: YunFeng Shen, M.D., Ph.D Less <<
NCT01106898 - Completed - -
NCT00281918 - Completed - -
NCT00531453 Multiple Myeloma Phase 2 Completed - Austria ... More >> Wilhelminenspital-1 Vienna, Austria, A-1160 Less <<
NCT02203643 MULTIPLE MYELOMA (MM) Phase 2 Active, not recruiting October 2020 Italy ... More >> IRCCS--CROB --CROB di Rionero in di Rionero in Vulture Rionero in Vulture, Italy, 85028 Less <<
NCT00531453 - Completed - -
NCT00801411 Breast Cancer Phase 2 Unknown - Singapore ... More >> Singapore General Hospital Recruiting Singapore, Singapore, 169608 Contact: Wong Chow Yin    65-6222-3322       National Cancer Centre - Singapore Recruiting Singapore, Singapore, 169610 Contact: Wong Nan Soon, MBBS, MRCP, FAMS    65-6-436-8088 Less <<
NCT01106898 Stage IA Breast Cancer ... More >> Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Less << Phase 2 Completed - United States, Nebraska ... More >> Saint Francis Medical Center Grand Island, Nebraska, United States, 68803 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 Less <<
NCT03103555 Adult-onset Immunodeficiency Phase 2 Recruiting November 1, 2019 Thailand ... More >> Faculty of Medicine Siriraj Hospital, Mahidol University Recruiting Bangkok, Thailand, 10700 Contact: Nasikarn Angkasekwinai, MD    66818708766    nasikarn@gmail.com    Sub-Investigator: Yupin =Suputtamongkol, MD. Less <<
NCT03402295 Multiple Myeloma ... More >> Effects of Chemotherapy Less << Phase 3 Completed - -
NCT02629120 X-Linked Chronic Granulomatiou... More >>s Disease Less << Early Phase 1 Suspended December 31, 2030 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03289819 Malignant Neoplasm of Breast Phase 2 Recruiting December 2018 Germany ... More >> Department of Gynecology, Tübingen University Hospital Recruiting Tübingen, Baden-Württemberg, Germany, 72076 Contact: Andreas Hartkopf, MD, Prof.    07071 29 ext 82211    andreas.hartkopf@med.uni-tuebingen.de    Department of Gynecology and Obstetrics, Erlangen University Hospital Recruiting Erlangen, Bavaria, Germany, 91054 Contact: Peter A Fasching, MD, Prof.    +49 9131 85 ext 33508    peter.fasching@uk-erlangen.de    Contact: Alexander Hein, MD    +49 9131 85 ext 33553    alexander.hein@uk-erlangen.de    Department for Gynecology and Obstetrics, Marienhospital Bottrop gGmbH Recruiting Bottrop, North Rhine-Westphalia, Germany, 46236 Contact: Hans-Christian Kolberg, MD    02041106 ext 1601    hans-christian.kolberg@mhb-bottrop.de    Department of Gynecology and Obstetrics, HELIOS Hospital Berlin Buch GmbH Recruiting Berlin, Germany, 13125 Contact: Michael Untch, MD, Prof.    030 9401 ext 53300    michael.untch@helios-gesundheit.de Less <<
NCT00915408 Multiple Myeloma Phase 1 Phase 2 Completed - United Kingdom ... More >> King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Royal Marsden NHS Foundation Trust London, United Kingdom, SM2 5PT Less <<
NCT03749850 Metastatic Breast Cancer ... More >> Breast Cancer Breast Neoplasms Stage IV Breast Cancer Metastatic Cancer Invasive Ductal Carcinoma of Female Breast Invasive Ductal Breast Cancer Adenocarcinoma Breast Less << Phase 1 Not yet recruiting January 2021 -
NCT00134017 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00258180 Diarrhea Gast... More >>rointestinal Complications Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00971737 Breast Cancer Phase 2 Unknown - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00134017 - Completed - -
NCT01689350 - Completed - -
NCT01191957 Acute Myeloid Leukemia (AML) Phase 3 Completed - Israel ... More >> Chaim Sheba Medical Center Tel Hashomer, Israel Italy Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy Policlinico di Bari-Ematologia con trapianti Bari, Italy Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Ospedale Regionale Generale- Divisione Ematologia Bolzano, Italy AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy Ospedale Ferrarotto - Ematologia Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy AOU-IRCCS San Martino-IST Ematologia II Genova, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy U.O. Ematologia I - Centro Trapianti di Midollo - Ospedale Maggiore - Policlinico Mangiagalli e Regina Elena Milano, Italy Cattedra di Medicina Interna ed Ematologia - Ospedale S. Gerardo de' i Tintori - Università degli Studi di Milano Monza, Italy A.O.U. Policlinico Federico II Napoli, Italy AOR Villa Sofia-Cervello - Bone Marrow Transplant Unit Palermo, Italy IRCCS Policlinico S. Matteo Pavia, Italy Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Divisione di Ematologia - Istituto di Semeiotica Medica - Policlinico A. Gemelli Roma, Italy Policlinico Universitario Tor Vergata Roma, Italy Sapienza University Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Az. Ospedaliera Universitaria Senese - Divisione Ematologia e Trapianti Siena, Italy AOU Città della Salute e della Scienza Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Ospedale S. Bortolo-Divisione Ematologia Vicenza, Italy Less <<
NCT00389506 Lymphoma Not Applicable Withdrawn - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00483119 - Terminated(Study was terminate... More >>d due to the death of the PI.) Less << - -
NCT02046070 Multiple Myeloma Phase 2 Completed - United States, Kentucky ... More >> Hazard, Kentucky, United States United States, Massachusetts Boston, Massachusetts, United States United States, Minnesota Rochester, Minnesota, United States United States, Missouri Saint Louis, Missouri, United States United States, New Jersey New Brunswick, New Jersey, United States United States, New York Rochester, New York, United States Australia, New South Wales Camperdown, New South Wales, Australia Concord, New South Wales, Australia Waratah, New South Wales, Australia Australia, South Australia Adelaide, South Australia, Australia Australia, Victoria Heidelberg, Victoria, Australia Melbourne, Victoria, Australia Greece Athens, Attiki, Greece Athens, Greece Patras, Greece Thessaloniki, Greece Poland Lublin, Lubelskie, Poland Warszawa, Mazowieckie, Poland Chorzow, Poland Gdansk, Poland Lodz, Poland Sweden Helsingborg, Skane lAN, Sweden Stockholm, Sodermanlands LAN, Sweden Lund, Sweden Less <<
NCT00165451 Neoplasms Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00483119 Pemphigus Vulgaris Phase 2 Terminated(Study was terminate... More >>d due to the death of the PI.) Less << - United States, New York ... More >> NYU Medical Center New York, New York, United States, 10016 Less <<
NCT03699475 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Phase 3 Not yet recruiting June 2024 -
NCT02999854 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Less << Phase 3 Recruiting February 2021 Belgium ... More >> Universitair Ziekenhuis Antwerpen Recruiting Antwerp, Belgium, 2650 Principal Investigator: Wilfried Schroyens, MD          Algemeen Ziekenhuis Sint-Jan Recruiting Brugge, Belgium, 8000 Principal Investigator: Dominik Selleslag, MD          Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Principal Investigator: Philippe Lewalle, MD          Universitair Ziekenhuis Gasthuisberg Recruiting Leuven, Belgium, 3000 Principal Investigator: Johan Maertens, MD          Centre Hospitalier Universitaire de Liège Recruiting Liège, Belgium, 4000 Principal Investigator: Yves Beguin, Prof MD          Canada, Quebec Maisonneuve-Rosemont Hospital Recruiting Montreal, Quebec, Canada, H1T 2M4 Principal Investigator: Denis Claude Roy, Prof MD          Croatia University Hospital Centre Zagreb Recruiting Zagreb, Croatia, 10000 Contact: Radovan Vrhovac, Prof MD          Germany University Hospital Frankfurt, Goethe University Not yet recruiting Frankfurt, Germany Principal Investigator: Gesine Bug, MD          University Medical Center Mainz Recruiting Mainz, Germany, 55131 Principal Investigator: Eva Maria Wagner, MD          Ludwig-Maximilians-University Hospital of Munich-Grosshadern Not yet recruiting Munich, Germany, 81377 Contact: Johanna Tischer, Prof MD          Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Principal Investigator: Götz-Ulrich Grigoleit, MD          Italy Milano Hospital, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico Not yet recruiting Milano, Italy, 20122 Contact: Francesco Onida, Prof MD          Fondazione IRCCS Policlinico San Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Paolo Bernasconi, MD          Portugal Faculdade de Medicina da Universidade de Lisboa Recruiting Lisboa, Portugal, 1649-028 Principal Investigator: João Forjaz de Lacerda, Prof MD          Spain University Hospital Barcelona Vall d' Hebron Recruiting Barcelona, Spain, 08035 Principal Investigator: David Valcarcel          Hospital Puerta de Hierro Majadahonda Recruiting Madrid, Spain, 28220 Principal Investigator: Rafael Duarte, MD          Servicio de Hematología Hospital, Universitari I politècnic La Fe Recruiting Valencia, Spain, 46026 Principal Investigator: Jose Luis Piñana, MD          United Kingdom Heartlands Hospital Not yet recruiting Birmingham, United Kingdom, B9 5SS Principal Investigator: Bhuvan Kishore, MD          St James University Hospital Not yet recruiting Leeds, United Kingdom, LS9 7TF Principal Investigator: Maria Gilleece, MD          Royal Liverpool University Hospital Not yet recruiting Liverpool, United Kingdom, L7 8XP Principal Investigator: Amit Patel, MD          Hammersmith Hospital Recruiting London, United Kingdom, W12 0HS Principal Investigator: Eduardo Olavarria, MD          Manchester Royal Infirmary Not yet recruiting Manchester, United Kingdom, M13 9WL Principal Investigator: Eleni Tholouli, MD Less <<
NCT00525642 Breast Neoplasms ... More >> Adjuvant Chemotherapy Less << Phase 2 Phase 3 Unknown June 2015 China, Beijing ... More >> Beijing 307 Hospital Beijing, Beijing, China China, Guangdong No2 affiliated hospital of Sun Yat-sen medical Univesity Guangzhou, Guangdong, China China, Liaoning Liaoning Province Cancer Hospital Shenyang, Liaoning, China China, Shanghai Cancer Hospital / Institute, Fudan University Shanghai, Shanghai, China, 200032 Shanghai No.6 hospital Shanghai, Shanghai, China Less <<
NCT01689350 Systemic Lupus Erythematosus Not Applicable Completed - China, Guangdong ... More >> School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou, Guangdong, China, 510006 Less <<
NCT00275054 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT00793377 Primary Breast Cancer Phase 3 Completed - Germany ... More >> German Breast Group Neu-Isenburg, Hessen, Germany, 06102 Less <<
NCT00927797 Immunocytoma/Morbus Waldenstr?... More >>m B-Cell Non-Hodgkin's Lymphoma B-Cell Chronic Lymphocytic Leukemia Less << Phase 2 Unknown January 2012 -
NCT03215524 Multiple Myeloma Phase 2 Recruiting March 2023 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada Contact: Nizar Bahlis, MD    403-944-5246    nbahlis@ucalgary.ca    CrossCancer Institute Recruiting Edmonton, Alberta, Canada Contact: Christopher Venner, MD    780-432-8757    christopherpaul.venner@albertahealthservices.ca    Canada, British Columbia Fraser Valley Cancer Centre Recruiting Surrey, British Columbia, Canada Contact: Jesse Shustik, MD    604-930-4064    jshustik@bccancer.bc.ca    Canada, Manitoba CancerCare Manitoba Recruiting Winnipeg, Manitoba, Canada Contact: Rami Kotb, MD    204-787-1036    rkotb@cancercare.mb.ca    Canada, New Brunswick Saint John Regional Hospital Recruiting Saint John, New Brunswick, Canada Contact: Anthony Reiman, MD    506-648-6884    anthony.reiman@horizonnb.ca    Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada Contact: Darrell White, MD    902-473-4642    darrell.white@cdha.nshealth.ca    Canada, Ontario Juravinski Cancer Centre (Hamilton Health Sciences Centre) Recruiting Hamilton, Ontario, Canada Contact: Tom Kouroukis, MD    905-387-9495    kourouk@hhsc.ca    The Ottawa Hospital Recruiting Ottawa, Ontario, Canada Contact: Andrea Kew, MD    613-737-8899 ext 71286    akew@toh.ca    Thunder Bay Regional Health Sciences Centre Recruiting Thunder Bay, Ontario, Canada Contact: Nicole Laferriere, MD    807-684-7566    lafferin@tbh.net    Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada Contact: Donna Reece, MD    416-946-2824    donna.reece@uhn.ca    Canada, Saskatchewan Saskatoon Cancer Centre Recruiting Saskatoon, Saskatchewan, Canada Contact: Julie Stakiw, MD    306-655-2980    julie.stakiw@saskcancer.ca Less <<
NCT01072773 Primary Systemic Amyloidosis Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00301600 IGA Nephropathy Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT02623439 Hematologic Malignancies Phase 2 Suspended(On hold for toxiciti... More >>y) Less << July 2020 United States, California ... More >> UCSD Medical Center La Jolla, California, United States, 92093 Less <<
NCT00499122 - Completed - -
NCT01298193 Breast Cancer Phase 4 Completed - Spain ... More >> Badalona, Barcelona, Spain, 08208 Alcalá de Henares, Madrid, Spain Alcorcón, Madrid, Spain, 28922 A Coruña, Spain, 15006 A Coruña, Spain, 15009 Barcelona, Spain, 08003 Barcelona, Spain, 08036 Jaén, Spain, 23007 Lleida, Spain Lugo, Spain Madrid, Spain, 28040 Valencia, Spain, 46015 Zaragoza, Spain, 50009 Less <<
NCT00499122 Breast Cancer Phase 2 Completed - United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, South Carolina Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02948101 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 2 Not yet recruiting December 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Amir A. Jazaeri    713-745-1613       Principal Investigator: Amir A. Jazaeri Less <<
NCT01078441 - Terminated(The study was close... More >>d early due to weak accrual on June 26, 2012.) Less << - -
NCT03655002 Recurrent Hepatocellular Carci... More >>noma Refractory Liver Carcinoma Stage IV Hepatocellular Carcinoma AJCC v8 Stage IVA Hepatocellular Carcinoma AJCC v8 Stage IVB Hepatocellular Carcinoma AJCC v8 Less << Phase 1 Not yet recruiting June 15, 2020 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Daneng Li, MD    626-256-4673    danli@coh.org    Principal Investigator: Daneng Li, MD Less <<
NCT01072773 - Completed - -
NCT00652041 Multiple Myeloma Phase 4 Completed - Spain ... More >> Hospital Morales Messeguer Murcia, Spain Hospital Virgen de la Vega Murcia, Spain Hospital de la Diputación de Navarra Navarra, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital La Fe Valencia, Spain Less <<
NCT00477945 Non Hodgkin's Lymphoma Phase 1 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01078441 Refractory Multiple Myeloma Phase 2 Terminated(The study was close... More >>d early due to weak accrual on June 26, 2012.) Less << - -
NCT02225652 Women With Primary Breast Canc... More >>er Less << Phase 2 Completed - Italy ... More >> Irccs Irst Meldola, FC, Italy, 47014 Less <<
NCT02414945 Pleural Mesothelioma Phase 1 Phase 2 Recruiting November 2025 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D.    416-946-4501 ext 5485    marcus.butler@uhn.ca    Principal Investigator: Marcus Butler, M.D. Less <<
NCT00513695 Inflammatory Breast Cancer ... More >> Male Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 2 Active, not recruiting - United States, Alaska ... More >> Anchorage Oncology Centre Anchorage, Alaska, United States, 99508 Katmai Oncology Group Anchorage, Alaska, United States, 99508 United States, Arizona Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 United States, Idaho Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States, 83712 United States, Washington Skagit Valley Hospital Mount Vernon, Washington, United States, 98273 Olympic Medical Center Port Angeles, Washington, United States, 98362 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00074139 Breast Cancer Phase 1 Withdrawn(No patients were enr... More >>olled) Less << - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5055 Less <<
NCT00513695 - Active, not recruiting - -
NCT00062140 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00413959 - Terminated - -
NCT00546377 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00809341 Non-Hodgkin's Lymphoma Phase 2 Terminated(Low accrual) - United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00809341 - Terminated(Low accrual) - -
NCT00546377 - Completed - -
NCT00682305 Acute Lymphoblastic Leukemia Phase 2 Completed - Germany ... More >> University Medical Center Hamburg-Eppendorf Hamburg, Germany, 20246 Less <<
NCT00118274 Melanoma (Skin) Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States, 19111-2497 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Virginia University of Virginia Cancer Center Charlottesville, Virginia, United States, 22908 Less <<
NCT00004563 Lung Diseases ... More >> Pulmonary Fibrosis Systemic Scleroderma Scleroderma, Systemic Less << Phase 3 Completed - -
NCT03263767 Graft Versus Host Disease Phase 2 Not yet recruiting February 2022 -
NCT01527149 Stage I Mantle Cell Lymphoma ... More >> Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting October 5, 2021 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00004563 - Completed - -
NCT01855750 Lymphoma Phase 3 Active, not recruiting June 16, 2020 -
NCT00004908 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01177371 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With T(15;17)(q22;q12) Adult Acute Myeloid Leukemia With T(16;16)(p13;q22) Adult Acute Myeloid Leukemia With T(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Acute Promyelocytic Leukemia (M3) Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Burkitt Lymphoma Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myeloid Leukemia in Remission Childhood Acute Myelomonocytic Leukemia (M4) Childhood Acute Promyelocytic Leukemia (M3) Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma De Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-Cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00711828 - Active, not recruiting - -
NCT00413959 Lymphoma, Non-Hodgkin ... More >> Lymphoma, B-Cell Less << Phase 2 Terminated - United States, Illinois ... More >> Onocology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 Less <<
NCT00410163 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 2 Completed - United States, Texas ... More >> GSK Investigational Site Houston, Texas, United States, 77030 United Kingdom GSK Investigational Site Plymouth, Devon, United Kingdom, PL68DH Less <<
NCT00711828 Extranodal Marginal Zone Lymph... More >>oma of Mucosa-Associated Lymphoid Tissue Nodal Marginal Zone Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia Less << Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00987480 Aplastic Anemia ... More >> Leukemia Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 The Rockefeller University New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT00410163 - Completed - -
NCT00073918 - Completed - -
NCT02517918 Solid Tumor O... More >>steosarcoma Less << Phase 1 Recruiting October 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Maud Toulmonde, Doctor          Centre Léon Bérard Not yet recruiting Lyon, France, 69008 Contact: Jean-Yves BLAY, Professor          Institut Curie Not yet recruiting Paris Cedex 05, France, 75248 Contact: Sophie PIPERNO-NEUMANN, Doctor          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Julien DOMONT, Doctor Less <<
NCT01974440 Lymphoma Phase 3 Active, not recruiting August 3, 2021 -
NCT00987480 - Completed - -
NCT00073918 Anaplastic Large Cell Lymphoma... More >> Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01660542 Locally Advanced Breast Cancer Phase 4 Completed - Korea, Republic of ... More >> Severance hospital Seoul, Korea, Republic of, 120-752 Less <<
NCT00190671 Breast Cancer Phase 1 Phase 2 Completed - Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Salzburg, Austria, 5020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wels, Austria, 4600 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Wien, Austria, A-1100 Czech Republic For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Brno, Czech Republic, 625 00 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Nova Ves Pod Plesi, Czech Republic, 26204 Hungary For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Budapest, Hungary, 1122 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Szeged, Hungary, 6720 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Gdansk, Poland, 80-210 Romania For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Bucharest, Romania, 022328 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Cluj-Napoca, Romania, 3400 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Iasi, Romania, 6600 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal ph Saint Petersburg, Russian Federation, 197022 Less <<
NCT01707004 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00281931 Prolymphocytic Leukemia Phase 2 Terminated - Germany ... More >> Helios Klinikum Erfurt Erfurt, Germany, 99012 Less <<
NCT01304797 Breast Cancer Phase 1 Active, not recruiting January 2017 United States, California ... More >> University of California San Francisco San Francisco, California, United States United States, Indiana University of Indiana Indianapolis, Indiana, United States United States, Massachusetts Dana Farber Cancer Center Boston, Massachusetts, United States United States, Michigan Karmanos Cancer Center Detroit, Michigan, United States United States, Missouri Washington University St. Louis, Missouri, United States Less <<
NCT00819806 NY-ESO-1-expressing Tumors Phase 1 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00343785 Aplastic Anemia Phase 2 Completed - United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00190671 - Completed - -
NCT03303950 Anemia ASXL1 ... More >>Gene Mutation EZH2 Gene Mutation IDH1 Gene Mutation IDH2 Gene Mutation Plasma Cell Myeloma Primary Myelofibrosis Recurrent Plasma Cell Myeloma Secondary Myelofibrosis Thrombocytopenia Less << Phase 2 Recruiting October 2022 United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Catherine Lee, MD    801-587-0231    Catherine.Lee@hci.utah.edu    Principal Investigator: Catherine Lee, MD Less <<
NCT00041119 Breast Cancer Phase 3 Completed - -
NCT00129922 Breast Cancer Phase 3 Active, not recruiting January 2019 -
NCT00041119 - Completed - -
NCT01090128 Stages II-III Breast Cancer Phase 1 Terminated(Drug Manufacturer w... More >>ithdrew support for studies not in metastatic breast cancer) Less << - United States, Utah ... More >> University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT01542255 Metastatic Melanoma Phase 2 Terminated(Low accrual not all... More >>owing to support statistical endpoints) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT00003288 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT03128359 Acute Leukemia ... More >> Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Follicular Lymphoma Graft Versus Host Disease Hodgkin Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Myelodysplastic Syndrome Less << Phase 2 Recruiting June 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD    626-256-4673    malmalki@coh.org    Principal Investigator: Monzr M. Al Malki, MD Less <<
NCT00016406 Breast Cancer Phase 3 Completed - -
NCT00523159 Renal Cell Carcinoma Phase 2 Completed - -
NCT00343785 - Completed - -
NCT02914470 Breast Cancer ... More >> Cervix Cancer Ovarian Cancer Endometrial Cancer Less << Phase 1 Active, not recruiting June 2018 Netherlands ... More >> Antoni van Leeuwenhoek Amsterdam, Netherlands Less <<
NCT02538926 B Acute Lymphoblastic Leukemia... More >> B Lymphoblastic Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent B Lymphoblastic Lymphoma Recurrent T Lymphoblastic Leukemia/Lymphoma Refractory B Lymphoblastic Lymphoma Refractory T Lymphoblastic Lymphoma T Acute Lymphoblastic Leukemia T Lymphoblastic Lymphoma Less << Phase 2 Withdrawn(Drugs unavailable) July 30, 2021 United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01106235 Stage IV Melanoma Phase 1 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01143545 Lung Cancer E... More >>sophageal Cancer Malignant Pleural Mesothelioma Sarcoma Thymic Carcinoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01542255 - Terminated(Low accrual not all... More >>owing to support statistical endpoints) Less << - -
NCT02192775 Multiple Myeloma Phase 2 Recruiting August 2020 United States, Arkansas ... More >> University of Arkansas for Medical Science Recruiting Little Rock, Arkansas, United States, 72205 Contact: Brittany Lehman    501-686-8274    blehman@uams.edu    Sub-Investigator: Faith Davies, MD          Sub-Investigator: Michele Fox, MD          Sub-Investigator: Gareth Morgan, MD, PhD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD          Sub-Investigator: Shadiqul Hoque, MD Less <<
NCT00609167 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2N9 Less <<
NCT00609167 - Completed - -
NCT00312208 - Completed - -
NCT01526512 Breast Cancer Phase 2 Unknown July 2013 China, Shanghai ... More >> Fudan University Cancer Center Active, not recruiting Shanghai, Shanghai, China, 200032 Fudan University Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Leiping Wang, MD    +862164175590 ext 8908    leipingwang@163.com Less <<
NCT02214381 Early Primary Breast Cancer in... More >> the Elderly. Less << Phase 2 Recruiting July 2021 Germany ... More >> Ev. Krankenhaus Bethesda Brustzentrum Niederrhein Recruiting Moenchengladbach, Germany, 41061 Contact: Ulrike Nitz, Prof. Dr.    +4921619812330    ulrike.nitz@wsg-online.com    Principal Investigator: Raquel von Schumann, MD          Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern Recruiting Munich, Germany, 81337 Contact: Nadia Harbeck, Prof. Dr.          Principal Investigator: Nadia Harbeck, Prof. Dr. Less <<
NCT00312208 Breast Cancer Phase 3 Completed - -
NCT00357500 Central Nervous System Tumor, ... More >>Pediatric Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Connecticut ... More >> Connecticut Children's Medical Center Hartford, Connecticut, United States, 06106 United States, Florida Miami Children's Hospital Miami, Florida, United States, 33155-4069 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maine Maine Medical Center Research Institute Scarborough, Maine, United States, 04074-7205 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Missouri St. Louis Children's Hospital Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York NYU Cancer Institute at New York University Medical Center New York, New York, United States, 10016 United States, Rhode Island Hasbro Children's Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT03333486 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Leukemia in Remission Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Gene Mutations Aplastic Anemia B-Cell Non-Hodgkin Lymphoma CD40 Ligand Deficiency Chronic Granulomatous Disease Chronic Leukemia in Remission Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Congenital Amegakaryocytic Thrombocytopenia Congenital Neutropenia Congenital Pure Red Cell Aplasia Glanzmann Thrombasthenia Immunodeficiency Syndrome Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Paroxysmal Nocturnal Hemoglobinuria Plasma Cell Myeloma Polycythemia Vera Recurrent Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Severe Aplastic Anemia Shwachman-Diamond Syndrome Sickle Cell Disease T-Cell Non-Hodgkin Lymphoma Thalassemia Waldenstrom Macroglobulinemia Wiskott-Aldrich Syndrome Less << Phase 2 Recruiting September 6, 2022 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Sophia R. Balderman    716-845-6972    Sophia.Balderman@roswellpark.org    Principal Investigator: Sophia R. Balderman Less <<
NCT00003829 Leukemia Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00379015 Breast Cancer Phase 2 Completed - Japan ... More >> Shikoku Cancer Center Matsuyama-shi, Ehime, Japan, 791-0288 National Kyushu Cancer Center Fukuoka-shi, Fukuoka, Japan, 811-1395 Niigata Cancer Center Hospital Niigata, Japan, 951-8566 Keio University Hospital Tokyo, Japan, 160-8582 Teikyo University School of Medicine Tokyo, Japan, 173-8605 Less <<
NCT00499733 Cancer Not Applicable Unknown - United States, Maryland ... More >> Brady Urological Institute at Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21205 Contact: Ronald Rodriguez, MD, PhD    410-614-6662 Less <<
NCT00357500 - Completed - -
NCT00545714 Lymphocytic Leukemia, Chronic Phase 2 Completed - Spain ... More >> Vitoria, Alava, Spain, 01009 Cádiz, Cadiz, Spain, 11009 Jerez de La Frontera, Cadiz, Spain, 11407 Santander, Cantabria, Spain, 39008 La Coruna, La Coruña, Spain, 15006 Alcorcon, Madrid, Spain, 28922 Mostoles, Madrid, Spain, 28935 Gandia, Valencia, Spain, 46702 Sagunto, Valencia, Spain, 46520 Bilbao, Vizcaya, Spain, 48013 Badajoz, Spain, 06080 Barcelona, Spain, 08907 Caceres, Spain, 10003 Castellon, Spain, 12004 Granada, Spain, 18014 Madrid, Spain, 28007 Madrid, Spain, 28034 Madrid, Spain, 28040 Madrid, Spain, 28041 Madrid, Spain, 28046 Madrid, Spain, 28050 Madrid, Spain, 28222 Madrid, Spain, 28805 Madrid, Spain, 28905 Malaga, Spain, 29010 Murcia, Spain, 30008 Salamanca, Spain, 37007 Valencia, Spain, 46014 Valencia, Spain, 46015 Valencia, Spain, 46017 Valencia, Spain, 46026 Zaragoza, Spain, 50009 Less <<
NCT02789332 Breast Cancer ... More >> Triple Negative Breast Neoplasms HRpos Breast Neoplasms BRCA 1 /2 and / or HRD Less << Phase 2 Recruiting November 2018 Germany ... More >> Kliniken Esslingen, Gynäkologie Onkologie Not yet recruiting Esslingen am Neckar, Baden-Württemberg, Germany, 73730 Universitätsklinikum Erlangen Recruiting Erlangen, Bayern, Germany, 91054 Onkologisches Zentrum am Rotkreuzklinikum München Not yet recruiting München, Bayern, Germany, 80638 Elisabeth Krankenhaus Not yet recruiting Kassel, Hessen, Germany, 34117 Klinikum Südstadt Not yet recruiting Rostock, Mecklenburg-Vorpommern, Germany, 18059 Sana Klinikum Hameln-Pyrmont Not yet recruiting Hameln, Niedersachsen, Germany, 31785 Gemeinschaftspraxis Not yet recruiting Hildesheim, Niedersachsen, Germany, 31134 Marienhospital Witten Not yet recruiting Witten, Nordrhein-Westfalen, Germany, 58452 Martin-Luther-Universität Halle Wittenberg Not yet recruiting Halle, Sachsen Anhalt, Germany, 06120 Johanniter-Krankenhaus Genthin-Stendal Not yet recruiting Stendal, Sachsen-Anhalt, Germany, 39576 SRH Wald-Klinikum Gera GmbH Not yet recruiting Gera, Thüringen, Germany, 07548 Praxisklinik Not yet recruiting Berlin, Germany, 10367 Less <<
NCT00841828 - Completed - -
NCT00841828 Breast Cancer Phase 2 Phase 3 Completed - Spain ... More >> Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital General de Granollers Granollers, Barcelona, Spain, 08400 Xarxa Asistencial de Manresa Manresa, Barcelona, Spain, 08243 Corporación Sanitaria Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital del Espíritu Santo Santa Coloma De Gramenet, Barcelona, Spain, 08923 Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain, 08221 Hospital Mutua de Terrassa Terrassa, Barcelona, Spain, 08221 Onkologikoa Donostia-San Sebastián, Guipuzcoa, Spain, 20012 Hospital Xeral Cíes Vigo, Pontevedra, Spain, 36204 Hospital Universitario de Canarias La Laguna, Santa Cruz De Tenerife, Spain, 38320 Complejo Hospitalario Universitario A Coruña A Coruña, Spain, 15006 Centro Oncológico de Galicia A Coruña, Spain, 15009 Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial Barcelona, Spain, 08036 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08041 Hospital General Yagüe Burgos, Spain, 09005 Complejo Hospitalario San Pedro de Alcántara Cáceres, Spain, 10003 Complejo Hospitalario Universitario Reina Sofía Córdoba, Spain, 14004 Complejo Hospitalario de Jaén Jaén, Spain, 23007 Hospital Universitario de la Princesa Madrid, Spain, 28006 Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Virgen de la Salud Toledo, Spain, 45004 Hospital Universitario La Fe Valencia, Spain, 46009 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT02054104 Thoracic Sarcomas ... More >> Thorasic Cancers Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura Sarcoma Melanoma Less << Phase 1 Phase 2 Suspended November 5, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00438984 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00121992 Breast Neoplasms Phase 3 Completed - Spain ... More >> Spanish Breast Cancer Research Group San Sebastián de los Reyes, Madrid, Spain, 28700 Less <<
NCT01477021 Adult Liposarcoma ... More >> Adult Synovial Sarcoma Recurrent Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00004067 Breast Cancer Phase 3 Active, not recruiting March 2020 -
NCT00544765 Breast Cancer Phase 3 Completed - -
NCT00254410 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00553306 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01378533 Breast Cancer Phase 3 Unknown June 2013 China, Beijing ... More >> Cancer institute and hospital Chinese academy of medical sciences Recruiting Beijing, Beijing, China, 100021 Contact: qing li, bachelor    0086-010-87788120    cheryliqing@yahoo.cn    Contact: ying han, master    0086-010-87788120    huani8023@gmail.com Less <<
NCT01088724 Post-transplant Lymphoprolifer... More >>ative Disease (PTLD) Non Burkitt Less << Phase 4 Completed - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24121 Less <<
NCT03023046 Adult Acute Lymphoblastic Leuk... More >>emia Adult Lymphoblastic Lymphoma Philadelphia Chromosome Positive Less << Phase 2 Recruiting December 1, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ryan D. Cassaday    206-606-1202    cassaday@seattlecca.org    Principal Investigator: Ryan D. Cassaday Less <<
NCT00991133 Lymphoblastic Leukemia, Acute,... More >> Childhood Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Colorado The Children's Hospital Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT01131195 Breast Cancer Phase 3 Active, not recruiting June 30, 2019 Switzerland ... More >> Hirslanden Klinik Aarau Aarau, Switzerland, CH-5001 Kantonspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Spitalzentrum Biel Biel, Switzerland, CH-2501 RSV-GNW Spitalzentrum Oberwallis Brig, Switzerland, 3900 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Kantonsspital Frauenfeld Frauenfeld, Switzerland, 8501 Kantonsspital Freiburg Fribourg, Switzerland, 1708 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Luzern Luzerne, Switzerland, CH-6000 Oncology Institute of Southern Switzerland - IOSI Ticino Mendrisio, Switzerland, CH-6850 Kantonsspital Olten Olten, Switzerland, CH-4600 Hopital Regional de Sion-Herens-Conthey Sion, Switzerland, CH -1951 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun Thun, Switzerland, 3600 Spital Uster Uster, Switzerland, 8610 Kantonsspital Winterthur Winterthur, Switzerland, 8401 Onkozentrum - Klinik im Park Zurich, Switzerland, 8002 Onkozentrum Hirslanden Zurich, Switzerland, CH-8008 City Hospital Triemli Zurich, Switzerland, CH-8063 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01547741 Breast Cancer Phase 3 Active, not recruiting May 2019 -
NCT00589238 Breast Cancer Phase 2 Terminated - Singapore ... More >> National Cancer Centre - Singapore Singapore, Singapore, 169610 KK Women's and Children Hospital Singapore, Singapore Less <<
NCT00254410 - Completed - -
NCT03143049 Relapse Multiple Myeloma Phase 3 Recruiting June 1, 2022 Hong Kong ... More >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Japan Not yet recruiting Japan, Japan Korea, Republic of Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan Less <<
NCT00254163 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 3 Completed - United States, Florida ... More >> Cancer Centers of Florida, P.A. Ocoee, Florida, United States, 34761 United States, Indiana Hope Center Terre Haute, Indiana, United States, 47802 United States, Maryland Alliance Hematology Oncology PA Westminster, Maryland, United States, 21157 United States, Missouri St Joseph Oncology, Inc St Joseph, Missouri, United States, 64507 United States, New York New York Oncology Hematology, PC Albany, New York, United States, 12208 United States, North Carolina Northwestern Carolina Oncology Hemato Hickory, North Carolina, United States, 28602 United States, Pennsylvania Medical Oncology Associates Kingston, Pennsylvania, United States, 18704 United States, Texas South Texas Cancer Center-McAllen McAllen, Texas, United States, 78503 Texas Oncology Cancer Center-Sugar Land Sugar Land, Texas, United States, 77479 United States, Washington Cancer Care Northwest-South Spokane, Washington, United States, 99202 Yakima Valley Mem Hosp/North Star Lodge Yakima, Washington, United States, 98902 Less <<
NCT00001155 Vasculitis We... More >>gener's Granulomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00003605 Lymphoma Phase 2 Withdrawn(no patient accrual) - United States, California ... More >> Hoag Memorial Hospital Presbyterian Newport Beach, California, United States, 92658 United States, Indiana Bloomington Hospital Bloomington, Indiana, United States, 47402 United States, Texas St. Joseph Regional Cancer Center Bryan, Texas, United States, 77802 Less <<
NCT01010217 Blood Stem Cell Transplant Fai... More >>lure Leukemia Hematologic Malignancies Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00595127 Fanconi Anemia Not Applicable Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00254163 - Completed - -
NCT00595127 - Completed - -
NCT00003764 Leukemia Phase 3 Completed - -
NCT02412423 Hematopoietic Stem Cell Transp... More >>lantation Less << Phase 4 Completed - China ... More >> Peking University People's Hospital Beijing, China, 100044 Less <<
NCT00576979 Leukemia Phase 1 Phase 2 Active, not recruiting June 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT02583828 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Not Applicable Recruiting December 2020 China ... More >> Capital Medical Unvierstiy Cancer Center/ Beijing Shijitan Hospital Recruiting Beijing, China, 100038 Contact: Jun Ren, MD, PhD    86-10-63926317    renjun9688@yahoo.com Less <<
NCT00001626 Severe Aplastic Anemia Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00003754 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01697293 Breast Adenocarcinoma ... More >> Estrogen Receptor Positive HER2/Neu Negative Recurrent Breast Carcinoma Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 1 Phase 2 Recruiting January 2019 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Hyo S. Han    813-745-8480    hyo.han@moffitt.org    Principal Investigator: Hyo S. Han          United States, New York Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Joseph A. Sparano    718-405-8404    jsparano@montefiore.org    Principal Investigator: Joseph A. Sparano Less <<
NCT00420563 Cancer Phase 2 Completed - France ... More >> Centre Oscar Lambret Lille, France, 59020 Hopital Saint Vincent Lille, France, 59020 Centre Hospitalier Regional - Dermatology Lille, France, 59035 Centre Hospitalier Regional - Oncology Lille, France, 59035 Less <<
NCT01671319 Female Breast Cancer Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT01204437 Breast Cancer Phase 2 Phase 3 Completed - Germany ... More >> German Breast Group, GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT00003340 Leukemia Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 Less <<
NCT01005537 - - - -
NCT03726879 Breast Cancer Phase 3 Not yet recruiting February 8, 2023 -
NCT00448019 - Completed - -
NCT01671319 - Completed - -
NCT00448019 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00516295 Ewing Sarcoma of Bone ... More >> Extraosseous Ewing Sarcoma Peripheral Primitive Neuroectodermal Tumor Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Completed - United States, Pennsylvania ... More >> Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00516295 - Completed - -
NCT00003659 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003659 - Completed - -
NCT02388594 Human Immunodeficiency Virus (... More >>HIV) Less << Phase 1 Active, not recruiting February 2019 United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00147901 B-cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 2 Completed - Germany ... More >> University of Cologne Cologne, NRW, Germany, 50924 Less <<
NCT01339663 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01416038 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Winthrop University Hospital Mineola, New York, United States, 11501 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas Mary Crowley Cancer Research Center Dallas, Texas, United States, 75230 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03152318 Malignant Glioma of Brain ... More >> Astrocytoma Malignant Astrocytoma Oligodendroglioma Anaplastic Oligodendroglioma of Brain (Diagnosis) Mixed Oligo-Astrocytoma Ependymoma Ganglioglioma Pylocytic/Pylomyxoid Astrocytoma Brain Tumor Glioma Brain Cancer Glioblastoma Glioblastoma Multiforme Less << Phase 1 Recruiting July 2022 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: E.Antonio Chiocca, MD, PhD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: E. Antonio Chiocca, MD, PhD    617-732-6939    echiocca@partners.org    Principal Investigator: E. Antonio Chiocca, MD, PhD Less <<
NCT02248597 Graft Versus Host Disease ... More >> Hematopoietic/Lymphoid Cancer Less << Phase 2 Recruiting January 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zachariah A. McIver    336-713-5440    zmciver@wakehealth.edu    Principal Investigator: Zachariah A. McIver Less <<
NCT00689156 Breast Neoplasms Phase 3 Completed - Denmark ... More >> Dept. of Oncology; Aalborg Sygehus Aalborg, Denmark, DK-9000 Dept. of Oncology; Rigshospitalet Copenhagen, Denmark, DK-2100 Dept. of Oncology; Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark, DK-6700 Dept. of Oncology; Herlev Hospital Herlev, Denmark, DK-2730 Dept. of Oncology; Regionshospitalet Herning Herning, Denmark, DK-7400 Dept. of Oncology; Nordsjællands Hospital Hillerød Hillerød, Denmark, DK-3400 Dept. of Oncology; Sygehus Syd Næstved Næstved, Denmark, DK-4700 Dept. of Oncology; Odense University Hospital Odense, Denmark, DK-5000 Dept. of Oncology; Sygehus Øst Roskilde Roskilde, Denmark, DK-4000 Dept. of internal medicine; Bornholms Hospital Rønne, Denmark, DK-3700 Dept. of Oncology; Vejle Sygehus Vejle, Denmark, DK-7100 Dept. of Oncology; Regionshospitalet Viborg Viborg, Denmark, DK-8800 Dept. of Oncology; Århus Sygehus Århus, Denmark, DK-8000 Less <<
NCT00551889 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - -
NCT02413320 Triple-negative Breast Cancer Phase 2 Active, not recruiting December 25, 2019 United States, Kansas ... More >> University of Kansas Cancer Center - CRC Fairway, Kansas, United States, 66205 Hays Medical Center Hays, Kansas, United States, 67601 University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States, 66210 Salina Regional Health Center Salina, Kansas, United States, 67401 University of Kansas Cancer Center - Westwood Westwood, Kansas, United States, 66205 United States, Missouri Truman Medical Center Kansas City, Missouri, United States, 64108 University of Kansas Cancer Center - South Kansas City, Missouri, United States, 64131 University of Kansas Cancer Center - North Kansas City, Missouri, United States, 64154 University of Kansas Cancer Center - Lee's Summit Lee's Summit, Missouri, United States, 64064 Less <<
NCT02315716 Multiple Myeloma Phase 2 Recruiting November 2026 United Kingdom ... More >> Queen's Hospital Recruiting Romford, Essex, United Kingdom, RM7 0AG Principal Investigator: Biju Krishan, Dr          Royal United Hospital Recruiting Bath, United Kingdom, BA1 3NG Principal Investigator: Sally Moore, Dr          Queen Elizabeth Hospital Not yet recruiting Birmingham, United Kingdom, B15 2TH Principal Investigator: Mark Cook, Dr          Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom, B9 5SS Principal Investigator: Bhuvan Kishore, Dr          Addenbrooke's Hospital Not yet recruiting Cambridge, United Kingdom, CB2 0QQ Principal Investigator: Mike Chapman, Dr          Kent and Canterbury Hospital Recruiting Canterbury, United Kingdom, CT1 3NH Principal Investigator: Jindriska Lindsay, Dr          University Hospital of Wales Recruiting Cardiff, United Kingdom, CF14 4XW Principal Investigator: Ceri Bygrave, Dr          Medway NHS Foundation Trust Recruiting Gillingham, United Kingdom, ME7 5NY Contact: Vivienne Andrews          Principal Investigator: Vivienne Andrews, Dr          St James' Hospital Recruiting Leeds, United Kingdom, LS9 7TF Principal Investigator: Gordon Cook, Prof.          St Bartholomew's Hospital Recruiting London, United Kingdom, EC1A 7BE Principal Investigator: James Cavenagh, Prof.          Barnet Hospital Recruiting London, United Kingdom, EN5 3DJ Principal Investigator: Andres Virchis, Dr          Guy's Hospital Recruiting London, United Kingdom, SE1 9RT Principal Investigator: Matthew Streetly, Dr          King's College Hospital Recruiting London, United Kingdom, SE5 9RS Contact: Matthew Streetly, Dr          Principal Investigator: Matthew Streetly, Dr          St George's Hospital Recruiting London, United Kingdom, SW17 0QT Principal Investigator: Fenella Willis, Dr          University College London Hospital Recruiting London, United Kingdom Principal Investigator: Rakesh Popat, Dr.          Maidstone Hospital Recruiting Maidstone, United Kingdom, ME16 9QQ Principal Investigator: Lalita Banerjee, Dr          Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Principal Investigator: Karthik Ramasamy, Dr          Royal Hallamshire Hospital Not yet recruiting Sheffield, United Kingdom, S10 2SB Principal Investigator: Andrew Chantry, Dr Less <<
NCT00004896 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01992653 Lymphoma, Non Hodgkin Phase 1 Phase 2 Active, not recruiting January 25, 2019 United States, Alabama ... More >> The University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Arizona Banner MD Anderson Cancer Center Gilbert, Arizona, United States, 85234 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University; Pediatrics Saint Louis, Missouri, United States, 63110 United States, Oregon Northwest Cancer Specialists Portland, Oregon, United States, 97210 Oregon Health and Science University Portland, Oregon, United States, 97239 Willamette Valley Clinical Studies; Cancer Institute Springfield, Oregon, United States, 97477 United States, Texas Cancer Care Centers of South Texas San Antonio, Texas, United States, 78212 United States, Virginia Blue Ridge Cancer Care Roanoke, Virginia, United States, 24014 United States, Washington Northwest Medical Specialties, PLLC; Research Department Tacoma, Washington, United States, 98405 France Hopital Henri Mondor, Unite Hemopathies lymphoides Creteil, France, 94010 Hopital Claude Huriez - CHU Lille; Service des maladies du sang Lille, France, 59037 Hopital Haut-Leveque - Centre Francois Magendie; Service d'Hematologie Clinique Pessac, France, 33604 Centre Hospitalier Lyon Sud; Hematolgie Pierre Benite, France, 69495 Hopital Pontchaillou - CHU de Rennes Rennes, France, 35033 Centre Henri Becquerel; Hematologie Rouen, France, 76038 Less <<
NCT00789581 Breast Cancer Phase 3 Completed - -
NCT01285817 Solid Tumours. Phase 2 Unknown March 2016 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: arnaud verschuur       arnaud.verschuur@ap-hm.fr Less <<
NCT00789581 - Completed - -
NCT03270748 Myeloid Malignancies Phase 2 Not yet recruiting January 1, 2021 Italy ... More >> Ospedale San Orsola Bologna, Italy AOU-IRCCS San Martino-IST Genova, Italy A.O.U. Citta della Salute e della Scienza Not yet recruiting Torino, Italy Principal Investigator: Benedetto Bruno Less <<
NCT02971982 Treatment Phase 1 Phase 2 Unknown December 2018 China, Jiangsu ... More >> First Affiliated Hospital, Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Fu chengcheng, Phd    13962191404    evergirl@sina.com Less <<
NCT00107094 Breast Cancer Phase 1 Completed - United States, North Carolina ... More >> Abraxis BioScience Inc. Durham, North Carolina, United States, 27703 Less <<
NCT03473691 Triple Negative Breast Cancer Early Phase 1 Withdrawn(Pharmaceutical compa... More >>ny decided to withdraw funding and not provide drug.) Less << May 1, 2018 -
NCT03426969 Myelofibrosis Early Phase 1 Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       sciurea@mdanderson.org Less <<
NCT00005970 Breast Adenocarcinoma ... More >> HER2 Positive Breast Carcinoma Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 Less << Phase 3 Active, not recruiting - -
NCT00544167 Breast Cancer Not Applicable Completed - United States, Florida ... More >> Integrated Community Oncology Network Jacksonville, Florida, United States, 32256 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Peninsula Cancer Institute Newport News, Virginia, United States, 23601 Less <<
NCT02785250 Recurrent Epithelial Ovarian C... More >>ancer Recurrent Fallopian Tube Cancer Recurrent Peritoneal Cancer Less << Phase 1 Phase 2 Recruiting May 2020 United States, California ... More >> Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Alma Gonzalez    650-498-0624    agonlex@stanford.edu    United States, Georgia Georgia Cancer Center at Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Sandra Wall, BSN    706-721-4430    swall@augusta.edu    United States, New York Lenox Hill Hospital Recruiting New York, New York, United States, 10028 Contact: Jeannine Villella, DO       jvillella@northwell.edu    Contact: Sangmi Lee, RN, MSN    212-434-4482    slee52@northwell.edu    United States, Oregon Oregon Health & Sciences University, Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Knight Clinical Trials Information Line    503-494-1080    trials@ohsu.edu    Principal Investigator: Tanja Pejovic, MD          United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Cathi Lee Ybarra, BSN    215-614-0234       United States, Texas Mary Crowley Cancer Research Center Recruiting Dallas, Texas, United States, 75230 Contact: Referral Office    972-566-3000    referral@marycrowley.org    Principal Investigator: John Nemunaitis, MD          Canada, Alberta Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada Contact: Minna Gill, BSN    403-521-3149    minna.gill@ahs.ca    Canada, Ontario Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Amit Oza, MD    416-946-2818    amit.oza@uhn.ca Less <<
NCT00544167 - Completed - -
NCT01282216 Transplant-Related Cancer Not Applicable Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT00994968 Breast Cancer Phase 2 Unknown - Korea, Republic of ... More >> Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of Contact: Joo Hyuk Sohn, MD, PhD    82-2-2228-8130 Less <<
NCT00004175 Breast Cancer Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Illinois Monroe Medical Associates Chicago, Illinois, United States, 60603 Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Less <<
NCT01019876 Bone Marrow Failure ... More >> Osteopetrosis Fanconi Anemia Severe Combined Immunodeficiency Less << Phase 2 Phase 3 Unknown May 2013 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: James Garvin, MD, PhD    212-305-5872    jhg1@columbia.edu    Contact: William A Kim, PhD    212-305-7213    billkim@columbia.edu    Principal Investigator: James Garvin, MD, PhD Less <<
NCT00978913 Breast Cancer ... More >> Malignant Melanoma Less << Phase 1 Completed - Denmark ... More >> Department of Oncology, Herlev University Hospital Herlev, Denmark, Dk 2730 Less <<
NCT00397800 Lymphoma Phase 1 Phase 2 Unknown May 2013 Germany ... More >> Medizinische Klinik, Klinikum Augsburg Augsburg, Germany, D-86156 Medizinische Klinik III - Universitaetsklinikum Erlangen Erlangen, Germany, D-91054 Universitaetsklinikum Goettingen Goettingen, Germany, D-37075 Universitaetsklinikum Schleswig-Holstein - Campus Luebeck Luebeck, Germany, D-23538 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, D-55101 LMU-Klinikum Grosshadern Munich, Germany, D-81366 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Klinikum der Universitaet Regensburg Regensburg, Germany, D-93042 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg Wuerzburg, Germany, D-97080 Less <<
NCT00003658 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01150513 Breast Cancer Phase 2 Phase 3 Completed - China ... More >> Cancer Institute & Hospital Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT00445900 Chronic Myeloproliferative Dis... More >>orders Secondary Myelofibrosis Less << Phase 2 Completed - -
NCT00002482 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Phase 2 Unknown - United States, California ... More >> St. Vincent Medical Center - Los Angeles Los Angeles, California, United States, 90057 Less <<
NCT02455141 Breast Neoplasm Phase 3 Recruiting December 2020 China, Fujian ... More >> The First Affiliated Hospital of Fujian Medical University Recruiting Fuzhou, Fujian, China, 350005 Contact: Xiangjin Chen, MD.          China, Guangdong Guangdong Maternal and Child Health Care Hospital Recruiting Guangzhou, Guangdong, China, 510000 Contact: Anqin Zhang, MD          China, Heilongjiang Cancer Hospital Affiliated to Harbin Medical University Recruiting Harbin, Heilongjiang, China, 150081 Contact: Guoqiang Zhang          China, Jiangsu Jiangsu Jiangyin People's Hospital Recruiting Jiangyin, Jiangsu, China, 214400 Contact: Qing Shao, MD.          The First People's Hospital of Wujiang District Recruiting Suzhou, Jiangsu, China, 215200 Contact: Xiaodong Wang, MD.          China, Shanghai Obstetrics & Gynecology Hospital of Fudan University Recruiting Shanghai, Shanghai, China, 200021 Contact: Kejin Wu, MD.          Shanghai JiaoTong University School of Medicine, Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Kunwei Shen, professor    0086-021-64370045 ext 602205    kwshen@medmail.com.cn    Central Hospital of Huangpu District, Shanghai Recruiting Shanghai, Shanghai, China Contact: Jialin Bao, MD.          Shanghai International Peace Maternal and child health care hospital Recruiting Shanghai, Shanghai, China Contact: QI He, MD.          The Ninth People's Hospital of Shanghai Not yet recruiting Shanghai, Shanghai, China Contact: Shanyu Guo, MD.          China, Zhejiang Jiaxin Maternal and Child Health Care Hospital Recruiting Jiaxin, Zhejiang, China, 310000 Contact: Juanying Zhu, MD          Lishui People's Hospital Recruiting Lishui, Zhejiang, China, 310000 Contact: Yong Shi, MD          Ningbo Medical Treatment Center Lihuili Hospital Recruiting Ningbo, Zhejiang, China, 315000 Contact: Weizhu Wu, MD.          Ningbo Women and Children's Hospital Recruiting Ningbo, Zhejiang, China, 315000 Contact: Zhanwen Li, MD.          Rui'an People's Hospital Recruiting Rui'an, Zhejiang, China, 325200 Contact: Weili Wu          Taizhou Central Hospital Recruiting Taizhou, Zhejiang, China, 318000 Contact: Yuechu Dai, MD.          Zhoushan Hospital Recruiting Zhoushan, Zhejiang, China, 316000 Contact: Xia Qiu, MD. Less <<
NCT00544232 Breast Cancer Phase 3 Completed - -
NCT00856180 Ovarian Cancer ... More >> Peritoneal Cancer Fallopian Tube Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02225795 Crohn's Disease Not Applicable Withdrawn(recruitment difficul... More >>ty) Less << December 2019 -
NCT00939653 Relapsed Acute Myelogenous Leu... More >>kemia Less << Phase 2 Terminated(Study lost funding ... More >>and it was decided that it could not meet it's accrual goals.) Less << - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Chicago, Illinois, United States United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, North Carolina Levine Children's Hospital at Carolinas Medical Center Charlotte, North Carolina, United States, 28203 United States, Tennessee Vanderbilt Children's Hospital Nashville, Tennessee, United States Less <<
NCT00429026 Renal Cell Cancer Phase 2 Terminated(Slow accrual, study... More >> terminated.) Less << - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03440411 Multiple Myeloma Phase 3 Recruiting February 18, 2023 Italy ... More >> FO.NE.SA.Onlus Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD    +390116336107    clinicaltrialoffice@fonesa.it Less <<
NCT03268889 Peripheral T Cell Lymphoma Not Applicable Recruiting September 15, 2020 China, Jiangsu ... More >> the First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215006 Contact: Zhengming Jin, MD, PhD    (+86)512-67781856 Less <<
NCT00856180 - Completed - -
NCT00407888 Estrogen Receptor-positive Bre... More >>ast Cancer HER2-positive Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01091831 Multiple Myeloma Phase 3 Active, not recruiting July 2019 Italy ... More >> Division of Hematology, Molinette Hospital Torino, Italy, 10126 Less <<
NCT00718549 Lymphocytic Leukemia, Chronic Phase 3 Completed - Belarus ... More >> City Clinical Hospital #9 Minsk, Belarus, 220116 Poland Medical University, Independent Public Clinical Hospital; Dept. of Hematology, SPSK Bialystok, Poland, 15-276 Szpital Uniwersytecki W Krakowie; Klinika Hematologii Krakow, Poland, 31-501 Medical University School; Dept. of Haematology Lodz, Poland, 93-510 Istytut Hematologii i Transfuzjologii; Hematologia Warszawa, Poland, 02 776 Medical Uni of Wroclaw; Hematology Wroclaw, Poland, 50-367 Less <<
NCT00407888 - Completed - -
NCT00317876 Fanconi Anemia Phase 1 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Brazil Universidade Federal do Parana Curitiba, Parana, Brazil, 80.060-000 Less <<
NCT00125606 Acute Myeloid Leukemia Phase 3 Terminated(insufficient patien... More >>t recruitement) Less << - Germany ... More >> Department of Medicine/Hematology and Oncology Muenster, NRW, Germany, 48149 Less <<
NCT00429026 - Terminated(Slow accrual, study... More >> terminated.) Less << - -
NCT02362165 Multiple Myeloma Phase 3 Unknown May 2018 China, Guangdong ... More >> Sun Yat-sen university cancer center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhongjun Xia, MD    020-87342439    xiazhj@sysucc.org.cn Less <<
NCT01966289 Metastatic Colorectal Cancer Phase 1 Active, not recruiting December 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00085423 - Completed - -
NCT00474747 Aplastic Anemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00024440 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Genta Incorporated Berkeley Heights, New Jersey, United States, 07922 Less <<
NCT00103792 Wegener's Granulomatosis ... More >> Vasculitis Less << Phase 3 Unknown January 2012 Netherlands ... More >> University Medical Centre Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Patricia Stassen, M.D.    +31503611295    p.m.stassen@int.umcg.nl    Contact: Coen Stegeman, M.D., Ph. D.    +31503616161    c.a.stegeman@int.umcg.nl    Sub-Investigator: Patricia Stassen, M.D. pH.D. Less <<
NCT00087178 Breast Cancer Phase 3 Completed - -
NCT00085423 Melanoma (Skin) Phase 2 Completed - United States, New Hampshire ... More >> Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 Less <<
NCT00801060 Chronic Lymphocytic Leukemia Phase 2 Terminated - -
NCT01283386 Lymphocytic Leukemia, Chronic Phase 4 Completed - Russian Federation ... More >> Irkutsk, Russian Federation, 664079 Kemerovo, Russian Federation, 650066 Moscow, Russian Federation, 115478 Moscow, Russian Federation, 125284 Saint-Petersburg, Russian Federation, 198205 St. Petersburg, Russian Federation, 197110 Tula, Russian Federation, 300053 UFA, Russian Federation, 450005 Less <<
NCT01124526 Non Hodgkin Lymphoma Phase 4 Completed - Spain ... More >> Hospital Infanta Cristina Badajoz, Badajoz_Extremadura, Spain, 06080 Hospital del Mar Barcelona, Barcelona_ Cataluña, Spain, 08003 Instituto Catalán de Oncología (ICO) Barcelona, Barcelona_Cataluña, Spain, 08907 Hospital San Pedro de Alcántara Cáceres, Cáceres_Extremadura, Spain, 10003 Hospital de Puerto Real Puerto Real, Cádiz_ Andalucía, Spain, 11510 Complejo Hospitalario Xeral_Calde Lugo, Lugo_ Galicia, Spain, 27004 Hospital Universitario Príncipe de Asturias Alcalá de Henares, Madrid, Spain, 28805 Fundación Hospital Alcorcón Alcorcón, Madrid, Spain, 28922 Hospital de Fuenlabrada Fuenlabrada, Madrid, Spain, 28943 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital de Móstoles Móstoles, Madrid, Spain, 28935 Hospital Clínico Universitario de Salamanca Salamanca, Salamanca_Castilla León, Spain, 37007 Hospital General de Segovia Segovia, Segovia_ Castilla León, Spain, 40001 Hospital Clínico del Río Hortega Valladolid, Valladolid_Castilla León, Spain, 47010 MD Anderson Internacional España Madrid, Spain, 28033 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Fundación Jiménez Díaz Madrid, Spain, 28040 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Less <<
NCT03731832 Refractory Multiple Myeloma Phase 2 Recruiting February 2022 Germany ... More >> Klinikum rechts der Isar der TU München / III. Med. Klinik und Poliklinik Recruiting Munich, Bayern, Germany, 81675 Contact: Florian Bassermann, Prof. Dr. med.       florian.bassermann@tum.de    phase drei Hämato-Onkologischer Studienkreis am Klinikum Aschaffenburg Recruiting Aschaffenburg, Germany, 63739 Contact: Manfred Welslau, Dr.med.       info@onkologie-ab.de    Sozialstiftung Bamberg / Klinik am Bruderwald, Zentrum für Innere Medizin, Med. Klinik V, Hämatologie und internistische Onkologie Recruiting Bamberg, Germany, 96049 Contact: Ruth Seggewiß-Bernhardt, PD.Dr. med.       ruth.seggewiss-bernhardt@sozialstiftung-bamberg.de    Klinikum der Johann Wolfgang Goethe-Universität Frankfurt am Main Not yet recruiting Frankfurt am main, Germany, 60590 Contact: Ivana von Metzler, Dr. med.       ivana.metzler@kgu.de    Universitätsklinikum Jena / Klinik für Innere Medizin II, Abteilung für Hämatologie und internistische Onkologie Recruiting Jena, Germany, 07747 Contact: Marie von Lilienfeld-Toal, Prof. Dr. med.       marie.von_lilienfeld-toal@med.uni-jena.de    Universitätsklinikum Magdeburg A.Ö.R / Klinik für Hämatologie und Onkologie Recruiting Magdeburg, Germany, 39120 Contact: Denise Wolleschak, Dr. med.       denise.wolleschak@med.ovgu.de    Kliniken Ostalb Stauferklinikum Schwäbisch Gmünd Recruiting Mutlangen, Germany, 73557 Contact: Holger Hebart, Prof. Dr. med.       holger.hebart@kliniken-ostalb.de    Universitätsklinikum Münster / Medizinische Klinik A Recruiting Münster, Germany, 48149 Contact: Julia Reusch, Dr. med.       julia.reusch@ukmuenster.de    Studienzentrum Onkologie Ravensburg Recruiting Ravensburg, Germany, 88212 Contact: Tobias Dechow, Prof. Dr. med.       dechow@onkonet.eu    Universitätsklinikum Ulm / Klinik für Innere Medizin III Not yet recruiting Ulm, Germany, 89081 Contact: Miriam Kull, Dr. med.       miriam.kull@uniklinik-ulm.de    Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Stefan Knop, Prof.       Knop_S@ukw.de Less <<
NCT01003054 Chronic Myelogenous Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77070 Less <<
NCT00343863 Male Breast Cancer ... More >> Nausea and Vomiting Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00208975 Lymphoma Phase 2 Terminated(slow accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00343863 - Completed - -
NCT00438841 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, California ... More >> Alta Bates Summit Comprehensive Cancer Center Berkeley, California, United States, 94704 Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Desert Regional Medical Center Comprehensive Cancer Center Palm Springs, California, United States, 92262 Sutter Cancer Center Sacramento, California, United States, 95816 United States, Florida Eugene M. and Christine E. Lynn Cancer Institute at Boca Raton Community Hospital - Main Campus Boca Raton, Florida, United States, 33486 United States, New York St. Vincent's Comprehensive Cancer Center - Manhattan New York, New York, United States, 10011 United States, Oregon Oregon Health and Science University Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Lone Star Oncology - Austin Austin, Texas, United States, 78759 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT01612247 Breast Cancer Not Applicable Unknown February 2014 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center Not yet recruiting Lebanon, New Hampshire, United States, 03756 Contact: Mary Chamberlin, MD    603-653-9000       Principal Investigator: Mary Chamberlin, MD          United States, New York Maimonides Cancer Center Recruiting Brooklyn,, New York, United States, 11220 Contact: Susan Radoux, MD    718-765-2644    SBurdette-Radoux@maimonidesmed.org    Principal Investigator: Susan Radoux, MD          United States, Vermont University of Vermont Recruiting Burlington, Vermont, United States, 05401 Contact: Marie E Wood, MD    802-656-5487       Contact: Kim Dittus, MD    802-656-5487       Principal Investigator: Marie E Wood, MD Less <<
NCT01206881 Breast Cancer Phase 2 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8200 Rigshospitalet Copenhagen, Denmark, 2100 Herlev Hospital Herlev, Denmark Odense University Hospital Odense, Denmark, 5000 Less <<
NCT03399747 Diffuse Large B-cell Lymphoma Phase 2 Enrolling by invitation December 31, 2024 -
NCT02643420 Neutropenia B... More >>reast Cancer Less << Phase 3 Active, not recruiting October 2018 United States, Tennessee ... More >> The West Clinic Germantown, Tennessee, United States, 38138 Less <<
NCT00718549 - Completed - -
NCT00080847 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Less << Phase 2 Terminated - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00228358 HER2-positive Breast Cancer ... More >> Recurrent Breast Cancer Recurrent Non-small Cell Lung Cancer Recurrent Ovarian Epithelial Cancer Recurrent Ovarian Germ Cell Tumor Stage IV Breast Cancer Stage IV Non-small Cell Lung Cancer Stage IV Ovarian Epithelial Cancer Stage IV Ovarian Germ Cell Tumor Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00005940 Adult Acute Myeloid Leukemia i... More >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Less << Phase 2 Completed - United States, Washington ... More >> Pacific Northwest National Laboratory Richland, Washington, United States, 99352 VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00208975 - Terminated(slow accrual) - -
NCT00176839 Leukemia, Lymphocytic, Acute ... More >> AML MDS Less << Phase 2 Phase 3 Terminated(Replaced by a diffe... More >>rent study) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00176839 - Terminated(Replaced by a diffe... More >>rent study) Less << - -
NCT03042585 Relapsed Non Hodgkin Lymphoma ... More >> Refractory Non-Hodgkin Lymphoma Less << Not Applicable Recruiting December 2019 United States, Illinois ... More >> Patrick Stiff, MD Recruiting Maywood, Illinois, United States, 60153 Contact: Patrick Stiff, MD    708-327-3148    pstiff@lumc.edu    Contact: Mary Lee, RN    708-327-2241    mlee@luc.edu Less <<
NCT00611351 - Completed - -
NCT02828592 Severe Aplastic Anemia Phase 2 Recruiting April 2022 United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    Contact: Stacey Brown    404-851-8238    stacey.brown@northside.com    Sub-Investigator: Scott Solomon, MD          Sub-Investigator: H. Kent Holland, MD          Sub-Investigator: Asad Bashey, MD, PhD          Sub-Investigator: Lawrence Morris, MD          Principal Investigator: Melhem Solh, MD Less <<
NCT00611351 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Secondary Myelofibrosis Less << Phase 2 Completed - -
NCT00002953 Breast Cancer Phase 3 Completed - South Africa ... More >> Groote Schuur Hospital, Cape Town Cape Town, South Africa, 7925 United Kingdom University Birmingham Birmingham, England, United Kingdom, B15 2TT Bristol Royal Hospital for Sick Children Bristol, England, United Kingdom, BS2 8BJ Bristol Oncology Centre Bristol, England, United Kingdom, BS2 8ED Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, L63 4JY Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Norfolk & Norwich Hospital Norwich, England, United Kingdom, NR1 3SR Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 7LJ Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Southend General Hospital Westcliff-On-Sea, England, United Kingdom Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Preston Hospital Preston, United Kingdom, PR2 9HT Less <<
NCT02210104 Melanoma Sarc... More >>oma Less << Phase 1 Withdrawn(Issues with tetramer... More >> staining) Less << - -
NCT00132522 Ovarian Cancer ... More >> Colorectal Cancer Carcinoma, Non-small-cell Lung Prostate Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Durate, California, United States, 91010 United States, New Hampshire Dartmouth Medical School, Pharmacology & Toxicology Dept. of Medicine Lebanon, New Hampshire, United States, 03756 United States, Pennsylvania Fox Chase Cancer Oncology Department of Medical Oncology Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin University of Wisconsin Division of Gynecologic Oncology Madison, Wisconsin, United States, 53792 Switzerland Centre pluridisciplinaire d'Oncologie Lausanne, Rue du Bugnon, Switzerland, 46 Less <<
NCT01632150 Relapsed and/or Refractory Mul... More >>tiple Myeloma Less << Phase 2 Completed - Spain ... More >> Local Institution Barcelona, Spain, 08035 Local Institution Barcelona, Spain, 08036 Local Institution Barcelona, Spain, 08041 Local Institution Barcelona, Spain, 08916 Local Institution LaLaguna, S Cruz Tener, Spain, 38320 Local Institution Madrid, Spain, 28034 Local Institution Madrid, Spain, 28041 Local Institution Salamanca, Spain, 37007 Local Institution Sevilla, Spain, 41013 Local Institution Zaragoza, Spain, 50009 Less <<
NCT01025089 Thymoma Thymi... More >>c Carcinoma Clinical Masaoka Stage II to IVA Less << Phase 2 Active, not recruiting December 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 United States, New Jersey Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 United States, Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01632150 - Completed - -
NCT03088709 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome Non-hodgkin Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Recruiting January 31, 2021 United States, Illinois ... More >> Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 Contact: Zeina Al-Mansour, MD    708-327-2336    Zeina.Al-Mansour@lumc.edu    Contact: Mary Lee, RN    708-327-2241    mlee@luc.edu    Principal Investigator: Patrick Stiff, MD Less <<
NCT00134082 Lymphoma Phase 1 Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT02204241 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting June 2021 Italy ... More >> FO.NE.SA.Onlus Torino, Italy, 10126 Less <<
NCT00553683 Breast Cancer ... More >> Colorectal Cancer Gastric Cancer Liver Cancer Melanoma (Skin) Metastatic Cancer Ovarian Cancer Pancreatic Cancer Less << Phase 1 Phase 2 Unknown July 2014 United States, New Jersey ... More >> Rutgrers University Hospital Newark, New Jersey, United States, 07101 Less <<
NCT00258960 Breast Cancer Phase 2 Completed - Spain ... More >> GEICAM (Spanish Breast Cancer Research Group) San Sebastián de los Reyes, Madrid, Spain, 28703 Less <<
NCT03294577 Chemotherapy-induced Neutropen... More >>ia Less << Phase 2 Phase 3 Recruiting April 18, 2019 China, Guangzhou ... More >> Cancer Center of Guangzhou Medical University Breast Oncology Recruiting Guangzhou, Guangzhou, China, 510000 Contact: Hongsheng Li, MD          China, Harbin Harbin Medical University Cancer Hospital Recruiting Harbin, Harbin, China, 150000 Contact: Qingyuan Zhang, MD          China, Shenyang Liaoning Cancer Hospital & Institute Recruiting Shenyang, Shenyang, China, 110000 Contact: Tao Sun, MD Less <<
NCT03135951 Breast Cancer ... More >> Pharmacokinetics Less << Phase 1 Recruiting December 2018 United States, California ... More >> Research Center Recruiting Anaheim, California, United States, 92804 Contact: Thuy Le       thuy.le@sppirx.com Less <<
NCT03264131 Lymphoma Adul... More >>t T-Cell Leukemia/Lymphoma Lymphatic Diseases Less << Phase 2 Recruiting January 30, 2026 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Bob Broomer    919-966-9257    bob_broomer@med.unc.edu Less <<
NCT02846428 Breast Cancer Phase 2 Completed - France ... More >> Bayonne, France, 64100 Beziers, France, 34500 Bourg En Bresse, France, 01012 Colmar, France, 68024 Dijon, France, 21079 Hyeres, France, 83400 La Tronche, France, 38700 Le Mans, France, 72037 Limoges, France, 87042 Lyon, France, 69437 Marseille, France, 13385 Montbeliard, France, 25209 Montfermeil, France, 93370 Nice, France, 06189 Nimes, France, 30029 Paris, France, 75181 Pierre Benite, France, 69310 Saint Herblain, France, 44805 Strasbourg, France, 67010 Toulouse, France, 31059 Vannes, France, 56001 Less <<
NCT02954055 Breast Cancer Phase 2 Recruiting October 2020 Italy ... More >> Centro di Riferimento Oncologico (CRO) Not yet recruiting Aviano, Italy Principal Investigator: Fabio Puglisi          A.O.U. di Bologna Policlinico S. Orsola-Malpighi Viale Ercolani 4/2 Recruiting Bologna, Italy, 40138 Contact: Claudio Zamagni, MD    +39 05 12 144 548    zamagniclaudio.sper@aosp.bo.it    Principal Investigator: Claudio Zamagni          Ospedale di Bolzano Oncologia Medica Via lorenz Bohler 5 Recruiting Bolzano, Italy, 39100 Contact: Claudio Graiff, MD    +39 04 71 908 572    Gonco.bz@sabes.it    Aziendale Spedali Civili di Brescia SSVD Breast Unit P.le Spedali Civili 1 Not yet recruiting Brescia, Italy, 25123 Contact: Edda Simoncini, MD    +39 03 039 95 260    edda.simoncini@asst-spedalicivili.it    "Antonio Perrino" Division of Medical Oncology Strada Statale 7 APPIA Recruiting Brindisi, Italy, 72100 Contact: Saverio Cinieri, MD    +39 08 31 537 219    saverio.cinieri@ieo.it    Principal Investigator: Saverio Cinieri          Candiolo Cancer Institute (FPO-IRCCS) Not yet recruiting Candiolo, Italy Principal Investigator: Filippo Montemurro          ASST Di Cremona, Unità di Patologia Mammaria-Breast Unit VIALE CONCORDIA 1 Not yet recruiting Cremona, Italy, 26100 Contact: Daniele Generali, MD    +39 03 724 08 042    d.generali@ospedale.cremona.it    E.O. Osepdali Galliera S.C. Oncologia Via Volta 6 Not yet recruiting Genova, Italy, 16128 Contact: Alessandra Gennari, MD    +39 01 05 634 502    alessandra.gennari@galliera.it    Ospedale Misericordia di Grosseto Not yet recruiting Grosseto, Italy Principal Investigator: Carmelo Bengala          ASST Ovest Milanese Oncology Department Via Papa Giovanni Paolo II Recruiting Legnano, Italy Contact: Elena Collova, MD    +39 03 31 449 161    elena.collova@asst-ovestmi.it    Principal Investigator: Elena Collova          Ospedale Generale Provinciale di Macerata Not yet recruiting Macerata, Italy Principal Investigator: Nicola Battelli          IRST IRCCS Division of medical oncology Via Maroncelli 40 Recruiting Meldola, Italy, 47014 Contact: Andrea Rocca, MD    +39 05 43 739 278    andrea.rocca@irst.emr.it    Principal Investigator: Andrea Rocca          Istituto Europeo di Oncologia, Division of Medical Senology, Via Ripamonti 435 Recruiting Milano, Italy, 20141 Contact: Elizabetta Munzone, MD    +390257489970    elisabetta.munzone@ieo.it    Ospedale S. gerardo - ASST Monza Hospital for medical therapy Unit Via Pergolesi 33 Not yet recruiting Monza, Italy, 20900 Contact: Marina Cazzaniga, MD    +39 03 923 39 037    marina.cazzaniga@hsgerardo.org    Osp. Sacro Cuore Don Calabria Division in Medical Oncology Recruiting Negrar, Italy Contact: Stefania Gori, MD    +39 33 94 554 035    stefania.gori@sacrocuore.it    Principal Investigator: Stefania Gori          Istituti Clinici Scientifici Maugeri SpA SB Not yet recruiting Pavia, Italy Principal Investigator: Antonio Bernardo          A.O. Universitaria Pisana Ospedale Santa Chiara Pisa Not yet recruiting Pisa, Italy Principal Investigator: Andrea Fontana          Ospedale S. Maria delle Croci Not yet recruiting Ravenna, Italy Principal Investigator: Laura Amaducci          Ospedale Infermi Uo Oncologia Via Settembrini 2 Recruiting Rimini, Italy, 47923 Contact: Lorenzo Gianni, MD    +39 05 41 705 413    lorenzo.gianni@auslromagna.it    Principal Investigator: Lorenzo Gianni          Fondazione Policlinico Universitario A.Gemelli Not yet recruiting Rom, Italy Principal Investigator: Riccardo Masetti          Policlinico Umberto I Not yet recruiting Rom, Italy Principal Investigator: Enrico Cortesi          A.O.U Città della Salute e della Scienza di Torino SSCVD Oncologia Medica Senologica (Oncology Dep.- Breast Unit) Via Cherasco 23 Recruiting Torino, Italy, 10126 Contact: Michela Donadio    +39 01 163 34 250    mdonadio@cittadellasalute.to.it    Principal Investigator: Michela Donadio          Asst Bg Ovest Ospedale Di Treviglio Not yet recruiting Treviglio, Italy Principal Investigator: Fausto Petrelli          ASST Settelaghi - Ospedale di Circolo e Fondazione Macchi U.O Oncologia Medica Viale L. Borri, 57 Recruiting Varese, Italy, 21100 Contact: Graziella Pinotti, MD    +39 03 322 78 556    graziella.pinotti@asst-settelaghi.it    Principal Investigator: Graziella Pinotti Less <<
NCT00774852 - Completed - -
NCT02117024 Non Small Cell Lung Cancer Phase 2 Active, not recruiting September 2018 United States, Arkansas ... More >> Highlands Oncology Group Rogers, Arkansas, United States, 72758 United States, California University of California San Diego La Jolla, California, United States, 92093 University of California at Los Angeles Los Angeles, California, United States, 90029 University of California Davis Sacramento, California, United States, 95817 United States, Georgia Georgia Regents University Augusta, Georgia, United States, 30912 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Massachusetts University of Massachusetts Worcester, Massachusetts, United States, 01655 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York SUNY Syracuse Syracuse, New York, United States, 13210 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Oregon Providence Portland Medical Center- Providence Lung Cancer Clinic Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas Texas Oncology PA Texas Cancer Center Abilene, Texas, United States, 79606 Mary Crowley Cancer Center Dallas, Texas, United States, 75201 United States, Washington Cancer Care Northwest Spokane, Washington, United States, 99216 United States, Wisconsin Aurora Research Institute Green Bay, Wisconsin, United States, 54311 Less <<
NCT01040871 Diffuse Large B-Cell Lymphoma Phase 2 Completed - Belgium ... More >> Universitair Ziekenhuis Gent - UZ GENT, Hematologie, 9K12IE 9de verdiep- polikliniek Hematologie Gent, Belgium Less <<
NCT00066482 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Less << Not Applicable Completed - -
NCT00774852 Lupus Nephritis ... More >> Lupus Erythematosus, Systemic Less << Phase 2 Completed - -
NCT00193115 Breast Cancer Phase 2 Completed - -
NCT01569750 CD20-positive B-cell Non-Hodgk... More >>in Lymphoma Less << Phase 1 Completed - United States, New York ... More >> New York, New York, United States Rochester, New York, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Houston, Texas, United States France Lille Cedex, France Paris, France Vandoeuvre Les Nancy, France Less <<
NCT01542203 - Withdrawn(study is classified ... More >>as ancillary / correlative) Less << - United States, Texas ... More >> UTSouthwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00005984 Leukemia Phase 2 Terminated(Study terminated as... More >> principal investigator [PI] left the university.) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00203502 Breast Cancer Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01040871 - Completed - -
NCT02566993 Small-cell Lung Cancer Phase 3 Active, not recruiting - -
NCT00433511 Estrogen Receptor Negative ... More >> Estrogen Receptor Positive HER2/Neu Negative Male Breast Carcinoma Stage IA Breast Cancer Stage IB Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 3 Active, not recruiting - -
NCT00203502 - Completed - -
NCT00856492 - Completed - -
NCT01955187 MEMBRANOUS NEPHROPATHY Phase 3 Recruiting April 2019 Spain ... More >> Hospital 12 de Octubre Recruiting Madrid, Spain Contact: MANUEL PRAGA, MD       mpragat@senefro.org    Principal Investigator: MANUEL PRAGA, MD Less <<
NCT03096275 Takayasu Arteritis Phase 3 Recruiting December 1, 2018 China, Hebei ... More >> Hebei Provincial Hospital Not yet recruiting Shijiazhuang, Hebei, China, 050051 Contact: Fengxiao Zhang, MD    13722879168    fengxiao.zhang@cstar.org.cn    Contact: Wei Lin, MD    17736909239    linwei272@163.com    China, Inner Mongolia the Affiliated Hospital of Inner Mongolia Medical University Not yet recruiting Huhehaote, Inner Mongolia, China, 010050 Contact: Hongbin Li, MD    13948536552    hongbin.li@cstar.org.cn    Contact: Ning Tie, MD    13948610720    tieting@126.com    China, Shanxi Xijing Hospital Not yet recruiting Xian, Shanxi, China, 710032 Contact: Zhenbiao Wu, MD    13700235112    ping.zhu@cstar.org.cn    Contact: Weitong Chen, MD    15771943030    chenweitong0818@163.com    China Beijing Chaoyang Hospital Not yet recruiting Beijing, China, 100020 Contact: Yi Zheng, MD    13911170090    yi.zheng@cstar.org.cn    Contact: Yongfeng Zhang, MD    13671239495    zyf760116@sina.com    Peking Union Medical College Hospital Recruiting Beijing, China, 100032 Contact: Xinping Tian, MD    86-13691165939    tianxp6@126.com    Contact: Shi Rong, MD    86-13601248311    rongshipumch@126.com    Sub-Investigator: XInping Tian, MD          Beijing Xuanwu Hospital Not yet recruiting Beijing, China, 100053 Contact: Xiaoxia Li, MD    13501164945    xiaoxia.li@cstar.org.cn    Contact: Yi Zhao, MD    13811038669    zhaoyi_peking@163.com    General Hospital of Tianjing Medical University Not yet recruiting Tianjin, China, 300052 Contact: Wei Wei, MD    13920182411    wei.wei@cstar.org.cn    Contact: Na Zhang, MD    13820489562    lunazhang22@hotmail.com Less <<
NCT00856492 Breast Cancer Phase 2 Completed - -
NCT02465983 Pancreatic Cancer Phase 1 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94158 Less <<
NCT00546156 - Completed - -
NCT02793544 Myelodysplastic Syndrome (MDS)... More >> Chronic Lymphocytic Leukemia (CLL) Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML) Acute Biphenotypic Leukemia (ABL) Acute Undifferentiated Leukemia (AUL) Less << Phase 2 Recruiting December 2019 United States, Florida ... More >> Shands HealthCare & University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Maxim Norkin, MD       Maxim.Norkin@medicine.ufl.edu    Contact: Meghan Vazquez       meghan.vazquez@medicine.ufl.edu    Principal Investigator: Maxim Norkin, MD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Antonio Jimenez, MD       amjimenez@miami.edu    Contact: Kirenia Correa       k.correa@med.miami.edu    Principal Investigator: Antonio Jimenez, MD          H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD       Farhad.Khimani@moffitt.org    Contact: Carmen Patton       Carmen.Patton@moffitt.org    Principal Investigator: Farhad Khimani, MD          United States, Maryland University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Hardy, MD       nhardy1@umm.edu    Contact: Sherri Bauman       sphilip1@umm.edu    Principal Investigator: Nancy Hardy, MD          The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Javier Bolanos Meade, MD       fbolano2@jhmi.edu    Contact: Leo Luznik, MD       luznile@jhmi.edu    Principal Investigator: Javier Bolanos Meade, MD          Principal Investigator: Leo Luznik, MD          United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Asif Alavi, MD       alavia@karmanos.org    Contact: Charlotte Brown       brownc@karmanos.org    Principal Investigator: Asif Alavi, MD          United States, New York Memorial Sloan Kettering Cancer Center - Adults Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD       shaffeb1@mskcc.org    Contact: Stephanie Chinapen       chinapes@mskcc.org    Principal Investigator: Brian Shaffer, MD          United States, North Carolina University of North Carolina Hospitals Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katarzyna Jamieson, MD       katarzyna_jamieson@med.unc.edu    Contact: Mary Owen       mary_owen@med.unc.edu    Principal Investigator: Katarzyna Jamieson, MD          United States, Ohio Ohio State Medical Center, James Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Hannah Choe, MD          Contact: Nicole Szuminski       Nicole.Szuminski@osumc.edu    Principal Investigator: Hannah Choe, MD          United States, Virginia Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program Recruiting Richmond, Virginia, United States, 23298 Contact: John McCarty, MD       john.mccarty@vcuhealth.org    Contact: Kathy Candler       kcandler@mcvh-vcu.edu    Principal Investigator: John McCarty, MD          United States, Wisconsin Froedtert Memorial Lutheran Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Bronwen Shaw, MD, PhD       beshaw@mcw.edu    Contact: Sharon Yim       syim@mcw.edu    Principal Investigator: Bronwen Shaw, MD, PhD Less <<
NCT02873819 Squamous Cell Carcinoma of the... More >> Oral Cavity Less << Phase 2 Recruiting December 2020 -
NCT00546156 Breast Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Dana-Farber at Faulkner Hospital Boston, Massachusetts, United States, 02130 United States, New Hampshire New Hampshire Oncology-Hematology PA Hooksett, New Hampshire, United States, 03106 Less <<
NCT00148317 - Completed - -
NCT00148317 Multiple Myeloma Phase 2 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00075582 Adult Rhabdomyosarcoma ... More >> Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Previously Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Unknown - -
NCT00075634 Recurrent Neuroblastoma ... More >> Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01362790 Mesothelioma ... More >>Adenocarcinoma of Lung Pancreatic Neoplasms Less << Phase 1 Phase 2 Unknown September 4, 2017 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00075582 - Unknown - -
NCT01255319 - Unknown November 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT00562978 Lymphoma Phase 1 Phase 2 Completed - -
NCT00424203 Breast Cancer ... More >> Cognitive/Functional Effects Depression Malnutrition Psychosocial Effects of Cancer and Its Treatment Less << Phase 2 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 Institut Sainte Catherine Avignon, France, 84082 Institut Bergonie Bordeaux, France, 33076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Hopital Perpetuel Secours Levallois, France, 92309 Centre Leon Berard Lyon, France, 69373 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Hopital Europeen Georges Pompidou Paris, France, 75015 Institut Curie Hopital Paris, France, 75248 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 C.H. Senlis Senlis, France, 60309 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Less <<
NCT02951819 Multiple Myeloma Phase 2 Active, not recruiting December 25, 2020 -
NCT01219907 HER2-positive Breast Cancer ... More >> Male Breast Cancer Stage IV Breast Cancer Less << Phase 1 Withdrawn - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00254592 Breast Cancer Phase 2 Active, not recruiting December 28, 2018 United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT01766375 Acute Myeloid Leukemia Phase 3 Unknown June 2016 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Lai Yongrong, doctor    0086-13517711828    laiyongrong@263.net    Contact: Zhang Zhongming, doctor    0086-15807801369    zzmmissyou@126.com    Principal Investigator: Lai Yongrong, doctor          Sub-Investigator: Zhang Zhongming, doctor          Sub-Investigator: Li Qiaochuan, doctor Less <<
NCT00278421 Lymphoma Phase 3 Completed - -
NCT00722137 Mantle Cell Lymphoma Phase 3 Completed - -
NCT02869217 NY-ESO-1 Expressing Solid Tumo... More >>rs in HLA-A2 Positive Patients Synovial Sarcoma Melanoma Esophageal Cancer Ovarian Cancer Lung Cancer Bladder Cancer Liver Cancer Less << Phase 1 Recruiting June 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D.    416-946-4521    marcus.butler@uhn.ca    Principal Investigator: Marcus Butler, M.D. Less <<
NCT00602459 Stage I Chronic Lymphocytic Le... More >>ukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 2 Completed - -
NCT00722137 - Completed - -
NCT01539083 Multiple Myeloma Phase 3 Completed - Australia ... More >> Adelaide, Australia Camperdown, Australia Geelong, Australia Greenslopes, Australia Heidelberg, Australia Herston, Australia Malvern, Australia Melbourne, Australia Nedlands, Australia Newcastle, Australia Prahran, Australia Sydney, Australia Westmead, Australia Woodville South, Australia Woolloongabba, Australia China Beijing, China Guangzhou, China Shanghai, China Tianjin, China Korea, Republic of Busan, Korea, Republic of Daegu, Korea, Republic of Hwasun Gun, Korea, Republic of Ulsan, Korea, Republic of Less <<
NCT01539083 - Completed - -
NCT00099281 Breast Cancer ... More >> Metastases Less << Phase 3 Terminated - United Kingdom ... More >> PharmOlam London, United Kingdom Less <<
NCT03349177 Breast Cancer ... More >> Pathological Complete Response Neoadjuvant Chemotherapy Less << Phase 2 Phase 3 Not yet recruiting November 27, 2019 -
NCT03153410 Pancreatic Cancer Early Phase 1 Recruiting September 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21231 Contact: Ana DeJesus, MD    443-287-0411    adejesu1@jhmi.edu Less <<
NCT03250325 Synovial Sarcoma Phase 1 Phase 2 Recruiting July 2020 Japan ... More >> Sapporo Medical University Hospital Recruiting Sapporo, Hokkaido, Japan, 060-8543 Mie University Hospital Recruiting Tsu, Mie, Japan, 514-8507 National Cancer Center Hospital Recruiting Chuo-ku, Tokyo, Japan, 104-0045 Kyushu University Hospital Recruiting Fukuoka, Japan, 812-8582 National Hospital Organization Osaka National Hospital Recruiting Osaka, Japan, 540-0006 Less <<
NCT00602459 - Completed - -
NCT00007904 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 UH-LUICC Mentor, Ohio, United States, 44060 UH-Chagrin Highlands Orange Village, Ohio, United States, 44122 Less <<
NCT02115204 Breast Cancer Phase 3 Completed - Germany ... More >> Ev. Hospital Bethesda Moenchengladbach, Germany, 41061 Less <<
NCT00004464 Aplastic Anemia ... More >> Paroxysmal Hemoglobinuria, Nocturnal Less << Not Applicable Unknown - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 Less <<
NCT02223312 Cancer Hemato... More >>logic Malignancies Less << Phase 1 Phase 2 Withdrawn(Sponsor decision to ... More >>discontinue study.) Less << January 31, 2019 -
NCT00254592 - Active, not recruiting - -
NCT00006042 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00772668 - Terminated(Funding) - -
NCT00525603 Leukemia Chro... More >>nic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00408967 Ovarian Cancer Phase 2 Withdrawn(Th trial got cancell... More >>ed and no subjects signed informed consent form (ICF); study design not appropriate any longer.) Less << - -
NCT00525603 - Completed - -
NCT01145976 Aplastic Anemia Phase 3 Unknown February 2016 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 138-736 Contact: Yae Eun Jang, Nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT02251548 Chronic Lymphocytic Leukemia ... More >> Leukemia Less << Phase 2 Active, not recruiting January 2022 United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States, 33146 University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States, 33442 Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States, 33136 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02027935 Melanoma Phase 2 Active, not recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03246906 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Hematopoietic Cell Transplantation Recipient Loss of Chromosome 17p Mantle Cell Lymphoma Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Hodgkin Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Recurrent Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting August 15, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda    206-667-4546    mueda@fredhutch.org    Principal Investigator: Masumi Ueda Less <<
NCT00003870 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 University of Washington Medical Center Seattle, Washington, United States, 98195-6043 Less <<
NCT00002837 Breast Cancer Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02623972 Inflammatory Breast Cancer ... More >> Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Less << Phase 2 Recruiting February 2023 United States, Massachusetts ... More >> Brigham and Women's Hospital Active, not recruiting Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Beth Overmoyer, MD    617-632-6157    bovermoyer@partners.org    Principal Investigator: Beth Overmoyer, MD Less <<
NCT00336414 Systemic Lupus Erythematosus N... More >>ephritis Less << Phase 3 Withdrawn(the study is withdra... More >>wn due to low and unexpected enrollment rate) Less << June 2007 Italy ... More >> Istituto Giannina Gaslini Genoa, Italy, 16148 Less <<
NCT02300571 - Recruiting January 2018 Italy ... More >> Fondazione del Piemonte per l'Oncologia Recruiting Candiolo, Italy, 10060 Contact: Luisa Gioeni, PharmD    +39011993 ext 3959    luisa.gioeni@ircc.it    Sub-Investigator: Fabrizio Carnevale Schianca, MD          Sub-Investigator: Daniela Caravelli, MD          Sub-Investigator: Dario Sangiolo, MD          Sub-Investigator: Susanna Gallo, MD          Sub-Investigator: Valentina Coha, MD          Sub-Investigator: Giovanni Grignani, MD          Sub-Investigator: Delia Rota Scalabrini, MD          Sub-Investigator: Marco Fizzotti, MD          Ospedale Regina Margherita Not yet recruiting Torino, Italy, 10126 Contact: Massimo Berger, MD    +39011.313 ext 5360    massimoberger@gmail.com    Principal Investigator: Franca Fagioli, MD          Sub-Investigator: Elena Vassallo, MD          Sub-Investigator: Massimo Berger, MD          Sub-Investigator: Francesca Nesi, MD          Sub-Investigator: Paola Quarello, MD Less <<
NCT02243371 Previously Treated Metastatic ... More >>Adenocarcinoma of the Pancreas Less << Phase 2 Active, not recruiting January 2019 United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 Stanford University Stanford, California, United States, 94305 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00278538 Systemic Lupus Erythematosus Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00911716 Breast Cancer Not Applicable Completed - Denmark ... More >> Dept. of Oncology; Rigshospitalet Copenhagen, Blegdamsvej 9, Denmark, 2100 Ireland Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital Dublin, Ireland, 24 St. Vincent's University Hospital Dublin, Ireland, 4 Mater Misericordiae University Hospital Dublin, Ireland, 7 Mater Private Hospital Dublin, Ireland, 7 St. James's Hospital Dublin, Ireland, 8 Beaumont Hospital Dublin, Ireland, 9 University College Hospital Galway, Ireland Mid-Western Cancer Centre at Mid-Western Regional Hospital Limerick, Ireland, 0009 Sligo General Hospital Sligo, Ireland Waterford Regional Hospital Waterford, Ireland Less <<
NCT01824693 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 2 Completed - -
NCT01824693 - Completed - -
NCT01731587 Non-small Cell Lung Cancer (NS... More >>CLC) Stage III Less << Phase 1 Withdrawn(The objectives of th... More >>is trial are no longer deemed appropriate for the clinical development of L-BLP25 therefore this trial is withdrawn) Less << - -
NCT00772668 Lymphoma Foll... More >>icular Lymphoma Marginal Zone Lymphoma Less << Not Applicable Terminated(Funding) - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00001676 Glomerulonephritis ... More >> Lupus Nephritis Systemic Lupus Erythematosus Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States, 20892 Less <<
NCT00002844 Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01140373 Prostate Cancer Phase 1 Active, not recruiting June 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01451580 Metastatic Breast Cancer Phase 2 Unknown - Taiwan ... More >> CGMH Recruiting Linko, Taiwan Contact: Wang, AN    +8862-2545-3105    monicachang@tty.com.tw    Principal Investigator: Chang Less <<
NCT00074178 Lymphoma Phase 2 Completed - United States, Oregon ... More >> Oregon Health & Science University Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00436709 Breast Cancer Not Applicable Unknown - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00425438 - Terminated(Study was terminate... More >>d early for administrative reasons.) Less << - -
NCT01685411 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Myelodysplastic Syndrome Less << Not Applicable Recruiting September 2025 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Margaret L. MacMillan, M.D.    612-626-2778    macmi002@umn.edu    Principal Investigator: Margaret L. MacMillan, M.D. Less <<
NCT02513186 Plasma Cell Myeloma Phase 1 Recruiting August 2022 France ... More >> Investigational Site Number 250002 Active, not recruiting Nantes Cedex 01, France, 44093 Investigational Site Number 250003 Completed Pierre Benite, France, 69310 Investigational Site Number 250001 Active, not recruiting Toulouse Cedex 9, France, 31059 Germany Investigational Site Number 276003 Active, not recruiting Berlin, Germany, 12200 Investigational Site Number 276002 Active, not recruiting Leipzig, Germany, 04103 Italy Investigational Site Number 380003 Active, not recruiting Milano, Italy, 20132 Investigational Site Number 380002 Completed Roma, Italy, 00161 Investigational Site Number 380001 Active, not recruiting Torino, Italy, 10126 Spain Investigational Site Number 724003 Recruiting Madrid, Spain, 28041 Investigational Site Number 724001 Recruiting Pamplona, Spain, 31008 Investigational Site Number 724002 Recruiting Salamanca, Spain, 37007 Less <<
NCT00005866 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 3 Completed - -
NCT02342613 Hematologic Malignancies ... More >> Graft-Versus-Host Disease Less << Phase 1 Active, not recruiting February 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00425438 Lupus Nephritis Phase 3 Terminated(Study was terminate... More >>d early for administrative reasons.) Less << - China ... More >> Beijing, China, 100005 Beijing, China, 100029 Beijing, China, 100853 Guangzhou, China, 510080 Guangzhou, China, 510515 Hangzhou, China, 310003 Nanjing, China, 210008 Shanghai, China, 200001 Shanghai, China, 200003 Shanghai, China, 200025 Shenyang, China, 110001 Less <<
NCT00868413 Chronic Lymphocytic Leukemia Phase 1 Completed - United States, California ... More >> Site Reference ID/Investigator# 17841 La Jolla, California, United States, 92093 Site Reference ID/Investigator# 25899 Stanford, California, United States, 94305-5821 United States, Maryland Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States, 21231-1000 United States, Ohio Site Reference ID/Investigator# 21621 Columbus, Ohio, United States, 43210 United States, Pennsylvania Site Reference ID/Investigator# 39613 Philadelphia, Pennsylvania, United States, 19111 United States, Texas Site Reference ID/Investigator# 17943 Houston, Texas, United States, 77030-4009 Less <<
NCT00317785 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02120157 Myeloablative Conditioning ... More >> HLA-mismatched Bone Marrow Transplantation Graft Survival Transplantion, Bone Marrow Less << Phase 2 Active, not recruiting December 2020 United States, Colorado ... More >> Children's Hospital of Colorado Aurora, Colorado, United States, 80045 United States, Delaware Nemours Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States, 19803 United States, Florida All Children's Hospital Johns Hopkins Medicine Saint Petersburg, Florida, United States, 33701 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, Missouri Washington University in St. Louis Saint Louis, Missouri, United States, 63110 United States, North Carolina Levine Cancer Center Charlotte, North Carolina, United States, 28203 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29423 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00630253 Fanconi Anemia Phase 1 Phase 2 Recruiting June 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2800    knelso62@fairview.org    Principal Investigator: Margaret MacMillan, M.D. Less <<
NCT00002475 Breast Cancer ... More >> Colorectal Cancer Kidney Cancer Lung Cancer Malignant Mesothelioma Pancreatic Cancer Less << Phase 2 Completed - United States, California ... More >> St. Vincent Medical Center - Los Angeles Los Angeles, California, United States, 90057-1901 Less <<
NCT00094380 Lupus Erythematosus, Systemic ... More >> Lupus Nephritis Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, New York Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02217163 Multiple Myeloma Phase 2 Active, not recruiting December 2020 Singapore ... More >> National University Hospital Singapore, Singapore Singapore General Hospital Singapore, Singapore Less <<
NCT02057770 Leukemia, Myeloid, Acute Phase 1 Terminated(Low accrual rate) - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00001384 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00652691 Ovarian Cancer ... More >> Peritoneal Cavity Cancer Less << Phase 1 Active, not recruiting December 2018 -
NCT00358657 Immunodeficiency Syndrome ... More >> Non-Cancer Diagnosis Severe Aplastic Anemia Less << Phase 2 Recruiting - United States, Tennessee ... More >> The Children's Hospital at TriStar Centennial Recruiting Nashville, Tennessee, United States, 37203 Contact: Haydar A. Frangoul    615-329-7339    Haydar.Frangoul@hcahealthcare.com    Principal Investigator: Haydar A. Frangoul          Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: James Connelly    615-936-1762    james.a.connelly@vanderbilt.edu    Principal Investigator: James Connelly          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fredhutch.org    Principal Investigator: Lauri M. Burroughs Less <<
NCT00669877 Burkitt's Lymphoma ... More >> Burkitt'S-like Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00849472 - Completed - -
NCT00074282 Leukemia Phase 2 Unknown - -
NCT00849472 Neoplasms, Breast Phase 2 Completed - -
NCT00135954 Glomerulonephritis, Membranous Phase 3 Completed - Netherlands ... More >> Department of Nephrology Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT01849380 Breast Neoplasms ... More >> Neoadjuvant Therapy Less << Phase 4 Unknown June 2018 China, Shandong ... More >> the Second Hospital of Shandong Universtity Not yet recruiting Jinan, Shandong, China, 250033 Contact: Gang Z Yu, Dr; PhD    +86 0531-85875048    yzg@medmail.com.cn    Principal Investigator: Gang Z Yu, Dr; PhD Less <<
NCT00381004 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00669877 - Completed - -
NCT02053597 Breast Cancer Phase 2 Withdrawn(due to evolving scie... More >>ntific knowledge in the field that would make the questions being addressed in the trial less relevant) Less << - Belgium ... More >> GZA Ziekenhuisen Campus Sint-Augustinus - Iridium Kankernetwerk Antwerp, Wilrijk, Belgium, 2610 Jules Bordet Institute Brussels, Belgium, 1000 Hôpital Erasme Brussels, Belgium, 1070 Clinique et Maternité Sainte Elisabeth Namur, Belgium, 5000 Less <<
NCT01788020 Waldenstr?m's Macroglobulinemi... More >>a Less << Phase 3 Recruiting September 2023 Germany ... More >> University Hospital Ulm Recruiting Ulm, Germany, 89081 Contact: Christian Buske, MD    +49 731 500 ext 65888    christian.buske@uni-ulm.de    Principal Investigator: Christian Buske, MD Less <<
NCT03575520 Breast Cancer Phase 2 Completed - Korea, Republic of ... More >> Division of Medical Oncology, Severance Breast Cancer Clinic, Yonsei Cancer Center, Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 03722 Less <<
NCT00869973 Emesis Phase 3 Terminated(We terminated the s... More >>tudy after enrolling 580/900 patients due to a slow accrual) Less << - Italy ... More >> Fausto Roila Terni, Italy, 05100 Less <<
NCT00001473 - Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT02812940 Graft-versus-Host Disease Phase 2 Recruiting June 2019 Germany ... More >> University of Cologne Recruiting Cologne, Germany, 50924 Contact: Christoph Scheid, MD PhD    49221478 ext 6296    c.scheid@uni-koeln.de    Sub-Investigator: Udo Holtick, MD Less <<
NCT00022516 Breast Cancer Phase 3 Completed - -
NCT00381004 - Completed - -
NCT00278525 - Completed - -
NCT00719888 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Adult Acute Lymphoblastic Leukemia in Complete Remission Aggressive Non-Hodgkin Lymphoma Beta-2-Microglobulin Greater Than 3 g/mL Blasts Under 5 Percent of Bone Marrow Nucleated Cells Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission Chromosome 13 Abnormality Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Lymphoblastic Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelofibrosis Pancytopenia Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Non-Hodgkin Lymphoma Less << Phase 2 Recruiting - United States, Colorado ... More >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey    206-764-2199    tchaunce@u.washington.edu    Principal Investigator: Thomas R. Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ann E. Dahlberg    206-667-1959    adahlber@fredhutch.org    Principal Investigator: Ann E. Dahlberg Less <<
NCT00022516 - Completed - -
NCT00278525 SYSTEMIC SCLERODERMA Phase 2 Completed - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01049425 Primary Breast Cancer ... More >> Her2 Non-overexpressing Less << Phase 3 Unknown December 2016 Germany ... More >> Bethesda Krankenhaus Moenchengladbach, Germany, 41061 Less <<
NCT01354522 Breast Cancer Phase 3 Unknown - China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Qiang Sun, Master    86-010-88068936    sunq@medmail.com.cn    Contact: Songjie Shen, Doctor    86-010-88068936    pumcssj@163.com    Principal Investigator: Qiang Sun, Master Less <<
NCT00478452 Ovarian Cancer Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00591851 Breast Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00591851 - Completed - -
NCT00364754 Metastatic/Recurrent Breast Ca... More >>ncer Less << Phase 1 Completed - Georgia ... More >> Pharmina Tbilisi, Georgia Russian Federation Chelyabinsk Regional Oncology Dispensary Chelyabinsk, Russian Federation Blokhin Cancer Research Center Moscow, Russian Federation Central Clinical Hospital named after Semashko Moscow, Russian Federation Scientific Research Institute of Oncology named after Petrov St. Petersburg, Russian Federation St. Petersburg City Oncology Center St. Petersburg, Russian Federation Regional Oncology Dispensary Yaroslavl, Russian Federation Ukraine Dnipropetrovsk Municipal Clinical Hospital No.4 Dnipropetrovsk, Ukraine Kyiv Municipal Oncology Hospital Kyiv, Ukraine Lviv Oncology Regional Treatment and Diagnostic Centre Lviv, Ukraine Less <<
NCT01898117 Breast Cancer Phase 2 Recruiting December 2029 Netherlands ... More >> MCA Not yet recruiting Alkmaar, Netherlands, 1815 JD Contact: S Vrijaldenhoven, MD          Principal Investigator: S Vrijaldenhoven, MD          ZGT Recruiting Almelo, Netherlands, 7609 PP Contact: I M Oving, MD       i.oving@zgt.nl    Principal Investigator: I M Oving, MD          BovenIJ Not yet recruiting Amsterdam, Netherlands, 1034 CS Contact: S E Dohmen, MD       s.dohmen@bovenij.nl    Principal Investigator: S E Dohmen, MD          Netherlands Cancer Institute Recruiting Amsterdam, Netherlands, 1066 CX Principal Investigator: Sabine C Linn, Prof. MD          AZVU Not yet recruiting Amsterdam, Netherlands, 1081 HV Contact: I R Konings, MD       m.konings@vumc.nl    Principal Investigator: I R Konings, MD          OLVG Active, not recruiting Amsterdam, Netherlands Gelre Ziekenhuis Recruiting Apeldoorn, Netherlands Contact: L Strobbe, MD          Principal Investigator: L Strobbe, MD          Lievensberg ziekenhuis Not yet recruiting Bergen op Zoom, Netherlands, 4624 VT Contact: M M Troost, MD       M.Troost@lievensberg.nl    Principal Investigator: M M Troost, MD          Rode Kruis Ziekenhuis Not yet recruiting Beverwijk, Netherlands, 1940 EB Contact: R C Rietbroek, MD       rrietbroek@rkz.nl    Principal Investigator: R C Rietbroek, MD          Amphia Recruiting Breda, Netherlands Contact: J Heijns, MD          Principal Investigator: J Heijns, MD          IJsselland ziekenhuis Not yet recruiting Capelle Aan Den IJssel, Netherlands, 2906 ZC Contact: D F Kehrer, MD          Principal Investigator: D F Kehrer, MD          Reinier de Graaf Gasthuis Recruiting Delft, Netherlands Contact: K Beelen, MD          Principal Investigator: K Beelen, MD          Haga Recruiting Den Haag, Netherlands, 2545 CH Contact: D Houtsma, MD       d.houtsma@hagaziekenhuis.nl    Principal Investigator: D Houtsma, MD          Deventer ziekenhuis Recruiting Deventer, Netherlands, 7416 SE Contact: A L Imholz, MD       imholza@dz.nl    Principal Investigator: A L Imholz, MD          Nijsmellinghe Not yet recruiting Drachten, Netherlands, 9202 NN Contact: S Hovenga, MD       s.hovenga@nijsmellinghe.nl    Principal Investigator: S Hovenga, MD          Ziekenhuis Gelderse Vallei Active, not recruiting Ede, Netherlands, 6716 RP Maxima Medisch Centrum Recruiting Eindhoven, Netherlands, 5631 BM Contact: M W Dercksen, MD          Principal Investigator: M W Dercksen, MD          Admiraal de Ruyter ziekenhuis Recruiting Goes, Netherlands Contact: H van Halteren, MD          Principal Investigator: H van Halteren, MD          Groene Hart Not yet recruiting Gouda, Netherlands, 2803 HH Contact: B C Tanis, MD       bea.tanis@ghz.nl    Principal Investigator: B C Tanis, MD          Groene Hart Ziekenhuis Active, not recruiting Gouda, Netherlands Martini Ziekenhuis Recruiting Groningen, Netherlands Contact: A.W.G. van der Velde, MD          Principal Investigator: A.W.G. van der Velde, MD          St. Jansdal Recruiting Harderwijk, Netherlands Contact: M Temizkan, MD          Principal Investigator: M Temizkan, MD          Spaarne ziekenhuis Not yet recruiting Hoofddorp, Netherlands, 2134 TM Contact: B de Valk, MD       bdevalk@spaarneziekenhuis.nl    Principal Investigator: B de Valk, MD          MCL Recruiting Leeuwarden, Netherlands, 8934 AD Contact: H de Graaf, MD       graafhi@znb.nl    Principal Investigator: H de Graaf, MD          LUMC Not yet recruiting Leiden, Netherlands, 2333 ZA Contact: J R Kroep, MD       j.r.kroep@lumc.nl    Principal Investigator: J R Kroep, MD          Haaglanden MC Recruiting Leidschendam, Netherlands, 2262 BA Contact: H M Oosterkamp, MD       h.oosterkamp@haaglandenmc.nl    Principal Investigator: H M Oosterkamp, MD          St. Antonius ziekenhuis Recruiting Nieuwegein, Netherlands Contact: M J Agterof, MD          Principal Investigator: M J Agterof, MD          St. Fransicus Gasthuis Not yet recruiting Rotterdam, Netherlands, 3045 PM Contact: A P Hamberg, MD       p.hamberg@sfg.nl    Principal Investigator: A P Hamberg, MD          Ikazia Not yet recruiting Rotterdam, Netherlands, 3083 AN Contact: F E de Jong, MD       fe.de.jongh@ikazia.nl    Principal Investigator: F E de Jong, MD          Stichting Franciscus Vlietland Groep locatie Gasthuis Active, not recruiting Rotterdam, Netherlands Vlietland ziekenhuis Not yet recruiting Schiedam, Netherlands, 3118 JH Contact: Q C van Rossum-Schornagel, MD          Principal Investigator: Q C van Rossum-Schornagel, MD          Elisabeth Tweesteden ziekenhuis Recruiting Tilburg, Netherlands, 5042 AD Contact: van Riel, MD          Principal Investigator: van Riel, MD          VieCuri Medisch Centrum voor Noord-Limburg Active, not recruiting Venlo, Netherlands Isala Klinieken Not yet recruiting Zwolle, Netherlands, 8025 AB Contact: A H. Honkoop, MD       a.h.honkoop@isala.nl    Principal Investigator: A H Honkoop, MD Less <<
NCT01342289 Hodgkin's Lymphoma ... More >> Leukemia Myelodysplastic Syndrome(MDS) Multiple Myeloma Non Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT03687463 - Enrolling by invitation April 10, 2020 -
NCT01869192 Malignant Neoplasm of Female B... More >>reast Less << Phase 2 Active, not recruiting June 2019 United States, Colorado ... More >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 Less <<
NCT00941720 - Active, not recruiting - -
NCT02158091 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Active, not recruiting July 2021 United States, Massachusetts ... More >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02158091 - Active, not recruiting - -
NCT00941720 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Active, not recruiting November 2018 United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00798070 Breast Cancer Phase 3 Active, not recruiting January 2022 -
NCT00352872 - Terminated(This study has been... More >> difficult to recruit.) Less << - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00493649 Breast Cancer Phase 2 Completed - -
NCT00493649 - Completed - -
NCT02594267 Peripheral T-Cell Lymphoma (PT... More >>CL) Less << Phase 1 Recruiting December 2018 United States, Washington ... More >> Seattle Cancer Care Alliance/University of Washington Recruiting Seattle, Washington, United States, 98109 Contact: Andrei Shustov, MD          Principal Investigator: Andrei Shustov, MD Less <<
NCT00072319 Breast Cancer Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01349101 Hematological Malignancies Phase 2 Recruiting February 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: John L Wagner, MD    215-955-8874       Contact: Donna Zuccarello    215-955-6612       Principal Investigator: John L Wagner, MD          Sub-Investigator: Neal Flomenberg, MD          Sub-Investigator: Seyfettin Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Beth Colombe, PhD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Dolores Grosso, DNP, CRNP          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Lisa Kearns, CRNP          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Maria Werner-Wasik, MD          Sub-Investigator: Ubaldo Martinez-Outschoorn, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Sameh Gaballa, MD Less <<
NCT00747877 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - -
NCT00393107 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Ospedale di Arezzo Arezzo, Italy, 52100 Ospedale Maggiore di Milano Milano, Italy, 20100 Ospedale Monteluce Perugia, Italy, 06110 Ospedale di Pescara Pescara, Italy, 89100 Ospedale di Piacenza Piacenza, Italy, 29100 Ospedale di Pisa Pisa, Italy, 56100 Ospedale di Reggio Calabria Reggio Calabria, Italy, 89100 Ospedale S. Maria Nuova Reggio Emilia, Italy, 42100 Ospedale Molinette Torino, Italy, 10100 Less <<
NCT02294552 Acute Myeloid Leukemia ... More >> Acute Lymphoid Leukemia Lymphoma Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Immune System Diseases Less << Phase 2 Completed - Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT00712881 Breast Cancer Phase 2 Completed - Austria ... More >> Teva Investigational Site 16 Kufstein, Austria Teva Investigational Site 15 Wien, Austria Belgium Teva Investigational Site 9 Brussels, Belgium Teva Investigational Site 29 Yvoir, Belgium France Teva Investigational Site 4 Clichy Cedex, France Teva Investigational Site 5 Nancy, France Teva Investigational Site 33 Reims, France Teva Investigational Site 8 Vandoeuvre-Les-Nancy CEDEX, France Germany Teva Investigational Site 30 Aachen, Germany Teva Investigational Site 11 Dusseldorf, Germany Teva Investigational Site 25 Dusseldorf, Germany Teva Investigational Site 32 Essen, Germany Teva Investigational Site 34 Lorrach, Germany Teva Investigational Site 14 Munchen, Germany Teva Investigational Site 27 München, Germany Italy Teva Investigational Site 20 Napoli, Italy Teva Investigational Site 23 Roma, Italy Teva Investigational Site 21 Verona, Italy Spain Teva Investigational Site 26 Barcelona, Spain Teva Investigational Site 3 Barcelona, Spain Teva Investigational Site 1 Lleida, Spain Teva Investigational Site 2 Zaragoza, Spain Less <<
NCT00772486 Chronic Lymphocytic Leukemia Phase 1 Unknown - United States, California ... More >> University of California, San Diego Moores Cancer Center San Diego, California, United States, 92093 Less <<
NCT01135329 - Terminated(The stopping rule w... More >>as met and hence the study was closed) Less << - -
NCT00737685 Anemia, Aplastic Phase 2 Unknown December 2012 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02685111 Breast Cancer ... More >> Neutropenia Febrile Neutropenia Less << Phase 2 Recruiting March 2019 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-746 Principal Investigator: Sung-Bae Kim, MD, PhD Less <<
NCT01135329 Lymphoma Leuk... More >>emia Myelodysplastic Syndrome Less << Phase 2 Terminated(The stopping rule w... More >>as met and hence the study was closed) Less << - United States, Maryland ... More >> The Sydney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT02349178 Leukemia, Acute Lymphoblastic ... More >> Acute Myeloid Leukemia Less << Phase 2 Terminated(Low accrual) - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 53205 United States, Wisconsin American Family Children's Hospital Madison, Wisconsin, United States, 53792 Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Froedtert Memorial Lutheran Hospital Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00396682 Advanced HCC Phase 3 Completed - Germany ... More >> Medizinische Hochschule Hannover Hannover, Germany, 30655 Less <<
NCT03596892 Allogeneic Hematopoietic Stem ... More >>Cell Transplantation Conditions Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia Less << Phase 2 Phase 3 Recruiting June 2022 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-62787883    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT01705691 Breast Cancer ... More >> HER2-negative Breast Cancer Less << Phase 2 Completed - United States, Colorado ... More >> CCOP, Colorado Cancer Research Program, Inc. Denver, Colorado, United States, 80222 United States, Florida CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States, 33140 United States, Georgia Phoebe Putney Memorial Hospital Albany, Georgia, United States, 31703 Memorial Health University Medical Center Savannah, Georgia, United States, 31404 United States, Michigan Henry Ford Health System Detroit, Michigan, United States, 48202 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 Providence Hospital - Southfield Southfield, Michigan, United States, 48075-9975 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, North Carolina Carolinas Medical Center/Levine Cancer Center Charlotte, North Carolina, United States, 28203 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Pennsylvania Albert Einstein Medical Center Philadelphia, Pennsylvania, United States, 19141 Allegheny General Hospital/Allegheny-Singer Research Institute Pittsburgh, Pennsylvania, United States, 15212 NSABP Foundation, Inc. Pittsburgh, Pennsylvania, United States, 15212 University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15232-1305 United States, South Carolina Roper Hospital Charleston, South Carolina, United States, 29401 Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29615 United States, Texas Joe Arrington Cancer Research & Treatment Center Lubbock, Texas, United States, 79410 United States, West Virginia Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown, West Virginia, United States, 26506 Canada, Quebec Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2W-1T8 Montreal General Hospital Montreal, Quebec, Canada, H3G 1A4 Less <<
NCT00789776 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Previously Treated Myelodysplastic Syndrome Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting May 18, 2021 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT03063983 Osteosarcoma Phase 2 Recruiting January 31, 2022 Brazil ... More >> Grupo de Apoio ao Adolescente e a Criança com Câncer Recruiting Sao Paulo, Brazil, 04039001 Contact: Antonio S Petrilli    +55 (11) 5080-8400    sergiopetrilli@graacc.org.br    Contact: Andreza A Senerchia    +55 (11) 5080-8400    andrezasenerchia@graacc.org.br Less <<
NCT01705691 - Completed - -
NCT00789776 - Active, not recruiting - -
NCT00365417 Breast Cancer Phase 2 Completed - United States, Pennsylvania ... More >> NSABP Foundation, Inc. Pittsburgh, Pennsylvania, United States, 15212 Less <<
NCT00365417 - Completed - -
NCT00769522 Chronic Lymphocytic Leukemia Phase 3 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Less <<
NCT00688740 - Completed - -
NCT00245089 Sarcoma Phase 2 Unknown - Japan ... More >> Anjo Kosei Hosptial Recruiting Anjo, Aichi, Japan, 446-8602 Contact: Yuji Miyajima, MD    81-566-75-2111    miyajima@kosei.anjo.aichi    Aichi Medical University Recruiting Nagakuti, Aichi, Japan, 480-1103 Contact: Toshinori Hori    81-561-62-3311       National Hospital Orgnization Nagoya Medical Center Recruiting Nagoya, Aichi, Japan, 460-0001 Contact: Keizo Horibe, MD, PhD    81-52-951-1111    horibek@nnh.hosp.go.jp    Ehime Prefectural Central Hospital Recruiting Matsuyama-shi, Ehime, Japan, 790-0024 Contact: Otoh Yoshiko    81-89-947-1111       National Kyushu Cancer Center Recruiting Fukuoka-shi, Fukuoka, Japan, 811-1395 Contact: Ryohei Yokoyama, MD    81-92-541-3231 ext. 5070    ryokoya@nk-cc.go.jp    Kurume University School of Medicine Recruiting Kurume City, Fukuoka, Japan, 830-0011 Contact: Hiroko Inada    81-942-31-7565       Gifu Municipal Hospital Recruiting Gifu-shi, Gifu, Japan, 500-8513 Contact: Akira Takao, MD    81-58-251-1101    oyuki@gmhosp.gifu.gifu.jp    Gunma Children's Medical Center Recruiting Seta-gun, Gunma, Japan, 377-8577 Contact: Manabu Sotomatsu, MD    81-279-52-3551    sotomatsu@gcmc.pref.gunma.jp    National Hospital Organization - Medical Center of Kure Recruiting Kure, Hiroshima, Japan, 737-0023 Contact: Takeo Tanaka, MD, PhD    81-82-322-3111       Sapporo Medical University Recruiting Sapporo, Hokkaido, Japan, 060-8556 Contact: Nobuhiro Suzuki, MD, PhD    81-11-611-2111       Hokkaido University Graduate School of Medicine Recruiting Sapporo, Hokkaido, Japan, 060-8638 Contact: Ryoji Kobayashi, MD    81-11-706-5954       Kobe City General Hospital Recruiting Kobe, Hyogo, Japan, 650 Contact: Ikuya Usami    81-78-302-4321       Ibaraki Children's Hospital Recruiting Mito-shi, Ibaraki, Japan, 311-4145 Contact: Kazutoshi Koike    81-29-254-1151    kazukoike@ibaraki-kodomo.com    University of Tsukuba Recruiting Tsukuba-city, Ibaraki, Japan, 305-8575 Contact: Michio Kaneko, MD, PhD    81-29-853-3094    mkaneko@md.tsukuba.ac.jp    Ishikawa Prefectural Central Hospital Recruiting Kanazawa-shi, Ishikawa, Japan, 920-02 Contact: Seiki Horita    81-76-237-8211    shorita@ipch.jp    Kanazawa Medical University Recruiting Kanazawa, Ishikawa, Japan, 920-8641 Contact: Yutaka Saikawa, MD, PhD    81-76-265-2314    saikawa@ped.m.kanazawa-u.ac.jp    Kagoshima City Hospital Recruiting Kagoshima City, Kagoshima, Japan, 892-8580 Contact: Kiyoshi Kawakami    81-99-224-2101       National Center for Child Health and Development Recruiting Tokyo, Kanagawa, Japan, 157-8535 Contact: Masa-aki Kumagai, MD    81-3-3416-0181    kumagai-ma@ncchd.go.jp    Showa University Fujigaoka Hospital Recruiting Yokohama-shi, Kanagawa, Japan, 227-8502 Contact: K. Isoyama    81-45-971-1151    isoyama@syowa-univesity-fujigaoka.gr.jp    Yokohama City University Recruiting Yokohama, Kanagawa, Japan, 236-0004 Contact: Hiroaki Goto    81-45-787-2800       Miyazaki Medical College University of Miyazaki Recruiting Miyazaki-gun, Miyazaki, Japan, 889-1692 Contact: Hiroshi Moritake    81-98-585-0989       Nagano Children's Hospital Recruiting Toyoshina-machi, Nagano, Japan, 399-8288 Contact: Eizaburo Ishii    81-263-73-6700       Osaka Medical Center and Research Institute for Maternal and Child Health Recruiting Izumi, Osaka, Japan, 594-1101 Contact: Keisei Kawa, MD, PhD    81-725-56-1220    kawakei@mch.pref.osaka.jp    Osaka City General Hospital Recruiting Suita-shi, Osaka, Japan, 565-0871 Contact: Junichi Hara    81-6-6929-1221       Osaka University Graduate School of Medicine Recruiting Suita-shi, Osaka, Japan, 565-0871 Contact: Hideaki Ohta, MD, PhD    81-6-6879-3937    ohta@ped.med.osaka-u.ac.jp    Osaka Medical College Recruiting Takatsuki City, Osaka, Japan, 569-8686 Contact: Tomoko Kuno    81-72-683-1221       Dokkyo University School of Medicine Recruiting Koshigaya, Saitama, Japan, 343-8555 Contact: Hitoshi Ikeda, MD    81-489-65-1111    hike@dokkyomed.ac.jp    National Defense Medical College Recruiting Tokorozawa, Saitama, Japan, 359-8513 Contact: Kazuhiro Kogawa    81-4-2995-1621       Shiga University of Medical Science Recruiting Otsu-shi, Shiga, Japan, 520-21 Contact: Shigeru Ohta, MD    81-775-48-2228    ohta@belle.shiga-med.ac.jp    Shimane University Hospital Recruiting Izumo, Shimane, Japan, 693-8501 Contact: Ken Taketani, MD    81-853-20-2219    ttaketani@med.shimane-u.ac.jp    Seirei Hamamatsu General Hospital Recruiting Hamamatsu, Shizuoka, Japan, 430-8558 Contact: Tadashi Matsubayashi    81-53-474-2222       Fukushima Medical University Hospital Recruiting Fukushima, Japan, 960-1295 Contact: Atsushi Kikuta, MD    81-24-547-1295       Gifu University Graduate School of Medicine Recruiting Gifu, Japan, 500-8705 Contact: Hideo Kaneko    81-58-230-6386       Hiroshima University Hospital Recruiting Hiroshima, Japan, 734-8551 Contact: Nishimura Shinichiro, MD    81-82-257-5212       Kagoshima University Recruiting Kagoshima, Japan, 890-8520 Contact: Yoshifumi Kawano    81-99-275-5351    ykawano@m3.kufm.kagoshima-u.ac.jp    Kyoto Prefectural University of Medicine Recruiting Kyoto, Japan, 602-8566 Contact: Hajime Hosoi    81-75-251-5571    hhosoi@koto.kpu-m.ac.jp    Kyoto University Hospital Recruiting Kyoto, Japan, 606-8507 Contact: Kenichiro Watanabe, MD    81-75-751-3297    wataken@kuhp.kyoto-u.ac.jp    Osaka City University Recruiting Osaka, Japan, 545-8586 Contact: Kazumi Yamato    81-6-6645-3175       Osaka General Medical Center Recruiting Osaka, Japan, 558-0056 Contact: Keiko Yumura-Yagi, MD    81-6-6692-1201       Saitama Children's Medical Center Recruiting Saitama, Japan, 339-8551 Contact: Akira Kikuchi, MD, PhD    81-48-758-1811    a1091069@pref.saitama.jp    Hokkaido Medical Center for Child Health and Rehabilitation Recruiting Sapporo, Japan, 006-0041 Contact: Tooru Kudoh, MD, PhD    81-11-691-5696       National Cancer Center Hospital Recruiting Tokyo, Japan, 104-0045 Contact: Atsushi Makimoto    81-3-3542-2511       St. Luke's International Hospital Recruiting Tokyo, Japan, 104 Contact: R. Hosoya, MD    81-3-3541-5151       Tokyo Medical and Dental University Recruiting Tokyo, Japan, 113-8510 Contact: Masayuki Nagasawa    81-3-5803-5246       Toho University School of Medicine Recruiting Tokyo, Japan, 143-8541 Contact: Akira Ohara    81-3-3762-4151       Keio University School of Medicine Recruiting Tokyo, Japan, 160-8582 Contact: Yasuhide Morikawa, MD    81-3-5363-2593    ymorikaw@sc.itc.keio.ac.jp    Nihon University Itabashi Hospital Recruiting Tokyo, Japan, 173 Contact: Hideo Mugishima, MD    81-3-3972-8111 ext. 2700       Yamagata University Hospital Recruiting Yamagata, Japan, 990-9585 Contact: Mitsui Tetsuo, MD, DMedSci    81-23-628-5329    tmitsui@med.id.yamagata-u.ac.jp Less <<
NCT01336933 - Completed - -
NCT00033293 Disseminated Neuroblastoma ... More >> Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Phase 3 Completed - -
NCT00238173 Bone Marrow Suppression ... More >> Brain and Central Nervous System Tumors Drug/Agent Toxicity by Tissue/Organ Long-term Effects Secondary to Cancer Therapy in Children Less << Phase 1 Terminated(OHSU IRB closed stu... More >>dy to further enrollment 2/17/2006) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT01336933 Anaplastic Large Cell Lymphoma... More >> Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, California Stanford University Stanford, California, United States, 94305 United States, Georgia Emory University School Of Medicine Atlanta, Georgia, United States, 30308 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts University of Massachusetts Medical School Worcester, Massachusetts, United States, 01655 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Siteman Cancer Center at Washington University Saint Louis, Missouri, United States, 63110 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00861705 Estrogen Receptor Negative ... More >> HER2/Neu Negative Male Breast Carcinoma Progesterone Receptor Negative Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 Triple-Negative Breast Carcinoma Less << Phase 2 Active, not recruiting - -
NCT00688740 Breast Cancer Phase 3 Completed - -
NCT00278408 Lymphoma Phase 3 Completed - -
NCT00597519 Cancer Leukem... More >>ia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00861705 - Active, not recruiting - -
NCT00470301 Breast Cancer ... More >> Male Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Montefiore Medical Center Bronx, New York, United States, 10467-2490 Mount Sinai Medical Center New York, New York, United States, 10029 Columbia University Medical Center New York, New York, United States, 10032 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00470301 - Completed - -
NCT01015456 Lupus Nephritis Phase 3 Terminated(Data Safety Monitor... More >>ing Board concerning of the participants' safety) Less << - Thailand ... More >> Nopparat Rajathani Bangkok, Thailand Khon Kaen University Khon Kaen, Thailand Thammasart University Pathumthani, Thailand Less <<
NCT00083031 Breast Cancer Phase 2 Unknown - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03321890 Peripheral T-cell Lymphoma Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Department of Medical Oncology,Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhiming Li, DM    +86-13719189172    Lizhm@sysucc.org.cn    Contact: Yu Wang, DM    86-20-87343765    Wangyu@sysucc.org.cn Less <<
NCT00597519 - Completed - -
NCT00687648 Breast Cancer Phase 2 Unknown - Singapore ... More >> National Cancer Centre - Singapore Recruiting Singapore, Singapore, 169610 Contact: Wong Nan Soon, MBBS, MRCP, FAMS    65-6-436-8088 Less <<
NCT00016458 Systemic Sclerosis Phase 2 Completed - United States, Colorado ... More >> University of Colorado Cancer Center Denver, Colorado, United States, 80262 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02162771 Lymphoma, Follicular Phase 3 Active, not recruiting June 2020 Spain ... More >> Hospital Universitario Germans Trias i Pujol Barcelona, Badalona, Spain, 08916 Less <<
NCT00033293 - Completed - -
NCT02650986 Adult Solid Neoplasm Phase 1 Phase 2 Recruiting December 20, 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Richard Koya Less <<
NCT03161379 Pancreatic Cancer Phase 2 Recruiting September 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Anna Ferguson, RN    410-614-7186    afergus1@jhmi.edu    Contact: Mark Yarchoan, MD    410-614-1058    mark.yarchoan@jhmi.edu    United States, Massachusetts Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Colin D Weekes, MD    617-724-7000    cdweekes@mgh.harvard.edu    Principal Investigator: Colin D Weekes, MD Less <<
NCT02094794 Adult Acute Myeloid Leukemia W... More >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Less << Phase 2 Recruiting November 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Anthony S. Stein    800-826-4673       Principal Investigator: Anthony S. Stein Less <<
NCT01925131 Acute Leukemias of Ambiguous L... More >>ineage B-cell Adult Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Less << Phase 1 Recruiting January 2023 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact    800-826-4673    becomingapatient@coh.org    Principal Investigator: Margaret R. O'Donnell          Stanford Cancer Institute Palo Alto Suspended Palo Alto, California, United States, 94304 United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Site Public Contact    585-275-5830       Principal Investigator: Paul M. Barr          United States, Ohio Cleveland Clinic Foundation Recruiting Cleveland, Ohio, United States, 44195 Contact: Site Public Contact    866-223-8100    CancerAnswer@ccf.org    Principal Investigator: Aaron T. Gerds          United States, Texas Ben Taub General Hospital Recruiting Houston, Texas, United States, 77030 Contact: Site Public Contact    713-873-2000       Principal Investigator: Martha P. Mims Less <<
NCT03617432 Experimental Tumor Phase 2 Recruiting September 30, 2022 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD    +86-10-88196596    zj@bjcancer.org    Contact: Weiping Liu, MD    +86-10-88196109    dreaming2217@126.com    Principal Investigator: Jun Zhu, MD Less <<
NCT00343447 Leukemia Phase 2 Withdrawn - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT03420963 Malignant Neoplasms of Bone an... More >>d Articular Cartilage Malignant Neoplasms of Female Genital Organs Malignant Neoplasms of Independent (Primary) Multiple Sites Malignant Neoplasms of Lip Oral Cavity and Pharynx Malignant Neoplasms of Male Genital Organs Malignant Neoplasms of Mesothelial and Soft Tissue Malignant Neoplasms of Thyroid and Other Endocrine Glands Malignant Neoplasms of Urinary Tract Melanoma and Other Malignant Neoplasms of Skin Less << Phase 1 Recruiting December 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       jsfoglesong@mdanderson.org Less <<
NCT02256150 Lupus Nephritis Phase 3 Active, not recruiting March 2019 -
NCT00010400 Systemic Lupus Erythematosus ... More >> Antiphospholipid Antibody Syndrome Less << Not Applicable Completed - United States, Maryland ... More >> Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 Less <<
NCT00296010 Breast Cancer Phase 3 Terminated(Accrual rate was to... More >>o low) Less << - -
NCT00669890 Acute Myeloid Leukemia ... More >> Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Less << Phase 1 Terminated(PI left institution... More >>) Less << - United States, New York ... More >> Morgan Stanley Children's Hospital of NYP New York City, New York, United States, 10032 Less <<
NCT01532856 Multiple Myeloma Phase 3 Unknown June 2012 Brazil ... More >> Universidade Federal do Rio Grande do Sul Porto Alegre, Rio Grande do Sul, Brazil Hospital Universitário Clementino Fraga Filho Rio de Janeiro, Brazil Santa Casa de Misericórdia de São Paulo São Paulo, Brazil Less <<
NCT02257697 Nephrotic Syndrome Phase 3 Active, not recruiting November 2018 -
NCT02414269 Malignant Pleural Disease ... More >> Mesothelioma Metastases Lung Cancer Breast Cancer Less << Phase 1 Recruiting April 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Basking Ridge (Sceening Consent only) Recruiting Basking Ridge, New Jersey, United States Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Monmouth (Screening Consent Only) Recruiting Middletown, New Jersey, United States, 07748 Contact: Prasad Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Bergen (Sceening Consent Only) Recruiting Montvale, New Jersey, United States, 07645 Contact: Prasad Adusumilli, MD    212-639-8093       United States, New York Memorial Sloan Kettering Commack (Screening Consent Only) Recruiting Commack, New York, United States Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Westchester (Screening Consent Only) Recruiting Harrison, New York, United States, 10604 Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Prasad Adusumilli, MD    212-639-8093       Contact: Marjorie Zauderer, MD    646-888-4656       Memorial Sloan Kettering Rockville Centre (Screening Consent Only) Recruiting Rockville Centre, New York, United States Contact: Prasad Adusumilli, MD    212-639-8093 Less <<
NCT02096614 Solid Tumors Phase 1 Recruiting - Japan ... More >> Mie University Hospital Recruiting Tsu, Mie, Japan Contact: Yasuyuki Ota, Ph.D.          Contact: Chisato Minamide, RN Less <<
NCT00286819 Breast Cancer Phase 2 Completed - Austria ... More >> AKH, Universitätsklinik für Innere Medizin 1 Vienna, Austria, 1090 Hungary Onkotherápiás Klinika, Szeged, Hungary Poland Medical University of Gdansk, Dept. of Oncology and Radiotherapy Gdansk, Poland, 80-211 Slovakia Nomocnica Sv. Alzbety, Narodny Onkologicky Ustav Bratislava, Slovakia, 81250 Oncology Institute, Department of Radiotherapy and Onclogy Kosice, Slovakia, 04191 Less <<
NCT02183805 Carcinoma Breast Stage IV Phase 2 Recruiting December 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhong-Yu Yuan, M.D.    86-20-87343794    yuanzhy@sysucc.org.cn Less <<
NCT00140075 Adenocarcinoma Phase 3 Completed - -
NCT02366546 Solid Tumors Phase 1 Active, not recruiting - Japan ... More >> Mie University Hospital Tsu, Mie, Japan Less <<
NCT01509300 Acute Leukemia ... More >> Myelodysplastic Syndrome Solid Tumors Less << Phase 1 Phase 2 Unknown March 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD    82-2-3010-3371    hojim@amc.seoul.kr    Principal Investigator: Ho Joon Im, MD & PhD Less <<
NCT00152191 Breast Cancer Phase 3 Completed - Japan ... More >> National Cancer Center 5-1-1, Tsukiji, chuo-ku, Tokyo, Japan Less <<
NCT02001519 Breast Cancer Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00114816 Breast Cancer Phase 3 Completed - Finland ... More >> Department of Oncology, Helsinki University Central Hospital, Finland Helsinki, Finland, FIN-00029 Less <<
NCT01883297 Recurrent, Platinum Resistant ... More >>High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Less << Phase 1 Recruiting December 2023 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D.    416-946-4501 ext 5485    marcus.butler@uhn.ca    Principal Investigator: Marcus Butler, M.D. Less <<
NCT03507465 Breast Cancer Phase 2 Phase 3 Recruiting November 29, 2020 China, Guangdong ... More >> Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510080 Contact: Liming Yao    00862083827812 ext 20984    13149395530@163.com Less <<
NCT02199184 Leukemia Phase 2 Recruiting January 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01415336 Breast Cancer Phase 2 Phase 3 Unknown - China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100730 Contact: Qiang Sun, Master    86-010-88068936    sunq@medmail.com.cn    Contact: Songjie Shen, Doctor    86-010-88068936    pumcssj@163.com    Principal Investigator: Qiang Sun, Master Less <<
NCT01417000 - Completed - -
NCT02294344 Anti-Neutrophil Cytoplasmic An... More >>tibody-Associated Vasculitis Less << Not Applicable Terminated(The recruitment of ... More >>subject is very difficult.) Less << - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT03477500 Multiple Sclerosis Phase 3 Recruiting March 21, 2024 Denmark ... More >> Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Morten Blinkenberg, MD, PhD       Morten.Blinkenberg@regionh.dk    Contact: Finn T Sellebjerg, MD, PhD       finn.thorup.sellebjerg@regionh.dk    Netherlands VUmc Not yet recruiting Amsterdam, Netherlands Contact: Joep Killestein, PhD       joep.killestein@vumc.nl    Norway Haukeland University Hospital Recruiting Bergen, Norway Contact: Øivind Torkildsen, MD, PhD    4755976032    ofto@helse-bergen.no    Contact: Lars Bø, MD, PhD    55977039    labo@helse-bergen.no    Akershus University Hospital Not yet recruiting Oslo, Norway Contact: Trygve Holmøy, MD, PhD       trygve.holmoy@medisin.uio.no    University Hospital of North Norway Recruiting Tromsø, Norway Contact: Margitta Kampman, MD, PhD       Margitta.T.Kampman@unn.no    St. Olav's University Hospital Recruiting Trondheim, Norway Contact: Kathrine Lian, MD       Kathrine.Krokenes.Lian@stolav.no    Sweden Sahlgrenska University Hospital Not yet recruiting Gothenburg, Sweden Contact: Jan Lycke, MD, PhD       jan.lycke@gu.se    Akademiska sjukhuset Not yet recruiting Uppsala, Sweden Contact: Joachim Burman, MD, PhD       joachim.burman@neuro.uu.se Less <<
NCT01417000 Metastatic Pancreatic Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York NYU Langone Medical Center New York, New York, United States, 10016 Herbert Irving Comprehensive Cancer Center of Columbia University New York, New York, United States, 10032 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States, 15213 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT03068624 Melanoma and Other Malignant N... More >>eoplasms of Skin Less << Phase 1 Recruiting September 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       sppatel@mdanderson.org Less <<
NCT02937662 Acute Myeloid Leukemia Phase 2 Recruiting December 2018 China ... More >> Institute of Hematology & Blood Diseases Hospital Recruiting Tianjin, China Contact: lijun Liu Less <<
NCT00001272 Ovarian Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01516307 Metastatic Breast Cancer Phase 2 Active, not recruiting August 2019 -
NCT02572492 Multiple Myeloma Phase 2 Active, not recruiting April 2019 Denmark ... More >> Aalborg University Hospital Aalborg, Denmark, 9000 Finland Turku University Hospital Turku, Finland, 20520 Lithuania Vilnius University hospital "Santariskiu Clinics" Vilnius, Lithuania Norway Oslo University Hospital Oslo, Norway, 4950 Sweden Skåne University Hospital Lund, Sweden, SE-221 85 Less <<
NCT01222052 Breast Cancer Phase 3 Active, not recruiting February 2019 Germany ... More >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT03533816 Acute Myeloid Leukemia ... More >> Chronic Myeloid Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Less << Phase 1 Not yet recruiting December 2022 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 Contact: Antonio Di Stasi, M.D.    205-934-0688    adistasi@uab.edu    Contact: Tiffany Hill, R.N.    205-996-8023    tiffanydhill@uabmc.edu Less <<
NCT02115152 Stage II Breast Cancer ... More >> Stage III Breast Cancer Less << Phase 2 Unknown - China, Guangxi ... More >> Breast Cancer Surgery Department of Guangxi Medical University Cancer Center Not yet recruiting Nanning, Guangxi, China Contact: Jianlun Liu, MD Less <<
NCT00261313 Breast Cancer Phase 2 Completed - -
NCT00464646 - Completed - -
NCT00464646 Breast Cancer Phase 2 Completed - -
NCT03332576 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 1 Active, not recruiting November 30, 2017 United States, New York ... More >> Winthrop University Hospital Mineola, New York, United States, 11501 Lenox Hill Hospital New York, New York, United States, 10028 Canada, Ontario Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02248428 Multiple Myeloma Phase 3 Recruiting September 2020 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: Zhai, doctor    13951947646    ypzhai@medmail.com.cn    Principal Investigator: Yongping Zhai, doctor Less <<
NCT00621452 B-cell Chronic Lymphocytic Leu... More >>kemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02595242 Diffuse Large B Cell Lymphoma Phase 1 Withdrawn June 2017 China ... More >> Tianjin people's Hospital Tianjin, China Less <<
NCT01936064 Haematological Abnormality Phase 1 Phase 2 Unknown January 2018 Nigeria ... More >> Lagos State University Teaching Hospital Recruiting Ikeja, Lagos, Nigeria, 100001 Contact: Abiodun Popoola, M.D.    2348033021434    okubena@health-forever.com    Principal Investigator: Abiodun Popoola, M.D.          Lagos State University Recruiting Ikeja, Lagos, Nigeria, 100001 Contact: Abiodun Popoola, M.D.    2348033021434    pabiodun2001@yahoo.com    Sub-Investigator: A. O. Dosunmu, M.D.          Sub-Investigator: O A Fatiregun, M.D.          Sub-Investigator: N S Bello, M.D.          Sub-Investigator: S Makanjuola, MD          Sub-Investigator: A I Igwilo, MD Less <<
NCT02732678 Angiosarcoma Phase 1 Phase 2 Not yet recruiting May 2019 France ... More >> Assistance Publique Hôpitaux de Marseille Active, not recruiting Marseill, France, 13354 Less <<
NCT00482391 - Completed - -
NCT00005892 Fanconi's Anemia ... More >> Myelodysplastic Syndromes Leukemia, Nonlymphocytic, Acute Leukemia, Lymphocytic, Acute Less << Not Applicable Completed - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00482391 Breast Cancer Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00948090 Lymphoma Phase 2 Completed - -
NCT00948090 - Completed - -
NCT01088022 Nausea Vomiti... More >>ng Less << Phase 3 Unknown April 2013 Italy ... More >> Azienda Ospedaliera di Perugia - Hematology dept. Not yet recruiting Perugia, Italy, 06100 Principal Investigator: Leonardo Flenghi, M.D. Less <<
NCT00601796 Lung Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00005891 Fanconi's Anemia Not Applicable Completed - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00110695 Breast Neoplasms Phase 2 Completed - United States, Pennsylvania ... More >> NSABP Operations Center Pittsburgh, Pennsylvania, United States, 15212 Less <<
NCT03434769 Non-Hodgkin Lymphoma Phase 1 Recruiting July 2021 United States, Ohio ... More >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Paolo F. Caimi, MD    800-241-6422    paolo.caimi@case.edu    Principal Investigator: Paolo F. Caimi, MD Less <<
NCT00601796 - Completed - -
NCT03056339 B-Lymphoid Malignancies ... More >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non-hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting June 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       krezvani@mdanderson.org Less <<
NCT00124813 Multiple Myeloma Phase 2 Unknown November 2010 Germany ... More >> Medical Clinic & Policlinic III, University of Bonn Recruiting Bonn, Germany, 53105 Contact: Ingo Schmidt-Wolf, MD    +49-228-287-15507    picasso@uni-bonn.de    Principal Investigator: Ingo Schmidt-Wolf, MD Less <<
NCT01370772 B-cell Chronic Lymphocytic Leu... More >>kemia CLL Less << Phase 2 Completed - France ... More >> Stephane LEPRETRE Rouen, CLCC Henri Becquerel, France, 76038 Guillaume CARTRON Montpellier, Regional university Hospital, France, 34295 Less <<
NCT00354822 Lymphoma, Non-Hodgkin Phase 2 Terminated(Inability to recrui... More >>t in time a sufficient number of patients) Less << - Italy ... More >> USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 U.O. Ematologia Ospedali Civili Brescia Brescia, BS, Italy Medicina Nucleare ed Oncologia Medica AOU Policlinico Universitario di Messina Messina, ME, Italy, 98125 Istituto per la Ricerca e la Cura del Cancro IRCC Candiolo, TO, Italy, 10060 SC Ematologia 2 ASO S. Giovanni Battista Torino, TO, Italy U.O. Ematologia Ospedale Cà Foncello Treviso, TV, Italy, 31100 Less <<
NCT00174707 Breast Neoplasms Phase 3 Completed - Italy ... More >> Sanofi-Aventis Administrative Office Milan, Italy Less <<
NCT00002653 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - United Kingdom ... More >> MRC Myelomatosis Trials Office Birmingham, England, United Kingdom, B15 2SZ Less <<
NCT03220022 AIDS-Related Lymphoma ... More >> Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma CD20 Negative CD20 Positive Human Immunodeficiency Virus Positive Less << Phase 1 Recruiting September 18, 2020 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Ida C. Wong-Sefidan    858-552-8585 ext 7106    icwong@ucsd.edu    Principal Investigator: Ida C. Wong-Sefidan          UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Ronald T. Mitsuyasu    310-825-6689    rmitsuya@mednet.ucla.edu    Principal Investigator: Ronald T. Mitsuyasu          UCSF Medical Center-Parnassus Recruiting San Francisco, California, United States, 94143 Contact: Lawrence D. Kaplan    415-353-2661    LKaplan@ucsf.edu    Principal Investigator: Lawrence D. Kaplan          United States, Illinois John H Stroger Jr Hospital of Cook County Recruiting Chicago, Illinois, United States, 60612 Contact: Paul G. Rubinstein    312-864-7277    prubinstein@cookcountyhhs.org    Principal Investigator: Paul G. Rubinstein          United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Richard F. Ambinder    410-955-8839    ambinri@jhmi.edu    Principal Investigator: Richard F. Ambinder          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Lee Ratner    314-747-7405    lratner@wustl.edu    Principal Investigator: Lee Ratner          United States, New York Montefiore Medical Center - Moses Campus Recruiting Bronx, New York, United States, 10467 Contact: Murali Janakiram    718-920-4826    mjanakir@montefiore.org    Principal Investigator: Murali Janakiram          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Ariela Noy    212-639-7423    noya@mskcc.org    Principal Investigator: Ariela Noy          United States, North Carolina UNC Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Christopher E. Dittus    919-962-8565    chris_dittus@med.unc.edu    Principal Investigator: Christopher E. Dittus          United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Robert A. Baiocchi    614-293-3196    Robert.Baiocchi@osumc.edu    Principal Investigator: Robert A. Baiocchi          United States, Pennsylvania Pennsylvania Oncology Hematology Associates Recruiting Philadelphia, Pennsylvania, United States, 19106 Contact: Douglas F. Beach    215-829-6307    douglas.beach@uphs.upenn.edu    Principal Investigator: Douglas F. Beach          Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Stefan K. Barta    215-728-2674    Stefan.barta@fccc.edu    Principal Investigator: Stefan K. Barta          United States, Washington Virginia Mason Medical Center Recruiting Seattle, Washington, United States, 98101 Contact: David M. Aboulafia    206-223-6193    hemda@vmmc.org    Principal Investigator: David M. Aboulafia          Harborview Medical Center Recruiting Seattle, Washington, United States, 98104 Contact: Manoj P. Menon    206-667-4636    mmenon@fredhutch.org    Principal Investigator: Manoj P. Menon Less <<
NCT00001426 Ovarian Neoplasm Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00010413 Pemphigus Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 Less <<
NCT02698891 Early Stage Breast Cancer Phase 2 Recruiting August 2023 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Dana-Farber at Milford Regional Cancer Center Recruiting Milford, Massachusetts, United States, 01757 Contact: Michael Constantine, MD    508-488-3700    Michael_Constantine@DFCI.HARVARD.EDU Less <<
NCT02271464 Metastatic Colorectal Cancer Phase 2 Completed - Italy ... More >> Istituto Ospedaliero Fondazione Poliambulanza Di Brescia Brescia, Italy, 25124 Pres.Ospedaliero Spedali Civili Brescia Brescia, Italy, 25125 Istituti Ospitalieri Di Cremona Cremona, Italy, 26100 Azienda Ospedaliera S. Croce E Carle Di Cuneo Cuneo, Italy, 12100 A.O. Universitaria Arcispedale S.Anna Di Ferrara Ferrara, Italy, 44100 Ausl Di Frosinone - Frosinone, Italy, 03100 E.O. Ospedali Galliera Genova, Italy, 16128 Ospedale Per Acuti Mater Salutis Di Legnago Legnago, Italy, 37045 Oncologia AUSL 2 Lucca Lucca, Italy Irccs Fondazione Centro S. Raffaele Del Monte Tabor Milano, Italy, 20132 A.O. Universitaria Federico Ii Di Napoli Napoli, Italy, 80131 Irccs Istituto Oncologico Veneto (Iov) Padova, Italy, 35128 Polo Oncologico Area Vasta Nord Ovest Pisa, Italy, 56100 Ausl 5 Di Pisa Pontedera, Italy, 56100 Ospedale Mesericordia E Dolce Prato, Italy, 59100 Ospedale S. Maria Nuova Reggio Emilia, Italy, 42100 Ospedale San Giovanni Calibita Fatebenefratelli Roma, Italy, 00186 Ospedale San Pietro Fatebenefratelli Di Roma Roma, Italy, 00189 Campus Biomedico Roma, Italy A.O. Universitaria S. Maria Della Misericordia Udine, Italy, 33100 Less <<
NCT02336386 Extramedullary Plasmacytoma Phase 3 Unknown December 2016 China, Beijing ... More >> Yuping ZHONG Recruiting Beijing, Beijing, China, 100043 Contact: Yuping ZHONG, Doctor    860105171-8999    zhongyp3352@126.com    Principal Investigator: Yuping ZHONG, Doctor          Principal Investigator: Jin LU, Doctor Less <<
NCT00003868 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00002809 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase-Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT03401372 Amyloidosis; Systemic Not Applicable Recruiting April 20, 2020 China ... More >> Peking Union Medical College Hospital Recruiting Beijing, China, 100730 Contact: Jian Li, MD Less <<
NCT00010387 Anemia, Hemolytic, Autoimmune ... More >> Felty Syndrome Purpura, Thrombocytopenic Autoimmune Diseases Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 Less <<
NCT00494780 Lymphoma, Follicular Phase 2 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14263 Less <<
NCT00005908 - Completed - -
NCT01427114 Lymphoma Phase 2 Active, not recruiting August 1, 2018 Korea, Republic of ... More >> Seoul St. Mary's Hospital Seoul, Korea, Republic of, 137-701 KonKuk University Medical Center Seoul, Korea, Republic of, 143-729 Less <<
NCT01105273 Aplastic Anemia Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT02260934 Lupus Nephritis Phase 2 Active, not recruiting February 19, 2019 United States, Alabama ... More >> University of Alabama, Birmingham Birmingham, Alabama, United States, 35294 United States, California UCLA Medical Center: Division of Rheumatology Los Angeles, California, United States, 90095 University of California, San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver: School of Medicine: Division of Rheumatology Aurora, Colorado, United States, 80045 Colorado Kidney Care Denver, Colorado, United States, 80218 United States, Georgia Emory University School of Medicine Atlanta, Georgia, United States, 30303 United States, Missouri Washington University in St. Louis Saint Louis, Missouri, United States, 36110 United States, New York Feinstein Institute, North Shore Hospital Manhasset, New York, United States, 10030 New York University, Langone Medical Center New York, New York, United States, 10016 Weill Cornell Medical College: Hospital for Special Surgery - New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina University of North Carolina School of Medicine: Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Wexner Medical Center: Columbus, Ohio, United States, 43213 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT00005908 Breast Cancer ... More >> Breast Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> National Naval Medical Center Bethesda, Maryland, United States, 20889 Less <<
NCT00538395 Breast Cancer Not Applicable Unknown September 2013 -
NCT00208923 Hematologic Malignancies Phase 2 Completed - United States, Georgia ... More >> Emory Universtiy Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00494780 - Completed - -
NCT00070278 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT03395860 Graft-versus-host-disease ... More >> Prophylaxis Less << Phase 2 Recruiting December 20, 2021 China, Shanghai ... More >> Shanghai First People's HOSPITAL Recruiting Shanghai, Shanghai, China, 200127 Contact: YANG JUN, master    18001890183    yangjuan74@hotmail.com    Contact: song xianmin, doctor    13501672508    shongxm@sjtu.edu.cn Less <<
NCT02605915 HER2-Positive Metastatic Breas... More >>t Cancer HER2-Negative Metastatic Breast Cancer Locally Advanced or Early Breast Cancer Less << Phase 1 Active, not recruiting October 31, 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-3300 United States, Arkansas University of Arkansas for Medical Sciences; Winthrop Rockefeller Cancer Institute Little Rock, Arkansas, United States, 72205 United States, Illinois Joliet oncology hematology associates Joliet, Illinois, United States, 60435 United States, Indiana Horizon Oncology Research, Inc. Lafayette, Indiana, United States, 47905 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Michigan Karmanos Cancer Center; Department of Oncology Detroit, Michigan, United States, 48201 United States, Missouri HCA Midwest Division Kansas City, Missouri, United States, 64132 United States, New York Montefiore Medical Center, Advanced Women's Health Center, Clinical Trials and Research Unit; Depart Bronx, New York, United States, 10461 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 Duke Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Oncology Hematology Care Inc Cincinnati, Ohio, United States, 45242 United States, Pennsylvania St. Luke's University Health Network Bethlehem, Pennsylvania, United States, 18015 Kimmel Cancer Center Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Magee Womens Hospital Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee Tennessee Oncology - Chattanooga; Tennessee Oncology - East Third Street Chattanooga, Tennessee, United States, 37404 West Clinic Germantown, Tennessee, United States, 38138 Tennessee Oncology Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Cancer Therapy and Research Center CTRC at UTHSCSA San Antonio, Texas, United States, 78229 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00877006 Non-Hodgkin's Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 3 Completed - -
NCT03336632 Leukemia, Acute ... More >> MDS Less << Phase 2 Not yet recruiting March 30, 2021 China, Sichuan ... More >> West China Hospital of Sichuan University Chengdu, Sichuan, China, 610044 West China Hospital of Sichuan University Not yet recruiting Chengdu, Sichuan, China, 610044 Contact: Jie Ji, MD    86-28-85422370    jieji@scu.edu.cn Less <<
NCT00877006 - Completed - -
NCT03728179 Solid Tumor, Adult Phase 1 Not yet recruiting March 15, 2023 Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Less <<
NCT01535183 Brain Tumor Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Chongno-gu, Korea, Republic of, 110-744 Contact: Hyoung Jin Kang, M.D., Ph.D    82-2-2072-3304    kanghj@snu.ac.kr    Contact: Hyery Kim, M.D.    82-2-2072-3452    taban@hanmail.net Less <<
NCT00715208 Relapsed Follicular Lymphoma Phase 2 Completed - -
NCT02871869 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 2 Phase 3 Recruiting December 2021 China, Xinjiang ... More >> Cancer Hospital Affiliated to Xinjiang Medical University Recruiting Ürümqi, Xinjiang, China, 830011 Contact: Shun-E Yang, Professor    13669926688    yangshune@medmail.com.cn Less <<
NCT00715208 - Completed - -
NCT03113500 Adult T-Cell Leukemia/Lymphoma... More >> Anaplastic Large Cell Lymphoma, ALK-Negative Anaplastic Large Cell Lymphoma, ALK-Positive Angioimmunoblastic T-Cell Lymphoma CD30-Positive Neoplastic Cells Present Enteropathy-Associated T-Cell Lymphoma Hepatosplenic T-Cell Lymphoma Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Peripheral T-Cell Lymphoma, Not Otherwise Specified Stage III Anaplastic Large Cell Lymphoma Stage IV Anaplastic Large Cell Lymphoma Less << Phase 2 Recruiting December 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Alex F. Herrera, MD    626-256-4673 ext 62405    aherrera@coh.org    Principal Investigator: Alex F. Herrera, MD          United States, New Jersey Hackensack University John Theurer Cancer Center Not yet recruiting Hackensack, New Jersey, United States, 07601 Contact: Tatyana Feldman, MD    551-996-4469    Tatyana.Feldman@hackensackmeridian.org    Principal Investigator: Tatyana Feldman, MD          United States, Ohio Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Jonathan Brammer, MD    614-366-6963    Jonathan.Brammer@osumc.edu    Principal Investigator: Jonathan Brammer, MD          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Swaminathan P. Iyer, MD    713-792-5242    spiyer@mdanderson.org    Principal Investigator: Swaminathan P. Iyer, MD          Canada, British Columbia British Columbia Cancer Agency Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Kerry Savage, MD MSc    604 877-6000    ksavage@bccancer.bc.ca    Principal Investigator: Kerry Savage, MD MSc Less <<
NCT00280241 - Completed - -
NCT00280241 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01292135 - Completed - -
NCT01292135 B-cell Chronic Lymphocytic Leu... More >>kemia Small Lymphocytic Lymphoma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, New York CLL Research and Treatment Program New Hyde Park, New York, United States, 11042 Weill Medical College of Cornell University New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Houston, Texas, United States, 77030 Less <<
NCT01982682 Hematopoietic/Lymphoid Cancer Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01982682 - Completed - -
NCT01231906 Non-Metastatic Extraskeletal E... More >>wing Sarcoma Peripheral Primitive Neuroectodermal Tumor of Bone Peripheral Primitive Neuroectodermal Tumor of Soft Tissues Less << Phase 3 Active, not recruiting - -
NCT01527422 Lymphoma Non ... More >>Hodgkin's Lymphoma Less << Phase 1 Phase 2 Completed - Puerto Rico ... More >> Hospital Auxilio Mutuo Cancer Center San Juan, Puerto Rico, 00919 Less <<
NCT02705703 Cancer Metast... More >>atic Solid Malignancies Less << Phase 1 Phase 2 Withdrawn(Sponsor decision to ... More >>discontinue study.) Less << January 31, 2019 -
NCT02709993 Cancer Hemato... More >>logic Malignancies Less << Phase 1 Phase 2 Recruiting January 31, 2019 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval G. Daver, MD    713-794-4392    NDaver@mdanderson.org Less <<
NCT01403285 Glioblastoma Phase 1 Terminated(Due to poor accrual... More >>. This decision was taken without any safety reasons. Since beginning of the study (June 2011) only six patients were enrolled.) Less << - United States, Maryland ... More >> Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT03648697 Nasopharyngeal Carcinoma Phase 2 Not yet recruiting October 10, 2020 China, Fujian ... More >> Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350014 Contact: Jianji Pan    0591-83660063    panjianji@126.com Less <<
NCT01190787 Multiple Myeloma Phase 2 Active, not recruiting May 2020 Italy ... More >> Division of Hematology, A.O.U. San Giovanni Battista Torino, Italy, 10126 Less <<
NCT00245141 Sarcoma Phase 2 Unknown - -
NCT00070200 Neuroblastoma Phase 1 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0106 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Mary Bridge Children's Hospital and Health Center - Tacoma Tacoma, Washington, United States, 98405 Australia, New South Wales Westmead Hospital Westmead, New South Wales, Australia, 2145 Less <<
NCT02450058 Breast Cancer ... More >> Chemotherapy, Adjuvant Less << Phase 3 Completed - Italy ... More >> Federico Castiglione Alba, Italy, 12051 Ornella Garrone Cuneo, Italy, 12100 Lucia Del Mastro Genoa, Italy, 16132 Giovanna Cavazzini Mantova, Italy, 46100 Andrea Michelotti Pisa, Italy, 56100 Tiziana Scotto Sassari, Italy, 07100 Antonio Durando Torino, Italy, 10126 Saverio Danese Torino, Italy, 10126 Less <<
NCT02004262 2nd-line, 3rd-line and Greater... More >> Metastatic Pancreatic Cancer Less << Phase 2 Completed - -
NCT02004262 - Completed - -
NCT00427336 - Completed - -
NCT00230282 Leukemia B-ce... More >>ll Leukemia Chronic Leukemia Chronic Lymphocytic Leukemia (CLL) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00427336 Aplastic Anemia Not Applicable Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00002707 Breast Cancer Phase 3 Completed - -
NCT00230282 - Completed - -
NCT02419742 Breast Cancer Phase 4 Recruiting December 28, 2020 India ... More >> Yashoda Hospital Recruiting Hyderabad, Andhra Pradesh, India, 500082 Rajiv Gandhi Cancer Institute & Research Center Recruiting New Delhi, Delhi, India, 110 085 Manipal Hospital; Department of Oncology Recruiting Bangalore, Karnataka, India, 560017 Jehangir Clinical Development Centre Pvt. Ltd; Cancer Research Room Active, not recruiting Pune, Maharashtra, India, 411001 MAX Balaji Hospital Active, not recruiting Delhi, India, 110092 Dr. GVN Cancer Institute; Medical Oncology Recruiting Trichy, India, 620008 Less <<
NCT00946023 - Terminated(Funding was unavail... More >>able to complete the study as originally planned.) Less << - -
NCT03315520 Relapsed/Refractory Malignant ... More >>Lymphomas Less << Phase 2 Recruiting December 31, 2020 Russian Federation ... More >> The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation Recruiting Moscow, Russian Federation, 105203 Contact: Vladislav Sarzhevskiy, MD, PhD    +74956037217    vladsar100@gmail.com    Contact: Nikita Mochkin, MD, PhD    +74956037217    nickmed@yandex.ru Less <<
NCT00562640 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00093795 Breast Cancer Phase 3 Completed - United States, Alabama ... More >> Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham Birmingham, Alabama, United States, 35294 United States, Alaska Providence Cancer Center Anchorage, Alaska, United States, 99508 United States, Florida Robert and Carol Weissman Cancer Center at Martin Memorial Stuart, Florida, United States, 34994 United States, Kentucky Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States, 40536-0093 United States, Massachusetts South Shore Hospital South Weymouth, Massachusetts, United States, 02190 United States, Nebraska Methodist Estabrook Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, North Carolina Blumenthal Cancer Center at Carolinas Medical Center Charlotte, North Carolina, United States, 28232-2861 United States, North Dakota Altru Cancer Center at Altru Hospital Grand Forks, North Dakota, United States, 58201 United States, Ohio Community Oncology Group at Cleveland Clinic Cancer Center Independence, Ohio, United States, 44131 United States, Pennsylvania Chestnut Hill Healthcare Cancer Center Philadelphia, Pennsylvania, United States, 19118 United States, Washington Madigan Army Medical Center - Tacoma Tacoma, Washington, United States, 98431 Less <<
NCT00603460 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 1 Phase 2 Withdrawn March 2013 United States, Pennsylvania ... More >> University of Pennsylania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03101748 Malignant Neoplasm of Breast Phase 1 Phase 2 Recruiting January 2026 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       blim@mdanderson.org Less <<
NCT00093795 - Completed - -
NCT00309842 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelofibrosis MDS Refractory Anemia Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Non-Hodgkin's Lymphoma Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00003136 Ovarian Cancer ... More >> Primary Peritoneal Cavity Cancer Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Less <<
NCT01048892 Adrenocortical Carcinoma ... More >> Gastrointestinal Carcinoid Tumor Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Children's Hospital of Orange County Orange, California, United States, 92868 UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60611 United States, Indiana Riley's Children Cancer Center at Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 2115 United States, Michigan C.S. Mott Children's Hospital at University of Michigan Medical Center Ann Arbor, Michigan, United States, 48109-0286 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis St. Louis, Missouri, United States, 63110 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229-3039 United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15213 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Baylor University Medical Center - Houston Houston, Texas, United States, 77030-2399 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 United States, Wisconsin Midwest Children's Cancer Center at Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01675765 Malignant Pleural Mesothelioma Phase 1 Active, not recruiting December 2018 United States, California ... More >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Pennsylvania University of Pennsylvania Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02025881 High-risk Medulloblastoma Phase 1 Phase 2 Recruiting September 2022 France ... More >> Gustave Roussy Recruiting Villejuif, Val de Marne, France, 94805 Contact: Christelle Dufour, MD    0142114247 ext +33    christelle.dufour@gustaveroussy.fr    Contact: Perrine Capolino    0142113590 ext +33    perrine.capolino@gustaveroussy.fr    Principal Investigator: Christelle Dufour, MD Less <<
NCT00003910 - Terminated - -
NCT02406222 Multiple Myeloma Phase 2 Recruiting March 2023 United Kingdom ... More >> Belfast Health & Social Care Trust Recruiting Belfast, United Kingdom, BT9 7AB University of Birmingham NHS Foundation Trust Recruiting Birmingham, United Kingdom, B15 2TH Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom, B9 5SS Royal Sussex County Hospital Recruiting Brighton, United Kingdom, BN2 5BE Queens Hospital Recruiting Burton on Trent, United Kingdom, DE13 0RB University Hospital of Wales NHS Trust Recruiting Cardiff, United Kingdom, CF14 4XW Ninewells Hospital Recruiting Dundee, United Kingdom, DD1 9SY Beatson Oncology Centre Not yet recruiting Glasgow, United Kingdom St James's Hopsital Recruiting Leeds, United Kingdom, LS9 7TF University Hospital of Leicester NHS Trust Recruiting Leicester, United Kingdom, LE1 5WW St Bartholomew Hospital Not yet recruiting London, United Kingdom, EC1M 6BQ University College London Hospital Recruiting London, United Kingdom, NW1 2BU Guy's and St Thomas' NHS Foundation Trust Recruiting London, United Kingdom, SE1 9RT The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Imperial College Hospital Recruiting London, United Kingdom, W2 1NY Central Manchester Univeristy Hospital NHS Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie Hospital Recruiting Manchester, United Kingdom, M20 4BX Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Sheffield Teaching Hospitals NHS FoundationTrust Recruiting Sheffield, United Kingdom, S10 2RB University Hospital of North Tees Recruiting Stockton-on-Tees, United Kingdom, TS19 8PE New Cross Hospital Recruiting Wolverhampton, United Kingdom, WV10 0QP Less <<
NCT00787527 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003910 Leukemia Phase 2 Terminated - -
NCT00911183 Lymphoma Phase 2 Unknown - France ... More >> Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Pierre Soubeyran, MD, PhD    33-556-333-267    soubeyran_p@bergonie.org Less <<
NCT02997813 - Completed - France ... More >> CHRU Dijon Dijon, France, 21000 Centre Hospitalier Universitaire (CHU) de Limoges Limoges, France, 87042 Centre Hospitalier Lyon Sud Lyon, France, 69495 CHRU Hôtel Dieu Nantes, France, 44035 Institut Curie Centre de Lutte Contre le Cancer (CLCC) Paris, France, 75005 La Pitié Salpetriêre Paris, France, 75013 Hôpital Saint-Antoine Paris, France, 75571 Hôpital Robert Debré Hématologie Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Less <<
NCT00002831 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00787527 - Completed - -
NCT00416910 Chronic Lymphocytic Leukemia Phase 3 Terminated(low recruitment) - -
NCT00278109 Breast Cancer Phase 1 Phase 2 Unknown - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01313429 Sarcoma Melan... More >>oma Epithelial Malignancies Pleural Malignancies Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00404066 - Completed - -
NCT00003088 Breast Cancer Phase 3 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT00937625 Melanoma Phase 1 Phase 2 Completed - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 Less <<
NCT00946023 Lymphoma B-ce... More >>ll Lymphoma Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Funding was unavail... More >>able to complete the study as originally planned.) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00404066 Breast Cancer ... More >> Metastatic Breast Cancer Less << Phase 2 Completed - United States, California ... More >> Santa Clara Valley Medical Center San Jose, California, United States, 95128 Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01481194 Multiple Myeloma Phase 2 Active, not recruiting December 2019 Denmark ... More >> Department of Hematology Vejle, Denmark Less <<
NCT01227408 Breast Cancer Phase 2 Withdrawn(Sponsor withdrew due... More >> to funding issues) Less << February 2011 United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Less <<
NCT03520647 Severe Aplastic Anemia (SAA) ... More >> Hypo-Plastic Myelodysplastic Syndrome (MDS) Less << Phase 2 Recruiting June 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03623750 Carcinoma, Non-Small-Cell Lung Phase 1 Phase 2 Recruiting June 2020 Spain ... More >> Hospital Universitario Insular de Gran Canaria Not yet recruiting Palmas de Gran Canaria, Canarias, Spain Contact: Delvys Rodríguez, M.D.          Principal Investigator: Delvys Rodríguez          Instituto Oncológico Dr. Rosell Not yet recruiting Barcelona, Spain, 08028 Contact: Niki Karachaliou, M.D., Ph.D.          Principal Investigator: Niki Karachaliou, M.D., Ph.D.          Hospital Clínic Barcelona Not yet recruiting Barcelona, Spain Contact: Noemi Reguart, M.D.          Principal Investigator: Noemi Reguart, M.D.          Hospital Universitario Regional de Málaga Recruiting Málaga, Spain Contact: Manuel Cobo          Principal Investigator: Manuel Cobo, M.D. Less <<
NCT00801580 Lymphoid Leukemia Phase 2 Unknown September 2010 Italy ... More >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Italy, 40138 Less <<
NCT00550771 - Completed - -
NCT00550771 Breast Neoplasm Phase 2 Completed - -
NCT01818479 High Risk Hematologic Malignan... More >>cies Less << Phase 1 Phase 2 Recruiting July 2020 United States, Utah ... More >> Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Principal Investigator: Michael Boyer, MD Less <<
NCT02390063 Prostate Cancer Phase 1 Active, not recruiting May 15, 2019 United Kingdom ... More >> University of Oxford Oxford, United Kingdom, OX3 7DQ Royal Hallamshire Hospital Sheffield, United Kingdom, S10 2IF Less <<
NCT00255684 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Not Applicable Terminated(low accrual) - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01598129 Malignant Solid Tumour Phase 1 Completed - Finland ... More >> Docrates Hospital Helsinki, Finland, 00180 Less <<
NCT01598129 - Completed - -
NCT00255684 - Terminated(low accrual) - -
NCT00302549 Lupus Nephritis Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT00518206 - Completed - -
NCT02434146 Neoplasm Oral... More >> Mucosa Transplant-Related Disorder Less << Phase 1 Phase 2 Terminated(A company in China ... More >>has decided to license the product) Less << - United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00314977 Breast Cancer Phase 3 Completed - Netherlands ... More >> Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands Rijnstate Ziekenhuis Arnhem, Netherlands Jeroen Bosch Ziekenhuis Den Bosch, Netherlands HAGA Ziekenhuis Den Haag, Netherlands Deventer Ziekenhuis Deventer, Netherlands Slingeland Hospital Doetinchem, Netherlands Catharina Ziekenhuis Eindhoven, Netherlands St. Anna Hospital Geldrop, Netherlands St. Jansdal Ziekenhuis Harderwijk, Netherlands Atrium Medisch Centrum Heerlen, Netherlands Elkerliek Ziekenhuis Helmond, Netherlands Spaarne Ziekenhuis Hoofddorp, Netherlands Leids Universitair Medisch Centrum (LUMC) Leiden, Netherlands Academical Hospital Maastricht (AZM) Maastricht, Netherlands St. Antonius Hospital Nieuwegein, Netherlands Canisius Wilhelmina Ziekenhuis Nijmegen, Netherlands Radboud University Medical Centre Nijmegen, Netherlands Waterland Hospital Purmerend, Netherlands Maasland Hospital Sittard, Netherlands St. Elisabeth Ziekenhuis Tilburg, Netherlands Mesos Medisch Centrum Utrecht, Netherlands UMC Utrecht Utrecht, Netherlands Maxima Medisch Centrum Veldhoven, Netherlands Zaans Medical Centre Zaandam, Netherlands Less <<
NCT02434146 - Terminated(A company in China ... More >>has decided to license the product) Less << - -
NCT00937300 Squamous Cell Carcinoma ... More >> Head and Neck Cancer Less << Phase 1 Withdrawn(The patients eligibl... More >>e for this trial do not exist anymore due to change in procedures.) Less << - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 Less <<
NCT00354744 Sarcoma Phase 3 Unknown - -
NCT00354744 - Unknown - -
NCT00518206 Melanoma Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Institute East Melbourne, Victoria, Australia, 3002 Austin Health (Ludwig Institute Oncology Unit) Heidelberg, Victoria, Australia, 3084 Less <<
NCT00021255 Breast Neoplasms Phase 3 Completed - -
NCT01329640 Locally Advanced HER2-positive... More >> Breast Cancer Less << Phase 2 Terminated - Brazil ... More >> Instituto do Cancer do Estado de Sao Paulo Sao Paulo, Brazil, 01246-000 Less <<
NCT02461316 - Completed - Serbia ... More >> Belgrade, Serbia, 11000 Kragujevac, Serbia, 34000 Novi Sad, Serbia, 21000 Less <<
NCT00021255 - Completed - -
NCT02081183 Lupus Nephritis Phase 3 Terminated - Venezuela ... More >> Barquisimeto, Venezuela, 3005 Caracas, Venezuela, 1040 Less <<
NCT01009970 Diffuse Large B-Cell Lymphoma Phase 2 Unknown May 2012 Italy ... More >> Ospedale SS Antonio Biagio e Cesare Arrigo Recruiting Alessandria, Italy Principal Investigator: Alessandro Levis, MD          Università di Bari Not yet recruiting Bari, Italy Principal Investigator: Giorgina Specchia, MD          Ospedale degli Infermi Not yet recruiting Biella, Italy Principal Investigator: Anna Tonso, MD          Spedali Civili Not yet recruiting Brescia, Italy Principal Investigator: Giuseppe Rossi, MD          Ospedale Civitanova Marche Not yet recruiting Civitanova Marche, Italy Principal Investigator: Riccardo Centurioni, MD          AO Annunziata Not yet recruiting Cosenza, Italy Ospedale San Carlo Not yet recruiting Cosenza, Italy Principal Investigator: Attilio Olivieri, MD          Ospedale Vito Fazzi Not yet recruiting Lecce, Italy Principal Investigator: Nicola Di Renzo, MD          Istituto Scientifico Romagnolo per lo studio e la cura dei tumori (IRST) Not yet recruiting Meldola (FC), Italy Principal Investigator: Dino Amadori, MD          A O Papardo Not yet recruiting Messina, Italy Principal Investigator: Maura Brugiatelli, MD          Ospedale Niguarda Cà Granda Not yet recruiting Milano, Italy Principal Investigator: Livio Gargantini, MD          Ospedale San Raffaele Not yet recruiting Milano, Italy Principal Investigator: Andres Ferreri, MD          Centro oncologico modenese Recruiting Modena, Italy Principal Investigator: Massimo Federico, MD          AO Universitaria Paolo Giaccone Not yet recruiting Palermo, Italy Principal Investigator: Salvatrice Mancuso, MD          Ospedale La Maddalena Not yet recruiting Palermo, Italy Principal Investigator: Maurizio Musso, MD          A O Universitaria di Parma Not yet recruiting Parma, Italy Principal Investigator: Vittorio Rizzoli, MD          Ospedale Santa Maria della Misericordia Not yet recruiting Perugia, Italy Principal Investigator: Leonardo Flenghi, MD          Ausl Ravenna Not yet recruiting Ravenna, Italy Principal Investigator: Alfonso Zaccaria, MD          Ospedale Bianchi Melacrino Morelli Not yet recruiting Reggio Calabria, Italy Principal Investigator: Caterina Stelitano, MD          AO Santa Maria Nuova Not yet recruiting Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD          Ausl Rimini Not yet recruiting Rimini, Italy Principal Investigator: Pier Paolo Fattori, MD          Istituto Regina Elena Not yet recruiting Roma, Italy Principal Investigator: Antonio Spadea, MD          Ospedale Sant'Eugenio Not yet recruiting Roma, Italy Principal Investigator: Elisabetta Abruzzese, MD          Università La Sapienza Not yet recruiting Roma, Italy Principal Investigator: Maurizio Martelli, MD          Clinica Humanitas Not yet recruiting Rozzano (MI), Italy Principal Investigator: Balzarotti Monica, MD          Casa sollievo della sofferenza Not yet recruiting San giovanni Rotondo, Italy Principal Investigator: Nicola Cascavilla, MD          Università di Sassari Not yet recruiting Sassari, Italy Principal Investigator: Maurizio Longinotti, MD          Azienda Ospedaliera senese Not yet recruiting Siena, Italy Principal Investigator: Alberto Fabbri, MD          Ospedale San Giovanni Battista Molinette Not yet recruiting Torino, Italy Principal Investigator: Umberto Vitolo, MD          Ospedale Riuniti Not yet recruiting Trieste, Italy Principal Investigator: Gabriele Pozzato, MD          Santa Maria della Misericordia Not yet recruiting Udine, Italy Principal Investigator: Francesco Zaja, MD          Ospedale di circolo e Fondazione Macchi Not yet recruiting Varese, Italy Principal Investigator: Gabriella Pinotti, MD Less <<
NCT02081183 - Terminated - -
NCT01088750 Lymphoma Phase 4 Unknown December 2018 Germany ... More >> Universitaetsklinikum Giessen-Marburg Recruiting Giessen, Germany, D-35385 Contact: Contact Person    0049-641-985- ext 57921    dieter.koerholz@paediat.med.uni-giessen.de    Contact: Christine Mauz-Koerholz, MD       christine.mauz-koerholz@paediat.med.uni-giessen.de Less <<
NCT00555048 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Terminated(Low accrual) - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104-1024 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00753220 Prostate Cancer Phase 1 Phase 2 Terminated(Withdrew the IND wi... More >>th the FDA.) Less << - United States, California ... More >> Community Memorial Hospital Ventura, California, United States, 93003 Less <<
NCT03188419 - Enrolling by invitation December 29, 2018 United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03467373 B-Cell Lymphoma ... More >> Non-Hodgkin Lymphoma Less << Phase 1 Recruiting June 1, 2023 United States, Alabama ... More >> University of Alabama Medical Center Not yet recruiting Birmingham, Alabama, United States, 35294 United States, Florida Florida Hospital Cancer Inst Not yet recruiting Orlando, Florida, United States, 32804 United States, Illinois Ingalls Memorial Hospital Not yet recruiting Harvey, Illinois, United States, 60426 United States, North Carolina Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28204 United States, Pennsylvania Fox Chase-Temple Cancer Center Not yet recruiting Philadelphia, Pennsylvania, United States, 19111 United States, West Virginia West Virginia University; Health Sciences Center Not yet recruiting Morgantown, West Virginia, United States, 26506 Australia, Victoria Peter Maccallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3000 Canada, Alberta Cross Cancer Institute; Clinical Trials Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Princess Margaret Hospital, Medical Oncology & Haematology Recruiting Toronto, Ontario, Canada, M5G 2M9 Denmark Rigshospitalet; Hæmatologisk Klinik Recruiting København Ø, Denmark, 2100 Germany Universitätsklinikum Erlangen, Translational Research Center (TRC), Medizin 5 Not yet recruiting Erlangen, Germany, 91054 Universitätsklinikum Freiburg; Klinik für Innere Medizin I; Hämatologie, Onkologie und Stammzelltr. Not yet recruiting Freiburg, Germany, 79106 Universitätsklinikum Ulm; Medizinische Uni-Klinik III Abt. Innere Medizin III Hämatologie u. Onkolo. Not yet recruiting Ulm, Germany, 89081 Universitätsklinikum Würzburg; Studienzentrale Hämatologie/Onkologie Not yet recruiting Würzburg, Germany, 97080 Italy ASST PAPA GIOVANNI XXIII; Ematologia Recruiting Bergamo, Lombardia, Italy, 24127 Spain Hospital Universitari Vall d'Hebron; Servicio de Hematologia Recruiting Barcelona, Spain, 08035 United Kingdom The HOPE Clinical Trials Unit Recruiting Leicester, United Kingdom, LE1 5WW University College London Hospitals NHS Foundation Trust; NIHR UCLH Clinical Research Facility Recruiting London, United Kingdom, W1T 7HA Derriford Hospital; Haematology Recruiting Plymouth, United Kingdom, PL6 8DH Less <<
NCT03475758 Ovarian Failure Phase 2 Not yet recruiting March 2020 -
NCT03240731 Sickle Cell Disease Phase 2 Recruiting September 2020 France ... More >> CHU Henri-Mondor Recruiting Créteil, France, 94000 Contact: Sébastien Maury          intercommunal hospital of Créteil Recruiting Créteil, France, 94000 Contact: Corinne Pondarre          Contact: Françoise Bernaudin          CHU La Timone Not yet recruiting Marseille, France Contact: Claire Galambrun          Hospital Necker Recruiting Paris, France Contact: Felipe Suarez          Hospital Robert-Debré Recruiting Paris, France Contact: Jean-Hugue Dalle          Saint-Louis hospital Recruiting Paris, France Contact: Nathalie Dhédin, MD, PhD          Contact: Gérard Socie          CHU Strasbourg Recruiting Strasbourg, France Contact: Catherine Paillard Less <<
NCT00863330 Melanoma (Skin) Phase 2 Terminated(administrative deci... More >>sion- PI retired and treating physician left the institution) Less << - United States, Wisconsin ... More >> Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00753220 - Terminated(Withdrew the IND wi... More >>th the FDA.) Less << - -
NCT00174655 Breast Neoplasms Phase 3 Completed - -
NCT02953184 Antineoplastic Combined Chemot... More >>herapy Protocols Less << Phase 2 Recruiting November 2020 China, Jilin ... More >> First Hospital of Jilin University Recruiting Changchun, Jilin, China, 130021 Contact: Aiping Shi, Doctor    0086-13364308696    13364308696@163.com    Contact: Zhimin Fan, Doctor    0086-13756661286    fanzhimn@163.com    Sub-Investigator: Di Wu, Doctor          Sub-Investigator: Hongyao Jia, Master          Sub-Investigator: Xin Guan, Master          Principal Investigator: Zhimin Fan, Doctor          Principal Investigator: Haibo Wang, Doctor          Sub-Investigator: Gang Nie, Doctor Less <<
NCT01413100 Systemic Scleroderma Phase 2 Recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Stephen J. Forman    626-359-8111 ext 62403    sforman@coh.org    Principal Investigator: Stephen J. Forman          UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Daniel Furst    310-206-5366    defurst@mednet.ucla.edu    Principal Investigator: Daniel Furst          United States, Colorado University of Colorado Not yet recruiting Denver, Colorado, United States, 80217-3364 Contact: Aryeh Fischer    720-848-0000    Aryeh.Fischer@ucdenver.edu    Principal Investigator: Aryeh Fischer          Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Richard A. Nash    720-754-4800    Richard.Nash@healthonecares.com    Principal Investigator: Richard A. Nash          United States, Massachusetts Boston Medical Center Recruiting Boston, Massachusetts, United States, 02118 Contact: Vaishali Sanchorawala    617-414-2507    vaishali.sanchorawala@bmc.org    Principal Investigator: Vaishali Sanchorawala          Boston University School of Medicine Recruiting Boston, Massachusetts, United States, 02118 Contact: Robert W. Simms    617-638-4310    rsimms@bu.edu    Principal Investigator: Robert W. Simms          United States, Michigan University of Michigan Comprehensive Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Dinesh Khanna    734-763-3110    khannad@med.umich.edu    Sub-Investigator: Dinesh Khanna          United States, New York Hospital for Special Surgery Recruiting New York, New York, United States, 10021 Contact: Jessica Gordon    212-606-1173    gordonj@HSS.edu    Principal Investigator: Jessica Gordon          Weill Medical College of Cornell University Not yet recruiting New York, New York, United States, 10065 Contact: Tsiporah B. Shore    212-746-2646    tbs2001@med.cornell.edu    Principal Investigator: Tsiporah B. Shore          United States, North Carolina Duke University Medical Center Not yet recruiting Durham, North Carolina, United States, 27710 Contact: Keith M. Sullivan    919-668-1011    sulli025@mc.duke.edu    Principal Investigator: Keith M. Sullivan          Sub-Investigator: William H. St. Clair          United States, Texas M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Chitra Hosing    713-794-5745    cmhosing@mdanderson.org    Principal Investigator: Chitra Hosing          The University of Texas Health Science Center, Houston Recruiting Houston, Texas, United States, 77030 Contact: Maureen Mayes    713-500-6905    Maureen.D.Mayes@uth.tmc.edu    Principal Investigator: Maureen Mayes          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Anne Stevens    206-987-2057    anne.stevens@seattlechildrens.org    Principal Investigator: Anne Stevens          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: George E. Georges    206-667-6886    ggeorges@fredhutch.org    Principal Investigator: George E. Georges          Canada, Alberta University of Calgary Withdrawn Calgary, Alberta, Canada, T2N 1N4 Rockyview General Hospital Withdrawn Calgary, Alberta, Canada, T2V 1P9 Less <<
NCT00782379 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00863330 - Terminated(administrative deci... More >>sion- PI retired and treating physician left the institution) Less << - -
NCT01807182 Stage III Skin Melanoma ... More >> Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Active, not recruiting June 30, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00555048 - Terminated(Low accrual) - -
NCT00507442 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55904-0001 Less <<
NCT00003782 Breast Cancer Phase 3 Completed - -
NCT00782379 - Completed - -
NCT00134004 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 Less <<
NCT00134004 - Completed - -
NCT02276300 Gastric Cancer ... More >> Breast Cancer Less << Phase 1 Unknown April 2017 Germany ... More >> III.Medizinische Klinik und Poliklinik, Klinikum rechts der Isar der TUM Recruiting Munic, Bavaria, Germany, 81675 Contact: Angela Krackhardt, Prof.Dr.med.    +49 89 4140 ext 4124    angela.krackhardt@lrz.tu-muenchen.de    Principal Investigator: Angela Krackhardt, Prof.Dr.med. Less <<
NCT01186640 T-cell-prolymphocytic Leukemia Phase 2 Completed - Germany ... More >> University Hospital Cologne Cologne, Germany, 50924 Less <<
NCT00003782 - Completed - -
NCT03425656 Malignant Neoplasm of Breast Phase 3 Recruiting October 30, 2018 Iran, Islamic Republic of ... More >> Imam Khomeini hospital Recruiting Tehran, Iran, Islamic Republic of Contact: Morteza Azhdarzadeh, Pharm D    00982143473000    azhdarzadeh.m@orchidpharmed.com Less <<
NCT00391066 Chronic Lymphocytic Leukemia Phase 2 Terminated - -
NCT00941330 Breast Cancer Phase 2 Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00971763 Lymphoma Phase 2 Completed - United Kingdom ... More >> Sussex Cancer Centre at Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Leeds General Infirmary Leeds, England, United Kingdom, LS1 3EX Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom, SE1 9RT Less <<
NCT00507442 - Completed - -
NCT01503905 Breast Cancer Nos Premenopausa... More >>l Less << Not Applicable Recruiting December 2021 China, Guangdong ... More >> The first People's Hospital of Foshan Recruiting Foshan, Guangdong, China, 528000 Contact: Jie Yang    86-13902805191       Guangdong Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Antai Zhang    86-13925115929       Guangzhou Army General Hospital Recruiting Guangzhou, Guangdong, China, 510010 Contact: Chenfang Zhang    86-13889908978       Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Siyu Wang    86-18688464714       The First Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Zhuanghong Wu    86-13602722502       Tumor Hospital of Guangzhou Recruiting Guangzhou, Guangdong, China, 510095 Contact: Hongsheng Li    86-13725111258       The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine Recruiting Guangzhou, Guangdong, China, 510100 Contact: Pengxi Liu    86-13560333752       Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Fengxi Su       fengxisu@vip.163.com    Guangzhou Women and Children Hospital Recruiting Guangzhou, Guangdong, China, 510180 Contact: Hongmin Ma    86-13922723808       The first People's Hospital of Guangzhou Recruiting Guangzhou, Guangdong, China, 510180 Contact: Li Zhao       gdzhaoli@163.com    The Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510260 Contact: Lehong Zhang    86-13719150959       Zhujiang Hospital of Nanfang Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Aiguo Wu       wagtyz@sina.com    Nanfang Hospital of Nanfang Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Changsheng Ye    86-13802954097       The First Affiliated Hospital of Jinan University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Ningxia Wang       Twnx@Jnu.edu.cn    The Third Affiliated Hospital of Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Renbin Liu    86-13570073298       Shenzhen People's Hospital Recruiting Shenzhen, Guangdong, China, 518020 Contact: Dongxian Zhou    86-13510363636       The first Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Xianming Wang    86-13500056238 Less <<
NCT00641381 Lymphoma Phase 1 Active, not recruiting October 2018 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00500890 Choroid Plexus Tumors Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00005798 Breast Cancer Phase 2 Completed - United States, Florida ... More >> Halifax Medical Center Daytona Beach, Florida, United States, 32114 Florida Cancer Specialists Fort Myers, Florida, United States, 33901 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT00941330 - Completed - -
NCT02086942 Multiple Myeloma Phase 2 Recruiting August 2017 China, Jiangsu ... More >> Jinling Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: zhai yo ping, doctor    13951947646    ypzhai@medmail.com.cn Less <<
NCT02876107 Malignant Neoplasm of Breast Phase 2 Recruiting October 2024 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00636441 Early-Stage Breast Cancer Phase 2 Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model) Less << - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00636441 - Terminated(Study terminated du... More >>e to reproducibility issues with genomics prediction model) Less << - -
NCT00525876 Lymphoma Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00525876 - Completed - -
NCT00073879 Kidney Cancer Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01530607 Breast Cancer Phase 3 Completed - -
NCT03106662 Hematopoietic Stem Cell Transp... More >>lantation Less << Phase 3 Completed - Turkey ... More >> Ankara University School of Medicine Department of Hematology Ankara, Turkey Less <<
NCT00002502 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00434031 Breast Cancer Phase 2 Withdrawn(lack of enrollment) - Italy ... More >> Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C Napoli, Italy, 80131 Less <<
NCT01340430 HER-2 Positive Breast Cancer Phase 2 Active, not recruiting May 2025 Italy ... More >> Istituto Nazionale per La Ricerca sul Cancro (IST) Genoa, Ge, Italy, 16132 Ospedale S. Maria della Misericordia - Oncologia Medica Perugia, PG, Italy, 06156 Fondazione del Piemonte per l'Oncologia - IRCC di Candiolo Candiolo, TO, Italy, 10060 Ospedale Ostetrico Ginecologico S. Anna Di Torino - Oncologia Medica Torino, To, Italy, 10100 Ospedale Mauriziano Umberto I - Ginecologia Oncologica Torino, TO, Italy, 10128 Ospedale Sacro Cuore - Don Calabria - Oncologia Medica Negrar, VR, Italy, 37024 Less <<
NCT01749293 Hematologic Malignancies Phase 2 Terminated(The protocol design... More >> is being reconfigured in order to open a new study.) Less << June 2017 United States, Illinois ... More >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 Less <<
NCT00129389 Breast Cancer Phase 3 Unknown December 2013 Spain ... More >> Spanish Breast Cancer Research Group (GEICAM) San Sebastián de los Reyes, Madrid, Spain, 28700 Less <<
NCT01925612 Lymphoma, B-cell ... More >> Lymphoma, Large B-cell, Diffuse Less << Phase 2 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization and changing treatment landscape in frontline DLBCL) Less << - -
NCT00003958 Adult Malignant Mesenchymoma ... More >> Adult Rhabdomyosarcoma Alveolar Childhood Rhabdomyosarcoma Childhood Malignant Mesenchymoma Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Nonmetastatic Childhood Soft Tissue Sarcoma Previously Untreated Childhood Rhabdomyosarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT02013375 Sickle Cell Disease Phase 2 Active, not recruiting October 1, 2018 United States, Illinois ... More >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 Less <<
NCT00028665 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-7284 Less <<
NCT01114048 Multiple Myeloma Phase 2 Unknown - Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Recruiting Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Principal Investigator: Je-Jung Lee, M.D. and Ph.D. Less <<
NCT01790737 Multiple Myeloma Phase 2 Active, not recruiting December 2018 Finland ... More >> Kuopio University Hospital Kuopio, North Savo, Finland, 70200 Tampere University Hospital Tampere, Pirkanmaa, Finland, 33100 Helsinki University Hospital Helsinki, Finland Kanta-Häme Central Hospital Hämeenlinna, Finland Jyväskylä Central Finland Central Hospital Jyväskylä, Finland Kainuu Kajaani Central Hospital Kajaani, Finland Länsi-Pohja Central Hospital Kemi, Finland Kymenlaakso Central Hospital Kotka, Finland Mikkeli Southern-Savo Central Hospital Mikkeli, Finland Oulu University Hospital Oulu, Finland Satakunta Central Hospital Pori, Finland Turku University Central Hospital Turku, Finland Less <<
NCT01925612 - Terminated(Sponsor decision ba... More >>sed on portfolio prioritization and changing treatment landscape in frontline DLBCL) Less << - -
NCT00770224 Lymphoma Phase 2 Active, not recruiting February 2019 -
NCT00003549 Neuroendocrine Carcinoma of th... More >>e Skin Less << Phase 2 Completed - -
NCT00268853 Diffuse Large-Cell Lymphoma Phase 2 Completed - -
NCT02593227 Breast Cancer Phase 2 Active, not recruiting December 2021 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Maryland University of Maryland - Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Center Detroit, Michigan, United States, 48201 United States, Missouri MidAmerica Division,Inc Kansas City, Missouri, United States, 64132 United States, New Jersey The Valley Hospital Paramus, New Jersey, United States, 07652 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 Montefiore Medical Center, Einstein Cancer Center New York, New York, United States, 10461 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas Texas Oncology Presbyterian Cancer Center Dallas Dallas, Texas, United States, 75231 Less <<
NCT00309478 Early-Stage Breast Cancer Phase 3 Completed - -
NCT03505762 B-Cell Non-Hodgkin Lymphoma Phase 2 Recruiting June 2024 United States, North Carolina ... More >> Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zanetta S. Lamar    336-716-5847    zlamar@wakehealth.edu    Principal Investigator: Zanetta S. Lamar Less <<
NCT00047281 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00516425 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> Charing Cross Hospital Recruiting London, England, United Kingdom, W6 8RF Contact: Robert C.F. Leonard, MD, BS, MB    44-208-846-7237       Southend University Hospital NHS Foundation Trust Recruiting Westcliff-On-Sea, England, United Kingdom, SS0 0RY Contact: Anne Robinson, MD    44-1702-221-226 Less <<
NCT00770224 - Active, not recruiting - -
NCT00107380 Lymphoma Phase 2 Completed - -
NCT00377637 - Completed - -
NCT00107380 - Completed - -
NCT01646736 Nephritis, Lupus Phase 2 Phase 3 Unknown December 2013 China, Beijing ... More >> Deptment of Rheumatology, Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100032 Contact: Fengchun Zhang, MD    861069158792    ZhangFCcra@yahoo.com.cn    Principal Investigator: Fengchun Zhang, MD Less <<
NCT00070564 Breast Cancer Phase 3 Active, not recruiting January 2027 -
NCT00193479 Non-Hodgkins Lymphoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Tennessee Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00070564 - Active, not recruiting - -
NCT00377637 Lupus Nephritis Phase 3 Completed - -
NCT00193479 - Completed - -
NCT01212887 Breast Cancer ... More >> Colorectal Cancer Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(due to safety conce... More >>rns and lack of efficacy) Less << - United Kingdom ... More >> Christie Hospital Manchester, England, United Kingdom, M20 4BX Less <<
NCT00256360 Breast Cancer Phase 2 Completed - Belgium ... More >> UZ Gasthuisberg Leuven Leuven, Belgium, B-3000 Less <<
NCT03550781 Takayasu Arteritis ... More >> Anti-Inflammatory Agents Less << Phase 2 Phase 3 Not yet recruiting May 31, 2021 -
NCT02981524 Metastatic Colorectal Cancer Phase 2 Active, not recruiting March 2025 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT02897700 Breast Cancer Phase 1 Recruiting December 2020 China, Jiangxi ... More >> Ganzhou City People's Hospital Recruiting Ganzhou, Jiangxi, China, 341000 Contact: Xiao-Ming Zhong, M.D    86-18160779919    jxthrz@qq.com    China, Jilin China-Japan Union Hospital, Jilin University Recruiting Changchun, Jilin, China, 130033 Contact: Xian-Ling Cong, M.D    86-0431-89876626    congxl888@hotmail.com    China Shanghai 10th People's Hospital, Tongji University School of Medicine Recruiting Shanghai, China, 200072 Contact: Da Fu, Ph.D    86-15921527578    fu800da900@126.com Less <<
NCT00334867 Sarcoma Phase 3 Withdrawn(withdrawn) - -
NCT01205217 Neoplasms, Breast Phase 2 Withdrawn(Data presented at SA... More >>BCS 2010 showing that dual blockade is superior to monotherapy) Less << December 2010 Austria ... More >> GSK Investigational Site Graz, Austria, A-8036 Hungary GSK Investigational Site Budapest, Hungary, 1122 GSK Investigational Site Gyula, Hungary, 5700 Norway GSK Investigational Site Oslo, Norway, 0310 GSK Investigational Site Oslo, Norway, 0407 Spain GSK Investigational Site Castellón, Spain, 12002 Less <<
NCT00544219 Lymphoma Not Applicable Completed - Italy ... More >> European Institute of Oncology Milan, Italy, 20141 Switzerland Hirslanden Klinik Aarau Aarau, Switzerland, CH-5001 Kantonspital Aarau Aarau, Switzerland, CH-5001 Kantonsspital Baden Baden, Switzerland, CH-5404 Praxis Dr. Streit Baden, Switzerland, CH-5404 Saint Claraspital AG Basel, Switzerland, CH-4016 Universitaetsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubuenden Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Geneva, Switzerland, CH-1211 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital Olten Olten, Switzerland, CH-4600 Praxis Dr. Beretta Rheinfelden, Switzerland, CH-4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Regionalspital Thun, Switzerland, 3600 Kantonsspital Winterthur Winterthur, Switzerland, CH-8400 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT02001506 Breast Cancer Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 05505 Less <<
NCT02844322 Waldenstr?m Macroglobulinemia Phase 4 Recruiting May 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT01750073 Estrogen Receptor Negative ... More >> Estrogen Receptor Positive HER2/Neu Negative HER2/Neu Positive Invasive Breast Carcinoma Progesterone Receptor Negative Progesterone Receptor Positive Stage IA Breast Cancer Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage III Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-Negative Breast Carcinoma Less << Phase 2 Recruiting December 2022 United States, Nebraska ... More >> Nebraska Medicine-Bellevue Recruiting Bellevue, Nebraska, United States, 68123 Contact: Elizabeth C. Reed    402-559-5749    ereed@unmc.edu    Principal Investigator: Elizabeth C. Reed          CHI Health Saint Francis Recruiting Grand Island, Nebraska, United States, 68803 Contact: Mehmet S. Copur    308-398-6518    mcopur@sfmc-gi.org    Principal Investigator: Mehmet S. Copur          Nebraska Medicine-Village Pointe Cancer Center Recruiting Omaha, Nebraska, United States, 68118 Contact: Elizabeth C. Reed    402-559-5749    ereed@unmc.edu    Principal Investigator: Elizabeth C. Reed          University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198 Contact: Elizabeth C. Reed    402-559-5749    ereed@unmc.edu    Principal Investigator: Elizabeth C. Reed Less <<
NCT02670252 Allogeneic Hematopoietic Stem ... More >>Cell Transplantation Busulfan Total Body Irradiation Acute Lymphocytic Leukemia Less << Phase 2 Phase 3 Recruiting December 2019 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT02273583 High Grade Osteosarcoma Phase 2 Unknown - Brazil ... More >> GRAACC- Institute of Pediatric Oncology Recruiting São Paulo, SP, Brazil, 04023-062 Contact: Antônio Sérgio Petrilli, MD    55-11-5080-8494    sergiopetrilli@graacc.org.br    Principal Investigator: Antônio Sérgio Petrilli, MD Less <<
NCT00053092 Lymphoma Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 United Kingdom Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Less <<
NCT02744742 Myelodysplastic Syndrome ... More >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Less << Phase 2 Phase 3 Recruiting March 2020 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT00466531 Leukemia Phase 1 Phase 2 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00210470 - Completed - -
NCT00596154 CNS Lymphoma ... More >>CNS Brain Cancer Non-Hodgkin's Lymphoma Less << Phase 2 Active, not recruiting December 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00354835 Adult Malignant Mesenchymoma ... More >> Adult Rhabdomyosarcoma Childhood Alveolar Rhabdomyosarcoma Childhood Botryoid-Type Embryonal Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Childhood Malignant Mesenchymoma Non-Metastatic Childhood Soft Tissue Sarcoma Stage I Adult Soft Tissue Sarcoma Stage II Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Completed - -
NCT00010335 Systemic Sclerosis ... More >> Systemic Lupus Erythematosus Dermatomyositis Juvenile Rheumatoid Arthritis Autoimmune Diseases Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00190489 Breast Cancer ... More >> Neoplasm Metastasis Less << Phase 3 Completed - Japan ... More >> National Cancer Center Hospital Chuo-ku, Tsukiji, 5-1-1, Tokyo, Japan, 104-0045 Less <<
NCT02143830 Fanconi Anemia ... More >> Severe Marrow Failure Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) Less << Phase 2 Recruiting May 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10174 Contact: Jessica Chaisson    646-888-5718    chaissoj@mskcc.org    Principal Investigator: Farid Boulad, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Principal Investigator: Parinda Mehta, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Sheri Ballard    206-667-4222    sballard@fredhutch.org    Principal Investigator: K. Scott Baker, MD Less <<
NCT00210470 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Iowa University of Iowa Hospital & Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky University of Kentucky Chandler Medical Center Lexington, Kentucky, United States, 40536 United States, Massachusetts Lahey Clinic Medical Center Burlington, Massachusetts, United States, 01805 United States, Michigan University of Michigan Hospitals Ann Arbor, Michigan, United States, 48109-0312 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00070018 Lymphoma Phase 2 Active, not recruiting November 2018 -
NCT00003352 Breast Cancer Phase 2 Completed - -
NCT01257802 Lupus Erythematosus, Systemic ... More >> Systemic Vasculitis Isolated Angiitis of Central Nervous System Lung Disease With Systemic Sclerosis Lung Disease Interstitial Diffuse Less << Phase 3 Terminated - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00354835 - Completed - -
NCT01257802 - Terminated - -
NCT01909752 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - United States, Louisiana ... More >> LSU Stanley S. Scott Cancer Center New Orleans, Louisiana, United States, 70112 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97213 Less <<
NCT01184885 Lymphoid Malignancies (New or ... More >>Relapsed) Acute Lymphoblastic Leukemia Burkitt Lymphoma Lymphoblastic Lymphoma Mantle Cell Lymphoma Adult T-cell Leukemia/Lymphoma Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00070018 - Active, not recruiting - -
NCT01184885 - Completed - -
NCT01539902 Lupus Nephritis Phase 2 Unknown May 2013 China, Yunan ... More >> Second Affiliated Hospital & SLE Research Centre, Kunming Medical University, Kunming China Recruiting Kunming, Yunan, China, 650000 Contact: PeiLian Zhang, Dr       mzczpl1968@163.com    Principal Investigator: DanQi Deng, Professor          Sub-Investigator: PeiLian Zhang, Dr Less <<
NCT02221310 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting June 2021 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Sandra Fabricatore, RN, PNP    914-594-2152    sandra.fabricatore@wmchealth.org    Contact: Erin Morris, RN    714-964-5359    erin_morris@nymc.edu    Principal Investigator: Mitchell S Cairo, MD Less <<
NCT00192764 Non-Hodgkin's Lymphoma Phase 2 Completed - Israel ... More >> Department of Oncology, Rambam Medical Center Haifa, Israel Less <<
NCT00002488 Lymphoma Phase 2 Unknown - Canada, Ontario ... More >> Ottawa Regional Cancer Center - General Division Ottawa, Ontario, Canada, K1H 8L6 Ottawa Regional Cancer Centre - Civic Campus Ottawa, Ontario, Canada, K1Y 4K7 Less <<
NCT02080195 Lupus Erythematosus ... More >> Graft-versus-host Disease Less << Phase 1 Phase 2 Terminated(Study was unable to... More >> accrue subjects) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT01031030 Breast Cancer Phase 3 Unknown - -
NCT02080195 - Terminated(Study was unable to... More >> accrue subjects) Less << - -
NCT00575406 Diffuse Large B-Cell Lymphoma Phase 2 Completed - Austria ... More >> Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria, A-6020 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria, A-4010 Krankenhaus der Elisabethinen Linz Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 AKH Wien / Haematologie u. Haemostaseologie Vienna, Austria, A-1090 Hanusch Krankenhaus Vienna, Austria, A-1140 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, A-4600 Less <<
NCT00668616 Breast Cancer Phase 3 Completed - Germany ... More >> Oskar-Ziethen-Krankenhaus Berlin, Germany, 10365 Less <<
NCT01300247 Lymphocytic Leukemia, Chronic Phase 1 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States, 35805 United States, California Duarte, California, United States, 91010 La Jolla, California, United States, 92093 Los Angeles, California, United States, 90095 United States, Connecticut Southington, Connecticut, United States, 06489 United States, Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Atlanta, Georgia, United States, 30322 Marietta, Georgia, United States, 30060 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Boston, Maryland, United States, 02115 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Minnesota St. Louis Park, Minnesota, United States, 55426 United States, Missouri Springfield, Missouri, United States, 65807 United States, New York Rochester, New York, United States, 14642 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98109 Tacoma, Washington, United States, 98405 United States, Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT00679029 HER2-negative Breast Cancer ... More >> Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 2 Terminated(drug toxicity) - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT01300247 - Completed - -
NCT02567435 Alveolar Rhabdomyosarcoma ... More >> Botryoid-Type Embryonal Rhabdomyosarcoma Embryonal Rhabdomyosarcoma Rhabdomyosarcoma Sclerosing Rhabdomyosarcoma Spindle Cell Rhabdomyosarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 3 Suspended(pending an analysis ... More >>of data) Less << November 1, 2022 -
NCT00742300 Autoimmune Diseases Phase 1 Phase 2 Unknown - Germany ... More >> Charité Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT00119262 Male Breast Cancer ... More >> Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00006252 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Veterans Affairs Medical Center - San Diego San Diego, California, United States, 92161 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Massachusetts UMASS Memorial Cancer Center - University Campus Worcester, Massachusetts, United States, 01655 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Elmhurst Hospital Center Elmhurst, New York, United States, 11373 Queens Cancer Center of Queens Hospital Jamaica, New York, United States, 11432 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT00055679 Breast Cancer Phase 3 Completed - -
NCT00119262 - Completed - -
NCT00679029 - Terminated(drug toxicity) - -
NCT00138229 Melanoma (Skin) Phase 2 Terminated - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT02901145 Antibodies, Neoplasm Phase 1 Phase 2 Not yet recruiting March 2020 -
NCT00284336 Breast Cancer ... More >> Elderly Less << Phase 2 Completed - Belgium ... More >> UZ gent Gent, Belgium, 9000 UH gasthuisberg Leuven, Belgium, 3000 Less <<
NCT00698009 - Terminated(Slow accrual.) - -
NCT00275015 Chronic Lymphocytic Leukemia Phase 2 Completed - -
NCT00485979 Breast Neoplasms Phase 2 Completed - Belgium ... More >> Sanofi-Aventis Administrative Office Diegem, Belgium Brazil Sanofi-Aventis Administrative Office Sao Paulo, Brazil France Sanofi-Aventis Administrative Office Paris, France Germany Sanofi-Aventis Administrative Office Berlin, Germany Poland Sanofi-Aventis Administrative Office Warszawa, Poland Tunisia Sanofi-Aventis Administrative Office Megrine, Tunisia United Kingdom Sanofi-Aventis Administrative Office Guildford, United Kingdom Uruguay Sanofi-Aventis Administrative Office Montevideo, Uruguay Less <<
NCT02838225 Breast Cancer Phase 2 Completed - -
NCT03164993 Cancer, Breast ... More >> Triple Negative Breast Cancer Less << Phase 2 Recruiting March 1, 2024 Denmark ... More >> Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Christina Bjerre, M.D.-Ph.d.    +45 35457965    christina.annette.bjerre@regionh.dk    Principal Investigator: Christina Bjerre, M.D.-Ph.d.          Vejle Sygehus Not yet recruiting Vejle, Denmark, 7100 Contact: Erik Hugger Jakobsen, M.D.-Ph.d    +4579406015    erik.hugger.jakobsen@rsyd.dk    Principal Investigator: Erik Hugger Jakobsen, M.D.-Ph.d          Norway Oslo University Hospital Recruiting Oslo, Norway Contact: Jon Amund Kyte, M.D.-Ph.D.    +4722934000    Jon.Amund.Kyte@rr-research.no    Principal Investigator: Jon Amund Kyte, M.D.-Ph.D.          Sub-Investigator: Bjørn Naume, M.D.-Ph.D.          Stavanger University Hospital Recruiting Stavanger, Norway Contact: Bjørnar Gilje, M.D.-Ph.D.    +4741432221    bjornar.gilje@sus.no    Principal Investigator: Bjørnar Gilje, M.D.-Ph.D.          University Hospital of North Norway Not yet recruiting Tromsø, Norway Contact: Egil Støre Blix, M.D.-Ph.D.       Egil.Store.Blix@unn.no    Principal Investigator: Egil Støre Blix, M.D.-Ph.D.          St. Olavs Hospital Recruiting Trondheim, Norway Contact: Sunil Xavier Raj, M.D.-Ph.D.       Sunil.Xavier.Raj@stolav.no    Principal Investigator: Sunil Xavier Raj, M.D Less <<
NCT00698009 Neuroblastoma Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00049413 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, California ... More >> Hoag Cancer Center at Hoag Memorial Hospital Presbyterian Newport Beach, California, United States, 92658 Less <<
NCT01246856 - Unknown - Netherlands ... More >> University Medical Centre Nijmegen Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Principal Investigator: H.W.M. van Laarhoven, Md Less <<
NCT01830244 Breast Cancer Phase 2 Active, not recruiting June 2020 Australia, New South Wales ... More >> Bankstown Lidcome Hospital Bankstown, New South Wales, Australia, 2200 Royal North Shore Hospital Sydney, New South Wales, Australia, 2065 Australia, Victoria Barwon Health Geelong, Victoria, Australia, 3220 St John of God Healthcare, Geelong Geelong, Victoria, Australia, 3220 South West Healthcare Warrnambool, Victoria, Australia, 3280 Less <<
NCT02867332 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Not yet recruiting November 2020 -
NCT01088789 Pancreatic Cancer Phase 2 Recruiting April 2023 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21205 Contact       jhcccro@jhmi.edu Less <<
NCT01341496 Sarcoma Melan... More >>oma Epithelial Malignancies Pleural Malignancy Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02408016 Advanced Pleural Malignant Mes... More >>othelioma HLA-A*0201 Positive Cells Present Recurrent Non-Small Cell Lung Carcinoma Recurrent Pleural Malignant Mesothelioma Stage III Non-Small Cell Lung Cancer AJCC v7 Stage III Pleural Malignant Mesothelioma AJCC v7 Stage IIIA Non-Small Cell Lung Cancer AJCC v7 Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Stage IV Pleural Malignant Mesothelioma AJCC v7 WT1 Positive Less << Phase 1 Phase 2 Active, not recruiting June 30, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00324623 Melanoma (Skin) Phase 1 Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT02867345 Hormone Refractory Prostate Ca... More >>ncer Less << Phase 1 Not yet recruiting December 2020 China, Beijing ... More >> Department of Urology Peking University First Hospital Beijing, Beijing, China, 100034 Less <<
NCT00150878 Acute Myeloid Leukemia Phase 3 Terminated(Insurance coverage ... More >>reached) Less << - Germany ... More >> Medizinische Klinik und Poliklinik I Dresden, Germany, 01307 Less <<
NCT00601003 Neuroblastoma ... More >> Medulloblastoma Less << Phase 2 Recruiting December 2020 United States, California ... More >> Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Mehrzad Milburn    858-966-8155       Principal Investigator: William Roberts, MD          United States, Connecticut Connecticut Children's Hospital Recruiting Hartford, Connecticut, United States, 06106 Contact: Sharon Huie-White    860-545-9337    shuie@connecticutchildrens.org    Principal Investigator: Michael Isakoff, MD          United States, Florida Arnold Palmer Hospital for Children- MD Anderson Recruiting Orlando, Florida, United States, 32806 Contact: Michelle Pope, RN    321-841-8588       Principal Investigator: Don Eslin, MD          United States, Hawaii Kapiolani Medical Center for Women and Children Recruiting Honolulu, Hawaii, United States, 96813 Contact: Andrea Siu, MPH    808-535-7169    andrea.siu@kapiolani.org    Principal Investigator: Randal Wada, MD          United States, Massachusetts Tufts Medical Center Recruiting Boston, Massachusetts, United States, 02111 Contact: Jennifer Truong    617-636-8885    jtruong@tuftsmedicalcenter.org    Principal Investigator: Michael Kelly, MD          United States, Michigan Helen DeVos Children's Hospital Recruiting Grand Rapids, Michigan, United States, 49503 Contact: Shannon MacKeigan    616-267-1162    shannon.mackeigan@helendevoschildrens.org    Principal Investigator: Deanna Mitchell, MD          Principal Investigator: Giselle Sholler, MD          United States, Minnesota Children's Hospital and Clinics on Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Courtney Haller    612-813-5913    courtney.haller@childrensmn.org    Principal Investigator: Jawhar Rawwas, MD          United States, Missouri Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Contact: Sara Soliman, RN    816-855-1977    sjsoliman@cmh.edu    Principal Investigator: Kathleen Neville, MD          Cardinal Glennon Children's Medical Center Recruiting Saint Louis, Missouri, United States, 63104 Contact: Katherine Maxwell, RN    314-268-4000       Principal Investigator: William Ferguson, MD          United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Elizabeth Arroyo-Green    980-442-2312    Elizabeth.ArroyoGreen@carolinashealthcare.org    Principal Investigator: Javier Oesterheld, MD          United States, Pennsylvania Penn State Milton S. Hershey Medical Center and Children's Hospital Recruiting Hershey, Pennsylvania, United States, 17033 Contact: Suzanne Treadway       streadway@hmc.psu.edu    Principal Investigator: Valerie Brown, MD          United States, South Carolina Medical University of South Carolina Recruiting Charleston, South Carolina, United States, 29425 Contact: Jacqueline Kraveka, MD    843-792-2957       Principal Investigator: Jaqueline Kraveka, MD          United States, Texas Children's Medical Center Recruiting Dallas, Texas, United States, 75235 Contact: Michelle Rivas    214-456-0004    michelle.rivas@childrens.com    Principal Investigator: Ted Laetsch, MD          Texas Children's Cancer and Hematology Centers Recruiting Houston, Texas, United States, 77030 Contact: Peter Zage, MD    832-824-4615    pezage@txch.org    Principal Investigator: Peter Zage, MD, PhD          United States, Utah Primary Children's Hospital Recruiting Salt Lake City, Utah, United States, 84113 Contact: Lisa Smith    801-662-4710    Lisa.Smith@imail.org    Principal Investigator: Mark Fluchel, MD Less <<
NCT02863913 Invasive Bladder Cancer Stage ... More >>IV Less << Phase 1 Not yet recruiting September 2019 China, Beijing ... More >> Department of Urology Peking University First Hospital Beijing, Beijing, China, 100034 Less <<
NCT01149902 Head and Neck Cancer Phase 1 Unknown - Japan ... More >> Umiversity of Yamanashi Hospital Recruiting Chuo, Yamanashi, Japan, 409-3898 Contact: Hiroki Ishii, MD    +81-55-273-6769    ishiih@yamanashi.ac.jp    Principal Investigator: Keisuke Masuyama, MD, PhD Less <<
NCT00486759 B-cell Lymphoma Phase 3 Terminated(Due to an unfavorab... More >>le benefit/risk ratio.) Less << - -
NCT00486759 - Terminated(Due to an unfavorab... More >>le benefit/risk ratio.) Less << - -
NCT02423928 Prostate Cancer Phase 1 Recruiting April 2019 Norway ... More >> Haukeland University Hospital Research Department Recruiting Bergen, Hordaland, Norway, No-5021 Contact: Bjorn Tore Gjertsen, MD PhD    55975000    Bjorn.Gjertsen@uib.no    Contact: Omenaas Ernst, MD PhD    55975000    Ernst.Omenaas@helse-bergen.no    Principal Investigator: Christian Beisland, MD PhD Less <<
NCT00004088 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT02118285 Ovarian Cancer ... More >> Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Less << Phase 1 Completed - United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT02446964 Adult Acute Lymphoblastic Leuk... More >>emia in Complete Remission Acute Myeloid Leukemia in Remission Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Complete Remission Less << Phase 1 Active, not recruiting November 2019 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Less <<
NCT01856192 Ann Arbor Stage II Diffuse Lar... More >>ge B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma CD20 Positive Less << Phase 2 Active, not recruiting - -
NCT00777673 Breast Cancer Phase 2 Unknown October 2013 United States, Tennessee ... More >> University of Tennessee Cancer Institute Memphis, Tennessee, United States, 38104 The West Clinic Memphis, Tennessee, United States, 38120 United States, Texas The Center for Cancer and Blood Disorders Ft. Worth, Texas, United States, 76104 Less <<
NCT01313884 Bone Cancer E... More >>wing's Sarcoma Less << Phase 2 Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01022138 Breast Cancer Phase 2 Active, not recruiting January 2018 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT01313884 - Terminated(Study did not reach... More >> primary objective; study did not accrue enough patients.) Less << - -
NCT00428142 Lymphoma Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Fraser Valley Cancer Centre Surrey, British Columbia, Canada, V3V 1Z2 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada, V8R 6V5 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Credit Valley Hospital Mississauga, Ontario, Canada, L5M 2N1 Regional Cancer Program of the Hopital Regional Sudbury, Ontario, Canada, P3E 5J1 Thunder Bay Regional Health Science Centre Thunder Bay, Ontario, Canada, P7B 6V4 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Toronto, Ontario, Canada, M9N 1N8 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHA-Hopital Du St-Sacrement Quebec City, Quebec, Canada, G1S 4L8 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT03208556 Relapsed or Refractory B-cell ... More >>Lymphoma Less << Phase 1 Recruiting June 1, 2020 China ... More >> Beijing Cancer Hosptical Recruiting Beijing, China Contact: Zhitao Ying, MD       yingzhitao001@163.com    Principal Investigator: Jun Zhu, MD          Sub-Investigator: Zhitao Ying, MD          Sub-Investigator: Xiaoyu Xiang, PhD Less <<
NCT00194779 Estrogen Receptor-negative Bre... More >>ast Cancer Estrogen Receptor-positive Breast Cancer HER2-positive Breast Cancer Progesterone Receptor-negative Breast Cancer Progesterone Receptor-positive Breast Cancer Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02766868 Lymphoblastic Leukemia, Acute,... More >> Adult Less << Phase 2 Recruiting July 2019 China ... More >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Ling Wang    86-21-64370045 ext 601818    cclingjar@163.com Less <<
NCT01082133 Fanconi Anemia Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00194779 - Completed - -
NCT03318900 Platinum Resistant Ovarian Can... More >>cer Less << Phase 1 Recruiting July 2020 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02161783 - Recruiting July 2021 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Troy C Lund, MD, PhD Less <<
NCT03654040 Liver Transplant Phase 1 Phase 2 Not yet recruiting December 2025 United States, California ... More >> University of California, San Francisco Not yet recruiting San Francisco, California, United States, 94143 Principal Investigator: Sandy Feng, MD, PhD Less <<
NCT03577431 Liver Transplant Phase 1 Phase 2 Not yet recruiting December 2025 United States, Massachusetts ... More >> Massachusetts General Hospital: Transplantation Not yet recruiting Boston, Massachusetts, United States, 02114 Contact: Kerry Crisali, RN, BSN    617-643-4087    KCRISALLI@mgh.harvard.edu    Contact: Margaret (Peg) Thomas    617-643-7555    mvthomas@mgh.harvard.edu    Principal Investigator: James F. Markmann, MD, PhD Less <<
NCT00129935 Breast Cancer Phase 3 Active, not recruiting January 2019 -
NCT01279902 Diffuse Large B-cell Lymphoma Phase 2 Unknown January 2017 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT03759093 Multiple Myeloma Phase 2 Phase 3 Not yet recruiting January 1, 2021 Singapore ... More >> National University Hospital Not yet recruiting Singapore, Singapore, 119228 Contact: Wee Joo Chng, Prof    67795555    mdccwj@nus.edu.sg    Contact: Sanjay de Mel, Dr    67795555    sanjay_widanalage@nuhs.edu.sg    Principal Investigator: Wee Joo Chng, Prof          Sub-Investigator: Edward Chow, Dr          Sub-Investigator: Dean Ho, Prof          Sub-Investigator: Sanjay de Mel, Dr          Sub-Investigator: Melissa Ooi, Dr Less <<
NCT00739141 Leukemia Myel... More >>odysplastic Syndrome Non-Hodgkins Lymphoma Chronic Myelogenous Leukemia Hodgkins Lymphoma Less << Phase 2 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02489448 Breast Neoplasms Phase 1 Phase 2 Recruiting October 2019 United States, Connecticut ... More >> Yale School of Medicine Recruiting New Haven, Connecticut, United States, 06511 Contact: Laurene Goode-Gade    203-737-8309    Laurene.goode-gade@yale.edu    Principal Investigator: Lajos Pusztai, MD, D.Phil. Less <<
NCT00006110 - Completed - -
NCT03274492 Diffuse Large B-Cell Lymphoma Phase 3 Recruiting April 15, 2023 -
NCT00006110 Breast Cancer Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7305 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT02107963 Sarcoma Osteo... More >>sarcoma Neuroblastoma Melanoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00069238 Lymphoma, T-Cell ... More >> Lymphoma, Extranodal NK-T-Cell Less << Phase 2 Active, not recruiting January 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00556192 Systemic Lupus Erythematosus Phase 2 Completed - China ... More >> Department of Medicine and Therapeutics Hong Kong, China Less <<
NCT01969032 Triple Negative Breast Cancer Phase 2 Completed - Russian Federation ... More >> Russian Cancer Research Center named after N.N.Blokhin RAMS Moscow, Russian Federation, 115478 Less <<
NCT01275677 Estrogen Receptor Negative ... More >> Estrogen Receptor Positive HER2/Neu Positive Progesterone Receptor Negative Progesterone Receptor Positive Recurrent Breast Carcinoma Stage IA Breast Cancer AJCC v7 Stage IB Breast Cancer AJCC v7 Stage IIA Breast Cancer AJCC v6 and v7 Stage IIB Breast Cancer AJCC v6 and v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Less << Phase 3 Active, not recruiting - -
NCT00003068 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Less << Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 Less <<
NCT00615173 Kidney Diseases ... More >> Lupus Nephritis Tacrolimus Induction Phase Maintenance Phase Less << Phase 3 Completed - China, Guangdong ... More >> The 1st Affiliated Hospital, Sun Yet-sen University Guangzhou, Guangdong, China, 510080 Less <<
NCT00079261 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 2 Completed - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Algemeen Ziekenhuis Sint-Augustinus Wilrijk, Belgium, 2610 Croatia University Hospital Rebro Zagreb, Croatia, 41000 Egypt National Cancer Institute - Cairo Cairo, Egypt France Institut Bergonie Bordeaux, France, 33076 Netherlands Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT03158935 Advanced Ovarian Cancer ... More >> Malignant Melanoma Less << Phase 1 Recruiting June 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D.    416-946-4521    marcus.butler@uhn.ca    Principal Investigator: Marcus Butler, M.D. Less <<
NCT00003116 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01444118 Carcinoma, Non-Small-Cell Lung Phase 3 Terminated(The early terminati... More >>on is not related to safety/toxicity but to initiate new Phase III with biomarker to enrich population & to further strengthen OS benefit) Less << - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, United Kingdom Less <<
NCT00787761 Myeloproliferative Disorders ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00354419 Aplastic Anemia Phase 1 Terminated(Low accrual) - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01292603 Lymphocytic Leukemia, Chronic Phase 1 Completed - -
NCT00400075 Polyarteritis Nodosa ... More >> Microscopic Polyangiitis Less << Phase 4 Unknown - Switzerland ... More >> Camillo Ribi Geneva, Switzerland Less <<
NCT00069238 - Active, not recruiting - -
NCT02994927 ANCA-Associated Vasculitis Phase 3 Active, not recruiting October 2019 -
NCT01292603 - Completed - -
NCT00902044 Sarcoma Phase 1 Recruiting July 2031 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD    832-824-4611    nmahmed@txch.org    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD    832-824-4611    nmamed@txch.org    Contact: Meenakshi Hegde, MD    832-824-4840    mghegde@txch.org Less <<
NCT01055496 Lymphoma, B-Cell Phase 1 Completed - -
NCT00399399 Churg-Strauss Syndrome Phase 4 Unknown - Switzerland ... More >> Camillo Ribi Geneva, Switzerland Less <<
NCT03600909 Fanconi Anemia ... More >> Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) Less << Phase 2 Recruiting May 2022 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Farid Boulad, MD    212-639-6684       Contact: Maria Cancio, MD    212-639-2446       Principal Investigator: Faird Boulad, MD Less <<
NCT03022123 Diffuse Large B-cell Lymphoma Not Applicable Unknown March 2018 China, Hebei ... More >> Fourth Hospital of Hebei Medical University Recruiting Shi Jiazhuang, Hebei, China, 050000 Contact: Liu Lihong, archiater    13831177920 Less <<
NCT00003679 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD Less <<
NCT03030976 Systemic Lupus Erythematosus (... More >>SLE) Less << Phase 1 Recruiting March 2018 China ... More >> Shanghai Jiaotong University School of Medicine, Renji Hospital Recruiting Shanghai, China, 200127 Contact: Qiang Guo, Doctor    86-21-63835620    bluedescent@126.com Less <<
NCT03006302 Metastatic Pancreatic Adenocar... More >>cinoma Less << Phase 2 Recruiting June 2023 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: SKCCC - Clinical Trials Office    410-955-8804    jhcccro@jhmi.edu Less <<
NCT00812669 Leukemia Phase 2 Active, not recruiting September 2022 Ireland ... More >> St. James's Hospital Dublin, Ireland, 8 University College Hospital Galway, Ireland Mid-Western Cancer Centre at Mid-Western Regional Hospital Limerick, Ireland, 0009 Midland Regional Hospital at Tullamore Tullamore, Ireland Waterford Regional Hospital Waterford, Ireland United Kingdom St. George's Hospital London, England, United Kingdom, SW17 ORE Less <<
NCT00787761 - Completed - -
NCT03142646 Leukemia Phase 1 Phase 2 Recruiting October 1, 2018 China ... More >> Beijing hospital Recruiting Beijing, China Contact: hui liu, md    15801390058    espinas@163.com    Peking University People's Hospital (PKUPH) Recruiting Peking, China Contact: Xiaojun Huang, MD          Principal Investigator: Xiaojun Huang, MD Less <<
NCT00963872 Leukemia Lymp... More >>homa Multiple Myeloma Myelodysplastic Syndromes Less << Phase 1 Phase 2 Terminated(Lack of efficacy af... More >>ter interim analysis) Less << - United States, Minnesota ... More >> University of Minnesota Medical Center - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT00149214 Breast Cancer Phase 2 Completed - Germany ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baden-Baden, Germany, 76532 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany, 10967 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hamburg, Germany, 20357 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Heidelberg, Germany, D-69115 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cremona, Italy, 26100 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rozzano, Italy, 20089 Russian Federation For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Moscow, Russian Federation, 129128 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Saint Petersburg, Russian Federation, 197022 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaen, Spain, 23007 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sabadell, Spain, 08208 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Valencia, Spain, 46010 Less <<
NCT03003520 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 2 Active, not recruiting March 13, 2023 United States, Arizona ... More >> Banner MD Anderson Cancer Center Gilbert, Arizona, United States, 85234 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Mid Ohio Oncology Hematology Inc Columbus, Ohio, United States, 43219 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Austria Innsbruck Medical University Department of Internal Medicine Innsbruck, Austria, 6020 Landeskrankenhaus Salzburg Salzburg, Austria, 5020 Medical University of Vienna Internalmedicine 1, Hematology Vienna, Austria, 1190 Hanusch Krankenhaus Wien, Austria, 1140 Denmark Aarhus Sygehus Arhus C, Denmark, DK-8000 Rigshospitalet, Kobenhavns Universitet - Centre for Clinical Intervention Research - The Copenhagen Copenhagen, Denmark, 2100 Odense Universitetshospital Odense C, Denmark, DK5000 Estonia (North Estonia Medical Centre) - Onkoloogia-ja Hematoloogiakliinik Tallinn, Estonia, 13419 Tartu University Hospital Tartu, Estonia, 51014 United Kingdom University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Royal Marsden Hospital London, United Kingdom, SW3 6JJ Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine Oxford, United Kingdom, 0X3 7LE Less <<
NCT03003676 Advanced or Unresectable Melan... More >>oma Progressing After PD1 Blockade Less << Phase 1 Recruiting - United States, Maryland ... More >> University of Maryland Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States Contact: Thomas Hornyak, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Contact: Alexander Shoushtari, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States Contact: Olzanski Anthony, MD Less <<
NCT00090051 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT00149214 - Completed - -
NCT02648282 Pancreatic Cancer Phase 2 Recruiting July 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Beth Onners, RN, BSN, MSN    410-502-2800    onnerbe@jhmi.edu    Contact: Lei Zheng, MD, PhD Less <<
NCT00499083 Breast Cancer Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Nebraska UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00398489 Breast Cancer Phase 2 Unknown - Germany ... More >> Klinikum Bayreuth Bayreuth, Germany, D 95448 Universitaetsfrauenklinik - Koeln Cologne, Germany, D-50391 Klinikum Deggendorf Deggendorf, Germany, 94469 Klinikum der Friedrich-Schiller Universitaet Jena Jena, Germany, D-07743 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00014755 Multiple Sclerosis Phase 1 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado Cancer Center Denver, Colorado, United States, 80262 United States, Missouri Washington University Barnard Cancer Center Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00002474 Ovarian Cancer Phase 2 Completed - United States, Illinois ... More >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153-5500 Less <<
NCT00963872 - Terminated(Lack of efficacy af... More >>ter interim analysis) Less << - -
NCT02280694 Colorectal Cancer Phase 2 Active, not recruiting January 2019 Israel ... More >> Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus, Petach Tiqva, Israel Less <<
NCT00499083 - Completed - -
NCT00070083 Lymphoma Phase 1 Completed - United States, California ... More >> Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305 Canada, British Columbia British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada, V3V 1Z2 British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00436566 Breast Cancer ... More >> Cardiac Toxicity Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Research Consortium Rochester, Minnesota, United States, 55905 Less <<
NCT00090051 - Completed - -
NCT00436566 - Completed - -
NCT00671658 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01918124 Prosthesis Survival Phase 2 Completed - China, Shanghai ... More >> Shanghai Cancer Center Shanghai, Shanghai, China, 200000 Less <<
NCT03159585 Bone Sarcoma ... More >>Soft Tissue Sarcoma Melanoma Liver Cancer Esophageal Cancer Breast Cancer Thyroid Cancer Ovarian Cancer Less << Phase 1 Recruiting May 31, 2019 China, Guang Dong ... More >> Zhujiang Hospital of Southern Mediacl University Recruiting Guangzhou, Guang Dong, China, 510282 Contact: Jian Zhang, Ph.D.    +8602062782356    blacktiger@139.com Less <<
NCT00002773 Pancreatic Cancer Phase 2 Completed - United States, California ... More >> St. Vincent Medical Center - Los Angeles Los Angeles, California, United States, 90057 Less <<
NCT00091104 Melanoma (Skin) Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT01071239 Fanconi Anemia Phase 2 Completed - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00002941 Lymphoma Phase 2 Completed - -
NCT02980965 Breast Cancer Female Phase 3 Completed - China, Shanghai ... More >> Cancer Hospital/ Institute, Fudan University Shanghai, Shanghai, China, 200032 Less <<
NCT00337246 Leukemia Phase 2 Completed - United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Blackpool Victoria Hospital Blackpool, England, United Kingdom, FY3 8NR Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR St Helier Hospital Carshalton, England, United Kingdom, SM5 1AA Darent Valley Hospital Dartford Kent, England, United Kingdom, DA2 8DA Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Leeds General Infirmary at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS1 3EX Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom, L7 8XP Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ Kent and Sussex Hospital Tunbridge Wells, Kent, England, United Kingdom, TN4 8AT Wishaw General Hospital Wishaw, England, United Kingdom, ML2 0DP Monklands General Hospital Airdrie, Scotland, United Kingdom, ML6 0JF University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT02844062 Glioblastoma Multiforme Phase 1 Recruiting July 2019 China ... More >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD    +86-10-13905918963    lzx1967@sina.com Less <<
NCT00003606 Lung Cancer Phase 3 Unknown - France ... More >> Hopital Arnaud de Villeneuve Montpellier, France, 34295 Less <<
NCT01247701 Myeloid Hematological Malignan... More >>cies Less << Not Applicable Recruiting November 2027 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD    832-824-4692    camartin@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT03202446 Breast Cancer Stage IIIA ... More >> Breast Cancer, Stage IIIB Breast Cancer Stage IV Less << Phase 3 Terminated - Peru ... More >> Clinica Ricardo Palma Lima, Peru Hospital Maria Auxiliadora Lima, Peru Hospital Nacional Arzobispo Loayza Lima, Peru Hospital Nacional Guillermo Almenara Irigoyen Lima, Peru Less <<
NCT02556931 Myelodysplastic Syndrome ... More >> Chronic Myelomonocytic Leukemia Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Chronic Myeloid Leukemia Chronic Myeloproliferative Disorders Multiple Myeloma Plasma Cell Neoplasm Plasma Cell Dyscrasia Myelofibrosis Polycythemia Vera Essential Thrombocythemia Plasma Cell Leukemia Less << Phase 2 Active, not recruiting December 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Less <<
NCT01008150 Breast Cancer Phase 2 Completed - -
NCT02792491 Diffuse Large B-cell Lymphoma Phase 2 Unknown December 2017 -
NCT00005622 Chronic Myeloproliferative Dis... More >>orders Leukemia Multiple Myeloma and Malignant Plasma Cell Neoplasms Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612-9497 Less <<
NCT02425306 Melanoma Phase 1 Phase 2 Terminated(Slow accrual to par... More >>t 2 of the study. Accrual to part 1 is complete.) Less << - United States, Virginia ... More >> Cancer Center at the University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT00549848 Acute Lymphoblastic Leukemia Phase 3 Active, not recruiting November 30, 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02954939 Lupus Nephritis Not Applicable Recruiting June 2019 Hong Kong ... More >> Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Desmond Yap, MD (HK)    85222554385    desmondy@hku.hk Less <<
NCT00486564 Neuroblastoma Phase 1 Completed - United States, Missouri ... More >> St. Louis University/Cardinal Glennon Childrens Medical Center St. Louis, Missouri, United States, 63104 United States, Vermont University of Vermont/Vermont Children's Hospital Burlington, Vermont, United States, 05401 Less <<
NCT01008150 - Completed - -
NCT02055820 Lymphoma, Non-Hodgkin Phase 1 Phase 2 Active, not recruiting February 27, 2020 -
NCT00255710 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00453388 - Active, not recruiting - -
NCT03029273 Lung Cancer, Nonsmall Cell, Re... More >>current Less << Phase 1 Recruiting December 2017 China, Guangdong ... More >> Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Shiyue Li, MD    8620-83062896    lishiyue@188.com    Principal Investigator: Shiyue Li, MD          Principal Investigator: Chengzhi Zhou, MD Less <<
NCT02806375 Primary Myelofibrosis ... More >> Myeloproliferative Disorders Less << Phase 1 Phase 2 Active, not recruiting June 2019 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT00167180 Leukemia, Myeloid, Chronic ... More >> Lymphomas Multiple Myeloma Myelodysplastic Syndrome Leukemia, Lymphocytic, Acute Leukemia, Lymphocytic, Chronic AML Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01240538 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT03766126 Acute Myeloid Leukemia, in Rel... More >>apse Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Refractory Less << Phase 1 Recruiting December 3, 2033 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed    855-216-0098    PennCancerTrials@emergingmed.com    Contact: Saar Gill, MD, PhD       Saar.Gill@pennmedicine.upenn.edu Less <<
NCT00453388 Acute Myeloid Leukemia in Remi... More >>ssion de Novo Myelodysplastic Syndrome Fanconi Anemia Previously Treated Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting - United States, California ... More >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609-1809 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Brazil Universidade Federal do Paraná Curitiba, Paraná, Brazil, 80060-000 Less <<
NCT03579888 Acute Lymphoblastic Leukemia ... More >> Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Blasts More Than 5 Percent of Peripheral Blood White Cells CD19 Positive Chronic Lymphocytic Leukemia Minimal Residual Disease Non-Hodgkin Lymphoma Small Lymphocytic Lymphoma Less << Phase 1 Not yet recruiting December 2021 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       pkebriae@mdanderson.org Less <<
NCT03123770 Breast Cancer Phase 4 Recruiting December 2021 China, Zhejiang ... More >> Cancer institute Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Zhang Zhigang, Dr    8657187315009    zzg2011@zju.edu.cn Less <<
NCT00062036 Melanoma (Skin) Phase 1 Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00096382 Melanoma (Skin) Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT00079105 Lymphoma Phase 2 Completed - -
NCT00167180 - Completed - -
NCT00002649 Recurrent Adult Burkitt Lympho... More >>ma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Less << Phase 3 Completed - United States, Texas ... More >> Southwest Oncology Group San Antonio, Texas, United States, 78245 Less <<
NCT00004010 Lymphoma Phase 2 Completed - -
NCT00589316 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts Less << Phase 1 Active, not recruiting October 1, 2024 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03229616 Autologous Hematopoietic Stem ... More >>Cell Transplantation Diffuse Large B-cell Lymphoma Conditioning Less << Phase 2 Phase 3 Recruiting June 2020 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com Less <<
NCT00244127 Aggressive Non-Hodgkin's Lymph... More >>oma in the Elderly. Less << Phase 2 Unknown - France ... More >> Paris, France Germany Berlin, Germany Italy Universita Degli Studi Di Modena AZ Ospedaliere Policlinico Modena, Italy, 41100 Spain Barcelona, Spain United Kingdom Leicester, United Kingdom Less <<
NCT00651755 Lymphoma Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00096382 - Completed - -
NCT02671708 Autologous Hematopoietic Stem ... More >>Cell Transplantation Acute Myeloid Leukemia Conditioning Less << Phase 2 Phase 3 Recruiting December 2019 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-61641613    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT00651755 - Completed - -
NCT00017628 Multiple Sclerosis Phase 1 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT03733327 Primary Central Nervous System... More >> Lymphoma Autologous Hematopoietic Stem Cell Transplantation Conditioning Less << Phase 2 Phase 3 Recruiting October 2021 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-62787883    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT00242996 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00726700 Lymphoma Phase 2 Completed - -
NCT00656123 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 1 Unknown - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Clinical Research Office    410-955-8866    jhcccro@jhmi.edu Less <<
NCT00429182 - Completed - -
NCT01646034 Breast Cancer Phase 3 Recruiting October 2020 Netherlands ... More >> NKI-AVL Recruiting Amsterdam, Netherlands, 1066 CX Contact: Gabe S Sonke, MD    +3120512 ext 2570    g.sonke@nki.nl    Contact: Ingrid AM Mandjes, MSc    +3120512 ext 2880    i.mandjes@nki.nl    Principal Investigator: Gabe S Sonke, MD Less <<
NCT00429182 Breast Cancer ... More >> Metastatic Breast Carcinoma Invasive Breast Carcinoma Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03017404 Breast Cancer Not Applicable Completed - China, Hebei ... More >> Fourth Hospital of Hebei Medical University Shi Jiazhuang, Hebei, China, 050019 Less <<
NCT00578864 - Completed - -
NCT01094548 Multiple Myeloma Phase 2 Completed - Germany ... More >> Please Contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT00278564 - Terminated(high relapse rate) - -
NCT02482090 Metastatic Ovarian Cancer Phase 1 Completed - Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT00670358 Lymphoma Phase 1 Phase 2 Recruiting May 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Active, not recruiting Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Active, not recruiting Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Grzegorz S. Nowakowski, M.D. Less <<
NCT00578864 Neuroblastoma Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00550784 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 1 Completed - -
NCT02274506 Blood And Marrow Transplantati... More >>on Leukemia Lymphoma Less << Phase 1 Withdrawn - -
NCT02428751 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Recruiting May 2020 China, Guangdong ... More >> Guangdong Provincial People's Hospital Recruiting Guangzhou, Guangdong, China, 510060 Contact: Wen-yu Li, M.D.    86-13924196915       Principal Investigator: Wen-yu Li, M.D.          Principal Investigator: Xin Du, M.D.          Nanfang Hospital of Southern Medical Unversity Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Bing Xu, M.D.    86-18688900980       Principal Investigator: Bing Xu, M.D.          Sun Yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510060 Contact: Zhi-ming Li, M.D.    86-13719189172    zhimingsysucc@163.com    Contact: Xi-wen Bi, M.D.    86-13826050380    xiwen_bi@163.com    Principal Investigator: Wen-qi Jiang, M.D.          The First Affiliated Hospital of Guangzhou Medical University Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Huo Tan, M.D.    86-13602725539       Principal Investigator: Huo Tan, M.D.          The Second Affiliated Hospital of Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Li-ping Ma, M.D.    86-13600450776       Principal Investigator: Li-ping Ma, M.D.          The Third Affiliated Hospital of Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Xiang-yuan Wu, M.D.    86-13729813256       Principal Investigator: Xiang-yuan Wu, M.D.          Wujing Zongdui Hospital of Guangdong Province Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Tao Zhou, M.D.    86-18820019866       Principal Investigator: Tao Zhou, M.D. Less <<
NCT00578643 - Completed - -
NCT00003217 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 United States, Illinois Children's Memorial Hospital, Chicago Chicago, Illinois, United States, 60614 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 University of Rochester Cancer Center Rochester, New York, United States, 14642 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Oklahoma Oklahoma Memorial Hospital Oklahoma City, Oklahoma, United States, 73126-0307 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 United States, Texas Simmons Cancer Center - Dallas Dallas, Texas, United States, 75235-9154 Cook Children's Medical Center - Fort Worth Fort Worth, Texas, United States, 76104 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00186225 Blood Cancer ... More >>Blood and Marrow Transplant (BMT) Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01094548 - Completed - -
NCT00054340 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02855359 Diffuse, Large B-Cell, Lymphom... More >>a Follicular Lymphoma, Grade 3b Transformed Lymphoma / DLBCL Less << Phase 2 Terminated(Sponsor decision ba... More >>sed on portfolio prioritization) Less << - -
NCT00578643 Chronic Granulomatous Disease Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00133991 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Drexel University College of Medicine - Center City Hahnemann Campus Philadelphia, Pennsylvania, United States, 19102 Less <<
NCT00133991 - Completed - -
NCT03118492 Secondary Myelofibrosis Phase 1 Recruiting October 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD    626-256-4673 ext 62405    malmalki@coh.org    Principal Investigator: Monzr M. Al Malki, MD Less <<
NCT01146834 Multiple Myeloma Phase 3 Active, not recruiting December 2022 United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10065 Less <<
NCT00124111 Breast Cancer Phase 2 Completed - -
NCT00462332 - Completed - -
NCT00877110 Neuroblastoma ... More >> Bone Marrow, Sympathetic Nervous System Less << Phase 1 Active, not recruiting April 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00450801 Lymphoma Phase 2 Completed - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00462332 Leukemia Phase 2 Completed - Italy ... More >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Universita Degli Studi di Bari Bari, Italy, 70124 Universita Cattolica del Sacro Cuore - Campobasso Campobasso, Italy, 86100 Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy, 95124 Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Ospedale Civile Cosenza Cosenza, Italy, 87100 Universita di Ferrara Ferrara, Italy, 44100 Azienda Ospedaliera di Firenze Firenze, Italy, 50011 Ospedale San Martino Genova, Italy, 16132 ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Azienda Ospedaliera Papardo Messina, Italy Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Ospedale Maggiore Policlinico Milano, Italy, 20122 Azienda Ospedaliera - Universitaria di Modena Modena, Italy, 41100 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy, 00133 Ospedale Sant' Eugenio Rome, Italy, 00144 Università Degli Studi "La Sapienza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Siena, Italy Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Turin, Italy, 10126 Policlinico Universitario Udine Udine, Italy, 33100 Less <<
NCT02609386 Squamous Cell Carcinoma of the... More >> Oral Cavity Less << Phase 2 Active, not recruiting December 2019 United States, Arizona ... More >> Banner University Medical Center Tucson, Arizona, United States, 85742 United States, Arkansas University of Arkansas For Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 Stanford University Medical Center Stanford, California, United States, 94305 United States, Georgia Emory University - Winship Cancer Center Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40506 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New York Monter Cancer Center - North Shore LIJ New Hyde Park, New York, United States, 11040 Lenox Hill Hospital New York, New York, United States, 10075 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Oregon Providence Cancer Center Portland, Oregon, United States, 97209 United States, Pennsylvania Hospital of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19106 Brazil Hospital Erasto Gaertner Curitiba, Brazil Instituto Goiano de Oncologia e Hematologia (INGOH) Goiânia, Brazil Instituto do Câncer de Londrina Londrina, Brazil Instituto Nacional do Cancer (INCA) Rio de Janeiro, Brazil Hospital de Base de São José do Rio Preto São José do Rio Prêto, Brazil Instituto Brasileiro de Controle do Câncer São Paulo, Brazil Instituto do Cancer do Estado de São Paulo - ICESP São Paulo, Brazil Canada Sunnybrook Research Institute Toronto, Canada United Kingdom Queen Elizabeth University Hospital Glasgow Glasgow, United Kingdom Less <<
NCT00450801 - Completed - -
NCT00270894 Breast Neoplasm Phase 2 Completed - United States, Florida ... More >> Advanced Medical Specialties Miami, Florida, United States, 33176 United States, Georgia Augusta Oncology Associates Augusta, Georgia, United States, 30901 Cental Georgia Cancer Care Macon, Georgia, United States, 31201 Northwest Georgia Oncology Centers, PC Marietta, Georgia, United States, 30060 United States, Montana Hematology Oncology Centers of the Northern Rockies, PC Billings, Montana, United States, 59101 United States, New York Arena Oncology Associates Great Neck, New York, United States, 11021 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 Less <<
NCT00167206 - Terminated(Treatment with thym... More >>ic shielding found safe, another study started.) Less << - -
NCT00270894 - Completed - -
NCT02512679 - Terminated(Optimal dose obtain... More >>ed for engraftment and minimizing toxicity) Less << - -
NCT01871766 Rhabdomyosarcoma Phase 2 Recruiting June 2024 United States, Florida ... More >> University of Florida Proton Therapy Institute Active, not recruiting Jacksonville, Florida, United States, 32206 Nemours Children's Clinic Active, not recruiting Jacksonville, Florida, United States, 32207 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Matthew J. Krasin, MD    866-278-5833    referralInfo@stjude.org    Principal Investigator: Matthew J. Krasin, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Karen Albritton, MD    682-885-2103    karen.albritton@cookchildrens.org    Principal Investigator: Karen Albritton, MD Less <<
NCT02500576 Melanoma Phase 2 Recruiting August 1, 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00141648 Osteolymphoma Not Applicable Completed - Australia, New South Wales ... More >> Royal Prince Alfred Hospital Camperdown, New South Wales, Australia, 2050 Liverpool Hospital Liverpool, New South Wales, Australia, 1871 Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2310 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Wollongong Hospital Wollongong, New South Wales, Australia Australia, Queensland The Wesley Radiation Oncology Pty Ltd Auchenflower, Queensland, Australia, 4006 Royal Brisbane Hospital Herston, Queensland, Australia, 4029 Mater QRI South Brisbane, Queensland, Australia, 4101 North Queensland Oncology Service Townsville, Queensland, Australia, 4810 East Coast Cancer Centre, John Flynn Hospital Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Tasmania Royal Hobart Hospital Hobart, Tasmania, Australia, 7000 Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Andrew Love Cancer Care Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 New Zealand Auckland Hospital Auckland, New Zealand, 1001 Waikato Hospital Hamilton, New Zealand, 3200 Palmerston North Hospital Palmerston North, New Zealand Less <<
NCT02512679 Stem Cell Transplantation ... More >> Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Allogeneic Transplantation Genetic Diseases Thalassemia Pediatrics Diamond-Blackfan Anemia Combined Immune Deficiency Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Lymphoproliferative Disease Metabolic Diseases Less << Phase 2 Terminated(Optimal dose obtain... More >>ed for engraftment and minimizing toxicity) Less << - -
NCT02419170 Carcinoma, Non-Small-Cell-Lung... More >> Non-Small Cell Lung Cancer Nonsmall Cell Lung Cancer Less << Early Phase 1 Withdrawn(Investigator who man... More >>ufactured the vaccine left the university.) Less << October 2023 -
NCT00003388 Lymphoma Phase 2 Completed - United States, California ... More >> Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States, 94304 Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, New Jersey Raritan Bay Medical Center Perth Amboy, New Jersey, United States, 08861 United States, New York Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 Less <<
NCT00278564 MYOPATHY Phase 1 Terminated(high relapse rate) - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT02506777 Breast Cancer Phase 2 Recruiting August 2017 Russian Federation ... More >> N.N. Petrov Research Institute of Oncology Clinical Diagnostic Department Recruiting Saint - Petersburg, Russian Federation, 191124 Contact: Tatiana Y Semiglazova, MD, PhD, DSc    +79219468072    tsemiglazova@mail.ru    Contact: Michael A Osipov, MD    +79052075653    Ocipovmixail@mail.ru    Principal Investigator: Tatiana Y Semiglazova, MD, PhD, DSc          Sub-Investigator: Petr V Krivorotko, MD, PhD, DSc Less <<
NCT01855828 Her2-Positive Breast Cancer Phase 2 Active, not recruiting December 2018 United States, Connecticut ... More >> Yale University Smilow Cancer Hospital New Haven, Connecticut, United States, 06520 Less <<
NCT00310089 Breast Cancer Not Applicable Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, New Jersey Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 Less <<
NCT00510367 Breast Cancer ... More >> Pregnancy Less << Early Phase 1 Active, not recruiting August 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00167206 Fanconi Anemia Phase 1 Phase 2 Terminated(Treatment with thym... More >>ic shielding found safe, another study started.) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00002819 Ovarian Cancer Phase 3 Terminated - -
NCT03385096 Autologous Hematopoietic Stem ... More >>Cell Transplantation Conditioning Multiple Myeloma Less << Phase 2 Phase 3 Not yet recruiting December 2021 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT02427620 Lymphoma Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02627248 Breast Cancer Phase 4 Recruiting October 2025 China, Shandong ... More >> Qilu hospital of Shandong University Recruiting Ji'nan, Shandong, China, 250012 Contact: Qifeng Yang, Professor    +86 18560085168       Contact: Ning Zhang, Resident    +86 18560085950 Less <<
NCT00004218 Leukemia Phase 3 Completed - -
NCT01762449 - Completed - -
NCT00337987 Peripheral T-Cell Lymphoma Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT00337987 - Completed - -
NCT03126864 Hematopoietic/Lymphoid Cancer ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting August 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       wwierda@mdanderson.org Less <<
NCT02905188 Hepatocellular Carcinoma Phase 1 Not yet recruiting October 2036 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD       axheczey@txch.org Less <<
NCT03498716 Triple Negative Breast Cancer Phase 3 Recruiting December 29, 2024 -
NCT01795976 Oesophageal Cancer Phase 2 Terminated(Withdrawal of fundi... More >>ng) Less << - United Kingdom ... More >> The Christie NHS Foundation Trust Manchester, United Kingdom, M20 3EE Less <<
NCT02781467 Leukemia, Myeloid, Acute Phase 1 Terminated(Business Decision) - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Center Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt Univ Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Wisconsin Froedtert Hospital BMT Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226-3522 Less <<
NCT00197912 Advanced Melanoma Phase 1 Phase 2 Completed - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2970 Less <<
NCT02772822 Diffuse Large B Cell Lymphoma Phase 3 Not yet recruiting December 2019 China, Beijing ... More >> Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing, China, 100076 Less <<
NCT00683670 Melanoma Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02742051 Breast Cancer Phase 2 Recruiting December 2019 China, Guangdong ... More >> Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jieqiong Liu, M.D.,Ph.D.    8620-81332576    liujieqiong01@163.com Less <<
NCT00290641 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03448978 Multiple Myeloma Phase 1 Recruiting March 1, 2020 United States, District of Col... More >>umbia Georgetown University Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 United States, Maryland The Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Virginia Virgina Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Less <<
NCT01554852 Multiple Myeloma Phase 3 Active, not recruiting December 2022 United Kingdom ... More >> 112 sites UK wide United Kingdom, United Kingdom Less <<
NCT00003927 Breast Cancer Phase 1 Active, not recruiting January 2019 United States, California ... More >> Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States, 91010-3000 Less <<
NCT03225924 DLBCL Phase 1 Phase 2 Recruiting September 2023 Belgium ... More >> Institut Jules Bordet Recruiting Bruxelles, Belgium, 1000 Contact: Marie MAEREVOET    +32 (0)25 55 56 85    marie.maerevoet@bordet.be    Clinique Universite Catholique de Louvain Saint-Luc Recruiting Bruxelles, Belgium, 1200 Contact: Nicole STRAETMANS    +32 (0)27 64 18 00    nicole.straetmans@uclouvain.be    University Hospital Gent Recruiting Gent, Belgium, 9000 Contact: Fritz OFFNER    +32 (0)93 32 21 32    fritz.offner@uzgent.be    Hopital Joliment Recruiting Haine-Saint-Paul, Belgium, 7100 Contact: Marie-Christine NGIRABACU    +32 (0) 64 23 50 71    mariechristine.ngirabacu@jolimont.be    Az Groeninge Recruiting Kortrijk, Belgium, 8500 Contact: Koenraad VAN EYGEN    +32 (0) 56 63 41 92    koen.vaneygen@azgroeninge.be    UCL Namur Recruiting Yvoir, Belgium Contact: Julien Depaus          France Ch de Bourg En Bresse Recruiting Bourg-en-Bresse, France, 0100 Contact: Hubert ORFEUVRE    05 31 15 63 51    horfeuvre@ch-bourg01.fr    CHU Côte de Nacre Recruiting Caen, France Contact: Christophe Fruchart          CHU Henri Mondor Recruiting Créteil, France Contact: Corinne Haioun          CHU de Dijon Recruiting Dijon, France Contact: Olivier Casasnovas          Ch de Versailles - Hopital Andre Mignot Recruiting Le Chesnay, France, 78150 Contact: Caroline BESSON    01 39 63 85 11    cbesson@ch-versailles.fr    Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Katell LE DU    02 43 47 94 93    k.ledu@cjb72.org    Chu de Limoges - Hopital Dupuytren Recruiting Limoges, France, 87042 Contact: Julie ABRAHAM    05 55 05 66 51    julie.abraham@chu-limoges.fr    Clinique de La Sauvegarde Recruiting Lyon, France, 69337 Contact: Isabelle MOULLET    04 37 49 18 20    i.moullet@wanadoo.fr    CHU Lyon Sud Recruiting Lyon, France Contact: Gilles Salles          CHU Montpellier Recruiting Montpellier, France Contact: Emmanuelle Tchernonog          Ch Region Mulhouse Et Sud Alsace Recruiting Mulhouse, France, 68070 Contact: Bernard DRENOU    03 89 64 77 43    drenoub@ghrmsa.fr    Hopital Necker Paris Recruiting Paris, France, 75015 Contact: David SIBON    01 44 49 52 96    david.sibon@aphp.fr    Chu de Bordeaux Recruiting Pessac, France, 33604 Contact: Kamal BOUABDALLAH    05 57 65 65 11    krimo.bouabdallah@chu-bordeaux.fr    Ch Annecy Genevois Recruiting Pringy, France, 74374 Contact: Nicolas DAGUINDEAU    04 50 63 69 50    ndaguindau@ch-annecygenevois.fr    Chu de Reims - Hopital Robert Debre Recruiting Reims, France, 51092 Contact: Eric DUROT    03 26 78 36 44    edurot@chu-reims.fr    Chu de Rennes - Pontchaillou Recruiting Rennes, France, 35033 Contact: Thierry LAMY DE LA CHAPELLE    02 99 28 42 26    thierry.lamy.de.la.chapelle@chu-rennes.fr    Ch de Roubaix-Hopital Victor Provo Recruiting Roubaix, France, 59056 Contact: Isabelle PLANTIER       isabelle.plantier@ch-roubaix.fr    Iuct Oncopole de Toulouse Recruiting Toulouse, France, 31059 Contact: Lucie OBERIC    05 31 15 63 51    oberic.lucie@iuct-oncopole.fr    Hôpital Bretonneau- Centre H. Kaplan Recruiting Tours, France, 37044 Contact: Emmanuel GYAN    02 47 47 37 12    e.gyan@chu-tours.fr    Ch de Valenciennes Recruiting Valenciennes, France, 59322 Contact: Sabine TRICOT    04 50 63 69 50    tricot-s@ch-valenciennes.fr    Chru de Nancy Recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Laurianne CLEMENT-FILLIATRE    03 83 15 32 82    la.clement@chru-nancy.fr Less <<
NCT02613026 Breast Neoplasms Phase 3 Completed - China, Hebei ... More >> The fourth hospital of Hebei Medical University Shijiazhuang, Hebei, China, 050010 China, Heilongjiang Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China, 150081 China, Hunan Hunan Provincial People's Hospital Changsha, Hunan, China, 410005 Xiangya Hospital, Central South University Changsha, Hunan, China, 410008 China, Jiangsu Jiangsu Cancer Hospital Nanjing, Jiangsu, China, 210000 Less <<
NCT00002521 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT03576378 Hodgkin Lymphoma Phase 1 Phase 2 Active, not recruiting October 30, 2023 Spain ... More >> Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet De Llobregat, Barcelona, Spain Hospital Costa del Sol Marbella, Málaga, Spain Hospital Clinic i Provincial de Barcelona Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital de Basurto Bilbao, Spain Hospital General Universitario Gregorio Marañon Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Son Llatzer Palma De Mallorca, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario Donostia - Arantzazu San Sebastián, Spain Hospital Universitario Marqués de Valdecilla Santander, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT00246103 Neoplasms, Advanced Phase 1 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02574728 Cancer Phase 2 Recruiting June 2020 United States, Delaware ... More >> Nemours/Alfred I. duPont Hospital for Children Recruiting Wilmington, Delaware, United States, 19803 Contact: Debra Bertz, CTR, MBA    302-651-5757    debra.bertz@nemours.org    Principal Investigator: Andrew W Walter, MD          United States, Florida Nemour's Children's Specialty Care Jacksonville Recruiting Jacksonville, Florida, United States, 32207 Contact: Howard Katzenstein, MD    904-697-3985    Howard.Katzenstein@nemours.org    Principal Investigator: Howard Katzenstein, MD          United States, Georgia Children's Healthcare of Atlanta-Egleston Recruiting Atlanta, Georgia, United States, 30322 Contact: Kate Glasscox    404-785-0002    Katherine.GlasscoxSuggs@choa.org    Children's Healthcare of Atlanta, Scottish Rite Recruiting Atlanta, Georgia, United States, 30342 Contact: Kate Glasscox    404-785-0002    Katherine.GlasscoxSuggs@choa.org    Principal Investigator: Thomas Cash, MD          United States, Missouri Children's Mercy Hospital Recruiting Kansas City, Missouri, United States, 64108 Contact: Amber Jenkins, MSc, CCRC    816-302-6891    amjenkins@cmh.edu    Principal Investigator: Jaszianne Tolbert, MD          United States, Virginia University of Virginia Health System Recruiting Charlottesville, Virginia, United States, 22908 Contact: Cindy Fischer, CCRC    434-243-0901    CRB3Y@hscmail.mcc.virginia.edu    Principal Investigator: William Petersen, MD Less <<
NCT02527746 Neutropenia B... More >>reast Cancer Less << Phase 1 Phase 2 Completed - -
NCT03658785 Recurrence Tumor ... More >> Metastatic Cancer Solid Tumor Less << Phase 1 Phase 2 Not yet recruiting December 31, 2024 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430000 Contact: Wang Less <<
NCT01220297 Hematologic Diseases ... More >> Acute-graft-versus-host Disease Leukemia Non-Hodgkin Lymphoma (NHL) Hodgkin Lymphoma Less << Phase 2 Terminated(Low accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT02053545 Leukemia Lymp... More >>homa MDS Less << Phase 1 Phase 2 Unknown December 2018 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Joseph Laskowski       jlaskowski@luriechildrens.org    Principal Investigator: Reggie Duerst Less <<
NCT01220297 - Terminated(Low accrual) - -
NCT02727387 Ewing's Sarcoma (ES) Phase 2 Recruiting May 2020 Italy ... More >> Centro di Riferimento Oncologico - Unit of Medical Oncology Not yet recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD    +390434659 ext 536    mascarin@cro.it    Principal Investigator: Maurizio Mascarin, MD          I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD    +39.011.9933 ext 628    massimo.aglietta@ircc.it    Principal Investigator: Massimo Aglietta, MD          Sub-Investigator: Giovanni Grignani, MD          Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366199 ext 199    stefano.ferrari@ior.it    Principal Investigator: Stefano Ferrari, MD          Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD    +39070504208       Principal Investigator: Rosamaria Mura, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Carla Manzitti, MD    0105636 2431       Principal Investigator: Carla Manzitti, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Rossella Bertulli, MD    +390223903 ext 287    rossella.bertulli@istitutotumori.mi.it    Principal Investigator: Rossella Bertulli, MD          Fondazione IRCCS INT Milano Recruiting Milano, Italy Contact: Roberto Luksch, MD    +390223903       Principal Investigator: Roberto Luksch, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD    +39065266919       Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT03066947 Breastcancer ... More >>Breast Neoplasm Less << Phase 1 Phase 2 Active, not recruiting March 2019 United States, California ... More >> St. Joseph Heritage Healthcare Santa Rosa, California, United States, 95403 United States, Florida University of Miami/Sylvester at Plantation Plantation, Florida, United States, 33324 United States, Kansas Cancer Center of Kansas (CCK) Wichita, Kansas, United States, 67214 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 United States, Washington Providence Regional Medical Center Everett, Washington, United States, 98201 Less <<
NCT00354172 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Terminated(Competing study was... More >> started.) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02529852 Lymphoma Phase 1 Phase 2 Active, not recruiting November 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00007813 Brain and Central Nervous Syst... More >>em Tumors Childhood Germ Cell Tumor Extragonadal Germ Cell Tumor Liver Cancer Neuroblastoma Ovarian Cancer Sarcoma Testicular Germ Cell Tumor Less << Phase 1 Unknown - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00960115 - Completed - -
NCT02156726 - Unknown July 2015 Czech Republic ... More >> Department of Hematology - Oncology, University Hospital Brno, Czech Republic, 60500 Department of Hemato-Oncology, University Hospital Olomouc, Czech Republic, 77520 Department of Hematology, University Hospital Plzen, Czech Republic, 30599 Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Praha, Czech Republic, 10034 1st Department of Medicine - Hematology, University General Hospital Praha, Czech Republic, 12808 Institute for Hematology and Blood Transfusion Praha, Czech Republic, 12820 4th Department of Medicine - Hematology, University Hospital Hradec Kralove, ČR, Czech Republic, 50005 Less <<
NCT00446173 Leukemia Phase 2 Withdrawn(Terminated due to lo... More >>w accrual.) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00354172 - Terminated(Competing study was... More >> started.) Less << - -
NCT00944047 Breast Cancer Phase 2 Completed - United States, Kansas ... More >> Hays Medical Center Hays, Kansas, United States, 67601 University of Kansas Medical Center Cancer Center Kansas City, Kansas, United States, 66205 Less <<
NCT03188198 Large B Cell Lymphoma Phase 2 Recruiting June 1, 2019 Egypt ... More >> Oncology center Recruiting Mansoura, Egypt Contact: Ahmed Eltantawy, Master    00201091203484    eltantawy.ahmed1@gmail.com Less <<
NCT00944047 - Completed - -
NCT01389427 Mantle Cell Lymphoma Refractor... More >>y Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 Less <<
NCT00281983 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, 12200 Universitaetsklinikum Essen Essen, Germany, 45122 Universitaetsklinikum Goettingen Goettingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, 24116 University Hospital of Leipzig Leipzig, Germany, 04103 Klinikum der Universitaet Regensburg Regensburg, Germany, 93053 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00960115 Non-small Cell Lung Cancer Phase 1 Phase 2 Completed - Germany ... More >> Please contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT00002628 Breast Cancer Phase 1 Phase 2 Unknown - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 United States, Missouri St. Louis University Health Sciences Center Saint Louis, Missouri, United States, 63110-0250 United States, Tennessee Methodist Hospital-Central Unit Memphis, Tennessee, United States, 38104 Less <<
NCT03173417 Leukemia Phase 1 Phase 2 Recruiting December 1, 2020 China ... More >> Hebei Yanda Ludaopei Hospital Recruiting Beijing, China Contact: Xinan lu, Dr       luxinan@immunochina.com    Contact    86-189-1157-6946 Less <<
NCT00336791 Breast Cancer Phase 3 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Mexico Centro Medico Nacional de Occidente Guadalajara, Mexico Peru Instituto Nacional de Enfermedades Neoplasicas Lima, Peru Spain Grupo Español de Investigacion en Cancer de Mama Madrid, Spain Less <<
NCT00256243 - Completed - -
NCT00002594 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 2 Completed - -
NCT00256243 Breast Cancer Phase 2 Completed - United States, California ... More >> Chao Family Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT02759822 - Recruiting - Brazil ... More >> Instituto Nacional de Cancer Recruiting Rio de Janeiro, Brazil, 20230-130 Contact: Leonardo J Arcuri, MD    +55(21)3207-1304    leonardojavier@gmail.com    Contact: Simone Lermontov    +55(21)3207-1261    simonelermontov@globo.com Less <<
NCT00005898 Fanconi's Anemia Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00756470 Breast Cancer Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02145039 Acute Leukemias ... More >> Burkitt's Lymphoma Chronic Myelogenous Leukemia Less << Not Applicable Active, not recruiting June 2020 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00756470 - Terminated(Slow accrual.) - -
NCT00349674 Systemic Wegener's Granulomato... More >>sis Less << Phase 3 Unknown - France ... More >> Christian PAGNOUX Paris, France, 75 Less <<
NCT01350232 Sickle Cell Anemia ... More >> Sickle Cell-hemoglobin C Disease Sickle Cell-β0-thalassemia Less << Not Applicable Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01350232 - Terminated(Poor accrual) - -
NCT00612716 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Recruiting December 2021 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Daniel J. Weisdorf, MD    612-624-0123    weisd001@umn.edu    Principal Investigator: Daniel Weisdorf, M.D. Less <<
NCT00070447 Lymphoma Phase 2 Completed - -
NCT02572596 Multiple Myeloma Not Applicable Recruiting December 31, 2018 China, Beijing ... More >> Beijing Chaoyang Hospital Recruiting Beijing, Beijing, China, 100020 Contact: Guorong Wang, doctor    +861085231572    blunlake@163.com    Contact: Wenming Chen, doctor    +861085231581    wenming_chen@yahoo.com Less <<
NCT01415882 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 2 Recruiting April 1, 2019 United States, Arizona ... More >> Mayo Clinic in Arizona Active, not recruiting Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Vivek Roy          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office    855-776-0015       Principal Investigator: Shaji K. Kumar Less <<
NCT00121134 Breast Cancer Not Applicable Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94122 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, North Carolina University of North Carolina Durham, North Carolina, United States, 27701 Less <<
NCT00024102 Breast Cancer Phase 3 Completed - -
NCT02105766 Sickle Cell Disease ... More >> Thalassemia Stem Cell Transplantation Graft vs Host Disease Less << Phase 2 Recruiting August 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT02065362 EBV-positive Nasopharyngeal Ca... More >>rcinoma Less << Phase 1 Active, not recruiting February 2033 United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00968162 Bone Marrow Transplantation ... More >> Sickle Cell Disease Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama-Birmingham Birmingham, Alabama, United States United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States United States, Florida All Children's Research Institute Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Michigan Wayne State University Detroit, Michigan, United States, 48202 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States United States, New York Montefiore Medical Center The Bronx, New York, United States United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27516 United States, Texas University of Texas Southwestern Dallas, Texas, United States Less <<
NCT03747965 Solid Tumor, Adult Phase 1 Recruiting May 2020 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Weidong Han, Dr    86-10-13651392893    hanwdrsw@sina.com Less <<
NCT00024102 - Completed - -
NCT00121134 - Completed - -
NCT00959231 Hematopoietic/Lymphoid Cancer Phase 2 Unknown - United Kingdom ... More >> Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8BJ Contact: Contact Person    44-117-342-8044       Cancer Research UK Clinical Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS16 6QB Contact: Contact Person    44-113-206-6020       University College of London Hospitals Recruiting London, England, United Kingdom, NW1 2PQ Contact: Rachael Hough, MD    44-845-155-5000 ext. 5239       UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2301       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person    44-207-813-8335       University of Newcastle-Upon-Tyne Northern Institute for Cancer Research Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE2 4HH Contact: Contact Person    44-191-222-7785 Less <<
NCT01868828 Multiple Myeloma Phase 4 Unknown May 2017 China, Beijing ... More >> Peking University People's Hospital, Institute of Hematology, Peking University Recruiting Beijing, Beijing, China, 100044 Contact: Jin Lu, PhD       onco_velcade123@163.com Less <<
NCT01719835 Peripheral T-cell Lymphoma NOS... More >> Anaplastic Large Cell Lymphoma, ALK-Negative Angioimmunoblastic T-cell Lymphoma Hepatosplenic Gamma/ Delta T-cell Lymphoma Enteropathy-Associated T-Cell Lymphoma Less << Phase 2 Active, not recruiting August 2022 United Kingdom ... More >> Royal Marsden NHS Foundation Trust - London and Surrey London, United Kingdom, SM2 5PT Less <<
NCT03328104 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 1 Recruiting December 31, 2019 United States, Georgia ... More >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Himalee Sabnis, MD, MS    404-727-3285    hsabnis@emory.edu Less <<
NCT02936375 Lupus Nephritis Phase 2 Recruiting August 2019 China, Shanghai ... More >> RenJi Hospital Recruiting Shanghai, Shanghai, China, 200001 Contact: Bao Chunde, MD    021－63284622    baochunde_1678@yahoo.com.cn    Principal Investigator: Bao Chunde, MD          Sub-Investigator: Qingran Yan, MD          Shanghai Tongji Hospital, Tongji University School of Medicine Recruiting Shanghai, Shanghai, China, 200065 Contact: Jianping Tang, MD    86-21-56051080    tangjp6512@126.com    Principal Investigator: Jianping Tang, MD Less <<
NCT02365805 Breast Cancer Phase 2 Completed - Spain ... More >> Hospital Universitario Puerta del Mar Cádiz, Spain, 11009 Hospital Universitario Reina Sofía Córdoba, Spain, 14004 Hospital Universitario Juan Ramón Jimenez Huelva, Spain, 21005 Complejo Hospitalario de Jaén Jaén, Spain, 23007 Hospital Universitario Virgen Macarena Seville, Spain, 41007 Hospital Universitario Virgen del Rocío Seville, Spain, 41013 Hospital Universitario Nuestra Señora de Valme Seville, Spain, 41014 Less <<
NCT00924326 Primary Mediastinal B-cell Lym... More >>phoma Diffuse, Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma Mantle Cell Less << Phase 1 Phase 2 Active, not recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001209 Neuroectodermal Tumor, Primiti... More >>ve Neuroepithelioma Osteosarcoma Sarcoma Sarcoma, Ewing's Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03528421 Non Hodgkin Lymphoma Phase 1 Recruiting May 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr.          Principal Investigator: Jun Zhu Less <<
NCT01271907 - Terminated(Study was terminate... More >>d due to withdrawal of CRADA partner.) Less << - -
NCT00493870 Breast Cancer Phase 3 Active, not recruiting May 2019 -
NCT02127905 Fanconi Anemia Not Applicable Withdrawn(Study was stopped du... More >>e to non-enrollment of subjects due to rarity of disease.) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT02879669 To Determine Safety, Tolerabil... More >>ity and Efficacy of ONCOS-102 in Combination With Chemotherapy Less << Phase 1 Phase 2 Recruiting - France ... More >> Centre Georges-François Leclerc Recruiting Dijon, France Contact: Nicolas Isambert, MD          CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: Hervé Lena, MD          Spain Hospital Universitario Quirón Recruiting Barcelona, Spain Contact: Santiago Viteri          Vall d'Hebron Univerity Hospital Recruiting Barcelona, Spain Contact: Susanna Cedres, MD          Hospital Universitari de Girona Doctor Josep Trueta - Institut Català d'Oncologia Recruiting Girona, Spain Contact: Joaquim Bosch          Hospital 12 de octubre Recruiting Madrid, Spain Contact: Luis Paz-Ares, MD          Hospital Universitario HM Sanchinarro Recruiting Madrid, Spain Contact: Javier de Castro, MD Less <<
NCT03263208 B-cell Acute Lymphocytic Leuke... More >>mia Less << Phase 1 Phase 2 Recruiting July 2019 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Not yet recruiting Luoyang, Henan, China Contact: Haiping Yang    +86 13938820189    13938820189@163.com    Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    +86 13521186987    ph200811@163.com Less <<
NCT03450122 Malignant Neoplasms of Bone an... More >>d Articular Cartilage Malignant Neoplasms of Mesothelial and Soft Tissue Synovial Sarcoma Myxoid Liposarcoma Less << Phase 1 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       nsomaiah@mdanderson.org Less <<
NCT03756090 Breast Cancer ... More >> Breast Diseases Breast Neoplasms Less << Not Applicable Not yet recruiting November 30, 2020 -
NCT03241940 B Acute Lymphoblastic Leukemia... More >> CD19 Positive Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting August 1, 2035 United States, California ... More >> Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Christin New    650-497-8815    newc@stanford.edu    Principal Investigator: Crystal L. Mackall Less <<
NCT00295893 Breast Cancer Phase 2 Active, not recruiting January 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00328861 Metastatic Melanoma ... More >> Metastatic Kidney Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01064375 Colorectal Cancer Phase 1 Phase 2 Unknown October 2017 Sweden ... More >> Department of Oncology, Karolinska University Hospital Stockholm, Sweden, 171 76 Less <<
NCT00328861 - Completed - -
NCT03190265 Pancreatic Cancer Phase 2 Recruiting October 2019 United States, Maryland ... More >> Johns Hopkins SKCCC Recruiting Baltimore, Maryland, United States, 21231 Contact: Dung Le, MD    443-287-0002    dle@jhmi.edu Less <<
NCT01129323 Severe Aplastic Anemia Not Applicable Withdrawn(This study did not a... More >>ccrue any subjects and due to this will be closed.) Less << - -
NCT01271907 Metastatic Cutaneous Melanoma Phase 2 Terminated(Study was terminate... More >>d due to withdrawal of CRADA partner.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03233854 B Acute Lymphoblastic Leukemia... More >> CD19 Positive Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Less << Phase 1 Recruiting September 1, 2035 United States, California ... More >> Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Matthew Abramian    650-736-3351    abramian@stanford.edu    Principal Investigator: David B. Miklos Less <<
NCT00665457 Breast Cancer Phase 2 Terminated(study drug was remo... More >>ved from the market and low enrollment.) Less << - -
NCT01315132 Hematological Malignancies ... More >> Leukemia Lymphoma Multiple Myeloma Hodgkin's Disease Less << Phase 2 Active, not recruiting January 2021 United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00665457 - Terminated(study drug was remo... More >>ved from the market and low enrollment.) Less << - -
NCT00897091 - Completed - United States, Illinois ... More >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT03107988 Neuroblastoma Phase 1 Recruiting December 2020 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD    323-361-5687    amarachelian@chla.usc.edu    UCSF Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco, California, United States, 94143 Contact: Katherine K. Matthay, MD    415-476-3831    matthayK@peds.ucsf.edu    United States, Colorado Children Hospital of Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Margaret Macy, MD    720-777-8856    Margaret.macy@childrenscolorado.org    United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD    404-785-0853    kgoldsmith@emory.edu    United States, Illinois University of Chicago, Comer Children's Hospital Recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD    773-843-3943    adesai12@peds.bsd.uchicago.edu    United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD    617-632-3725    suzanne_shusterman@dfci.harvard.edu    United States, Michigan C.S Mott Children's Hospital Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Rajen Mody, MD       rmody@umich.edu    United States, North Carolina University of North Carolina Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD       patom@email.unc.edu    United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD    513-636-9866    brian.weiss@chmcc.org    United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD    215-590-0965    mosse@chop.edu    United States, Texas Cook Children's Healthcare System Recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD    682-885-4007    mgranger@cookchildrens.org    United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD    206-987-5783    navin.pinto@seattlechildrens.org    Canada, Ontario Hospital for Sick Children Not yet recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Meredith Irwin, MD    416-813-7654    meredith.irwin@sickkids.ca    France Institut Curie Not yet recruiting Paris, Cedex, France, 05 Contact: Gudrun Schleiermacher, MD    144324550    gudrun.schleiermacher@curie.fr    United Kingdom Royal Marsden Hospital Not yet recruiting Sutton, Surrey, United Kingdom, SM25NG Contact: Louis Chelser, MD    2087224204    Louis.Chesler@icr.ac.uk Less <<
NCT00203372 Breast Cancer Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 Wilshire Oncology Medical Group, Inc. Pomona, California, United States, 91767 United States, Florida Cancer Institute of Florida, P.A. Orlando, Florida, United States, 32804 United States, Georgia Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States, 30060 United States, Texas South Texas Oncology and Hematology, P.A. San Antonio, Texas, United States, 78207 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Quebec McGill University Montreal, Quebec, Canada, H2W 1S6 Ireland St. Vincent's University Hospital Dublin, Ireland, 4 St. James's Hospital Dublin, Ireland, 8 Less <<
NCT00933127 - Completed - -
NCT00544505 Breast Cancer Not Applicable Unknown September 2013 -
NCT00179816 Ewing's Sarcoma ... More >> Soft Tissue Sarcoma Hepatoblastoma Hodgkin's Disease Germ Cell Tumor Less << Phase 1 Phase 2 Unknown September 2012 United States, Illinois ... More >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Less <<
NCT00586014 Multiple Myeloma Phase 2 Completed - -
NCT03344705 Hematological Malignancies Phase 1 Recruiting December 1, 2020 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr    86-189-1157-6946    luxian@immunochina.com Less <<
NCT03631862 Newly Diagnosed Peripheral T-c... More >>ell Lymphoma Less << Phase 4 Recruiting December 31, 2019 China, Henan ... More >> Oncology Department of The First Affilliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT00934739 Oral Cavity Cancer Phase 2 Phase 3 Terminated - -
NCT01857934 Neuroblastoma Phase 2 Recruiting July 2021 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Wayne L. Furman, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Wayne L. Furman, MD Less <<
NCT03185429 Tumor Gastric ... More >> Tumor, Colorectal Less << Not Applicable Not yet recruiting June 2019 -
NCT02527317 - Completed - Ireland ... More >> Beaumont Hospital Dublin, Ireland, DUBLIN 9 Less <<
NCT00001507 Breast Neoplasm ... More >> Neoplasm Metastasis Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01026116 Breast Neoplasms Phase 3 Unknown - China ... More >> Department of Breast Surgery, Cancer Hospital, Fudan University Not yet recruiting Shanghai, China, 200032 Contact: Wenjin Yin    86(21)64175590 ext 8700    followroad@yahoo.com.cn    Principal Investigator: Zhimin Shao          Department of Breast Surgery, Cancer Hospital, Fudan University Recruiting Shanghai, China, 200032 Contact: Zhimin Shao    86(21)64175590 ext 8807    zhimingshao1962@yahoo.com.cn    Contact: Wenjin Yin    86(21)64175590 ext 8700    followroad@yahoo.com.cn    Principal Investigator: Zhimin Shao Less <<
NCT01182415 Non-Hodgkin's Lymphoma ... More >> CNS Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03602612 Myeloma-Multiple ... More >> Myeloma, Plasma-Cell Less << Phase 1 Recruiting January 1, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01236573 Skin Cancer M... More >>etastatic Melanoma Less << Phase 1 Phase 2 Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01182415 - Completed - -
NCT02778763 Breast Cancer Phase 2 Completed - -
NCT01236573 - Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - -
NCT01891578 - Unknown December 2013 Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT01868269 Opsoclonus Myoclonus Syndrome ... More >> Neuroblastoma Less << Phase 3 Recruiting April 2031 Austria ... More >> St. Anna Kinderkrebsforschung e.V. CHILDREN'S CANCER RESEARCH INSTITUTE Recruiting Wien, Austria, 1090 Principal Investigator: Ruth LADENSTEIN, Dr.          France Chu de Bicetre Recruiting Le Kremlin-Bicêtre, LE Kremlin Bicetre, France, 94275 Contact: DEIVA Kumaran, dr          Principal Investigator: DEIVA Kumaran, DR          Centre Oscar Lambret Recruiting Lille, Lille Cedex, France, 59020 Contact: DESFACHELLES THOMASSIN Anne-Sophie, DR          Principal Investigator: DESFACHELLES THOMASSIN Anne-Sophie, DR          Centre Leon Berard Recruiting Lyon, LYON Cedex 08, France, 69373 Contact: FAURE CONTER Cécile, DR          Principal Investigator: FAURE CONTER Cécile, DR          Hopita D'Enfants de La Timone Recruiting Marseille, Marseille Cedex 5, France, 13385 Contact: COZE CAROLE, DR          Principal Investigator: COZE Carole, DR          Hopital Arnaud de Villeneuve Not yet recruiting Montpellier, Montpellier Cedex 4, France, 34295 Contact: HAOUY Stéphanie, DR          Principal Investigator: HAOUY Stéphanie, DR          Chr de Nantes Recruiting Nantes, Nantes Cedex01, France, 44093 Contact: THEBAUD Estelle, DR          Principal Investigator: THEBAUD Estelle, DR          Chu de Nice Archet 2 Recruiting Nice, NICE Cedex 03, France, 06202 Contact: BENADIBA Joy, dr          Principal Investigator: BENADIBA Joy, DR          Ch Trousseau Recruiting Paris, Paris Cedex 12, France, 75571 Contact: PETIT Arnaud, dr          Principal Investigator: PETIT Arnaud, dr          Chu Hopital Sud Not yet recruiting Rennes, Rennes Cedex 02, France, 35056 Contact: TAQUE Sophie, dr          Principal Investigator: TAQUE Sophie, dr          Chu de Rouen Not yet recruiting Rouen, Rouen Cedex, France, 76031 Contact: SCHNEIDER Pascale, DR          Principal Investigator: SCHNEIDER Pascale, DR          CHU DE STRASBOURG HOPITAL Hautepierre Not yet recruiting Strasbourg, Strasbourg Cedex, France, 67098 Contact: Natacha ENTZ-WERLE, MD          Principal Investigator: Natacha ENTZ-WERLE, MD          Chu Toulouse Hopital Des Enfants Recruiting Toulouse, Toulouse Cedex 9, France, 31059 Contact: Marion GAMBART, dr          Principal Investigator: Marion GAMBART, dr          Chu Amiens Not yet recruiting Amiens, France, 80054 Contact: DEVOLDERE Catherine, DR          Principal Investigator: DEVOLDERE Catherine, DR          Chu Angers Not yet recruiting Angers, France, 49933 Contact: PELLIER Isabelle, DR          Principal Investigator: PELLIER Isabelle, DR          Hopital Jean Minjoz Not yet recruiting Besancon, France, 25030 Contact: KLEIN Stéphane, DR          Principal Investigator: KLEIN Stéphane, DR          Chr Pellegrin Recruiting Bordeaux, France, 33076 Contact: BOUYN-ICHER Céline, DR          Principal Investigator: BOUYN-ICHER Céline, DR          CHU CAEN Not yet recruiting Caen, France, 14033 Contact: MINCKES ODILE, DR          Principal Investigator: MINCKES Odile, DR          Chu D'Estaing Not yet recruiting Clermont Ferrand, France, 63003 Contact: KANOLD Justina, DR          Principal Investigator: KANOLD Justina, DR          Chu Dijon Recruiting Dijon, France, 21079 Contact: DESPLANTES Claire, DR          Principal Investigator: DESPLANTES Claire, DR          Chu de Grenoble Recruiting Grenoble, France, 38045 Contact: PLANTAZ Dominique, DR          Principal Investigator: PLANTAZ Dominique, DR          Chu de Limoges Recruiting Limoges, France, 87042 Contact: PIGUET Christophe, DR          Principal Investigator: PIGUET Christophe, DR          Institut Curie Recruiting Paris, France, 75005 Contact: Schleiermacher Gudrun, dr          Principal Investigator: Schleiermacher Gudrun, dr          Chu de Poitiers Not yet recruiting Poitiers, France, 86021 Contact: MILLOT Frédéric, DR          Principal Investigator: MILLOT Frédéric, dr          Chu de Reims Not yet recruiting Reims, France, 51092 Contact: PLUCHART Claire, DR          Principal Investigator: PLUCHART Claire, dr          CHU LA REUNION Site Félix Guyon Recruiting Saint-denis, France, 97400 Principal Investigator: Yves REGUERRE, MD          Chu Saint Etienne Not yet recruiting Saint-Étienne, France, 42055 Contact: STEPHAN Jean-Louis, DR          Principal Investigator: STEPHAN Jean-Louis, dr          Chu Tours Hopital Clocheville Not yet recruiting Tours, France, 37044 Contact: BLOUIN Pascale, dr          Principal Investigator: BLOUIN Pascale, dr          Hopital Nancy Brabois Recruiting Vandoeuvre Les Nancy, France, 54500 Contact: CHASTAGNER PASCAL, DR          Principal Investigator: CHASTAGNER Pascal, DR          Institut de Cancerologie Gustave Roussy Recruiting Villejuif, France, 94805 Contact: VALTEAU COUANNET Dominique, dr          Principal Investigator: VALTEAU COUANNET Dominique, DR          Italy G. Gaslini Institut Recruiting Genova, Italy, 16148 Contact: DE GRANDIS ELISA, DR          Principal Investigator: DE GRANDIS Elisa, dr          Spain The Fundación para la Formación e Investigación Sanitarias de la Región de Murcia Recruiting El Palmar, Spain, 30120 Principal Investigator: Mar Bermúdez Cortés, Dr.          Sweden University Hospital Lund Recruiting Lund, Sweden, 22185 Contact: ORA Ingrid, dr          Principal Investigator: ORA Ingrid, dr          Switzerland Universitätskinderklinik Recruiting Bern, Switzerland, CH 3010 Principal Investigator: Maja STEINLIN, DR          Kinderspital Zurich Recruiting Zurich, Switzerland, 8032 Principal Investigator: Andrea KLEIN          United Kingdom John Radcliffe Hospital Recruiting Oxford, United Kingdom, 0X3 9DU Contact: PIKE Michael, dr          Principal Investigator: PIKE Michael, dr Less <<
NCT00876616 Lupus Nephritis Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology,Jinling Hospital Nanjing, Jiangsu, China, 210002 Less <<
NCT03054298 Lung Adenocarcinoma ... More >> Ovarian Cancer Peritoneal Carcinoma Fallopian Tube Cancer Mesotheliomas Pleural Mesothelioma Peritoneum Less << Phase 1 Active, not recruiting March 2021 United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01139359 Lymphoma Phase 1 Withdrawn(Study enrollment was... More >> withdrawn as it is no longer the sponsor's intention to study this indication under this protocol.) Less << June 2011 -
NCT03170141 Glioblastoma Multiforme of Bra... More >>in Glioblastoma Multiforme Less << Phase 1 Enrolling by invitation December 2020 China, Guangdong ... More >> Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China, 518000 Less <<
NCT00028730 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02917083 Hodgkin's Lymphoma ... More >> Non-Hodgkin Lymphoma Less << Phase 1 Recruiting February 2035 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Munu Bilgi, MS    832-824-1518    mxbilgi@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Munu Bilgi, MS    832-824-1518    mxbilgi@txch.org Less <<
NCT00636155 Lymphoma, Small Lymphocytic ... More >> Leukemia, Lymphocytic, Chronic Less << Phase 2 Terminated(funding) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00849745 Systemic Lupus Erythematosus ... More >> Systemic Sclerosis Less << Phase 1 Terminated(low accrual) - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27705 Less <<
NCT02641314 Neuroblastoma Recurrent Phase 2 Recruiting March 2021 Germany ... More >> University of Cologne; Dept. Ped. Oncology Recruiting Cologne, Germany, 50924 Contact: Frank Berthold, Prof.    00492214786853 ext 6853    frank.berthold@uk-koeln.de    Contact: Barbara Hero, Dr.    00492214786853 ext 6853    barbara.hero@uk-koeln.de Less <<
NCT02844309 Waldenstr?m Macroglobulinemia Phase 4 Recruiting May 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT02359162 Lymphoma, Extranodal NK-T-Cell Phase 3 Terminated(The study is out of... More >> date) Less << - China, Guangdong ... More >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 Less <<
NCT03719105 NK-Cell Lymphoma ... More >> NK-Cell Leukemia Peripheral T Cell Lymphoma Less << Early Phase 1 Not yet recruiting December 31, 2023 -
NCT01532635 - Terminated(Slow accrual) - -
NCT00003114 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00636155 - Terminated(funding) - -
NCT02533700 Peripheral T-Cell Lymphoma ... More >> Angioimmunoblastic T Cell Lymphoma ALK-negative Anaplastic Large Cell Lymphoma Enteropathy Associated T Cell Lymphoma Subcutaneous Panniculitis Like T Cell Lymphoma Acute Adult T-Cell Leukemia/Lymphoma Less << Phase 4 Unknown December 2017 China, Shandong ... More >> Shandong Provincial Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xin Wang, MD, PHD    86-531-13156012606    xinw@sdu.edu.cn    Contact: Yujie Jiang, MD    86-531-13370506886    yujiejiang05@126.com Less <<
NCT02932956 Solid Tumors Phase 1 Not yet recruiting February 2037 United States, Texas ... More >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras A Heczey, M.D.       axheczey@txch.org Less <<
NCT01532635 Hematologic Malignancy ... More >> Leukemia Acute Lymphoblastic Leukemia ALL Acute Myelogenous Leukemia AML Chronic Lymphocytic Leukemia CLL Lymphoma Hodgkin's Lymphoma Non-hodgkin's Lymphoma Myeloma Less << Phase 2 Terminated(Slow accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00182793 Breast Cancer Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT01458730 Central Nervous System Lymphom... More >>a Less << Phase 2 Active, not recruiting October 2020 Denmark ... More >> Elisa Jacobsen Pulczynski Aarhus, Denmark, DK-8000 Less <<
NCT01959477 Adult Grade III Lymphomatoid G... More >>ranulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Hodgkin Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage IA Mycosis Fungoides/Sezary Syndrome Stage IB Mycosis Fungoides/Sezary Syndrome Stage II Adult Hodgkin Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Hodgkin Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage IIA Mycosis Fungoides/Sezary Syndrome Stage IIB Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IIIA Mycosis Fungoides/Sezary Syndrome Stage IIIB Mycosis Fungoides/Sezary Syndrome Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IVA Mycosis Fungoides/Sezary Syndrome Stage IVB Mycosis Fungoides/Sezary Syndrome T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Early Phase 1 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01036087 Breast Cancer Phase 2 Active, not recruiting November 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00182793 - Completed - -
NCT00832338 - Terminated(Funding withdrawn) - -
NCT00832338 Breast Neoplasms ... More >> Breast Cancer Cancer of the Breast Less << Phase 2 Terminated(Funding withdrawn) - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Midtown Atlanta, Georgia, United States, 30308 Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02842099 Breast Cancer Phase 2 Recruiting - China, Beijing ... More >> Dept. Breast Surgery, PUMCH Recruiting Beijing, Beijing, China, 100730 Contact: Yan Lin, Doctor    +86-10-69152700    birds90@163.com Less <<
NCT00002772 Breast Cancer Phase 3 Terminated(poor accrual) - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00157196 Carcinoma, Non-Small-Cell Lung... More >> Lung Neoplasms Less << Phase 2 Completed - -
NCT03329378 Locally Advanced Breast Cancer Phase 2 Not yet recruiting October 16, 2019 United States, New York ... More >> Mount Sinai Beth Israel Not yet recruiting New York, New York, United States, 10011 Contact: Damien Francois    212-604-6021    damien.francois@mssm.edu    Contact: Tiffany Xing    212-604-6021    tiffany.xing@mountsinai.org    Principal Investigator: Paula Klein, MD          Mount Sinai West Not yet recruiting New York, New York, United States, 10019 Contact: Tahkir Mirzoyev, MD    212-523-7289    takhir.mirzoyev@mountsinai.org    Principal Investigator: Anupama Goel, MD          Icahn School of Medicine at Mount Sinai Not yet recruiting New York, New York, United States, 10029 Contact: Neha Kumarley    212-824-7659    neha.kumarley@mssm.edu    Contact: Jalwa Afroz    212-824-7320    jalwa.afroz@mssm.edu    Principal Investigator: Aarti Bhardwaj, MD Less <<
NCT03697824 Neoplasms Phase 2 Not yet recruiting July 17, 2022 -
NCT01385891 Acute Leukemia Phase 2 Phase 3 Completed - Italy ... More >> G.Gaslini Children's Hospital Genova, Italy, 16147 Less <<
NCT03533101 Cytokine Release Syndrome ... More >> Stem Cell Transplant Complications Less << Phase 1 Phase 2 Recruiting June 15, 2019 Mexico ... More >> Hospital Universitario Dr. Jose E Gonzalez UANL Recruiting Monterrey, Nuevo Leon, Mexico, 64460 Contact: César H Gutiérrez-Aguirre, MD    52 8183488510    hematohu@yahoo.com    Contact: Oscar O Márquez-Pinedo, MD    52 8115273932    omp0287@hotmail.com    Principal Investigator: David Gomez-Almaguer, MD Less <<
NCT00157196 - Completed - -
NCT01642771 Breast Cancer Phase 3 Active, not recruiting May 2020 -
NCT03196414 Multiple Myeloma Phase 1 Phase 2 Recruiting December 2026 China, Jiangsu ... More >> First Affiliated Hospital, Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Ling zhi Yan, Phd    13584821140    yanlingzhi@suda.edu.cn Less <<
NCT03514836 Castration-resistant Prostate ... More >>Cancer Less << Phase 1 Phase 2 Recruiting April 2021 Czechia ... More >> Fakultní nemocnice v Motole Recruiting Praha, Czechia, 150 06 Less <<
NCT01171378 Richter's Syndrome Phase 2 Completed - United Kingdom ... More >> Queen Elizabeth Hospital Birmingham Birmingham, United Kingdom, B15 2TT Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ St James University Hospital Leeds, United Kingdom, LS9 7TF Royal Liverpool University Hospital Liverpool, United Kingdom, L7 8XP St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Kings College Hospital London, United Kingdom, SE5 9RS Christie Hospital Manchester, United Kingdom, M20 4BX Churchill Hospital Oxford, United Kingdom, OX3 7LJ Less <<
NCT00750971 Systemic Lupus Erythematosus Phase 2 Recruiting August 2020 Germany ... More >> Universitätsmedizin Charité Recruiting Berlin, Germany, 10117 Contact: Falk Hiepe, Prof    +49 30 450 513026       Principal Investigator: Falk Hiepe, Prof.          Universitätsklinik Düsseldorf Recruiting Düsseldorf, Germany, 40225 Contact: Mathias Schneider, Prof.    +49 (0) 211-8117817       Principal Investigator: Mathias Schneider, Prof.          Universitätsklinikum Essen Recruiting Essen, Germany, 45239 Essen Contact: Christoph Specker, Prof.    +49 (0)201-84081214       Principal Investigator: Christoph Specker, Prof.          Universitätsklinik Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Hanns-Marting Lorenz, Prof.    +49 (0) 6221-568044       Principal Investigator: Hanns-Martin Lorenz, Prof.          Universitätsklinik Köln Recruiting Köln, Germany, 50937 Contact: Andrea Rubbert-Roth, PD    +49 (0) 221-4783993       Principal Investigator: Andrea Rubbert-Roth, PD          Universitäsklinik Mainz Recruiting Mainz, Germany, 55101 Contact: Karin Kolbe, MD          Principal Investigator: Karin Kolbe, MD          Universitätsklinik Tübingen Recruiting Tübingen, Germany, 72026 Contact: Ina Kötter, PD    +49 (0) 7071-2984095       Principal Investigator: Ina Kötter, PD          Universitätsklinik Würzburg Recruiting Würzburg, Germany, 97070 Contact: Hans-Peter Tony, Prof.    +49 (0) 931-20170420       Principal Investigator: Hans-Peter Tony, Prof. Less <<
NCT00847444 Breast Cancer Phase 3 Unknown September 2016 Germany ... More >> Frauenklinik der Heinrich Heine Universität Düsseldorf, Germany, 40225 Less <<
NCT02889523 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 1 Phase 2 Suspended(Waiting for more inf... More >>ormation regarding a lymphoblastic T lymphoma in one patient receiving tazemetostat in another study) Less << May 2023 France ... More >> CHRU Lille - Hôpital Claude Huriez Lille Cedex, France, 59037 CHU de Nantes - Hôtel Dieu Nantes, France, 44093 CHU Lyon Sud Pierre-Bénite Cedex, France, 69495 Centre Henri Becquerel Rouen, France, 76000 Institut Gustave Roussy Villejuif, France, 94085 Less <<
NCT03617328 Melanoma Phase 1 Phase 2 Recruiting March 8, 2021 United States, Virginia ... More >> University of Virgini Recruiting Charlottesville, Virginia, United States, 22908 Less <<
NCT03676504 Acute Lymphoblastic Leukemia, ... More >>Adult Acute Lymphoblastic Leukemia, Pediatric Chronic Lymphocytic Leukemia Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Less << Phase 1 Phase 2 Recruiting October 1, 2020 Germany ... More >> University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt    +49-6221-566614    michael.schmitt@med.uni-heidelberg.de    University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt    +49-6221-566614    michael.schmitt@med.uni-heidelberg.de    Principal Investigator: Prof. Dr. Michael Schmitt          Principal Investigator: Prof. Dr. Andreas Kulozik Less <<
NCT00121199 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Less << Phase 2 Completed - United States, Oregon ... More >> SWOG Portland, Oregon, United States, 97239 Less <<
NCT03294954 Neuroblastoma Phase 1 Recruiting August 10, 2034 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD    832-824-4233    axheczey@txch.org Less <<
NCT01661400 Glioma Neuroe... More >>ctodermal Tumors, Primitive Wilms Tumor Rhabdomyosarcoma Sarcoma, Ewing Osteosarcoma Retinoblastoma Less << Early Phase 1 Recruiting February 2022 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Andrew Cluster, M.D.    314-454-6018    acluster@wustl.edu    Sub-Investigator: Robert Hayashi, M.D.          Sub-Investigator: Shalini Shenoy, M.D.          Sub-Investigator: Jeffrey Bednarski, M.D.          Sub-Investigator: Monica Hente, ARNP          Sub-Investigator: Geetika Khanna, M.D.          Sub-Investigator: Joshua Shimony, Ph.D.          Principal Investigator: Andrew Cluster, M.D Less <<
NCT01314833 Breast Cancer Phase 3 Unknown December 2018 China, Shanghai ... More >> Feifei Shanghai, Shanghai, China Less <<
NCT00052936 Lymphoma Phase 3 Unknown - -
NCT00121199 - Completed - -
NCT00878254 Mantle-Cell Lymphoma Phase 2 Recruiting December 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33186 Contact: Izidore S. Lossos, MD    305-243-4785    ilossos@med.miami.edu    Principal Investigator: Izidore S Lossos, MD Less <<
NCT03705429 Breast Neoplasms Phase 3 Not yet recruiting December 2020 -
NCT01839097 Peripheral T-cell Lymphoma Phase 1 Completed - United States, Connecticut ... More >> Yale University New Haven, Connecticut, United States, 06511 United States, Georgia Northeast Georgia Cancer Care, LLC Athens, Georgia, United States, 30607 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Hematology - Oncology Associates of Northern NJ P.A Morristown, New Jersey, United States, 07962 United States, New York Columbia University Medical Center/Center for Lymphiod Malignancies New York, New York, United States, 10019 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00887536 Breast Cancer Phase 3 Active, not recruiting January 2022 -
NCT02636322 Lymphoma Phase 2 Recruiting March 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01451489 FSGS Not Applicable Terminated(The recruitment of ... More >>subject is very difficult) Less << - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT00860548 - Completed - United States, Texas ... More >> University of Texas, Houston Medical School Houston, Texas, United States, 77030 Less <<
NCT03502577 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Recruiting July 30, 2034 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Andrew J. Cowan Less <<
NCT01653717 Advanced Cancers ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01762202 B-cell Lymphoid Leukemia ... More >> Young Patients Less << Phase 2 Active, not recruiting December 2018 Italy ... More >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti Asti, Italy ASL12 - Biella Ospedale degli Infermi - Dip. di Medicina e Geriatria - Struttura Complessa di Medicina Interna Biella, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy RCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Padiglione Cesalpino - I piano - Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Policlinico Umberto I, Hematology Department - Sapienza Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Siena, Italy SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Div. di Ematologia Ospedale "S.Giovanni Battista" Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Less <<
NCT02280525 Leukemia Phase 1 Active, not recruiting March 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00578435 Genetic Disorders ... More >> Sickle Cell Anemia Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00002481 Lymphoma Phase 2 Unknown - United States, Wisconsin ... More >> St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT02310997 Leukaemia Lym... More >>phoma Other Haematological Diseases Less << Phase 2 Terminated(Trial closed early ... More >>due to poor recruitment) Less << - United Kingdom ... More >> University College London Hospital London, Greater London, United Kingdom, W1T 4TJ University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ St James' University Hospital Leeds, United Kingdom, LS9 7TF St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children London, United Kingdom, WC1N 3JH Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham City Hospital Nottingham, United Kingdom, NG5 1PB Royal Hallamshire Hospital Sheffield, United Kingdom, S10 2JF Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Less <<
NCT01897441 Stage IIA Breast Cancer ... More >> Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less << Not Applicable Recruiting June 2019 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Joseph A. Sparano    718-405-8404    jsparano@montefiore.org    Principal Investigator: Joseph A. Sparano Less <<
NCT01962636 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphocytic Leukemia (ALL) Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelofibrosis Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large B Cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma Less << Not Applicable Recruiting October 2023 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD    612-625-3918    bruns072@umn.edu    Principal Investigator: Claudio Brunstein, MD Less <<
NCT00075387 Glioma Phase 2 Recruiting April 30, 2021 United States, Minnesota ... More >> University of Minnesota/Masonic Cancer Center Active, not recruiting Minneapolis, Minnesota, United States, 55455 United States, Ohio Cleveland Clinic Foundation Active, not recruiting Cleveland, Ohio, United States, 44195 United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Edward A. Neuwelt    503-494-5626    neuwelte@ohsu.edu    Principal Investigator: Edward A. Neuwelt Less <<
NCT03121001 Sickle Cell Disease Phase 2 Recruiting October 28, 2026 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD    312-413-3547    drond@uic.edu Less <<
NCT00645606 Leukemia Phase 3 Completed - France ... More >> French Innovative leukemia Organization TOURS Cedex, France, 37044 Less <<
NCT01341301 - Completed - -
NCT02379195 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting January 2020 Denmark ... More >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT00796562 MDS Leukemias... More >> Lymphomas Less << Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT02328950 - Unknown December 2017 China, Fujian ... More >> Union Hospital,Fujian Medical University Recruiting Fuzhou, Fujian, China, 350001 Contact: Ting Yang, Prof.    +86-591-83357896 ext 8041    yang.hopeting@gmail.com    Contact: Jianda Hu, Prof.    +86-591-83357896 ext 8041    jdhu@medmail.com.cn    Principal Investigator: Jianda Hu, Dr.          Sub-Investigator: Ting Yang, Dr. Less <<
NCT02678143 Sickle Cell Disease Phase 1 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mark A Schroeder, M.D.    314-454-8304    markschroeder@wustl.edu    Principal Investigator: Mark A Schroeder, M.D.          Sub-Investigator: Bader Alahmari, M.D.          Sub-Investigator: Morey Blinder, M.D.          Sub-Investigator: Allison King, M.D. Less <<
NCT02324088 Inflammatory Breast Cancer Phase 3 Completed - -
NCT01341301 Hematologic Malignancy Phase 2 Completed - United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02581007 Chronic Myelogenous Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myelofibrosis CMML Multiple Myeloma Less << Phase 2 Active, not recruiting October 2019 United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT00634179 - Completed - -
NCT00326417 Anemia, Aplastic Phase 1 Phase 2 Completed - -
NCT00787722 Devic's Disease Phase 1 Phase 2 Active, not recruiting January 2019 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00005024 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 3 Unknown - -
NCT00634179 Lymphoma, B-Cell ... More >> Follicular Lymphoma Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00931229 Non-Hodgkin's Lymphoma Not Applicable Unknown December 2017 Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT01067989 Chemotherapy ... More >>Breast Cancer, Metastatic Less << Phase 2 Terminated(No satisfactory acr... More >>ual) Less << - Israel ... More >> Oncology unit Afula, Israel, 18101 Less <<
NCT00001630 Autoimmune Disease ... More >> Autoimmune Hemolytic Anemia Thrombocytopenia Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00326417 - Completed - -
NCT01943188 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Terminated - United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 Less <<
NCT00049504 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03689465 Hematopoietic Stem Cell Transp... More >>lantation Less << Phase 4 Recruiting December 31, 2020 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin, MD    +86-020-61641613    lansinglinren@hotmail.com    Principal Investigator: Qifa Liu          Guangzhou First People's Hospital Not yet recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang          Sub-Investigator: Shunqing Wang          Sun Yat-sen Memorial Hospital, Sun Yat-sen University Not yet recruiting Guangzhou, Guangdong, China Contact: Danian Nie          Sub-Investigator: Danian Nie          The Third Affiliated Hospital, Sun Yat-Sen University Not yet recruiting Guangzhou, Guangdong, China Contact: Dongjun Lin          Sub-Investigator: Dongjun Lin          China, Hunan Xiangya Hospital, Central South University Not yet recruiting Changsha, Hunan, China Contact: Yajing Xu          Sub-Investigator: Yajing Xu          Chenzhou First People's Hospital Not yet recruiting Chenzhou, Hunan, China Contact: Xinquan Liang          Sub-Investigator: Xinquan Liang          China Peking University People's Hospital Not yet recruiting Beijing, China Contact: Wang Yu          Sub-Investigator: Xiaojun Huang Less <<
NCT00525759 Breast Cancer Phase 2 Completed - United Kingdom ... More >> Sheffield Teaching Hospitals NHS Foundation Trust / Weston Park Hospital Sheffield, South Yorkshire, United Kingdom, S10 2SJ Less <<
NCT00016276 Cardiac Toxicity ... More >> Inflammatory Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IV Breast Cancer Less << Phase 3 Terminated(Administratively co... More >>mplete.) Less << - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00049504 - Completed - -
NCT01370694 Follicular Lymphoma Phase 1 Terminated(The study was termi... More >>nated for business reasons.) Less << - -
NCT02876302 Inflammatory Breast Cancer (IB... More >>C) Less << Phase 2 Recruiting February 2024 United States, Maryland ... More >> Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Vered Stearns, MD       vstearn1@jhmi.edu    Johns Hopkins at Green Spring Station Recruiting Lutherville, Maryland, United States, 21093 Contact: Vered Stearns, MD       Vstearn1@jhmi.edu    United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Beth Overmoyer, MD, FACP    617-632-4056    bovermoyer@partners.org    Principal Investigator: Beth Overmoyer, MD, FACP          United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Catherine Van Poznak, MD       cvanpoz@med.umich.edu    United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tufia Haddad, MD       Haddad.Tufia@mayo.edu    United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Contact: Jeremy Force, MD       Jeremy.force@duke.edu    United States, Pennsylvania University of Pennslyvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Amy Clark, MD       Clarkamy@mail.upenn.edu    United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naoto Ueno, MD       Nueno@mdanderson.org Less <<
NCT01370694 - Terminated(The study was termi... More >>nated for business reasons.) Less << - -
NCT03635632 Relapsed Neuroblastoma ... More >> Refractory Neuroblastoma Less << Phase 1 Not yet recruiting December 2037 United States, Texas ... More >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Bilal Omer, MD    832-824-6855    bomer@bcm.edu    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org Less <<
NCT01679041 Multiple Sclerosis Phase 2 Terminated(Insufficient accrua... More >>ls; PI leaving site) Less << - United States, Texas ... More >> Amarillo Diagnostic Clinic Amarillo, Texas, United States, 79106 Dr Ruby Saulog Amarillo, Texas, United States, 79106 Texas Oncology Amarillo, Texas, United States, 79106 Less <<
NCT01430390 Acute Lymphocytic Leukemia ... More >> Lymphoma Less << Phase 1 Recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center 1275 York Avenue Recruiting New York, New York, United States, 10065 Contact: Kevin Curran, MD    212-639-5836       Contact: Nancy Kernan, MD    212-639-7250       Principal Investigator: Kevin Curran, MD Less <<
NCT02774291 HLA-A2 Positive Cells Present ... More >> Metastatic Malignant Neoplasm Metastatic Malignant Neoplasm in the Brain Less << Not Applicable Recruiting February 2020 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Ira Braunschweig    718-920-4826    aecc@aecom.yu.edu    Principal Investigator: Ira Braunschweig Less <<
NCT01690325 Breast Cancer Phase 2 Terminated(Therapy of HER2+ pa... More >>tients according to protocol was no longer appropriate. Patient enrolment behind planned schedule and challenges of site performance) Less << - Germany ... More >> Breast Centre, University of Munich, LMU Munich, Bavaria, Germany, 81377 Less <<
NCT03774654 Refractory B-Cell Non-Hodgkin ... More >>Lymphoma Refractory B-Cell Small Lymphocytic Lymphoma Relapsed Adult ALL Relapsed CLL Relapsed Non Hodgkin Lymphoma Less << Phase 1 Not yet recruiting March 2034 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu    Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu Less <<
NCT01448096 Large B Cell Diffuse Lymphoma Phase 2 Active, not recruiting August 2019 Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Less <<
NCT02385955 Hematologic Malignancy Phase 2 Not yet recruiting April 2019 -
NCT02166463 Ann Arbor Stage IIB Hodgkin Ly... More >>mphoma Ann Arbor Stage IIIB Hodgkin Lymphoma Ann Arbor Stage IV Hodgkin Lymphoma Ann Arbor Stage IVA Hodgkin Lymphoma Ann Arbor Stage IVB Hodgkin Lymphoma Childhood Hodgkin Lymphoma Classic Hodgkin Lymphoma Less << Phase 3 Recruiting - -
NCT03549442 Multiple Myeloma Phase 1 Recruiting May 2021 United States, Pennsylvania ... More >> Univ. of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Alfred Garfall, MD Less <<
NCT01032681 Non-Hodgkin Lymphoma Phase 1 Completed - Germany ... More >> Universitäts-Klinikum Mainz III.Medizinische Klinik Mainz, Germany Medizinische Klinik Universitätsklinikum Mannheim Medizinische Fakultät Mannheim Mannheim, Germany Switzerland Istituto Oncologico della Svizzera Italiana Ospedale Regionale Bellinzona e Valli (IOSI) Bellinzona, Switzerland University of Lausanne Hospitals (CHUV) and Hospitals of Riveria-Chablais Lausanne, Switzerland Kantonsspital St. Gallen St.Gallen, Switzerland Less <<
NCT02623582 Relapsed or Refractory Acute M... More >>yeloid Leukemia Less << Early Phase 1 Terminated(This study was term... More >>inated due to lack of funding.) Less << - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03575234 Human Papillomavirus Positive ... More >>Oropharyngeal Squamous Cell Carcinoma Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Less << Phase 1 Phase 2 Not yet recruiting January 31, 2025 United States, Georgia ... More >> Emory University Hospital Midtown Not yet recruiting Atlanta, Georgia, United States, 30308 Contact: Swathi Chinaranagari    404-686-0239    swathi.chinaranagari@emory.edu    Emory University Hospital/Winship Cancer Institute Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Shantina Walls    404-778-4995    shantina.n.walls@emory.edu Less <<
NCT02406092 Non-Hodgkin Lymphoma Phase 3 Active, not recruiting July 16, 2019 Algeria ... More >> Hôpital Dorban CHU Annaba, Service d'Hématologie Annaba, Algeria, 23000 EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria, 09000 EHU Oran, Service d'Hématologie et de Thérapie Cellulaire Oran, Algeria, 31000 Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria, 15000 Morocco CHU 20 Aout Service D'Onco-Hematologie Pediatrique Casablanca, Morocco, 20100 Clinique AlMadina; Service hematologie Casablanca, Morocco, 20340 Centre Hospitalier Uni Ire de Marrakech; Oncologie-Hématologie Marrakech, Morocco, 40000 CHU Ibn Sina Rabat Service de medecine interne Rabat, Morocco, 10090 Tunisia CHU Fattouma Bourguiba, Monastir; Service d'hématologie Monastir, Tunisia, 5000 CHU Hédi Chacker; Service d'hématologie Sfax, Tunisia, 3025 CHU Farhat Hached; Service d'hématologie Sousse, Tunisia, 4000 Aziza Othmana Hospital; Clinical Haematology Tunis, Tunisia, 1008 Hopital Militaire d'instruction de Tunis; Service d'hématologie Tunis, Tunisia, 1008 Less <<
NCT00005581 Breast Cancer Phase 3 Unknown - Italy ... More >> Ospedale San Lazzaro Alba, Italy, 12051 Ospedale Civile di Asti Asti, Italy, 14100 Ospedale Oncologico A. Businco Cagliari, Italy, 09124 Santo Spirito Hospital Casale Monferato, Italy, 1-15033 Ospedale Santa Croce Cuneo, Italy, 12100 Ospedale Galliera Oncologia Genoa, Italy, 16128 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Ospendale S. Andrea EST La Spezia, Italy, 19100 Ospedale Civile di Livorno Livorno, Italy, 57121 Carlo Poma Hospital Mantova, Italy, 46100 Azienda USSL NO 8 Merate, Italy, 22055 Instituto Scientifico H.S. Raffaele Milan, Italy, 20132 Ospedale Santa Croce Moncalieri, Italy, 10024 I.R.C.C.S. Policlinico San Matteo Pavia, Italy, 27100 Ospedale St. Santa Chiara Pisa, Italy, 56100 USL NO 1 San Remo, Italy, 18038 Azienda U.S.L. 1 - Sassari Sassari, Italy, 07100 Ospedale S. Paolo Savona, Italy, 17100 Osp. Civile USL 18 Sestri Lev., Italy, 16039 Ospedale Sant Anna Torino, Italy, 10100 Ospedale Evangelico Valdese Torino, Italy, 10125 OIRM - Sant Anna Torino, Italy, 10126 Ospedale Mauriziano Umberto I Torino, Italy, 10128 Ospedale Maggiore dell' Universita Trieste, Italy, 34100 Ospedale Molinette Turin, Italy, 10126 Less <<
NCT01606878 Recurrent Childhood Anaplastic... More >> Large Cell Lymphoma Recurrent Neuroblastoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Active, not recruiting - -
NCT02562365 Ovarian Cancer Phase 2 Recruiting November 2023 China, Shanghai ... More >> Wu Xiaohua Recruiting Shanghai, Shanghai, China, 200023 Contact: zhong zheng, MD&PHD    862164175590 ext 66073    alizheng@126.com Less <<
NCT03386617 Breast Cancer Phase 2 Recruiting December 31, 2019 Hong Kong ... More >> Department of Clinical Oncology, Prince of Wales Hospital Recruiting Hong Kong, Hong Kong Contact: Winnie Yeo, MD, FRCP    3505 2118    winnie@clo.cuhk.edu.hk    Contact: Dong LAI, RN    3505 1138    dong@clo.cuhk.edu.hk Less <<
NCT00489281 Sickle Cell Disease Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01445821 Scleroderma, Systemic Phase 3 Recruiting September 2019 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Sub-Investigator: Sanjiv Shah, MD          Sub-Investigator: Eric Ruderman, MD          Principal Investigator: Richard Burt, MD Less <<
NCT03380039 Refractory or Relapsed Multipl... More >>e Myeloma Less << Not Applicable Recruiting September 30, 2020 China, Shanghai ... More >> Xin Hua Hospital of Shanghai Jiao Tong University of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Siguo Hao, MD    +86-021-25077600    haosghj88@hotmail.com    Principal Investigator: Siguo Hao, MD Less <<
NCT01319565 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Active, not recruiting June 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02224872 Severe Aplastic Anemia ... More >> Bone Marrow Failure Syndromes Less << Phase 2 Recruiting - United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy DeZern, MD    410-502-7208    adezern1@jhmi.edu    Contact: Clinical Trials Office- SKCCC    410-955-8804    jhcccro@jhmi.edu    Principal Investigator: Amy DeZern, MD          United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: David Margolis, MD    414-337-7066    dmargoli@mcw.edu    Contact: Monica Thakar, MD    414-955-7546    mthakar@mcw.edu Less <<
NCT03666000 Non-Hodgkin Lymphoma ... More >> B-cell Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Not yet recruiting August 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 Less <<
NCT03304756 Triple Negative Breast Cancer ... More >>Patients Less << Phase 2 Completed - -
NCT02287311 Hodgkin Disease ... More >> Non-Hodgkin Lymphoma Severe Chronic Active Epstein Barr Virus T/NK-lymphoproliferative Disease Less << Phase 1 Recruiting March 2023 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Helen E Heslop    832-824-4662    hheslop@bcm.edu    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne H Rouce, MD    832-824-4716    rouce@bcm.edu Less <<
NCT00152178 Breast Cancer Phase 3 Completed - Japan ... More >> Osaka Medical Center for Cancer and Cardiovascular Diseases 1-1-3, Nakamichi, Higashinari-ku, Osaka, Osaka, Japan Less <<
NCT02132949 - Active, not recruiting - -
NCT01421472 ER Positive, Her2 Negative Bre... More >>ast Cancer Patients Triple Negative Breast Cancer Patients Less << Phase 2 Completed - -
NCT02132949 Breast Cancer Phase 2 Active, not recruiting August 18, 2020 -
NCT02734771 Diffuse Large B-Cell Lymphoma Phase 2 Recruiting June 2021 United States, New York ... More >> James P. Wilmot Cancer Institute, University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Patrick M Reagan, MD    585-273-3258    Patrick_Reagan@urmc.rochester.edu    Contact: Yelena Lerman, PhD    585-275-8333    YLerman@urmc.rochester.edu    United States, Virginia University of Virginia Cancer Center Recruiting Charlottesville, Virginia, United States, 22908 Contact: Amelia Hodson, BSN, RN    434-297-4182    ASC5Y@virginia.edu Less <<
NCT03716856 Refractory or Relapsed Multipl... More >>e Myeloma Less << Phase 1 Recruiting August 31, 2020 China, Zhejiang ... More >> First Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310006, Contact: Jin Jie, MD    +86-0571-87236896    jiej0503@163.com    Contact: Haitao Meng, MD    +86-0571-87236896    menghait2004@163.com Less <<
NCT01421472 - Completed - -
NCT01858571 Malignant Childhood Neoplasm Phase 3 Completed - India ... More >> All India Institute of Medical Sciences New Delhi, Delhi, India, 110029 Less <<
NCT00278642 Pemphigus Phase 1 Terminated(sponsor stopped the... More >> study because of lack of elligible participants) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01507103 Rectal Cancer Phase 2 Completed - Netherlands ... More >> NKI (Nederlands Kanker Instituut) Amsterdam, Netherlands Less <<
NCT00115414 Breast Cancer ... More >> Fever Neutropenia Less << Phase 2 Completed - -
NCT01507103 - Completed - -
NCT00278616 ANTIPHOSPHOLIPID SYNDROME Phase 1 Withdrawn - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00103558 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site San Diego, California, United States United States, Maryland Research Site Baltimore, Maryland, United States United States, Ohio Research Site Columbus, Ohio, United States United States, Texas Research Site Houston, Texas, United States Less <<
NCT02588612 Neoplasms Phase 1 Active, not recruiting September 19, 2019 United States, Florida ... More >> GSK Investigational Site Tampa, Florida, United States, 33612 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Less <<
NCT03267680 Cervical Squamous Cell Carcino... More >>ma In Situ Vulvar High Grade Squamous Intraepithelial Lesion Less << Phase 2 Recruiting November 8, 2022 United States, California ... More >> USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Kristy Watkins, RN    323-865-0452    watkins_k@med.usc.edu    Contact: Grace Facio, RN    323-409-7027    GFacio@med.usc.edu    Principal Investigator: Lynda D. Roman, MD Less <<
NCT02987244 T Cell Non-Hodgkin's Lymphoma Phase 1 Phase 2 Recruiting March 2023 China, Beijing ... More >> Peking Union medical college hospital Recruiting Beijing, Beijing, China, 100730 Contact: Wei Zhang          China, Tianjin Tianjin medical universty cancer institute & hospital Recruiting Tianjin, Tianjin, China, 300060 Less <<
NCT02926053 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Recruiting December 2018 Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Recruiting Herlev, Denmark, 2730 Contact: Inge Marie, Prof., MD    +4538683868    inge.marie.svane@regionh.dk    Contact: Magnus Pedersen, MD    +4538683868    magnus.pedersen@regionh.dk Less <<
NCT02529813 Leukemia Lymp... More >>homa Less << Phase 1 Recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00004898 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT01099436 Breast Cancer Phase 3 Completed - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 RC Less <<
NCT01955460 Melanoma Phase 1 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02354690 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting August 2020 Denmark ... More >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT01493453 CD19 Positive Non-Hodgkin Lymp... More >>homa Less << Phase 1 Unknown December 2014 United Kingdom ... More >> The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 3EE Contact: Ian Emerson, BA    01619187443    ian.emerson@christie.nhs.uk    Principal Investigator: Robert E Hawkins, BA, MB BS, MCRP, Phd, FRCP          Sub-Investigator: Fiona C Thistlethwaite, MB BChir, PhD, MRCP Less <<
NCT01995344 Metastatic Melanoma Phase 2 Unknown December 2018 United Kingdom ... More >> The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M20 4BX Less <<
NCT00120198 Non-Hodgkin's Lymphoma Phase 2 Terminated(slow accrual) - United States, California ... More >> Oxnard, California, United States, 93030 United States, District of Columbia Washington, District of Columbia, United States, 20007 United States, Florida Inverness, Florida, United States, 34452 Lecanto, Florida, United States, 34461 United States, New Jersey Belleville, New Jersey, United States, 07109 Less <<
NCT01898039 Malignant Melanoma Phase 1 Phase 2 Recruiting April 2019 Israel ... More >> Sharett Institute of Oncology, Hadassah Medical Organization Recruiting Jerusalem, Israel, 91120 Contact: Hani Steinberg, RN       hanis@hadassah.org.il Less <<
NCT03118986 Vomiting in Infants and/or Chi... More >>ldren Nausea Hematopoietic System--Cancer Less << Phase 2 Recruiting April 2023 Canada, Ontario ... More >> Hospital for Sick Children Recruiting Toronto, Ontario, Canada, M5G 1X8 Contact: Lee Dupuis, PhD    416-813-7654 ext 309355    lee.dupuis@sickkids.ca Less <<
NCT01363388 Vasculitis Phase 2 Completed - -
NCT01622361 Breast Cancer Phase 3 Unknown February 2016 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Songpa-gu, Korea, Republic of, 138-736 Contact: Ahn Sei Hyun, M.D.    82-2-3010-3490    ahnsh@amc.seoul.kr    Principal Investigator: A. S. Hyun, MD.PhD Less <<
NCT02666898 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 2 Completed - France ... More >> Sponsor FILO Tours, France, 37054 Less <<
NCT02833805 Severe Aplastic Anemia ... More >> Aplastic Anemia Bone Marrow Failure Immunosuppression Less << Phase 2 Recruiting August 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy E DeZern, MD    410-502-7208    adezern1@jhmi.edu Less <<
NCT03283202 Diffuse B-Cell Lymphoma Phase 1 Phase 2 Recruiting May 28, 2022 United States, California ... More >> Ronald Reagan UCLA Medical Center Not yet recruiting Santa Monica, California, United States, 90404 United States, District of Columbia George Washington University Recruiting Washington, District of Columbia, United States, 20037 United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 United States, Missouri Washington University Recruiting Saint Louis, Missouri, United States, 63110 Belgium UZ Gent Recruiting Gent, Belgium, 9000 University Hospital Gasthuisberg Recruiting Lueven, Belgium, B-3000 Canada, Alberta Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Spain Hospital Germans Trias I Pujol Recruiting Badalona, Spain, 8916 Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 8035 Hospital de San Pedro de Alcantara Recruiting Caceres, Spain, 10003 Hospital Universitario Fundacion Jimenez Diaz Recruiting Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain, 37007 Hospital Universitario Virgen Del Rocio Recruiting Sevilla, Spain, 41013 Less <<
NCT00301652 Vasculitis An... More >>ti-Neutrophil Cytoplasmic Antibody Less << Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT00151281 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00151281 - Completed - -
NCT03049449 Lymphoma, Large-Cell, Anaplasi... More >>tc Hodgkin Disease Lymphoma, Hodgkins Enteropathy-Associated T-Cell Lymphoma Lymphoma, Extranodal NK-T-Cell Less << Phase 1 Recruiting June 30, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02793856 Metastatic Non-small Cell Lung... More >> Cancer Less << Phase 1 Active, not recruiting December 2018 China, Sichuan ... More >> West China Hospital, Sichuan University Chengdu, Sichuan, China, 610041 Less <<
NCT01706666 - Completed - -
NCT03146533 B Cell Lymphoma Phase 1 Phase 2 Recruiting October 2019 China, Guangdong ... More >> The Second People's Hospital of Shenzhen Recruiting Shenzhen, Guangdong, China Contact: geng tian    13724395569    tiangeng666@aliyun.com    Principal Investigator: geng tian Less <<
NCT02858999 Multiple Myeloma Phase 2 Completed - France ... More >> CH Pays d'Aix Aix-en-Provence, France, 13616 CHU Amiens Amiens, France, 80054 CHU Besançon Besançon, France, 25030 CHU Caen Caen, France, 14033 CHU Clermont Ferrand Clermont Ferrand, France, 63003 CHU Dijon Dijon, France, 21034 CH Dunkerque Dunkerque, France, 59385 CHRU Lille Lille, France, 59037 Hospices Civils de Lyon Lyon, France, 69229 CHU Nancy Nancy, France, 54035 CHU Nantes Nantes, France, 44093 CHU Nice Nice, France, 06003 AP-HP Paris, France, 75004 CHU Poitiers Poitiers, France, 86021 CHU Rennes Rennes, France, 35033 CHU Strasbourg Strasbourg, France, 67091 CHU Toulouse Toulouse, France, 31059 CHU Tours Tours, France, 37044 Less <<
NCT01181999 Lymphoma, Large B-cell, Diffus... More >>e Less << Phase 2 Unknown September 2014 Korea, Republic of ... More >> Chonnam National University Hwasun Hosptial Recruiting Jeollanam-do, Korea, Republic of, 519-809 Contact: Deok-Hwan Yang, M.D. and Ph.D.    82-61-3797636    drydh1685@gmail.com    Contact: So-Young Lee, Nurse    82-61-3768090    kaosin@naver.com Less <<
NCT00656669 Breast Cancer Not Applicable Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT01706666 Stage I Multiple Myeloma ... More >> Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Texas Baylor Medical Center Garland, Texas, United States, 75042 Less <<
NCT03101709 B Cell Lymphoma Phase 1 Recruiting July 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    -86-13521186987    ph200811@163.com    Contact: Yongping Song          Principal Investigator: Yongping Song, MD Less <<
NCT02924753 B-cell Acute Lymphoblastic Leu... More >>kemia Less << Phase 1 Recruiting December 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song       ph200811@163.com Less <<
NCT03322735 Multiple Myeloma Phase 1 Phase 2 Recruiting December 2019 China, Henan ... More >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    +86-13521186987    ph200811@163.com    Principal Investigator: Yongping Song Less <<
NCT02897050 Breast Cancer Phase 2 Recruiting September 2023 China, Guangdong ... More >> Sun Yat-sen Memorial Hospital Recruiting Guangzhou, Guangdong, China, 510120 Contact: Erwei Song       songew@mail.sysu.edu.cn    Contact: Jieqiong Liu       liujieqiong01@163.com    Peking University Shenzhen Hospital Recruiting Shenzhen, Guangdong, China Contact: Wei Wei, M.D.,Ph.D.    86-13600405191    rxwei1123@163.com    China, Hunan Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China Contact: Enxiang Zhou, M.D.    86-13548636806    zhouenxiang@medmail.com.cn    China, Xinjiang Xinjiang Medical School Cancer Hospital Not yet recruiting Urumqi, Xinjiang, China, 830000 Contact: Binlin Ma, M.D.    86-13809951599    mbldoctor@126.com Less <<
NCT00161564 Idiopathic Thrombocytopenic Pu... More >>rpura (ITP) Less << Phase 2 Withdrawn - United States, New York ... More >> Weill Medical College of Cornell University Division of Pediatric Hematology-Oncology New York, New York, United States, 10021 Less <<
NCT00068601 - Completed - -
NCT00068601 Breast Cancer ... More >> Infertility Menopausal Symptoms Less << Phase 3 Completed - -
NCT00656669 - Completed - -
NCT01848197 Breast Cancer ... More >> Paclitaxel Epirubicin Cyclophosphamide Less << Not Applicable Not yet recruiting December 2020 -
NCT02816112 Early Stage Breast Cancer Phase 4 Recruiting August 2020 Canada, Ontario ... More >> The Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada Principal Investigator: Mark Clemons, MD Less <<
NCT00002627 Breast Cancer Phase 1 Phase 2 Unknown - United States, Missouri ... More >> St. Louis University Health Sciences Center Saint Louis, Missouri, United States, 63110-0250 Less <<
NCT00302003 Childhood Favorable Prognosis ... More >>Hodgkin Lymphoma Childhood Lymphocyte Depletion Hodgkin Lymphoma Childhood Mixed Cellularity Hodgkin Lymphoma Childhood Nodular Sclerosis Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Phase 3 Unknown - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01273181 Metastatic Cancer ... More >> Metastatic Renal Cancer Metastatic Melanoma Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01273181 - Terminated - -
NCT00002679 Breast Cancer Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 Less <<
NCT00496665 Metastatic Breast Cancer Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00000596 Lung Diseases ... More >> Pulmonary Fibrosis Sarcoidosis Less << Phase 2 Completed - -
NCT00302003 - Unknown - -
NCT00467961 CML (Chronic Myelogenous Leuke... More >>mia) CLL (Chronic Lymphocytic Leukemia) AML (Acute Myelogenous Leukemia) Acute Lymphocytic Leukemia MDS (Myelodysplastic Syndrome) Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00652899 - Terminated(Withdrawn due to to... More >>xicity) Less << - -
NCT00038844 Lymphoma Leuk... More >>emia Less << Not Applicable Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03287674 Metastatic Ovarian Cancer Phase 1 Phase 2 Active, not recruiting October 2020 Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Denmark, 2730 Less <<
NCT00186810 Sickle Cell Disease Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00652899 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Terminated(Withdrawn due to to... More >>xicity) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00409188 Non-small Cell Lung Cancer Phase 3 Completed - -
NCT00409188 - Completed - -
NCT00467961 - Completed - -
NCT00124514 Systemic Lupus Erythematosus Phase 2 Completed - United States, California ... More >> Children's Hospital of Los Angeles Los Angeles, California, United States, 90027 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Morgan Stanley Children's Hospital of New York New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Columbus Children's Hospital Columbus, Ohio, United States, 43205 United States, Oklahoma Children's Hospital of Oklahoma Oklahoma City, Oklahoma, United States, 73104 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Brazil University of San Paulo San Paulo, Brazil Less <<
NCT02626455 Lymphoma, Non-Hodgkin Phase 3 Recruiting December 31, 2024 -
NCT00433537 - Completed - -
NCT01414855 Lymphoma, B-Cell Phase 2 Completed - -
NCT00433537 Contiguous Stage II Mantle Cel... More >>l Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Stage I Mantle Cell Lymphoma Stage III Mantle Cell Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT03155191 Lymphoblastic Leukemia, Acute ... More >>Adult Less << Phase 1 Phase 2 Recruiting March 31, 2020 Japan ... More >> Kyushu University Hospital Recruiting Higashi-ku, Fukuoka, Japan, 812-8582 Hokkaido University Hospital Recruiting Sapporo-shi, Hokkaido, Japan, 060-8648 Mie University Hospital Recruiting Tsu-shi, Mie, Japan, 514-8507 Jichi Medical University hospital Recruiting Shimotsuke-shi, Tochigi, Japan, 329-0498 The Institute of Medical Science, The University of Tokyo Recruiting Minato-ku, Tokyo, Japan, 108-8639 Less <<
NCT01414855 - Completed - -
NCT03356860 Breast Cancer ... More >> Triple Negative Breast Cancer Luminal B Less << Phase 1 Phase 2 Recruiting April 2021 Belgium ... More >> Grand Hôpital de Charleroi Recruiting Charleroi, Hainaut, Belgium, 6000 Contact: Javier Carrasco, MD, PhD       javier.carrasco@ghdc.be    Cliniques universitaires St Luc Not yet recruiting Brussels, Belgium, 1320 Contact: Francois Duhoux, MD, PhD       francois.duhoux@uclouvain.be Less <<
NCT02520479 Treatment Refusal Phase 2 Terminated - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT01895244 Scleroderma C... More >>ardiac Involvement Autologous Stem Cell Transplantation Less << Phase 2 Recruiting September 2022 Germany ... More >> University Hospital Tuebingen; Department of oncology, hematology, rheumatology, immunology and pulmology Recruiting Tuebingen, Germany, 72076 Contact: Joerg C Henes, MD    +4970712982711    joerg.henes@med.uni-tuebingen.de    Sub-Investigator: Theodoros Xenitidis, MD          Sub-Investigator: Robert Moehle, MD Less <<
NCT01953900 Osteosarcoma ... More >>Neuroblastoma Less << Phase 1 Recruiting April 2036 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Lisa L Wang, MD    832-824-4822    llwang@texaschildrens.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org    Principal Investigator: Lisa L Wang, MD          Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD    832-824-1471    sbwhittl@txch.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org    Principal Investigator: Sara Whittle, MD Less <<
NCT02486952 - Completed - Serbia ... More >> Belgrade, Serbia, 11000 Belgrade, Serbia, 11070 Kragujevac, Serbia, 34000 NIS, Serbia, 18000 Sremska Kamenica, Serbia, 21204 Less <<
NCT00924001 Melanoma Mali... More >>gnant Melanoma Melanoma, Experimental Less << Phase 1 Phase 2 Terminated(study was stopped d... More >>ue to low accrual) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00924001 - Terminated(study was stopped d... More >>ue to low accrual) Less << - -
NCT02306161 Metastatic Ewing Sarcoma ... More >> Metastatic Malignant Neoplasm in the Bone Metastatic Malignant Neoplasm in the Bone Marrow Metastatic Malignant Neoplasm in the Lung Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone Peripheral Primitive Neuroectodermal Tumor of Soft Tissues Less << Phase 3 Recruiting December 31, 2020 -
NCT00343798 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Colorado, United States, 80217-3364 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00513292 HER2/Neu Positive ... More >> Stage IA Breast Cancer Stage IB Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Phase 3 Unknown - -
NCT00513292 - Unknown - -
NCT00176826 Hemophagocytic Lymphohistiocyt... More >>osis X-Linked Lymphoproliferative Disorders Chediak-Higashi Syndrome Griscelli Syndrome Immunologic Diseases Langerhans-Cell Histiocytosis Hematologic Diseases Less << Phase 2 Phase 3 Terminated(Replaced by another... More >> protocol) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00136565 Peripheral T-cell Lymphoma Phase 2 Completed - Belgium ... More >> Groupe d'Etude des Lymphomes de l'Adulte Yvoir, Belgium France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Less <<
NCT01324596 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Completed - -
NCT00176826 - Terminated(Replaced by another... More >> protocol) Less << - -
NCT01321008 Lymphoma Phase 1 Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01321008 - Terminated(Slow Accrual) - -
NCT02792114 Breast Cancer ... More >> Metastatic HER2-negative Breast Less << Phase 1 Recruiting June 2019 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center (Consent and follow-up only) Recruiting Basking Ridge, New Jersey, United States Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Monmouth (Consent and follow-up only) Recruiting Middletown, New Jersey, United States, 07748 Contact: Prasad Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Bergen (Consent and follow-up only) Recruiting Montvale, New Jersey, United States, 07645 Contact: Prasad Adusumilli, MD    212-639-8093       United States, New York Memorial Sloan Kettering Cancer Center at Commack (Consent and follow-up only) Recruiting Commack, New York, United States Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Westchester (Consent and follow-up only) Recruiting Harrison, New York, United States, 10604 Contact: Prasad S Adusumilli, MD    212-639-8093       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Prasad Adusumilli, MD    212-639-8093       Contact: Shanu Modi, MD    646-888-4564       Principal Investigator: Prasad Adusumilli, MD          Memorial Sloan Kettering at Mercy Medical Center (Consent and follow-up only) Recruiting Rockville Centre, New York, United States Contact: Prasad Adusumilli, MD    212-639-8093 Less <<
NCT02423915 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02486952 - Completed - -
NCT02694224 Breast Cancer Phase 2 Recruiting December 2018 Spain ... More >> Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Contact: Amaya Izal    +34948255400 ext 2724    aizal@unav.es Less <<
NCT03712878 Hematopoietic and Lymphoid Cel... More >>l Neoplasm Less << Phase 2 Recruiting December 2021 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, CRNP    215-955-8874    dolores.grosso@jefferson.edu Less <<
NCT00004174 Breast Cancer Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00499603 Breast Cancer Phase 2 Unknown April 2017 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00003696 Lung Cancer Phase 3 Unknown - Netherlands ... More >> Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1007 MB Less <<
NCT00083915 - Completed - -
NCT00083915 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00003269 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Lung Cancer Lymphoma Ovarian Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, California ... More >> Scripps Clinic La Jolla, California, United States, 92037 Less <<
NCT00135499 Lymphoma, Large-Cell, Diffuse Phase 3 Terminated(Recruitment too low... More >>) Less << - Belgium ... More >> Groupe d'Etude des Lymphomes de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland Less <<
NCT01028716 Acute Biphenotypic Leukemia ... More >> Acute Erythroid Leukemia in Remission Acute Leukemia in Remission Acute Megakaryoblastic Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Multilineage Dysplasia Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Myelodysplastic Syndrome Recurrent Anaplastic Large Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Acute Myeloid Leukemia T Lymphoblastic Lymphoma Less << Phase 2 Recruiting - United States, Washington ... More >> VA Puget Sound Health Care System Not yet recruiting Seattle, Washington, United States, 98101 Contact: Thomas Chauncey    206-764-2969    thomas.chauncey@va.gov    Principal Investigator: Thomas Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit    206-667-1317    rsalit@fredhutch.org    Principal Investigator: Rachel B. Salit Less <<
NCT01746992 ALK-negative Anaplastic Large ... More >>Cell Lymphoma Peripherial T Cell Lymphoma,Not Otherwise Specified Angioimmunoblastic T Cell Lymphoma Enteropathy Associated T Cell Lymphoma Hepatosplenic T Cell Lymphoma Subcutaneous Panniculitis Like T Cell Lymphoma Less << Phase 4 Active, not recruiting December 2018 China, Shanghai ... More >> Ruijin hospital Shanghai, Shanghai, China, 200025 Less <<
NCT02504047 Hematologic Neoplasms Not Applicable Recruiting July 2019 Canada, Alberta ... More >> Foothills Medical Center / Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Andrew Daly, MD    4035213706    andrew.daly@albertahealthservices.ca    Contact: Mamta Kantharia       mamta.kantharia@albertahealthservices.ca    Principal Investigator: Andrew Daly, MD          Canada, Manitoba Health Sciences Center Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Contact: Kristjan Paulson, MD       kpaulson@cancercare.mb.ca    Principal Investigator: Kristjan Paulson, MD          Sub-Investigator: Donna Wall, MD          Sub-Investigator: David Szwajcer, MD          Canada, Ontario Ottawa General Hospital Not yet recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Bredeson, MD       cbredeson@toh.on.ca    Principal Investigator: Christopher Bredeson, MD          Canada, Quebec McGill University Health Centre Not yet recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Gizelle Popradi, MD       gizelle.popradi@mcgill.ca    Principal Investigator: Gizelle Popradi, MD          Canada, Saskatchewan Royal University Hospital Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N 0W8 Contact: Mark Bosch, MD       Mark.Bosch@saskcancer.ca    Principal Investigator: Mark Bosch Less <<
NCT02285062 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Active, not recruiting August 3, 2022 -
NCT00587925 Breast Cancer ... More >> Osteoporosis Less << Not Applicable Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center Commack, New York, United States Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01175785 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01287741 Diffuse Large B-Cell Lymphoma Phase 3 Completed - -
NCT03554109 Triple Negative Breast Cancer ... More >>(TNBC) Less << Phase 2 Not yet recruiting December 2021 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT01287741 - Completed - -
NCT00499603 - Unknown - -
NCT00925548 Breast Cancer Phase 3 Terminated(See termination rea... More >>son in the below Purpose statement) Less << - -
NCT00925548 - Terminated(See termination rea... More >>son in the below Purpose statement) Less << - -
NCT03016377 Acute Lymphoblastic Leukemia ... More >> Immune System Diseases Immunoproliferative Disorders Less << Phase 1 Recruiting October 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    (919) 445-4208    spencer.laing@med.unc.edu    Principal Investigator: Matthew Foster, MD Less <<
NCT02724579 Medulloblastoma ... More >> Untreated Childhood Medulloblastoma Less << Phase 2 Recruiting May 31, 2025 -
NCT02641847 Triple Negative Breast Cancer ... More >> Breast Cancer Less << Phase 2 Phase 3 Recruiting - China, Shanghai ... More >> Fudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200032 Contact: Zhi-Min Shao, MD.PhD.    86-18017312288    zhimingshao@yahoo.com Less <<
NCT00683241 Ovarian Cancer ... More >> Peritoneal Cancer Less << Phase 1 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03342638 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 3 Recruiting January 1, 2024 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley, RN    312-695-8192    kathleen.quigley@nm.org Less <<
NCT01818063 - Active, not recruiting - -
NCT01929811 pCR Rate BCT ... More >>Rate Safety Less << Phase 2 Recruiting September 2020 China, Shandong ... More >> Linyi People's Hospital Not yet recruiting Linyi, Shandong, China, 276003 Contact: Hong Liang          Principal Investigator: Hong Liang          China, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Xiaosong Chen          Principal Investigator: Kunwei Shen, Dr Less <<
NCT03086564 Hepatocellular Carcinoma Phase 1 Phase 2 Recruiting May 1, 2020 China, Guangdong ... More >> The Third Affiliated Hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Yurong Gu, Doctor    8620-85252702    guyr163@163.com    Contact: Yuehua Huang, Doctor    86-18922103516    huangyh53@sysu.edu.cn Less <<
NCT00578344 Sickle Cell Disease ... More >> Hemoglobin SC Less << Not Applicable Terminated(Terminated due to n... More >>o new subject enrollment during the last 3 year period.) Less << - United States, Texas ... More >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02096588 Breast Cancer ... More >> Stage I Breast Cancer Stage II Breast Cancer Stage III Breast Cancer Less << Phase 2 Active, not recruiting April 2021 United States, District of Col... More >>umbia Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital Washington, District of Columbia, United States, 20016 United States, Maryland Kimmel Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287-0013 Less <<
NCT01818063 Estrogen Receptor-negative Bre... More >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-negative Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-negative Breast Cancer Less << Phase 2 Active, not recruiting April 30, 2019 United States, Maryland ... More >> Walter Reed National Military Medical Center Bethesda, Maryland, United States, 20889 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Reading Hospital Reading, Pennsylvania, United States, 19611 Less <<
NCT00002788 Leukemia Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01199432 Breast Cancer Phase 4 Completed - China, Beijing ... More >> Beijing Cancer Hospital Beijing, Beijing, China, 100142 Less <<
NCT00950300 Breast Cancer Phase 3 Completed - -
NCT00950300 - Completed - -
NCT02293109 Contiguous Stage II Adult Lymp... More >>hoblastic Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting December 2018 United States, California ... More >> University of California Davis Recruiting Sacramento, California, United States, 95817 Contact: Mehrdad Abedi    916-734-3771    mabedi@ucdavis.edu    Principal Investigator: Mehrdad Abedi Less <<
NCT00960063 Neoplasms Sol... More >>id Tumors Bone Cancer Kidney Tumor Neuroblastoma Less << Phase 1 Terminated(Study was terminate... More >>d for business reasons.) Less << - -
NCT00960063 - Terminated(Study was terminate... More >>d for business reasons.) Less << - -
NCT01946373 Melanoma Phase 1 Recruiting December 2018 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, SE-171 76 Contact: Roger Tell, MD, PhD    +46760293911    roger.tell@ki.se    Principal Investigator: Roger Tell, MD, PhD Less <<
NCT00186849 Neuroblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00005960 Pain Prostate... More >> Cancer Less << Phase 2 Unknown - United States, California ... More >> Wilshire Oncology Medical Group, Inc. Los Angeles, California, United States, 90057 United States, Florida Geffen Cancer Center and Research Institute Vero Beach, Florida, United States, 32960-6541 United States, New York Arena Oncology Associates Great Neck, New York, United States, 11021 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina N.W. Carolina Oncology & Hematology, P.A. Hickory, North Carolina, United States, 28603 United States, Pennsylvania Associates of Hematology/Oncology Upland, Pennsylvania, United States, 19013 Less <<
NCT03527628 Classical Hodgkin Lymphoma ... More >> Hodgkin Lymphoma (Category) Hodgkin Disease Hodgkin Lymphoma Less << Phase 2 Recruiting January 15, 2022 Saudi Arabia ... More >> King Abdulaziz Medical City, Ministry of National Guard Recruiting Riyadh, Saudi Arabia, 22390 Contact: Ayman Hejazi, MD    +966 8011111 ext 53388    hejazia@ngha.med.sa Less <<
NCT03399773 Acute Biphenotypic Leukemia ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes Less << Phase 2 Recruiting August 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Less <<
NCT01462513 Colon Carcinoma ... More >> Rectum Carcinoma Less << Phase 2 Completed - Austria ... More >> Salzburger Universitätsklinikum, Universitätsklinik für Innere Medizin III Salzburg, Austria, 5020 Germany Klinikum Altenburger Land Altenburg, Germany, 04600 Campus Virchow-Klinikum, Charite Centrum 8 Berlin, Germany, 13353 Klinikum Darmstadt Darmstadt, Germany, 64283 Universitätsklinikum Essen WTZ-Ambulanz, Innere Medizin (Tumorforschung) Essen, Germany, 45122 Klinik für Allgemeine Innere Medizin, Onkologie / Hämatologie Esslingen, Germany, 73730 Klinikum der Johann W- Goethe Unversität, Klinik für Allgemein- und Viszeralchirurgie Frankfurt, Germany, 60590 Onkologische Schwerpunktpraxis Eppendorf Hamburg, Germany, 20249 Städtisches Klinikium Abt. Allgemein- und Visceralchirurgie Karlsruhe, Germany, 76133 Universitätsklinikum Leipzig Leipzig, Germany, 04103 Universitätsklinikum Magdeburg Magdeburg, Germany, 39120 Universitätsmedizin Mainz Mainz, Germany, 55131 Universtitäsmedizin Gießen und Marburg Marburg, Germany, 35033 Praxis für Hämatologie und Onkologie Mülheim an der Ruhr, Germany, 45468 Klinikum der Universität München-Grosshadern, Medizinische Klinik III München, Germany, 81377 GP für Hämatologie und Onkologie Offenburg Offenburg, Germany, 77654 Oncologianova GmbH Recklinghausen, Germany, 45657 Universitätsklinikum Regensburg Regensburg, Germany, 93042 Robert-Bosch Krankenhaus, Zentrum für Innere Medizin Stuttgart, Germany, 70376 Krankenhaus der Barmherzigen Brüder Trier, Germany, 54292 Klinikum Weiden, Medizinische Klinik I Weiden, Germany, 92637 Less <<
NCT02676622 Crohn's Disease Phase 2 Withdrawn(PI moved to a differ... More >>ent institution.) Less << - -
NCT02320383 Chronic Lymphocytic Leucemia Phase 2 Active, not recruiting September 2022 Germany ... More >> German CLL Study Group Cologne, Germany, 50923 Less <<
NCT02187367 Carcinoma, Non-Small-Cell Lung Phase 3 Recruiting March 2020 -
NCT01192555 Neuroblastoma Phase 1 Phase 2 Active, not recruiting September 2026 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03670966 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Chronic Myelomonocytic Leukemia Myeloproliferative Neoplasm, Unclassifiable Less << Phase 1 Phase 2 Not yet recruiting September 1, 2024 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Phuong Vo          Principal Investigator: Phuong Vo Less <<
NCT02959905 Metastatic Melanoma Phase 1 Unknown March 2018 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510030 Contact: Ye Cao, Doctor    86-20-87343826    contact@sysucc.org.cn    Principal Investigator: Xiao Sh Zhang, Doctor Less <<
NCT03197935 Triple-negative Breast Cancer Phase 3 Recruiting September 26, 2021 -
NCT01459887 Diffuse Large B Cell Lymphoma Phase 3 Completed - China, Guangdong ... More >> SUN-YAT-SEN university cancer center Guangzhou, Guangdong, China, 510060 Less <<
NCT00578461 Leukemia Canc... More >>er Lymphoma Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Less << Not Applicable Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00002554 Leukemia Phase 2 Completed - -
NCT02650648 Neuroblastoma ... More >> High-Risk Less << Phase 1 Recruiting January 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Shakeel Modak, MD    212-639-7623       Contact: Katharine Hsu, MD, PhD    646-888-2667 Less <<
NCT01775475 AIDS-related Diffuse Large Cel... More >>l Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Stage III AIDS-related Lymphoma Stage IV AIDS-related Lymphoma Less << Phase 2 Active, not recruiting February 2021 Kenya ... More >> Moi Teaching and Referral Hospital Eldoret, Kenya, 4606-30100 Zimbabwe University of Zimbabwe College of Health Sciences Harare, Zimbabwe Less <<
NCT01106950 - Terminated(study drug (Ontak) ... More >>no longer available) Less << - -
NCT00076752 Lupus Erythematosus, Systemic Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00076752 - Completed - -
NCT00578461 - Terminated - -
NCT00809276 - Completed - -
NCT00809276 Lymphoma Mult... More >>iple Myeloma Leukemia Myelodysplastic Syndrome Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> The Sydney Kimmel Comprehensive Cancer center Baltimore, Maryland, United States, 21231 United States, Texas Marcos deLima, MD Houston, Texas, United States, 77030 United States, Washington Paul V. O'Donnell, M.D., Ph.D. Seattle, Washington, United States, 98109 Less <<
NCT01106950 Leukemia, Myelogenous, Acute Phase 2 Terminated(study drug (Ontak) ... More >>no longer available) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00095862 Breast Cancer ... More >> Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Terminated - United States, California ... More >> Glendale Memorial Hospital Comprehensive Cancer Center Glendale, California, United States, 91204 Hollywood Presbyterian Medical Center Los Angeles, California, United States, 90027-0902 Los Angeles, California, United States, 90057 Less <<
NCT02596971 Diffuse Large B-Cell Lymphoma,... More >> Lymphoma Follicular Less << Phase 1 Phase 2 Active, not recruiting April 17, 2020 United States, Colorado ... More >> Rocky Mountain Cancer Center - Aurora Aurora, Colorado, United States, 80012 United States, District of Columbia Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Florida University Miami Miami, Florida, United States, 33136 United States, New York New York Uni Medical Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Oregon Oncology Associates of Oregon, P.C.; Willamette Valley Cancer Institute Springfield, Oregon, United States, 97477 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Texas Oncology Austin, Texas, United States, 78705 Texas Oncology-Tyler Irving, Texas, United States, 75063 Australia, New South Wales Concord Repatriation General Hospital; Haematology Sydney, New South Wales, Australia, 2139 Calvary Mater Newcastle Waratah, New South Wales, Australia, 2298 Australia, Queensland Royal Brisbane Hospital Brisbane, Queensland, Australia, 4029 Australia, South Australia The Queen Elizabeth Hospital; Haematology/Oncology Woodville South, South Australia, Australia, 5011 Australia, Victoria Monash Medical Centre Clayton, Victoria, Australia, 3168 Austin Hospital Heidelberg, Victoria, Australia, 3084 Italy Azienda Ospedaliera S. Orsola-Malpighi Bologna, Emilia-Romagna, Italy, 40138 Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori Meldola, Emilia-Romagna, Italy, 47014 Az. Osp. S. Maria Delle Croci; U.O. Di Ematologia Ravenna, Emilia-Romagna, Italy, 48100 Ospedale Infermi di Rimini Rimini, Emilia-Romagna, Italy, 47900 AOU Città della Salute e della Scienza di Torino - Presidio Le Molinette Torino, Lazio, Italy, 10126 Asst Papa Giovanni XXIII Bergamo, Lombardia, Italy, 24100 Azienda Ospedaliera Univ Firenze, Toscana, Italy, 50141 Less <<
NCT00930891 Small Cell Lung Cancer Phase 2 Phase 3 Completed - -
NCT02684708 Classical Hodgkin Lymphoma Phase 3 Recruiting September 2021 Germany ... More >> Justus Liebig University of Giessen Recruiting Giessen, Germany, 35392 Contact: Dieter Koerholz, MD       dieter.koerholz@paediat.med.uni-giessen.de    Contact: Christine Mauz-Koerholz, MD       christine.mauz-koerholz@paediat.med.uni-giessen.de Less <<
NCT02445404 Peripheral T-cell Lymphoma Phase 2 Recruiting December 31, 2019 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Seoul, Korea, Republic Of, Korea, Republic of, 135-710 Contact: Won Seog Kim, M.D, Ph. D    234106548 ext 82    wskimsmc@skku.edu    Contact: Seok Jin Kim, M.D,Ph. D    234101766 ext 82    kstwoh@skku.edu Less <<
NCT02727803 Leukemia Lymp... More >>homa Myeloma Myeloproliferative Diseases Less << Phase 2 Recruiting May 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02566395 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Chronic Myelogenous Leukemia Non-Hodgkin Lymphoma Hodgkin Lymphoma Less << Phase 3 Recruiting December 2020 United States, New York ... More >> Cohen Children's Medical Center Recruiting New Hyde Park, New York, United States, 11040 Contact: Joel A Brochstein, MD    718-470-3460    jbrochstein@nshs.edu    Contact: Nan Werther, CPNP    718-470-3620    nwerther@nshs.edu Less <<
NCT02118311 Hematologic Malignancies Phase 2 Withdrawn(Changing study desig... More >>n. Will replace with a different protocol.) Less << September 2018 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03418779 IgA Nephropathy at High Risk o... More >>f Developing ESRD Less << Phase 2 Phase 3 Recruiting August 31, 2021 China, Beijing ... More >> Guang anmen Hospital, China Academy of Chinese Medical Sciences Recruiting Beijing, Beijing, China, 100053 Contact: Shen Li    010-88001057    lishen58173@163.com    Contact: Jinpu Li    +86 18642168989 Less <<
NCT00496873 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03585764 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 1 Recruiting October 2035 United States, Pennsylvania ... More >> University of Pennsylvania Health System Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Payal D Shah, MD    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT01446211 Wegeners Granulomatosis Phase 3 Terminated(Change of design co... More >>nsideration) Less << - Czech Republic ... More >> Všeobecná fakultní nemocnice v Praze Praha, Czech Republic, 128 08 Less <<
NCT00925652 Breast Cancer Phase 2 Active, not recruiting July 2019 United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Indiana Indiana Unversity Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Massachusetts Faulkner Hospital Boston, Massachusetts, United States, 02130 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center Milford, Massachusetts, United States, 01757 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT02807103 Eosinophilic Granulomatosis Wi... More >>th Polyangiitis (EGPA) Less << Phase 3 Recruiting June 2020 France ... More >> Hôpital Cochin Recruiting Paris, France, 75014 Contact: Benjamin TERRIER, MD, PhD    +33 1 58 41 14 61    benjamin.terrier@aphp.fr Less <<
NCT01141959 - Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00496873 - Completed - -
NCT00003667 Sarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00022230 Breast Cancer Phase 1 Phase 2 Withdrawn(PI left Institution) - United States, Rhode Island ... More >> Roger Williams Medical Center Providence, Rhode Island, United States, 02908-4735 Less <<
NCT00345865 Lymphoma Phase 2 Active, not recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00972478 Ann Arbor Stage II Non-Hodgkin... More >> Lymphoma Ann Arbor Stage III Non-Hodgkin Lymphoma Ann Arbor Stage IV Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00194753 Breast Neoplasm Phase 2 Completed - United States, Washington ... More >> University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00972478 - Active, not recruiting - -
NCT02345850 Acute Leukemia ... More >> Myelodysplasia Less << Phase 3 Recruiting September 2021 -
NCT03710421 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Not yet recruiting December 10, 2021 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD    626-218-2405    htut@coh.org    Principal Investigator: Myo Htut, MD Less <<
NCT00389818 - Completed - -
NCT00389818 Lymphoma Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 United States, Florida University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Louisiana Ochsner Cancer Institute at Ochsner Clinic Foundation New Orleans, Louisiana, United States, 70121 United States, Massachusetts Boston University Cancer Research Center Boston, Massachusetts, United States, 02118 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Joan Karnell Cancer Center at Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19106 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT02937844 Glioblastoma Multiforme Phase 1 Recruiting July 2019 China ... More >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD    +86-10-13905918963    lzx1967@sina.com Less <<
NCT01265901 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT00578266 Anemia, Aplastic Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02830724 Pancreatic Cancer ... More >> Renal Cell Cancer Breast Cancer Melanoma Ovarian Cancer Less << Phase 1 Phase 2 Recruiting January 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01967823 Melanoma Meni... More >>ngioma Breast Cancer Non-Small Cell Lung Cancer Hepatocellular Cancer Less << Phase 2 Recruiting July 28, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00322101 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Acute Myeloid Leukemia/Transient Myeloproliferative Disorder Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 3 Completed - United States, Colorado ... More >> HealthOne Presbyterian St. Lukes Medical Center Denver, Colorado, United States United States, Georgia Emory University Altanta, Georgia, United States, 30322 United States, New York Weill Cornell University New York, New York, United States, 10021 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College Wisconsin Milwaukee, Wisconsin, United States Germany Technical University Dresden Dresden, Saxony, Germany, 01307 Less <<
NCT03318861 Multiple Myeloma Phase 1 Recruiting October 2032 United States, California ... More >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90024 Contact: Bruck Habtemariam       bhabtemariam@mednet.ucla.edu    Contact: Cynthia Courtney       clcourtney@mednet.ucla.edu    United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Tolu Adewuya       tolu.adewuya@emory.edu    United States, Illinois University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Becky Malloy       rmalloy@medicine.bsd.uchicago.edu    Contact: Linda Schroeder       lschroed@medicine.bsd.uchicago.edu    United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD    617-724-4000    NRAJE@mgh.harvard.edu    Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: David Avigan, MD       davigan@bidmc.harvard.edu    United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tracee Shevlin       shevlin.tracee@mayo.edu    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sergio Giralt, MD       GiraltS@mskcc.org    United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cancer Trials Information Program    800-811-8480       Contact: CAR-T Cell Line    615-936-2102       United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ashley Morphey       alandry1@mdanderson.org Less <<
NCT03070327 Multiple Myeloma Phase 1 Recruiting February 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sham Mailankody, MD    212-639-2131       Contact: Craig Sauter, MD    212-639-3460       Principal Investigator: Sham Mailankody, MD Less <<
NCT00322101 - Completed - -
NCT00941928 Leukemia Pedi... More >>atric Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00941928 - Terminated(Slow accrual) - -
NCT00262210 Non-Hodgkin's Lymphoma Phase 2 Completed - Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan Less <<
NCT02457650 Bladder Carcinoma ... More >> Breast Cancer Esophagus Carcinoma Lung Cancer Melanoma Multiple Myeloma Neuroblastoma Ovarian Cancer Synovial Sarcoma Other Metastatic Solid Cancers Less << Phase 1 Recruiting December 2019 China, Guangdong ... More >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D.    15814723218    mingjunw429@163.com    Contact: Geng Tian, M.D., Ph.D.    13724395569    tiangeng666@aliyun.com    Principal Investigator: Geng Tian, M.D., Ph.D.          Principal Investigator: Mingjun Wang, M.D., Ph.D. Less <<
NCT00278512 Vasculitis Phase 1 Terminated(No participant enro... More >>lled over five years. No plan to continue the study.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00201318 Non-Hodgkin's Lymphoma Phase 2 Completed - Taiwan ... More >> Mackay Memorial Hospital Taipei, Taiwan Less <<
NCT03576521 Breast Cancer ... More >> Breast Carcinoma Adriamycin Toxicity Cyclosporine Toxicity Less << Phase 2 Completed - Cuba ... More >> National Institute of Oncology and Radiobiology (INOR) La Habana, Cuba, 10400 Less <<
NCT03530462 - Completed - China, Zhejiang ... More >> The First Affiliated Hospital, Zhejiang University Hangzhou, Zhejiang, China Less <<
NCT02446431 Solid Tumor Early Phase 1 Recruiting July 2029 United States, California ... More >> Miller Children's and Women's Hospital Long Beach Recruiting Long Beach, California, United States, 90806 Contact: Ted Zwerdling, MD    562-933-8600    tzwerdling@memorialcare.org    Contact: Devin Murphy, MSW    562-933-8601    dmurphy@memorialcare.org    Children's Hospital Orange County Recruiting Orange, California, United States, 92868 Contact: Elyssa Rubin, MD    714-509-4348    erubin@choc.org    Contact: Dorian Chan, RN,BSN,CCRC    714-509-7868    dchan@CHOC.ORG    Principal Investigator: Elyssa Rubin, MD Less <<
NCT03477643 - Recruiting December 13, 2019 Spain ... More >> Hospital de Sant Joan de Déu Not yet recruiting Barcelona, Spain Contact: Cristina Motllo, Dr    + 34 932 53 21 00    cristinamotllo@gmail.com    Hospital Donostia-Donostia Ospitalea Not yet recruiting Donostia, Spain Contact: Mailen Sirvent, Dr    + 34 943 00 70 00    MAIALEN.SIRVENTAUZMENDI@osakidetza.eus    Hospital Universitario Virgen de Las Nieves Not yet recruiting Granada, Spain Contact: Rafael Rios, Dr    + 34 958 02 00 00    rriost33@gmail.com    Hospital General San Jorge - Huesca Not yet recruiting Huesca, Spain Contact: Ilda Maria Murillo, Dr    + 34 974 24 70 00    immurillof@gmail.com    Hospital de Jaén Not yet recruiting Jaén, Spain Contact: Soledad Duran, Dr    + 34 902 50 50 61    soledadduran@hotmail.com    Hospital Lucus Augusti Not yet recruiting Lugo, Spain Contact: Esperanza la Villa, Dr    + 34 982 29 60 00    esperanza.lavilla.rubira@sergas.es    Hospital Clínico San Carlos Not yet recruiting Madrid, Spain Contact: Belen Iñigo, Dr    + 34 913 30 30 01    belen.inigo@gmail.com    Hospital Del Tajo Not yet recruiting Madrid, Spain Contact: Ana Lafuente, Dr    + 34 918 01 41 00    apaz.lafuenteguijosa@salud.madrid.org    Hospital General Universitario Gregorio Marañón Not yet recruiting Madrid, Spain Contact: Cristina Encinas, Dr    + 34 915 86 80 00    crisenro@hotmail.com    Hospital Ramón Y Cajal Not yet recruiting Madrid, Spain Contact: Mª Jesus Blanchard, Dr    + 34 913 36 80 00    mjesusblanchard@yahoo.es    Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Contact: Juan José Lahuerta, Dr    + 34 913 90 80 00    jjlahuerta@telefonica.net    Hospital Universitario de La Princesa Not yet recruiting Madrid, Spain Contact: Adrián Alegre, Dr    + 34 915202200    adrian.alegre@telefonica.net    Hospital Universitario Virgen de La Arrixaca Not yet recruiting Murcia, Spain Contact: Valentin Cabañas, Dr    + 34 968 36 95 00    valentin.cabanas@gmail.com    Complejo Hospitalario de Especialidades Virgen de La Victoria Not yet recruiting Málaga, Spain Contact: Ricarda García, Dr    + 34 951 03 20 00    ricarda_g@yahoo.es    Hospital Central de Asturias Not yet recruiting Oviedo, Spain Contact: Ana Pilar Gonzalez, Dr    + 34 985 10 80 00    anapilargonzalez@gmail.com    Hospital Universitari Son Espases Not yet recruiting Palma De Mallorca, Spain Contact: Antonia Sampol, Dr    + 34 871 20 50 00    antonia.sampolm@ssib.es    Complejo Hospitalario de Navarra Not yet recruiting Pamplona, Spain Contact: Jose María Arguiñano Pérez, Dr    948 25 54 00    jm.arguinano.perez@cfnavarra.es    Hospital El Bierzo Not yet recruiting Ponferrada, Spain Contact: Erik de Cabo, Dr    + 34 987 45 52 00    erikbierzo@hotmail.com    Hospital Universitario de Salamanca Not yet recruiting Salamanca, Spain Contact: María Victoria Mateos, Dr    + 34 983 42 00 00    mvmateos@usal.es    Hospital Mutua Terrassa Recruiting Terrassa, Spain Contact: Josep Mª Tutusaus, Dr    + 34 93 736 50 50    jmarti@mutuaterrassa.es    Complejo Hospitalario de Toledo Not yet recruiting Toledo, Spain Contact: Luis Casado Montero, Dr    + 34 925 26 92 00    lfcasadom@telefonica.net    Hospital Universitario Dr. Peset Aleixandre Not yet recruiting Valence, Spain Contact: Paz Ribas    + 34 961622300    ribas_paz@gva.es    Hospital Arnau de Vilanova Not yet recruiting Valencia, Spain Contact: Aurelio Lopez, dr    + 34 973 705 246 ...    aureliolopmar@hotmail.com    Hospital Universitario La Fe Not yet recruiting Valencia, Spain Contact: Mario Arnao, Dr    +34 961 244 350    arnao_mar@gva.es    HOSPITAL CLíNICO UNIVERSITARIO DE VALLADOLID Recruiting Valladolid, Spain Contact: Alfonso García de Coca, Dr    +34 983 42 00 00    agarciadecoca@gmail.com    Hospital Txagorritxu Not yet recruiting Vitoria, Spain Contact: Ernesto Pérez, Dr    + 34 945007000    ernesto.perezpersona@osakidetza.net Less <<
NCT01055301 Multiple Myeloma ... More >> Plasma Cell Myeloma Less << Phase 2 Withdrawn(lack of accrual) - United States, Louisiana ... More >> Tulane Cancer Center Office of Clinical Research Alexandria, Louisiana, United States, 71315-3198 Hematology-Oncology Clinic Baton Rouge, Louisiana, United States, 70809 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Washington Island Hospital Cancer Care Center at Island Hospital Anacortes, Washington, United States, 98221 St. Joseph Cancer Center Bellingham, Washington, United States, 98225 Olympic Hematology and Oncology Bremerton, Washington, United States, 98310 Highline Medical Center Cancer Center Burien, Washington, United States, 98166 Columbia Basin Hematology Kennewick, Washington, United States, 99336 Skagit Valley Hospital Cancer Care Center Mount Vernon, Washington, United States, 98274 Harrison Poulsbo Hematology and Onocology Poulsbo, Washington, United States, 98370 Harborview Medical Center Seattle, Washington, United States, 98104 Minor and James Medical, PLLC Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Group Health Central Hospital Seattle, Washington, United States, 98112 Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle, Washington, United States, 98122-4307 University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195 North Puget Oncology at United General Hospital Sedro-Woolley, Washington, United States, 98284 Cancer Care Northwest - Spokane South Spokane, Washington, United States, 99202 Evergreen Hematology and Oncology, PS Spokane, Washington, United States, 99218 Wenatchee Valley Medical Center Wenatchee, Washington, United States, 98801-2028 Less <<
NCT03256071 Acute Myeloid Leukemia ... More >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Less << Phase 2 Phase 3 Recruiting September 2021 China, Jiangsu ... More >> The First Affiliated Hospital of Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Xiaowen Tang, MD    +86-512-67781851    xwtang1020@163.com    Principal Investigator: Depei Wu, MD Less <<
NCT01096368 Cellular Ependymoma ... More >> Childhood Anaplastic Ependymoma Childhood Infratentorial Ependymoma Childhood Supratentorial Ependymoma Clear Cell Ependymoma Ependymoma Newly Diagnosed Childhood Ependymoma Papillary Ependymoma Less << Phase 3 Recruiting - -
NCT00278512 - Terminated(No participant enro... More >>lled over five years. No plan to continue the study.) Less << - -
NCT00646854 Lymphoma, T-Cell, Peripheral Phase 3 Unknown December 2016 -
NCT00773695 Breast Cancer Phase 2 Active, not recruiting January 16, 2023 Norway ... More >> The Norvegian Radium Hospital Montebello; Dept of Oncology Oslo, Norway, 0379 Ullevael Sykehus; Dept of Oncology Oslo, Norway, 0407 St. Olavs Hospital; Kreftavdelingen Trondheim, Norway, 7000 Less <<
NCT03513601 Diffuse Large B Cell Lymphoma Phase 4 Recruiting May 2019 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT00054665 B-Cell Lymphoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 United States, New York Roswell Parck Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT00305682 Myeloproliferative Disorders ... More >> Leukemia Lymphoma Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting June 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00054665 - Completed - -
NCT00003490 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01010854 Breast Cancer Phase 2 Terminated(Premature closure f... More >>or lack of efficacy.) Less << - United States, California ... More >> University of California San Francisco San Francisco, California, United States, 94115 Less <<
NCT03201861 Tubular Breast Cancer ... More >> Mucinous Breast Cancer Invasive Duct Carcinoma of Breast Less << Phase 3 Recruiting December 31, 2021 China, Shanghai ... More >> Renji Hospital, School of Medicine, Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200127 Contact: Yueyao Du, M.D.    86-21-68385569    jessicayy8629@126.com    Contact: Jie Zhang, M.D.    86-21-68385516    doudou090227@163.com Less <<
NCT01010854 - Terminated(Premature closure f... More >>or lack of efficacy.) Less << - -
NCT00157209 Lung Neoplasms ... More >> Carcinoma, Non-Small-Cell Lung Less << Phase 2 Completed - Germany ... More >> Please Contact the Merck KGaA Communication Center Darmstadt, Germany Less <<
NCT01205503 - Completed - -
NCT01205503 Breast Cancer ... More >> Non-Hodgkin's Lymphoma Less << Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 Less <<
NCT02605460 Acute Myeloid Leukemia ... More >> Acute Lymphoid Leukemia Less << Phase 2 Recruiting December 2018 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Distrito Federal, Mexico, 14080 Contact: Eucario Leon Rodriguez, M.D.    525554870900 ext 2255    eucarios@hotmail.com    Contact: Monica M Rivera Franco, M.D.    525554870900 ext 2254    monrif90d@gmail.com Less <<
NCT00006261 Breast Cancer Phase 2 Withdrawn - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00857389 Stem Cell Transplantation ... More >> Leukemia Lymphoma Less << Phase 2 Active, not recruiting March 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03044743 Stage IV Gastric Carcinoma ... More >> Stage IV Nasopharyngeal Carcinoma T-Cell Lymphoma Stage IV Stage IV Adult Hodgkin Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting March 2022 China, Jiangsu ... More >> The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Jing Yan, MD    0086-15805182426    firefreebird@163.com    The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang    18602568379    wing_young7@hotmail.com Less <<
NCT00513955 Lymphoma Phase 2 Completed - United Kingdom ... More >> Basingstoke and North Hampshire NHS Foundation Trust Basingstoke, England, United Kingdom, RG24 9NA Good Hope Hospital Birmingham, England, United Kingdom, B75 7RR Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Blackpool Victoria Hospital Blackpool, England, United Kingdom, FY3 8NR Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Darent Valley Hospital Dartford, England, United Kingdom, DA2 8DA Harrogate District Hospital Harrogate, England, United Kingdom, HG2 7SX Leeds General Infirmary Leeds, England, United Kingdom, LS1 3EX Royal Liverpool University Hospital Liverpool, England, United Kingdom, L7 8XP Guy's Hospital London, England, United Kingdom, SE1 9RT Mid Kent Oncology Centre at Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP James Paget Hospital Norfolk, England, United Kingdom, NR31 6LA Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Whiston Hospital Prescot Merseyside, England, United Kingdom, L35 5DR Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Sunderland Royal Hospital Sunderland, England, United Kingdom, SR4 7TP Musgrove Park Hospital Taunton, England, United Kingdom, TA1 5DA Torbay Hospital Torquay, England, United Kingdom, TQ2 7AA Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Ysbyty Gwynedd Bangor, Wales, United Kingdom, LL57 2PW Prince Philip Hospital Llanelli, Wales, United Kingdom, SA14 8QF Less <<
NCT00157209 - Completed - -
NCT00002535 Melanoma (Skin) Phase 2 Completed - United States, Wisconsin ... More >> St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00394251 - Completed - -
NCT00394251 Breast Cancer Phase 2 Completed - -
NCT01920932 Stage II Childhood Hodgkin Lym... More >>phoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 2 Active, not recruiting April 30, 2025 United States, California ... More >> Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, Illinois St. Jude Midwest Affiliate Peoria, Illinois, United States, 61637 United States, Maine Maine Children's Cancer Program (MCCP) Scarborough, Maine, United States, 04704 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States, 02115 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00533923 AML ALL ... More >> CLL Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Hodgkin's Lymphoma Multiple Myeloma Aplastic Anemia Myeloproliferative Disorder Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00177047 Multiple Myeloma Phase 2 Phase 3 Active, not recruiting January 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01328496 Hematologic Malignancies ... More >> Disorder Related to Transplantation Hematopoietic Malignancy Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01496131 - Completed - -
NCT03497819 Pancreatic Cancer Early Phase 1 Active, not recruiting October 31, 2020 China, Zhejiang ... More >> First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China, 325000 Less <<
NCT00640796 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphocytic, Acute, T-Cell Juvenile Myelomonocytic Leukemia Lymphoblastic T-cell Lymphoblastic Lymphoma Myelodysplastic Syndrome Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01496131 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Please Contact US Medical Information Rockland, Massachusetts, United States Less <<
NCT01959490 Stage II Breast Cancer ... More >> Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 2 Completed - United States, Ohio ... More >> University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01328496 - Completed - -
NCT02659943 Lymphoma, B-Cell ... More >> Lymphoma, Non-hodgkins Less << Phase 1 Active, not recruiting December 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02447055 Multiple Myeloma ... More >> Myeloma-Multiple Less << Early Phase 1 Withdrawn - -
NCT00602693 Leukemia Lymp... More >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03704298 Refractory Large B-cell Lympho... More >>ma Less << Phase 1 Phase 2 Recruiting June 2035 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Less <<
NCT03139370 Solid Tumor Phase 1 Recruiting November 2034 United States, California ... More >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Anna Crosetti       ACrosetti@mednet.ucla.edu    Principal Investigator: Alexandra Drakaki, MD          United States, Florida University of Miami Health System Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis    301-243-7648    nluis@med.miami.edu    Principal Investigator: Peter Hosein, MD          Moffitt Cancer Center Recruiting Tampa, Florida, United States, 12902 Contact: Jeffrey Edelman       jeffrey.edelman@moffitt.org    Principal Investigator: Benjamin Creelan, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jami Brown    617-724-9190    jbrown56@mgh.harvard.edu    Principal Investigator: Marcela Maus, MD, PhD          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Cynthia Knauer, RN    212-241-9955    Cynthia.knauer@mountsinai.org    Contact: Ash Tewari, MD    1-212-241-9955    Ash.tewari@mountsinai.org    Principal Investigator: Ash Tewari, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Geoffrey Noah    646-888-4593       Contact: Shanette Bourne    646-888-4593       Principal Investigator: Chris Klebanoff, MD          United States, Texas Baylor Scott and White Health Recruiting Dallas, Texas, United States, 75246 Contact: Carlos Becerra, MD    214-370-1254    carlos.becerra@usoncology.com    Contact: Delia Graham    1-214-820-5424    delia.graham@bswhealth.com    Principal Investigator: Carlos Becerra, MD          MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ly Nguyen    713-563-2169    lmnguyen1@mdanderson.org    Principal Investigator: Partow Kebriaei, MD Less <<
NCT03200015 Diffuse Large B Cell Lymphoma Phase 2 Active, not recruiting January 27, 2019 Mexico ... More >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo Leon, Mexico, 64610 Less <<
NCT00820690 - Unknown September 2017 Brazil ... More >> Barretos Cancer Hospital Barretos, São Paulo, Brazil, 14.784-400 Less <<
NCT00063817 End-stage Renal Disease ... More >> Renal Transplantation Kidney Transplantation Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00376805 - Terminated(Withdrawn due to to... More >>xicity) Less << - -
NCT02215967 Myeloma, Plasma-Cell ... More >> Myeloma-Multiple Less << Phase 1 Active, not recruiting October 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00376805 Breast Cancer Phase 2 Terminated(Withdrawn due to to... More >>xicity) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01585428 Cervical Cancer ... More >> Oropharyngeal Cancer Vaginal Cancer Anal Cancer Penile Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01585428 - Completed - -
NCT00854139 Multiple Myeloma ... More >> End Stage Renal Disease Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT00193011 Breast Cancer Phase 3 Completed - -
NCT02133196 Advanced Non-Small Cell Lung C... More >>ancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas Less << Phase 2 Recruiting October 23, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01208818 Chronic Renal Failure With Ure... More >>mic Nephropathy Less << Phase 3 Completed - France ... More >> Hôpital Saint Louis Paris, France, 75010 Less <<
NCT00477412 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting April 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03638193 Pancreatic Cancer Not Applicable Recruiting February 1, 2022 China, Jiangsu ... More >> Nanjing First Hospital Recruiting Nanjing, Jiangsu, China, 210006 Contact: Jinfei CHEN, MD, PhD    (+86)18951670922       Principal Investigator: Jinfei CHEN, MD, PhD Less <<
NCT02153905 Breast Cancer ... More >> Cervical Cancer Renal Cancer Melanoma Bladder Cancer Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02213913 Adult Grade III Lymphomatoid G... More >>ranulomatosis B-cell Chronic Lymphocytic Leukemia Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Progressive Hairy Cell Leukemia, Initial Treatment Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage 0 Chronic Lymphocytic Leukemia Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Untreated Hairy Cell Leukemia Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Recruiting July 29, 2021 United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Reem Karmali, MD       reem_karmali@rush.edu    University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Sonali Smith    773-834-2895    smsmith@medicine.bsd.uchicago.edu    Principal Investigator: Sonali Smith          Decatur Memorial Hospital Cancer Care Institute Recruiting Decatur, Illinois, United States, 62526 Contact: James L. Wade, MD    217-876-6603       NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Lynne Kaminer, MD    847-570-2515       Illinois Cancer Care Recruiting Peoria, Illinois, United States, 61615 Contact: Paul AS Fishkin, MD    309-243-3000       Principal Investigator: Paul AS Fishkin, MD          United States, Maryland University of Maryland Recruiting Baltimore, Maryland, United States, 21202 Contact: Amy Kimball       akimball@umm.edu Less <<
NCT03081910 T-cell Acute Lymphoblastic Lym... More >>phoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting June 1, 2036 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org Less <<
NCT00002461 Lymphoma Phase 2 Completed - United States, New York ... More >> Albert Einstein Comprehensive Cancer Center Bronx, New York, United States, 10461 Less <<
NCT01468818 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01468818 - Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - -
NCT00448266 Breast Cancer Phase 2 Phase 3 Terminated(Activation of a sim... More >>ilar multicenter study for same population) Less << - Netherlands ... More >> NKI-AVL Amsterdam, Netherlands, 1066 CX Less <<
NCT00088881 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Terminated - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00088881 - Terminated - -
NCT03475602 - Recruiting December 31, 2018 China, Guangdong ... More >> Nephrology Dept,Guangdong General Hospital Recruiting Guangzhou, Guangdong, China Contact: Xinling Liang, MD,PhD    86-13808819770    xinlingliang@139.com Less <<
NCT01454596 Malignant Glioma ... More >> Glioblastoma Brain Cancer Gliosarcoma Less << Phase 1 Phase 2 Recruiting December 28, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT02111850 Cervical Cancer ... More >> Renal Cancer Urothelial Cancer Melanoma Breast Cancer Less << Phase 1 Phase 2 Recruiting December 27, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01878617 Medulloblastoma Phase 2 Recruiting December 2026 -
NCT03690011 T-cell Acute Lymphoblastic Leu... More >>kemia T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma Less << Phase 1 Not yet recruiting May 1, 2038 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: LaQuisa HIll, MD    832-824-4670    LaQuisa.Hill@bcm.edu    Contact: Jacqueline Castello    713-441-1450    jxcastel@txch.org    Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@txch.org Less <<
NCT02390739 Metastatic Thyroid Cancer Phase 1 Phase 2 Withdrawn - -
NCT00002945 Leukemia Phase 3 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT02876978 Lung Squamous Cell Carcinoma Phase 1 Recruiting April 2019 China, Shanghai ... More >> Shanghai Chest Hospital,Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200030 Less <<
NCT01014767 Brain Cancer ... More >>Choroid Plexus Tumors Less << Phase 3 Suspended(PI departure from co... More >>ordinating institution) Less << - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 United States, Texas Children's Cancer Hospital at UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Germany St. Hedwig Children's Hospital, University of Regensburg (International Study Center) Regensburg, Germany Hungary Semmelweis University Budapest, Hungary New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT03412409 Acute Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting March 1, 2020 China ... More >> Peking University, Institute of Hematolgoy Recruiting Beijing, China Contact: Xiao-Dong Mo Less <<
NCT00003972 Breast Cancer Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00053768 Lymphoma Phase 3 Unknown - -
NCT03412266 Myelodysplastic Syndromes Phase 2 Recruiting March 1, 2020 China, Beijing ... More >> Peking University Institute of Hematology,Beijing Recruiting Beijing, Beijing, China, 100044 Contact: Xiao-Dong Mo       mxd453@163.com    Principal Investigator: Xiao-Jun Huang, MD Less <<
NCT01740557 Melanoma Phase 1 Phase 2 Recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00033683 Breast Cancer Phase 2 Unknown - -
NCT03110640 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Chronic Lymphocytic Leukemia Adult Acute Lymphoblastic Leukemia in Remission Hematopoietic/Lymphoid Cancer Refractory Chronic Lymphocytic Leukemia Less << Phase 1 Not yet recruiting September 2020 -
NCT01339910 Leukemia, Myelocytic, Acute Phase 3 Terminated(Accrual terminated ... More >>as recommended by the data and safety monitoring board.) Less << - -
NCT01339910 - Terminated(Accrual terminated ... More >>as recommended by the data and safety monitoring board.) Less << - -
NCT00002598 Leukemia Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02062359 - Terminated(Study was closed du... More >>e to poor accrual.) Less << - -
NCT02062359 Metastatic Cancer ... More >> Metastatic Melanoma Less << Phase 2 Terminated(Study was closed du... More >>e to poor accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00003211 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center Houston, Texas, United States, 77030-2399 Australia, New South Wales Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Victoria Royal Children's Hospital Parkville, Victoria, Australia, 3052 Less <<
NCT00349778 - Completed - -
NCT00349778 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03328026 Breast Cancer Female ... More >> Breast Neoplasm Female Less << Phase 1 Phase 2 Recruiting December 31, 2020 United States, California ... More >> St. Joseph Heritage Healthcare Recruiting Santa Rosa, California, United States, 95403 Contact: Jennafer Carlin-Rosset, MPH    707-521-3830    Jennafer.Carlin@stjoe.org    Contact: Kim Young, RN, CCRC    707-521-3830    Kimberly.Young@stjoe.org    Principal Investigator: Jarrod P Holmes, M.D.          United States, Florida University of Miami/Sylvester at Plantation Recruiting Plantation, Florida, United States, 33324 Contact: Deborah M Conte, CCRC    954-210-1171    dmc238@med.miami.edu    Principal Investigator: Carmen J Calfa, MD          United States, Kansas Cancer Center of Kansas (CCK) Recruiting Wichita, Kansas, United States, 67214 Contact: Susan Davis, RN, BSN    316-613-4318    susan.davis@cancercenterofkansas.com    Contact: Julie Hintz    316-613-4317    julie.hintz@cancercenterofkansas.com    Principal Investigator: Shaker Dakhil, MD          United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Rita Murphy, MA, MPH    215-955-9626    rita.murphy@jefferson.edu    Principal Investigator: Saveri Bhattacharya, DO          United States, Washington Providence Regional Medical Center Recruiting Everett, Washington, United States, 98201 Contact: Rachel Macomber, CMA    425-297-5532    rachel.macomber@providence.org    Contact: Katie Lyon    425-297-5532    katie.lyon@providence.org    Principal Investigator: Jason Lukas, MD, PhD Less <<
NCT02443831 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Less << Phase 1 Recruiting December 2030 United Kingdom ... More >> Great Ormond Street Hospital Recruiting London, United Kingdom Contact: Prof. Persis Amrolia          University College Hospital Recruiting London, United Kingdom Contact: Dr Rachael Hough          Royal Manchester Infirmary Not yet recruiting Manchester, United Kingdom Contact: Eleni Tholouli          Royal Manchester Royal Children's Hopsital (part of MRI) Recruiting Manchester, United Kingdom Contact: Dr Rob Wynn Less <<
NCT02280811 - Completed - -
NCT00002854 Cancer Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00048737 Lymphoma Leuk... More >>emia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03745326 Gastrointestinal Cancer ... More >> Pancreatic Cancer Gastric Cancer Colon Cancer Rectal Cancer Less << Phase 1 Phase 2 Recruiting December 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00048737 - Completed - -
NCT02280811 Vaginal Cancer ... More >> Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03190941 Pancreatic Cancer ... More >> Gastric Cancer Gastrointestinal Cancer Colon Cancer Rectal Cancer Less << Phase 1 Phase 2 Recruiting June 29, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00002466 Kidney Cancer ... More >> Sarcoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00176904 - Completed - -
NCT03585465 Childhood Solid Tumor ... More >> Childhood Lymphoma Less << Phase 1 Phase 2 Not yet recruiting July 2027 -
NCT01985841 Breast Cancer Phase 2 Terminated(Due to poor accrual... More >>) Less << - Greece ... More >> "IASO" General Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece Heraklion, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Euromedica" Hospital of Thessaloniki Thessaloniki, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT00712582 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02933775 CD19 Positive Malignant B-cell... More >> Leukemia and Lymphoma Less << Phase 1 Not yet recruiting January 2020 China, Shanghai ... More >> Renji Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Honghui Huang, MD       honghui_huang@163.com    Principal Investigator: Fangyuan Chen, MD          Sub-Investigator: Honghui Huang, MD Less <<
NCT00176904 Adrenoleukodystrophy ... More >> Metachromatic Leukodystrophy Globoid Cell Leukodystrophy Gaucher's Disease Fucosidosis Wolman Disease Niemann-Pick Disease Batten Disease GM1 Gangliosidosis Tay Sachs Disease Sandhoff Disease Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01539174 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Less << Phase 2 Withdrawn(No Funding Source an... More >>d Competing Trials) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT02489266 Metastatic Melanoma Phase 1 Withdrawn - -
NCT00176917 - Completed - -
NCT00004237 Breast Cancer Phase 2 Completed - United Kingdom ... More >> Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Less <<
NCT00022178 Carcinoma of Unknown Primary Phase 3 Unknown - United Kingdom ... More >> Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Less <<
NCT00014573 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00088530 Lymphoma, Non-Hodgkin Phase 3 Completed - -
NCT00176917 Mucopolysaccharidosis I ... More >> Mucopolysaccharidosis VI Mannosidosis Mucolipidosis Type II (I-cell Disease) Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00005834 Multiple Myeloma Phase 3 Terminated(poor accrual) - -
NCT00923845 Renal Cell Carcinoma ... More >> Graft-Versus-Host Disease Engraftment Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00088530 - Completed - -
NCT02601313 Relapsed/Refractory Mantle Cel... More >>l Lymphoma Less << Phase 2 Recruiting March 2034 -
NCT02660710 Diffuse Large B-cell Lymphoma ... More >> HIV Less << Phase 2 Recruiting December 2022 Malawi ... More >> UNC Project, Lighthouse Trust Recruiting Lilongwe, Malawi Contact: Sam Phiri, PhD       samphiri@lighthouse.org.mw Less <<
NCT03096782 Hematopoietic/Lymphoid Cancer Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       alolson@mdanderson.org Less <<
NCT00923845 - Completed - -
NCT02561273 Anaplastic Large Cell Lymphoma... More >>, ALK-Negative Anaplastic Large Cell Lymphoma, ALK-Positive Hepatosplenic T-Cell Lymphoma Peripheral T-Cell Lymphoma, Not Otherwise Specified Stage II Angioimmunoblastic T-cell Lymphoma Stage II Enteropathy-Associated T-Cell Lymphoma Stage III Angioimmunoblastic T-cell Lymphoma Stage III Enteropathy-Associated T-Cell Lymphoma Stage IV Angioimmunoblastic T-cell Lymphoma Stage IV Enteropathy-Associated T-Cell Lymphoma Less << Phase 1 Phase 2 Active, not recruiting October 2021 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Stanford Cancer Institute Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00797810 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Less << Phase 4 Unknown - Italy ... More >> Institute of Haematology "L. e A. Seragnoli" Recruiting Bologna, Italy Contact: Giovanni Martinelli, MD Less <<
NCT03538613 Gastrointestinal Epithelial Ca... More >>ncer Gastrointestinal Neoplasm Cancer of Gastrointestinal Tract Cancer, Gastrointestinal Less << Phase 1 Phase 2 Withdrawn(NCI not moving forwa... More >>rd with study execution.) Less << - -
NCT03755804 Hodgkin Lymphoma Phase 2 Recruiting July 1, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jamie Flerlage, MD, MS    866-278-5833    referralinfo@stjude.org Less <<
NCT00701701 Pompe Disease ... More >> Glycogen Storage Disease Type II (GSD-II) Glycogenesis 2 Acid Maltase Deficiency Less << Phase 4 Active, not recruiting January 2020 United States, Kentucky ... More >> Louisville, Kentucky, United States United States, North Carolina Durham, North Carolina, United States United States, Utah Salt Lake City, Utah, United States United States, Virginia Norfolk, Virginia, United States Israel Haifa, Israel Less <<
NCT03250546 Hematopoietic Stem Cell Transp... More >>lant Less << Phase 2 Recruiting November 30, 2022 France ... More >> Saint Louis hospital Recruiting Paris, France, 75010 Contact: Nathalie DHEDIN, MD    33+142385127    nathalie.dhedin@aphp.fr    Principal Investigator: Nathalie Dhedin, MD          Service Hématologie Clinique Recruiting Paris, France, 75013 Contact: Stéphanie NGUYEN, MD PhD    33+142162823    stephanie.nguyen-quoc@aphp.fr Less <<
NCT00187096 Acute Myeloid Leukemia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02173262 Breast Cancer Phase 4 Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT03749018 Aggressive Non-Hodgkin Lymphom... More >>a Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Diffuse Large B-Cell Lymphoma High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma, Not Otherwise Specified Indolent Non-Hodgkin Lymphoma Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Transformed Non-Hodgkin Lymphoma Less << Phase 2 Not yet recruiting December 31, 2021 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Not yet recruiting Columbus, Ohio, United States, 43210 Contact: Kami J. Maddocks    614-293-3196    Kami.maddocks@osumc.edu    Principal Investigator: Kami J. Maddocks Less <<
NCT00060346 - Terminated(slow accrual) - -
NCT01690702 Breast Cancer Phase 3 Active, not recruiting December 2020 Germany ... More >> Klinikum Frankfurt Höchst Frankfurt, Hessen, Germany, 65929 Less <<
NCT02522234 Neutropenia Phase 1 Phase 2 Completed - China ... More >> Fudan University Shanghai Cancer Center Shanghai, China, 200032 Less <<
NCT00060346 Lymphoma Phase 2 Terminated(slow accrual) - -
NCT03475134 Metastatic Melanoma Phase 1 Recruiting June 1, 2024 Switzerland ... More >> CHUV Oncology Department Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: George Coukos    +41213140627    george.coukos@chuv.ch Less <<
NCT02647255 Glomerulonephritis, IGA ... More >> Kidney Diseases Acute Renal Insufficiency Rapidly Progressive Glomerulonephritis Less << Phase 2 Phase 3 Enrolling by invitation December 2020 China, Beijing ... More >> Renal Division, Department of Medicine, Peking University First Hospital Beijing, Beijing, China, 100034 Renal division, Peking University First Hospital Beijing, Beijing, China, 100034 Less <<
NCT00886522 Hematological Malignancies Phase 2 Completed - Italy ... More >> Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy, 40138 Less <<
NCT02063022 Ewing's Sarcoma Phase 3 Recruiting December 2018 Italy ... More >> Centro di Riferimento Oncologico - Unit of Medical Oncology Recruiting Aviano, Pordenone, Italy, 33081 Contact: Maurizio Mascarin, MD    +390434659 ext 536    mascarin@cro.it    Principal Investigator: Maurizio Mascarin, MD          I.R.C.C. - Unit of Medical Oncology Recruiting Candiolo, Torino, Italy, 10060 Contact: Massimo Aglietta, MD    +39.011.9933 ext 628    massimo.aglietta@ircc.it    Contact: Luisa Gioeni, Pharmacist    +39.011.9933 ext 278    luisa.gioeni@ircc.it    Principal Investigator: Massimo Aglietta, MD          Sub-Investigator: Giovanni Grignani, MD          Presidio Sanitario Gradenigo Recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151 ext 211    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituto Ortopedico Rizzoli Recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari, MD    +390516366 ext 411    stefano.ferrari@ior.it    Contact: Emanuela Marchesi, PhD    +390516366 ext 400    emanuela.marchesi@ior.it    Principal Investigator: Stefano Ferrari, MD          A.O. Universitaria Policlinico S. Orsola Malpighi di Bologna Recruiting Bologna, Italy, 40138 Contact: Arcangelo Prete, MD    +390516363 ext 111    tmoped@aosp.bo.it    Principal Investigator: Arcangelo Prete, MD          Servizio di Oncoematologi Pediatrica Ospedale microcitemico ASL 8 Recruiting Cagliari, Italy, Rosamaria Contact: Rosamaria Mura, MD          Principal Investigator: Rosamaria Mura, MD          A.O. Universitaria Meyer Recruiting Firenze, Italy, 50139 Contact: Angela Tamburini, MD    +3905556 ext 621    a.tamburini@meyer.it    Principal Investigator: Angela Tamburini, MD          Istituto Giannina Gaslini Recruiting Genova, Italy Contact: Alberto Garaventa, MD    +390105636 ext 694    albertogaraventa@ospedale-gaslini.ge.it    Principal Investigator: Alberto Garaventa, MD          FONDAZIONE IRCCS Istituto Nazionale dei Tumori Recruiting Milano, Italy Contact: Roberto Luksch, MD          Principal Investigator: Roberto Luksch, MD          Azienda Ospedaliera di Padova Recruiting Padova, Italy Contact: Gianni Bisogno, MD          Principal Investigator: Gianni Bisogno, MD          Istituto Nazionale Tumori Regina Elena - Unit of Medical Oncology I Recruiting Roma, Italy, 00144 Contact: Virginia Ferraresi, MD    +390652666 ext 773    ferraresi@ifo.it    Contact: , MD          Principal Investigator: Virginia Ferraresi, MD          Ospedale Pediatrico Bambin Gesu' Recruiting Roma, Italy Contact: Raffaele Cozza, MD          Principal Investigator: Raffaele Cozza, MD          Ospedale Infantile Regina Margherita - Unit of Paediatric Oncoematology Recruiting Torino, Italy, 10126 Contact: Franca Fagioli, MD    +39.011.3135 ext 230    franca.fagioli@unito.it    Principal Investigator: Franca Fagioli, MD Less <<
NCT00187096 - Completed - -
NCT03017131 Recurrent Fallopian Tube Carci... More >>noma Recurrent Ovarian Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 1 Recruiting August 15, 2020 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Kunle Odunsi Less <<
NCT00336843 Non-Hodgkin's Lymphoma Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, Departement of Internal Medicine, Division of Oncology Seoul, Korea, Republic of, 138-736 Less <<
NCT00365274 Anaplastic Large Cell Lymphoma Phase 2 Terminated - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01495572 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(Due to slow accrual... More >>, the investigator decided to close the study.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00365274 - Terminated - -
NCT01015742 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Leukemia, Myeloid, Chronic Less << Phase 2 Phase 3 Unknown January 2013 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +98-21    aahamidieh@sina.tums.ac.ir    Sub-Investigator: Ardeshir Ghavamzadeh, MD          Principal Investigator: Amir Ali Hamidieh, MD          Sub-Investigator: Omid Modiramani, MD Less <<
NCT03042429 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Koln, Germany, 50924 Less <<
NCT01516567 Primary Mediastinal Large B Ce... More >>ll Lymphoma Less << Phase 2 Active, not recruiting April 2019 Belgium ... More >> University Hospitals Leuven Leuven, Belgium, 3000 Canada Children Oncology Group Operations centres Monrovia, Canada France Gustave Roussy Villejuif, France, 94805 Hungary 2nd Dept. of Pediatrics Semmelweis Univ. Budapest, Hungary, 1094 Italy Associazione Italiana di Ematologia ed Oncologia Pediatrica Padova, Italy, 35128 Netherlands Emma Children's Hospital Amsterdam, Netherlands, 1105 AZ Poland Rectorat of Medical University Wroclaw, Poland Spain Sociedad Española de Hematología y Oncología Pediátricas Valencia, Spain, 46010 United Kingdom University of Birmingham Birmingham, United Kingdom Less <<
NCT03171220 Advanced Malignant Solid Tumor Phase 1 Phase 2 Recruiting December 31, 2020 China, Jiangsu ... More >> The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Baorui Liu, M.D. & Ph.D    +86-25-83304616 ext 61331    baoruiliu@nju.edu.cn    Contact: Zhengyun Zou, M.D. & Ph.D    +86-25-83304616 ext 61331    zouzhengyun@medmail.com.cn Less <<
NCT01495572 - Terminated(Due to slow accrual... More >>, the investigator decided to close the study.) Less << - -
NCT01516580 B-cell Non Hodgkin Lymphoma ... More >> Mature B-cell Leukemia Burkitt-type Less << Phase 3 Active, not recruiting December 2021 Belgium ... More >> University Hospitals Leuven Leuven, Belgium, 3000 Canada Children Oncology Group Operations centres Monrovia, Canada China The University of Hong Kong (Clinical Trials Centre) Hong-Kong, China France Institut de Cancérologie Gustave roussy Villejuif, France, 94805 Hungary 2nd Dept. of Pediatrics Semmelweis Univ. Budapest, Hungary, 1094 Italy Associazione Italiana di Ematologia ed Oncologia Pediatrica Padova, Italy, 35128 Netherlands Emma Children's Hospital Amsterdam, Netherlands, 1105 AZ Poland Rectorat of Medical University Wroclaw, Poland Spain Sociedad Española de Hematología y Oncología Pediátricas Valencia, Spain, 46010 United Kingdom University of Birmingham Birmingham, United Kingdom Less <<
NCT00067002 Leukemia, Lymphocytic, Acute ... More >> Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 770030 Less <<
NCT02529839 Multiple Sclerosis Not Applicable Unknown October 2017 -
NCT00751868 Breast Cancer Phase 2 Completed - Italy ... More >> Azienza Osped.Treviglio - Caravaggio Treviglio, BG, Italy, 24047 Azienda Ospedaliera G. Rummo Benevento, BN, Italy, 82100 Ospedale Civile di Campobasso - A. Cardarelli Campabasso, CB, Italy, 86100 Ospedale civile Renzetti di Lanciano Lanciano, CH, Italy, 66034 Azienda Ospedaliera S. Anna Como, CO, Italy, 22100 Azienda Ospedaliera Nesina Garibaldi Catania, CT, Italy, 95124 I.S.T. - Istituto Nazionale per la Ricerca sul Cancro Genova, GE, Italy, 16131 Presidio Ospedaliero di Macerata Mecerata, MC, Italy, 62100 I.R.C.C.S. Multimedica - Casa di Cura Accreditata Sesto San Giovanni, Milano, Italy, 20099 Azienda Ospedaliera R. Silvestrini Perugia, PG, Italy, 06132 Azienda Ospedaliera SS. Annunziata Sassari, SS, Italy, 07100 Ospedale S. Cuore Don Calabria Negrar, Verona, Italy, 37024 Ist. Nazionale per lo Studio e la Cura dei Tumori - Fondazione Pascale Napoli, Italy, 80131 Università Federico II Napoli, Italy, 80131 Istituto Regina Elena Roma, Italy, 00100 Less <<
NCT00825149 Non-Hodgkin's Lymphoma Phase 1 Completed - -
NCT00991211 Non-Hodgkin Lymphomas ... More >> Follicular Lymphomas Immunocytomas Lymphocytic Lymphomas Marginal Zone Lymphomas Less << Phase 3 Completed - Germany ... More >> StiL Head Office; Justus-Liebig-University Giessen, Germany, 35392 Less <<
NCT02134262 Relapsed or Refractory B-Cell ... More >>Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Unknown March 2017 Japan ... More >> Jichi Medical University Recruiting Shimotsuke, Tochigi, Japan, 329-0498 Contact: Ken Ohmine, MD, PhD    +81-285-58-7353    omineken@jichi.ac.jp    Principal Investigator: Keiya Ozawa, MD, PhD Less <<
NCT02644655 Recurrent B-Cell Tumor ... More >> Refractory B-Cell Tumor Less << Phase 1 Phase 2 Unknown September 2017 China ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, China, 200438 Contact: Huajun Jin, PHD    +86-21-81875372    hj-jin@hotmail.com    Principal Investigator: Qijun Qian, PHD          Principal Investigator: Huajun Jin, PHD          Principal Investigator: Zhengang Yuan, PHD          Sub-Investigator: Yao Huang, MD          Sub-Investigator: Fuping Zhou, MD          Sub-Investigator: Yongmei Ding, MD Less <<
NCT00186797 Aplastic Anemia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00931645 Chronic Lymphocytic Leukemia Phase 3 Completed - France ... More >> DBIM Hopital Saint Louis Paris, France, 75000 Less <<
NCT03330834 Advanced Lung Cancer Phase 1 Not yet recruiting September 30, 2019 -
NCT00307671 Vasculitis We... More >>gener's Granulomatosis Microscopic Polyangiitis Churg-Strauss Syndrome Polyarteritis Nodosa Less << Phase 4 Completed - France ... More >> Hôpital Cochin Paris, France, 75679 Less <<
NCT00135967 Glomerulonephritis, Membranous Phase 2 Phase 3 Completed - Netherlands ... More >> Department of Nephrology Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500 HB Less <<
NCT00049439 Lymphoma Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 United States, Ohio Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Kenya University of Nairobi College of Health Sciences Nairobi, Kenya Uganda Uganda Cancer Institute Kampala, Uganda Less <<
NCT00392327 Anaplastic Medulloblastoma ... More >> Medulloblastoma Untreated Childhood Medulloblastoma Less << Phase 3 Suspended(Temporarily stopped ... More >>for assessment. Contact ctsucontact@westat.com for specifics) Less << - -
NCT03318835 Thalidomide Phase 3 Recruiting August 22, 2020 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: FangFang Lv    18017312613    lvff80@163.com Less <<
NCT03089203 Prostate Cancer Phase 1 Recruiting September 8, 2021 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Naomi Haas, MD    855-216-0098    CancerTrials@emergingmed.com Less <<
NCT00644124 Lymphoma, Non-Hodgkin Phase 1 Completed - France ... More >> Sanofi-Aventis Administrative Office Paris, France Less <<
NCT00006184 - Completed - -
NCT00801281 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Small Lymphocytic Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 3 Completed - Poland ... More >> Podkarpacki Oncology Centre Brzozów, Poland, 36-200 Voivodeship Hospital, Oncology Ward Elbląg, Poland, 82-300 Academic Clinical Centre, Hospital of Medical Academy, Clinic of Haematology and Transplantology Gdańsk, Poland, 80-211 Silesian Medical University, Chair and Clinic of Haematology and Bone Marrow Transplantation Katowice, Poland, 40-029 Collegium Medicum Jagiellonian University, Clinic of Haematology Kraków, Poland, 31-501 Oncology Centre of Lublin Region Lublin, Poland, 20-090 Central Clinical Hospital, Ministry of Internal Matters and Administration; Clinic of Oncology, Haematology and Internal Diseases Warszawa, Poland, 02-507 Institute of Haematology and Transfusiology Warszawa, Poland, 02-776 M.Sklodowska-Curie Institute - Oncology Centre Warszawa, Poland, 02-782 Medical Academy in Wrocław; Chair and Clinic of Haematology, Blood Neoplasm and Bone Marrow Transplantation Wrocław, Poland, 50-367 SP ZOZ Silesian Centre of Cellular Transplantation Wrocław, Poland, 53-439 Regional Oncology Centre, Ward of Proliferative Diseases Łódź, Poland, 93-509 Less <<
NCT03019666 Multiple Myeloma ... More >> Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Mantle-Cell Lymphoma Follicular Lymphoma Indolent B Cell Lymphoma Primary Mediastinal Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting March 31, 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Veronika Bachanova, MD, PhD Less <<
NCT00278213 Prolymphocytic Leukemia Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria, A-1090 Hanuschkrankenhaus Vienna, Austria, A-1140 Germany Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany, 29223 St. Johannes Hospital - Medical Klinik II Duisburg, Germany, D-47166 Helios Klinikum Erfurt Erfurt, Germany, D-99089 Universitaetsklinikum Essen Essen, Germany, D-45147 Klinikum Garmisch - Partenkirchen GmbH Garmisch-Partenkirchen, Germany, N 82467 Sana Klinikum Hof Hof, Germany, 95032 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24116 Internistische Praxis - Ludwigsburg Ludwigsburg, Germany, 71638 Sana Kliniken Luebeck Luebeck, Germany, D-23560 Haematologische Praxis - Moenchengladbach Moenchengladbach, Germany, 41239 Gemeinschaftliche Schwerpunktpraxis - Osnabrueck Osnabrueck, Germany, 49074 Caritasklinik St. Theresia Saarbrucken, Germany, D-66113 Schwerpunktpraxis fuer Haematologie und Onkologie Saarbruecken, Germany, 66113 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 Klinikum des Landkreises Loebau-Zittau GmbH Zittau, Germany, 02763 Less <<
NCT00006184 Multiple Myeloma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03000296 Crohn's Disease ... More >> Inflammatory Bowel Diseases Gastroenteritis Less << Not Applicable Recruiting March 2020 Brazil ... More >> Beneficencia Portuguesa Recruiting Sao Jose do Rio Preto, SP, Brazil, 15015-750 Contact: Ana Lucia, secretary    +5517 33047091    dlrserv@yahoo.com.br Less <<
NCT02763475 Acute Myeloid Leukemia ... More >> Leukemia Myeloid Leukemia Less << Phase 2 Recruiting February 2022 Spain ... More >> Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Principal Investigator: Itciar Astigarraga Aguirre, MD          Hospital Materno Infantil de Badajoz Recruiting Badajoz, Spain, 06010 Principal Investigator: Jose Manuel Vagace Valero, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact    0034913908868       Principal Investigator: José Luis Vivanco Martínez, MD.          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: María Posada, MSc.    0034912071466    maria.posada@idipaz.es    Contact: Alicia Herranz Estelles, MD, MSc    0034912071466    alicia.herranz@idipaz.es    Principal Investigator: Antonio Pérez Martínez, MD, PhD          Hospital de la Arrixaca Recruiting Murcia, Spain, 30120 Principal Investigator: José Luis Fuster, MD          Hospital Materno-Infantil de Málaga Recruiting Málaga, Spain, 29011 Principal Investigator: Antonia Pascual Martínez, MD Less <<
NCT00501826 Leukemia Lymp... More >>hoblastic Lymphoma Leukemia, Lymphoblastic, Acute Less << Phase 2 Recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03338972 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma TNFRSF17 Positive Less << Phase 1 Recruiting December 15, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Damian J. Green Less <<
NCT02685657 Triple Negative Breast Cancer Phase 2 Unknown - -
NCT02213705 SYSTEMIC SCLERODERMA ... More >> ALLOGENEIC MESENCHYMAL STEM CELLS ADULT Less << Phase 1 Phase 2 Recruiting June 2019 France ... More >> Saint-Louis Hospital Recruiting Paris, France, 75010 Contact: dominique farge, MD PHD    + 33 142499768    dominique.farge-bancel@sls.aphp.fr    Contact: Chen Wu    + 33 142499768    chen.wu.tec@gmail.com Less <<
NCT00610883 - Completed - -
NCT00486668 Invasive Breast Cancer Phase 3 Unknown March 2017 -
NCT02208037 Acute Leukemia ... More >> Chronic Myelogenous Leukemia Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Hodgkin's Lymphoma Less << Phase 2 Completed - -
NCT00610883 Non-Hodgkin's Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00619879 Leukemia, Myelogenous, Chronic... More >> Leukemia, Lymphoblastic, Acute Leukemia, Myelogenous, Acute Myeloproliferative-Myelodysplastic Diseases Lymphoma, Malignant Less << Phase 3 Recruiting January 2020 United States, Illinois ... More >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Morris Kletzel, MD Less <<
NCT00000899 HIV Infections Phase 1 Completed - United States, North Carolina ... More >> Univ of North Carolina Chapel Hill, North Carolina, United States, 275997215 Duke Univ Med Ctr Durham, North Carolina, United States, 27710 Less <<
NCT01679119 Diffuse Large B Cell Lymphoma Phase 2 Recruiting April 2021 United Kingdom ... More >> Stoke Mandeville Hospital (including Wycombe Hospital) Recruiting Aylesbury, United Kingdom Contact: Beena Pushkaran          North Hampshire Hospital Recruiting Basingstoke, United Kingdom Contact: Noel Ryman          Royal United Hospital Recruiting Bath, United Kingdom Contact: Christopher Knechtli          Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Renata Walewska          Bristol Oncology Centre Recruiting Bristol, United Kingdom Contact: Lisa Lowry          West Suffolk Hospital Recruiting Bury St Edmunds, United Kingdom Contact: Mamtha Karanth          Castle Hill Hospital Recruiting Cottingham, United Kingdom Contact: Rusell Patmore          University Hospital, Coventry Recruiting Coventry, United Kingdom Contact: Simon Watt          Darent Valley Hospital Recruiting Dartford, United Kingdom Contact: Tariq Shafi          Royal Devon & Exeter Hospital Recruiting Exeter, United Kingdom Contact: Paul Kerry          Medway Maritime Hospital Recruiting Gillingham, United Kingdom Contact: Maadh Abdul-Wahab Aldouri          Beatson West of Scotland Cancer Centre (including Gartnavel Royal Hospital) Recruiting Glasgow, United Kingdom Contact: Pam McKay          James Paget University Hospital Recruiting Great Yarmouth, United Kingdom Contact: Shalal Sadullah          Northwick Park Hospital Recruiting Harrow, United Kingdom Contact: Nicki Panoskaltsis          Kent and Canterbury Hospital Active, not recruiting Kent, United Kingdom Kettering General Hospital Recruiting Kettering, United Kingdom Contact: Matthew Lyttelton          St James's University Hospital Recruiting Leeds, United Kingdom Contact: Cathy Burton          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Contact: Fiona Miall          Aintree University Hospital Recruiting Liverpool, United Kingdom Contact: Jeffery Smith          Royal Liverpool University Hospital Recruiting Liverpool, United Kingdom Contact: Nagesh Kalakonda          Guy's Hospital (including St Thomas's Hospital) Recruiting London, United Kingdom Contact: Paul Fields          Royal Free Hospital Active, not recruiting London, United Kingdom University College London Hospital Recruiting London, United Kingdom Contact: Kate Cwynarski          Luton and Dunstable Hospital Recruiting Luton, United Kingdom Contact: Peter Hoskin          Christie Hospital Recruiting Manchester, United Kingdom Contact: Kim Linton          Freeman Hospital Recruiting Newcastle, United Kingdom Contact: Anne Lennard          North Tyneside Hosptial (including Wansbeck Hospital and Hexham General Hospital) Recruiting North Shields, United Kingdom Contact: Mari Kilner          Norfolk and Norwich University Hospital Recruiting Norwich, United Kingdom Contact: Nimish Shah          Nottingham City Hospital Recruiting Nottingham, United Kingdom Contact: Andrew McMillan          Princess Royal University Hospital Active, not recruiting Orpington, United Kingdom Churchill Hospital Recruiting Oxford, United Kingdom Contact: Graham Collins          Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Simon Rule          Queen's Hospital Recruiting Romford, United Kingdom Contact: Paul Greaves          Southampton General Hospital Recruiting Southampton, United Kingdom Contact: Andy Davies          Kings Mill Hospital Recruiting Sutton-in-Ashfield, United Kingdom Contact: Steve Jones          Torbay Hospital Recruiting Torquay, United Kingdom Contact: Deborah Turner          Royal Cornwall Hospital Recruiting Truro, United Kingdom Contact: Bryson Pottinger          Royal Hampshire County Hospital Recruiting Winchester, United Kingdom Contact: Katherine Lowndes          Worcester Royal Hospital (including Kidderminster Hospital and Alexandra Hospital) Recruiting Worcester, United Kingdom Contact: Mark Crowther          Wythenshawe Hospital (including Trafford General Hospital) Recruiting Wythenshawe, United Kingdom Contact: Simon Watt Less <<
NCT02875314 Medulloblastoma ... More >> Central Nervous System Embryonal Tumors Less << Phase 4 Recruiting September 2020 -
NCT01804634 Refractory and/or Relapsed Met... More >>astatic Solid Tumors Less << Phase 2 Recruiting December 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Heather Symons, MD, MHS    410-502-4997    hsymons2@jhmi.edu    Principal Investigator: Heather Symons, MD, MHS Less <<
NCT00791037 HER2-positive Breast Cancer ... More >> Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00290433 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03467256 B-cell Acute Lymphoblastic Leu... More >>kemia Acute Lymphocytic Leukemia, Pediatric Less << Phase 1 Phase 2 Recruiting March 2023 Russian Federation ... More >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117198 Contact: Zhanna Shekhovtsova    4956647078    zhanna.shekhovtsova@fccho-moscow.ru    Contact: Eugene Pashanov, Prof. PhD    +79262205578    e.pashanov@gmail.com    Sub-Investigator: Olga Molostvova Less <<
NCT03269669 Grade 1 Follicular Lymphoma ... More >> Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Follicular Lymphoma Refractory Follicular Lymphoma Less << Phase 2 Recruiting December 31, 2022 -
NCT00378534 Chronic Myelogenous Leukemia ... More >> Acute Myelogenous Leukemia Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03773744 Metastatic Melanoma ... More >> Squamous Cell Skin Carcinoma Less << Phase 1 Not yet recruiting December 31, 2021 -
NCT00378534 - Completed - -
NCT01949818 Diffuse Large B Cell Lymphoma Phase 4 Unknown September 2018 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhanf, Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Dr    13838565629    mingzhi_zhang@126.com Less <<
NCT03277729 CD20 Positive ... More >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Transformed Indolent Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting November 16, 2037 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mazyar Shadman    206-667-5467    mshadman@uw.edu    Principal Investigator: Mazyar Shadman Less <<
NCT00473551 Leukemia Lymp... More >>homa Myeloma Less << Phase 1 Terminated(Terminated due to s... More >>low accrual.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03710772 CD20 Positive ... More >> Mantle Cell Lymphoma Less << Phase 2 Not yet recruiting May 18, 2023 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Luhua (Michael) Wang    713-792-2860       Principal Investigator: Luhua (Michael) Wang Less <<
NCT02420717 Leukemia Phase 2 Recruiting July 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01510613 Primary Amyloidosis of Light C... More >>hain Type Less << Phase 2 Completed - Italy ... More >> Centro per lo Studio e la Cura delle Amiloidosi Sistemiche - Fondazione IRCCS Policlinico S.Matteo Pavia, Italy, 27100 Less <<
NCT01636947 - Completed - -
NCT01636947 Nausea Vomiti... More >>ng Less << Phase 4 Completed - -
NCT01455259 Malignant Melanoma Phase 1 Phase 2 Completed - Sweden ... More >> Uppsala University Hospital Uppsala, Sweden, 75185 Less <<
NCT00791037 - Completed - -
NCT02670109 Triple-Negative Invasive Breas... More >>t Carcinoma Residual Tumor Less << Phase 2 Recruiting November 2019 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Distrito Federal, Mexico, 14080 Contact: Eucario Leon Rodriguez, M.D.    525554870900 ext 2255    eucarios@hotmail.com    Contact: Monica M Rivera Franco, M.D.    525554870900 ext 2719    monrif90d@gmail.com    Sub-Investigator: Alejandra Armengol Alonso, M.D. Less <<
NCT00001832 - Completed - -
NCT00204659 Primary Gastric Diffuse-Large ... More >>B-Cell Lymphoma Less << Phase 2 Completed - Germany ... More >> Zentralklinikum Augsburg Augsburg, Germany, 86156 University of Giessen Giessen, Germany, 35392 Klinikum Reutlingen Reutlingen, Germany University of Tubingen Tuebingen, Germany, 72076 Schwarzwald-Baar Clinic Villingen-Schwenningen, Germany, 78050 Less <<
NCT02877303 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00001832 Melanoma Neop... More >>lasm Metastasis Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03339700 Acute Lymphoblastic Leukemia, ... More >>Adult Less << Early Phase 1 Recruiting December 30, 2018 Mexico ... More >> Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran Recruiting Mexico City, Distrito Federal, Mexico, 14080 Contact: Eucario Leon Rodriguez, M.D.    525554870900 ext 2255    eucarios@hotmail.com    Contact: Monica M Rivera Franco, M.D.    525554870900 ext 2719    monrif90d@gmail.com Less <<
NCT00526292 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00144807 Diffuse Large Cell Lymphoma Phase 2 Completed - Belgium ... More >> Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium France Polyclinique Bordeaux Nord Bordeaux, France, 33300 Hôpital Henri Mondor Créteil, France, 94010 Hématologie CHU de Lille Lille, France, 59000 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Switzerland Schweirische Arbeitsgruppe fur klinische Krebsforschung Lausanne, Switzerland Less <<
NCT00002600 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 Less <<
NCT00622895 Systemic Scleroderma ... More >> Severe Systemic Sclerosis Less << Phase 1 Phase 2 Completed - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00526292 - Completed - -
NCT00499616 Neuroblastoma Phase 3 Completed - -
NCT00622895 - Completed - -
NCT03015974 - Recruiting January 2019 China ... More >> Peking University First Hospital Recruiting Beijing, China, 100034 Contact: Xuhui Zhong, Dr.    8613683556856    xuhui7876@126.com Less <<
NCT00126243 AIDS Related Lymphoma Phase 2 Terminated - France ... More >> Service de Medecine Interne Hopital Antoine Beclere Clamart, France, 92140 Less <<
NCT00005613 Lymphoma Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01312376 Ovarian Carcinoma ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03594162 - - - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00499616 - Completed - -
NCT00584766 Metastatic Breast Cancer Phase 2 Completed - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT01958996 High Grade Lymphomas CD20 Posi... More >>tive Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Poitiers Poitiers, France, 86000 Less <<
NCT00455533 Breast Cancer Phase 2 Completed - -
NCT03448393 Acute Lymphoid Leukemia ... More >> B-Cell Leukemia Leukemia, Lymphocytic, B Cell B-Cell Lymphoma Lymphoma, Non-Hodgkin Less << Phase 1 Recruiting December 1, 2032 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02456350 Chronic Lymphocytic Leukemia ... More >> Acute Lymphocytic Leukemia Lymphoma Less << Phase 1 Recruiting December 2019 China, Guangdong ... More >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D.    15814723218    mingjunw429@163.com    Contact: Weihong Chen, M.D., Ph.D.    13923871697    whitney-cindy@hotmail.com    Principal Investigator: Xin Du, M.D., Ph.D.          Principal Investigator: Mingjun Wang, M.D., Ph.D.          Principal Investigator: Geng Tian, M.D., Ph.D.          Principal Investigator: Weihong Chen, M.D., Ph.D. Less <<
NCT01822314 Breast Cancer Phase 3 Active, not recruiting October 2025 -
NCT00455533 - Completed - -
NCT00696735 Follicular Lymphoma Phase 3 Completed - France ... More >> Emmanuel GYAN Tours, France, 37000 Philippe COLOMBAT Tours, France, 37000 Less <<
NCT00001498 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03536039 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 2 Recruiting January 27, 2020 Italy ... More >> Ospedale San Raffaele Recruiting Milan, Italy, 20132 Contact: Andrés Jose Maria Ferreri, MD    00390226437649    ferreri.andres@hsr.it    Contact: Teresa Calimeri, MD    00390226437642    calimeri.teresa@hsr.it Less <<
NCT00501332 Chemotherapy-Induced Neutropen... More >>ia Breast Cancer Less << Phase 2 Unknown - Poland ... More >> Recruiting Bydgoszcz, Poland Recruiting Gdansk, Poland Recruiting Lublin, Poland Romania Active, not recruiting Alba-Iulia, Romania Active, not recruiting Bucuresti, Romania Recruiting Jud. Bacau, Romania Recruiting Suceava, Romania Recruiting Timisoara, Romania Russian Federation Active, not recruiting Leningrad region, Russian Federation Recruiting Moscow Area, Russian Federation Active, not recruiting Moscow, Russian Federation Active, not recruiting Ryazan, Russian Federation Active, not recruiting St. Petersburg, Russian Federation Ukraine Recruiting Dnipropetrovsk, Ukraine Recruiting Uzhorod, Ukraine Less <<
NCT01410344 - Active, not recruiting - -
NCT01410344 Leukemia Lymp... More >>homa HIV Less << Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic - Phoenix Phoenix, Arizona, United States, 85054 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 University of CA, SF San Francisco, California, United States, 94143-0324 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Blood & Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas/MD Anderson CRC Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT03084380 Hepatocellular Carcinoma Phase 1 Phase 2 Not yet recruiting May 31, 2020 China, Chongqing ... More >> Department of Oncology, Xinqiao Hospital ChongQing, Chongqing, China, 400037 Less <<
NCT03105336 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Indolent Non-Hodgkin Lymphoma Less << Phase 2 Recruiting March 2034 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States, 85234 Contact: Andrea Winkle    480-256-3421    andrea.winkle@bannerhealth.com    Principal Investigator: Javier Munoz, MD          United States, California USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Kevin Kelly, MD    323-865-3828    kevin.kelly@med.usc.edu    Principal Investigator: Kevin Kelly, MD          University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Sven de Vos, MD, PhD    310-267-2756    devos@mednet.ucla.edu    Principal Investigator: Sven de Vos, MD, PhD          United States, District of Columbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20057 Contact: Pashna Munshi, MD    202-444-1212    pashna.n.munshi@gunet.georgetown.edu    Principal Investigator: Pashna Munshi, MD          United States, Florida University of Miami Hospital and Clinics Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis    305-243-7648    nluis@med.miami.edu    Principal Investigator: Joseph Rosenblatt, MD          H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott    813-745-7227    matthew.scott@moffitt.org    Principal Investigator: Julio Chavez, MD          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Krystle Benedict    617-582-8713    Krystle_Benedict@dfci.harvard.edu    Principal Investigator: Caron Jacobson, MD          United States, New Jersey Hackensack University Medical Center - John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara Yannotti    551-996-5168    kara.yannotti@hackensackmeridian.org    Principal Investigator: Lori Leslie, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10037 Contact: Julia Gould    212-342-3849    jg3686@cumc.columbia.edu    Principal Investigator: Ran Reshef, MD          University of Rochester Medical Center (URMC) Recruiting Rochester, New York, United States, 14642 Contact: Erin Enfield    585-276-4404    erin_enfield@urmc.rochester.edu    Principal Investigator: Carla Casulo, MD          United States, Ohio Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski    614-688-9796    nicole.szuminski@osumc.edu    Principal Investigator: Basem William, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Elisabeth Giraud       Elisabeth.Giraud@fccc.edu    Contact: Laura McIntyre       Laura.McIntyre@fccc.edu    Principal Investigator: Henry Fung, MD          UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Linda Fukas    412-623-6037    fukaslj@upmc.edu    Principal Investigator: Alison Sehgal, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Ask Sarah    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: Ian Flinn, MD, PhD          Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Delia Darst    615-343-7190    delia.h.darst@vumc.org    Principal Investigator: Olalekan Oluwole, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo    713-563-4167    lnvallejo@mdanderson.org    Contact: Sherry Adkins    713-745-3035    sadkins@mdanderson.org    Principal Investigator: Sattva Neelapu, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: David Maloney, MD, PhD          France Centre Hospitalier Régional Universitaire de Lille Recruiting Lille, France, 59037 Principal Investigator: Ibrahim Yakoub-Agha, MD          Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Principal Investigator: Gilles Salles, MD Less <<
NCT03314974 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma Chronic Myelogenous Leukemia Plasma Cell Leukemia Myeloproliferative Neoplasms Myelofibrosis Myelodysplasia Refractory Anemia High Risk Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large Cell Non Hodgkins Lymphoma Lymphoblastic Lymphoma Burkitt Lymphoma High Grade Non-Hodgkin's Lymphoma, Adult Multiple Myeloma Juvenile Myelomonocytic Leukemia Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Natural Killer Cell Malignancies Acquired Bone Marrow Failure Syndromes Less << Phase 2 Recruiting November 10, 2023 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55337 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@Fairview.org Less <<
NCT01822652 Neuroblastoma Phase 1 Active, not recruiting October 2030 United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03466320 AML MDS Phase 1 Recruiting August 2021 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 United States, New York New York School of Medicine Recruiting New York, New York, United States, 10016 Belgium Institute Jules Bordet Recruiting Brussels, Belgium UZ Gent Recruiting Gent, Belgium Less <<
NCT00004125 Breast Cancer Phase 3 Completed - -
NCT00017641 Systemic Lupus Erythematosus Phase 1 Unknown - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-0001 Less <<
NCT01639456 Acute Myelogenous Leukemia Phase 2 Withdrawn(study was abandoned ... More >>and a new study was written to replace this one) Less << January 2017 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00005986 Leukemia Phase 2 Terminated(Principal investiga... More >>tor left the university.) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT02125344 Tubular Breast Cancer Stage II... More >> Tubular Breast Cancer Stage III Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer HER2 Positive Breast Cancer Inflammatory Breast Cancer Less << Phase 3 Completed - Germany ... More >> NTC Heidelberg, Baden-Württemberg, Germany, 69120 Less <<
NCT02339441 - Completed - -
NCT02700022 Diffuse Large B-cell Lymphoma ... More >> Follicular Lymphoma Burkitt Lymphoma Less << Phase 1 Terminated(Lack of funding) - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, North Carolina University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center Chapel Hills, North Carolina, United States, 27599 Less <<
NCT02625480 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2034 -
NCT02541565 Composite Lymphoma ... More >> Grade 3b Follicular Lymphoma Stage I Diffuse Large B-Cell Lymphoma Stage I Follicular Lymphoma Stage II Diffuse Large B-Cell Lymphoma Stage II Follicular Lymphoma Stage III Diffuse Large B-Cell Lymphoma Stage III Follicular Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Stage IV Follicular Lymphoma Less << Phase 1 Recruiting November 24, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Stephen D. Smith    206-288-6546    ssmith50@seattlecca.org    Principal Investigator: Stephen D. Smith Less <<
NCT03564704 Leukemia Leuk... More >>emia, Acute Adult Lymphoblastic Lymphoma Leukemia, Lymphoblastic Leukemia, T Cell Adult Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoblastic Leukemia Less << Phase 2 Phase 3 Recruiting May 30, 2021 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT03706547 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Progression Less << Phase 1 Not yet recruiting December 2021 China ... More >> Department of Hematology ,Fudan University Zhongshan Hospital Active, not recruiting Shanghai, China, 200032 Less <<
NCT00290498 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02111863 Melanoma Skin... More >> Cancer Less << Phase 2 Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02750254 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia Less << Phase 1 Active, not recruiting October 14, 2020 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT02111863 - Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - -
NCT03412877 Glioblastoma ... More >>Non-Small Cell Lung Cancer Ovarian Cancer Breast Cancer Gastrointestinal/Genitourinary Cancer Less << Phase 2 Recruiting March 23, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00085202 - Active, not recruiting - -
NCT00570180 Multiple Myeloma Phase 2 Completed - Canada, Alberta ... More >> Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada, T6G-1Z2 Canada, Manitoba CancerCare Manitoba 675 McDermot Ave. Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada, N6A 4L6 The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Saskatchewan Saskatoon Cancer Centre 20 Campus Drive Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00085202 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Active, not recruiting January 2023 United States, North Carolina ... More >> Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital Houston, Texas, United States, 77030-2399 Australia, New South Wales Sydney Children's Hospital Randwick, New South Wales, Australia, 2031 Children's Hospital at Westmead Westmead, New South Wales, Australia, 2145 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Australia, Victoria Royal Children's Hospital Parkville, Victoria, Australia, 3052 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00217425 - Completed - -
NCT02212574 Medulloblastoma Not Applicable Recruiting May 2022 United States, Arizona ... More >> Phoenix Childrens Hospital Hematology/Oncology Recruiting Phoenix, Arizona, United States, 85016-7710 Contact: Michael Etzl, Dr    602-546-0920    metzl@phoenixchildrens.com    United States, Colorado Children's Hospital Colorado Center for Cancer & Blood Disorders Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, M.D., M.S.    720-777-6772    kathleen.dorris@childrenscolorado.org    United States, Florida M D Anderson Cancer Center-Orlando Pediatric Hematology/Oncology Not yet recruiting Orlando, Florida, United States, 32806 Contact: Amy Smith, Dr    321-841-8588    amy.smith@orlandohealth.com    All Children's Hospital Pediatric Hematology/Oncology Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Stacie Stapleton, Dr    727-767-4176    Stacie.Stapleton@allkids.org    United States, Georgia Children's Healthcare of Atlanta- Egleston Pediatric Neuro-Oncology Recruiting Atlanta, Georgia, United States, 30322 Contact: Tobey MacDonald, Dr    404-727-1447    tobey.macdonald@emory.edu    United States, Illinois Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology Recruiting Chicago, Illinois, United States, 60611 Contact: Stewart Goldman, Dr    312-227-4844    sgoldman@northwestern.edu    United States, Maryland Johns Hopkins University Recruiting Baltimore, Maryland, United States, 21287 Contact: Kenneth Cohen, MD, MBA    410-614-5055    kcohen@jhmi.edu    Contact: Tammy Scott, RN    4140-614-5990    scottta@jhmi.edu    United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Pratiti Bandopadhayay, MBBS, PhD          United States, Missouri Washington University School of Medicine Pediatric Hematology/Oncology Recruiting Saint Louis, Missouri, United States, 63110 Contact: Joshua Rubin, Dr    314-454-6018    rubin_j@kids.wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Derek Hanson, MD    551-996-5437    dhanson@hackensackumc.org    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Kevin De Braganca, MD    212-639-3449    debragak@mskcc.org    United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Contact: David Ashley, MD, PhD       david.ashley@duke.edu    Principal Investigator: David Ashley, MD, PhD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mohamed S AbdelBaki, MBBCh    614-722-3250    mohamed.abdelbaki@nationwidechildrens.org    United States, Oregon Oregon Health and Science University Pediatric Hematology/Oncology Not yet recruiting Portland, Oregon, United States, 97239-3098 Contact: Kellie Nazemi, Dr    503-494-0714    nazemik@ohsu.edu    United States, Washington Seattle Children's Hospital Hematology/Oncology Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, Dr    206-987-2106    sarah.leary@seattlechildrens.org    United States, Wisconsin Childrens Hospital of Wisconsin (Medical College of Wisconsin) Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Jeffrey Knipstein, MD    414-955-4108    jknipstein@jhmi.edu Less <<
NCT02449252 Follicular Lymphoma Phase 3 Recruiting October 2025 China, Hubei ... More >> DiDeng Recruiting Wuhan, Hubei, China, 430071 Less <<
NCT00217425 Lymphoma Phase 2 Completed - -
NCT01144403 Diffuse Large B-Cell Lymphoma Phase 2 Terminated - Romania ... More >> Brasov, Romania, 500326 Bucharest, Romania, 005098 Bucharest, Romania, 022328 Bucuresti, Romania, 030171 Cluj-Napoca, Romania, 400015 Iasi, Romania, 700111 Targu-mures, Romania, 540136 Timisoara, Romania, 300079 Less <<
NCT02858804 Mantle Cell Lymphoma Phase 4 Recruiting June 2020 China ... More >> Shuhua Yi Recruiting Tianjin, China, 300020 Contact: Shuhua Yi, Doc    86-22-23909106    yishuhua@ihcams.ac.cn    Contact: Lugui Qiu, Doc    86-22-23909172    qiulg@ihcams.ac.cn Less <<
NCT02614066 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting March 2034 -
NCT03281954 Triple Negative Breast Cancer Phase 3 Recruiting June 30, 2024 -
NCT02988466 Hematologic Malignancies Phase 2 Recruiting January 2021 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski    612-273-2800    tkrepsk1@fairview.org Less <<
NCT00634881 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany, 16225 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69115 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Less <<
NCT01144403 - Terminated - -
NCT03485118 Diffuse Large B-cell Lymphoma Phase 2 Completed - -
NCT01905943 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT00003553 Kidney Cancer Phase 2 Unknown - United States, Maryland ... More >> NIH - Warren Grant Magnuson Clinical Center Recruiting Bethesda, Maryland, United States, 20892-1182 Contact: Patient Recruitment    800-411-1222 Less <<
NCT00002942 Breast Cancer Phase 3 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT01905943 - Completed - -
NCT00167219 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 1 Phase 2 Recruiting December 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT00187161 Non-Hodgkin Lymphoma ... More >> Acute Lymphoblastic Leukemia, Mature B-Cell Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01904136 Leukemia Myel... More >>oproliferative Diseases Less << Phase 1 Phase 2 Recruiting April 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02298946 Colorectal Cancer ... More >> Colorectal Neoplasms Colorectal Carcinoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00002858 Lung Cancer Phase 3 Unknown - France ... More >> Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 Centre Paul Papin Angers, France, 49036 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Hopital Antoine Beclere Clamart, France, 92141 Centre Hospitalier Sud Francilien - Site Corbeil Corbeil, France, 91100 Hopital Intercommunal De Creteil Creteil, France, 94010 Hopital De La Trouhade Dijon, France, 21034 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 C.H. General Andre Boulloche Montbeliard, France, 25209 CRLCC Nantes - Atlantique Nantes-Saint Herblain, France, 44805 Centre Antoine Lacassagne Nice, France, 06189 Hopital Haut Leveque Pessac, France, 33604 C.H. De Saumur Saumur, France, 49403 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 CHRU de Nancy - Hopitaux de Brabois Vandoeuvre-Les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00036868 Breast Cancer Phase 2 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Institut Jules Bordet Brussels, Belgium, 1000 Universitair Ziekenhuis Antwerpen Edegem, Belgium, B-2650 Denmark Herlev Hospital - University Hospital of Copenhagen Copenhagen, Denmark, DK-2730 Egypt National Cancer Institute of Egypt Cairo, Egypt France Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Nijmegen Cancer Center at Radboud University Medical Center Nijmegen, Netherlands, NL-6500 HB Poland Medical University of Gdansk Gdansk, Poland, 80-211 Serbia Institute of Oncology and Radiology of Serbia Belgrade, Serbia, 11000 South Africa Medical Oncology Centre of Rosebank Johannesburg, South Africa, 2193 United Kingdom Western Infirmary Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT02930967 Recurrent PD-L1+ Malignant Tum... More >>ors Metastatic PD-L1+ Malignant Tumors Less << Phase 1 Recruiting August 2019 China ... More >> China Meitan General Hospital Recruiting Beijing, China, 100028 Contact: Shidong Wei, MD    +86-13146634751    liqinghe9644679@163.com Less <<
NCT00115700 Follicular Lymphoma Phase 3 Active, not recruiting December 2022 Australia, Australian Capital ... More >>Territory The Canberra Hospital Garran, Australian Capital Territory, Australia, 2605 Australia, New South Wales Albury Base/Murray Valley Private Hospital Albury/Wodonga, New South Wales, Australia, 2640/3690 Calvary Mater Newcastle Newcastle, New South Wales, Australia, 2298 Prince of Wales Hospital Randwick, New South Wales, Australia, 2031 Westmead Hospital Wentworthville, New South Wales, Australia, 2145 Illawarra Cancer Care Centre Wollongong, New South Wales, Australia, 2500 Australia, Queensland Radiation Oncology - Mater Centre South Brisbane, Queensland, Australia, 4101 Genesis Cancer Care (previously Premion) Tugun, Queensland, Australia, 4224 Princess Alexandra Hospital Woolloongabba, Queensland, Australia, 4102 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 The Queen Elizabeth Hospital Woodville, South Australia, Australia, 5011 Australia, Tasmania Launceston General Hospital Launceston, Tasmania, Australia, 7250 Australia, Victoria St John of God Hospital Ballarat, Victoria, Australia, 3350 Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Andrew Love Cancer Care Centre, Geelong Hospital Geelong, Victoria, Australia, 3220 Austin Health Heidelberg, Victoria, Australia, 3084 Australia, Western Australia Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia, 6009 Canada Princess Margaret Hospital Toronto, Canada New Zealand Auckland Hospital Auckland, New Zealand, 1001 Waikato Hospital Hamilton, New Zealand, 3200 Wellington Hospital Wellington, New Zealand, 7902 Less <<
NCT02579005 Lung Cancer Phase 1 Recruiting February 2021 Canada, Quebec ... More >> Hopital Sacre-Coeur Recruiting Montréal, Quebec, Canada, H4J 1C5 Contact: Razvan Diaconescu, MD    1-514-338-2150    razvan.diaconescu@umontreal.ca    Contact: Stephanie Ibrahim, SCRC    1-514-338-2222 ext 7630    stephanie.ibrahim@crhsc.rtss.qc.ca Less <<
NCT00368355 Acute Lymphoblastic Leukemia ... More >> Non Hodgkins Lymphoma Myelodysplastic Syndrome Acute Myeloid Leukemia Chronic Myelogenous Leukemia Hemophagocytic Lymphohistiocytosis (HLH) Familial Hemophagocytic Lymphohistiocytosis (FLH) Viral-associated Hemophagocytic Syndrome (VAHS) X-linked Lymphoproliferative Disease (XLP) Less << Phase 2 Recruiting April 2020 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Robert A. Krance, MD    832-824-4661    rakrance@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org    Texas Children's Hosptial Recruiting Houston, Texas, United States, 77030 Contact: Robert A. Krance, MD    832-824-4661    rakrance@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT03711864 Multiple Myeloma Phase 1 Recruiting December 20, 2020 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Jian Li, M.D.    +86-18610852525    lijian@pumch.cn    Contact: Lu Zhang, M.D.    +86-18610728815    pumczhanglu@163.com Less <<
NCT00186680 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01319981 Leukemia Phase 2 Active, not recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03373708 Breast Cancer ... More >> Chemotherapy Endocrine Breast Diseases Less << Phase 2 Phase 3 Not yet recruiting December 20, 2019 -
NCT02181478 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Myelofibrosis Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Lymphoid Malignancies Chronic Myelogenous Leukemia Less << Early Phase 1 Recruiting November 2018 United States, Ohio ... More >> Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Leland Metheny, MD    216-983-4946    Leland.Metheny@uhhospitals.org    Contact: Marcos de Lima, MD    216-286-6869    Marcos.deLima@uhhospitals.org    Principal Investigator: Leland Metheny Less <<
NCT00903812 - Completed - -
NCT00003012 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00239343 Breast Cancer Phase 2 Completed - Denmark ... More >> Research Stie Herlev, Denmark Research Site København N, Denmark Research Site København Ø, Denmark Research Site Vejle, Denmark Research Site Århus C, Denmark Norway Research Site Oslo, Norway Research Site Trondheim, Norway Sweden Research Site Lund, Sweden Less <<
NCT00002498 Breast Cancer Phase 2 Unknown - Netherlands ... More >> Leiden University Medical Center Leiden, Netherlands, 2300 ZA St. Radboud University Hospital Nijmegen, Netherlands, 6500 HB Less <<
NCT03403712 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Phase 3 Recruiting October 2018 -
NCT02845999 Gastrointestinal Metastatic Ca... More >>ncer Less << Phase 1 Completed - France ... More >> University hospital of Besançon Besançon, France, 25000 Less <<
NCT00418743 - Unknown May 2010 France ... More >> Centre Hospitalier Universitaire Recruiting Angers, France, 49033 Contact: Thierry URBAN, Doctor    +33241355844    thurban@chu-angers.fr    Principal Investigator: Thierry URBAN, Doctor          Sub-Investigator: Nathalie BAIZE, Doctor          Sub-Investigator: Thierry JEANFAIVRE, Doctor          Sub-Investigator: José HUREAUX, Doctor          Site 05 Recruiting Bastia, France, 20200 Contact: Jean Cl MOURIES, Doctor    +33495591080    jcmouries@ch-bastia.fr    Principal Investigator: Jean Cl MOURIES, Doctor          Site 22 Recruiting Beauvais, France, 60021 Contact: Eric BOUCHAERT, Doctor          Principal Investigator: Eric BOUCHAERT, Doctor          Centre Hospitalier du Morvan Recruiting Brest, France, 29200 Contact: Gilles ROBINET, Doctor    +33298223428    gilles.robinet@chu-brest.fr    Principal Investigator: Gilles ROBINET, Doctor          Centre François Baclesse Recruiting Caen, France, 14000 Contact: Radj GERVAIS, Doctor    +33231455013    r.gervais@baclesse.fr    Principal Investigator: Radj GERVAIS, Doctor          Site 43 Recruiting Caen, France, 14000 Contact: Radj GERVAIS, Professor          Principal Investigator: Radj GERVAIS, Professor          Centre Hospitalier René Dubos Recruiting Cergy-pontoise, France, 95301 Contact: Gislaine FRABOULET, Doctor    +33130754282    gislaine.fraboulet@ch-pontoise.fr    Principal Investigator: Gislaine FRABOULET, Doctor          Site 33 Recruiting Creteil, France, 94010 Contact: Isabelle MONNET, Doctor          Principal Investigator: Isabelle MONNET, Doctor          Site 07 Recruiting Draguignan, France, 83300 Contact: Hervé LECAER, Doctor    +33 4 94 60 51 12    herve.lecaer@ch-draguignan.fr    Principal Investigator: Hervé LE CAER, Doctor          Site 32 Recruiting Elbeuf, France, 76503 Contact: Philippe DAVID          Principal Investigator: Philippe DAVID, Professor          Site 04 Recruiting GAP, France, 05000 Contact: Pascal THOMAS, Doctor    +33 4 92 40 61 26    pascal.thomas@chicas-gap.fr    Principal Investigator: Pascal THOMAS, Doctor          Centre Hospitalier Les Oudairies Recruiting La Roche Sur Yon, France, 85000 Contact: Acya BIZIEUX-TAMINY, Doctor    +33251446164    acya.bizieux@chd-vendee.fr    Principal Investigator: Acya BIZIEUX-TAMINY, Doctor          Sub-Investigator: Marie MARCQ, Doctor          Hospital du Cluzeau Recruiting Limoges, France, 87042 Contact: Alain VERGNENEGRE, Professor    +33 5 55 05 66 29    avergne@unilim.fr    Principal Investigator: Alain VERGNENEGRE, Professor          Centre Hospitalier Régional Recruiting Longjumeau, France, 91160 Contact: Gérard OLIVIERO, Doctor    +33164543181    gerard.oliviero@ch-longjumeau.fr    Principal Investigator: Gérard OLIVIERO, Doctor          Sub-Investigator: Pascal ASSOULINE, Doctor          Centre Hospitalier Lyon Sud Recruiting Lyon, France, 69495 Contact: Laurence GERINIERE, Doctor    +33478861328    lairence.geriniere@chu-lyon.fr    Principal Investigator: Laurence GERINIERE, Doctor          Sub-Investigator: Pierre J SOUQUET, Professor          Site 25 Recruiting Mantes La Jolie, France, 78200 Contact: Jean B AULIAC, Doctor          Principal Investigator: Jean Be AULIAC, Doctor          Site 06 Recruiting Marseille, France, 13274 Contact: Fabrice BARLESI, Doctor    +33 4 91 74 47 36    fabrice.barlesi@aphm.fr    Principal Investigator: Fabrice BARLESI, Professor          Sub-Investigator: Laurent GREILLIER, Doctor          Sub-Investigator: Philippe ASTOUL, Professor          Site 27 Recruiting Martigues, France, 13695 Contact: Hervé JULLIAN, Doctor          Principal Investigator: Hervé JULLIAN, Doctor          Site 01 Recruiting Meaux, France, 77108 Contact: Francois BLANCHON, Doctor    +33 1 64 35 38 56    f-blanchon@ch-meaux.fr    Principal Investigator: Francois BLANCHON, Doctor          Hospital Saint Antoine Recruiting Paris, France, 75012 Contact: Christos CHOUAID, Professor    +33 1 48 28 25 16    christos.chouaid@sat.ap-hop-paris.fr    Principal Investigator: Christos CHOUAID, Professor          Site 17 Recruiting Rouen, France, 76233 Contact: Dominique PAILLOTIN, DOCTOR          Principal Investigator: Dominique PAILLOTIN, Doctor          Hôpital Yves Le Foll Recruiting Saint Brieuc, France, 22023 Contact: Gwenaelle LE GARFF, Doctor    +33296017123    gwenaelle.legarff@ch-stbrieuc.fr    Principal Investigator: Gwenaelle LE GARFF, Doctor          Site 14 Recruiting Toulon, France, 83800 Contact: Henri BERARD, Doctor          Principal Investigator: Henri BERARD, Doctor          Site 11 Recruiting Villefranche Sur Saone, France, 69655 Contact: Lionel FALCHERO, Doctor    +33 4 74 09 27 23       Principal Investigator: Lionel FALCHERO, Doctor Less <<
NCT00945724 Large B-cell Diffuse Lymphoma ... More >>of Testis Less << Phase 2 Recruiting December 2019 Italy ... More >> A.O. SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, Italy Contact: Flavia Salvi, MD          Spedali Civili Recruiting Brescia, Italy Ematologia Ospedale Businco Recruiting Cagliari, Italy Contact: Giuseppina Cabras, MD          S. Martino Hospital Recruiting Genova, Italy European Institute of Oncology Recruiting Milan, Italy Principal Investigator: Giovanni Martinelli, MD          San Raffaele H Scientific Institute Recruiting Milan, Italy Contact: Andres Ferreri, MD       ferreri.andres@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          Policlinico Recruiting Modena, Italy A.O. San Gerardo Recruiting Monza, Italy AOU Maggiore della Carità Recruiting Novara, Italy S. Matteo Recruiting Pavia, Italy Principal Investigator: Luca Arcaini, MD          Ospedale Civile Recruiting Piacenza, Italy U.O. Ematologia AUSL Ravenna Recruiting Ravenna, Italy Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy IFO Regina Elena Recruiting Roma, Italy Principal Investigator: Francesco Pisani, MD          Policlinico Universitario Campus Biomedico Recruiting Roma, Italy Contact: Giuseppe Avvisati, MD          Università La Sapienza Recruiting Rome, Italy Humanitas Recruiting Rozzano, Italy Contact: Monica Balzarotti          Azienda Ospedaliero-Universitaria Recruiting Sassari, Italy A.O. S. Maria Recruiting Terni, Italy A.O.U. San Giovanni Battista-Molinette, S.C. Ematologia 2 Recruiting Torino, Italy, 10134 Contact: Umberto Vitolo, M.D.       uvitolo@molinette.piemonte.it    Principal Investigator: Umberto Vitolo, M.D.          Ospedale di Circolo Fondazione Macchi Recruiting Varese, Italy Contact: Graziella Pinotti, MD          Switzerland IOSI Recruiting Bellinzona, Switzerland, 6500 Contact: Emanuele Zucca, MD    +41 91 8119040    ielsg@ticino.com    Principal Investigator: Emanuele Zucca, M.D. Less <<
NCT00593697 Breast Neoplasms Phase 3 Completed - Finland ... More >> Helsinki University Central Hospital, Department of Oncology Helsinki, Finland, 00029 HUS Less <<
NCT03190733 Chronic Graft-versus-host-dise... More >>ase Leukemia Relapse Less << Phase 4 Not yet recruiting September 30, 2021 -
NCT00670878 Breast Cancer Phase 3 Completed - Germany ... More >> Frauenklinik der Universität München Campus Innenstadt Munich, Germany, 80337 Less <<
NCT03677141 B-cell Non-Hodgkin Lymphoma Phase 1 Phase 2 Recruiting July 2, 2022 United States, Alabama ... More >> University of Alabama Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294 United States, Arizona Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States, 85234 Mayo Clinic Cancer Center Not yet recruiting Scottsdale, Arizona, United States, 85259 United States, California University of California; Moores Cancer Center Not yet recruiting La Jolla, California, United States, 92093 United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 United States, Michigan University of Michigan Not yet recruiting Ann Arbor, Michigan, United States, 48109-0934 United States, Rhode Island Lifespan Cancer Institute Not yet recruiting Providence, Rhode Island, United States, 02905 Korea, Republic of Pusan National University Yangsan Hospital Not yet recruiting Gyeongsangnam-do, Korea, Republic of, 50612 Seoul National University Hospital Not yet recruiting Seoul, Korea, Republic of, 03080 Asan Medical Center Not yet recruiting Seoul, Korea, Republic of, 05505 Samsung Medical Center Not yet recruiting Seoul, Korea, Republic of, 6351 Less <<
NCT00186290 Lymphoma, Non-Hodgkin ... More >> Leukemia Blood and Marrow Transplant (BMT) Lymphomas: Non-Hodgkin Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01779206 Breast Cancer Phase 2 Phase 3 Unknown - Germany ... More >> Breast Center of the University of Munich (LMU) Universitätsfrauenklinik Großhadern Recruiting Munich, Bavaria, Germany, 81377 Contact: Nadia Harbeck, Prof. Dr.    +49897095 ext 4531    nadia.harbeck@med.uni-muenchen.de    Principal Investigator: Nadia Harbeck, Prof. Dr.          Ev. Krankenhaus Bethesda Brustzentrum Niederrhein Recruiting Mönchengladbach, NRW, Germany, 41061 Contact: Ulrike Nitz, Prof. Dr.    +492161981 ext 2330    ulrike.nitz@wsg-online.com    Principal Investigator: Raquel von Schumann Less <<
NCT03752723 Triple Negative Breast Cancer Phase 1 Phase 2 Not yet recruiting January 2023 -
NCT00043979 Sarcoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00670631 Multiple Myeloma Phase 2 Completed - -
NCT00043979 - Completed - -
NCT03608059 Myeloid Tumor Phase 4 Recruiting July 28, 2023 China, Shandong ... More >> General Hospital of Jinan Military Command. Recruiting Qinan, Shandong, China Contact: fang zhou    021-63240090    shongxm@139.com    China, Shanghai Shanghai Ruijin Hospital, affiliated with the Medical School of Shanghai Jiaotong University, Recruiting Shanghai, Shanghai, China, 200002 Contact: jiong hu, M.D    13764313546    hujiong@medmail.com.cn    Contact: xianming song, M.D    021-63240090*3171    shongxm@139.com    Changhai Hospital Recruiting Shanghai, Shanghai, China, 200080 Contact: xiaxiao hu, Doctor    86-21-63240090-3932    shongxm@sjtu.edu.cn    Xianmin Song Recruiting Shanghai, Shanghai, China, 200080 Contact: Xianmin Song, Doctor    86-21-63240090-3932    shongxm@sjtu.edu.cn    Shanghai Xinghua Hospital, affiliated with the Medical School of Shanghai Jiaotong University, Recruiting Shanghai, Shanghai, China Contact: siguo hao, M.D    15301655537    shongxm@139.com Less <<
NCT01564056 Breast Cancer Phase 3 Active, not recruiting March 2026 -
NCT03103971 Adult B Acute Lymphoblastic Le... More >>ukemia BCL2 Gene Rearrangement BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified MYC Gene Rearrangement Recurrent Adult Acute Lymphoblastic Leukemia Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Adult Acute Lymphoblastic Leukemia Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma Less << Phase 1 Recruiting July 17, 2033 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Cameron J. Turtle    206-667-7073    cturtle@fredhutch.org    Principal Investigator: Cameron J. Turtle Less <<
NCT00091611 Kidney Neoplasms Phase 1 Terminated(This study was term... More >>inated due to low accrual.) Less << - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00670631 - Completed - -
NCT02532777 Henoch-Schoenlein Purpura Neph... More >>ritis Less << Phase 2 Recruiting July 2020 China, Jiangsu ... More >> Nanjing Children's Hospital Recruiting Nanjing, Jiangsu, China, 210000 Contact: Aihua Zhang, M.D.    +8618951769017    bszah@163.com Less <<
NCT00005797 Chronic Myeloproliferative Dis... More >>orders Leukemia Multiple Myeloma and Malignant Plasma Cell Neoplasms Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 Less <<
NCT00000801 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 2 Completed - United States, California ... More >> San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, Colorado Univ of Colorado Health Sciences Ctr Denver, Colorado, United States, 80262 United States, Massachusetts Beth Israel Deaconess - West Campus Boston, Massachusetts, United States, 02215 ECOG Data Management Office Brookline, Massachusetts, United States, 02146 United States, New York Mount Sinai Med Ctr New York, New York, United States, 10029 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT00569985 Lymphoma Phase 1 Active, not recruiting July 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00003204 Stage III Grade 1 Follicular L... More >>ymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Small Lymphocytic Lymphoma Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT01585415 Metastatic Cancer ... More >> Melanoma Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00186342 Acute Disease ... More >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic Myeloproliferative Disorders Blood and Marrow Transplant (BMT) Myelodysplastic Syndromes (MDS) Leukemia Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00005867 Lymphoma Phase 3 Completed - United Kingdom ... More >> Stoke Mandeville Hospital Aylesbury-Buckinghamshire, England, United Kingdom, HP21 8AL Horton Hospital Banbury, England, United Kingdom, OX16 9AL Basildon University Hospital Basildon, England, United Kingdom, SS16 5NL Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Bradford Hospitals NHS Trust Bradford, England, United Kingdom, BD9 6RJ Bristol Haematology and Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Countess of Chester Hospital NHS Foundation Trust Chester, England, United Kingdom, CH2 1UL Saint Richards Hospital Chichester, England, United Kingdom, P019 4SE Essex County Hospital Colchester, England, United Kingdom, C03 3NB Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Russells Hall Hospital Dudley, England, United Kingdom, DY1 2HQ Chase Farm Hospital Enfield, England, United Kingdom, EN 28 JL Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Hull Royal Infirmary Hull, England, United Kingdom, HU3 2KZ Hinchingbrooke Hospital Huntingdon, England, United Kingdom, PE18 6NT Queen Elizabeth Hospital King's Lynn, England, United Kingdom, PE30 4ET Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom, L7 8XP Aintree University Hospital Liverpool, England, United Kingdom, L9 7AL Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE St. Thomas' Hospital London, England, United Kingdom, SE1 7EH St. George's Hospital London, England, United Kingdom, SW17 0QT Middlesex Hospital London, England, United Kingdom, WC1E 6HX Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, CH63 4JY Norfolk and Norwich University Hospital Norwich, England, United Kingdom, NR4 7UY Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Pontefract General Infirmary Pontefract West Yorkshire, England, United Kingdom, WF8 1PL Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Scunthorpe General Hospital Scunthorpe, England, United Kingdom, DN15 7BH Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD University Hospital of North Staffordshire Stoke-On-Trent Staffs, England, United Kingdom, ST4 6QG East Surrey Hospital Surrey, England, United Kingdom, RH1 5RH Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Sandwell General Hospital West Bromwich, England, United Kingdom, B71 4HJ Cancer Care Centre at York Hospital York, England, United Kingdom, Y031 8HE Centre for Cancer Research and Cell Biology at Belfast City Hospital Belfast, Northern Ireland, United Kingdom, BT9 7AB Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Pinderfields Hospital NHS Trust Wakefield, Scotland, United Kingdom, WF1 4DG Ysbyty Gwynedd Bangor, Wales, United Kingdom, LL57 2PW University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XN Glan Clywd District General Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Mount Vernon Cancer Centre at Mount Vernon Hospital Rhyl, Denbighshire, Wales, United Kingdom, LL 18 5UJ Less <<
NCT00003412 Breast Cancer Phase 1 Unknown - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01153971 Non-Hodgkin's Lymphoma Phase 2 Completed - Italy ... More >> Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia Pescara, Abruzzo, Italy, 65100 Ospedale Civile; Divisione Di Oncologia Pescara, Abruzzo, Italy, 65124 Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia Rionero in Vulture, Basilicata, Italy, 85028 Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy, 89100 A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica Modena, Emilia-Romagna, Italy, 41100 Az. Osp. Arcispedale S. Maria Nuova; U.O. Di Ematologia Reggio Emilia, Emilia-Romagna, Italy, 42100 Universita' Degli Studi La Sapienza-Ist.Di Ematologia;Dip. Biotecnologie Cel CELLULARI ED EMATOLOGIA Roma, Lazio, Italy, 00161 A.O. Spedali Civili Di Brescia-P.O. Spedali Civili;U.O. Ematologia Brescia, Lombardia, Italy, 25123 Ospedale Maggiore Di Milano; U.O. Ematologia I - Padiglione Marcora Milano, Lombardia, Italy, 20122 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Az. Osp. S. Croce Ospedale Generale; Sezione Di Ematologia Cuneo, Piemonte, Italy, 12100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1 Torino, Piemonte, Italy, 10126 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 Az. Osp. Di Careggi; Divisione Di Ematologia Firenze, Toscana, Italy, 50135 Less <<
NCT03151044 Diffuse Large B-cell Lymphoma Phase 3 Recruiting July 2017 China, Jiangsu ... More >> Changzhou No.2 People's Hospital Recruiting Changzhou, Jiangsu, China, 213003 Contact: Xuzhang Lu, M.D.    8615295189493    luxuzhang2008@163.com    Principal Investigator: Xuzhang Lu, M.D.          Jiangyin People's hospital Recruiting Jiangyin, Jiangsu, China, 214400 Contact: Dong Shen, M.D.    8615961663515    sdshendong@126.com    Principal Investigator: Dong Shen, M.D.          Nanjing General Hospital Recruiting Nanjing, Jiangsu, China, 210002 Contact: Jinghua Wang, M.D.    8613951740778    jinghua56@sina.com    Principal Investigator: Jinghua Wang, M.D.          Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School Recruiting Nanjing, Jiangsu, China, 210008 Contact: Jingyan Xu, M.D.    8613951969610    xiy1967@sina.com    Principal Investigator: Jingyan Xu, M.D.          Jiangsu Cancer Institute and Hospital Recruiting Nanjing, Jiangsu, China, 210009 Contact: Jianqiu Wu, M.D.    8613951671579    drwujq@vip.126.com    Contact: Jifeng Feng, M.D.    8613901581264    fjif@vip.sina.com    Principal Investigator: Jifeng Feng, M.D.          Jiangsu Province Hospital Recruiting Nanjing, Jiangsu, China, 210029 Contact: Xuemei Sun, M.D.    8613913911666    13913911666@qq.com    Principal Investigator: Xuemei Sun, M.D.          Nantong Tumor Hospital Recruiting Nantong, Jiangsu, China, 226361 Contact: Xiaohong Xu, M.D.    8618912296003    xhx107@163.com    Principal Investigator: Xiaohong Xu, M.D.          Wuxi People's hospital Recruiting Wuxi, Jiangsu, China, 214023 Contact: Xin Zhou, M.D.    8613358111962    13358111962@189.cn    Principal Investigator: Xin Zhou, M.D.          Northern Jiangsu People's Hospital Recruiting Yangzhou, Jiangsu, China, 225001 Contact: Bin He, M.D.    8618932371190    yzhebin2013@qq.com    Principal Investigator: Bin He, M.D. Less <<
NCT01724866 Neutropenia Phase 2 Completed - -
NCT03765177 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Less << Phase 1 Phase 2 Not yet recruiting March 31, 2022 -
NCT01066429 Diffuse Large B-Cell Lymphoma ... More >>(DLBCL) Less << Phase 2 Unknown December 2012 Spain ... More >> Principe de Asturias University Hospital Recruiting Alcala de Henares, Madrid, Spain, 28805 Contact: Julio Garcia-Suarez, MD, PhD    34-91-8878100 ext 2099    jgarciasu.hupa@salud.madrid.org Less <<
NCT01153971 - Completed - -
NCT01176006 DOCK8 Deficiency Phase 2 Recruiting December 31, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT03161054 Aggressive Non-Hodgkin Lymphom... More >>a Less << Phase 2 Recruiting May 2020 Italy ... More >> Università Politecnica delle Marche - Clinica di Ematologia Not yet recruiting Ancona, Italy Contact: Guido Gini, MD       guido.gini@ospedaliriuniti.marche.it    Principal Investigator: Guido Gini, MD          AOU Policlinico Consorziale - U.O. Ematologia con Trapianto Not yet recruiting Bari, Italy Contact: Giorgina Specchia, MD       giorgina.specchia@uniba.it    Principal Investigator: Giorgina Specchia, MD          IRCCS Istituto Tumori Giovanni Paolo II - U.O.C Ematologia Not yet recruiting Bari, Italy Contact: Attilio Guarini, MD       attilioguarini@oncologico.bari.it    Principal Investigator: Attilio Guarini, MD          A.O. Spedali Civili di Brescia - Ematologia Not yet recruiting Brescia, Italy Contact: Alessandra Tucci, MD       alessandra.tucci@asst-spedalicivili.it    Principal Investigator: Alessandra Tucci, MD          Ospedale Antonio Perrino - U.O. Ematologia Not yet recruiting Brindisi, Italy Contact: Angela Maria Melpignano, MD       angelamelpignano@gmail.com    Principal Investigator: Angela Maria Melpignano, MD          Università Cattolica - Ematologia Not yet recruiting Campobasso, Italy Contact: Sergio Storti, MD       sergio.storti@unicatt.it    Principal Investigator: Sergio Storti, MD          Osp. civile di Carrara - Oncologia Medica Not yet recruiting Carrara, Italy Contact: Roberta Della Seta, MD       rdellaseta@alice.it    Principal Investigator: Roberta Della Seta, MD          Ospedale di Castelfranco Veneto - Ematologia Not yet recruiting Castelfranco Veneto, Italy Contact: Roberto Sartori, MD       roberto.sartori@aulss2.veneto.it    Principal Investigator: Roberto Sartori, MD          Arnas Nuovo Ospedale Garibaldi Nesima - U.O.C. Ematologia Not yet recruiting Catania, Italy Contact: Ugo Consoli, MD       ugo.consoli@tin.it    Principal Investigator: Ugo Consoli, MD          AO S.Antonio Abate - Oncologia Not yet recruiting Gallarate, Italy Contact: Fabrizio Ciambelli, MD       ciambelli@libero.it    Principal Investigator: Fabrizio Ciambelli, MD          Ospedali Riuniti del Canavese - S.C.Medicina trasfusionale ed Ematologia Not yet recruiting Ivrea, Italy Contact: Roberto Freilone, MD       rfreilone@aslto4.piemonte.it    Principal Investigator: Roberto Freilone, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia Recruiting Meldola, Italy Contact: Gerardo Musuraca, MD       g.musuraca@irst.emr.it    Principal Investigator: Gerardo Musuraca, MD          Ospedale Dell'Angelo - U.O. Ematologia Not yet recruiting Mestre, Italy Contact: Renato Bassan, MD       renato.bassan@aulss3.veneto.it    Principal Investigator: Renato Bassan, MD          ASST Grande Ospedale Metropolitano Niguarda - SC Ematologia Not yet recruiting Milano, Italy Contact: Vittorio Ruggero Zilioli, MD       vittorioruggero.zilioli@ospedaleniguarda.it    Principal Investigator: Vittorio Ruggero Zilioli, MD          P.O. San Martino - Ematologia Not yet recruiting Oristano, Italy Contact: Paolo Casula, MD       paolo.casula@asloristano.it    Principal Investigator: Paolo Casula, MD          AOU di Parma - UO Ematologia e CTMO Not yet recruiting Parma, Italy Contact: Francesca Re, MD       fre@ao.pr.it    Principal Investigator: Francesca Re, MD          Ospedale Guglielmo da Saliceto - U.O.Ematologia Not yet recruiting Piacenza, Italy Contact: Annalisa Arcari, MD       a.arcari@ausl.pc.it    Principal Investigator: Annalisa Arcari, MD          A.O.R. "San Carlo" - U.O. Ematologia Not yet recruiting Potenza, Italy Contact: Michele Cimminiello, MD       miki-doc@virgilio.it    Principal Investigator: Michele Cimminiello, MD          Ospedale delle Croci - Ematologia Not yet recruiting Ravenna, Italy Contact: Monica Tani, MD       monica.tani@auslromagna.it    Principal Investigator: Monica Tani, MD          A.O. Bianchi Melacrino Morelli - Ematologia Not yet recruiting Reggio Calabria, Italy Contact: Caterina Stelitano, MD       caterinastelitano27@gmail.com    Principal Investigator: Caterina Stelitano, MD          Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS c/o CORE (II piano) - Ematologia Recruiting Reggio Emilia, Italy Contact: Francesco Merli, MD       merli.francesco@asmn.re.it    Principal Investigator: Francesco Merli, MD          Ospedale degli Infermi di Rimini - U.O. di Ematologia Not yet recruiting Rimini, Italy Contact: Anna Lia Molinari, MD       annalia.molinari@auslromagna.it    Principal Investigator: Anna Lia Molinari, MD          AO Sant'Andrea - Ematologia Recruiting Roma, Italy Contact: Maria Christina Cox, MD       chrisscox@gmail.com    Principal Investigator: Maria Christina Cox, MD          Ospedale S. Camillo - Ematologia Not yet recruiting Roma, Italy Contact: Roberta Battistini, MD       rbattistini@scamilloforlanini.rm.it    Principal Investigator: Roberta Battistini, MD          Policlinico Tor Vergata - Ematologia Not yet recruiting Roma, Italy Contact: Maria Cantonetti, MD       cantonetti@med.uniroma2.it    Principal Investigator: Maria Cantonetti, MD          Università Cattolica S. Cuore - Ematologia Not yet recruiting Roma, Italy Contact: Stefan Hohaus, MD       stefan.hohaus@Unicatt.it    Principal Investigator: Stefan Hohaus, MD          Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Recruiting Sassuolo, Italy Contact: Giovanni Partesotti, MD       g.partesotti@ospedalesassuolo.it    Principal Investigator: Giovanni Partesotti, MD          AOU Senese - U.O.C. Ematologia Not yet recruiting Siena, Italy Contact: Alberto Fabbri, MD       a.fabbri@ao-siena.toscana.it    Principal Investigator: Alberto Fabbri, MD          Azienda Ospedaliera della Valtellina e della Valchiavenna P.O. Sondrio - Medicina Interna - Centro Malattie del Sangue P.O. Sondrio Not yet recruiting Sondrio, Italy Contact: Roberto Palazzolo, MD       roberto.palazzolo@asst-val.it    Principal Investigator: Roberto Palazzolo, MD          Ospedale SS. Annunziata ASL1 Abruzzo - U.O.S. Ematologia Universitaria Not yet recruiting Sulmona, Italy Contact: Sara Plebani, MD       plebani.sara@yahoo.it    Principal Investigator: Sara Plebani, MD          A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria Not yet recruiting Torino, Italy Contact: Federica Cavallo, MD       f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          AO Ordine Mauriziano - SCDU Ematologia e Terapie Cellulari Not yet recruiting Torino, Italy Contact: Guido Parvis, MD       gparvis@mauriziano.it    Principal Investigator: Guido Parvis, MD Less <<
NCT03089411 - Active, not recruiting July 15, 2017 -
NCT01369875 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03408223 Acute Leukemia Not Applicable Recruiting December 2022 China, Beijing ... More >> Affiliated Hospital to Academy of Military Medical Sciences (307 Hospital of PLA) Recruiting Beijing, Beijing, China, 100071 Contact: Xiao Lou, M.D., Ph.D.    +8610-66947122    louxiao@163.com Less <<
NCT00452985 - Completed - Bangladesh ... More >> Sanofi-Aventis Dhaka, Bangladesh Less <<
NCT01369875 - Completed - -
NCT03408210 Myelodysplastic Syndromes ... More >> Acute Leukemia Less << Not Applicable Recruiting August 2022 China, Beijing ... More >> Affiliated Hospital to Academy of Military Medical Sciences (307 Hospital of PLA) Recruiting Beijing, Beijing, China, 100071 Contact: Xiao Lou, M.D., Ph.D.    +8610-66947122    louxiao@163.com Less <<
NCT00923390 Renal Cancer ... More >>Kidney Cancer Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00349115 Multiple Myeloma Phase 2 Unknown June 2008 Korea, Republic of ... More >> Je-Jung Lee Recruiting Hwsun-eup, Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Contact: Yeo-Kyeoung Kim, MD, PhD    82-61-379-7639    yeokim@chonnam.ac.kr    Principal Investigator: Je-Jung Lee, MD, PhD Less <<
NCT00548899 Breast Cancer Phase 2 Completed - Germany ... More >> St. Gertrauden Krankenhaus Berlin, Germany, 10713 Klinikum der J. W. Goethe Universität Frankfurt am Main, Germany, 60590 Henriettenstiftung Hannover, Germany, 30559 Elisabeth Krankenhaus Kassel, Germany, 34177 Universitätsklinikum Schleswig-Holstein Campus Kiel Kiel, Germany, 24105 Klinikum der Universität zu Köln Köln, Germany, 50924 Klinikum Offenbach Offenbach, Germany, 63069 Klinikum Südstadt Rostock, Germany, 18059 Dr.-Horst-Schmidt-Kliniken GmbH Wiesbaden, Germany, 65199 Less <<
NCT00276809 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, D-12200 Universitaetsklinikum Essen Essen, Germany, D-45122 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, 55101 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Less <<
NCT02637375 Breast Cancer Not Applicable Withdrawn(Study never opened (... More >>terminated as study drug no longer available)) Less << December 2018 -
NCT02876510 Cancer Solid ... More >>Tumor Less << Phase 1 Recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Apostolia M. Tsimberidou, M.D., Ph.D. Less <<
NCT01993719 Metastatic Melanoma Phase 2 Recruiting September 28, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01446562 Follicular Lymphoma Phase 2 Completed - Canada, Ontario ... More >> Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01857232 CINV Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark Less <<
NCT02268045 Diffuse Large B-cell Lymphoma Phase 3 Completed - -
NCT02502708 Glioblastoma Multiforme ... More >> Glioma Gliosarcoma Malignant Brain Tumor Ependymoma Medulloblastoma Diffuse Intrinsic Pontine Glioma Primary CNS Tumor Less << Phase 1 Recruiting December 2019 United States, Georgia ... More >> Children's Heathcare of Atlanta Recruiting Atlanta, Georgia, United States, 30342 Contact: Amy Autry-Bush    404-785-6011    amy.autry-bush@choa.org    Principal Investigator: Tobey MacDonald, MD          Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Robin Dobbins    706-721-2154    RDOBBINS@augusta.edu    Principal Investigator: Theodore Johnson, MD Less <<
NCT00004145 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT01998906 Breast Cancer Phase 3 Completed - Austria ... More >> Wien, Austria, 1090 Germany Muenchen, Germany, 80637 Italy Bologna, Emilia-Romagna, Italy, 40138 Carpi, Emilia-Romagna, Italy, 41012 Udine, Friuli-Venezia Giulia, Italy, 33100 Milano, Lombardia, Italy, 20133 Pavia, Lombardia, Italy, 27100 Varese, Lombardia, Italy, 21100 San Giovanni Rotondo, Puglia, Italy, 71013 Sassari, Sardegna, Italy, 07100 Pisa, Toscana, Italy, 56100 Trento, Trentino-Alto Adige, Italy, 38100 Bellunoi, Veneto, Italy, 32100 Castelfranco Veneto, Veneto, Italy, 31033 Mirano, Veneto, Italy, 30035 Santorso, Veneto, Italy, 36014 Vicenza, Veneto, Italy, 36100 Portugal Lisboa, Portugal, 1099-023 Russian Federation Kazan, Russian Federation, 420029 Moscow, Russian Federation, 107005 Moscow, Russian Federation, 115478 Moscow, Russian Federation, 117837 Moscow, Russian Federation, 129128 Saint-Petersburg, Russian Federation, 197758 St Petersburg, Russian Federation, 197022 Spain Terrassa, Barcelona, Spain, 08221 Jerez de La Frontera, Cadiz, Spain, 11407 San Sebastian, Guipuzcoa, Spain, 20080 Barcelona, Spain, 08022 Barcelona, Spain, 08035 Barcelona, Spain, 08041 Barcelona, Spain, 08907 Madrid, Spain, 28041 Valencia, Spain, 46009 Valencia, Spain, 46010 Zaragoza, Spain, 50009 Less <<
NCT01998906 - Completed - -
NCT02159495 Adult Acute Myeloid Leukemia i... More >>n Remission Acute Biphenotypic Leukemia Early Relapse of Acute Myeloid Leukemia Late Relapse of Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Blastic Plasmacytoid Dendritic Cell Neoplasm Acute Myeloid Leukemia Adult Acute Lymphoblastic Leukemia Interleukin-3 Receptor Subunit Alpha Positive Minimal Residual Disease Refractory Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Recruiting December 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Lihua E. Budde    800-826-4673    ebudde@coh.org    Principal Investigator: Lihua E. Budde Less <<
NCT00578539 Leukemia Hodg... More >>kin Lymphoma Non Hodgkin Lymphoma Myeloproliferative Disorders Less << Not Applicable Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00578539 - Terminated - -
NCT00795678 - Completed - United States, New York ... More >> Memorial Sloan Kettering New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01759732 Acquired Aplastic Anemia Phase 2 Unknown December 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD, PhD    82-2-3010-3371    hojim@amc.seoul.kr    Sub-Investigator: Kyung Nam Koh, MD, PhD Less <<
NCT02809573 Peripheral T-cell Lymphoma Phase 1 Recruiting December 2019 China, Beijing ... More >> Cancer Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, Beijing, China, 100000 Contact: Yuankai Shi, MD    +86-10-8778-8293    syuankai@cicams.ac.cn Less <<
NCT00719472 Non-Hodgkin's Lymphoma Phase 3 Completed - -
NCT01914718 Diffuse Large B-cell Lymphoma Phase 2 Terminated(Poor accrual of eli... More >>gible patients) Less << December 2017 China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00719472 - Completed - -
NCT01663714 Lymphoma, Non-Hodgkin Phase 2 Completed - -
NCT02375984 Metastatic Melanoma Phase 2 Terminated(PI changed institut... More >>ions) Less << - United States, California ... More >> John Wayne Cancer Institute Santa Monica, California, United States, 90404 Less <<
NCT02451982 Pancreatic Cancer Phase 1 Phase 2 Recruiting February 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce    410-955-8804    jhcccro@jhmi.edu Less <<
NCT02757391 Cholangiocarcinoma ... More >> Colorectal Adenocarcinoma Esophageal Carcinoma Metastatic Digestive System Carcinoma Metastatic Gastric Carcinoma Metastatic Pancreatic Adenocarcinoma Stage IV Colorectal Cancer AJCC v7 Stage IV Esophageal Cancer AJCC v7 Stage IV Gastric Cancer AJCC v7 Stage IV Pancreatic Cancer AJCC v6 and v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7 Less << Phase 1 Not yet recruiting December 31, 2022 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Cassian Yee    713-563-3750       Principal Investigator: Cassian Yee Less <<
NCT02960646 Leukemia Phase 1 Recruiting January 1, 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       sciurea@mdanderson.org Less <<
NCT02354443 Metabolic Disorders Phase 1 Terminated(Business decision) - United States, Massachusetts ... More >> Boston Children's Hospital Boston, Massachusetts, United States, 02115-5450 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT02957968 Breast Adenocarcinoma ... More >> Estrogen Receptor- Negative Breast Cancer Estrogen Receptor-positive Breast Cancer HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Negative Progesterone Receptor Positive Tumor Stage II Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Triple-negative Breast Carcinoma Less << Phase 2 Recruiting January 31, 2029 United States, Virginia ... More >> Virginia Commonwealth University/Massey Cancer Center Recruiting Richmond, Virginia, United States, 23298 Contact: Mary Beth Tombes, ACNP-BC    804-628-1357    masseysiit@vcu.edu    Contact: Harry D. Bear, M.D., Ph.D.    804-628-3242    harry.bear@vcuhealth.org Less <<
NCT01502982 Diffuse Large B-Cell Lymphoma Phase 2 Completed - Denmark ... More >> Odense University Hospital Odense, Denmark Finland Helsinki University central Hospital Helsinki, Finland Norway Oslo University Hospital Oslo, Norway Sweden Lund University Hospital Lund, Sweden Less <<
NCT01663714 - Completed - -
NCT02348216 Refractory Diffuse Large B Cel... More >>l Lymphoma (DLBCL) Relapsed Diffuse Large B-Cell Lymphoma Transformed Follicular Lymphoma (TFL) Primary Mediastinal B-cell Lymphoma (PMBCL) High Grade B-cell Lymphoma (HGBCL) Less << Phase 1 Phase 2 Recruiting October 2034 -
NCT02670616 Epstein-Barr Virus-positive Di... More >>ffuse Large B-cell Lymphoma Less << Phase 2 Recruiting June 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Seoul, Gangnam-gu, Korea, Republic of, 135-710 Contact: Wonseog Kim, M.D., Ph.D.    82-2-3410-6548    wonseog.kim@samsung.com    Sub-Investigator: Seogjin Kim, M.D., Ph.D.          Principal Investigator: Wonseog Kim, M.D. Ph.D Less <<
NCT02354443 - Terminated(Business decision) - -
NCT01853631 Non-Hodgkin Lymphoma ... More >> Chronic Lymphocytic Leukemia Acute Lymphocytic Leukemia Less << Phase 1 Recruiting February 2033 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org Less <<
NCT00950846 Congenital Pediatric Disorders Not Applicable Recruiting January 2025 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD    832-824-4692    camartin@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT00618813 Ewing Sarcoma of Bone ... More >> Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Monrovia, California, United States, 91016 Less <<
NCT00618813 - Completed - -
NCT02194374 Leukemia Phase 1 Withdrawn(Study closed with no... More >> enrollment due to unavailability of reagent.) Less << - -
NCT02561832 Breast Cancer Phase 1 Completed - United States, New York ... More >> Research Site New York, New York, United States Research Site Stony Brook, New York, United States Spain Research Site Barcelona, Spain Research Site Madrid, Spain Research Site Valencia, Spain Research Site Zaragoza, Spain Less <<
NCT02012088 Lymphoma Phase 2 Active, not recruiting August 2021 Spain ... More >> Hospital Universitario de Alava Vitoria, Alava, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragón, Spain, 50009 Hospital de Cabueñes GIjón, Asturas, Spain, 33203 Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO- Hospital Duran i Reynals L´Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Universitario de Salamanca Salamanca, Castilla Y Leon, Spain, 37007 Hospital Clínico Universitario de Valladolid Valladolid, Castilla Y Leon, Spain, 47005 Hospital Fundación de Alcorcón Alcorcón, Madrid, Spain, 28922 Hospital del Mar Barcelona, Spain, 08003 Hospital General Universitario Gregorio Marañón Madrid, Spain, 28007 Hospital Universitario Infanta Leonor Madrid, Spain, 28031 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clínico Universitario Virgen de la Arrixaca Murcia, Spain, 30120 Less <<
NCT00303667 Acute Myelogenous Leukemia Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02431988 Diffuse Large B-Cell Lymphoma Phase 1 Recruiting December 2020 United Kingdom ... More >> University College London Hospital Recruiting London, United Kingdom Contact: Karl Peggs    +44 2076796236    k.peggs@ucl.ac.uk    Principal Investigator: Karl Peggs Less <<
NCT02234921 Adenocarcinoma of the Prostate Phase 1 Completed - United States, Oregon ... More >> Providence Health & Services Portland, Oregon, United States, 97213 Less <<
NCT00808899 - Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - -
NCT01619761 Leukemia Chro... More >>nic Lymphocytic Leukemia Less << Phase 1 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00303667 - Completed - -
NCT00808899 Neuroblastoma Phase 2 Terminated(Voluntarily closed ... More >>and terminated by the PI due to lack of feasibility) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00382109 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Graft Versus Host Disease L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Unknown - -
NCT00382109 - Unknown - -
NCT03192059 Cervical Cancer ... More >> Endometrial Cancer Uterine Cancer Less << Phase 2 Recruiting June 2022 Belgium ... More >> University Hospital Antwerp Recruiting Antwerp, Belgium Contact: Peter Van Dam          Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Alex De Caluwé          University Hospital Gent Recruiting Gent, Belgium, 9000 Contact: Hannelore Denys          CMSE Namur Recruiting Namur, Belgium Contact: Peter Vuylsteke Less <<
NCT00107198 - Unknown - -
NCT00668564 - Terminated(Replaced by another... More >> study) Less << - -
NCT03188172 Multiple Myeloma Phase 2 Recruiting December 31, 2021 United Kingdom ... More >> Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2TH Contact: Guy Pratt    01214243698    guy.pratt@uhb.nhs.uk    Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Contact: Anand Lokare          Blackpool Victoria Hospital Recruiting Blackpool, United Kingdom Contact: Mark Grey          Royal Hampshire County Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW Contact: Noel Ryman          Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Rachel Hall          Bristol Haematology & Oncology Centre Recruiting Bristol, United Kingdom Contact: Jenny Bird          Ninewells Hospital Recruiting Dundee, United Kingdom, DD1 9SY Contact: Gordon Marron          Beatson Oncology Centre Recruiting Glasgow, United Kingdom Contact: Jennifer Travers          Kettering General Hosptial Recruiting Kettering, United Kingdom, NN16 8UZ Contact: Auran Razzak          Leicester Royal Infirmary Recruiting Leicester, United Kingdom, LE1 5WW Contact: Mamta Garg          Kings College Hosptial Recruiting London, United Kingdom Contact: Kirsty Cuthill          Manchester Royal Infirmary Recruiting Manchester, United Kingdom Contact: Alberto Rocci          The Christie Hospital Recruiting Manchester, United Kingdom Contact: Jim Cavet          Norfolk and Norwich University Hospital Recruiting Norwich, United Kingdom Contact: Kristian Bowles          Nottingham University Hosptial Recruiting Nottingham, United Kingdom Contact: Dean Smith          Churchill Hospital Recruiting Oxford, United Kingdom Contact: Karthik Ramasamy          Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Hannah Hunter          Southampton General Hospital Recruiting Southampton, United Kingdom, SO16 6YD Contact: Matthew Jenner    02381204438    matthew.jenner@uhs.nhs.uk    Royal Stoke Hospital Recruiting Stoke-on-Trent, United Kingdom Contact: Kamaraj Karunanithi          Royal Marsden Hospital Recruiting Sutton, United Kingdom, SM2 5PT Contact: Martin Kaiser    02087224265    martin.kaiser@icr.ac.uk    Worcester Royal Hospital Recruiting Worcester, United Kingdom, WR5 1DD Contact: Salim Shafeek Less <<
NCT01303887 Follicular Lymphoma Phase 3 Unknown September 2016 -
NCT00107198 Childhood Lymphocyte Predomina... More >>nt Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Less << Not Applicable Unknown - -
NCT02828358 Acute Leukemia of Ambiguous Li... More >>neage Childhood B Acute Lymphoblastic Leukemia KMT2A Gene Rearrangement Mixed Phenotype Acute Leukemia Less << Phase 2 Suspended(Met accural pending ... More >>evaluation of enrolled pats.) Less << September 30, 2019 -
NCT00169130 Lymphoma, Large-Cell, Diffuse Phase 2 Phase 3 Completed - Belgium ... More >> Service d'Hematologie Mont-Godinne, Belgium France Hôpital Henri Mondor Creteil, France Hôpital Saint Louis Paris, France, 75010 Centre Hospitalier Lyon Sud Pierre-Bénite, France Centre Henri Becquerel Rouen, France, 76000 Less <<
NCT01015261 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT00668564 Hurler's Syndrome ... More >> Maroteaux-Lamy Syndrome Sly Syndrome Alpha Mannosidosis Fucosidosis Aspartylglucosaminuria Sphingolipidoses Krabbe Disease Wolman's Disease Niemann-Pick Disease Type B Niemann-Pick Disease, Type C Less << Phase 2 Terminated(Replaced by another... More >> study) Less << - United States, Minnesota ... More >> University of Minnesota, Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT00314106 - Completed - -
NCT00851110 High-Risk Breast Cancer Phase 2 Terminated - Netherlands ... More >> Free University Hospital Amsterdam, Netherlands, 1007 MB The Netherlands Cancer Institute Amsterdam, Netherlands, 1066 CX Academic Medical Center Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7511 JX University Medical Centre Groningen Groningen, Netherlands, 9713 GZ Leiden University Medical Centre Leiden, Netherlands, 2333 JS University Hospital Maastricht Maastricht, Netherlands, 6202 AZ University Medical Centre Nijmegen St. Radboud Nijmegen, Netherlands, 6525 GA Erasmus MC, Daniel den Hoed Cancer Center Rotterdam, Netherlands, 3075 EA University Medical Centre Utrecht Utrecht, Netherlands, 3584 CX Less <<
NCT01356290 Medulloblastoma Phase 2 Recruiting April 2023 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611-2605 Contact: Emily Golbeck       egolbeck@luriechildrens.org    Contact: Kevin Ritt       kritt@luriechildrens.org    Principal Investigator: Stewart Goldman, MD          Sub-Investigator: Rishi Lulla, MD          United States, Massachusetts Dana-Farber Cancer Institute and Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Joanne Kennedy, RN, BA    617-632-5324    Joanne_Kennedy1@dfci.harvard.edu    Principal Investigator: Susan Chi, MD          Austria Medical University of Graz Recruiting Graz, Austria, 8036 Contact: Elisabeth Hulla-Gumbsch    +43 316 385 ext 82686    elisabeth.hulla-gumbsch@klinikum-graz.at    Principal Investigator: Martin Benesch, MD          Medical University of Innsbruck Recruiting Innsbruck, Austria, 6020 Contact: Yvonne Ennemoser, MSc    +43 512 504 ext 23605    yvonne.ennemoser@tirol-kliniken.at    Principal Investigator: Roman Crazzolara, MD          Kepler Universitätsklinikum Med Campus IV Recruiting Linz, Austria, 4020 Contact: Martina Winkler    +43 5 7680 84 ext 24302    martina.winkler@gespag.at    Principal Investigator: Georg Ebetsberger, MD          Salzburger Universitätsklinikum Recruiting Salzburg, Austria, 5020 Contact: Agnes Gamper, MD    +43 662 448257 ext 759    a.gamper@salk.at    Principal Investigator: Agnes Gamper, MD          Medical University of Vienna Recruiting Vienna, Austria, 1090 Contact: Andreas Peyrl, MD    +43 1 40400 ext 32320    andreas.peyrl@meduniwien.ac.at    Contact: Irene Slavc, MD    +43 1 40400 ext 32320    irene.slavc@meduniwien.ac.at    Principal Investigator: Andreas Peyrl, MD          Sub-Investigator: Irene Slavc, MD          Czechia University Hospital Brno Recruiting Brno, Czechia, 61300 Contact: Alexandra Martincekova, MD    +420532234755    Martincekova.Alexandra@fnbrno.cz    Principal Investigator: Jaroslav Sterba, MD          Sub-Investigator: Zdenek Pavelka, MD          Motol University Hospital Prague Recruiting Prague, Czechia, 15006 Contact: Klara Hruba    +42 0224436401    klara.hruba@fnmotol.cz    Principal Investigator: David Sumerauer, MD          Denmark University hospital Rigshospitalet Recruiting Copenhagen, Denmark, 2100 Contact: Karsten Nysom, MD    +45 3545 0809    karsten.nysom@regionh.dk    Principal Investigator: Karsten Nysom, MD          France Centre Oscar Lambret Terminated Lille, France, 59037 Sweden Sahlgrenska Universitetssjukhuset Recruiting Göteborg, Sweden, 416 85 Contact: Karin Fritzson    +46 31 343 58 65    karin.fritzson@vgregion.se    Contact: Anna Schröder- Håkansson    +46 31 343 58 65    anna.schroder_hakansson@vgregion.se    Principal Investigator: Magnus Sabel, MD          Sub-Investigator: Birgitta Lannering, Prof          Universitetssjukhuset Linköping Recruiting Linköping, Sweden, 581 85 Contact: Birgitta Hellström    +46 10 103 13 54    birgitta.hellstrom@regionostergotland.se    Contact: Pernilla Augustsson    +46 10-103 13 50    pernilla.augustsson@regionostergotland.se    Principal Investigator: Irene Devenney, MD          Skånes universitetssjukhus Recruiting Lund, Sweden, 221 85 Contact: Yvonne Håkansson    +46 46-17 80 64    Yvonne.Hakansson@skane.se    Contact: Simon Johansson    +46 46-17 80 64    simon.johansson@skane.se    Principal Investigator: Helena Mörse, MD          Karolinska University Hospital Recruiting Stockholm, Sweden, SE-171 76 Contact: Carina Rinaldo    +46 8 517 701 51    carina.rinaldo@karolinska.se    Contact: Yvonne Copeland    +46 8 517 724 84    yvonne.copeland-wahlo@karolinska.se    Principal Investigator: Stefan Holm, MD          Norrlands Universitetssjukhus Recruiting Umeå, Sweden, 901 85 Contact: Marita Wikström-Larsson    +46 90-785 02 44    Marita.Vikstrom.Larsson@vll.se    Principal Investigator: Mattias Mattsson          Akademiska sjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Katarina Vallin    +46 18 611 34 94    katarina.vallin@akademiska.se    Principal Investigator: Anders Öberg, MD Less <<
NCT01045889 HIV-related Lymphoma ... More >> HIV Infections Less << Phase 2 Completed - Italy ... More >> AO Spedali Civili di Brescia Brescia, Italy, 25123 Less <<
NCT00314106 Metastatic Melanoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02752815 Diffuse Large B-cell Lymphoma Phase 4 Recruiting June 2019 China, Shanghai ... More >> Shanghai Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200023 Contact: Weili Zhao, MD,PhD    64370045 ext 610707    zhao.weili@yahoo.com    Contact: Pengpeng Xu, MD    64370045 ext 610707    xpproc@msn.com Less <<
NCT02162420 Dyskeratosis Congenita ... More >> Aplastic Anemia Less << Not Applicable Recruiting July 2024 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Jakub Tolar, MD Less <<
NCT02722668 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia/Lymphoma Burkitt's Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndrome Large-cell Lymphoma Hodgkin Lymphoma Multiple Myeloma Relapsed Chronic Lymphocytic Leukemia Relapsed Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-cell Lymphoma Prolymphocytic Leukemia Bone Marrow Failure Syndromes Myeloproliferative Neoplasms/Myelofibrosis Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Leukemia or MDS in Aplasia Relapsed T-Cell Lymphoma Relapsed Multiple Myeloma Plasma Cell Leukemia Less << Phase 2 Recruiting December 2029 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD    612-625-3918    bruns072@umn.edu Less <<
NCT00667927 Acute Myeloid Leukemia Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01875601 Solid Tumors ... More >>Brain Tumors Sarcoma Pediatric Cancers Neuroblastoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00990496 Glioblastoma Multiforme Phase 1 Terminated(Accrual goals not m... More >>et) Less << - -
NCT00003203 Brain Tumors ... More >>Central Nervous System Tumors Neuroblastoma Less << Phase 2 Completed - -
NCT00003838 Myeloproliferative Disorders ... More >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00004135 Kidney Cancer ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT02483767 Breast Cancer Phase 3 Completed - -
NCT03629873 Lymphoma, Large B-Cell, Diffus... More >>e Mantle Cell Lymphoma Peripheral T Cell Lymphoma Double-hit Lymphoma Less << Phase 2 Recruiting August 1, 2020 China, Jiangsu ... More >> Hematological Department, People's Hospital of Jiangsu Province Recruiting Nanjing, Jiangsu, China, 210029 Contact: Wei Xu, Ph.D.    +86-2568302182    xuwei10000@hotmail.com Less <<
NCT01777152 Anaplastic Large-Cell Lymphoma... More >> Non-Hodgkin Lymphoma T-Cell Lymphoma Less << Phase 3 Active, not recruiting December 2019 -
NCT00008034 Breast Cancer Phase 1 Completed - Switzerland ... More >> Hopital Cantonal Universitaire de Geneva Geneva, Switzerland, CH-1211 Less <<
NCT02605421 Neuroblastoma Phase 2 Recruiting January 2023 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org    Principal Investigator: Heather Stefanski, MD Less <<
NCT00963729 Breast Cancer Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 United Kingdom West Middlesex University Hospital Isleworth, England, United Kingdom, TW7 6AF Guy's Hospital London, England, United Kingdom, SE1 9RT St. Mary's Hospital London, England, United Kingdom, W2 1NY Charing Cross Hospital London, England, United Kingdom, W6 8RF Less <<
NCT02199041 Hematological Malignancies Phase 2 Terminated(The study was halte... More >>d early due to slow accrual.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00338377 Melanoma Phase 2 Recruiting February 2019 United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Patrick Hwu, MD    713-792-2921    phwu@mdanderson.org    Principal Investigator: Patrick Hwu, MD Less <<
NCT00006461 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT02282514 Stiff-Person Syndrome Phase 1 Phase 2 Recruiting October 2021 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Richard Burt, MD    312-695-4960    rburt@northwestern.edu    Sub-Investigator: Senda Ajroud Driss, MD          Sub-Investigator: Jeffrey Allen, MD          Sub-Investigator: Robert Sufit, MD          Sub-Investigator: Teepu Siddique, MD          Sub-Investigator: Roumen Balabanov, MD Less <<
NCT02880293 Hematologic Malignancy Not Applicable Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD    212-639-2212       Principal Investigator: Brian Shaffer, MD Less <<
NCT01070862 Multiple Myeloma de Novo Treat... More >>ment Less << Phase 3 Completed - France ... More >> CHU CAEN Dept of Hematology Caen, France, 14033 CHU Henri Mondor Creteil, France, 94010 CHU Saint Louis Dept of Hematology Paris, France, 75475 Less <<
NCT03263559 Sickle Cell Disease Phase 2 Recruiting December 2024 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Hilary Haines, MD       hhaines@peds.uab.edu    United States, California UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Mark C. Walters, MD    925-783-5070    mwalters@mail.cho.org    United States, Florida University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 Contact: Lucien Black       vblack@ufl.edu    Nicklaus Children's Hospital/University of Miami Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Kamar Godder       kamar.godder@nicklaushealth.org    H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Michael L. Nieder, MD    813-745-2191    michael.nieder@moffitt.org    United States, Georgia Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    United States, Missouri Washington University, St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy       shalinishenoy@wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jennifer Krajewski       jennifer.krajewski@hackensackmeridian.org    United States, New York Northwell Health/Monter Cancer Center Recruiting Lake Success, New York, United States, 11042 Contact: Ruthee-Lu Bayer       rbayer@northwell.edu    United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Contact: Paul J. Shaughnessy, MD    210-575-6904    Paul.Shaughnessy@MHShealth.com Less <<
NCT02073097 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Less << Phase 1 Phase 2 Recruiting December 2018 United States, Georgia ... More >> Winship Cancer Institute, Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Christopher Flowers, MD, MS    404-778-1827    crflowe@emory.edu    Principal Investigator: Christopher Flowers, MD, MS          United States, Ohio University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Paolo Caimi, MD    216-844-0362    paolo.caimi@uhhospitals.org    Principal Investigator: Paolo Caimi, MD          Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Brian T. Hill, MD, PhD    216-445-9451    hillb2@ccf.org    Principal Investigator: Brian T. Hill, MD, PhD Less <<
NCT00580333 Breast Cancer Phase 2 Active, not recruiting June 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03622788 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Aplastic Anemia Bone Marrow Failure Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Follicular Lymphoma Hematopoietic Cell Transplantation Recipient Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Near Complete Response of Multiple Myeloma or Plasma Cell Leukemia Non-Hodgkin Lymphoma Partial Response of Multiple Myeloma or Plasma Cell Leukemia Plasma Cell Myeloma Less << Phase 1 Phase 2 Not yet recruiting April 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Richard E. Champlin    713-792-8750       Principal Investigator: Richard E. Champlin Less <<
NCT00580333 - Active, not recruiting - -
NCT00003519 Breast Cancer Phase 3 Completed - -
NCT02199041 - Terminated(The study was halte... More >>d early due to slow accrual.) Less << - -
NCT00505921 Lymphoma Phase 2 Terminated(Slow Accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00505921 - Terminated(Slow Accrual.) - -
NCT03100877 Plasma Cell Leukemia in Remiss... More >>ion Plasma Cell Myeloma Less << Phase 1 Phase 2 Withdrawn(Feasibility Issues) May 24, 2020 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00586755 Mantle Cell Lymphoma Phase 2 Completed - -
NCT00146588 Breast Cancer ... More >> Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Not Applicable Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 Less <<
NCT00923351 Neuroblastoma ... More >> Sarcoma Rhabdomyosarcoma-Embryonal Rhabdomyosarcoma- Alveolar Neuroectodermal Tumors, Primitive, Peripheral Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00866307 - Completed - -
NCT00923351 - Completed - -
NCT00509496 - Terminated(Low accrual) - -
NCT00866307 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, Arizona ... More >> Phoenix Childrens Hospital Phoenix, Arizona, United States, 85016 United States, California Miller Children's Hospital Long Beach, California, United States, 90806 Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Rady Children's Hospital - San Diego San Diego, California, United States, 92123 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Florida Nemours Children's Clinic-Jacksonville South Jacksonville, Florida, United States, 32207 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 Kosair Children's Hospital Louisville, Kentucky, United States, 40202 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, New York The Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 United States, North Carolina University of North Carolina Chapel Hill, North Carolina, United States, 27599 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Legacy Emanuel Children's Hospital Portland, Oregon, United States, 97227 Legacy Emanuel Hospital and Health Center Portland, Oregon, United States, 97227 United States, Pennsylvania Children's Oncology Group Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Methodist Children's Hospital of South Texas San Antonio, Texas, United States, 78229 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6008 Canada, Ontario Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada, K1H 8L1 Less <<
NCT00509496 Skin Cancer M... More >>elanoma Less << Phase 2 Terminated(Low accrual) - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01570348 Crohn Disease Phase 2 Active, not recruiting February 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00301821 Lymphoma Phase 2 Completed - -
NCT01864109 Newly Diagnosed Ewing Sarcoma Phase 2 Recruiting May 2020 United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Paul Meyers, MD    212-639-5952       United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Paul Meyers, MD    212-639-5952       Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Paul Meyers, MD    212-639-5952       Contact: Emily Slotkin, MD    212-639-8856       Principal Investigator: Paul Meyers, MD          Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Paul Meyers, MD    212-639-5952 Less <<
NCT00301821 - Completed - -
NCT00002696 Breast Cancer Phase 3 Suspended - Argentina ... More >> Policlinica Privada Instituto De Medicina Nuclear Bahia Blanca, Buenos Aires, Argentina, 8000 Consultorio Oncologico Privado Mar del Plata, Buenos Aires, Argentina, 7600 Centro De Oncologia y Terapia Radiante Santa Rosa, La Pampa, Argentina, 6300 Unidad Oncologica Del Comahue Neuquen, Argentina Consultorio Oncologico Privado Rio Gallegos, Argentina, 9400 Centro Oncologico Del Litoral Santa Fe, Argentina, 3000 Centro Oncologico Tres Arroyos Tres Arroyos, Argentina, 7500 Less <<
NCT01664975 Peripheral T-cell Lymphoma Phase 4 Completed - China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China, 450052 Less <<
NCT02419495 Advanced Cancers Phase 1 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02702960 Fibrolamellar Hepatocellular C... More >>arcinoma Hepatocellular Carcinoma (Fibrolamellar Variant) Hepatocellular Carcinoma Less << Phase 2 Withdrawn(This study was withd... More >>rawn due to lack of necessary resources from the liver transplant surgical group.) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT01218867 Metastatic Cancer ... More >> Metastatic Melanoma Renal Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01472146 Breast Cancer ... More >> Breast Disease Neoplasms Neoplasms by Site Less << Phase 2 Completed - Brazil ... More >> Hospital do Cancer III - INCA Rio de Janeiro, Brazil, 20560-120 Less <<
NCT00002875 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 3 Completed - -
NCT01218867 - Completed - -
NCT00929591 Breast Cancer Phase 3 Completed - -
NCT01664975 - Completed - -
NCT02013817 Lymphocytic Leukemia, Chronic Phase 2 Completed - Austria ... More >> Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria, 6020 LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria, 8700 Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria, 4010 A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria, 4020 Kepler Universitätskliniken GmbH - Med Campus III; I. Medizinische Abteilung Linz, Austria, 4020 Landeskrankenhaus Rankweil; Interne E Rankweil, Austria, 6830 Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt. Salzburg, Austria, 5020 Klinikum Kreuzschwestern Wels; Iii. Interne Abt. Wels, Austria, 4600 Less <<
NCT00206518 Breast Cancer Phase 2 Active, not recruiting September 2017 United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less <<
NCT02013817 - Completed - -
NCT00578292 Thalassemia Not Applicable Terminated(Over the course of ... More >>this study stem cell transplant was determined to be standard of care for this disease and as such the study is no longer relevant.) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01814046 Metastatic Ocular Melanoma ... More >> Metastatic Uveal Melanoma Less << Phase 2 Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03531736 Myeloid Diseases Phase 1 Recruiting May 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roni Tamari, MD    212-639-5987       Contact: Miguel-Angel Perales, MD    212-639-8682       Principal Investigator: Roni Tamari, MD Less <<
NCT01814046 - Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - -
NCT01889069 Lymphoma Phase 3 Active, not recruiting June 15, 2019 Italy ... More >> Irccs Crob Rionero in Vulture, Basilicata, Italy, 85028 Azienda Ospedaliera Bianchi-Melacrino-Morelli; Unità Operativa di Ematologia Reggio Calabria, Calabria, Italy, 89100 Azienda Ospedaliera S.G. Moscati; Divisione Ematologia Avellino, Campania, Italy, 83100 Asl ce - p.o. Avers; Uoc ematologia Aversa, Campania, Italy, 81031 A.O. San Sebastiano; U.O.C. Oncologia Caserta, Campania, Italy, 81100 Seconda università degli studi di napoli; Medicina clinica e sperimentale magrassi - lanzara Napoli, Campania, Italy, 80138 Osp. Santa Maria Goretti; Ematologia Latina, Lazio, Italy, 04100 Ospedale S. Eugenio; Divisione Di Ematologia Roma, Lazio, Italy, 00144 Regina Elena National Cancer Institute; Hematology Roma, Lazio, Italy, 00144 Az. Osp. S. Camillo Forlanini; Uo Ematologia E Trapianti Di Midollo Osseo Roma, Lazio, Italy, 00152 Universita' Degli Studi La Sapienza-Ist.Di Ematologia; Dip Biot Cel e Ematol Roma, Lazio, Italy, 00161 Azienda Ospedaliera S. Giovanni Addolorata; UOC Ematologia Roma, Lazio, Italy, 00184 ASL Viterbo; Presidio Ospedaliero di Ronciglione; UOC Ematologia Ronciglione, Lazio, Italy, 01037 Ospedale Valduce;U.O.S. Oncologia Ed Ematologia Como, Lombardia, Italy, 22100 ASST DI CREMA; U O Oncologia Medica Crema, Lombardia, Italy, 26013 ASST DI LECCO; Oncologia Medica Lecco, Lombardia, Italy, 23900 Az. Osp. Carlo Poma; Divisione Di Oncologia Medica Mantova, Lombardia, Italy, 46100 Osp. San Raffaele; Dip. Di Oncoematologia Milano, Lombardia, Italy, 20132 Ist. Nazionale Per Lo Studio E Cura Dei Tumori; Div. Ematologia Trapianto Midollo Osseo Allogenico Milano, Lombardia, Italy, 20133 Irccs Policlinico San Matteo; Divisione Di Ematologia Pavia, Lombardia, Italy, 27100 Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia Rozzano, Lombardia, Italy, 20089 Ospedale Gen.Le Prov.Le 'C.G.Mazzoni'; Ematologia Ascoli Piceno, Marche, Italy, 63100 Ospedale di Civitanova Marche; Medicina Interna Civitanova Marche, Marche, Italy, 62012 Ospedale di Macerata; Medicina Generale Macerata, Marche, Italy, 62100 Università Cattolica Del Sacro Cuore S.S. Giovanni Paolo Ii; Uoc Di Onco-Ematologia Campobasso, Molise, Italy, 86100 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Univ. Piemonte Est Amedeo Avogadro; Div.Ematologia- Dip.Clinica Med.Sperim.& Ircad Novara, Piemonte, Italy, 28100 Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica Bari, Puglia, Italy, 70124 Azienda ospedaliera oo rr di foggi; Hematology Foggia, Puglia, Italy, 71100 Ospedale S.Nicola Pellegrino; Reparto Di Ematologia Trani, Puglia, Italy, 70059 Ospedale Roberto Binaghi; Centro trapianti di midollo osseo Cagliari, Sardegna, Italy, 09126 Osp. San Francesco; Ematologia e CTMO Nuoro, Sardegna, Italy, 08100 ARNAS Garibaldi; Ematologia Catania, Sicilia, Italy, 95122 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 ARNAS-Ospedale Civico Maurizio Ascoli; Unità Operativa di Oncologia Medica Palermo, Sicilia, Italy, 90127 Azienda Uni Ria Policlinico P. Giaccone ; Divisione Di Ematologia E Trapianto Palermo, Sicilia, Italy, 90127 Ospedale Santa Chiara; Unita Operativa Di Ematologia Pisa, Toscana, Italy, 56100 USL 4 di Prato - Nuovo Ospeale di Prato Prato, Toscana, Italy, 59100 A.O. Santa Maria Terni; S.C. Oncoematologia Terni, Umbria, Italy, 05100 IOV - Istituto Oncologico Veneto - IRCCS; Oncologia Medica II Padova, Veneto, Italy, 35128 Less <<
NCT00206518 - Active, not recruiting - -
NCT00867178 Medulloblastoma ... More >> Pineoblastoma Supratentorial Embryonal Tumor, Not Otherwise Specified Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Not Applicable Active, not recruiting - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Illinois Lurie Children's Hospital-Chicago Chicago, Illinois, United States, 60611 United States, Maryland National Cancer Institute Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Tennessee Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT01548573 Multiple Myeloma Phase 2 Terminated(Met study stopping ... More >>rules) Less << - United States, Iowa ... More >> University of Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 Less <<
NCT03630211 Systemic Sclerosis ... More >> Diffuse Sclerosis Systemic Interstitial Lung Disease Pulmonary Hypertension Less << Phase 2 Recruiting August 1, 2025 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Jason Rowan, RN    412-692-6195    jason.rowan@chp.edu    Principal Investigator: Paul Szabolcs, MD          Sub-Investigator: Mounzer Agha, MD          Sub-Investigator: Robyn Domsic, MD, MPH          Sub-Investigator: William Follansbee, MD          Sub-Investigator: Dwight Heron, MD          Sub-Investigator: Annie Im, MD          Sub-Investigator: Daniel Kass, MD          Sub-Investigator: Geoffrey Kurland, MD          Sub-Investigator: Robert Lafyatis, MD          Sub-Investigator: Adam Olson, MD          Sub-Investigator: Kathryn Torok, MD          Sub-Investigator: Allison Morris, MD, MS          University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Robyn Domsic, MD, MPH    412-383-8000    domsicrt@upmc.edu    University of Pittsburgh Medical Center Recruiting Pittsburgh, Pennsylvania, United States, 15261 Contact: Robert Lafyatis, MD    412-647-6700    lafyatisra@upmc.edu Less <<
NCT03145480 Richter Syndrome Phase 2 Recruiting December 2023 United States, New York ... More >> Northwell Health/CLL Research and Treatment Program Recruiting New Hyde Park, New York, United States, 11042 Contact: John Katsetos, PA-C    516-470-4050    jkatsetos@northwell.edu    Contact: Alexis Mark, MS    516-470-4743    amark1@northwell.edu Less <<
NCT00114738 Lymphoma, Mantle Cell ... More >> Mantle Cell Lymphoma Less << Phase 2 Active, not recruiting August 11, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01848132 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 2 Completed - Spain ... More >> Hospital Clínico Universitario Lozano Blesa Zaragoza, Aragón, Spain, 50009 Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Institut Català d'Oncologia, Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Institut Català d'Oncologia, Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11407 Hospital Son Llàtzer Palma, Islas Baleares, Spain, 07198 Hospital Universitario Fundación Alcorcón Alcorcón, Madrid, Spain, 28922 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36036 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitari de Girona Doctor Josep Trueta Girona, Spain, 17007 Hospital Universitario Infanta Leonor Madrid, Spain, 28031 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Centro Integral Oncológico Clara Campal Madrid, Spain, 28050 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario de Canarias Santa Cruz de Tenerife, Spain, 38320 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario Doctor Peset Valencia, Spain, 46017 Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 Less <<
NCT01548573 - Terminated(Met study stopping ... More >>rules) Less << - -
NCT00114738 - Active, not recruiting - -
NCT02978495 BRCA1 Hereditary Breast and Ov... More >>arian Cancer Syndrome Less << Phase 2 Recruiting December 2022 Brazil ... More >> Barretos Cancer Hospital Recruiting Barretos, SP, Brazil, 14784-400 Less <<
NCT00004323 Aplastic Anemia Phase 2 Completed - United States, California ... More >> Center for Health Sciences Los Angeles, California, United States, 90024-1714 Less <<
NCT00001379 Lymphomatoid Granulomatosis ... More >> Granulomatosis, Lymphomatoid Non-Hodgkins Lymphoma Lymphoproliferative Disorder Less << Phase 2 Recruiting February 1, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT01641406 Infiltrating Duct and Lobular ... More >>Carcinoma In Situ Invasive Lobular Breast Carcinoma Inflammatory Breast Carcinoma Less << Phase 2 Unknown March 2013 Puerto Rico ... More >> Hospital Auxilio Mutuo Cancer Center Recruiting San Juan, Puerto Rico, 00918 Contact: Fernando Cabanillas, MD    787-758-2000 ext 3513    fcabanil@mdanderson.org    Contact: Idalia Liboy, MD    787-758-2000 ext 3569    iliboy@auxiliomutuo.com    Principal Investigator: Fernando Cabanillas, MD Less <<
NCT00741455 Hematologic Malignancies Not Applicable Active, not recruiting December 2023 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT02395822 Acute Myelogenous Leukemia Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02395822 - Completed - -
NCT02782754 Intracranial Germinoma Phase 2 Unknown - Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT00096460 Recurrent Grade 1 Follicular L... More >>ymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Follicular Lymphoma Less << Phase 2 Phase 3 Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT01849783 Extramedullary Plasmacytoma ... More >> Isolated Plasmacytoma of Bone Light Chain Deposition Disease Primary Systemic Amyloidosis Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Active, not recruiting December 2020 United States, Iowa ... More >> University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 Less <<
NCT00390793 Acute Lymphoblastic Leukemia ... More >> BCR-ABL1 Fusion Protein Expression Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia t(9;22) Less << Phase 2 Active, not recruiting August 31, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00096460 - Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT00169156 Untreated T-cell Angioimmunobl... More >>astic Lymphoma Less << Phase 2 Completed - France ... More >> Hôpital Henri Mondor Créteil, France Hôpital Saint Louis Paris, France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Henri Becquerel Rouen, France Less <<
NCT03609047 Breast Cancer Stage II ... More >> Breast Cancer Stage III Less << Phase 2 Not yet recruiting January 7, 2031 -
NCT03076437 Acute Lymphocytic Leukemia ... More >> Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Phase 2 Recruiting December 31, 2019 China, Guangdong ... More >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Yirong Jiang, MD    13688967985    dgjyr0769@163.com    Contact: Mingjun Wang, MD, PhD    15814723218    mingjunw429@163.com    Principal Investigator: Yirong Jiang, MD Less <<
NCT03767725 Multiple Myeloma in Relapse Phase 1 Recruiting September 1, 2021 China, Guangdong ... More >> Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Weihong Chen    86-755-83366388 ext 8199    whitney-cindy@hotmail.com    Contact: Xin Du    86-755-83366388 ext 8197    duxingz@medmail.com.cn Less <<
NCT03050216 Acute Myeloid Leukemia Phase 2 Suspended(Interim Analysis) September 2020 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00871689 Leukemia Phase 2 Terminated(Due to graft failur... More >>e.) Less << - United States, Minnesota ... More >> University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT00101010 Lymphoma Phase 2 Completed - United States, Arkansas ... More >> Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States, 72913 United States, Michigan CCOP - Grand Rapids Grand Rapids, Michigan, United States, 49503 CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Missouri Cancer Research for the Ozarks Springfield, Missouri, United States, 65804 United States, New York Hematology Oncology Associates of Central New York, PC - Northeast Center East Syracuse, New York, United States, 13057-4510 United States, South Carolina CCOP - Upstate Carolina Spartanburg, South Carolina, United States, 29303 United States, Texas University of Texas M.D. Anderson CCOP Research Base Houston, Texas, United States, 77030-4009 Less <<
NCT01696669 Ewing's Sarcoma Phase 2 Completed - Spain ... More >> Hospital Clínic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Sant Joan de Déu Esplugues de Llobregat, Spain Institut Català d'Oncologia l'Hospitalet Hospitalet de Llobregat, Spain Hospital Universitario de Canarias La Laguna, Spain Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Son Espases Palma de Mallorca, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT00429143 - Completed - -
NCT00572169 Multiple Myeloma Phase 3 Active, not recruiting August 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences/Myeloma Institute Little Rock, Arkansas, United States, 72205 Less <<
NCT00429143 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00712452 Infertility Not Applicable Terminated(problems of insuffi... More >>sant recruitment) Less << - France ... More >> AP-HP Hôpital Antoine Béclère Clamart, France, 92141 Less <<
NCT02116530 Hematopoietic/Lymphoid Cancer ... More >> Nausea and Vomiting Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 3 Completed - -
NCT00273364 Multiple Sclerosis Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00433420 Breast Cancer Phase 3 Unknown - -
NCT02116530 - Completed - -
NCT00871689 - Terminated(Due to graft failur... More >>e.) Less << - -
NCT00676806 Leukemia Lymp... More >>homa Multiple Myeloma Aplastic Anemia Less << Phase 2 Terminated(Slow accrual) - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT01004497 Acute Lymphoblastic Leukemia Phase 2 Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Chonju, Chonbuk, Korea, Republic of, 561-712 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 National Cancer Center Goyang, Gyeonggi-do, Korea, Republic of, 410-769 Chonnam National University Hwasun Hospital Hwasun, Jeonnam, Korea, Republic of, 519-809 St. Vincent's Hospital, The Catholic University of Korea Suwon, Kyonggi-do, Korea, Republic of, 442-723 Yonsei University Severance Hospital Seoul, Korea, Republic of, 120-752 Catholic BMT Center, Seoul St. Mary's Hospital, The Catholic University of Korea Seoul, Korea, Republic of, 137-701 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Less <<
NCT00676806 - Terminated(Slow accrual) - -
NCT00309569 Early Stage Breast Cancer Phase 3 Completed - -
NCT00082641 Breast Cancer Phase 1 Phase 2 Completed - United States, Nebraska ... More >> UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT00082641 - Completed - -
NCT00412360 - Completed - -
NCT01424982 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting October 31, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT00020722 - Terminated(Lack of funding to ... More >>continue study.) Less << - -
NCT00670748 Metastatic Melanoma ... More >> Metastatic Renal Cell Cancer Metastatic Cancer Less << Phase 2 Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02724163 Acute Myeloid Leukaemia Phase 3 Recruiting December 2032 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Aberdeen Royal Infirmary, NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN Belfast City Hospital, Belfast Health and Social Care Trust Not yet recruiting Belfast, United Kingdom, BT9 7AB Birmingham Children's Hospital NHS Foundation Trust Recruiting Birmingham, United Kingdom, B4 6NH University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Cardiff and Vale University Health Board, Noah's Ark Children's Hospital for Wales Recruiting Cardiff, United Kingdom, CF14 4XW NHS Lothian, Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF NHS Greater Glasgow and Clyde, The Royal Hospital for Children Recruiting Glasgow, United Kingdom, G51 4TF Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, United Kingdom, L12 2AP University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Great Ormond Street Hospital For Children NHS Trust Recruiting London, United Kingdom, WC1N 3JH Royal Manchester Childrens' Hospital , Central Manchester University Hospitals NHS Foundation Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie NHS Foundation Not yet recruiting Manchester, United Kingdom, M20 4BX The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital, Oxford Radcliffe Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 9DU Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2TH Southampton University Hospitals NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD Less <<
NCT00670748 - Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - -
NCT03391466 Relapsed/Refractory Diffuse La... More >>rge B-Cell Lymphoma (DLBCL) Less << Phase 3 Recruiting January 15, 2035 -
NCT03497702 Breast Cancer ... More >> Invasive Breast Cancer Less << Phase 2 Recruiting January 2024 Korea, Republic of ... More >> National Cancer Center Recruiting Goyang-si, Korea, Republic of Contact: Keun Seok Lee, MD, PhD Less <<
NCT02153580 Post-transplant Lymphoprolifer... More >>ative Disorder B-Cell Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting December 2021 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Tanya Siddiqi    800-826-4673       Principal Investigator: Tanya Siddiqi Less <<
NCT00039481 Cardiac Toxicity ... More >> Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03013504 HER2 Positive Breast Cancer Phase 3 Active, not recruiting December 2019 Belarus ... More >> Minsk Clinical Oncological Dispensary Minsk, Belarus, 220013 Bulgaria Complex Oncology Center Plovdiv, Bulgaria, 4002 Estonia East Tallinn Central Hospital Tallinn, Estonia, 10138 France Centre René Huguenin (Institut Curie) Saint-Cloud, France, 92210 Georgia S. Khechinashvili University Hospital Tbilisi, Georgia, 0179 Hungary National Institute of Oncology Budapest, Hungary, 1122 University of Debrecen Debrecen, Hungary, 4032 Italy Modena Hospital Modena, Italy, 41124 Malaysia Beacon International Specialist Centre Kuala Lumpur, Malaysia, 46050 Hospital Kuala Lumpur Kuala Lumpur, Malaysia, 50586 Poland Szpital Specjalistyczny Brzeziny Brzeziny, Poland, 95-060 Russian Federation LLC "Vitamed" Moscow, Russian Federation, 129515 Spain Hospital Universitario Virgen Macarena Sevilla, Spain, 41009 Thailand Maharaj Nakorn Chiang Mai Hospital Chiang Mai, Thailand, 50200 Ukraine GI "V. T. Zaycev Institute General and Urgent Surgery of NAMS of Ukraine " Kharkiv, Ukraine, 61018 Less <<
NCT00388349 Hodgkin Disease ... More >> Hodgkin's Lymphoma Lymphoma Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00020722 Breast Cancer Phase 2 Terminated(Lack of funding to ... More >>continue study.) Less << - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00416676 Neuroblastoma Phase 3 Unknown - -
NCT03742986 Breast Cancer Phase 2 Not yet recruiting June 2025 United States, New York ... More >> NYU Langone Health Not yet recruiting New York, New York, United States, 10016 Contact: Fraustina Hsu    646-754-7124    Fraustina.Hsu@nyulangone.org    Principal Investigator: Maryann Kwa, MD Less <<
NCT00412360 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Natural Killer Cell Lymphoblastic Leukemia/Lymphoma Less << Phase 3 Completed - -
NCT00388349 - Completed - -
NCT00801216 B-Cell Lymphomas Phase 2 Unknown January 2012 Italy ... More >> San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Contact: Roberto Crocchiolo, MD       roberto.crocchiolo@hsr.it    Contact: Silvia Govi, MD       silvia.govi@hsr.it    Sub-Investigator: Andrea Assanelli, MD          San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Sub-Investigator: Roberto Crocchiolo, MD          Sub-Investigator: Silvia Govi, MD Less <<
NCT01280526 Peripheral T Cell Lymphoma Phase 1 Phase 2 Completed - France ... More >> Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Claude Huriez Lille, France, 59037 Centre Léon Bérard Lyon cedex 8, France, 69373 Hôpital St Louis Paris, France, 75475 Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69495 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT03117751 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Lymphoma Less << Phase 2 Phase 3 Recruiting March 31, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Hiroto Inaba, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Hiroto Inaba, MD, PhD Less <<
NCT03526185 Metastatic Melanoma Early Phase 1 Recruiting December 1, 2019 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Michael E Hurwitz, MD, PhD Less <<
NCT01118026 Lymphoma Phase 2 Active, not recruiting - -
NCT03147612 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia With BCR-ABL1 Philadelphia Chromosome Positive Recurrent Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting February 8, 2024 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-4764       Principal Investigator: Elias Jabbour Less <<
NCT00872625 Breast Cancer Phase 1 Completed - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT01670084 B-cell Adult Acute Lymphoblast... More >>ic Leukemia Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Withdrawn(No Accrual) September 2017 United States, Arizona ... More >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00352976 Fanconi Anemia Phase 2 Phase 3 Recruiting December 2018 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Margaret L MacMillan, M.D.    612-626-2778    macmi002@umn.edu Less <<
NCT03556358 Breast Cancer ... More >> Breast Neoplasms HER2-positive Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Less << Phase 3 Recruiting March 2020 Bulgaria ... More >> Tanvex Investigational Site Recruiting Burgas, Bulgaria, 8000 Tanvex Investigational Site Recruiting Dobrich, Bulgaria, 9300 Tanvex Investigational Site Recruiting Gabrovo, Bulgaria, 5300 Tanvex Investigational Site Recruiting Pleven, Bulgaria, 5800 Tanvex Investigational Site Recruiting Plovdiv, Bulgaria, 4004 Chile Tanvex Investigational Site Recruiting Temuco, Chile, 4810469 Tanvex Investigational Site Recruiting Viña Del Mar, Chile, 2520598 Georgia Tanvex Investigational Site Recruiting Batumi, Georgia, 6000 Tanvex Investigational Site Recruiting Batumi, Georgia, 6010 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 0144 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 0159 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 0177 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 0179 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 0186 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 112 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 131 Tanvex Investigational Site Recruiting Tbilisi, Georgia, 141 Hungary Tanvex Investigational Site Recruiting Budapest, Hungary, 1122 Tanvex Investigational Site Recruiting Debrecen, Hungary, 4032 Tanvex Investigational Site Recruiting Győr, Hungary, 9024 Tanvex Investigational Site Recruiting Miskolc, Hungary, 3526 Tanvex Investigational Site Recruiting Pécs, Hungary, 7264 Less <<
NCT02918292 Severe Aplastic Anemia Phase 2 Recruiting February 2022 -
NCT03269292 - Not yet recruiting December 1, 2018 -
NCT00866749 Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00004171 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00931918 Non-Germinal B-Cell-like (GCB)... More >> Diffuse Large B-cell Lymphoma (DLBCL) Less << Phase 2 Completed - -
NCT00966498 High Risk Solid Tumors ... More >> Recurrent Solid Tumors Less << Not Applicable Terminated(poor enrollment) - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 Less <<
NCT01159236 Breast Cancer Not Applicable Withdrawn(Recent developments ... More >>lead to re-evaluation of study.) Less << - -
NCT02472392 EWINGS SARCOMA Phase 1 Completed - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT00931918 - Completed - -
NCT00625729 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Terminated(No patients exhibit... More >>ed natural killer cell expansion (primary endpoint).) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00625729 - Terminated(No patients exhibit... More >>ed natural killer cell expansion (primary endpoint).) Less << - -
NCT00025363 Alveolar Childhood Rhabdomyosa... More >>rcoma Embryonal Childhood Rhabdomyosarcoma Embryonal-botryoid Childhood Rhabdomyosarcoma Previously Treated Childhood Rhabdomyosarcoma Recurrent Childhood Rhabdomyosarcoma Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03191773 Acute Lymphocytic Leukemia ... More >> Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China Contact: Yirong Jiang, MD    0086 13688967985    dgjyr0769@163.com    Principal Investigator: Yirong Jiang, MD          Department of Hematology, the First People's Hospital of Foshan Recruiting Foshan, Guangdong, China Contact: Zhuowen Chen, MD    0086 18928617712    czwen@fsyyy.com    Contact: Wei Luo, MD    0086 18038865996    luowei_421@163.com    Principal Investigator: Zhuowen Chen, MD          Department of Hematology, Guangzhou First People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang    0086 13437801998    drwangshq@medmail.com.cn    Principal Investigator: Shunqing Wang, MD          Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University Recruiting Guangzhou, Guangdong, China Contact: Xueyi Pan    0086 13922217835    xypan88@163.com    Principal Investigator: Xueyi Pan, MD          Department of Hematology,the Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Ying Feng, MD    0086 13602723030    fyzlply@163.com    Principal Investigator: Ying Feng, MD Less <<
NCT01087398 Osteopetrosis Phase 2 Phase 3 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +98-21    aahamidieh@sina.tums.ac.ir    Sub-Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT00085735 Untreated Childhood Medullobla... More >>stoma Less << Phase 3 Completed - -
NCT02449278 Diffuse Large B-cell Lymphoma Phase 3 Recruiting October 2025 China, Hubei ... More >> DiDeng Recruiting Wuhan, Hubei, China, 430071 Less <<
NCT02685670 Hematopoietic/Lymphoid Cancer ... More >> Adult Acute Lymphoblastic Leukemia in Remission B-cell Adult Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Adult Diffuse Large Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 1 Phase 2 Recruiting December 2019 China, Henan ... More >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D. Less <<
NCT02167958 Leukemia MDS ... More >> Myelofibrosis Lymphoma Less << Phase 1 Recruiting July 2020 United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN    412-647-8571    Johnsonr1@upmc.edu    Sub-Investigator: Annie P Im, MD          Sub-Investigator: Alison R Sehgal, MD          Sub-Investigator: Mounzer E Agha, MD          Sub-Investigator: Jing-Zhou Hou, MD          Sub-Investigator: Mounzer Agha, MD          Sub-Investigator: Kathleen Dorritie, MD          Sub-Investigator: Anastasios Raptis, MD Less <<
NCT01457131 Metastatic Cancer ... More >> Metastatic Melanoma Metastatic Renal Cancer Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00440583 Diffuse Large B-cell Lymphoma Phase 2 Completed - Thailand ... More >> Siriraj Hospital, Mahidol University Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT01640301 Recurrent Adult Acute Myeloid ... More >>Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting October 1, 2030 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Daniel Egan    206-667-4971    degan@fredhutch.org    Principal Investigator: Daniel Egan Less <<
NCT03093168 Multiple Myeloma Phase 1 Recruiting February 2020 China, Henan ... More >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D.    +(86)-139-3852-6995    clinicaltrials.chengzhi@outlook.com Less <<
NCT00002838 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00542191 Breast Cancer Phase 2 Terminated(Enrollment Complete... More >>d) Less << - United States, North Carolina ... More >> Brody School of Medicine at East Carolina University Greenville, North Carolina, United States, 27834 Less <<
NCT00176852 Sickle Cell Disease ... More >> Thalassemia Severe Congenital Neutropenia Diamond-Blackfan Anemia Shwachman-Diamond Syndrome Less << Phase 2 Phase 3 Active, not recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00085735 - Completed - -
NCT01537536 Breast Cancer Phase 2 Completed - Belgium ... More >> Institut Jules Bordet Brussels, Belgium, 1000 Less <<
NCT00176852 - Active, not recruiting - -
NCT02191930 Hodgkin Lymphoma Phase 2 Recruiting April 2019 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Recruiting Cologne, Germany, 50924 Contact: Michael Fuchs       ghsg@uk-koeln.de Less <<
NCT00209222 Lymphoma, Mantle-Cell Phase 3 Unknown December 2014 France ... More >> Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Recruiting Paris, France, F-75743 Contact: Guylène Chartier    +33-1-42499811    Guylene.chartier@chu-stlouis.fr    Contact: Olivier Hermine, PhD    +33-1-44 49 52 83    hermine@necker.fr    Principal Investigator: Olivier Hermine, PhD          Germany German Low Grade Study Group (Glsg) Recruiting Munich, Germany, D-81377 Contact: Michael Unterhalt, Dr.    +49-89-7095 ext 4915    Michael.Unterhalt@med.uni-muenchen.de    Contact: Martin Dreyling, PhD    +49-89-7095 ext 2202    Martin.Dreyling@med.uni-muenchen.de    Principal Investigator: Wolfgang Hiddemann, PhD          Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Recruiting Warszawa, Poland, PL-02-781 Contact: Jan Walewski, MD    +48-22-546-2223    walewski@coi.waw.pl    Contact: Marek P Nowacki, MD    +48-22-546-2223       Principal Investigator: Jan Walewski, MD Less <<
NCT01265849 Squamous Cell Carcinoma of the... More >> Oral Cavity Squamous Cell Carcinoma of the Soft Palate Less << Phase 3 Completed - -
NCT03247088 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting July 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT03248427 Breast Cancer Phase 2 Recruiting May 2019 Spain ... More >> Hospital Clinic de Barcelona Recruiting Barcelona, Spain Contact: Montse Muñoz          Hospital General de Catalunya Recruiting Barcelona, Spain Contact: Xavier González Farré          Hospital Universitari Vall d' Hebron Recruiting Barcelona, Spain Contact: Cristina Saura          Institut Català d'Oncologia l'Hospitalet Not yet recruiting Barcelona, Spain Contact: Juan Miguel Gil          Consorcio Hospitalario Provincial de Castellón Recruiting Castelló, Spain Contact: Eduardo Martínez Dueñas          Hospital San Pedro de Alcántara Recruiting Cáceres, Spain Contact: Santiago Gonzalez          Fundació Privada Hospital Asil de Granollers Not yet recruiting Granollers, Spain Contact: Vanesa Ortega          Centro Integral Oncologico Clara Campal Recruiting Madrid, Spain Contact: Laura García Estevez          Centro Oncológico MD Anderson International España Recruiting Madrid, Spain Contact: Raquel Bratos Lorenzo          Hospital Quirón Madrid Recruiting Madrid, Spain Contact: Lucía González Cortijo          Hospital Rey Juan Carlos Recruiting Madrid, Spain Contact: Sergio Hoyos Simón          Hospital Universitario 12 de octubre Recruiting Madrid, Spain Contact: Eva Ciruelos          Hospital Universitario Fundación de Alcorcón Recruiting Madrid, Spain Contact: Carlos Jara Sánchez          Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain Contact: Yann Izarzugaza          Hospital Universitari Son Espases Recruiting Palma, Spain Contact: Neus Ferrer Tur          Complexo Hospitalario Universitario de Santiago Recruiting Santiago de Compostela, Spain Contact: Rafael Lopez Lopez          Hospital Virgen del Rocío Recruiting Sevilla, Spain Contact: Alvaro Montaño          Hospital Virgen Macarena Recruiting Sevilla, Spain Contact: Juan Antonio Virizuela Echaburu          Fundación Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: Joaquin Gavilá          Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain Contact: Begonia Bermejo          Hospital Universitari Arnau de Vilanova de València Recruiting Valencia, Spain Contact: Antonio Llombart Cussac Less <<
NCT00352027 Hodgkin's Lymphoma Phase 2 Active, not recruiting November 2022 United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Maine Maine Children's Medical Center Portland, Maine, United States, 04102-3175 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02784015 Unresectable Localized Soft Ti... More >>ssue Sarcoma Less << Phase 2 Recruiting May 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01652014 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Withdrawn(Funding unavailable) January 2017 United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT01451515 Lymphoblastic Lymphoma Phase 2 Active, not recruiting June 30, 2021 United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03036904 Diffuse Large B-Cell Lymphoma ... More >> High Grade B-Cell Lymphoma Less << Phase 1 Recruiting August 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02284 Contact: Patricia Renaudie, RN    617-643-7018    prenaudie@mgh.harvard.edu    Principal Investigator: Jeremy Abramson, MD          Principal Investigator: Ann LaCasce, MD          United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Principal Investigator: Nancy Bartlett, MD          United States, New York Weill Cornell Medicine Recruiting New York, New York, United States, 10065 Contact: Amelyn Rodriguez, RN    212-746-1362    amr2017@med.cornell.edu    Contact: Rita Vaccaro, RN    212-746-0702    rig9021@med.cornell.edu    Principal Investigator: Sarah Rutherford, M.D.          United States, Ohio Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Principal Investigator: Kami Maddocks, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Principal Investigator: Stefan Barta, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Donna Griffith, RN    713-563-9057    dgriffi@mdanderson.org    Principal Investigator: Jason Westin, MD Less <<
NCT00608517 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Not Applicable Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37067-1631 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37067-5615 Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00061893 Sarcoma Phase 2 Completed - -
NCT01583686 Cervical Cancer ... More >> Pancreatic Cancer Ovarian Cancer Mesothelioma Lung Cancer Less << Phase 1 Phase 2 Recruiting December 31, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00061893 - Completed - -
NCT00608517 - Terminated(slow accrual) - -
NCT02532400 Breast Cancer Phase 3 Unknown December 2018 China, Shanghai ... More >> Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Yan Fang, doctor    64370045 ext 602215    fangyan4743@163.com Less <<
NCT02122081 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Recruiting November 2018 United States, Ohio ... More >> Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Nicholas Voss       Nicholas.Voss@osumc.edu    Principal Investigator: Meng X. Welliver, MD Less <<
NCT00352027 - Active, not recruiting - -
NCT01468740 HIV-associated Hodgkin Lymphom... More >>a Less << Phase 2 Unknown July 2012 Germany ... More >> Vivantes Auguste Victoria Klinikum Recruiting Berlin, Germany, 12157 Contact: Markus Müller, MD    0049 30 130 20 2321    Markus.Mueller2@vivantes.de    Contact: Marcel Berger, MD    0049 30 130 20 2321    Marcel.Berger@vivantes.de    Sub-Investigator: Markus Müller, MD          Sub-Investigator: Marcel Berger, MD          Principal Investigator: Keikawus Arasteh, MD          Ärzteforum Seestrasse Recruiting Berlin, Germany, 13347 Contact: Jan Siehl, MD    0049 30 455095-0    jan.siehl@aerzteforum-seestrasse.de    Principal Investigator: Jan Siehl, MD          Universiy of Bonn Recruiting Bonn, Germany, 53127 Contact: Juergen Rockstroh, MD    0049 228 287 16558    Rockstroh@uni-bonn.de;    Principal Investigator: Jürgen Rockstroh, MD          University of Cologne Recruiting Cologne, Germany, 50924 Contact: Christoph Wyen, MD    0049 221 478 88835    christoph.wyen@uk-koeln.de    Contact: Gerd Fätkenheuer, MD    0049 221 478 4886    g.faetkenheuer@uni-koeln.de    Sub-Investigator: Christoph Wyen, MD          Principal Investigator: Gerd Fätkenheuer, MD          University of Frankfurt Recruiting Frankfurt, Germany, 60590 Contact: Timo Wolf, MD    0049 69 6301 5452    Timo.Wolf@kgu.de    Principal Investigator: Timo Wolf, MD          Asklepios Klinikum St. Georg Recruiting Hamburg, Germany, 20099 Contact: Maike Nickelsen, MD    0049 40 18 18 85 20 05    m.nickelsen@asklepios.com    Principal Investigator: Maike Nickelsen, MD          Infektionsmedizinisches Zentrum Hamburg Recruiting Hamburg, Germany, 20146 Contact: Christian Hoffmann, MD    0049 40 4132420    hoffmann@ich-hamburg.de;    Principal Investigator: Christian Hoffmann, MD          Harlaching Hospital Recruiting Munich, Germany, 81545 Contact: Marcus Hentrich, MD    0049 89 6210 2663 or 2731    marcus.hentrich@klinikum-muenchen.de    Principal Investigator: Marcus Hentrich, MD Less <<
NCT00074165 - Terminated(Lack of accrual) - -
NCT00074165 Brain and Central Nervous Syst... More >>em Tumors Drug/Agent Toxicity by Tissue/Organ Lymphoma Thrombocytopenia Less << Phase 2 Terminated(Lack of accrual) - United States, Ohio ... More >> Good Samaritan Hospital Cancer Treatment Center, Hatton Institute Cincinnati, Ohio, United States, 45220 United States, Oregon Knight Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 Less <<
NCT00577629 Lymphoma, B-Cell Phase 2 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00559104 Lymphoma Phase 2 Completed - United States, Arizona ... More >> Good Samaritan Regional Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope National Medical Center--Main Campus Duarte, California, United States, 91010-3000 Less <<
NCT00577629 - Completed - -
NCT00559104 - Completed - -
NCT00003992 Breast Cancer Phase 2 Completed - -
NCT01147016 Breast Cancer Phase 2 Active, not recruiting December 2018 United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00274924 - Active, not recruiting - -
NCT01055314 - Completed - -
NCT02784054 Intracranial Non-germinomatous... More >> Germ Cell Tumor Less << Phase 2 Recruiting March 2022 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT01055314 Adult Rhabdomyosarcoma ... More >> Childhood Alveolar Rhabdomyosarcoma Childhood Embryonal Rhabdomyosarcoma Metastatic Childhood Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Untreated Childhood Rhabdomyosarcoma Less << Phase 2 Completed - -
NCT00101101 - Active, not recruiting - -
NCT02559154 Multiple Myeloma Phase 4 Active, not recruiting December 2018 China ... More >> Shanghai General Hospital Shanghai, China, 200080 Less <<
NCT00274924 Lymphoma Phase 2 Active, not recruiting March 2019 -
NCT00101101 Lymphoma Phase 2 Active, not recruiting March 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 Less <<
NCT01251107 Hodgkin Lymphoma Phase 3 Completed - Italy ... More >> Fondazione IRCCS Istituto Nazionale di Tumori di Milano Milano, Italy Less <<
NCT02049151 Carcinoma, Non-Small-Cell Lung Phase 3 Terminated(The study is termin... More >>ated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC) Less << - United States, Massachusetts ... More >> Please Contact U.S. Medical Information Located in Rockland, Massachusetts, United States Germany Please contact the Merck KGaA Communication Center Located in Darmstadt, Germany Less <<
NCT01043640 - Completed - -
NCT02049151 - Terminated(The study is termin... More >>ated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC) Less << - -
NCT02790515 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myeloid Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Less << Phase 2 Recruiting June 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon Triplett, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Brandon Triplett, MD Less <<
NCT00801918 Anaplastic Large-Cell Lymphoma Phase 2 Withdrawn(Lack of funding) June 2012 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT01000285 Leukemia-Lymphoma, Adult T-Cel... More >>l Less << Phase 1 Phase 2 Completed - United States, Florida ... More >> University of Miami Hospital/Sylvester Miami, Florida, United States, 33136 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21231 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 Columbia University, College of Physicians and Surgeons New York, New York, United States, 10032 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01043640 Mucopolysaccharidosis ... More >> Hurler Syndrome Hunter Syndrome Maroteaux-Lamy Syndrome Sly Syndrome Alpha Mannosidosis Fucosidosis Aspartylglucosaminuria Adrenoleukodystrophy (ALD) Krabbe Disease Metachromatic Leukodystrophy (MLD) Sphingolipidoses Peroxisomal Disorders Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01000285 - Completed - -
NCT03171831 Thalassemia Major Phase 4 Recruiting April 1, 2022 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 510515 Contact: Yongrong Lai, MD    +86（0771）5356510    laiyongrong@hotmail.com Less <<
NCT00003974 Lung Cancer M... More >>alignant Mesothelioma Less << Phase 1 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01880385 Inflammatory Breast Cancer Phase 1 Unknown April 2017 Tunisia ... More >> Institut Salah Azaiz Recruiting Bab Saadoun, Tunis, Tunisia, 1006+ Contact: ghozlane lakhoua    00 216 98 354 190    ghozlane_lakhoua@hotmail.fr    Sub-Investigator: henda raies, professor Less <<
NCT00324831 Lymphoma Phase 3 Suspended - United States, California ... More >> Tower Cancer Research Foundation Beverly Hills, California, United States, 90211 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00002755 Breast Cancer Phase 3 Completed - Ireland ... More >> St. Vincent's Hospital Dublin, Ireland, 4 United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Northwick Park Hospital Harrow, England, United Kingdom, HA1 3UJ Huddersfield Royal Infirmary Huddersfield, West Yorks, England, United Kingdom, HD3 3EA St. James's Hospital Leeds, England, United Kingdom, LS9 7TF St. George's Hospital London, England, United Kingdom, SW17 0QT Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1N 8AA Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal South Hants Hospital Southampton, England, United Kingdom, SO14 0YG Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Infirmary Edinburgh, Scotland, United Kingdom, EH3 9YW Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Infirmary Glasgow, Scotland, United Kingdom, G4 0SF Velindre Hospital Cardiff, Wales, United Kingdom, CF4 7XL Less <<
NCT01181271 - Completed - -
NCT00352209 - Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike Bethesda, Maryland, United States, 20892 National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03449108 Malignant Neoplasms of Bone an... More >>d Articular Cartilage Malignant Neoplasms of Female Genital Organs Less << Phase 2 Recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT01843868 Lymphoma, Non-Hodgkin Not Applicable Unknown December 2015 -
NCT00109837 Leukemia Phase 2 Completed - -
NCT00006055 Purpura, Schoenlein-Henoch ... More >> Graft Versus Host Disease Anemia, Hemolytic, Autoimmune Rheumatoid Arthritis Churg-Strauss Syndrome Hypersensitivity Vasculitis Wegener's Granulomatosis Systemic Lupus Erythematosus Giant Cell Arteritis Pure Red Cell Aplasia Juvenile Rheumatoid Arthritis Polyarteritis Nodosa Autoimmune Thrombocytopenic Purpura Takayasu Arteritis Less << Not Applicable Unknown - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT02206425 Multiple Myeloma Phase 1 Phase 2 Terminated(Data collection for... More >> endpoints have been reached) Less << - United States, California ... More >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 John Muir Health Clinical Research Center Concord, California, United States, 94520 California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States, 92024 Robert A. Moss, MD, FACP, Inc Fountain Valley, California, United States, 92708 cCARE Fresno Fresno, California, United States, 93720 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 James Berenson, MD, Inc West Hollywood, California, United States, 90069 United States, Florida Cancer Specialists of North Florida Fleming Island, Florida, United States, 32003 United States, Georgia Lewis Hall Singletary Oncology Center Thomasville, Georgia, United States, 31792 United States, Illinois Oncology Specialists, SC Niles, Illinois, United States, 60714 United States, Mississippi Hattiesburg Clinic Hematology/Oncology Hattiesburg, Mississippi, United States, 39401 United States, Washington Vista Oncology Olympia, Washington, United States, 98502 Less <<
NCT00109837 - Completed - -
NCT03092453 Melanoma Phase 1 Recruiting December 2018 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Gerald P Linette, MD, PhD    215-573-7032    glinette@upenn.edu    Contact: Emerging Medicine    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT00000689 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 1 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 90033 Less <<
NCT02228512 Large Cell Lymphoma Arising in... More >> KSHV-associated Multicentric Castleman Disease Primary Effusion Lymphoma Less << Phase 1 Phase 2 Withdrawn - -
NCT00365365 Breast Cancer Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT00026208 - Completed - -
NCT02627573 Leukemia, Chronic Myeloid ... More >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Less << Phase 2 Suspended July 2020 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT01807611 Leukemia Lymp... More >>homa Less << Phase 2 Recruiting July 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon M. Triplett, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Brandon M. Triplett, MD Less <<
NCT00026208 Lymphoma, Hodgkin Disease ... More >> Lymphoma Hodgkin Disease Lymphoma: Hodgkin Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Kaiser Permanente Medical Center Vallejo, California, United States, 94589 Less <<
NCT00136084 Leukemia, Myelocytic, Acute Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States, 48201 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 MD Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Cancer Center Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT03553537 Peripheral T-cell Lymphoma Phase 3 Not yet recruiting July 2021 -
NCT00365365 - Completed - -
NCT01193842 AIDS-Related Plasmablastic Lym... More >>phoma AIDS-Related Primary Effusion Lymphoma Ann Arbor Stage I Diffuse Large B-Cell Lymphoma Ann Arbor Stage I Grade 3 Follicular Lymphoma Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma CD20 Positive HIV Infection Plasmablastic Lymphoma Primary Effusion Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Grade 3 Follicular Lymphoma Less << Phase 1 Phase 2 Active, not recruiting - -
NCT00022945 Mantle Cell Lymphoma Phase 2 Completed - United States, Illinois ... More >> Rush-Presbyterian-St. Lukes Medical Center Chicago, Illinois, United States, 60612 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02753647 Diffuse Large B-cell Lymphoma Phase 2 Recruiting April 2019 China, Shanghai ... More >> Shanghai Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200023 Contact: Weili Zhao, MD,PhD    64370045 ext 610707    zhao.weili@yahoo.com    Contact: Pengpeng Xu, MD    64370045 ext 610707    xpproc@msn.com Less <<
NCT00387959 - Completed - -
NCT01181271 Diffuse, Large B-Cell, Lymphom... More >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00580372 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00580372 - Completed - -
NCT00040482 Multiple Sclerosis Phase 2 Completed - United States, Texas ... More >> The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00079144 Melanoma (Skin) Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00424489 - Terminated(No participants enr... More >>olled for more than two years. No plan to continue study.) Less << - -
NCT02928991 Bone Marrow Failure Syndromes Early Phase 1 Recruiting April 2020 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Timothy Olson, MD, PhD       OLSONT@email.chop.edu    Contact: Barbara McGlynn, RN, BSN       MCGLYNN@email.chop.edu    Principal Investigator: Timothy Olson, MD Less <<
NCT01193842 - Active, not recruiting - -
NCT00363090 Lymphoma Phase 1 Phase 2 Unknown - Canada, British Columbia ... More >> St. Paul's Hospital at Providence Health Care - Vancouver Recruiting Vancouver, British Columbia, Canada, V6Z 1Y6 Contact: Contact Person    604-806-9656       Canada, Ontario Margaret and Charles Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, N6A 4L6 Contact: Graeme Fraser, MD, FRCPC    905-575-7820       London Regional Cancer Program at London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 4L6 Contact: Joy Mangel, MD    519-685-8615    joy.mangel@lhsc.on.ca    Odette Cancer Centre at Sunnybrook Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Rena Buckstein, MD    416-480-5847    rena.buckstein@sunnybrook.ca    Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Michael R. Crump, MD, FRCPC    416-946-4567    michael.crump@uhn.on.ca Less <<
NCT00136084 - Completed - -
NCT00424489 Myasthenia Gravis Phase 1 Terminated(No participants enr... More >>olled for more than two years. No plan to continue study.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00740467 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition Less << Phase 2 Unknown - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Contact Person    33-4-91-22-37-54 Less <<
NCT00290667 Lymphoma Phase 2 Completed - -
NCT00455312 - Completed - -
NCT00455312 Dyskeratosis Congenita ... More >> Aplastic Anemia Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01203228 Myelodysplastic Syndromes ... More >> Secondary Acute Myeloid Leukemia Less << Phase 3 Terminated - Germany ... More >> University Hospital Düsseldorf, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany University Hospital Eppendorf Hamburg, Germany University Hospital Heidelberg, Germany UKSH Campus Kiel Kiel, Germany University Hospital Köln, Germany University Hospital Leipzig, Germany Universitätsklinikum Munster Munster, Germany University Hospital Tübingen, Germany Italy Santi Antonio e Biagio Alessandria, Italy Ospedale di Careggi Firenze, Italy Ospedale Maggiore di Milano Milano, Italy Netherlands Radboud University MC Nijmegen, Netherlands Russian Federation SPb State I. Pavlov Medical University St. Petersburg, Russian Federation Less <<
NCT02797717 Classical Hodgkins Lymphoma in... More >> Children and Adolescents. Less << Not Applicable Recruiting December 2027 Israel ... More >> Schneider children's medical center Recruiting Petach-Tikva, Israel, 4920235 Contact: Galia Avrahami, MD    972-3-9253356    Galia2@clalit.org.il Less <<
NCT00225173 Hodgkin Disease Phase 2 Terminated - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305 Less <<
NCT00186875 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Lymphoblastic Less << Phase 2 Completed - United States, California ... More >> Rady Children's Hospital and Health Center San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00387959 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03593902 Systemic Sclerosis ... More >> Scleroderma Less << Phase 2 Phase 3 Recruiting January 2026 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley    312-695-4960    k-quigley@northwestern.edu    Principal Investigator: Richard Burt, MD          Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley, RN    312-695-8192    kathleen.quigley@nm.org    Principal Investigator: Richard Burt, MD Less <<
NCT01358877 Breast Cancer Phase 3 Active, not recruiting December 1, 2023 -
NCT02909751 Breast Cancer Phase 2 Active, not recruiting April 2020 Denmark ... More >> Vejle hospital, Department of Oncology Vejle, Denmark Less <<
NCT01358877 - Active, not recruiting - -
NCT00871481 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00186875 - Completed - -
NCT02449265 Diffuse Large B-cell Lymphoma Phase 3 Recruiting October 2025 China, Hubei ... More >> DiDeng Recruiting Wuhan, Hubei, China, 430071 Less <<
NCT03742258 Diffuse Large B-Cell Lymphoma ... More >> Diffuse Large B-Cell Lymphoma Activated B-Cell Type Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements High Grade B-Cell Lymphoma, Not Otherwise Specified T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Less << Phase 1 Not yet recruiting August 1, 2021 United States, Illinois ... More >> Northwestern University Not yet recruiting Chicago, Illinois, United States, 60611 Contact: Reem Karmali    312-695-0711    reem.karmali@northwestern.edu    Principal Investigator: Reem Karmali Less <<
NCT00038402 Breast Cancer Phase 3 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00131313 Chronic Lymphocytic Leukemia Phase 4 Unknown - -
NCT00536978 - Completed - -
NCT01359592 Lymphoma Phase 2 Active, not recruiting March 2024 -
NCT00602667 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Active, not recruiting April 30, 2023 United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 Rady Children's Hospital San Diego, California, United States, 92123 United States, Minnesota Children's Hospitals and Clinics of Minnesota - St. Paul Saint Paul, Minnesota, United States, 55102 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Australia, Queensland Lady Cilento Children's Hospital, Brisbane Brisbane, Queensland, Australia, 4029 Less <<
NCT01964391 Breast Cancer Phase 3 Active, not recruiting December 22, 2018 Algeria ... More >> Centre hospitalo-univerisitaire de Rouiba;Service d'oncologie médicale Algiers, Algeria, 16016 Centre Anti Cancer Beau-fraisier;Service d'oncologie médicale Algiers, Algeria, 16340 CHU Annaba; Service d'Oncologie Médicale Annaba, Algeria, 23000 EHS Oncologie Emir Abdelkader Oran; Service d'Oncologie Médicale Oran, Algeria, 31000 Morocco Clinique Littoral Casablanca, Morocco, 20052 Centre Hospitalier Universitaire Mohamed VI; Oncologie-Hématologie Marrakech, Morocco, 40000 Institut National D'oncologie Sidi Med Benabdellah Rabat, Morocco, 6213 Saudi Arabia International Medical Center (IMC) Jeddah, Saudi Arabia, 21451 King Khaled Uni Hospital; Oncology Riyadh, Saudi Arabia, 11472 Tunisia Abderrahmen Mami Hospital; Medical Oncology department Ariana, Tunisia, 2080 Habib Bourguiba Hospital; Oncology department Sfax, Tunisia, 3029 Farhat Hached Hospital; Oncology department Sousse, Tunisia, 4031 Institut Salah Azaïz; Service de Médecine Carcinologique Tunis, Tunisia, 1029 Turkey Gazi University Medical Faculty; Department of İnternal Medicine Ankara, Turkey, 06500 Akdeniz Univesity Medical Faculty Antalya, Turkey, 07058 Dicle University Faculty of Medicine Diyarbakir, Turkey, 21280 Trakya University Medical Faculty Edirne, Turkey, 22030 Gaziantep Univ. Med. Fac. Gaziantep, Turkey, 27310 İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi İstanbul, Turkey, 34098 Bezmialem Vakif Univ Medical Istanbul, Turkey, 34286 Marmara Uni Faculty of Medicine; Medical Oncology Istanbul, Turkey, 34890 Ege University Medical Faculty Izmir, Turkey, 35100 Hacettepe Uni Medical Faculty Hospital; Oncology Dept Sıhhiye, Ankara, Turkey, 06100 Less <<
NCT00536978 Lymphoma Leuk... More >>emia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00896519 Lymphoma Phase 2 Unknown - -
NCT02400567 Neoadjuvant Operable Breast Ca... More >>ncer Less << Phase 2 Active, not recruiting April 2019 France ... More >> Institut Curie Paris, France Gustave Roussy Villejuif, France Less <<
NCT00186355 Lymphoma, Non-Hodgkin Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00899847 - Completed - -
NCT00899847 Transplantation, Homologous ... More >> Transplantation, Autologous Multiple Myeloma Blood and Marrow Transplant (BMT) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00524303 Neoplasms, Breast Phase 2 Completed - United States, California ... More >> GSK Investigational Site Fountain Valley, California, United States, 92708 GSK Investigational Site Los Angeles, California, United States, 90057 United States, Colorado GSK Investigational Site Denver, Colorado, United States, 80220 United States, Florida GSK Investigational Site Hudson, Florida, United States, 34667 GSK Investigational Site Miami, Florida, United States, 33176 GSK Investigational Site Pembroke Pines, Florida, United States, 33028 United States, Indiana GSK Investigational Site Indianapolis, Indiana, United States, 46219 United States, Nevada GSK Investigational Site Henderson, Nevada, United States, 89052 United States, Pennsylvania GSK Investigational Site Philadelphia, Pennsylvania, United States, 19107 United States, Texas GSK Investigational Site Austin, Texas, United States, 78731 GSK Investigational Site Beaumont, Texas, United States, 77702-1449 GSK Investigational Site Bedford, Texas, United States, 76022 GSK Investigational Site Dallas, Texas, United States, 75231 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Dallas, Texas, United States, 75320-2510 GSK Investigational Site El Paso, Texas, United States, 79915 GSK Investigational Site Houston, Texas, United States, 77024 GSK Investigational Site Lewisville, Texas, United States, 75067 GSK Investigational Site Sugar Land, Texas, United States, 77479 GSK Investigational Site Tyler, Texas, United States, 75702 United States, Virginia GSK Investigational Site Norfolk, Virginia, United States, 23502 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98117 GSK Investigational Site Yakima, Washington, United States, 98902 Less <<
NCT00524303 - Completed - -
NCT01901146 Breast Cancer Phase 3 Completed - -
NCT01779050 Breast Neoplasms Phase 2 Active, not recruiting October 31, 2019 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00630565 Leukemia Phase 2 Phase 3 Recruiting December 2021 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Daniel J. Weisdorf, M.D. Less <<
NCT02890602 Diffuse Large B-cell Lymphoma Phase 2 Active, not recruiting December 31, 2018 -
NCT02531308 - Terminated(poor accrual) - -
NCT01798004 Disseminated Neuroblastoma ... More >> Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << October 2018 -
NCT02531308 Diffuse Large B-Cell Lymphoma Phase 2 Terminated(poor accrual) - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01966471 Breast Cancer Phase 3 Active, not recruiting January 31, 2024 -
NCT03518112 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 2 Recruiting December 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77339 Contact       ejabbour@mdanderson.org Less <<
NCT01798004 - Suspended(CRM 31684 - CTEP PIO... More >> requested) Less << - -
NCT01093235 Breast Cancer ... More >> Cardiac Toxicity Perioperative/Postoperative Complications Less << Phase 3 Unknown - United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Contact Person    44-1223-336-800    Hme22@cam.ac.uk Less <<
NCT00001251 Leukemia Lymp... More >>homa Meningeal Neoplasm Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01005914 Leukemia Phase 2 Terminated(Increased rate of b... More >>acterial infections) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT03480360 Acute Myeloid Leukemia ... More >> Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelodysplasia Myeloproliferative Disorder Myelofibrosis Lymphoma Lymphoma, Non-Hodgkin Plasma Cell Disorder Less << Phase 3 Recruiting December 31, 2022 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse    800-639-6918    cancer.research.nurse@dartmouth.edu    Contact: Michael Sainz    603-650-5153    michael.sainz@hitchcock.org Less <<
NCT01005914 - Terminated(Increased rate of b... More >>acterial infections) Less << - -
NCT00209209 Lymphoma, Mantle-Cell Phase 3 Active, not recruiting December 2018 Czech Republic ... More >> General University Hospital, 1St Department of Medicine Praha, Czech Republic, CZ-12808 Denmark Nordic Lymphoma Group Copenhagen, Denmark, DK-2100 France Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Paris, France, F-75743 Germany German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Italy Ospedale Ferratotto, Divisione Di Ematologia Catania, Italy, I-95124 Netherlands HOVON - Dutch Haemato-Oncology Association (HOVON-Datacenter) Rotterdam, Netherlands, NL-3008 AE Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Warszawa, Poland, PL-02-781 Less <<
NCT01682226 Leukemia Myel... More >>odysplastic Syndrome Lymphoma Less << Phase 2 Active, not recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00140595 Diffuse Large-Cell Lymphoma Phase 3 Completed - Belgium ... More >> Groupe d'étude des lymphomes de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Hématologie Adultes - Hôpital Necker Paris, France, 75743 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Hématologie CHU Purpan Toulouse, France, 31059 Institut Gustave Roussy Villejuif, France Less <<
NCT02379585 HER2-positive Breast Cancer Phase 1 Phase 2 Terminated(PI Decision) - United States, Arizona ... More >> Western Regional Medical Center Goodyear, Arizona, United States, 85338 Less <<
NCT02870907 Retinoblastoma Phase 2 Recruiting September 2026 France ... More >> Hopital Nord Chu Amiens Recruiting Amiens, France, 80054 Principal Investigator: Antoine GOURMEL, MD          Chu Angers Recruiting Angers, France, 49033 Principal Investigator: Isabelle PELLIER, MD          Hopital Jean Minioz Recruiting Besancon, France, 25030 Principal Investigator: Véronique LAITHIER, MD          Chu R; Pellegrin Recruiting Bordeaux, France, 33076 Principal Investigator: Céline BOUYN-ICHER, MD          Chu Morvan Recruiting Brest, France, 29609 Principal Investigator: Liana-Sthéphania CARAUSU, MD          CHU CAEN Recruiting Caen, France, 14033 Principal Investigator: Odile MINCKES, MD          Chu Estaing Recruiting Clermont Ferrand, France, 63003 Principal Investigator: Justyna KANOLD          Chu Bocage Recruiting Dijon, France, 21079 Principal Investigator: Claire BRIANDET, MD          Chu de Grenoble Recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, MD          Centre Oscar Lambret Recruiting Lille, France, 59020 Principal Investigator: Hélène SUDOUR-BONNANGE, MD          Chu Limoges Recruiting Limoges, France, 87042 Principal Investigator: Christophe PIGUET, MD          Centre Leon Berard Recruiting Lyon, France, 69373 Principal Investigator: Cécile FAURE CONTER, MD          Hopital D'Enfants La Timone Recruiting Marseille, France, 13385 Principal Investigator: Carole COZE, MD          Hopital Arnaud de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Nicolas SIRVENT, MD          Chu Nantes Recruiting Nantes, France, 44093 Principal Investigator: Estelle THEBAUD, MD          Chu de Nice Recruiting Nice, France, 06202 Principal Investigator: Maryline DUPUY-POIREE          Institut Curie Recruiting Paris, France, 75005 Principal Investigator: Isabelle AERTS, MD          Chu de Poitiers Recruiting Poitiers, France, 86021 Principal Investigator: Frédéric MILLOT, MD          Chur de Reims Recruiting Reims, France, 51100 Principal Investigator: Claire PLUCHART, MD          Chu de Rennes Recruiting Rennes, France, 35056 Principal Investigator: Céline CHAPPE, MD          Chu de Rouen Recruiting Rouen, France, 76031 Principal Investigator: Pascale SCHNEIDER, MD          Chr Felix Guyon Recruiting Saint Denis DE LA Reunion, France, 97405 Principal Investigator: Mathilde JEHANNE, MD          Chu Saint Etienne Recruiting Saint Etienne, France, 420555 Principal Investigator: Jean-Louis STEPHAN, MD          Hoptial Hautepierre Recruiting Strasbourg, France, 67098 Principal Investigator: Natacha ENTZ WERLE, MD          Chu Toulouse Recruiting Toulouse, France, 31026 Principal Investigator: Anne-Isabelle BERTOZZI-SALAMON, MD          Chu Tours Recruiting Tours, France, 37044 Principal Investigator: Odile LEJARS, MD          Chu Nancy Recruiting Vandoeuvre Les Nancy, France, 54500 Principal Investigator: Ludovic MANSUY, MD Less <<
NCT02379585 - Terminated(PI Decision) - -
NCT00002576 Lymphoma Phase 3 Completed - United Kingdom ... More >> Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Less <<
NCT00976989 Breast Cancer Phase 2 Completed - -
NCT00976989 - Completed - -
NCT01148446 Elderly Patients (>65 Years) ... More >> Diffuse Large B Cell Lymphoma (DLBCL) Less << Phase 3 Completed - Italy ... More >> Ospedale di Vigevano Vigevano, Pavia, Italy S.C. di Ematologia, Spedali Civili Brescia, Italy, 25123 Ospedale Garibaldi-Nesima Catania, Italy Ospedale civile Divisione di Ematologia Civitanova Marche (MC), Italy Ospedale San Sebastiano Correggio (RE), Italy Presidio Ospedaliero Annunziata Cosenza, Italy Istituto Vito Fazzi Lecce, Italy Azienda Ospedaliera Policlinico Modena, Italy AO Arcispedale S.Maria Nuova Ematologia Reggio Emilia, Italy Ospedale civile DH oncologico Sassuolo (MO), Italy Ospedale San Giovanni Battista - Molinette Torino, Italy Less <<
NCT00002544 Breast Cancer Phase 3 Completed - Germany ... More >> Diakonissen-Krankenhaus Stuttgart Stuttgart, Germany, D-70176 Less <<
NCT03396575 Diffuse Intrinsic Pontine Glio... More >>ma (DIPG) Less << Phase 1 Recruiting June 2022 United States, Florida ... More >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Contact: Marcia Hodik, RN    352-273-6971    marcia.hodik@neurosurgery.ufl.edu    Principal Investigator: Sridharan Gururangan, FRCP          University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 Less <<
NCT03633773 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 1 Phase 2 Recruiting December 31, 2024 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Qi Zhang, MD    8613819137113 Less <<
NCT03023358 Peripheral T Cell Lymphoma Phase 3 Not yet recruiting March 2019 China, Guangdong ... More >> Ru Feng Not yet recruiting Guangzhou, Guangdong, China, 510515 Contact: Ru Feng, M.D.    +86 13725119762    ruth1626@hotmail.com    Contact: Qi Wei, M.D.    +86 13427564102    sinbad37@126.com    Principal Investigator: Ru Feng, M.D. Less <<
NCT02441803 Leukemia Phase 2 Active, not recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02621021 Melanoma Phase 2 Recruiting June 16, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01860937 Relapsed B-Cell Acute Lymphobl... More >>astic Leukemia Less << Phase 1 Active, not recruiting May 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute:Dana- Farber/Children's Hospital Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03721068 Neuroblastoma Phase 1 Not yet recruiting April 1, 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT00005824 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02129 Less <<
NCT00890656 - Completed - -
NCT00027846 - Active, not recruiting - -
NCT02682693 Breast Cancer Female NOS ... More >> Tubular Breast Cancer Stage II Mucinous Breast Cancer Stage II Invasive Ductal Breast Cancer HER2 Positive Breast Cancer Inflammatory Breast Cancer Tubular Breast Cancer Stage III Less << Phase 2 Recruiting December 2018 Germany ... More >> Kliniken Essen-Mitte Recruiting Essen, NRW, Germany, 45136 Contact: Sherko Kümmel, MD    ++49 201 174 ext 33003    s.kuemmel@kliniken-essen-mitte.de Less <<
NCT00890656 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00096135 Leukemia Not Applicable Completed - -
NCT01746849 Leukemia Mult... More >>iple Myeloma Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Less << Phase 2 Recruiting December 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Christina Cho, MD    212-639-7523       Contact: Miguel-Angel Perales, MD    212-639-8682       Principal Investigator: Christina Cho, MD Less <<
NCT00096135 - Completed - -
NCT00027846 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 2 Active, not recruiting - -
NCT03136406 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2018 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00005946 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT02223208 Peripheral T-cell Lymphomas (P... More >>TCL) PTCL-NOS Angioimmunoblastic T-cell Lymphoma (AITL) ALK- Anaplastic Large Cell Lymphoma (ALCL) Less << Phase 1 Phase 2 Recruiting March 2025 Italy ... More >> Ospedale SS. Antonio e Biagio e Cesare Arrigo Recruiting Alessandria, AL, Italy, 15121 Contact: Manuela Zanni, MD    0039 0131206133    manuela.zanni@ospedale.al.it    Principal Investigator: Flavia Salvi, MD          Ospedali Riuniti Umberto I Not yet recruiting Ancona, AN, Italy, 60126 Contact: Attilio Olivieri, PROF    0039 0715964226    a.olivieri@unipm.it    Principal Investigator: Attilio Olivieri, PROF          AOU Policlinico di Bari Not yet recruiting Bari, BA, Italy, 70124 Contact: Giorgina Specchia, PROF    0039 0805593471    giorgina.specchia@uniba.it    Principal Investigator: Giorgina Specchia, PROF          Policlinico S. Orsola Malpighi Recruiting Bologna, BO, Italy, 40138 Contact: Vittorio Stefoni, MD    0039 0516364042    vittorio.stefoni2@unibo.it    Principal Investigator: Vittorio Stefoni, MD          Spedali Civili Recruiting Brescia, BS, Italy, 26123 Contact: Alessandro Re, MD    0039 0303995438    ematologia@spedalicivili.it    Principal Investigator: Alessandro Re, MD          Ospedale Businco Recruiting Cagliari, CA, Italy, 09121 Contact: Giuseppina Cabras, MD    0039 0706095171    cabras.giuseppina@tiscali.it    Principal Investigator: Giuseppina Cabras, MD          Fondazione di Ricerca e Cura "Giovanni Paolo II" Not yet recruiting Campobasso, CB, Italy, 86100 Contact: Sergio Storti, MD    0039 0874312317    sstorti@rm.unicatt.it    Principal Investigator: Sergio Storti, MD          Azienda Ospedaliera S.Croce e Carle Recruiting Cuneo, CN, Italy, 12100 Contact: Claudia Castellino, MD    0039 0171641070    castellino.c@ospedale.cuneo.it    Principal Investigator: Claudia Castellino, MD          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Sede di Meldola Not yet recruiting Meldola, FC, Italy, 47014 Contact: Gerardo Musuraca, MD    0039 0543739280    g.musuraca@irst.em.it    Principal Investigator: Gerardo Musuraca, MD          IRCCS Casa Sollievo Della Sofferenza Not yet recruiting San Giovanni Rotondo, FG, Italy, 71013 Contact: Nicola Cascavilla, MD    0039 0882410566    ematologia@operapadrepio.it    Principal Investigator: Nicola Cascavilla, MD          IRCCS AOU San Martino - Clinica Ematologica Not yet recruiting Genova, GE, Italy, 16321 Contact: Filippo Ballerini, PROF    0039 0105554336    ballerini@unige.it    Principal Investigator: Filippo Ballerini, PROF          IRCCS AOU San Martino - UO Ematologia 1 Recruiting Genova, GE, Italy, 16321 Contact: Angela Giovanna Congiu, MD    0039 0105513731    angelagiovanna.congiu@hsanmartino.it    Principal Investigator: Angela Giovanna Congiu, MD          Istituto Clinico Humanitas Terminated Rozzano, Milano, Italy, 20089 Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Recruiting Milano, MI, Italy, 20122 Contact: Luca Baldini, MD    0039 02 55033334    luca.baldini@unimi.it    Principal Investigator: Luca Baldini, PROF          Fondazione IRCCS "Istituto Nazionale dei Tumori" Recruiting Milano, MI, Italy, 20133 Contact: Paolo Corradini, PROF    0039 0223902950    paolo.corradini@unimi.it    Principal Investigator: Paolo Corradini, PROF          Azienda Ospedaliera Ospedale Niguarda Ca' Granda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD    0039 02 64447597    chiara.rusconi@ospedaleniguarda.it    Principal Investigator: Chiara Rusconi, MD          AO Ospedali Riuniti Villa Sofia - Cervello (Presidio Cervello) Not yet recruiting Palermo, PA, Italy, 90146 Contact: Caterina Patti, MD    0039 0917803162    kpatti@ospedaliriunitipalermo.it    Principal Investigator: Caterina Patti, MD          P.O. di Pescara-Ospedale Civile Spirito Santo Not yet recruiting Pescara, PE, Italy, 65126 Contact: Francesco Angrilli, MD    0039 0854252838    f.angrilli@virgilio.it    Principal Investigator: Francesco Angrilli, MD          IRCCS Centro di Riferimento Oncologico (CRO) Not yet recruiting Aviano, PN, Italy, 33081 Contact: Michele Spina, MD    0039 043459730    mspina@cro.it    Principal Investigator: Michele Spina, MD          AOU di Parma Not yet recruiting Parma, PR, Italy, 43100 Contact: Francesca Re, MD    0039 0521 703962    fre@ao.pr.it    Principal Investigator: Francesca Re, MD          Fondazione IRCCS - Policlinico San Matteo Recruiting Pavia, PV, Italy, 27100 Contact: Luca Arcaini, MD    0039 0382501381    luca.arcaini@unipv.it    Principal Investigator: Luca Arcaini, MD          IRCCS Centro di Riferimento Oncologico della Basilicata (CROB) Not yet recruiting Rionero in Vulture, PZ, Italy, 85028 Contact: Roberto Guariglia, MD    0039 0972726225    robertoguariglia@libero.it    Principal Investigator: Roberto Guariglia, MD          A.O. Bianchi - Melacrino - Morelli Not yet recruiting Reggio Calabria, RC, Italy, 89125 Contact: Caterina Stelitano, MD    0039 0965397653    cstelit@libero.it    Principal Investigator: Caterina Stelitano, MD          IRCCS Arcispedale "Santa Maria Nuova" Not yet recruiting Reggio Emilia, RE, Italy, 42123 Contact: Francesco Merli, MD    0039 0522296618    merli.francesco@asmn.re.it    Principal Investigator: Francesco Merli, MD          Università di Roma "La Sapienza" Active, not recruiting Roma, RM, Italy, 00161 Università Cattolica del Sacro Cuore - Policlinico "A. Gemelli" Not yet recruiting Roma, RM, Italy, 00168 Contact: Stefan Hohaus, MD    0039 0630154278    stephan.hohaus@rm.unicatt.it    Principal Investigator: Stefan Hohaus, MD          Ospedale degli Infermi Not yet recruiting Rimini, RN, Italy, 47900 Contact: Annalia Molinari, MD    0039 0541705423    annalia.molinari@auslrn.net    Principal Investigator: Annalia Molinari, MD          AO Città della Salute e della Scienza - Ematologia 1U Not yet recruiting Torino, TO, Italy, 10126 Contact: Federica Cavallo, MD    0039 0116334198    f.cavallo@unito.it    Principal Investigator: Federica Cavallo, MD          AO Città della Salute e della Scienza - SC Ematologia Recruiting Torino, TO, Italy, 10126 Contact: Annalisa Chiappella, MD    0039 0116336751    achiappella@cittadellasalute.to.it    Principal Investigator: Annalisa Chiappella, MD          AOU "Santa Maria della Misericordia" Recruiting Udine, UD, Italy, 33100 Contact: Francesco Zaja, MD    0039 0432559604    zaja.francesco@aoud.sanita.fgv.it    Principal Investigator: Francesco Zaja, MD          Ospedale Borgo Roma Not yet recruiting Verona, VR, Italy, 37134 Contact: Fabio Benedetti, MD    0039 045 8124647    fabio.benedetti@univr.it    Principal Investigator: Fabio Benedetti, MD          Azienda Ospedaliero-Universitaria Careggi Not yet recruiting Firenze, Italy, 50134 Contact: Luigi Rigacci, MD    0039 055 7946448    luigi.rigacci@unifi.it    Principal Investigator: Luigi Rigacci, MD          Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale Recruiting Napoli, Italy, 80131 Contact: Antonio Pinto, MD    0039 0815903381    a.pinto@istitutotumori.na.it    Principal Investigator: Antonio Pinto, MD          Università del Piemonte Orientale - SCDU Ematologia Recruiting Novara, Italy, 28100 Contact: Gianluca Gaidano, PROF    0039 03213732194    gaidano@med.unipmn.it    Principal Investigator: Gianluca Gaidano, MD          A.O. di Perugia - Santa Maria della Misericordia Not yet recruiting Perugia, Italy, 06132 Contact: Leonardo Flenghi, MD    0039 075 5784110    flenghi@yahoo.it    Principal Investigator: Leonardo Flenghi, MD          Ospedale G. Da Saliceto - AUSL di Piacenza Not yet recruiting Piacenza, Italy, 29121 Contact: Annalisa Arcari, MD    0039 0523 303719    a.arcari@ausl.pc.it    Principal Investigator: Annalisa Arcari, MD          UO Ematologia Ospedale S.Maria delle Croci Recruiting Ravenna, Italy, 48121 Contact: Monica Tani, MD    0039 0544286223    monica.tani@auslromagna.it    Principal Investigator: Monica Tani, MD Less <<
NCT00983944 Lymphoma Phase 2 Withdrawn(Inadequate Accrual) - -
NCT00793845 Neuroblastoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00004181 Chronic Myeloproliferative Dis... More >>orders Leukemia Multiple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03696004 Breast Cancer Phase 2 Phase 3 Not yet recruiting December 2020 Egypt ... More >> Assiut University Hospital Enrolling by invitation Assiut, Egypt, 71515 Less <<
NCT00775931 Severe Osteopetrosis Phase 2 Phase 3 Unknown October 2015 United States, Minnesota ... More >> University of MInnesota, Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT02753036 - Recruiting July 2020 Germany ... More >> Charité Universitätsmedizin Berlin Recruiting Berlin, Germany, 10117 Less <<
NCT02419469 Leukemia Prec... More >>ursor-B Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma Lymphoma Less << Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02419469 - Terminated(Slow Accrual) - -
NCT00268567 Nephritis, Lupus Phase 2 Phase 3 Completed - China ... More >> Renal Division, Peking University First Hospital Beijing, China, 100034 Department of Nephrology, Kidney Center and key Lab of PLA, Chinese General Hospital of PLA Beijing, China Division of Nephrology, Nanfang Hospital, Southern Medical University Guangzhou, China Renal Division, the First Affiliated Hospital, Sun Yat-sen University Guangzhou, China Department of Rheumatology, the Second Affiliated Hospital, Harbin Medical University Harbin, China Department of Nephrology, Shanghai Changzheng Hospital Shanghai, China Renal Division, Huashan Hospital, Fudan University Shanghai, China Renal Division, Renji Hospital, Shanghai Jiaotong University Shanghai, China Less <<
NCT00004092 - Completed - -
NCT01659658 Relapsed or Refractory Systemi... More >>c Light Chain Amyloidosis Less << Phase 3 Recruiting August 31, 2022 -
NCT00723099 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Indolent Non-Hodgkin Lymphoma Lymphoma Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Chronic Lymphocytic Leukemia Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Follicular Lymphoma Refractory Hodgkin Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 2 Active, not recruiting November 13, 2019 United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01118091 - Completed - -
NCT02481310 Adult Burkitt Lymphoma ... More >> B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Diffuse Large B-Cell Lymphoma MYC Gene Mutation Plasmablastic Lymphoma Less << Phase 1 Phase 2 Recruiting July 2020 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Barbara Pro, MD    312-695-6180       Principal Investigator: Barbara Pro, MD          United States, Massachusetts Tufts University Recruiting Medford, Massachusetts, United States, 02155 Contact: Andreas Klein, MD    617-636-2694       Principal Investigator: Andreas Klein, MD          United States, New Jersey Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08901 Contact: Andrew Evens, DO, MSc          Principal Investigator: Andrew Evens, DO, MSc          United States, Ohio Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 Contact: Deepa Jagadeesh, MD    216-445-6503       Principal Investigator: Deepa Jagadeesh, MD          United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Mehdi Hamadani, MD    414-805-0505       Principal Investigator: Mehdi Hamadani, MD Less <<
NCT03647423 Chordoma Unre... More >>sectable Malignant Neoplasm Less << Phase 1 Phase 2 Not yet recruiting August 30, 2022 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00004092 Breast Cancer Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00003141 Brain Tumors ... More >>Central Nervous System Tumors Neuroblastoma Sarcoma Less << Phase 1 Completed - -
NCT01118091 Skin Cancer M... More >>elanoma Metastatic Melanoma Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02951728 Diffuse Large B Cell Lymphoma Phase 1 Phase 2 Recruiting October 2019 China ... More >> Shanghai Ruijin Hospital Recruiting Shanghai, China, 20025 Contact: Weili Zhao, MD,PhD    64370045 ext 610707    zhao.weili@yahoo.com    Contact: Pengpeng Xu, MD    64370045 ext 610707    xpproc@msn.com Less <<
NCT03450044 Breast Cancer Female Phase 1 Phase 2 Recruiting July 2020 Colombia ... More >> Fundación Salud de los Andes Recruiting Bogota, Cundinamarca, Colombia, 111321 Contact: Doris Mejía    3202735366    secretariagerencia@saluddelosandes.com    Principal Investigator: David A Bernal-Estévez, MD PhD          Sub-Investigator: Mauren A Ortiz, Msc Less <<
NCT03036488 Triple Negative Breast Neoplas... More >>ms Less << Phase 3 Active, not recruiting March 14, 2025 -
NCT03586869 Pancreatic Cancer Phase 1 Phase 2 Recruiting May 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT01350245 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Biphenotypic Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Plasma Cell Neoplasms Lymphoma Hodgkin's Disease Aplastic Anemia Less << Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01350245 - Completed - -
NCT02782546 Acute Myeloid Leukemia Phase 2 Recruiting February 28, 2022 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-454-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D. Less <<
NCT02114229 Malignant Rhabdoid Tumor ... More >> Atypical Teratoid Rhabdoid Tumor Less << Phase 2 Recruiting May 2027 United States, California ... More >> Children's Hospital of Los Angeles Withdrawn Los Angeles, California, United States, 90027 Lucille Packard Children's Hospital at Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Sonia Partap, MD    650-723-0993    spartap@stanford.edu    Principal Investigator: Sonia Partap, MD          Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: John Crawford, MD, MS    858-576-1700    jcrawford@rchsd.org    Principal Investigator: John Crawford, MD, MS          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Kathleen Dorris, MD    720-777-6672    kathleen.dorris@childrenscolorado.org    Principal Investigator: Kathleen Dorris, MD          United States, District of Columbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Lindsay B. Kilburn, MD    202-476-2800    lkilburn@childrensnational.org    Principal Investigator: Lindsay B. Kilburn, MD          United States, Florida UF Cancer Center at Orlando Health Recruiting Orlando, Florida, United States, 32806 Contact: Amy A. Smith, MD    321-841-7246    amy.smith@orlandohealth.com    Principal Investigator: Amy A. Smith, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Sindy Moon    404-785-1441    cindy.moon@choa.org    Contact: Jaclyn Smith    404-785-0692    jaclyn.smith@choa.org    Principal Investigator: Dolly Aguilera, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Anne Bendel, MD    651-220-6732    anne.bendel@childrensmn.org    Principal Investigator: Anne Bendel, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tabatha E. Doyle, RN    901-595-2544    tabatha.doyle@stjude.org    Principal Investigator: Santhosh Upadhyaya, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Patricia Baxter, MD    832-824-1000    pabaxter@txch.org    Principal Investigator: Patricia Baxter, MD          United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Sarah Leary, MD    866-987-2000    sarah.leary@seattlechildrens.org    Principal Investigator: Sarah Leary, MD Less <<
NCT00025545 Leukemia Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00871013 Myeloma Phase 2 Recruiting December 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, M.D.,Ph.D.          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD Less <<
NCT00869232 Multiple Myeloma Phase 2 Active, not recruiting October 2019 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02775292 Adult Solid Neoplasm ... More >> Childhood Solid Neoplasm Metastatic Neoplasm Less << Phase 1 Recruiting June 2019 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Siwen Hu-Lieskovan    310-794-4955       Principal Investigator: Antoni Ribas Less <<
NCT03387111 Squamous Cell Carcinoma Phase 1 Phase 2 Recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Contact: NantKWest Clinical Review Team    800-988-6083    clinical.trials@NantKwest.com Less <<
NCT03169764 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT03169738 Non-small Cell Lung Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00179842 Crohn Disease Phase 2 Withdrawn - United States, Illinois ... More >> Children's Memorial Hospital Chicago, Illinois, United States, 60614 Less <<
NCT02950051 Chronic Lymphocytic Leukemia Phase 3 Recruiting January 2024 -
NCT03387085 Triple Negative Breast Cancer Phase 1 Phase 2 Recruiting January 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT02767674 Diffuse Large B Cell Lymphoma Phase 3 Recruiting July 2019 China, Hubei ... More >> Tongji Medical College of HUST Recruiting Wuhan, Hubei, China, 430030 Contact: Jianfeng Zou          China, Jiangsu The first Affiliated Hospital Of Nanjing Medical University(JiangSu Province Hospital) Recruiting NanJing, Jiangsu, China, 21002 Contact: Huayuan Zhu, M.D., Ph.D.    +86 68136034    huayuan.zhu@hotmail.com    Principal Investigator: Wei Xu, M.D., Ph.D.          China, Shandong QiLu Hospital of Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Luqun Wang, M.D., Ph.D.          Shandong Province Hospital Recruiting Jinan, Shandong, China, 250021 Contact: Xin Wang, M.D., Ph.D.          China, Shanghai Rui Jin Hospital Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili Zhao, M.D., Ph.D.          Sudan University Shanghai Cancer Center Recruiting Shanghai, Shanghai, China, 200433 Contact: Ye Guo, M.D., Ph.D. Less <<
NCT03387098 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT02845596 Severe Aplastic Anemia Not Applicable Recruiting May 2020 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Nini Huynh    323-361-5286    huhuynh@chla.usc.edu    Principal Investigator: Michael Pulsipher, MD          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Wendy Moore    720-777-6353    Wendy.moore2@childrenscolorado.org    Principal Investigator: Taizo Nakano, MD          United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Maggie Malsch, MSN       maggie.malsch@childrens.harvard.edu    Contact: Leah Cheng       leah.cheng@childrens.harvard.edu    Principal Investigator: David A Williams, MD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh    551-996-3457    jeanette.haugh@hackensackmeridian.org    Principal Investigator: Alfred Gillio, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn    215-590-1303    mcglynn@email.chop.edu    Principal Investigator: Timothy Olson, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Margaret Nagel    832-824-1538    menagel@texaschildrens.org    Principal Investigator: Alison Bertuch, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Bernie McLaughlin    206-667-4916    bmclaugh@fredhutch.org    Principal Investigator: Lauri Burroughs, MD Less <<
NCT00336024 Untreated Childhood Medullobla... More >>stoma Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor Less << Phase 3 Completed - -
NCT03197571 Urothelial Carcinoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT03169777 Colorectal Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT03197584 Ovarian Cancer Phase 1 Phase 2 Not yet recruiting April 2019 -
NCT03329248 Pancreatic Cancer Phase 1 Phase 2 Active, not recruiting December 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT03175666 Triple Negative Breast Cancer Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02756546 Systemic Lupus Erythematosis Phase 1 Phase 2 Completed - -
NCT00336024 - Completed - -
NCT03488225 Acute Lymphocytic Leukemia Phase 2 Recruiting March 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       ejabbour@mdanderson.org Less <<
NCT00005089 Lymphoma Phase 2 Completed - -
NCT03563157 Colorectal Cancer Metastatic ... More >> mCRC Less << Phase 1 Phase 2 Recruiting December 30, 2021 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT02228772 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma B-cell Adult Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting July 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Philip Amrein, MD    617-726-8748    Amrein.Philip@mgh.harvard.edu    Principal Investigator: Philip Amrein, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Malgotzata McMasters, MD    617-667-9920    mmcmaste@bidmc.harvard.edu    Principal Investigator: Malgorzata McMasters, MD          Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel DeAngelo, MD, Ph.D    617-632-2645    DDEANGELO@PARTNERS.ORG    Principal Investigator: Daniel DeAngelo, MD, Ph.D Less <<
NCT02639650 Gestational Trophoblastic Neop... More >>lasms Less << Phase 3 Recruiting March 2021 China, Zhejiang ... More >> Weiguo Lv Recruiting Hangzhou, Zhejiang, China Contact: Weiguo Lv, Doctor Less <<
NCT03249831 Sickle Cell Disease ... More >> Sickle Cell Disorder Hemoglobinopathies Thalassemia Anemia, Sickle Cell Less << Phase 1 Recruiting December 2022 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Joseph Rosenthal, MD    626-256-4673 ext 88442    jrosenthal@coh.org    Principal Investigator: Joseph Rosenthal, MD Less <<
NCT03061656 High Risk Neuroblastoma Phase 2 Active, not recruiting December 31, 2018 -
NCT00098839 Recurrent Childhood Acute Lymp... More >>hoblastic Leukemia Less << Phase 1 Phase 2 Completed - -
NCT00004031 Lymphoma Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada, T6G 1Z2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Newfoundland and Labrador Doctor H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, AIB 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Odette Cancer Centre at Sunnybrook Toronto, Ontario, Canada, M4N 3M5 Canada, Quebec Hopital Notre-Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 Hopital Du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 Centre Hospitalier Universitaire de Quebec Quebec City, Quebec, Canada, G1R 2J6 Hopital du Saint-Sacrement - Quebec Quebec City, Quebec, Canada, G1S 4L8 Canada, Saskatchewan Saskatoon Cancer Centre at the University of Saskatchewan Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT01369888 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 1 Phase 2 Terminated(Closed this protoco... More >>l due to autoimmune toxicity.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00098839 - Completed - -
NCT03595592 Invasive Breast Cancer Phase 3 Not yet recruiting June 15, 2027 Italy ... More >> A.O. Ospedale Civile di Legnano Not yet recruiting Legnano, MI, Italy, 20025 Principal Investigator: Elena Collovà, MD          Ospedale Papa Giovanni XXIII Not yet recruiting Bergamo, Italy, 24128 Principal Investigator: Elena Rota, MD          Policlinico S. Orsola Malpighi Not yet recruiting Bologna, Italy, 40138 Principal Investigator: Claudio Zamagni, MD          Presidio Ospedaliero Di Summa-Perrino Not yet recruiting Brindisi, Italy, 72100 Principal Investigator: Saverio Cinieri, MD          Dipartimento di Oncologia Medica AUSL della Romagna Not yet recruiting Faenza, Italy, 48018 Principal Investigator: Laura Amaducci, MD          IST San Martino Not yet recruiting Genova, Italy, 16132 Principal Investigator: Lucia Del Mastro, MD          Istituto Scientifico Romagnolo per lo studio e la cura dei tumori Not yet recruiting Meldola, Italy, 47014 Principal Investigator: Andrea Rocca, MD          Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milano, Italy, 20133 Principal Investigator: Mariani Gabriella, MD          Istituto Europeo di Oncologia Not yet recruiting Milano, Italy, 20141 Principal Investigator: Marco Colleoni, MD          Ospedale Luigi Sacco Not yet recruiting Milano, Italy, 20160 Principal Investigator: Anna Gambaro, MD          Ospedale San Raffaele Not yet recruiting Milano, Italy Principal Investigator: Luca Gianni, MD          AO Universitaria Policlinico di Modena Not yet recruiting Modena, Italy, 41124 Principal Investigator: Luca Moscetti, MD          Ospedale Sacro Cuore - Don Calabria Not yet recruiting Negrar, Italy, 37024 Principal Investigator: Stefania Gori, MD          Fondazione Salvatore Maugeri Not yet recruiting Pavia, Italy, 27100 Principal Investigator: Antonio Bernardo, MD          Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara Not yet recruiting Pisa, Italy, 56100 Principal Investigator: Andrea Michelotti, MD          Arcispedale Santa Maria Nuova - A.O. Reggio Emilia Not yet recruiting Reggio Emilia, Italy, 42123 Principal Investigator: Giancarlo Bisagni, MD          Ospedale Infermi AUSL della Romagna Not yet recruiting Rimini, Italy, 247900 Principal Investigator: Lorenza Gianni, MD          Istituto Nazionale Tumori - Regina Elena Not yet recruiting Roma, Italy, 00144 Principal Investigator: Alessandra Fabi, MD          Ospedale Santa Maria della Misericordia Not yet recruiting Udine, Italy, 33100 Principal Investigator: Mauro Mansutti, MD Less <<
NCT01697527 Malignant Neoplasm Phase 2 Recruiting November 2, 2019 United States, California ... More >> University of California at Los Angeles (UCLA ) Recruiting Los Angeles, California, United States, 90095 Contact: Arun Singh    310-829-5471    asingh@mednet.ucla.edu    Principal Investigator: Arun Singh Less <<
NCT01369888 - Terminated(Closed this protoco... More >>l due to autoimmune toxicity.) Less << - -
NCT00031590 Brain Tumors ... More >>Central Nervous System Tumors Medulloblastoma Primitive Neuroectodermal Tumor Less << Phase 2 Terminated(The study was termi... More >>nated prematurely due to slow accrual.) Less << - United States, California ... More >> Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto, California, United States, 94304 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104-4318 Less <<
NCT03169790 Non Hodgkin Lymphoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02161692 Testicular Neoplasms ... More >> Germ Cell Tumors Less << Phase 2 Completed - Italy ... More >> Istituto Nazionale dei Tumori Milano, Italy, 20133 Less <<
NCT00000361 Hearing Loss, Sensorineural Phase 3 Terminated - United States, California ... More >> House Ear Institute Los Angeles, California, United States, 90057 UCSD Medical Center San Diego, California, United States, 92103-8895 United States, Iowa Univ of Iowa Hosp and Clinic Iowa City, Iowa, United States, 52242-1078 United States, Maryland Johns Hopkins Univ Baltimore, Maryland, United States, 21287-0008 United States, Massachusetts Massachusetts Eye and Ear Infirmary Boston, Massachusetts, United States, 02114 United States, Michigan Univ of Michigan Ann Arbor, Michigan, United States, 48109-0005 United States, New York New York University New York, New York, United States United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195-5245 United States, Texas University of Texas, Southwestern Medical Center at Dallas Dallas, Texas, United States Less <<
NCT01979536 Anaplastic Large Cell Lymphoma... More >>, ALK-Positive Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma CD30-Positive Neoplastic Cells Present Less << Phase 2 Recruiting December 31, 2021 -
NCT03125642 Non-Hodgkin Lymphoma ... More >> Hodgkin Lymphoma Less << Phase 2 Recruiting April 30, 2026 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Veronika Bachanova, MD Less <<
NCT01363128 Leukemia Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00911222 - Completed - Germany ... More >> iOMEDICO AG Freiburg, Baden-Württemberg, Germany, 79108 Less <<
NCT00002740 Neuroblastoma Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States, 94115-0128 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5265 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 Children's Hospital of Columbus Columbus, Ohio, United States, 43205-2696 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00004188 Neuroblastoma Phase 3 Completed - -
NCT03704714 Aggressive Non-Hodgkin Lymphom... More >>a B-Cell Non-Hodgkin Lymphoma CD20 Positive Diffuse Large B-Cell Lymphoma Unclassifiable Intravascular Large B-Cell Lymphoma Primary Mediastinal (Thymic) Large B-Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting June 11, 2022 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Reem Karmali, MD    312-695-0990       Principal Investigator: Reem Karmali, MD          Rush University Medical Center Not yet recruiting Chicago, Illinois, United States, 60612 Contact: Parameswaran Venugopal    312-942-5978    Parameswaran_Venugopal@rush.edu    Principal Investigator: Parameswaran Venugopal          Northwestern University- Lake Forest Hospital Recruiting Lake Forest, Illinois, United States, 60045 Contact: Valerie Nelson, MD    847-582-2134       Principal Investigator: Valerie Nelson, MD Less <<
NCT01200758 - Completed - -
NCT01200758 Non-Hodgkin's Lymphoma Phase 3 Completed - -
NCT00054587 Breast Cancer Phase 3 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 Centre Hospitalier d'Annecy Annecy, France, 74011 Cedex Institut Bergonie Bordeaux, France, 33076 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Hopital Intercommunal De Creteil Creteil, France, 94010 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 Institut Prive de Cancerologie Grenoble, France, 38100 Clinique du Petit Colmouilins Harfleur, France, 76700 Centre Hospitalier de Lagny Lagny Sur Marne, France, 77405 Hopital Andre Mignot Le Chesnay, France, 78157 CMC Les Ormeaux Le Havre, France, 76600 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Hospitalier Regional Metz Thionville Metz, France, 57038 Centre Hospitalier General Andre Boulloche Montbeliard, France, 25209 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Hospitalier de Mulhouse Mulhouse, France, 68051 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Hopital Avicenne Paris, France, 75674 Clinique Saint - Pierre Perpignan, France CHU Poitiers Poitiers, France, 86021 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Clinique Sainte Clotilde Sainte Clotilde, France, 97492 Centre Paul Strauss Strasbourg, France, 67065 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03399448 Multiple Myeloma ... More >> Melanoma Synovial Sarcoma Myxoid/Round Cell Liposarcoma Less << Phase 1 Recruiting January 2033 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT02652455 Melanoma (Skin) ... More >> Skin Cancer Less << Early Phase 1 Active, not recruiting August 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02070406 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Recruiting July 17, 2020 United States, California ... More >> Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas    310-206-3928    aribas@mednet.ucla.edu    Principal Investigator: Antoni Ribas Less <<
NCT00299182 Lymphoma Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00498316 Myelodysplastic Syndrome ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02405676 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 2 Phase 3 Recruiting December 2024 China, Sichuan ... More >> West China Second University Hospital of Sichuan University Recruiting Chengdu, Sichuan, China Contact: Yi-Ping Zhu, MD       zhuyiping@918.com    Contact: Xia Guo, MD       guoxkl@163.com Less <<
NCT00691015 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00691015 - Completed - -
NCT01025778 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 2 Completed - Sweden ... More >> Lund University Hospital Lund, Sweden, SE-22185 Less <<
NCT02652468 Lymphoma Not Applicable Active, not recruiting March 15, 2020 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53705 Less <<
NCT00000658 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Phase 3 Completed - United States, California ... More >> USC CRS Los Angeles, California, United States, 900331079 UCLA CARE Center CRS Los Angeles, California, United States, 90095 Ucsf Aids Crs San Francisco, California, United States, 941102859 United States, Colorado University of Colorado Hospital CRS Aurora, Colorado, United States, 80262 United States, Illinois Northwestern University CRS Chicago, Illinois, United States, 60611 Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States, 60612 United States, Indiana Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis, Indiana, United States, 462025250 United States, Maryland Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States United States, Massachusetts Beth Israel Deaconess Med. Ctr., ACTG CRS Boston, Massachusetts, United States, 02118 Beth Israel Deaconess - East Campus A0102 CRS Boston, Massachusetts, United States, 02215 Bmc Actg Crs Boston, Massachusetts, United States United States, Missouri Washington U CRS St. Louis, Missouri, United States United States, New York SUNY - Buffalo, Erie County Medical Ctr. Buffalo, New York, United States, 14215 Beth Israel Med. Ctr. (Mt. Sinai) New York, New York, United States, 02215 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Ctr. New York, New York, United States, 10021 Univ. of Rochester ACTG CRS Rochester, New York, United States, 14642 United States, North Carolina Unc Aids Crs Chapel Hill, North Carolina, United States, 275997215 United States, Ohio Case CRS Cleveland, Ohio, United States The Ohio State Univ. AIDS CRS Columbus, Ohio, United States, 432101228 United States, Pennsylvania Hosp. of the Univ. of Pennsylvania CRS Philadelphia, Pennsylvania, United States, 19104 Pitt CRS Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT01181258 Non-Hodgkin Lymphoma ... More >> Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03515798 Inflammatory Breast Cancer Phase 2 Not yet recruiting April 30, 2025 France ... More >> Institut Sainte Catherine Not yet recruiting Avignon, France Contact: Julien GRENIER, Dr          Principal Investigator: Julien GRENIER, Dr          Institut BERGONIE Not yet recruiting Bordeaux, France Contact: Camille CHAKIBA-BRUGERE, Dr          Principal Investigator: Camille CHAKIBA-BRUGERE, Dr          CENTRE Francois Baclesse Not yet recruiting Caen, France Contact: Christelle LEVY, Dr          Principal Investigator: Christelle LEVY          Centre Oscar Lambret Not yet recruiting Lille, France Contact: Nuria Koteki, Dr          Principal Investigator: Nuria Koteki, Dr          Centre Leon Berard Not yet recruiting Lyon, France Contact: Thomas BACHELOT, Dr          Principal Investigator: Thomas BACHELOT, Dr          Centre Antoine Lacassagne Not yet recruiting Nice, France Contact: Jean-Marc FERRERO, Pr          Principal Investigator: Jean-Marc FERRERO, Pr          Institut Curie Not yet recruiting Paris, France Contact: Jean-Yves PIERGA, Pr          Principal Investigator: Jean-Yves PIERGA, Pr          Centre Henri Becquerel Not yet recruiting Rouen, France Contact: Marianne LEHEURTEUR, Dr          Principal Investigator: Marianne LEHEURTEUR, Dr          Institut Curie hopital rene huguenin Not yet recruiting Saint-Cloud, France Contact: Florence Lerebours, Dr          Principal Investigator: Florence Lerebours          Institut De Cancérologie de l'Ouest Not yet recruiting Saint-Herblain, France Contact: Marie ROBERT, Dr          Principal Investigator: Marie ROBERT, Dr          Institut de cancérologie de la loire Not yet recruiting Saint-Priest-en-Jarez, France Contact: Jean-Philippe JACQUIN, Pr          Principal Investigator: Jean-Philippe JACQUIN, Pr          Centre Paul Strauss Not yet recruiting Strasbourg, France Contact: Thierry PETIT, Pr          Principal Investigator: Thierry PETIT, Pr          IUCT-Oncopole Institut Claudius Rigaud Not yet recruiting Toulouse, France Contact: Florence DALENC, Dr          Principal Investigator: Florence DALENC, Dr          Institut Gustave Roussy Not yet recruiting Villejuif, France Contact: Suzette Delaloge, Dr          Principal Investigator: Suzette Delaloge, Dr Less <<
NCT00187005 Acute Lymphoblastic Leukemia Phase 3 Terminated(Toxicity) - United States, Tennessee ... More >> St.Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00195871 Lymphoblastic Lymphoma Phase 2 Unknown December 2015 Belgium ... More >> Chr de La Citadelle Liege, Belgium, 4000 Cliniques Universitaires U C L de Mont Godinne Yvoir, Belgium, 5530 France C H U D'Angers Angers, France, 49033 Centre Hospitalier de La Region Annecienne Annecy, France, 74011 Chu de Grenoble Grenoble, France, 38043 Centre Hospitalier de Lens Lens, France, 62300 Edouard Herriot Hospital Lyon, France, 69437 Pierre Benite Hospital Lyon, France, 69495 Institut Paoli Calmettes Marseilles, France, 13273 Saint-Louis Hospital Paris, France, 75000 La Pitie Salpetriere Hospital Paris, France, 75013 Cochin Hospital Paris, France, 75014 Marechal Joffre Hospital Perpignan, France, 66046 Centre Hospitalier de Poitiers Poitiers, France, 86000 Chu de Reims Robert Debre Hospital Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut de Cancerologie de La Loire Saint Priest En Jarez, France, 42271 Bretonneau Hospital Tours, France, 37044 Chu de Brabois Vandoeuvre Les Nancy, France, 54511 Less <<
NCT02660762 Leukaemia,Lymphoblastic Phase 2 Recruiting January 2019 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: yue lu, MD.    0086-02087342438    dr_luyue@sina.com Less <<
NCT00482053 Lymphoma, B-cell ... More >> Lymphoma, Non-Hodgkin Diffuse Large B-cell Lymphoma (DLBCL) Malignant Lymphoma, Non-Hodgkin Less << Phase 2 Terminated(Low accrual) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01181258 - Completed - -
NCT00017108 Leukemia Phase 3 Unknown - Belgium ... More >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 Czech Republic University Hospital - Olomouc Olomouc, Czech Republic, 775 20 Hungary County Hospital Kaposvar, Hungary, H-7400 Italy Azienda Ospedaliera Papardo Messina, Italy Ospedale Sant' Eugenio Rome, Italy, 00144 Macedonia, The Former Yugoslav Republic of Clinical Center Skopje Skopje, Macedonia, The Former Yugoslav Republic of, 91000 Netherlands Leyenburg Ziekenhuis 's-Gravenhage, Netherlands, 2545 CH Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT00217503 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01847001 Locally Advanced Malignant Neo... More >>plasm Breast Cancer Less << Phase 2 Active, not recruiting December 2018 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03531281 Hematopoietic and Lymphoid Cel... More >>l Neoplasm Hematopoietic Cell Transplantation Recipient Less << Phase 1 Withdrawn(Administratively wit... More >>hdrawn) Less << December 30, 2022 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT03524235 Multiple Myeloma ... More >> CLL Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Recruiting May 2023 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman    310-967-4376    hannah.coleman@cshs.org Less <<
NCT03615105 Acute Lymphoid Leukemia (ALL) ... More >> Acute Myeloid Leukemia (AML) Chronic Myeloid Leukemia (CML) Hodgkin Lymphoma Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Recruiting July 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD    212-639-2212       Contact: Miguel-Angel Perales, MD    212-639-8682       Principal Investigator: Brian Shaffer, MD Less <<
NCT00481832 - Terminated(Accrual Factor) - -
NCT00481832 Lymphoma, Non-Hodgkin Phase 2 Terminated(Accrual Factor) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01796002 Peripheral T-cell Lymphoma Phase 3 Active, not recruiting July 2024 -
NCT00482053 - Terminated(Low accrual) - -
NCT00109031 Cancer Lympho... More >>ma Leukemia Less << Phase 3 Completed - -
NCT00270881 Acute Myelogenous Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 1 Phase 2 Completed - Japan ... More >> Keio University School of Medicine Tokyo, Japan, 160-8582 Less <<
NCT00109031 - Completed - -
NCT03032783 Hematopoietic and Lymphoid Cel... More >>l Neoplasm Less << Phase 2 Recruiting July 24, 2020 United States, Pennsylvania ... More >> Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP    215-955-8874 Less <<
NCT03018626 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Recruiting January 2021 China, Guangdong ... More >> Ru Feng Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ru Feng, M.D.    +86 13725119762    ruth1626@hotmail.com    Contact: Xiaolei Wei, M.D.    +86 13826407312    smuxiaoleiwei@163.com    Principal Investigator: Ru Feng, M.D. Less <<
NCT00977691 Peripheral Blood Stem Cell Tra... More >>nsplantation Anemia, Sickle Cell Graft-Versus-Host Disease Sirolimus (Rapamune ) Alemtuzumab (Campath ) Less << Phase 1 Phase 2 Active, not recruiting August 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03573700 Acute Lymphoblastic Leukemia, ... More >>in Relapse Acute Lymphoblastic Leukemia, Refractory Less << Phase 1 Phase 2 Recruiting July 1, 2024 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Aimee C. Talleur, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Aimee C. Talleur, MD Less <<
NCT00302523 Idiopathic Membranous Nephropa... More >>thy Less << Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Research Institute of Nephrology, Jinling Hospital Nanjing, Jiangsu, China, 210002 Less <<
NCT03610490 High Grade Ovarian Serous Aden... More >>ocarcinoma Oligometastasis Ovarian Carcinosarcoma Pancreatic Ductal Adenocarcinoma Recurrent Osteosarcoma Recurrent Ovarian Carcinoma Refractory Osteosarcoma Refractory Ovarian Carcinoma Less << Phase 2 Recruiting September 30, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ljiljana Milojevic    713-792-8578    lmilojev@mdanderson.org    Principal Investigator: Amir A. Jazaeri Less <<
NCT00039546 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2TH Cancer Research UK Clinical Trials Unit - Birmingham Birmingham, England, United Kingdom, B15 2TT City Hospital - Birmingham Birmingham, England, United Kingdom, B18 7QH Birmingham Heartlands and Solihull NHS Trust -Teaching Birmingham, England, United Kingdom, B9 5SS Queen's Hospital, Burton Burton-upon-Trent, England, United Kingdom, DE14 3QH Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Broomfield Hospital Chelmsford, Essex, England, United Kingdom, CM1 5ET Essex County Hospital Colchester, England, United Kingdom, C03 3NB Walsgrave Hospital Coventry, England, United Kingdom, CV2 2DX Dorset County Hospital Dorchester, England, United Kingdom, DT1 2JY Royal Devon and Exeter Hospital Exeter, England, United Kingdom, EX2 5DW Princess Royal Hospital Hull, England, United Kingdom, HU8 9HE Hinchingbrooke Hospital Huntingdon, England, United Kingdom, PE18 6NT King George Hospital Ilford, Essex, England, United Kingdom, IG3 8YB Crosshouse Hospital Kilmarnock, England, United Kingdom, KA2 OBE Cookridge Hospital at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS16 6QB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF St. George's Hospital London, England, United Kingdom, SW17 0QT Christie Hospital N.H.S. Trust Manchester, England, United Kingdom, M20 4BX Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, L63 4JY James Cook University Hospital Middlesbrough, England, United Kingdom, TS4 3BW Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-upon-Tyne, England, United Kingdom, NE4 6BE Northampton General Hospital NHS Trust Northampton, England, United Kingdom Nottingham City Hospital NHS Trust Nottingham, England, United Kingdom, NG5 1PB Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Oldchurch Hospital Romford, England, United Kingdom, RM7 OBE Thornbury Hospital Sheffield, England, United Kingdom, S10 3BR Cancer Research Centre at Weston Park Hospital Sheffield, England, United Kingdom, S1O 2SJ Royal Shrewsbury Hospital Shrewsbury, England, United Kingdom West Suffolk Hospital Suffolk, England, United Kingdom, IP33 2QZ Torbay Hospital Torquay Devon, England, United Kingdom, TQ2 7AA Walsall Manor Hospital Walsall, England, United Kingdom, WS2 9PS Sandwell General Hospital West Bromwich, England, United Kingdom, B71 4HJ Good Hope Hospital Trust West Midlands, England, United Kingdom, B75 7RR Worcester Royal Hospital Worcester, England, United Kingdom, WR5 1JG Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Infirmary - Castle Glasgow, Scotland, United Kingdom, G4 0SF Velindre Cancer Center at Velinde Hospital Cardiff, Wales, United Kingdom, CF4 7XL Hairmyres Hospital East Kilbride, United Kingdom, G75 8RG Hull Royal Infirmary Hull, United Kingdom, HU3 2KZ Queen Elizabeth Hospital King's Lynn, United Kingdom, PE30 4ET Glan Clywd District General Hospital Rhyl, Denbighshire, United Kingdom, LL 18 5UJ Singleton Hospital Swansea, United Kingdom, SA 2 8QA Morriston Hospital NHS Trust West Glamorgen, United Kingdom, SA6 6NL Less <<
NCT02451774 Acute Lymphoblastic Leukemia Phase 2 Phase 3 Recruiting December 2020 Mexico ... More >> Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Recruiting Guadalajara, Jalisco, Mexico, 44340 Contact: Ramon O Gonzalez Ramella, PhD    5213331719826    glezramella@hotmail.com    Contact: Fabiola P Medina Barajas, PhD    5213313461917    favyri@hotmail.com Less <<
NCT03215810 Non-Small Cell Lung Cancer ... More >> Metastatic Non-small Cell Lung Cancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas Less << Phase 1 Recruiting March 2021 United States, Florida ... More >> University of Florida Health Cancer Center. Not yet recruiting Gainesville, Florida, United States, 32608 H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Ben Creelan, M.D.    813-745-3050    thoraciccro@moffitt.org    Principal Investigator: Ben Creelan, M.D.          Sub-Investigator: Scott Antonia, M.D., Ph.D.          Sub-Investigator: Alberto Chiappori, M.D.          Sub-Investigator: Jhanelle Gray, M.D.          Sub-Investigator: Eric Haura, M.D.          Sub-Investigator: Amod Sarnaik, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D. Less <<
NCT00460421 Leukemia Phase 1 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States United States, California Loma Linda University Loma Linda, California, United States Children´s Hospital Los Angeles, California, United States Regents of University of California Los Angeles, California, United States Children´s Hospital of Orange Orange, California, United States United States, Illinois Children´s Memorial Chicago, Illinois, United States United States, Texas University of Texas Dallas, Texas, United States Less <<
NCT00282438 Sarcoidosis Phase 1 Phase 2 Terminated(No plan to continue... More >> enrollment) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00282438 - Terminated(No plan to continue... More >> enrollment) Less << - -
NCT01994850 CD30 Positive Primary Mediasti... More >>nal Large B-cell Lymphoma, CD30 Positive Diffuse Large B-cell Lymphoma or CD30 Positive Grey Zone Lymphoma Less << Phase 1 Phase 2 Active, not recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00017381 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Waldenstr?m Macroglobulinemia Less << Early Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 Less <<
NCT02779283 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting June 1, 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon    503-494-8950    spurgeos@ohsu.edu    Principal Investigator: Stephen E. Spurgeon Less <<
NCT00553202 Leukemia Phase 2 Unknown - -
NCT02757885 Sickle Cell Disease Phase 2 Recruiting December 2020 United States, Georgia ... More >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30033 Contact: Lakshmanan Krishnamurti, MD    404-785-1441    lakshmanan.krishnamurti@emory.edu Less <<
NCT01678430 Chronic Lymphocytic Leukaemia Phase 3 Unknown December 2017 United Kingdom ... More >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger          Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule          Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner          Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy          Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa          Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin          Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson          Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe          Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis          Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock          Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam          Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord          Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord          West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi          Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle          Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli          Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson          Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad          Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall          Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss          Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams          Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa          St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen          Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis          Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt Less <<
NCT01232062 - Completed - China ... More >> Beijing Cancer Hospital Beijing, China, 100142 Less <<
NCT01395056 - Completed - China ... More >> Beijing Cancer Hospital Beijing, China, 100142 Less <<
NCT01571518 Neutropenia Phase 4 Unknown October 2013 Korea, Republic of ... More >> Soonchunhyang university Puchun Hospital Not yet recruiting Puchun, Korea, Republic of Contact: Hyuk moon Kim, MD    82-32-621-5114    hmkim@soonchunhyang.com    Principal Investigator: ChulWan Lim, MD.PhD Less <<
NCT03600363 Lymphoma, Large B-Cell, Diffus... More >>e Stage III Follicular Lymphoma Less << Phase 2 Not yet recruiting December 2020 -
NCT00553202 - Unknown - -
NCT00027573 Kidney Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Oklahoma CCOP - Oklahoma Tulsa, Oklahoma, United States, 74136 Less <<
NCT00553358 Neoplasms, Breast Phase 3 Active, not recruiting December 23, 2019 -
NCT00583622 Ovarian Cancer Phase 2 Terminated(Slow Accrual) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00553358 - Active, not recruiting - -
NCT02461121 Acute Myeloid Leukemia Phase 3 Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences , Beijing, Beijing, China, 100071 Less <<
NCT00583622 - Terminated(Slow Accrual) - -
NCT00854568 Lymphoma Phase 3 Completed - China, Shanghai ... More >> Fudan University Cancer Hospital Shanghai, Shanghai, China, 200032 Less <<
NCT00626197 Lupus Nephritis ... More >> Systemic Lupus Erythematosus Less << Phase 3 Completed - -
NCT03455517 Chronic Myeloid Leukemia Phase 2 Not yet recruiting March 2021 -
NCT02042690 Acute Lymphoblastic Leukemia Phase 3 Unknown December 2018 China, Beijing ... More >> Aerospace Center Hospital Beijing, Beijing, China, 100044 Peking University First Hospital Beijing, Beijing, China, 100044 Less <<
NCT00001830 Chronic Lymphocytic Leukemia ... More >> Graft vs Host Disease Hodgkin's Disease Multiple Myeloma Non Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00005092 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 United States, Missouri Washington University Barnard Cancer Center Saint Louis, Missouri, United States, 63110 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00776295 Small Cell Lung Cancer Phase 2 Terminated(Low accrual) - United States, Florida ... More >> HLeeMoffitt Tampa, Florida, United States, 33612 Less <<
NCT01858259 - Unknown June 2016 France ... More >> Université Paris Descartes, Hôpital Cochin, Service de Rhumatologie A & INSERM 1016 Recruiting Paris, France, 75014 Principal Investigator: Yannick Allanore, Prof.          Germany Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology Recruiting Bad Nauheim, Germany, 61231 Principal Investigator: Ulf Müller-Ladner, Prof.          Sub-Investigator: Ingo H. Tarner, Dr.          Sub-Investigator: Marc Frerix, Dr.          Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie Recruiting Berlin, Germany, 10117 Principal Investigator: Gabriela Riemekasten, Prof.          Centre for Pediatric Rheumatology, Klinikum Eilbek Recruiting Hamburg, Germany, 22081 Principal Investigator: Ivan Foeldvari, Dr.          Hungary Pecsi Tudomanyegyetem - University of Pecs Recruiting Pecs, Hungary, H-7622 Principal Investigator: Laszlo Czirjak, Prof.          Italy University of Florence, Denothe Centre, Division of Rheumatology AOUC, Department of Biomedicine Recruiting Firenze, Italy, 50139 Principal Investigator: Marco Matucci-Cerinic, Prof.          Policlinico, Via Pansini Recruiting Napoli-Italia, Italy, 5-80131 Principal Investigator: Gabriele Valentini, Prof          Switzerland Felix-Platter Spital, University of Basel Recruiting Basel, Switzerland, CH 4012 Basel Principal Investigator: Ulrich Walker, Prof.          University of Zurich, Department of Rheumatology Recruiting Zurich, Switzerland, 8006 Principal Investigator: Oliver Distler, Prof.          United Kingdom The Universitiy of Leeds, Division of Rheumatic and Musculoskeletal Disease, St James's University Hospital Recruiting Leeds, United Kingdom, LS9 7TF Principal Investigator: Francesco Del Galdo, Dr.          Royal Free Hospital, University College London Recruiting London, United Kingdom, NW3 2QG Principal Investigator: Christopher Denton, Prof. Less <<
NCT02858310 Papillomavirus Infections ... More >> Cervical Intraepithelial Neoplasia Carcinoma In Situ Vulvar Neoplasms Vulvar Diseases Less << Phase 1 Phase 2 Recruiting January 1, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01005745 - Active, not recruiting - -
NCT01395563 Pancreatic Neoplasms ... More >> Cachexia Myopathy Less << Not Applicable Withdrawn December 2011 Germany ... More >> European Pancreas Center Heidelberg, Germany, 69120 German Cancer Research Center Heidelberg, Germany, 69120 Technische Universität München Munich, Germany, 81675 Less <<
NCT01005745 Metastatic Melanoma Not Applicable Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00051311 Hematologic Neoplasms Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001901 Vasculitis We... More >>gener's Granulomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00776295 - Terminated(Low accrual) - -
NCT00176462 Acute Lymphocytic Leukemia Phase 2 Completed - United States, New Jersey ... More >> Jersey Shore University Medical Center Neptune, New Jersey, United States, 07754 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT03720457 CD19-positive ... More >> Diffuse Large B-cell Lymphoma Follicular Lymphoma Less << Phase 1 Recruiting October 2023 China, Shanghai ... More >> Fudan University Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Peng Liu, Professor    021-60267405    Liu.peng@zs-hospital.sh.cn Less <<
NCT00513604 - Completed - -
NCT00176462 - Completed - -
NCT00520130 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Disease Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00431080 Breast Cancer Phase 3 Completed - Greece ... More >> University Hospital of Crete Heraklion, Crete, Greece, 71110 University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece "Marika Iliadis" Hospital of Athens, Dep of Medical Oncology Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece State General Hospital of Larissa, Dep of Medical Oncology Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT03688958 Breast Cancer Phase 2 Recruiting June 2020 Mexico ... More >> Hospital Médico TEC100 Recruiting Querétaro City, Queretaro, Mexico, 76000 Contact: Guillermo Peralta Castillo, MD    524424699698    drmemop@gmail.com    Clínica Hospital Dr. Ismael Vázquez Ortiz ISSSTE Recruiting Querétaro, Queretaro, Mexico, 76001 Contact: Carlos Avecilla, MD    442 2154944    drcavecilla@gmail.com    Contact: Jose Miguel Torres-Martel, MD    524422381067    jmiguelmex@hotmail.com    Hospital General Regional #1 IMSS Recruiting Querétaro, Queretaro, Mexico, 76001 Contact: Joel Rojas, Md    52 442 216 26 62    joelro_onco@hotmail.com    Contact: Guillermo Peralta, MD    524422381067    drmemop@gmail.com Less <<
NCT01390584 Lymphoma Phase 2 Terminated(slow accrual) - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Pennsylvania McGlinn Family Regional Cancer Center at Reading Hospital and Medical Center Reading, Pennsylvania, United States, 19612-6052 Less <<
NCT00117897 Non-Hodgkin's Lymphoma Phase 2 Completed - -
NCT00520130 - Active, not recruiting - -
NCT00079625 Breast Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00203697 Idiopathic Pulmonary Fibrosis Phase 3 Unknown - United States, California ... More >> UCLA Pulmonary Outpatient Clinic Los Angeles, California, United States, 90095 Less <<
NCT00001256 Inflammation ... More >>Vasculitis Wegener's Granulomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT01996267 Breast Cancer ... More >> HER2 Positive Less << Phase 3 Active, not recruiting December 2019 Netherlands ... More >> MCA Alkmaar, Netherlands, 1815 JD ZGT Almelo, Netherlands, 7609 PP Antoni van Leeuwenhoek Amsterdam, Netherlands, 1066 CX AZVU Amsterdam, Netherlands, 1081 HV OLVG Amsterdam, Netherlands, 1090 HM Rode Kruis Ziekenhuis Beverwijk, Netherlands, 1940 EB Amphia ziekenhuis Breda, Netherlands, 4819 EV Reinier de Graaf Groep Delft, Netherlands, 2625 AD Jeroen Bosch Hospital Den Bosch, Netherlands Haga Den Haag, Netherlands, 2545 CH Bronovo Ziekenhuis den Haag, Netherlands, 2597 AX Deventer ziekenhuis Deventer, Netherlands, 7416 SE Ziekenhuis Gelderse Vallei Ede, Netherlands, 6716 RP Catharina Ziekenhuis Eindhoven, Netherlands, 5602 ZA Maxima Medisch Centrum Eindhoven, Netherlands, 5631 BM St Anna Geldrop Geldrop, Netherlands, 5664 EH Orbis Medisch Centrum Geleen, Netherlands, 6162 BG Groene Hart Gouda, Netherlands, 2803 HH Kennemer Gasthuis Haarlem, Netherlands, 2035 RC Atrium Medisch Centrum Parkstad Heerlen, Netherlands, 6401 CX Spaarne ziekenhuis Hoofddorp, Netherlands, 2134 TM Westfries Gasthuis Hoorn, Netherlands, 1624 NP MCL Leeuwarden, Netherlands, 8934 AD LUMC Leiden, Netherlands, 2300 RC Diaconessenhuis Meppel Meppel, Netherlands, 7943 KA Canisius-Wilhelmina Hospital Nijmegen, Netherlands Waterlandziekenhuis Purmerend, Netherlands, 1441 RN Vlietland Ziekenhuis Schiedam, Netherlands, 3100 AE St. Elisabeth Tilburg, Netherlands, 5022 GC Diaconessenhuis Utrecht Utrecht, Netherlands, 3582 KE VieCuri Medisch Centrum voor Noord-Limburg Venlo, Netherlands Zaans Medisch Centrum Zaandam, Netherlands, 1502 DV Isala Klinieken Zwolle, Netherlands, 8025 AB Less <<
NCT03009058 Metastatic Cancer Phase 1 Phase 2 Terminated(Commercial reasons) - France ... More >> Centre Léon Bérard, Dpt Medecine & INSERM Lyon, France, 69373 Gustave Roussy Cancer Center Villejuif, France, 94805 United Kingdom St George's University of London, Institute of Infection and Immunity London, United Kingdom, SW17 0RE Royal Marsden Hospital Foundation Trust London, United Kingdom, SW3 6JJ Less <<
NCT02054559 Diffuse Large B-cell Lymphoma Phase 3 Withdrawn(No consensus among t... More >>rial centers regarding protocol) Less << January 2020 Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01238328 Mucopolysaccharidosis Phase 2 Phase 3 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Teharn, Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +9821    aahamidieh@sina.tums.ac.ir    Principal Investigator: Amir Ali Hmidieh, MD          Sub-Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Kamran Alimoghaddam, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT00006379 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00040651 Scleroderma S... More >>ystemic Sclerosis Less << Phase 1 Terminated - United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT03104595 Febrile Neutropenia Phase 2 Recruiting March 31, 2019 Korea, Republic of ... More >> Yonsei University Health System Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Contact    82-2-2228-8135       Asan Medical Center Recruiting Seoul, Korea, Republic of, 05505 Contact    82-2-3010-3217 Less <<
NCT02499367 Breast Cancer Phase 2 Recruiting August 2022 Netherlands ... More >> Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066 CX Contact: Marleen Kok, MD    +3120512 ext 7901    m.kok@nki.nl    Contact: Ingrid AM Mandjes, MSc    +3120512 ext 2667    i.mandjes@nki.nl    Principal Investigator: Marleen kok, MD Less <<
NCT00002718 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03620578 Non Hodgkin Lymphoma ... More >> Lymphoma, B-Cell High-grade B-cell Lymphoma MYC Translocation BCL-2 Translocation Less << Phase 2 Recruiting August 2026 Belgium ... More >> ZNA Not yet recruiting Antwerp, Belgium Principal Investigator: K.L. Wu          UZ Leuven Not yet recruiting Leuven, Belgium Principal Investigator: V. Vibeke          Netherlands Flevoziekenhuis Not yet recruiting Almere, Netherlands Principal Investigator: K de Heer          Meander MC Not yet recruiting Amersfoort, Netherlands Principal Investigator: R. Fijnheer          AMC Not yet recruiting Amsterdam, Netherlands Principal Investigator: M.J. Kersten          VUmc Recruiting Amsterdam, Netherlands Principal Investigator: M.E.D. Chamuleau          Jeroen Bosch Ziekenhuis Not yet recruiting Den Bosch, Netherlands Principal Investigator: D. Issa          HagaZiekenhuis Not yet recruiting Den Haag, Netherlands Principal Investigator: L.H. Böhmer          Maxima MC Not yet recruiting Eindhoven, Netherlands Principal Investigator: L. Nieuwenhuizen          MST Not yet recruiting Enschede, Netherlands Principal Investigator: T.J.F. Snijders          ADRZ Not yet recruiting Goes, Netherlands Principal Investigator: M.Y. Bilgin          UMCG Not yet recruiting Groningen, Netherlands Principal Investigator: M. Nijland          Spaarne Gasthuis Not yet recruiting Hoofddorp, Netherlands Principal Investigator: A. Beeker          Westfries Gasthuis Not yet recruiting Hoorn, Netherlands Principal Investigator: T. van Maanen          MC Leeuwarden Not yet recruiting Leeuwarden, Netherlands Principal Investigator: R. van Rijn          LUMC Not yet recruiting Leiden, Netherlands Principal Investigator: J. vermaat          MUMC Not yet recruiting Maastricht, Netherlands Principal Investigator: M. van der Poel          Radboud UMC Not yet recruiting Nijmegen, Netherlands Principal Investigator: W.B.C. Stevens          Erasmus MC Not yet recruiting Rotterdam, Netherlands Principal Investigator: P.J. Luchtenburg          Maasstadziekenhuis Not yet recruiting Rotterdam, Netherlands Principal Investigator: Y. Sandberg          Zuyderland MC Not yet recruiting Sittard, Netherlands Principal Investigator: R.J.W. van Kampen          Sint Elisabeth Ziekenhuis Not yet recruiting Tilburg, Netherlands Principal Investigator: M. Durian          UMCU Not yet recruiting Utrecht, Netherlands Principal Investigator: R. Mous          Isala Klinieken Not yet recruiting Zwolle, Netherlands Principal Investigator: O. Visser Less <<
NCT00513604 Melanoma Mali... More >>gnant Melanoma Melanoma, Experimental Experimental Melanomas Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00395655 Locally Advanced Breast Cancer Phase 2 Terminated - Mexico ... More >> Instituto Nacional de Cancerologia Mexico City, Tlalpan, Mexico, 14080 Less <<
NCT01704716 Neuroblastoma Phase 3 Recruiting September 2024 -
NCT00002657 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - -
NCT03563170 Hepatocellular Carcinoma Non-r... More >>esectable Hepatocellular Carcinoma Recurrent Less << Phase 1 Phase 2 Recruiting December 30, 2022 United States, California ... More >> Chan Soon-Shiong Institute for Medicine Recruiting El Segundo, California, United States, 90245 Less <<
NCT02443077 Diffuse Large B-Cell Lymphoma ... More >>Activated B-Cell Type Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High Grade B-Cell Lymphoma, Not Otherwise Specified Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 3 Recruiting - -
NCT00002812 Leukemia Phase 3 Completed - -
NCT00041132 Lymphoma Phase 2 Completed - -
NCT00006721 - Active, not recruiting - -
NCT01290120 Burkitt Lymphoma ... More >> B-ALL Less << Phase 2 Completed - Italy ... More >> Divisione di Ematologia e TMO, Ospedale San Maurizio Bolzano, (bz), Italy Ematologia e centro TMO - Ospedale Armando Businco Cagliari, (ca), Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, (cn), Italy Onco-Ematologia - Ospedale Civile Noale, (ve), Italy Dipartimento di Ematologia e Medicina Trasfusionale - Azienda Osp. Nazionale Santi Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy Divisione Ematologia Spedali Civili Brescia, BS, Italy, 25123 Ematologia - AOU Careggi Firenze, FI, Italy Ematologia e TMO - Ospedale San Raffaele Milano, MI, Italy Ematologia - TMO - Ospedale San Gerardo Monza, MI, Italy Ematologia Ospedale San Bortolo Vicenza, VI, Italy, 36100 USC Ematologia Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Less <<
NCT00006721 Lymphoma Phase 3 Active, not recruiting June 2023 -
NCT02128230 Multiple Myeloma Phase 2 Recruiting May 2025 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan M Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Contact: Doug Steward    501-526-6990 ext 2452    dmsteward@uams.edu    Sub-Investigator: Michele Fox, MD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD          Sub-Investigator: Shadiqul Hoque, MD          Sub-Investigator: Sharmilan Thanendrarajan, MD Less <<
NCT00041132 - Completed - -
NCT00374699 Peripheral T-Cell Lymphomas ... More >> Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00014222 Breast Cancer Phase 3 Completed - -
NCT01818908 NHL With Hemophagocytic Lympho... More >>histiocytosis Less << Phase 2 Unknown April 2014 China, Jiangsu ... More >> ChangZhou No.2 People's Hospital Recruiting ChangZhou, Jiangsu, China, 213011 Contact: Min Zhou, Dr.          Principal Investigator: Min Zhou, M.D.          HuaiAn First People's Hospital Recruiting HuaiAn, Jiangsu, China, 223300 Contact: Liang Yu, Dr.          Principal Investigator: Liang Yu, M.D., Ph.D.          JiangSu Province Hospital Recruiting NanJing, Jiangsu, China, 210029 Contact: LEI FAN, Dr.    86 25 6813 6034       Principal Investigator: WEI XU, M.D., Ph.D.          WuXi People's Hospital Recruiting WuXi, Jiangsu, China, 214023 Contact: Yun Zhuang, M.D.          Principal Investigator: YunFeng Shen, M.D., Ph.D. Less <<
NCT00040469 Sickle Cell Anemia ... More >> Hemoglobinopathy Thalassemia Less << Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01724021 Diffuse Large B-Cell Lymphoma,... More >> Non-Hodgkin's Lymphoma Less << Phase 3 Completed - -
NCT01724021 - Completed - -
NCT00003389 - Completed - -
NCT01760226 Diffuse Large B Cell Lymphoma ... More >> Post Transplant Lymphoproliferative Disorder Primary Mediastinal (Thymic) Large B-cell Lymphoma Less << Early Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00303836 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Terminated - United States, Maryland ... More >> National Cancer Institute Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT00003389 Lymphoma Phase 3 Completed - -
NCT01898793 Leukemia, Myeloid, Acute Phase 1 Phase 2 Recruiting December 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-434-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Lukas Wartman, M.D.          Sub-Investigator: John Welch, M.D.,Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Michael Tomasson, M.D.          Sub-Investigator: Matthew Walter, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Brad Kahl, M.D.          Sub-Investigator: Terrence Wong, M.D. Ph.D.          Sub-Investigator: Jeffery Bednarski, M.D., Ph.D.          Sub-Investigator: Shalini Shenoy, M.D.          Sub-Investigator: Robert Hayashi, M.D.          Sub-Investigator: Sima Bhatt, M.D. Less <<
NCT00392990 Lymphoma Phase 2 Active, not recruiting October 2019 United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 John H. Stroger Cook County Hospital Chicago, Illinois, United States, 60612 Rush University Medical Center Chicago, Illinois, United States, 60612 Loyola University Medical Center Maywood, Illinois, United States, 60153 Advocate Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068-1174 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Less <<
NCT00386321 Diffuse Large B-cell Lymphoma Phase 2 Terminated(Participants are no... More >> longer being examined or treated.) Less << January 2010 Thailand ... More >> King Chulalongkorn Memorial Hospital Bangkok, Thailand, 10330 Less <<
NCT02277392 Ovarian, Fallopian Tube and Pe... More >>ritoneal Cancer Less << Phase 1 Withdrawn - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00058422 Lymphoma Phase 2 Active, not recruiting February 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00005893 Neutropenia S... More >>ickle Cell Anemia Thalassemia Major Red-Cell Aplasia, Pure Less << Not Applicable Completed - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01030900 Hodgkin Lymphoma ... More >> Diffuse Large B-Cell Lymphoma Less << Phase 2 Active, not recruiting September 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00012207 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 University of Washington School of Medicine Seattle, Washington, United States, 98195 Less <<
NCT00727194 - Terminated - -
NCT03054896 Richter Syndrome Phase 2 Recruiting September 1, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Matthew S. Davids, MD, MMSc    617-632-6331    Matthew_Davids@dfci.harvard.edu    Principal Investigator: Matthew S. Davids, MD, MMSc          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Kerry Rogers, MD       Kerry.Rogers@osumc.edu    United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Philip Thompson, MD       PAThompson2@mdacc.org Less <<
NCT00001765 Chronic Granulomatous Disease Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00004036 Chronic Myeloproliferative Dis... More >>orders Drug/Agent Toxicity by Tissue/Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Unknown - United States, Ohio ... More >> Cleveland Clinic Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00727194 Myasthenia Gravis Phase 2 Terminated - -
NCT00807599 Multiple Myeloma Phase 2 Completed - United States, New Jersey ... More >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00006413 Mastocytosis Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03571308 Non Hodgkin Lymphoma Phase 2 Recruiting December 31, 2021 United Kingdom ... More >> Southampton University Hospitals NHS Tust Recruiting Southampton, Hampshire, United Kingdom, SO16 6YD Contact: Kerry Gready    0238120 ext 5113    lymphomaresearcnurses@soton.ac.uk    Contact: Julie Gwilt    0238120 ext 4202    j.gwilt@soton.ac.uk    St James's University Hospital Not yet recruiting Leeds, United Kingdom, LS9 7TF Contact: Amy Humphries    0113206 ext 8984    amyhumphries@nhs.net    Contact: Sophie Robertson Robertson    0113206 ext 8984    sophierobertson@nhs.net    Principal Investigator: Cathy Burton          University College London Hospitals Not yet recruiting London, United Kingdom, NW12PG Contact: Tebereh Mesfin    0203 447 ext 5078    tebereh.mesfin@uclh.nhs.uk    Contact: Jessica Rubio-Lorente    0203 4478049 ext 8049    jessica.rubio-lorente@uclh.nhs.uk    Principal Investigator: Kirit Ardeshna          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom, M204XB Contact: Clare Day    0161 918 ext 7516    Clare.Day@christie.nhs.uk    Contact: Rachel Stevenson    0161 918 ext 7226    rachel.stevenson@christie.nhs.uk    Principal Investigator: John Radford          Nottingham City Hospital Campus Not yet recruiting Nottingham, United Kingdom, NG51PB Contact: Melanie Jones    0115 9691169 ext 53474    Melanie.Jones@nuh.nhs.uk    Contact: Carol Evans    0115 9691169 ext 53474    carol.evans@nuh.nhs.uk    Churchill Hospital Recruiting Oxford, United Kingdom, OX37LE Contact: Eileen McKenzie McKenzie    01865 23 ext 5312    trialadministrator02@oncology.ox.ac.uk    Contact: Raqeeb Mahmood    01865 23 ext 5216    raqeeb.mahmood@oncology.ox.ac.uk    Principal Investigator: Graham Collins          Derriford Hospital Not yet recruiting Plymouth, United Kingdom, PL68DH Contact: Nicola Crosbie    01752 43 ext 1043    nicola.crosbie@nhs.net    Contact: Claire Brown    01752 43 ext 9638    clairebrown10@nhs.net    Principal Investigator: Simon Rule Less <<
NCT00278551 RHEUMATOID ARTHRITIS Phase 1 Terminated - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00392886 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Unknown - -
NCT00441025 Peripheral T-Cell Lymphoma Phase 2 Terminated(a lack of a potenti... More >>al patient.) Less << August 2009 Thailand ... More >> Siriraj Hospital, Mahidol University Bangkoknoi, Bangkok, Thailand, 10700 Less <<
NCT01445535 T-Cell Peripheral Lymphoma ... More >> Gamma Delta Hepatosplenic T-Cell Lymphoma Subcutaneous Panniculitis-Like T-Cell Lymphoma NK T-Cell Lymphoma Less << Phase 1 Active, not recruiting October 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02135510 Solid Tumors Phase 3 Recruiting July 2019 Netherlands ... More >> Gemini Ziekenhuis Recruiting Den Helder, Noord Holland, Netherlands, 1782 GZ Contact: S.C.S. Tromp-van Driel    (0223) 69 69 69       Tergooiziekenhuizen Recruiting Hilversum, Noord Holland, Netherlands, 1213 XZ Contact: H.P. van den Berg    088 753 17 53       Medisch Centrum Alkmaar Recruiting Alkmaar, Noord-Holland, Netherlands, 1815 JD Contact: S Vrijaldenhoven    (072) 548 2870       Ziekenhuis Amstelland Recruiting Amstelveen, Noord-Holland, Netherlands, 1186 AM Contact: A. van Zweeden    (020) 755 7000       Waterland Ziekenhuis Not yet recruiting Purmerend, Noord-Holland, Netherlands, 1441 RN Contact: J Brakenhoff    0299 457 457       De Heel - Zaans Medisch Centrum Not yet recruiting Zaandam, Noord-Holland, Netherlands, 1502 DV Contact: A. van Bochove    (075) 650 29 11       Rijnstate Recruiting Arnhem, Netherlands Contact: T van Voorthuizen    +31(0)88 005 8888 Less <<
NCT02670317 Lymphoma, B-Cell Phase 2 Terminated(GA101-CHOP not adva... More >>ntage from rituximab-CHOP) Less << - Italy ... More >> IRCCS Candiolo - Fondazione del Piemonte per l'oncologia Candiolo, TO, Italy AO SS. Antonio e Biagio e C. Arrigo Alessandria, Italy, 15121 AOU Policlinico Consorziale Bari, Italy AO Papa Giovanni XXIII Bergamo, Italy Ospedale di Bolzano Bolzano, Italy Ospedale Businco Cagliari, Italy AO di Cosenza Cosenza, Italy AOU Careggi Firenze, Italy P.O. Vito Fazzi Lecce, Italy IRST Meldola Meldola, Italy Ospedale Papardo Messina, Italy Istituto Europeo Oncologico Milano, Italy AOU Policlinico di Modena Modena, Italy Ospedale San Gerardo Monza, Italy IRCCS Napoli Pascale Napoli, Italy Ospedale Maggiore della Carità Novara, Italy AOOR Villa Sofia Cervello Palermo, Italy AOU di Parma Parma, Italy Ospedale G. Da Saliceto Piacenza, Italy AOR San Carlo Potenza, Italy Ospedale Degli Infermi Rimini, Italy Policlinico Gemelli Roma, Italy Policlinico Umberto I Roma, Italy Humanitas Rozzano, Italy Casa Sollievo della Sofferenza San Giovanni Rotondo, Italy AOU Città Della Salute e Della Scienza Ematologia Universitaria Torino, Italy AOU Città Della Salute e Della Scienza SC Ematologia Torino, Italy AOU di Udine Udine, Italy Ospedale di Circolo e Fondazione Macchi Varese, Italy Less <<
NCT00342134 Multiple Sclerosis Phase 2 Completed - United States, Illinois ... More >> Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT01537861 Multiple Myeloma Early Phase 1 Terminated(Unexpected toxicity... More >> (2 early deaths)) Less << - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00005785 Hematologic Neoplasm ... More >> HIV Infection Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT01266668 - Completed - Korea, Republic of ... More >> Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Less <<
NCT01393756 Follicular Lymphoma Phase 2 Completed - France ... More >> Institut Bergonié Bordeaux, France, 33076 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33077 CHU Estaing Clermont ferrand, France, 63000 Hôpital Henri Mondor Creteil, France, 94010 CHU de DIJON Dijon, France, 21034 Chru Lille Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13273 Hôpital Notre Dame de Bon Secours Metz, France, 57038 Hôpital Saint Eloi Montpellier, France, 34295 CHU de NANTES Nantes, France, 44093 Hôpital Saint Antoine Paris, France, 75012 Hôpital de la Pitié Salpétrière Paris, France, 75013 Hôpital Necker Paris, France, 75015 Institut Curie Paris, France, 75231 Hôpital St Louis Paris, France, 75475 Chu Lyon Sud Pierre-benite, France, 69310 CHU de Poitiers Poitiers, France, 86021 Hôpital Robert Debré Reims, France, 51092 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri BECQUEREL Rouen, France, 76038 Hôpital René Huguenin Saint-Cloud, France, 92211 Chu Brabois Vandoeuvre-les-nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00562965 Lymphoma, Follicular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00006417 Chronic Granulomatous Disease Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00005988 Graft Versus Host Disease ... More >> Leukemia Lymphoma Myelodysplastic Syndromes Myeloma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01208662 Multiple Myeloma Phase 3 Active, not recruiting September 2018 -
NCT00072280 Sarcoma Phase 2 Terminated(Due to poor accrual... More >>) Less << - -
NCT00003552 Stage IV Melanoma ... More >> Recurrent Melanoma Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 Less <<
NCT00072280 - Terminated(Due to poor accrual... More >>) Less << - -
NCT00002571 Lymphoma Phase 2 Completed - -
NCT00562965 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02314273 Pancytopenia Due to Chemothera... More >>py Less << Phase 4 Completed - China, Beijing ... More >> Beijing Children's Hospital Beijing, Beijing, China China, Jiangsu Nanjing Children's Hospital Nanjing, Jiangsu, China Soochow University Affiliated Children's Hospital Soochow, Jiangsu, China China, Shanghai Shanghai Children's Medical Center Shanghai, Shanghai, China, 200127 Children's Hospital of Fudan University Shanghai, Shanghai, China Less <<
NCT02776605 ALL Phase 2 Recruiting December 2020 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Josep Mª Ribera, Dr       jribera@iconcologia.net    Hospital Clinic Recruiting Barcelona, Spain, 08036 Contact: Jordi Esteve, Dr       JESTEVE@clinic.ub.es    Hospital Universitario Vall d'Hebron Recruiting Barcelona, Spain Contact: Pere Barba, Dr       pebarba@vhebron.net    Hospital 12 de Octubre Recruiting Madrid, Spain Contact: Mª Pilar Martinez Sánchez, Dr       mpmartinezs.hdoc@salud.madrid.org    Hospital Virgen de la Victoria Recruiting Málaga, Spain Contact: Mª José Moreno, Dr       mjmorenorico@hotmail.com    Hospital Clinico Universitario de Salamanca Recruiting Salamanca, Spain Contact: Jesús Maria Hernández Rivas, Dr       jmhr@usal.es    Hospital Marques de Valdecilla Recruiting Santander, Spain Contact: Mª Aranzazu Bermudez, Dr       mbermudez@humv.es    C H Santiago de Compostela Recruiting Santiago de Compostela, Spain Contact: Natalia Alonso, Dr       natalia.alonso.vence@sergas.es    Hospital Virgen del Rocio Recruiting Sevilla, Spain Contact: Jose Gonzalez Campos, Dr       jose.gonzalez.sspa@juntadeandalucia.es    Hospital Clinico de Valencia Recruiting Valencia, Spain Contact: Mª del Mar Tormo, Dr       tormo_mar@gva.es    Hospital La Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT00028964 Breast Cancer ... More >> Drug/Agent Toxicity by Tissue/Organ Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115-1710 Less <<
NCT01719341 - Unknown - Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Zi Yi Lim, MB ChB    65 6779 5555    Zi_Yi_Lim@nuhs.edu.sg    Principal Investigator: Zi Yi Lim, MB ChB Less <<
NCT00569101 Lupus Nephritis Phase 2 Unknown March 2008 Korea, Republic of ... More >> SeoulNUH Seoul, Chongno-gu, Korea, Republic of, 110-744 Less <<
NCT00039351 Lymphoma Phase 2 Completed - Belgium ... More >> Ziekenhuis Network Antwerpen Middelheim Antwerp, Belgium, 2020 Centre Hospitalier Universitaire Brugmann Brussels, Belgium, B 1020 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Egypt National Cancer Institute of Egypt Cairo, Egypt France Centre D'Oncologie Du Pays-Basque Bayonne, France, F-64100 Hopital Saint Andre Bordeaux, France, 33075 Institut Bergonie Bordeaux, France, 33076 Centre Hospitalier de Dax Dax, France, 40107 Hopital Robert Boulin Libourne, France, 33500 Polyclinique de Francheville Perigueux, France, 24004 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Academisch Ziekenhuis Groningen Groningen, Netherlands, 9700 RB University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Portugal Hospitais da Universidade de Coimbra (HUC) Coimbra, Portugal, 3001-301 Switzerland Hopitaux Universitaires de Geneve Thonex-Geneve, Switzerland, CH-1226 United Kingdom New Cross Hospital Wolverhampton, England, United Kingdom, WV10 0QP Dumfries Royal Infirmary Dumfries, United Kingdom, DG1 4AP Less <<
NCT01393366 Chronic Lymphocytic Leukemia Not Applicable Completed - France ... More >> Centre Hospitalier de la côte basque Bayonne, France, 64109 CH Saint Jean Perpignan, France, 66046 CHU Purpan Toulouse, France, 31059 Less <<
NCT02303821 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 1 Recruiting October 18, 2019 -
NCT00001335 Ewing's Sarcoma ... More >> Neuroblastoma Rhabdomyosarcoma Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00278486 Retinal Disease Phase 1 Terminated(First subject over ... More >>five years after the transplant. The second subject is not in compliance with follow ups. We do not plan to enroll more subjects.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00901615 Lymphoma, Large B-Cell, Diffus... More >>e Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Dijon Dijon, France, 21034 CHRU Lille Lille, France, 59037 CHU Lyon Sud Pierre Benite, France, 69310 Centre Henri Becquerel Rouen, France, 76038 CHU Brabois Vandoeuvre les Nancy, France, 54511 Less <<
NCT00006734 Sarcoma Phase 3 Completed - -
NCT01350258 Hematologic Malignancies ... More >> Acute Leukemia Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myeloma Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy Less << Phase 1 Phase 2 Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT01796197 Breast Cancer Phase 2 Active, not recruiting March 2020 United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02518750 Acute Lymphoblastic Leukemia ... More >> Lymphoma, Non-Hodgkin's Leukemia, T-Cell Leukemia, B-Cell Less << Phase 2 Terminated(Due to slow accrual... More >>) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00003953 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Metro Health Medical Center Cleveland, Ohio, United States, 44109 Less <<
NCT01350258 - Terminated(Poor accrual) - -
NCT03187210 Lymphoma Phase 1 Phase 2 Recruiting June 2022 Switzerland ... More >> Department for Medical Oncology University Hospital/Inselspital Recruiting Berne, Switzerland, 3010 Principal Investigator: Thomas Pabst, Prof Dr med Less <<
NCT00003185 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT02181101 Breast Neoplasms Phase 3 Completed - Germany ... More >> Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Campus Innenstadt Munich, Bavaria, Germany, 80337 Less <<
NCT01746173 T-cell Non-Hodgkin Lymphoma Phase 2 Terminated(Slow accrual and fu... More >>tility) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT03157037 Anti-Glomerular Basement Membr... More >>ane Disease Less << Phase 2 Recruiting March 1, 2019 Sweden ... More >> Department of Nephrology, University Hospital, Recruiting Linkoping, Sweden, SE-581 85 Contact: Anders Fernström, Ass. Prof MD    +46 10 103 86 47    anders.fernstrom@regionostergotland.se    Contact: Micael Gylling, RN    46 10 103 1805    micael.gylling@regionostergotland.se Less <<
NCT01746173 - Terminated(Slow accrual and fu... More >>tility) Less << - -
NCT00118209 Large B Cell Lymphoma Phase 3 Active, not recruiting - -
NCT00637819 Systemic Lupus Eythematosus (S... More >>LE) Less << Phase 2 Completed - Hong Kong ... More >> Sanofi-Aventis Hong Kong, Hong Kong Less <<
NCT00582725 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 2 Completed - United States, Wisconsin ... More >> University Of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT00278629 Chronic Inflammatory Demyelina... More >>ting Polyneuropathy Less << Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00530075 Wegener's Granulomatosis Phase 2 Completed - Czech Republic ... More >> General Faculty Hospital Prague, Czech Republic, 12808 Denmark Reumatologisk Klinik Copenhagen, Denmark, 2100 Germany Universitatsklinikum Schleswig-Holstein Luebeck, Germany, 23538 Netherlands University Hospital Maastricht Maastricht, Netherlands, 6202 Sweden Karolinska University Hospital Stockholm, Sweden, 14186 United Kingdom Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Addenbrookes Hospital Cambridge, United Kingdom, CB2 2QQ Less <<
NCT01325194 Primary Disease Phase 2 Active, not recruiting December 2017 Denmark ... More >> Department of Hematology, Århus University Hospital Århus, Denmark Finland Department of Oncology, Helsinki University Central Hospital Helsinki, Finland Norway Department of Oncology, Oslo University Hospital Oslo, Norway Sweden Department of Oncology, Lund University Hospital Lund, Sweden Less <<
NCT03293173 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 2 Recruiting June 2022 Denmark ... More >> Aarhus University Hospital Not yet recruiting Aarhus, Denmark Contact: Judit Joergensen, MD, PhD          Principal Investigator: Judit Joergensen          Finland Helsinki University Hospital Cancer Centre Recruiting Helsinki, Finland, 00029 Contact: Laura K Hakala    +358503729043    ext-laura.k.hakala@hus.fi    Principal Investigator: Sirpa Leppä, prof          Norway Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Harald Holte, MD, PhD          Principal Investigator: Harald Holte          Sweden Skåne University Hospital Not yet recruiting Lund, Sweden Contact: Kristina Drott, MD, PhD          Principal Investigator: Kristina Drott Less <<
NCT02188368 Multiple Myeloma Phase 2 Recruiting December 2018 United States, California ... More >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Alberto Bessudo, MD          Contact: Beth Kimball, RN    (760) 452-3909    BKimball@ccare.com    Compassionate Care Research Group Recruiting Fountain Valley, California, United States, 92708 Contact: Haresh Jhangiani, MD          Contact: Barbara Lepthien    (714) 698-0300    barbaral@compcareresearch.com    Comprehensive Cancer Center at Desert Regional Medical Center Completed Palm Springs, California, United States, 92262 Inland Hematology Oncology Medical Group, Inc Recruiting San Bernardino, California, United States, 92404 Contact: Samir Kubba, MD          Contact: Emmarin Saribut    (909) 886-6806    es.ihomg@gmail.com    Wellness Oncology and Hematology Recruiting West Hills, California, United States, 91307 Contact: Ashkan Lashkari, MD          Contact: Mary Mau    (818) 346-1773    mary@wellnessoncology.com    James R. Berenson, MD, Inc. Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, RN    310-623-1222    rswift@berensononcology.com    Contact: James R. Berenson, MD    310-623-1214    jberenenson@imbcr.org    Principal Investigator: James Berenson, MD          United States, Nevada VA Sierra Nevada Completed Reno, Nevada, United States, 89502 United States, New Mexico San Juan Oncology Associates Recruiting Farmington, New Mexico, United States, 87401 Contact: Jeffrey Neidhart, MD          Contact: Rosemarie Mestas    (505) 564-6874    rosemarie@sjonc.com    United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Nashat Gabrail, MD          Contact: Kirstie Armstrong    (330) 492-3345    karmstrong@gabrailcancercenter.com    United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Tennessee Wellmont Medical Associates Oncology and Hematology Recruiting Kingsport, Tennessee, United States, 37660 Contact: Ibrahim Nakhoul, MD          Contact: Justin Reynolds    (423) 578-8553    Justin.Reynolds@wellmont.org    United States, Washington Vista Oncology Completed Olympia, Washington, United States, 98502 Less <<
NCT00145626 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplasia Chronic Myeloid Leukemia Histiocytosis Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03571633 HER2-positive Breast Cancer ... More >> Operable Breast Cancer Less << Phase 2 Recruiting November 2021 France ... More >> Centre Leon Berard Recruiting Lyon, France Contact: Olivier TREDAN          Principal Investigator: Olivier TREDAN          Sub-Investigator: Thomas BACHELOT          Sub-Investigator: Olivia BALLY          Sub-Investigator: Alice BONNEVILLE-LEVARD          Sub-Investigator: Mehdi BRAHMI          Sub-Investigator: Olfa DERBEL MILED          Sub-Investigator: Armelle DUFRESNE          Sub-Investigator: Pierre-Etienne HEUDEL          Sub-Investigator: Isabelle RAY-COQUARD          Sub-Investigator: Pauline ROCHEFORT          Sub-Investigator: Philippe TOUSSAINT Less <<
NCT00145626 - Completed - -
NCT02603679 Early-Stage Breast Carcinoma ... More >> Estrogen Receptor Positive Tumor Less << Phase 2 Recruiting June 2024 Sweden ... More >> Theodoros Foukakis Recruiting Stockholm, Sweden, 17176 Contact: Ingrid Lundin, RN    +46 8 517 ext 72310    ingrid.lundin@karolinska.se Less <<
NCT01652092 SCID Omenn's ... More >>Syndrome Reticular Dysgenesis Wiskott-Aldrich Syndrome Bare Lymphocyte Syndrome Common Variable Immunodeficiency Chronic Granulomatous Disease CD40 Ligand Deficiency Hyper IgM Syndrome X-linked Lymphoproliferative Disease Hemophagocytic Lymphohistiocytosis Griscelli Syndrome Chediak-Higashi Syndrome Langerhan's Cell Histiocytosis Less << Not Applicable Recruiting December 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela R. Smith, M.D.    612-626-2778    smith719@umn.edu    Principal Investigator: Angela R. Smith, M.D. Less <<
NCT02849912 - Completed - France ... More >> CHU de Nice Nice, France, 06000 Less <<
NCT03300492 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Phase 2 Recruiting January 31, 2023 Switzerland ... More >> University Hospital Basel Recruiting Basel, Switzerland, 4031 Contact: Matyas Ecsedi, MD-PhD    +41612652525    matyas.ecsedi@usb.ch Less <<
NCT03750240 Breast Cancer ... More >> Triple Negative Breast Cancer Less << Not Applicable Recruiting June 2019 United States, New York ... More >> NYU Langone Health Recruiting New York, New York, United States, 10016 Contact: Terlinka Sood    212-263-3343    terlika.sood@nyumc.org    Principal Investigator: Guillaume Sood, MD Less <<
NCT02861859 Breast Cancer Phase 3 Recruiting December 2020 Canada, Ontario ... More >> The Ottawa Hospital Research Institute Cance Center Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Mark J Clemons, MD Less <<
NCT00530075 - Completed - -
NCT02840890 Breast Cancer Not Applicable Recruiting June 2019 France ... More >> CGFL Recruiting Dijon, France, 21079 Contact: Emilie REDERSTORFF, PhD    +33 (0)3 80 73 75 00 ext 34 61    ERederstorff@cgfl.fr Less <<
NCT00005090 Lymphoma Phase 3 Terminated(poor accrual) - -
NCT01105650 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Breast Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01105650 - Completed - -
NCT03620903 Waldenstrom Macroglobulinemia Phase 2 Not yet recruiting November 2024 -
NCT02126046 Thalassemia Major Not Applicable Unknown March 2016 China, Guangdong ... More >> Department of paediatrics，Nangfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Chunfu Li, professor    +86 20-61641921    chunfugzcn@126.com Less <<
NCT02617485 Diffuse Large B-Cell Lymphoma Phase 3 Unknown June 2017 Bosnia and Herzegovina ... More >> University Clinical Center Banja Luka Recruiting Banja Luka, Bosnia and Herzegovina, 78 000 University Clinical Center Sarajevo Recruiting Sarajevo, Bosnia and Herzegovina, 71 000 University Clinical Center Tuzla Recruiting Tuzla, Bosnia and Herzegovina, 75 000 General Hospital Zenica Recruiting Zenica, Bosnia and Herzegovina, 72 000 Croatia GH "dr.Josip Bencevic" Recruiting Slavonski Brod, Croatia, 35000 CH Merkur Recruiting Zagreb, Croatia, 10000 CHC Zagreb Recruiting Zagreb, Croatia, 10000 Georgia S. Khechinashvili state University clinic Recruiting Tbilisi, Georgia, 0179 HEMA Recruiting Tibilisi, Georgia, 0112 Medulla - Chemotherapy and Immunotherapy Clinic Recruiting Tibilisi, Georgia, 0186 Moldova, Republic of Institut of Oncology, Hematology Department Recruiting Chisinau, Moldova, Republic of, 2025 Poland Wojewódzki Szpital Specjalistyczny w Legnicy, Oddział Hematologiczny Recruiting Legnica, Poland, 59-220 Samodzielny Publiczny Szpital Kliniczny nr1, Klinika Hematologii i Transplantacji Szpiku Recruiting Lublin, Poland, 20-081 Szpital Wojewódzki w Opolu, Oddział Hematologii i Onkologii Hematologicznej Recruiting Opole, Poland, 45-061 Contact    +48 774433678       MTZ Clinical Research Sp. Z o.o. Recruiting Warsaw, Poland, 02-106 Serbia Clinical Hospital Center Zemun Recruiting Belgrade, Serbia, 11000 Clinical Hospital Center Zvezdara Recruiting Belgrade, Serbia, 11000 Military Hospital Academy Recruiting Belgrade, Serbia, 11000 Ukraine Public utility "Chernivtsi regional clinical oncology dispensary", Day patient department Recruiting Chernivtsi, Ukraine, 58013 Municipal Institution "Dnipropetrovsk City multi-field Clinical Hospital #4", Oncology and medical radiology department Recruiting Dnipropetrovsk, Ukraine, 49102 Regional Clinical Hospital of Ivano-Frankivsk, Hematology Department. Recruiting Ivano-Frankivsk, Ukraine, 76008 Regional Clinical Oncology Dispensary, Chemotherapy Department Recruiting Ivano-Frankivsk, Ukraine, 76018 Kharkiv Regional Clinical Oncology Centre, Deartment of haematology Recruiting Kharkiv, Ukraine, 61070 Contact: N          National Institute of Cancer, Department of chemotherapy Recruiting Kiev, Ukraine, 03022 Kiev City Clinical Oncological Center, Department of chemotherapy #2 Recruiting Kiev, Ukraine, 03115 Utility Enterprise "Kirovograd regional oncology dispensary" Recruiting Kirovograd, Ukraine, 25011 Kryvyi Rih Oncology Dispensary, Dnipropetrovsk Highway Recruiting Krivoy Rog, Ukraine, 50048 Volyn' Regional clinical hospital, Haematology Department Recruiting Lutsk, Ukraine, 45634 State institution "Institute for haemotopathology and haemotransfusion of National Academy of science of Ukraine Recruiting Lviv, Ukraine, 79044 Mykolayiv Region Clinical Hospital, Heamotology department Recruiting Mykolayiv, Ukraine, 54058 Poltava regional oncology hospital, heamotherapy department Recruiting Poltava, Ukraine, 36011 Regional clinical Hospital named after Novak, Hematology Department Recruiting Uzhgorod, Ukraine, 88000 Vinnitsya Regional Clinical Oncology Dispensary, Chemotherapy Department, Recruiting Vinnitsya, Ukraine, 21029 Regional Oncology dispensary Recruiting Zaporizhzhia, Ukraine, 69040 Zaporizhzhya Regional Clinical Hospital, Deartment of haematology and intensive therapy Recruiting Zaporizhzhia, Ukraine, 69600 Less <<
NCT00907348 Non Hodgkin Lymphoma ... More >> Follicular Lymphoma Less << Phase 2 Unknown January 2012 Italy ... More >> Divisione di Ematologia Osp. SS. Antonio e Biagio Alessandria, Italy Divisione di Oncologia Medica A Centro di Riferimento Oncologico Aviano, Italy Cattedra di Ematologia Università Policlinico Bari, Italy IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy Istituto di Ematologia "Seragnoli" Polic.S.Orsola-Malpighi Bologna, Italy, 40138 Divisione di Ematologia Spedali Civili Brescia, Italy Divisione di Ematologia Osp. Businco Cagliari, Italy Onco-Ematologia I.R.C.C. Candiolo (TO), Italy Ematologia 1 Ospedale S. Martino Genova, Italy, 16132 Divisione di Ematologia Ospedale Niguarda Milano, Italy UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy Divisione di Ematologia Università Avogadro Novara, Italy UO Ematologia Università - Policlinico San Matteo Pavia, Italy Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I - La Sapienza Roma, Italy Oncoematologia - Univ. Perugia Sede Terni, Terni, Italy, 05100 S.C.Ematologia 1 AOU San Giovanni Battista Torino, Italy, 10126 SC Ematologia 2 ASO San Giovanni Battista Torino, Italy UO Ematologia Osp. Cardinale Panico Tricase (LE), Italy Less <<
NCT02028650 - Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences Beijing, Beijing, China, 100071 Less <<
NCT00949013 - Completed - -
NCT00149136 Acute Lymphocytic Leukemia Phase 2 Unknown - France ... More >> Xavier THOMAS Lyon, France, 69437 Less <<
NCT00615602 Breast Cancer Phase 3 Completed - Greece ... More >> University Hospital of Crete Heraklion, Crete, Greece, 71110 University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupolis, Greece "IASO" General Hospital of Athens, 1st Dep of Medical Oncology Athens, Greece "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece "Marika Iliadis" Hospital of Athens, Dep of Medical Oncology Athens, Greece 401 Military Hospital of Athens Athens, Greece Air Forces Military Hospital of Athens Athens, Greece State General Hospital of Larissa, Dep of Medical Oncology Larissa, Greece "Metaxa's" Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology Piraeus, Greece "Theagenion" Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology Thessaloniki, Greece Less <<
NCT01810926 Graft Versus Host Disease Phase 2 Unknown October 2016 Italy ... More >> University of Cagliari Active, not recruiting Cagliari, Italy, 09126 San Raffaele Scientific Institute Active, not recruiting Milano, Italy, 20132 University of Milano-Bicocca San Gerardo Hospital Active, not recruiting Monza, Italy, 20052 Bambino Gesù Hospital and Research Institute Recruiting Rome, Italy, 00165 Contact: Maria Ester Bernardo, MD       mebernardo@gmail.com    Principal Investigator: Franco Locatelli Less <<
NCT01299922 Lupus Nephritis Phase 3 Withdrawn(IT was impossible to... More >> find patients) Less << October 2014 Spain ... More >> Hospital Universitario Fundación Alcorcón Alcorcon, Madrid, Spain, 28922 Less <<
NCT00002548 Multiple Myeloma Phase 3 Completed - -
NCT00002967 Breast Cancer Phase 3 Completed - -
NCT00089479 Breast Cancer Phase 3 Completed - United States, Texas ... More >> Houston, Texas, United States, 77060 Less <<
NCT00089479 - Completed - -
NCT01121029 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Mexico ... More >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT00002529 Breast Cancer Phase 3 Completed - Australia, New South Wales ... More >> Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, NSW 2310 Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Anti-Cancer Council of Victoria, Melbourne Carlton South, Victoria, Australia, 3053 Australia, Western Australia Sir Charles Gairdner Hospital, Perth Perth, Western Australia, Australia, 6009 Italy Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Universita di Brescia Brescia, Italy, 25124 Istituto Europeo Di Oncologia Milano, Italy, 20141 Ospedale Civile Rimini Rimini, Italy, 47037 Ospedale San Eugenio Rome, Italy, 00144 New Zealand Auckland Adventist Hospital Auckland, New Zealand, 5 Slovenia Institute of Oncology, Ljubljana Ljubljana, Slovenia, Sl-1000 South Africa Groote Schuur Hospital, Cape Town Cape Town, South Africa, 7925 Sweden Sahlgrenska University Hospital Gothenburg (Goteborg), Sweden, S-413 45 Switzerland University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Hopital des Cadolles, Neuchatel Neuchatel, Switzerland, 2000 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Universitaetsspital Zurich, Switzerland, CH-8091 Less <<
NCT03616782 Mantle Cell Lymphoma Phase 2 Not yet recruiting December 31, 2022 Korea, Republic of ... More >> Kosin University Gospel Hospital Not yet recruiting Busan, Western, Korea, Republic of, 49267 Contact: Ho Sup Lee, MI    82-51-990-6363    hs3667@hanmail.net Less <<
NCT01499147 Acute Myeloid Leukemia ... More >> Acute Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Multiple Myeloma Lymphocytic Leukemia Myeloproliferative Disorder Polycythemia Vera Myelofibrosis Aplastic Anemia Less << Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT01499147 - Completed - -
NCT02220985 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Donor Lymphoblastic Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Recruiting - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Alison Sehgal    412-864-7764    sehgalar@upmc.edu    Principal Investigator: Alison Sehgal          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley    206-667-6572    mbleakle@fredhutch.org    Principal Investigator: Marie Bleakley Less <<
NCT03349502 Acute Myeloid Leukemia Phase 2 Recruiting January 1, 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Sang-A Kim, MD    +82 10 3026 0621    sanga0906@naver.com    Principal Investigator: Youngil Koh, MD          Sub-Investigator: Sung soo Yoon, MD, PhD          Sub-Investigator: In ho Kim, MD          Sub-Investigator: Dong-Yeop Shin, MD Less <<
NCT00723658 Lymphoma Phase 2 Withdrawn(lack of accrual) - United States, Connecticut ... More >> Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services Richmond, Indiana, United States, 47374 United States, Kansas Lawrence Memorial Hospital Lawrence, Kansas, United States, 66044 Wesley Medical Center Wichita, Kansas, United States, 67214 United States, Michigan Saint Joseph Mercy Cancer Center Ann Arbor, Michigan, United States, 48106-0995 CCOP - Michigan Cancer Research Consortium Ann Arbor, Michigan, United States, 48106 Oakwood Cancer Center at Oakwood Hospital and Medical Center Dearborn, Michigan, United States, 48123-2500 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Genesys Hurley Cancer Institute Flint, Michigan, United States, 48503 Hurley Medical Center Flint, Michigan, United States, 48503 Van Elslander Cancer Center at St. John Hospital and Medical Center Grosse Pointe Woods, Michigan, United States, 48236 Foote Memorial Hospital Jackson, Michigan, United States, 49201 Sparrow Regional Cancer Center Lansing, Michigan, United States, 48912-1811 St. Mary Mercy Hospital Livonia, Michigan, United States, 48154 St. Joseph Mercy Oakland Pontiac, Michigan, United States, 48341-2985 Mercy Regional Cancer Center at Mercy Hospital Port Huron, Michigan, United States, 48060 Seton Cancer Institute at Saint Mary's - Saginaw Saginaw, Michigan, United States, 48601 St. John Macomb Hospital Warren, Michigan, United States, 48093 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 CCOP - Dayton Dayton, Ohio, United States, 45420 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Middletown Regional Hospital Franklin, Ohio, United States, 45005-1066 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 Clinton Memorial Hospital Wilmington, Ohio, United States, 45177 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT02283983 Breast Neoplasms Not Applicable Recruiting May 2020 France ... More >> Institut de cancérologie de l'Ouest - Angers Recruiting Angers, France, 49933 Principal Investigator: Sophie ABADIE LACOURTOISIE, PH          Centre Hospitalier de Cholet Recruiting Cholet, France, 49300 Principal Investigator: Alain ZANNETI, PH          CHD Vendee Recruiting La Roche sur Yon, France, 85925 Principal Investigator: Frank PRIOU, PH          CH du Mans Recruiting Le Mans, France, 72000 Principal Investigator: Oana COJOCARASU, PH          Centre hospitalier Bretagne Sud Recruiting Lorient, France, 56100 Principal Investigator: Régine LAMY, PH          Centre Catherine de Sienne Recruiting Nantes, France, 44202 Principal Investigator: Claude EL KOURI, PH          Institut de cancérologie de l'Ouest - Nantes Recruiting Saint-Herblain, France, 44805 Principal Investigator: Emmanuelle BOURBOULOUX, PH          Clinique Mutualiste de l'Estuaire Recruiting Saint-Nazaire, France, 44606 Principal Investigator: Valérie DELECROIX, PH          Centre d'Oncologie Saint-Yves Suspended Vannes, France, 56000 CHBA Vannes Suspended Vannes, France, 56000 Less <<
NCT03249870 Acute Lymphoblastic Leukemia (... More >>ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP) Less << Phase 2 Recruiting October 2021 France ... More >> CH Amiens sud Recruiting Amiens, France Contact: Grusson          CHU Angers Recruiting Angers, France Contact: Hunault          CHU Besançon Recruiting Besançon, France Contact: Berceanu          Hopital Avicenne Recruiting Bobigny, France Contact: Braun          Hopital Duchenne Recruiting Boulogne-sur-Mer, France Contact: Choufi          CHU Caen Recruiting Caen, France Contact: Chantepie          CH metropole Savois_ chambery Recruiting Chambéry, France Contact: Sutton          HIA Percy Recruiting Clamart, France Contact: Konopacki          CHU Clermond Ferrand Recruiting Clermont-Ferrand, France Contact: Cacheux          Hopital Mondor Recruiting Créteil, France Contact: Maury          Hopital Dijon Recruiting Dijon, France Contact: Caillot          CHU Grenoble Recruiting Grenoble, France Contact: Thiebaut          CH Versailles Recruiting Le Chesnay, France Contact: Rousselot          CHU Limoges Recruiting Limoges, France Contact: Turlure          Centre Leon Berard Recruiting Lyon, France Contact: Gilis          IPC Recruiting Marseille, France Contact: Vey          CH Meaux Recruiting Meaux, France Contact: Frayfer          CH Montpellier Recruiting Montpellier, France Contact: Hicheri          CHU Nantes Recruiting Nantes, France Contact: Chevallier          Centre Lacassagne Recruiting Nice, France Contact: Gastaud          CHU Nice Recruiting Nice, France Contact: Cluzeau          CHR Orléans Recruiting Orléans, France Contact: Alexis          Hopital Necker Recruiting Paris, France Contact: Marcais          Hopital St Antoine Recruiting Paris, France Contact: Isnard          Hopital St Louis Recruiting Paris, France Contact: Dombret          CHU Haut Leveque Recruiting Pessac, France Contact: Leguay          CH Lyon Sud Recruiting Pierre-Bénite, France Contact: Thomas          CH Reims Recruiting Reims, France Contact: Himberlin          CH Roubaix Recruiting Roubaix, France Contact: Plantier          Centre H Becquerel Rouen Recruiting Rouen, France Contact: Lepretre          Institut de cancerologie Recruiting Saint-Priest-en-Jarez, France Contact: Tavernier          CHU Strasbourg Recruiting Strasbourg, France Contact: Bilger          IUCT Oncopole Recruiting Toulouse, France Contact: Huguet          CH Valenciennes Recruiting Valenciennes, France Contact: Fernandes          CHRU Nancy Recruiting Vandœuvre-lès-Nancy, France Contact: Roth Guepin Less <<
NCT01872416 Small Cell Lung Cancer Phase 2 Unknown May 2015 China, Guangdong ... More >> he First Affiliated Hospital of Guangzhou Medical College Recruiting Guangzhou, Guangdong, China, 510120 Contact: Jianxing He, MD    +86-20-83062808    hejx@vip.163.com    Contact: Yalei Zhang, Master    +86-20-83062821    yayazhang2004@163.com Less <<
NCT01432873 Mucositis Hem... More >>atopoietic Stem Cell Transplantation Less << Phase 1 Phase 2 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of Contact: Molouk Hadjibabaie, Pharma D.    +989122838464       Principal Investigator: Molouk Hadjibabaie, Pharma D          Sub-Investigator: Zahra Jahangard rafsanjani, Pharma D Less <<
NCT01016795 Malignant Lymphoma Phase 2 Terminated(Study closed Nov 20... More >>00 by Amgen, who stopped drug delivery) Less << - Denmark ... More >> Aalborg Hospital Aalborg, Denmark, 9000 Rigshospitalet Copenhagen, Denmark, 2100 Herlev University Hospital Copenhagen, Denmark Finland University Hospital Helsinki Helsinki, Finland University Hospital Turku Turku, Finland Norway Radiumhospitalet Oslo, Norway Sweden University Hospital Linköping Linköping, Sweden University Hospital Umeå Umeå, Sweden Less <<
NCT00235235 - Terminated(Funding terminated) - United States, Indiana ... More >> Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Center for Cancer Care at Goshen Health System Goshen, Indiana, United States, 46527 Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Mary Lou Mayer, M.D. Indianapolis, Indiana, United States, 46227 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 United States, Texas Baylor College of Medicine - Methodist Breast Center Houston, Texas, United States, 77030 Peru Instituto de Enfermedades Neoplasticas (INEN) Lima, Peru Less <<
NCT03381417 Breast Cancer Female Phase 3 Completed - Vietnam ... More >> Vietnam National Cancer Institute (Hospital K) Hanoi, Vietnam Less <<
NCT01061359 - Completed - -
NCT00567567 - Completed - -
NCT00126191 - Terminated(closed due to slow ... More >>accrual) Less << - -
NCT00567567 Localized Resectable Neuroblas... More >>toma Localized Unresectable Neuroblastoma Recurrent Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Stage 4S Neuroblastoma Less << Phase 3 Completed - -
NCT01061359 - Completed - -
NCT03145727 Breast Cancer Female ... More >> Acupuncture Less << Not Applicable Recruiting October 30, 2018 Brazil ... More >> Fabrício Edler Macagnan Recruiting Porto Alegre, Rio Grande do Sul, Brazil, 90050-170 Contact: Fabrício Macagnan, PhD    +55 (51) 3309.8876    fabriciom@ufcspa.edu.br    Comitê de Ética em Pesquisa - Santa Casa de Misericórdia de Porto Alegre Recruiting Porto Alegre, Rio Grande do Sul, Brazil Contact: Elizete Keitel, Dr    +55 (51) 3214.8571    cep@santacasa.tche.br Less <<
NCT00126191 Burkitt Lymphoma ... More >> Non-Hodgkins Lymphoma Atypical Burkitt Lymphoma Less << Phase 2 Terminated(closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00248547 Cancer Not Applicable Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT03219359 Crohn Disease Phase 2 Recruiting January 1, 2020 United States, New York ... More >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Mauricio Arcila-Mesa, MD    212-241-8233    crohnstransplant@mssm.edu    Principal Investigator: Amir Steinberg, MD          Principal Investigator: Louis Cohen, MD Less <<
NCT00187070 Lymphoma, Large Cell ... More >> Lymphoma, Non-Hodgkin Less << Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Reaearch Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00636909 AML ALL ... More >> CML Chronic Phase, Accelerated Phase, or Blast Crisis CLL MDS RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA APLASTIC ANEMIA MULTIPLE MYELOMA MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) Less << Phase 2 Completed - -
NCT03376503 Breast Cancer Phase 1 Completed - Vietnam ... More >> Vietnam National Cancer Institute (Hospital K) Hanoi, Vietnam Less <<
NCT01015183 Mucositis Bon... More >>e Marrow Transplantation Less << Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT00392834 - Completed - -
NCT00248547 - Completed - -
NCT03016806 Acute Leukemia ... More >> Immune Deficiency Disorder Congenital Hematological Disorder Metabolism Disorder Aplastic Anemia Myelodysplastic Syndromes Chronic Leukemia Lymphoma Multiple Myeloma Solid Tumor Less << Phase 1 Recruiting June 2026 United States, New York ... More >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jane L Liesveld, MD    585-275-4099    jane_liesveld@urmc.rochester.edu    Contact: Michael W Becker, MD    585-275-4099    michael_becker@urmc.rochester.edu Less <<
NCT03319901 Leukemia Phase 1 Recruiting April 30, 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Daniel DeAngelo, MD, PhD    617-632-2645    Daniel_DeAngelo@DFCI.Harvard.Edu    Principal Investigator: Daniel DeAngelo, MD, PhD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Nitin Jain, MD    713-745-6080    njain@mdanderson.org    Principal Investigator: Nitin Jain, MD Less <<
NCT00392834 Lymphoma Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States, 90095-1793 UCSF Medical Center at Parnassus San Francisco, California, United States, 94143-0296 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Pennsylvania Oncology Hematology Associates, Incorporated - Philadelphia Philadelphia, Pennsylvania, United States, 19106 United States, Washington Floyd and Delores Jones Cancer Institute at Virginia Mason Medical Center Seattle, Washington, United States, 98101 United States, West Virginia West Virginia University Health Sciences Center - Charleston Charleston, West Virginia, United States, 25304 Less <<
NCT00002610 Kidney Cancer Phase 3 Completed - -
NCT01174121 Metastatic Colorectal Cancer ... More >> Metastatic Gastric Cancer Metastatic Pancreatic Cancer Metastatic Hepatocellular Carcinoma Progressive Glioblastoma Metastatic Ovarian Cancer Metastatic Breast Cancer Less << Phase 2 Recruiting December 27, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00586547 Leukemia Canc... More >>er Less << Phase 1 Completed - United States, Texas ... More >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT03286634 Down Syndrome ... More >> Acute Lymphoblastic Leukemia Childhood Cancer Less << Phase 2 Recruiting March 31, 2033 Hong Kong ... More >> Prince of Wales Hospital Recruiting Shatin, New Territories, Hong Kong Contact: Chi Kong Li, MBBS       ckli@cuhk.edu.hk    Japan Kagoshima University Hospital Recruiting Kagoshima, Japan, 890-8544 Contact: Yasuhiro Okamoto       okamoto@m2.kufm.kagoshima-u.ac.jp    Malaysia University of Malaya Medical Centre Not yet recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS       hany@ummc.edu.my    Subang Jaya Medical Centre Not yet recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Sub-Investigator: Lee Lee Chan, MBBS          Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS       allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS       tan.ah.moy01@singhealth.com.sg    Taiwan National Taiwan University Children's Hospital Not yet recruiting Taipei, Taiwan, 100 Contact: Tsamn Lin Dong, MD       dtlin@ntuh.gov.tw    Mackay Memorial Hospital Not yet recruiting Taipei, Taiwan, 10449 Contact: Hsi-Che Liu, MD       hsiche@mmh.org.tw    Chang Gung Memorial Hopsital, Linkou Not yet recruiting Taoyuan, Taiwan, 333 Contact: Shih-Hsiang Chen, MD       samechen@cgmh.org.tw Less <<
NCT02390648 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Phase 2 Completed - Thailand ... More >> Siriraj Hospital Bangkok, Thailand, 10700 Less <<
NCT01690520 Acute Biphenotypic Leukemia ... More >> Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Stanford Cancer Institute Palo Alto Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03263026 Diffuse Large B-Cell Lymphoma Phase 3 Recruiting September 2021 -
NCT03054883 - Completed - -
NCT03730298 Cancer Related Fatigue ... More >> Breast Cancer Female Less << Not Applicable Not yet recruiting August 2020 Italy ... More >> Oncology Department, Perugia Hospital Active, not recruiting Perugia, Italy, 06100 Less <<
NCT00186888 Retinoblastoma ... More >> Retinal Neoplasm Less << Phase 3 Active, not recruiting September 2021 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00200681 Multiple Myeloma Phase 3 Completed - France ... More >> CHU de Nantes, Service d'Hématologie Nantes, France, 44093 Less <<
NCT03361748 Multiple Myeloma Phase 2 Active, not recruiting November 1, 2023 United States, California ... More >> University of California - San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Belgium Universitaire Ziekenhuizen Leuven Leuven, Flemish Brabant, Belgium, 3000 Canada Princess Margaret Cancer Centre Toronto, Canada, M5G 2M9 France Centre Hospitalier Regional Universitaire de Lille-Hopital Calude Huriez Service des Maladies du Sang Lille, Hauts-de-France, France, 59037 Centre Hospitalier Universitaire de Nantes - Hotel Dieu Nantes, Pays De La Loire, France, 44093 Germany Universitatsklinikum Heidelberg Medizinische Klinik Krehl-Klinik Haematologie, Onkologie, Rheumato Heidelberg, Baden-Württemberg, Germany, 69120 University of Tübingen Tübingen, Baden-Württemberg, Germany, 72076 Universitatsklinikum Würzburg Würzburg, Bavaria, Germany, 97080 Italy Azienda Ospedaliero Universitaria Di Bologna Policlinico Bologna, Emilia-Romagna, Italy, 40138 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Spain Hospital Universitari Germans Trias i Pujol Can Ruti Badalona, Barcelona, Spain, 08916 Clinica Universidad de Navarra Pamplona, Navarre, Spain, 31008 Less <<
NCT00186888 - Active, not recruiting - -
NCT00970385 Peripheral T Cell Lymphoma Phase 3 Completed - France ... More >> Dr REMY GRESSIN Grenoble, France, 38043 Less <<
NCT02061800 Chronic Myeloid Leukemia (CML)... More >> Acute Myelogenous Leukemia (AML) Myelodysplastic Syndrome (MDS) Juvenile Myelomonocytic Leukemia (JMML) Acute Lymphoblastic Leukemia (ALL) Lymphoma (Hodgkin's and Non-Hodgkin's) Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN    212-305-2050       Principal Investigator: Diane George, MD Less <<
NCT01341262 Multiple Myeloma Phase 2 Completed - -
NCT00001337 Diffuse Large B-Cell Lymphoma ... More >>(DLBCL) Primary Mediastinal Large B-cell Lymphoma Burkitt Lymphoma Anaplastic Large-Cell Lymphoma Gray Zone Lymphoma Less << Phase 2 Recruiting March 31, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00003638 Breast Cancer Phase 3 Completed - Canada, Alberta ... More >> Biomira Inc. Edmonton, Alberta, Canada, AB T6N 1H1 Less <<
NCT01021800 Pancreatic Tubular Adenocarcin... More >>oma Less << Phase 2 Unknown December 2012 Slovenia ... More >> University Medical Centre Ljubljana, Department for Gastroenterolgy Recruiting Ljubljana, Slovenia, 1000 Contact: Borut Stabuc, MD, PhD    +38615222210    borut.stabuc@kclj.si    Contact: Lojze Smid, MD       lojze.smid.jr@mf.uni-lj.si    Principal Investigator: Borut Stabuc, MD, PhD Less <<
NCT00003311 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT01420679 Peripheral T-cell Lymphoma Phase 3 Terminated - -
NCT00002477 Ovarian Cancer Phase 3 Unknown - United Kingdom ... More >> Cochrane Cancer Network Oxford, England, United Kingdom, OX3 7LF Less <<
NCT03406091 - Recruiting January 31, 2022 Italy ... More >> A.O.U. Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD    +390116334263    mario.boccadoro@unito.it    Contact: FO.NE.SA. Onlus    +390116336107    clinicaltrialoffice@fonesa.it Less <<
NCT00206466 Breast Cancer Phase 2 Completed - United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less <<
NCT00281879 - Terminated - -
NCT00006390 Leukemia Phase 2 Completed - United States, Illinois ... More >> Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States, 60611-4494 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Pennsylvania CCOP - Geisinger Clinic and Medical Center Danville, Pennsylvania, United States, 17822-2001 Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15236 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-0001 CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Less <<
NCT00425516 Individualized Chemotherapy Phase 2 Completed - France ... More >> Hospital center Brive La Gaillarde, France, 19100 Centre Jean Perrin Clermont Ferrand, France, 63011 University Hospital La Tronche Grenoble, France, 38043 Edouard Herriot University Hospital Lyon, France, 69000 Institut Jean Godinot Reims, France, 51056 Institut de Cancérologie de la Loire Saint Priest en Jarez, France, 42270 Less <<
NCT02383212 Advanced Cancer ... More >> Advanced Malignancies Less << Phase 1 Active, not recruiting December 20, 2019 -
NCT02159716 Metastatic Pancreatic (Ductal)... More >> Adenocarcinoma Epithelial Ovarian Cancer Malignant Epithelial Pleural Mesothelioma Less << Phase 1 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00281879 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood Less << Phase 2 Terminated - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00930605 Peripheral T-cell Lymphoma Phase 2 Completed - Thailand ... More >> King Chulalongkorn Memorial Hospital Bangkok, Thailand Less <<
NCT02278887 Metastatic Melanoma Phase 3 Recruiting September 2020 Denmark ... More >> CCIT Department of Oncology and Haematology Herlev Hospital Recruiting Copenhagen, Denmark Contact: Inge Marie Svane, Prof.       Inge.Marie.Svane@regionh.dk    Contact: Troels H. Borch       troels.holz.borch@regionh.dk    Principal Investigator: Inge Marie Svane, Prof.          Netherlands Netherlands Cancer Institute Recruiting Amsterdam, NH, Netherlands, 1066CX Contact: Maartje Rohaan    +31205126186    m.rohaan@nki.nl    Principal Investigator: John B.A.G. Haanen, Prof. Less <<
NCT02176967 Ganglioneuroblastoma ... More >> Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4 Neuroblastoma Less << Phase 3 Recruiting - -
NCT00085098 Brain Tumor C... More >>entral Nervous System Tumor Less << Phase 3 Completed - -
NCT00662948 Lymphoma Phase 2 Suspended(No inclusion) - Spain ... More >> Hospital de Alcorcón Alcorcón, Spain Hospital germans Trias i Pujol Badalona, Spain Hospital Clínic Barcelona, Spain Hospital de la santa Creu i Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Juan Canalejo La Coruña, Spain Hospital Clinico San Carlos Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital La Paz Madrid, Spain Hospital Ramón y Cajal Madrid, Spain MD Anderson Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital son Dureta Palma de Mallorca, Spain Hospital Clínico Salamanca, Spain Hospital de Donostia San Sebastián, Spain Hoaspital Marqués de Valdecilla Santander, Spain Hospital Clínico Universitario Santiago de Compostela, Spain Hospital General V Alencia, Spain Hospital Clínico Valencia, Spain Hospital Dr Pesset Valencia, Spain Hospital La Fe Valencia, Spain Less <<
NCT01779531 - Unknown June 2015 China, Guangdong ... More >> Guangdong Academy of Medical Sciences Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Wen Ling Zhu    13763316144    dearecho@msn.com Less <<
NCT02142049 Diffuse Large B Cell Lymphoma ... More >>Relapsed Diffuse Large B Cell Lymphoma Refractory Less << Phase 1 Phase 2 Unknown November 2017 United States, California ... More >> SITE-1 Duarte, California, United States, 91010 SITE-2 Los Angeles, California, United States, 90095 SITE-10 Orange, California, United States, 92868 United States, Illinois SITE-3 Chicago, Illinois, United States, 60612 United States, Maryland SITE-5 Baltimore, Maryland, United States, 21201 SITE-6 Bethesda, Maryland, United States, 20892 United States, Michigan SITE-4 Ann Arbor, Michigan, United States, 48109 United States, New Mexico SITE-8 Albuquerque, New Mexico, United States, 87106 United States, New York SITE-9 Stony Brook, New York, United States, 11794 United States, South Carolina SITE-7 Charleston, South Carolina, United States, 29425 Less <<
NCT00243165 Breast Cancer Phase 2 Unknown - -
NCT00666484 Lymphoma Neur... More >>otoxicity Less << Phase 2 Completed - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF University College Hospital - London London, England, United Kingdom, NW1 2PG King's College Hospital London, England, United Kingdom, SE5 9RS Northern Centre for Cancer Treatment at Newcastle General Hospital Newcastle-Upon-Tyne, England, United Kingdom, NE4 6BE Mount Vernon Cancer Centre at Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Less <<
NCT03152526 Acute Myelogenous Leukemia Not Applicable Recruiting June 2022 United States, Illinois ... More >> Universtiy of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Preeti Karmali    773-702-9440    pkarmali@medicine.bsd.uchicago.edu    Principal Investigator: Satyajit Kosuri, MD          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Erica Orcholski    612-626-5174    eorchols@umn.edu    Principal Investigator: Sarah Cooley, MD Less <<
NCT00004230 Cancer Phase 3 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03407144 Hodgkin Lymphoma Phase 2 Recruiting November 24, 2023 United States, Michigan ... More >> Karmanos Cancer Institute ( Site 0002) Recruiting Detroit, Michigan, United States, 48201 Contact: Study Coordinator    313-576-8673       United States, South Carolina St. Francis Hospital Cancer Center ( Site 0001) Recruiting Greenville, South Carolina, United States, 29607 Contact: Study Coordinator    864-603-6213       Korea, Republic of Severance Hospital Yonsei University Health System ( Site 0221) Recruiting Seoul, Korea, Republic of, 03722 Contact: Study Coordinator    +82222274726       Samsung Medical Center ( Site 0222) Recruiting Seoul, Korea, Republic of, 06351 Contact: Study Coordinator    +82234103524 Less <<
NCT00085098 - Completed - -
NCT01132014 Chemotherapy ... More >>Tumor Ovarian Cancer Less << Early Phase 1 Completed - United States, Pennsylvania ... More >> Ovarian Cancer Research Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02158702 Multiple Myeloma ... More >> Relapse After Use of Lenalidomide and Bortezomib Less << Phase 2 Active, not recruiting November 2018 Singapore ... More >> National University Hospital Singapore, Singapore, 119074 Singapore General Hospital Singapore, Singapore Less <<
NCT00323323 Non-Hodgkin's Lymphoma Phase 1 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00478244 - Terminated(Competing studies) - -
NCT00331097 Breast Cancer Phase 3 Completed - Italy ... More >> Azienda Sanitaria S. Giuseppe Moscati Monteforte Irpino, AV, Italy Azienda Ospedaliera G. Rummo Benevento, BN, Italy Policlinico Monteluce Sant'Andrea delle Frate, PG, Italy Azienda Ospedaliera Cardarelli Napoli, Italy, 80131 Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C Napoli, Italy, 80131 Università Federico II, Cattedra di Oncologia Medica Napoli, Italy Az. Osp. Treviglio - Caravaggio Treviglio, Italy Ospedale S. Luca ASL SA 3 Vallo della Lucania, Italy Less <<
NCT00002803 Neuroblastoma Phase 2 Completed - Germany ... More >> University of Cologne Frechen, Germany, DOH-5-0226 Less <<
NCT00478244 Epidermolysis Bullosa Not Applicable Terminated(Competing studies) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02660281 Hematological Disease ... More >> Immune Deficiencies Solid Tumors Myelofibrosis Multiple Myeloma Lymphoma Less << Phase 1 Recruiting October 2026 United States, New York ... More >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jeffrey Andolina, MD    585-275-2981    jeffrey_andolina@urmc.rochester.edu    Contact: Jessica Mavor    585-275-9680    jessica_mavor@urmc.rochester.edu Less <<
NCT00278655 - Terminated - -
NCT00933517 Pathological Response Rate Phase 2 Completed - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Pole Santé République Clermont-Ferrand, France, 63100 Centre Georges François Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 CHU Dupuytren Limoges, France, 87042 Centre Léon Bérard Lyon, France, 69373 Centre Hospitalier Montluçon, France, 03113 Hôpital Tenon Paris, France, 75970 Institut Jean Godinot Reims, France, 51056 Institut de Cancérologie de la Loire Saint Priest en Jarez, France, 42270 Centre Paul Strauss Strasbourg, France, 67065 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less <<
NCT02918747 Lymphoma Phase 3 Recruiting December 2021 China, Hunan ... More >> Hunan Cancer Hospital Recruiting Changsha, Hunan, China, 4100013 Contact: Pingyong Yi, MD.    (86-0731)89762281    yipingy1964@163.com    Principal Investigator: Pingyong Yi, MD. Less <<
NCT00278655 Multiple Sclerosis Phase 1 Phase 2 Terminated - -
NCT02771743 Newly Diagnosed High Risk Neur... More >>oblastoma Less << Phase 2 Recruiting March 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT02519114 Multiple Myeloma Phase 1 Phase 2 Recruiting June 2017 Netherlands ... More >> Maastricht university Medical center Recruiting Maastricht, Netherlands Contact: Janine Van Elssen, MD, PhD       janine.van.elssen@mumc.nl    Contact: Gerard Bos, MD, PhD       gerard.bos@mumc.nl Less <<
NCT02032277 Triple Negative Breast Cancer Phase 3 Active, not recruiting November 2, 2020 -
NCT03004287 Multiple Myeloma Phase 2 Recruiting January 2021 United States, Arkansas ... More >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu Less <<
NCT02655458 Multiple Myeloma Phase 1 Completed - United States, New York ... More >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Less <<
NCT00005578 Cardiac Toxicity ... More >> Lymphoma Less << Phase 3 Completed - -
NCT02337985 AIDS-Related Burkitt Lymphoma ... More >> AIDS-Related Diffuse Large B-cell Lymphoma AIDS-Related Plasmablastic Lymphoma AIDS-Related Primary Effusion Lymphoma HIV Infection AIDS Related Non-Hodgkin Lymphoma Less << Phase 1 Active, not recruiting February 2019 United States, Maryland ... More >> NCI Lymphoid Malignancies Branch Bethesda, Maryland, United States, 20892 Less <<
NCT01431196 Stage II Breast Cancer ... More >> Stage III Breast Cancer Less << Phase 2 Completed - Spain ... More >> Clínica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Less <<
NCT00003270 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00061581 Acute Lymphocytic Leukemia ... More >> Chronic Myeloid Leukemia Acute Myelocytic Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03137641 - Recruiting October 16, 2018 France ... More >> Hôpital Pellegrin Recruiting Bordeaux, France, 33000 Contact: VERDUN-ESQUER Catherine, Dr    5 56 79 61 65 ext +33    catherine.verdun-esquer@chu-bordeaux.fr    Contact: CANAL-RAFFIN Mireille, Dr    5 56 79 59 91 ext +33    mireille.raffin@chu-bordeaux.fr    Sub-Investigator: PARTARRIEU Isabelle, Dr          Sub-Investigator: VIDEAU Nathalie, Dr          Sub-Investigator: LAPLACE Véronique, Dr          Principal Investigator: VERDUN-ESQUER Catherine, Dr          CHU de Toulouse Recruiting Toulouse, France, 31000 Contact: MARPINARD Monique, Dr       Marpinard.Monique@iuct-oncopole.fr    IUCT-Oncopole Recruiting Toulouse, France, 31000 Contact: MARPINARD Monique, Dr    5 31 15 50 30 ext +33    Marpinard.Monique@iuct-oncopole.fr    Contact: PORTES Eric       Portes.Eric@iuct-oncopole.fr    Principal Investigator: MARPINARD Monique, Dr Less <<
NCT00405860 MPO-ANCA Vasculitis ... More >> Microscopic Polyangiitis Less << Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00058578 Systemic Sclerosis Phase 1 Completed - United States, Texas ... More >> The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01365559 Multiple Myeloma Phase 1 Phase 2 Completed - United States, California ... More >> Pacific Oncology and Hematology Encinitas, California, United States, 92024 Pacific Cancer Care Salinas, California, United States, 93901 Central Coast Medical Oncology Santa Maria, California, United States, 93454 James R. Berenson, MD, Inc. West Hollywood, California, United States, 90069 United States, Illinois Cancer Centers of America Zion, Illinois, United States, 60099 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Family Cancer Center Foundation, Inc. Memphis, Tennessee, United States, 38119 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 233031 Less <<
NCT00002592 Leukemia Phase 2 Completed - United States, Pennsylvania ... More >> University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00393029 Anti-p53 TCR-Gene Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT01679860 Lymphoma, T-Cell, Peripheral Phase 2 Completed - Italy ... More >> Azienda Ospedaliera S. Luigi Orbassano, Torino, Italy, 10043 Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy, 15100 University of Ancona - Division of Hematology Ancona, Italy, 62020 Ospedale Riuniti, Bergamo - Division of Hematology Bergamo, Italy, 24128 Ospedale Generale Regionale Bolzano Bolzano, Italy, 39100 Spedali Civili di Brescia Brescia, Italy, 25123 Azienda Ospedale Vittorio Emanuele Ferrarorro S. Bambino- Università di Catania Catania, Italy, 94124 Ospedale S. Croce - Division of Hematology Cuneo, Italy, 12100 IRCCS Ospedale Maggiore Policlinico di Milano Milano, Italy, 20122 Ospedale San Raffaele, Milano - Division of Hematology Milan, Italy, 20100 Division of Hematology - Fondazione IRCCS Istituto Nazionale Tumori Milan, Italy, 20133 Ospedale Cervello - Bone Marrow Transplantation Unit Palermo, Italy Ospedale San Carlo Potenza, Italy, 85100 Azienda OspedalieraSan Giovanni Battista Torino, Italy, 10126 Università di Torino- Azienda Ospedaliera S. Giovanni Battista Torino, Italy, 10126 Policlinico Universitario Udine Udine, Italy Azienda Ospedaliera Policlinico di Verona Verona, Italy, 37134 Less <<
NCT00793351 Neuroblastoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT01046825 Mature B-Cell Lymphoma Phase 2 Phase 3 Recruiting October 31, 2022 United States, California ... More >> Rady Children's Hospital San Diego Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5811    dschiff@rchsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: John T Sandlund, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: John T Sandlund, MD          Egypt Children's Cancer Hospital Recruiting Cairo, Egypt, 11787 Contact: Hany Abdel Rahman, MD          Principal Investigator: Hany Abdel Rahman, MD          Singapore National University Health System Recruiting Singapore, Singapore, 119228 Contact: Allen Yeoh, MD       allen_yeoh@nuhs.edu.sg    Principal Investigator: Allen Yeoh, MD Less <<
NCT00089453 Multiple Myeloma Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT02592577 Non-Small Cell Lung Cancer ... More >> Carcinoma Less << Phase 1 Recruiting April 2019 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Cara Nolan    626-256-4673 ext 32341    canolan@coh.org    Principal Investigator: Karen Reckamp, MD          Stanford Cancer Center Recruiting Palo Alto, California, United States, 94304 Contact: Jordan S Preiss, BA    650-723-1002    jpreiss2@stanford.edu    Contact: Melanie G San Pedro-Salcedo          Principal Investigator: Joel W Neal, MD PhD          United States, Florida University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Michelle Liendo    305-243-0864    mliendo@med.miami.edu    Principal Investigator: Raja Mudad, M.D.          H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Jeff L Edelman, MS    813-745-1040    Jeffrey.Edelman@moffitt.org    Contact: Matt Taddeo       Matt.Taddeo@moffitt.org    Principal Investigator: Ben Creelan, MD, MS          United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Shantina N Walls, BS    404-778-4995    shantina.n.walls@emory.edu    Contact: Ellie C Butler          Principal Investigator: Taofeek K Owonikoko, MD, PhD          United States, Indiana Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46033 Contact: Margaret M Uhrich, RN    317-274-4505    muhrich@iu.edu    Contact: Namratha Kolur    317-278-2356    nkolur@iu.edu    Principal Investigator: Shadia I Jalal, MD          United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21157 Contact: Brett Goldberger, MS    410-328-1160    brett.goldberger@umm.edu    Contact: Maha Khalil          Principal Investigator: Nancy Hardy, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Justin F Gainor, M.D.    617-724-4000    jgainor@partners.org    Principal Investigator: Justin F Gainor, M.D.          United States, Missouri Washington University, School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Usha Rawat    314-286-2098    rawat@wustl.edu    Principal Investigator: Ramaswamy Govindan, MD          United States, North Carolina Duke University Medical Center, Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Shawna Savage, RN, BSN    919-668-1462    shawna.savage@duke.edu    Principal Investigator: Jeffrey M Clarke, MD          United States, Ohio Ohio State University Wexner Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Catherine Schweitzer    614-685-5414    catherine.schweitzer@osumc.edu    Principal Investigator: Kai He, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly    215-728-2195    patricia.murphy@fccc.edu    Principal Investigator: Martin Edelman, MD          United States, Tennessee Tennessee Oncology- Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7400    asksarah@sarahcannon.com    Principal Investigator: Melissa Johnson, MD          United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Matthew Parker, RN    713-745-6767    mrparker@mdanderson.org    Contact: Sara Nasser       SNasser@mdanderson.org    Principal Investigator: Vincent K Lam, MD          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Penelope Bradbury, MD    416-946-4501 ext 3544    TIP@uhn.ca    Contact: Ausmeema Hossain    416-946-4501 ext 8084    Ausmeema.Hossain@uhn.ca    Principal Investigator: Penelope Bradbury, MD          Spain Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain, 28040 Contact: Adriana Armellini    91 550 48 00 ext 2486    adriana.armellini@start.stoh.com    Contact: Raquel Martinez       raquel.garcia@startmadrid.com    Principal Investigator: Victor Moreno, MD          Hospital Universitario 12 Octubre Avda. de Córdoba s/n Recruiting Madrid, Spain, 28041 Contact: Sara Gomez    +34 91 4692313    abecia@@h12o.es    Contact: Carlos Gonzalez          Principal Investigator: Luis Paz-Ares Rodríguez, MD          United Kingdom University College Hospital Macmillan Cancer Centre Recruiting London, United Kingdom, WC1E 6AG Contact: Gemma Hector    07852219920    Gemma.Hector@uclh.nhs.uk    Contact: Krishna Patel       krishna.patel@uclh.nhs.uk    Principal Investigator: Martin D Forster, MBBS, FRCP, PhD          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Shweta Vyas    +44 (0) 161 918 2323    Shweta.vyas@christie.nhs.uk    Contact: Kate Armitage    +44 (0) 161 918 7887    Kate.Armitage@christie.nhs.uk    Principal Investigator: Fiona Thistlethwaite, MD Less <<
NCT00393029 - Completed - -
NCT00950768 Multiple Myeloma ... More >> Diagnosis Less << Phase 3 Completed - -
NCT01357733 Lymphoma, Large B-Cell, Diffus... More >>e Less << Not Applicable Recruiting December 31, 2020 Korea, Republic of ... More >> The Catholic University of Korea Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 06591 Contact: Seok-Goo Cho, MD, PhD    82-2-2258-1551    chosg@catholic.ac.kr    Contact: Joo Hyun O, MD    82-2-2258-1551    ojoohyun@catholic.ac.kr    Sub-Investigator: Joo Hyun O, MD          Sub-Investigator: Eun Ji Han, MD          Sub-Investigator: Seung-Eun Jung, MD, PhD          Sub-Investigator: Hye Lim Park, MD          Sub-Investigator: Woo Hee Choi, MD          Principal Investigator: Seok-Goo Cho, MD, PhD          Principal Investigator: Sung Hoon Kim, MD, PhD Less <<
NCT01555281 Multiple Myeloma Phase 1 Phase 2 Active, not recruiting December 2019 Italy ... More >> Istituto Europeo di Oncologia IEO Milano, Italy, 20141 University of Torino Torino, Italy, 10127 Switzerland Kantonsspital Aarau Aarau, Switzerland, 5001 Kantonsspital Baden Baden, Switzerland, 5404 Istituto Oncologico Svizzera Italiana IOSI Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, 3010 Kantonsspital Graubünden Chur, Switzerland, 7000 Kantonsspital Olten Olten, Switzerland, 4600 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Regionalspital Thun, Switzerland, 3600 UniversitätsSpital Zürich Zürich, Switzerland, 8091 Less <<
NCT00003631 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT03583294 Leukemia Not Applicable Recruiting April 1, 2021 France ... More >> Assistance Publique Hopitaux de Marseille Recruiting Marseille, France, 13354 Contact: Blandine Courbiere, MD/PhD       blandine.courdbiere@ap-hm.fr Less <<
NCT00003631 - Completed - -
NCT03229876 Acute Lymphoblastic Leukemia (... More >>ALL) Non Hodgkin Lymphoma (NHL) Less << Not Applicable Recruiting December 30, 2020 China, Henan ... More >> First Affliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Xinfeng Chen, PhD          Principal Investigator: Yi Zhang, Professor          China, Hunan Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD          Principal Investigator: Yunxiao Xu, Professor Less <<
NCT00002510 Lymphoma Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Temple University Cancer Center Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02299999 Metastatic Breast Cancer Phase 2 Recruiting December 2022 France ... More >> Institut de Cancérologie de l'Ouest/Paul Papin Recruiting Angers, France Contact: Mario CAMPONE, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario CAMPONE, MD          Institut Sainte-Catherine Recruiting Avignon, France Contact: Alice Mege, MD       a.mege@isc84.org    Principal Investigator: Alice Mege, MD          Polyclinique Bordeaux Nord Aquitaine Recruiting Bordeaux, France, 33077 Contact: Nadine DOHOLLOU, MD       n.dohollou@bordeauxnord.com    Contact: Nadine DOHOLLOU, MD          Institut Bergonié Recruiting Bordeaux, France Contact: Hervé Bonnefoi, MD       h.bonnefoi@bordeaux.unicancer.fr    Principal Investigator: Hervé Bonnefoi, MD          Centre François Baclesse Recruiting Caen, France Contact: Christelle Lévy, MD       c.levy@baclesse.unicancer.fr    Principal Investigator: Christelle Lévy, MD          Centre Jean Perrin Recruiting Clermont-Ferrand, France Contact: Marie-Ange Mouret Reynier, MD       marie-ange.mouret-reynier@cjp.fr    Principal Investigator: Marie-Ange Mouret Reynier, MD          Ch Alpes Leman Not yet recruiting Contamine Sur Arve, France, 74130 Contact: Carol ALLIOT, MD       calliot@ch-alpes-leman.fr    Contact: Carol ALLIOT, MD          Centre Georges François Leclerc Recruiting Dijon, France, 21079 Contact: Nicolas Isambert, MD       nisambert@cgfl.fr    Principal Investigator: Nicolas Isambert, MD          Chd Vendee Recruiting La Roche-sur-Yon, France, 85925 Contact: Tifenn L'Haridon, MD       tifenn.lharidon@chd-vendee.fr    Contact: Tifenn L'Haridon, MD          Centre Oscar Lambret Recruiting Lille, France Contact: Nuria KOTECKI, MD          Principal Investigator: Nuria KOTECKI, MD          Chu Dupuytren Not yet recruiting Limoges, France, 87000 Contact: Laurence VENAT-BOUVET, MD       laurence.venat-bouvet@chu-limoges.fr    Contact: Laurence VENAT-BOUVET, MD          Hopital Privé Jean Mermoz Not yet recruiting Lyon, France, 69008 Contact: Olfa DERBEL, MD       o.derbelmermoz@gmail.com    Contact: Olfa DERBEL, MD          Centre Hospitalier Lyon Sud Recruiting Lyon, France Contact: Benoit You, MD          Principal Investigator: Benoit You, MD          Centre Léon Bérard Recruiting Lyon, France Contact: Thomas Bachelot, MD       thomas.bachelot@lyon.unicancer.fr    Principal Investigator: Thomas Bachelot, MD          Institut Paoli Calmettes Recruiting Marseille, France Contact: Anthony Gonçalves, MD       goncalvesa@ipc.unicancer.fr    Principal Investigator: Anthony Gonçalves, MD          Institut Régional du Cancer Montpellier Val d'Aurelle Recruiting Montpellier, France Contact: William Jacot, MD       william.jacot@icm.unicancer.fr    Principal Investigator: William Jacot, MD          Centre Alexis Vautrin Recruiting Nancy, France Contact: Elisabeth Luporsi, MD       e.luporsi@nancy.unicancer.fr    Principal Investigator: Elisabeth Luporsi, MD          Institut de Cancérologie de l'Ouest/ René Gauducheau Recruiting Nantes, France Contact: Mario Campone, MD       mario.campone@ico.unicancer.fr    Principal Investigator: Mario Campone, MD          Centre Antoine Lacassagne Recruiting Nice, France Contact: Jean-Marc Ferrero, MD       jean-marc.ferrero@nice.unicancer.fr    Principal Investigator: Jean-Marc Ferrero, MD          Institut Curie Recruiting Paris, France Contact: Marie-Paule Sablin, MD       mariepaule.sablin@curie.fr    Principal Investigator: Marie-Paule Sablin, MD          Centre Eugène Marquis Recruiting Rennes, France Contact: Claudia Lefeuvre-Plesse, MD       c.lefeuvre@rennes.unicancer.fr    Principal Investigator: Claudia Lefeuvre-Plesse, MD          Centre Henri Becquerel Recruiting Rouen, France Contact: Jean-Christophe Théry, MD          Principal Investigator: Jean-Christophe Théry, MD          Institut Curie Recruiting Saint-Cloud, France Contact: Florence COUSSY, MD       florence.coussy@curie.fr    Principal Investigator: Florence COUSSY, MD          Hopitaux Universitaire de Strasbourg - Hopital Civil Recruiting Strasbourg, France Contact: Philippe BARTHELEMY, MD       philippe.barthelemy@chru-strasbourg.fr    Principal Investigator: Philippe BARTHELEMY, MD          Hopitaux Du Leman Recruiting Thonon-les-Bains, France, 74200 Contact: Francesco DEL PIANO, MD       f-delpiano@ch-hopitauxduleman.fr    Contact: Francesco DEL PIANO, MD          Institut Claudius Regaud Recruiting Toulouse, France Contact: Florence Dalenc, MD       dalenc.florence@iuct-oncopole.fr    Principal Investigator: Florence Dalenc, MD          Gustave Roussy Recruiting Villejuif, France Contact: Monica Arnedos, MD       Monica.ARNEDOS@gustaveroussy.fr    Principal Investigator: Monica Arnedos, MD          Sub-Investigator: Fabrice André, MD Less <<
NCT03752541 Multiple Myeloma Not Applicable Recruiting November 20, 2020 China, Hunan ... More >> Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD          Principal Investigator: Yunxiao Xu, Professor Less <<
NCT01358201 Acute Lymphoblastic Leukemia Phase 4 Recruiting December 2020 -
NCT00002630 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Florida ... More >> Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT01967576 Pheochromocytoma ... More >> Paraganglioma Less << Phase 2 Active, not recruiting December 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00001193 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02786719 Neuroblastoma Not Applicable Recruiting June 2019 United States, California ... More >> Rady Children's Hospital Recruiting San Diego, California, United States, 92123 Contact: Laura Conner    858-966-5983    LConner@rchsd.org    Principal Investigator: Peter Zage, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD, BA    832-822-4242    sbwhittl@txch.org Less <<
NCT01873807 Acute Lymphoblastic Leukemia Phase 4 Unknown December 2015 China, Fujian ... More >> Department of Hematology, Union Hospital of Fujian Medical University Recruiting Fuzhou, Fujian, China Contact: Jianda Hu, MD          Principal Investigator: Jianda Hu, MD          China, Guangdong Guangzhou General Hospital of Guangzhou Military Command Recruiting Guangzhou, Guangdong, China, 510010 Contact: Yang Xiao, MD       jdxiao111@163.com    Principal Investigator: Yang Xiao, MD          Guangdong General Hospital Recruiting Guangzhou, Guangdong, China, 510030 Contact: Suijin Wu, MD       songwu55555@163.com    Principal Investigator: Suijin Wu, MD          Guangdong No.2 Provincial People's Hospital Recruiting Guangzhou, Guangdong, China, 510317 Contact: Qing Zhang, MD       zhqing@vip.163.com    Principal Investigator: Qing Zhang, MD          Department of Hematology, Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, MD PhD    86-20-62787883    hanson2008@gmail.com    Contact: Qifa Liu, MD    86-20-61641612    liuqifa628@163.com    Sub-Investigator: Hongsheng Zhou, MD PhD          Third Affiliated Hospital, Sun Yat-Sen University Recruiting Guangzhou, Guangdong, China, 510630 Contact: Dongjun Lin, MD       lindongjun0168@163.com    Principal Investigator: Dongjun Lin, MD          Department of Hematology, 1st Guangzhou People Hospital Recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang, MD          Principal Investigator: Shunqing Wang, MD          Oncology-Hematology Center, 1st Affiliated Hospital, Guangzhou Medical Collgege Recruiting Guangzhou, Guangdong, China Contact: Huo Tan, MD PhD          Principal Investigator: Huo Tan, MD PhD          Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China Contact: Yuhua Li, MD PhD       li_yuhua@yahoo.com    Principal Investigator: Yuhua Li, MD PhD          Zhongshan People Hospital,Guangdong Recruiting Zhongshan, Guangdong, China, 528403 Contact: Xiaojun Xu, MD       doctorxu@163.com    Principal Investigator: Xiaojun Xu, MD          China, Guangxi Department of Hematology, 1st Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 530021 Contact: Yongrong Lai, MD          Principal Investigator: Yongrong Lai, MD          China, Hubei Department of Hematology, Union Hospital, Huazhong Science and Technology Recruiting Wuhan, Hubei, China, 430022 Contact: Yu Hu, MD PhD          Principal Investigator: Yu Hu, MD PhD          Department of Hematology, Tongji Hospital, Huazhong Science and Technology Recruiting Wuhan, Hubei, China, 430030 Contact: Jianfeng Zhou, MD PhD       jfzhou@tjh.tjmu.edu.cn    Principal Investigator: Jianfeng Zhou, MD PhD Less <<
NCT02464774 Breast Cancer Not Applicable Not yet recruiting - -
NCT03470935 - Recruiting September 30, 2018 France ... More >> Centre investigateur CARIO-HPCA Recruiting Plérin, France, 22190 Contact: Jérôme Martin-Babau    33.2.96.75.22.16       Contact: Anne-Hélène Boivin    33.2.57.24.02.43 Less <<
NCT01824615 Ovarian Cancer ... More >> Adverse Effects Less << Phase 2 Completed - Taiwan ... More >> Cathay General Hospital Taipei, Taiwan, 106 Less <<
NCT00003425 Breast Cancer ... More >> Leukemia Lymphoma Neuroblastoma Ovarian Cancer Sarcoma Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Phase 2 Completed - United States, Kentucky ... More >> Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Maryland Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Pennsylvania Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107-5541 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00307645 ANCA Associated Systemic Vascu... More >>litis Including Wegener’s Granulomatosis and Microscopic Polyangiitis and Renal Limited Vasculitis Less << Phase 3 Terminated - France ... More >> Hopital Cochin Paris, France, 75679 United Kingdom Addenbrooke's Hospital - Departement of Medecine Cambridge, United Kingdom, CB2 2SP Less <<
NCT00578903 Aplastic Anemia Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00578903 - Terminated - -
NCT01521689 Chronic Lymphocytic Leukemia Phase 2 Unknown June 2015 France ... More >> Institut Paoli Calmettes Marseille, France, 13009 Less <<
NCT02810743 Breast Cancer Phase 3 Recruiting December 2029 France ... More >> Institut Paoli Calmettes Not yet recruiting Marseille, France, 13009 Contact: A Goncalves, MD          Principal Investigator: A Goncalves          Hopital Tenon, University Marie-Curie Not yet recruiting Paris, France Contact: J-P Lotz, MD          Principal Investigator: J-P Lotz, MD          Germany Heinrich Heine University Düsseldorf, Women's Health Study Group Not yet recruiting Dusseldorf, Germany Contact: U Nitz, MD          Principal Investigator: U Nitz, MD          Netherlands Medical spectrum Twente Recruiting Enschede, Overijssel, Netherlands, 7500 KA Contact: M Wymenga, MD          Principal Investigator: M Wymenga, MD          Antoni van Leeuwenhoek Recruiting Amsterdam, Netherlands, 1066 CX Contact: Sabine C Linn, MD    +3120512 ext 2951    s.linn@nki.nl    Contact: Sonja Vliek, MD       s.vliek@nki.nl    Principal Investigator: Sabine C Linn, MD          AZVU Recruiting Amsterdam, Netherlands, 1081 HV Contact: I Konings, MD       i.konings@vumc.nl    Principal Investigator: I Konings, MD          University Medical Center Groningen Recruiting Groningen, Netherlands Contact: C Schroder, MD          Principal Investigator: C Schroder, MD          LUMC Recruiting Leiden, Netherlands, 2333 ZA Contact: J R Kroep, MD       j.r.kroep@lumc.nl    Principal Investigator: J R Kroep, MD          Maastricht University Medical Center Recruiting Maastricht, Netherlands Contact: V Tjan-Heijnen, MD          Principal Investigator: V Tjan-Heijnen, MD          Radboud UMC Not yet recruiting NIjmegen, Netherlands, 6225GA Contact: E Kuip, MD          Principal Investigator: E Kuip, MD          Erasmus Medical Center Cancer Institute Recruiting Rotterdam, Netherlands, 3015CE Contact: A Jager, MD          Principal Investigator: A Jager, MD          University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3584CX Contact: E van der Wall, MD          Principal Investigator: E van der Wall, MD Less <<
NCT01163201 Hematologic Malignancy ... More >> Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia in Blast Crisis Anemia, Refractory, With Excess of Blasts Chronic Myeloproliferative Disease Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Lymphoma Large Cell Non-Hodgkin's Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma High Grade Non-Hodgkin's Lymphoma Less << Phase 1 Phase 2 Withdrawn(Replaced by a new st... More >>udy) Less << January 2015 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55445 Less <<
NCT00146562 Breast Cancer ... More >> Stage I Breast Cancer Stage II Breast Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Faulkner Hospital Boston, Massachusetts, United States, 02130 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Lowell General Hospital Lowell, Massachusetts, United States, 01854 North Shore Cancer Center Peabody, Massachusetts, United States, 01960 Less <<
NCT03402737 Head and Neck Neoplasm Not Applicable Recruiting January 31, 2021 Belgium ... More >> Radiotherapy department, University Hospital Ghent Recruiting Ghent, Oost-Vlaanderen, Belgium, 9000 Contact: Wilfried De Neve, MD, PhD    +32 9 332 30 15    wilfried.deneve@uzgent.be    Contact: Fréderic Duprez, MD, PhD    +32 9 332 30 15    frederic.duprez@uzgent.be    Principal Investigator: Wilfried De Neve, MD, PhD          Sub-Investigator: Fréderic Duprez, MD, PhD          Sub-Investigator: Katrien Vandecasteele, MD, PhD          Sub-Investigator: Sylvie Rottey, MD, PhD          UZ Leuven Recruiting Leuven, Belgium Contact: Sandra Nuyts, MD, PhD          CHU Namur Recruiting Namur, Belgium Contact: Jean-François Daisne, MD Less <<
NCT02127268 Cancer Related Fatigue ... More >> Quality of Life Less << Phase 3 Recruiting April 2018 China, Zhejiang ... More >> Cancer institute Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Zhigang Zhang    8657187315009    zzg2011@zju.edu.cn Less <<
NCT00003032 Breast Cancer Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada, T2N 4N2 Canada, British Columbia BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6ZB Saint John Regional Hospital Saint John, New Brunswick, Canada, E2L 4L2 Canada, Newfoundland and Labrador Newfoundland Cancer Treatment and Research Foundation St. Johns, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario William Osler Health Centre Brampton, Ontario, Canada, L6W 2Z8 Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Cancer Care Ontario-London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Ottawa Regional Cancer Centre - General Campus Ottawa, Ontario, Canada, K1H 1C4 Hotel Dieu Hospital - St. Catharines St. Catharines, Ontario, Canada, L2R 5K3 Northeastern Ontario Regional Cancer Centre, Sudbury Sudbury, Ontario, Canada, P3E 5J1 Northwestern Ontario Regional Cancer Centre, Thunder Bay Thunder Bay, Ontario, Canada, P7A 7T1 Toronto Sunnybrook Regional Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital Weston, Ontario, Canada, M9N 1N8 Cancer Care Ontario - Windsor Regional Cancer Centre Windsor, Ontario, Canada, N8W 2X3 Canada, Prince Edward Island Queen Elizabeth Hospital, PEI Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec L'Hotel Dieu de Levis Levis, Quebec, Canada, G6V 3Z1 Centre Hospitalier de l'Universite de Montreal Montreal, Quebec, Canada, H2L-4M1 McGill University Department of Oncology Montreal, Quebec, Canada, H2W 1S6 Hotel Dieu de Montreal Montreal, Quebec, Canada, H2W 1T8 Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec Quebec City, Quebec, Canada, G1R 2J6 Less <<
NCT00278577 CROHN'S DISEASE Phase 1 Terminated - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT03399513 Diffuse Large B Cell Lymphoma Phase 2 Recruiting February 2022 Germany ... More >> Universitätsklinikum Münster Recruiting Münster, Nordrhein-Westfalen, Germany, 48149 Less <<
NCT00245115 Leukemia Phase 1 Terminated(Expiration of study... More >> supply) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00447265 - Terminated(The perceived risk-... More >>benefit ratio for individuals with early active RA) Less << - -
NCT00855452 Metastatic Breast Cancer ... More >> Malignant Melanoma Renal Cell Cancer Gastrointestinal Cancer Less << Phase 2 Completed - Israel ... More >> Hadassah University Hospital Jerusalem, Israel, 91120 Less <<
NCT02692742 Chemotherapy-Induced Neutropen... More >>ia Myelosuppression Breast Cancer Less << Phase 2 Completed - Germany ... More >> Site 20 Aachen, Germany Site 16 Aurich, Germany Site 21 Dresden, Germany Site 26 Dresden, Germany Site 05 Erlangen, Germany Site 09 Esslingen, Germany Site 02 Frankfurt a.M., Germany Site 13 Frankfurt a.M., Germany Site 01 Friedrichshafen, Germany Site 25 Goslar, Germany Site 11 Hamburg, Germany Site 10 Hannover, Germany Site 22 Hannover, Germany Site 07 Konstanz, Germany Site 29 Lübeck, Germany Site 03 Mainz, Germany Site 23 Mainz, Germany Site 04 Offenbach, Germany Site 19 Oldenburg, Germany Site 17 Ravensburg, Germany Site 24 Rosenheim, Germany Site 28 Tübingen, Germany Site 12 Westerstede, Germany Less <<
NCT00873093 - Completed - -
NCT02438982 Nephrotic Syndrome Phase 3 Completed - India ... More >> NRS Medical College & Hospital Kolkata, West Bengal, India, 700014 Less <<
NCT00873093 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Lymphoblastic Lymphoma T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - -
NCT02018458 Breast Cancer Phase 1 Phase 2 Unknown March 2018 United States, Texas ... More >> Baylor University Medical Center Recruiting Dallas, Texas, United States, 75246 Principal Investigator: Joyce O' Shaughnessy, MD          Sub-Investigator: Karolina Palucka, PhD Less <<
NCT00447265 Lupus Nephritis Phase 2 Terminated(The perceived risk-... More >>benefit ratio for individuals with early active RA) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California University of California at San Francisco San Francisco, California, United States, 94143 United States, Colorado University of Colorado Health Sciences Center Aurora, Colorado, United States, 80045 United States, New York Feinstein Institute for Medical Research NS-L1J Health System Manhasset, New York, United States, 11030 University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27709 Less <<
NCT00275678 Blood Stem Cell Transplant Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00004169 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00036985 Breast Cancer Phase 2 Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States, 92868 United States, Florida Comprehensive Breast Center of Coral Springs Coral Springs, Florida, United States, 33071 United States, Oklahoma Oklahoma University Medical Center at University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Mroz-Baier Breast Care Center Memphis, Tennessee, United States, 38119 United States, Virginia Breast Care Specialists, P.C. Norfolk, Virginia, United States, 23510 United States, Washington Tacoma, Washington, United States, 98405 Less <<
NCT00925821 Multiple Myeloma Phase 2 Completed - Germany ... More >> Charité University Hospital - Virchow Klinikum Berlin, Germany Dresden University Hospital Dresden, Germany, 01307 Erlangen University Hospital Erlangen, Germany, 91054 Freiburg University Hospital Freiburg, Germany, 79106 Jena University Hospital Jena, Germany Kiel University Hospital Kiel, Germany, 24105 Munich Grosshadern University Hospital Munich, Germany, 81377 University Hospital of Munich Technical University Munich, Germany, 81675 Klinikum Nuremberg Nuremberg, Germany, 90419 Regensburg University Hospital Regensburg, Germany, 93053 Rostock University Hospital Rostock, Germany, 18057 Ulm University Hospital Ulm, Germany, 89081 Less <<
NCT02379520 Human Papillomavirus-Related C... More >>arcinoma Human Papillomavirus Positive Oropharyngeal Carcinoma Human Papillomavirus Positive Cervical Carcinoma Human Papillomavirus Positive Anal Carcinoma Human Papillomavirus Positive Vulvar Carcinoma Human Papillomavirus Positive Penile Carcinoma Less << Phase 1 Recruiting October 2033 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vtorrano@bcm.edu Less <<
NCT03290664 Acute Myelogenous Leukemia Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00001430 Hodgkin's Disease ... More >> Non Hodgkin's Lymphoma Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03543527 - Recruiting June 1, 2024 France ... More >> La pitié Salpétrière Recruiting Paris, France, 75013 Contact: David Saadoun, MD PhD    142178009 ext +33    dsaadoun@wanadoo.fr Less <<
NCT02989064 Urinary Bladder Cancer ... More >> Head and Neck Cancer Melanoma Less << Phase 1 Recruiting May 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryan Sullivan, MD    617-724-4000    rsullivan7@partners.org    Principal Investigator: Ryan Sullivan, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly    215-728-2195    patriciamurphy@fccc.edu    Principal Investigator: Anthony Olszanski, MD, RPh          United States, Tennessee Tennessee Oncology - Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: Melissa Johnson, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Danxia Ke    713-792-4384    dke@mdanderson.org    Contact: Ly M Nguyen          Principal Investigator: David S Hong, MD          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Marcus Butler, MD    416-946-4501    TIP@uhn.ca    Contact: Anna Spreafico          Principal Investigator: Marcus Butler, MD Less <<
NCT02297230 Breast Cancer Phase 1 Phase 2 Terminated(PI Left Institution... More >> prior to reaching accrual goal and analyzing data.) Less << - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10065 Less <<
NCT02297230 - Terminated(PI Left Institution... More >> prior to reaching accrual goal and analyzing data.) Less << - -
NCT02382575 Nephrotic Syndrome Phase 4 Recruiting December 2018 India ... More >> NRS Medical College & Hospital Recruiting Kolkata, West Bengal, India, 700014 Contact: Biswanath Basu    009123456731 ext 1804    basuv3000@gmail.com    Principal Investigator: Biswanath Basu Less <<
NCT02935257 Leukemia, Lymphoblastic, Acute Phase 1 Recruiting November 2024 United Kingdom ... More >> University College London Hospital Recruiting London, United Kingdom Contact: Prof. Karl Peggs          Principal Investigator: Prof. Karl Peggs Less <<
NCT00799799 Myeloblastic Leukemia Phase 1 Unknown December 2009 Italy ... More >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Bo, Italy, 40138 Less <<
NCT01306955 Behcet's Disease Phase 4 Unknown August 2011 Iran, Islamic Republic of ... More >> Rheumatology Research Center, Tehran University of Medical Science Recruiting Tehran, Iran, Islamic Republic of, 1411713135 Contact: Shahram Farhad, Professor    0098-21-8802-6956    Shahramf@tums.ac.ir    Contact: Mastaneh Mohammadi, MD    0098-21-8802-6956    Mastanehmohammadi88@gmail.com Less <<
NCT00293072 Systemic Lupus Erythematosus ... More >> ANCA Associated Vasculitis Less << Phase 2 Completed - United Kingdom ... More >> Addenbrooke's Hospital Cambridge, Cambridgeshire, United Kingdom, CB2 2QQ Less <<
NCT00001761 Vasculitis We... More >>gener's Granulomatosis Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00001789 Glomerulonephritis, Membranopr... More >>oliferative Lupus Nephritis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Bethesda, Maryland, United States, 20892 Less <<
NCT01339455 Neuromyelitis Optica Phase 1 Phase 2 Terminated(recruitment failure... More >>) Less << - Canada, Alberta ... More >> Foothills Medical Centre, University of Calgary Calgary, Alberta, Canada, T2N 2T9 Less <<
NCT00084695 Childhood Langerhans Cell Hist... More >>iocytosis Fanconi Anemia Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Unknown - United States, Pennsylvania ... More >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Kenneth G. Lucas, MD    717-531-6012    klucas@psu.edu Less <<
NCT00427245 Breast Cancer ... More >> Infertility Menopausal Symptoms Less << Phase 3 Completed - -
NCT01268033 Childhood Idiopathic Nephrotic... More >> Syndrome Less << Phase 2 Phase 3 Completed - Belgium ... More >> Queen Fabiola Universitary Children's Hospital Brussels, Belgium, 1020 France Chu Amiens Amiens, France, 80054 Chu Besancon Besancon, France, 25030 Chu Bordeaux Bordeaux, France, 33076 Chu Brest Brest, France, 29609 CHU CAEN Caen, France, 14033 Chu Clermont Ferrand Clermont Ferrand, France, 63058 Chu Grenoble Grenoble, France, 38043 Chu Lille Lille, France, 59800 Chu Limoges Limoges, France, 87042 AP-HM - Hôpital La Timone Marseille, France, 13385 Chu Montpellier Montpellier, France, 34295 Chu Nantes Nantes, France, 44033 CHU NICE Nice, France, 06202 AP-HP - Hôpital Necker Paris, France, 75015 AP-HP - Hôpital Trousseau Paris, France, 75571 CHU REIMS - American Memorial Hospital Reims, France, 51092 Chu Rennes Rennes, France, 35000 Chu Rouen Rouen, France, 76031 Chu Saint Etienne Saint Etienne, France, 42055 Chu Strasbourg Strasbourg, France, 67098 Chu Toulouse Toulouse, France, 31059 Chu Tours Tours, France, 37044 Chu Nancy Vandoeuvre les Nancy, France, 54511 Less <<
NCT03407430 - Terminated(Low patient accrual... More >>) Less << - -
NCT03731845 Breast Cancer Not Applicable Not yet recruiting August 2026 France ... More >> Antoine Béclère Hospital Not yet recruiting Clamart, France, 92140 Contact: Charlotte SONIGO, MD       charlotte.sonigo@aphp.fr Less <<
NCT01134432 Anemia, Hemolytic, Autoimmune Phase 3 Completed - Denmark ... More >> Aalborg Hospital Aalborg, Denmark, DK-9000 Rigshospitalet - Copenhagen University Hospital Copenhagen, Denmark, DK-2100 Esbjerg Sygehus Esbjerg, Denmark, DK-6700 Haderslev Sygehus Haderslev, Denmark, DK-6100 Department of Haematology, Herlev Hospital Herlev, Denmark, DK-2730 Holstebro Sygehus Holstebro, Denmark, DK-7500 Naestved Sygehus Naestved, Denmark, DK-4700 Odense University Hospital Odense, Denmark, DK-5000 Roskilde Hospital Roskilde, Denmark, DK-4000 Vejle Hospital Vejle, Denmark, DK-7100 Viborg Sygehus Viborg, Denmark, DK-8800 Less <<
NCT00224614 Leukemia, Myeloid, Acute Phase 3 Unknown - France ... More >> Henri Mondor Hospital Recruiting Créteil, Val de Marne, France, 94010 Contact: CORDONNIER Catherine, professor    +33 1 49 81 20 57    carlcord@club-internet.fr Less <<
NCT00450892 Breast Cancer Phase 1 Phase 2 Completed - Belgium ... More >> C.H.U. Sart-Tilman Liege, Belgium Clinique Sainte Elisabeth Namur, Belgium France Institut Bergonie Bordeaux, France Institut Bergonié Bordeaux, France CHRU de Limoges Limoges, France Centre Leon Berard Lyon, France CRLC Val D'Aurelle Montpellier, France Centre Henri Becquerel Rouen, France Hopital Rene Huguenin - Institut Curie Saint-Cloud, France Centre Paul Strauss Strasbourg, France Institut Gustave Roussy Villejuif, France Slovenia The Institute Of Oncology Ljubljana, Slovenia Switzerland Hôpitaux universitaires de Genève - HUG - site de Cluse-Roseraie Geneve, Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland United Kingdom Western General Hospital Edinburgh, United Kingdom Less <<
NCT00301613 Henoch-Schoenlein Purpura ... More >> Nephritis Less << Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Less <<
NCT00863460 Primary Central Nervous System... More >> Lymphoma Less << Phase 2 Active, not recruiting May 2026 France ... More >> Cancérologie Hôpital Sud Amiens, France, 80054 Chu D'Angers Angers, France CHR Argenteuil Argenteuil, France, 95100 CHU de Besancon Besançon, France Institut Bergonié Bordeaux, France, 33076 CHU Hôtel Dieu Clermont-Ferrand, France CHU Michalon Grenoble, France, 38043 Centre Hospitalier Lens Lens, France CHU de Limoges Limoges, France, 87042 CHU de la Timone Marseille, France, 13009 Hôtel Dieu Nantes Nantes, France Centre Antoine Lacassagne Nice, France CHU de Nimes Nîmes, France GH Pitié-Salpétrière Paris, France, 75013 CHG Saint Jean Perpignan, France, 66046 CHU Hôpital Bernard Poitiers, France, 86021 Chu Reims Reims, France Hôpital Pontchaillou Rennes, France, 35033 Centre René Huguenin Saint Cloud, France, 92210 Institut de Cancérologie Saint-Priest en Jarez, France CH de Saint-Quentin Saint-Quentin, France Hôpital Bretonneau Tours, France CHU Nancy - Hôpital Neurologique Vandoeuvre les Nancy, France, 54500 Less <<
NCT01655875 Pediatric Acute Myeloblastic L... More >>eukemia, Relapsed Pediatric Acute Lymphoblastic Leukemia, Relapsed Less << Phase 1 Terminated(lack of patient enr... More >>ollment) Less << - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT03077542 Sickle Cell Disease Phase 1 Phase 2 Recruiting August 31, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT03201471 Diffuse Large B Cell Lymphoma Phase 2 Recruiting February 5, 2020 China, Zhejiang ... More >> The first affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310000 Contact: Wenbin Qian, MD. PhD.    (+86)13605801032 Less <<
NCT00897026 - Recruiting - United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Matthew Ellis, MD, PhD, FRCP    (713) 798-1999 Less <<
NCT00965276 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00418535 Lymphoma, T-Cell Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT00455897 Lymphoma, Non-Hodgkin ... More >> Lymphoma, B-Cell Lymphoma, Diffuse Less << Phase 2 Terminated(Accrual was too slo... More >>w. Trial terminated) Less << - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT00877747 - Unknown October 2015 Italy ... More >> Azienda Ospedaliera Santa Croce e Carle Cuneo, Italy, 12100 Less <<
NCT00986518 Colorectal Cancer Phase 1 Phase 2 Completed - France ... More >> Service hépato-gastro-enterologie, Pitié-Salpêtrière Hospital Paris, France, 75013 Less <<
NCT02765789 Anti-glomerular Basement Membr... More >>ane Glomerulonephritis Less << Phase 4 Recruiting December 1, 2022 Netherlands ... More >> University Medical Center Groningen Recruiting Groningen, Gromiongen, Netherlands, 9713 GZ Contact: Casper Franssen, MD PhD    +31503616161    c.f.m.franssen@umcg.nl    Contact: Coen Stegeman, MD PhD    +31503616161    c.a.stegeman@umcg.nl Less <<
NCT03407430 Breast Cancer ... More >> Lymphoma Pain Less << Phase 2 Terminated(Low patient accrual... More >>) Less << - United States, North Carolina ... More >> North Carolina Cancer Hospital Chapel Hill, North Carolina, United States, 27514 Less <<
NCT00325741 Lupus Erythematosus, Systemic Phase 1 Unknown July 2010 United States, California ... More >> Stanford University School of Medicine Recruiting Stanford, California, United States, 94305 Contact: Judith A. Shizuru, MD, PhD    650-723-0822    jshizuru@stanford.edu    Contact: Sam Strober, MD    650-723-6500    glenna@stanford.edu Less <<
NCT00161590 T-Cell Lymphoma ... More >> Lymphoma, Non-Hodgkin's Less << Phase 1 Completed - United States, New York ... More >> Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT01358747 Hodgkin's Lymphoma Phase 3 Completed - -
NCT02280902 - Recruiting June 2020 France ... More >> Service de Médecine Interne - CH d'Agen Not yet recruiting Agen, France, 47923 Contact: Patrick RISPAL, MD       patrick.rispal@ch-agen.fr    Principal Investigator: Patrick RISPAL, MD          Service de Médecine Interne et maladies Infectieuses - Hôpital Saint-André Recruiting Bordeaux, France, 33075 Contact: Fabrice BONNET, Prof.    (0)5 56 79 58 26 ext +33    fabrice.bonnet@chu-bordeaux.fr    Principal Investigator: Fabrice BONNET, Prof.          Sub-Investigator: Partick MERCIE, Prof.          Sub-Investigator: Julien SENESCHAL, MD          Sub-Investigator: Jean-François VIALLARD, Prof.          Sub-Investigator: Pierre MERVILLE, Prof.          Sub-Investigator: Christophe RICHEZ, MD          service de médecine interne - CH de Libourne Not yet recruiting Libourne, France Contact: Olivier CAUBET, MD       olivier.caubet@ch-libourne.fr    Service de Médecine Interne - CHU de Limoges Not yet recruiting Limoges, France, 87042 Contact: Guillaume GONDRAN, MD       guillaume.gondran@chu-limoges.fr    Principal Investigator: Guillaune GONDRAN, MD          Service de Médecine Interne - CH de Pau Not yet recruiting Pau, France, 64000 Contact: Xavier DELBREL, MD       xavier.delbrel@ch-pau.fr    Principal Investigator: Xavier DELBREL, MD          service Médecine Interne - CHU de Toulouse - Hôpital Purpan (5) Recruiting Toulouse, France, 31300 Contact: Laurent SAILLER, Prof.       sailler.l@chu-toulouse.fr    Principal Investigator: Laurent SAILLER, Prof.          service Médecine Interne - CHU de Toulouse - Hôpital Purpan (7) Not yet recruiting Toulouse, France Contact: Laurent ALRIC, Prof       alric.l@chu-toulouse.fr Less <<
NCT00274794 Lymphoma Not Applicable Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute Cleveland, Ohio, United States, 44195 Less <<
NCT00080444 Vomiting Phase 3 Completed - -
NCT00784589 Pemphigus Disease Phase 3 Completed - France ... More >> CHU de Rouen - Hôpitaux de Rouen Rouen, Seine Maritime, France, 76031 Less <<
NCT00001239 Breast Cancer ... More >> Breast Neoplasms Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03011528 Ewing Sarcoma Family of Tumors Phase 2 Recruiting December 2022 France ... More >> Chr Felix Guyon Not yet recruiting La Réunion, Saint Denis, France, 97400 Principal Investigator: Yves REGUERRE, MD          Bordeaux Chu Recruiting Bordeaux, France, 33076 Contact: Cécile VERITE-GOULARD, MD    +33(0)556795430    cecile.verite@chu-bordeaux.fr    CHU Grenoble Alpes Not yet recruiting Grenoble, France, 38043 Principal Investigator: Dominique PLANTAZ, P          LILLE Centre Oscar Lambret Recruiting Lille, France, 59000 Contact: Cyril LERVAT, MD    +33(0)320295935    c-lervat@o-lambret.fr    LYON Centre Léon Bérard Recruiting Lyon, France, 69000 Contact: Nadège CORRADINI, MD    +33(0)469166572    nadege.corradini@lyon-unicancer.fr    Marseille Chu Not yet recruiting Marseille, France, 13000 Contact: Jean-Claude GENTET, MD    +33(0)491386821    jcgentet@ap-hm.fr    CHRU Montpellier - Hôpital A. de Villeneuve Recruiting Montpellier, France, 34295 Principal Investigator: Laure SAUMET, MD          Nantes Chu Recruiting Nantes, France, 44000 Contact: Estelle THEBAUD, MD    +33(0)240083810    estelle.thebaud@chu-nantes.fr    PARIS Institut Curie Recruiting Paris, France, 75005 Contact: Valérie LAURENCE, MD    +33(0)1 44 32 42 07    valerie.laurence@curie.fr    PARIS Trousseau Recruiting Paris, France, 75012 Contact: Marie-Domnique TABONE, MD    +33(0)144736062    marie-dominique.tabone@aphp.fr    CHU Hôpital Sud Not yet recruiting Rennes, France, 35056 Principal Investigator: Sophie TAQUE, MD          Strasbourg Chu Recruiting Strasbourg, France, 67098 Contact: Natacha ENTZ-WERLE, MD    +33(0)388128072    natacha.entz-werle@chu-strasbourg.fr    Toulouse Chu Recruiting Toulouse, France, 31059 Contact: Marie-Pierre CASTEX, MD    +33(0)534558610    castex.mp@chu-toulouse.fr    TOULOUSE Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD    +33(0)531155151    chevreau.christine@iuct-oncopole.fr    NANCY Institut de Cancérologie de Lorraine Not yet recruiting Vandoeuvre les Nancy, France, 54519 Contact: Maria RIOS, MD    +33(0)383598358    m.rios@nancy.unicancer.fr    Nancy Chu Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Ludovic MANSUY, MD    +33(0)383154734    l.mansuy@chu-nancy.fr    VILLEJUIF Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Nathalie GASPAR, MD    +33(0)142114166    nathalie.gaspar@gustaveroussy.fr Less <<
NCT02526823 Lymphoma, Non-Hodgkin;Hodgkin ... More >>Disease Less << Phase 4 Recruiting February 2019 China, Shandong ... More >> Department of Hematology, Provincial Hospital Affiliated to Shandong University Recruiting Jinan, Shandong, China, 250012 Contact: Xin Wang, MD, PHD    +86-531-68778331    xinw007@126.com    Contact: Lili Feng, MD    +86-531-68776358    fenglili1982624@163.com Less <<
NCT02387099 Breast Cancer ... More >> Hormone Receptor Positive Tumor Less << Phase 2 Recruiting March 2018 Germany ... More >> Sana Klinikum Offenbach / German Breast Group Not yet recruiting Neu Isenburg, Hessen, Germany, 63263 Contact: Sibylle Loibl, PD.MD    +49 6102 7840 ext 426    Sibylle.Loibl@GermanBreastGroup.de    Principal Investigator: Sibylle Loibl, MD          TU Dresden Recruiting Dresden, Sachsen, Germany, 01307 Principal Investigator: Karin Kast, MD, Prof          Recruiting Bielefeld, Germany, 33604 University of Erlangen Recruiting Erlangen, Germany, 91054 Recruiting Essen, Germany, 45136 Not yet recruiting Goslar, Germany, 38642 Recruiting Hanau, Germany, 63450 Active, not recruiting Karlsruhe, Germany, 76135 Active, not recruiting Kiel, Germany, 24105 Active, not recruiting Köln, Germany, 50931 Recruiting Mainz, Germany, 55131 Active, not recruiting München, Germany, 80638 Recruiting Rotenburg, Germany, 27356 Recruiting Weinheim, Germany, 69469 Less <<
NCT00040248 Wegener's Granulomatosis Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT02278796 Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Follicular Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting December 2019 Austria ... More >> Krankenhaus der Elisabethinen Linz Linz, Austria, 4020 Hanusch Krankenhaus Wien Wien, Austria, 1140 Switzerland Department for Medical Oncology University Hospital/Inselspital Berne, Switzerland, 3010 Universitätsspital Zürich Zürich, Switzerland, 8091 Less <<
NCT01332968 Non-Hodgkin's Lymphoma Phase 3 Active, not recruiting April 8, 2021 -
NCT03494296 - Recruiting December 31, 2026 China, Heilongjiang ... More >> The First Affiliated Hospital of Harbin Medical University, Department of Hematology, Lymphoma Ward Recruiting Harbin, Heilongjiang, China, 150001 Contact: Shuye Wang, PhD    0451-85552226    wsywangshuye@126.com Less <<
NCT00425724 Purpura, Schoenlein-Henoch Phase 4 Completed - Finland ... More >> Dept. of Pediatrics, Oulu University Hospital Oulu, Finland, 90029 OYS Less <<
NCT00001764 Vasculitis We... More >>gener's Granulomatosis Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00625898 Breast Cancer Phase 3 Terminated - -
NCT01332968 - Active, not recruiting - -
NCT00509288 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02049424 - Terminated(low recruitment) - Italy ... More >> Istituto Clinico Humanitas Rozzano, MI, Italy, 20089 Less <<
NCT03725059 Breast Cancer Phase 3 Not yet recruiting January 24, 2031 -
NCT00003595 Lymphoma Phase 3 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90033-0804 Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 San Francisco General Hospital Medical Center San Francisco, California, United States, 94110 United States, Florida Sylvester Cancer Center, University of Miami Miami, Florida, United States, 33136 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 United States, New Jersey University Hospital/New Jersey Cancer Center Newark, New Jersey, United States, 07103 United States, New York NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Mount Sinai School of Medicine New York, New York, United States, 10029 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT00509288 - Completed - -
NCT00566696 Leukemia, Acute Lymphocytic (A... More >>LL) Leukemia, Myeloid, Acute(AML) Leukemia, Myeloid, Chronic(CML) Juvenile Myelomonocytic Leukemia (JMML) Hemoglobinuria, Paroxysmal Nocturnal (PNH) Hodgkin Lymphoma Lymphoma, Non-Hodgkin (NHL) Myelodysplastic Syndrome (MDS) Less << Phase 2 Active, not recruiting December 2018 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00566696 - Active, not recruiting - -
NCT00039130 - Completed - -
NCT00846833 Melanoma Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT01412879 Lymphoma Phase 2 Active, not recruiting August 2021 -
NCT02199301 End Stage Renal Disease Not Applicable Unknown December 2017 Korea, Republic of ... More >> Samsung Medical Center, Organ Transplant Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Sung Joo Kim, MD, PhD    82-2-3410-3476    kmhyj.kim@samsung.com    Contact: Jae Berm Park, MD, PhD    82-2-3410-3647    jbparkmd@gmail.com    Principal Investigator: Sung Joo Kim, MD, PhD          Sub-Investigator: Jae Berm Park, MD, PhD Less <<
NCT01412879 - Active, not recruiting - -
NCT00039130 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT03273595 Neoplasms, Breast Phase 2 Recruiting December 2019 China, Shanxi ... More >> Xijing Hospital Recruiting Xi'an, Shanxi, China, 710032 Contact: Juliang Zhang, Doctor    +862984775271    zhangjl@fmmu.edu.cn    Principal Investigator: Juliang Zhang, Doctor Less <<
NCT00002547 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT01461837 Sickle Cell Disease Phase 2 Recruiting April 2019 United States, California ... More >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Theodore Moore, MD    310-825-6708    tbmoore@mednet.ucla.edu    Contact: LaMarr Taylor, CCRP    310-794-8929    LaMarrTaylor@mednet.ucla.edu    Principal Investigator: Theodore Moore, MD          Children's Hospital and Research Center Oakland Completed Oakland, California, United States, 94609 United States, Illinois Lurie Children's Hospital Completed Chicago, Illinois, United States, 60611-2605 United States, Missouri Washington University/St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD    314-454-6018    Shenoy@kids.wustl.edu    Contact: Megan Holtmann    314-454-6018       Principal Investigator: Shalini Shenoy, MD          United States, New York New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu    Contact: Sandi Fabricatore, RN, PNP    914-594-2152    Fabricatores@wcmc.com    Principal Investigator: Mitchell S Cairo, MD          United States, Ohio Cincinnati Children's Hospital Withdrawn Cincinnati, Ohio, United States, 45229 United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Julie Talano, MD    414-955-4185    jtalano@mcw.edu    Contact: Kathy Jodarski    414-266-2681    kjodarski@chw.org    Principal Investigator: Julie Talano, MD Less <<
NCT00002836 Breast Cancer Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT02867566 Diffuse, Large B-Cell, Lymphom... More >>a Less << Phase 3 Unknown December 2018 China ... More >> Institute of Hematology; Chinese Academy of Medical Sciences Recruiting Tianjin, China Contact: Lugui Qiu, Prof    13821266636 Less <<
NCT03243838 Triple-Negative Breast Cancer Phase 1 Phase 2 Not yet recruiting December 30, 2019 China, Guangdong ... More >> Guangdong general hospital Not yet recruiting Guangzhou, Guangdong, China, 510080 Contact: Liming Yao    00862083827812 ext 20984    13149395530@163.com Less <<
NCT02622074 Triple Negative Breast Neoplas... More >>ms Less << Phase 1 Active, not recruiting November 4, 2019 -
NCT00581854 Mantle Cell Lymphoma Phase 2 Completed - United States, Wisconsin ... More >> UWCCC Madison, Wisconsin, United States, 53792 Less <<
NCT00581854 - Completed - -
NCT00013533 Hodgkin Lymphoma ... More >> Lymphocytic Leukemia Mixed Cell Leukemia Myelodysplastic Syndrome Non Hodgkin's Lymphoma CML ALL AML Lymphoma Less << Early Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03585517 AML Phase 1 Recruiting November 1, 2020 China ... More >> Xian Lu Recruiting Beijing, China Contact: xian lu    86 ext 86    luxinan@immunochina.com Less <<
NCT00686556 Acute Lymphoblastic Leukemia ... More >> Myelodysplastic Syndrome Multiple Myeloma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02042391 Posttransplant Lymphoprolifera... More >>tive Disorder Less << Phase 2 Recruiting December 2022 Germany ... More >> Uniklinik RWTH Aaachen Klinik für Onkologie, Hämatologie und Stammzell-transplantation Med. Klinik IV Recruiting Aachen, Germany, 52074 Charite Universitätsmedizin Berlin Campus Mitte, Medizinische Klinik mit Schwerpunkt Hämatologie und Onkologie Recruiting Berlin, Germany, 10117 Charité - Universitätsmedizin Berlin CCM Medizinische Klinik m. S. Nephrologie Recruiting Berlin, Germany, 10117 Universitätsklinikum Bonn Med. Klinik III/ZIM Hämatologie/Onkologie Recruiting Bonn, Germany, 53105 DIAKO Bremen gGmbH, Klinik für Hämatologie und Onkologie Recruiting Bremen, Germany, 28239 Universitätsklinikum Erlangen Med. Klinik 5 Hämatologie und Intern. Onkologie Recruiting Erlangen, Germany, 91054 Universitätsklinikum Essen Klinik für Hämatologie Recruiting Essen, Germany, 45147 Malteser Krankenhaus St. Franziskus-Hospital Med. Klinik 1 Recruiting Flensburg, Germany, 24939 Universitätsklinikum Frankfurt Med. Klinik III, Nephrologie Recruiting Frankfurt/Main, Germany, 60590 Universitätsklinikum Gießen Med. Klinik IV Recruiting Gießen, Germany, 35385 Universitätsmedizin Göttingen, Klinik für Hämatologie und medizinische Onkologie Not yet recruiting Göttingen, Germany, 37075 Nephrologisches Zenrtum Niedersachsen Not yet recruiting Hann-Münden, Germany, 34346 Medizinische Hochschule Hannover Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation Recruiting Hannover, Germany, 30625 Medizinische Universitätsklinik Heidelberg Abteilung Innere Medizin V Recruiting Heidelberg, Germany, 69120 II. Medizinische Klinik, Universitätsklinikum Schleswig-Holstein Campus Kiel Recruiting Kiel, Germany, 24105 Universitätsmedizin der Johannes-Gutenberg-Universität III. Medizinische Klinik Recruiting Mainz, Germany, 55101 Klinikum der Universität München-Großhadern Med. Klinik III Recruiting München, Germany, 81377 Klinikum Oldenburg gGmbH Klinik für Innere Medizin II Recruiting Oldenburg, Germany, 26133 Klinikum Passau II. Med. Klinik Recruiting Passau, Germany, 94032 Universitätsmedizin Rostock Klinik für Innere Medizin III Hämatologie, Onkologie, Palliativmedizin Not yet recruiting Rostock, Germany, 18057 Klinikum Stuttgart Klinik für Hämatologie und int. Onkologie Recruiting Stuttgart, Germany, 70174 Less <<
NCT00795613 HODGKIN LYMPHOMA Phase 2 Unknown October 2015 Israel ... More >> The Chaim Sheba Medical Center Tel Hashomer, Israel Italy Ospedale S. Gerardo Monza, Milano, Italy, 20052 A.O. Universitaria S. Luigi Gonzaga Orbassano, Torino, Italy, 10043 A.O. Universitaria Ospedali Riuniti Osp. Umberto I Ancona, Italy, 60100 Ospedali Riuniti Bergamo, Italy, 24128 Ospedale Generale Regionale Bolzano Bolzano, Italy, 39100 Ospedale Roberto Binaghi Cagliari, Italy, 09126 A.O. Universitaria Osp. Vittorio Emanuele E Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera S. Croce E Carle Cuneo, Italy, 12100 Azienda Ospedaliera Universitaria S. Martino Genova, Italy, 16126 Ospedale S. Raffaele Turro Milano, Italy, 20127 Irccs - Istituto Nazionale Dei Tumori (Int) Milano, Italy, 20133 Irccs Istituto Nazionale Dei Tumori (Int) Milano, Italy, 20133 A.O. Universitaria Federico Ii Napoli, Italy, 80131 Azienda Ospedaliera Padova, Italy, 35127 Azienda Ospedaliera V. Cervello Palermo, Italy, 90146 Ospedale Silvestrini-S.Andrea Delle Fratte Perugia, Italy, 06156 Ospedale S. Carlo Potenza, Italy, 85100 A.O. Universitaria Policlinico Tor Vergata Roma, Italy, 00133 Azienda Ospedaliera San Camillo-Forlanini Roma, Italy, 00149 Ospedale Mauriziano Umberto I Torino, Italy, 10128 A.O. Universitaria S. Giovanni Battista-Molinette Torino, Italy, 10134 Ospedale Policlinico G.B. Rossi Verona, Italy, 37134 Ospedale Di Vicenza Vicenza, Italy, 36100 Less <<
NCT03430011 Multiple Myeloma Phase 1 Phase 2 Recruiting March 2021 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Tiffany D Hill, RN, BSN    205-996-8023    tiffanydhill@uabmc.edu    Principal Investigator: Luciano Costa, MD, PhD          United States, California City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD    626-218-2405 ext 82405    mhtut@coh.org    Principal Investigator: Myo Htut, MD          University of California Recruiting San Francisco, California, United States, 94143 Contact: Helen Diller Family Comprehensive Cancer Center       HDFCCC.CIP@ucsf.edu    Principal Investigator: Sandy Wong, MD          United States, Georgia Winship Cancer Institute at Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Jonathan Kaufman, MD    404-778-1900    jlkaufm@emory.edu    Principal Investigator: Jonathan Kaufman, MD          United States, Illinois The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Rebecca Malloy    773-834-1475    rmalloy@medicine.bsd.uchicago.edu    Principal Investigator: Andrzej Jakubowiak, MD, PhD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Leah Cappadona, RN    551-996-5078    Leah.Cappadona@hackensackmeridian.org    Principal Investigator: David Siegel, MD, PhD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14203 Contact: Lisa Martin    716-845-4892    Lisa.Martin@RoswellPark.org    Contact: Aaron Pry    716-845-2910    Aaron.Pry@RoswellPark.org    Principal Investigator: Kelvin Lee, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Claudia Diamonte, RN    212-639-5317    diamontc@mskcc.org    Principal Investigator: Sham Mailankody, MD          United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Tenzin Tsomo    206-386-2831    Tenzin.Tsomo@swedish.org    Principal Investigator: William Bensinger, MD Less <<
NCT01228331 Leukemia Phase 2 Phase 3 Recruiting September 2021 Germany ... More >> Krankenanstalten Gilead gCmbH Neurochirurgische Klinik Recruiting Bielefeld, Germany, 33617 Contact: Contact Person    49-521-144-2728       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Contact Person    49-421-497-5413       Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-81-17662       Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald Recruiting Greifswald, Germany, 17487 Contact: Contact Person    49-3834-86-6321       University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Contact Person    49-407-4105-2580    horstmann@uke.uni-hamburg.de    Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Contact Person    49-6781-66-1582       Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: Contact Person    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Contact Person    49-341-9726-113       Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: Contact Person    49-6131-17-2642       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Contact Person    49-89-5160-2843       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Contact Person    49-89-6210-2720       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Contact Person    49-941-2080-493       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Contact Person    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: Contact Person    49-202-896-2444 Less <<
NCT03433313 Breast Cancer Phase 3 Not yet recruiting September 3, 2021 -
NCT00563953 Breast Cancer Phase 2 Completed - Spain ... More >> Institut Català d'Oncologia L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Son Llàtzer Palma de Mallorca, Illes Balears, Spain, 07198 Hospital Universitario Sant Joan de Reus Reus, Tarragona, Spain, 42301 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitari Arnau de Vilanova Lleida, Spain, 25198 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario Morales Meseguer Murcia, Spain, 30008 Less <<
NCT00047060 Mycosis Fungoides ... More >> Sezary Syndrome Less << Phase 1 Active, not recruiting July 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00023192 Chronic Granulomatous Disease Phase 3 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00006515 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02973191 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 1 Phase 2 Withdrawn(Development of JCAR0... More >>15 has been discontinued. No subjects were enrolled/treated under protocol JCAR015-ALL-001) Less << January 24, 2021 Belgium ... More >> Universitair Ziekenhuis Gent Gent, Belgium, 9000 France University de Lille Lille, France, 59037 Hopital Saint Louis Paris, France, 75010 Germany Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet Dresden Dresden, Germany, 1307 Universitatsklinikum Frankfurt Frankfurt, Germany, 60590 University of Munich Grosshadern Grosshadern Campus, Germany, D-81377 University of Cologne Köln, Germany, 50924 University of Leipzig Leipzig, Germany, 4103 Universitaetsklinikum Ulm Ulm, Germany, 89081 Italy USC Ematologia, Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy, 24127 Istituto Clinico Humanitas - Istituti di Ricovero E Cura A Carattere Scientifico (IRCSS) Milan, Italy, 20089 Universita La Sapienza Roma, Italy, 00168 Azienda Ospedaliera Citta della Salute e della Scienza di Torino Torino, Italy, 10126 Spain ICO-Hospital Germans Trias i Pujol Barcelona, Spain, 08916 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Switzerland Chuv Bh-04 Lausanne, Switzerland, 1011 United Kingdom Bristol Royal Infirmary, University of Bristol Foundation Trust Bristol, United Kingdom, BS2 8BJ UCL Cancer Institute London, United Kingdom, WC1E 6BT Less <<
NCT00547196 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Not Applicable Active, not recruiting September 2019 United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT02996617 Lymphoma,Non-Hodgkin Phase 4 Unknown December 2018 China, Shandong ... More >> Department of Hematology, Provincial Hospital Affiliated to Shandong University Recruiting Jin'an, Shandong, China, 250012 Contact: Xin Wang, MD, PHD    86-531-68778331    xinw007@126.com    Contact: changqing zhen, MD    86-531-68778331    zcq1521@163.com Less <<
NCT01526850 Chronic Graft Versus Host Dise... More >>ase Less << Phase 2 Phase 3 Unknown June 2014 China, Zhejiang ... More >> Zhejiang University Recruiting Hangzhou, Zhejiang, China Contact: He Huang, MD    86-0571-87236706    hehuangyu@126.com Less <<
NCT00050713 Membranous Glomerulonephritis ... More >> Lupus Membranous Nepropathy Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00080353 Melanoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02436707 Lymphoma Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Douglas A. Stewart    403 521-3347       Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Neil Sun Chua    780 432-8340       Canada, British Columbia BCCA - Vancouver Cancer Centre Suspended Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Suspended Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Recruiting Moncton, New Brunswick, Canada, E1C 6Z8 Contact: Nizar Abdel-Samad    506 870-2404       The Vitalite Health Network - Dr. Leon Richard Suspended Moncton, New Brunswick, Canada, E1C 8X3 Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 1V7 Contact: Stephen Couban    902 473-8562       Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Graeme Fraser    905 575-7820       Kingston Health Sciences Centre Recruiting Kingston, Ontario, Canada, K7L 2V7 Contact: Annette Hay    613 533-6430 ext 77094       Ottawa Hospital Research Institute Suspended Ottawa, Ontario, Canada, K1H 8L6 Odette Cancer Centre Suspended Toronto, Ontario, Canada, M4N 3M5 University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: John Kuruvilla    416 946-2827       Canada, Quebec CIUSSS de l'Est-de-I'lle-de-Montreal Suspended Montreal, Quebec, Canada, H1T 2M4 CHUM-Centre Hospitalier de l'Universite de Montreal Suspended Montreal, Quebec, Canada, H2X 3E4 CHU de Quebec-Hopital l'Enfant-Jesus (HEJ) Recruiting Quebec City, Quebec, Canada, G1J 1Z4 Contact: Jean-Francois Larouche    418 649-5726       Canada, Saskatchewan Allan Blair Cancer Centre Suspended Regina, Saskatchewan, Canada, S4T 7T1 Less <<
NCT00043667 Uveitis Phase 2 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT00003846 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Children's Hospital of Orange County Orange, California, United States, 92668 United States, Colorado Children's Hospital of Denver Denver, Colorado, United States, 80218 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 United States, New York NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 Children's Hospital of Columbus Columbus, Ohio, United States, 43205-2696 United States, Oregon Oregon Cancer Center at Oregon Health Sciences University Portland, Oregon, United States, 97201-3098 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT03287817 Diffuse Large B Cell Lymphoma ... More >> Relapsed Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma DLBCL Less << Phase 1 Phase 2 Recruiting March 2021 United Kingdom ... More >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Kirit Ardeshna          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Principal Investigator: Dr Adrian Bloor          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Wendy Osborne Less <<
NCT02405364 Multiple Myeloma Phase 2 Active, not recruiting December 2019 France ... More >> CHU de Toulouse Toulouse, France, 31000 University hospital of Toulouse Toulouse, France, 31000 Less <<
NCT02290132 - Unknown July 2017 China, Shanghai ... More >> Shanghai First People's HOSPITAL Recruiting Shanghai, Shanghai, China, 200127 Contact: YANG JUN, master    13564880726    yangjuan74@hotmail.com    Contact: wang chun, doctor    13386259777    wangchun2@medmail.com.cn Less <<
NCT00355199 Diffuse Large B-Cell Lymphoma Phase 3 Completed - Italy ... More >> Clinica di Ematologia - Nuovo Ospedale Torrette Ancona, Italy U.O. Ematologia - Ospedali Riuniti di Bergamo Bergamo, Italy Divisione di Ematologia - Ospedale Centrale di Bolzano Bolzano, Italy CTMO - Ematologia - Ospedale "R. Binaghi" Cagliari, Italy Divisione di Ematologia - Ospedale Ferrarotto Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Divisione Ematologia - Istituto S. Raffaele Milano, Italy Oncologia Medica - Istituto Nazionale dei Tumori Milano, Italy U.O. Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione di Ematologia - Azienda Ospedaliera Padova, Italy Ematologia - Azienda Ospedaliera V. Cervello Palermo, Italy Ematologia Clinica - Ospedale Civile di Pescara Pescara, Italy Ematologia e TMO - Ospedale S. Camillo Roma, Italy Divisione Universitaria di Ematologia - Azienda Ospedaliera S. Giovanni Battista (Molinette) Torino, Italy Dipartimento di Medicina Clinica e Sperimentale - Università di Verona Verona, Italy Divisione di Ematologia - Presidio Ospedaliero S. Bortolo Vicenza, Italy Less <<
NCT00072592 Wegener's Granulomatosis Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT01285765 DLBCL Phase 3 Active, not recruiting December 2020 -
NCT00308178 Breast Cancer Not Applicable Completed - United States, Massachusetts ... More >> Massacusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00005780 Mantle Cell Lymphoma ... More >> Lymphoma, Mantle Cell Less << Phase 2 Active, not recruiting June 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00355199 - Completed - -
NCT00353860 Immunosuppression ... More >> Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00049517 - Active, not recruiting - -
NCT00049517 Leukemia Phase 3 Active, not recruiting January 2019 -
NCT00031005 Leukocyte-Adhesion Deficiency ... More >>Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00001144 Chronic Myeloid Leukemia ... More >> Graft vs Host Disease Less << Phase 2 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT03715296 - Not yet recruiting September 15, 2020 China, Shanghai ... More >> Ruijin hospital Shanghai, Shanghai, China, 200025 Less <<
NCT03666871 HIV Infections Phase 1 Phase 2 Not yet recruiting February 28, 2024 -
NCT00678327 Lymphoma Phase 3 Active, not recruiting December 2018 United Kingdom ... More >> Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Less <<
NCT00001863 Uveitis Phase 2 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT03198689 Diffuse Cutaneous Systemic Scl... More >>erosis Less << Phase 2 Not yet recruiting June 1, 2019 Canada, Ontario ... More >> Rheumatology Clinic, St. Joseph's Health Care Not yet recruiting London, Ontario, Canada, N6A 4V2 Contact: Janet E Pope    519-646-6332    janet.pope@sjhc.london.on.ca    Principal Investigator: Janet E Pope          Sub-Investigator: Tatiana Nevskaya          Sub-Investigator: Louise Vanderhoek          Sub-Investigator: Sara Hewitt Less <<
NCT03720496 Non-hodgkin Lymphoma,B Cell Phase 1 Recruiting December 1, 2021 China, Hainan ... More >> The Second Affiliated Hospital of Hainan Medical University Recruiting Haikou, Hainan, China, 570100 Contact: Haifeng Lin    +86 13322060949    13322060949@163.com    Contact: Yasong Wu    +86 18020091931    yasong.wu@timmune.com Less <<
NCT03497533 Non-hodgkin Lymphoma,B Cell Phase 1 Phase 2 Recruiting December 31, 2020 China, Hunan ... More >> Hunan Provincial People's Hospital Recruiting Changsha, Hunan, China, 410005 Contact: Jianjun Chen    +86 0731 83928147       Contact: Ming Zhou    +86 0731 83928145    zhouming_0321@163.com Less <<
NCT00040508 Focal Glomerulosclerosis Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00230035 Systemic Lupus Erythematosus Phase 2 Withdrawn(Recommended by DSMB ... More >>due to lack of accrual) Less << - United States, California ... More >> UCSD, Thornton Hospital La Jolla, California, United States, 92037-0943 UCLA, Rehabilitation Center Los Angeles, California, United States, 90095-1670 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New York Feinstein Institute for Medical Research NS-LIJ Health System Manhassat, New York, United States, 11030 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27709 Less <<
NCT01947322 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - France ... More >> Service d'Hématologie Clinique du Pr. Leblond- Hôpital Pitié salpêtrière Paris, France, 75013 Service d'Hématologie adultes du Pr. Hermine - Hôpital Necker Enfants Malades Paris, France, 75015 Service d'Hématologie oncologie du Pr. Mohty -Hôpital Saint Antoine Paris, France, 75571 Service d'Hématologie Clinique du Pr. Cordonnier-Hôpital Henri Mondor Paris, France, 94010 Less <<
NCT03153462 - - - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Contact: Elizabeth Budde, MD       ebudde@coh.org    Stanford Cancer Institute Stanford, California, United States, 94305 Contact: Julianna Craig       jkcraig@stanford.edu    United States, Florida H. Lee Moffitt Cancer and Research Institute Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 Contact: Linda Schroeder       lschroed@medicine.bsd.uchicago.edu    Principal Investigator: Peter Reidell, MD          United States, Kansas The University of Kansas Hospital Investigational Drug Services Westwood, Kansas, United States, 66205 Contact: Renee Sol       rsol@kumc.edu    United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Contact: Michael Rocchio       michaelj_rocchio@dfci.harvard.edu    United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Contact: Kristin Arends       arends.kristen@mayo.edu    United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6840 Contact: Susan Blumel    402-559-9183    sblumel@unmc.edu    United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Contact: Miguel-Angel Perales, MD       peralesm@MSKCC.ORG    United States, Ohio James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski       nicole.szuminski@osumc.edu    United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Contact: Sherry Adkins       sadkins@mdanderson.org    Contact: Liliana Vallejo       lnvallejo@mdanderson.org Less <<
NCT00001737 Eye Disease I... More >>nflammation Uveitis Less << Phase 1 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT03463057 NHL DLBCL Phase 2 Recruiting April 2025 Belgium ... More >> UZ Antwerpen Not yet recruiting Antwerpen, Belgium Principal Investigator: A. Gadisseur          ZNA Not yet recruiting Antwerpen, Belgium Principal Investigator: K.L. Wu          AZ St Jan Brugge Not yet recruiting Brugge, Belgium Principal Investigator: S. Snauwaert          UZ Leuven Not yet recruiting Leuven, Belgium Principal Investigator: G.E.G. Verhoef          AZ Delta Not yet recruiting Roeselare, Belgium Principal Investigator: D. Deeren          Netherlands Meander Medisch Centrum Not yet recruiting Amersfoort, Netherlands Principal Investigator: R. Fijnheer          OLVG Oost Not yet recruiting Amsterdam, Netherlands Principal Investigator: W.E. Terpstra          VUmc Not yet recruiting Amsterdam, Netherlands Principal Investigator: J.M. Zijlstra          Amphia Ziekenhuis Not yet recruiting Breda, Netherlands Principal Investigator: R.S. Boersma          Reinier de Graaf Groep Not yet recruiting Delft, Netherlands Principal Investigator: R.E. Brouwer          Jeroen Bosch Ziekenhuis Not yet recruiting Den Bosch, Netherlands Principal Investigator: D.E. Issa          Haga hospital Not yet recruiting Den Haag, Netherlands Principal Investigator: L.H. Böhmer          Albert Schweitzer Ziekenhuis Not yet recruiting Dordrecht, Netherlands Principal Investigator: H.W.A. Berenschot          Ziekenhuis Gelderse Vallei Not yet recruiting Ede, Netherlands Principal Investigator: G. Velders          Catharina Ziekenhuis Not yet recruiting Eindhoven, Netherlands Principal Investigator: M.R. Nijziel          Maxima Medisch Centrum Not yet recruiting Eindhoven, Netherlands Principal Investigator: L. Nieuwenhuizen          Medisch Spectrum Twente Not yet recruiting Enschede, Netherlands Principal Investigator: R.J.F. Snijders          UMCG Recruiting Groningen, Netherlands Principal Investigator: M. Nijland          Tergooi Ziekenhuizen Not yet recruiting Hilversum, Netherlands Principal Investigator: M.H. Silbermann          Spaarne Gasthuis Not yet recruiting Hoofddorp, Netherlands Principal Investigator: A. Beeker          Medisch Centrum Leeuwarden Not yet recruiting Leeuwarden, Netherlands Principal Investigator: R.S. van Rijn          LUMC Not yet recruiting Leiden, Netherlands Principal Investigator: J. Vermaat          MUMC Not yet recruiting Maastricht, Netherlands Principal Investigator: M. van der Poel          St. Antonius Ziekenhuis Not yet recruiting Nieuwegein, Netherlands Principal Investigator: H.R. Koenen          Canisius Wilhelmina Ziekenhuis Not yet recruiting Nijmegen, Netherlands Principal Investigator: C.M.P.W. Mandigers          Radboud Umc Withdrawn Nijmegen, Netherlands Erasmus MC Not yet recruiting Rotterdam, Netherlands Principal Investigator: P.J. Lugtenburg          Maasstad Ziekenhuis Not yet recruiting Rotterdam, Netherlands Principal Investigator: M.B.L. Leijs          Zuyderland Medisch Centrum Not yet recruiting Sittard, Netherlands Principal Investigator: R.J.W. van Kampen          Elisabeth/Tweesteden Ziekenhuis Not yet recruiting Tilburg, Netherlands Principal Investigator: M.F. Durian          UMCU Not yet recruiting Utrecht, Netherlands Principal Investigator: M.C. Minnema          Isala Klinieken Not yet recruiting Zwolle, Netherlands Principal Investigator: O. Visser Less <<
NCT03289455 B Acute Lymphoblastic Leukemia... More >> Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia B-cell Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting December 2021 United Kingdom ... More >> Great Ormond Street Hospital for Children NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Professor Persis Amrolia          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rachael Hough          Royal Manchester Children's Hospital Recruiting Manchester, United Kingdom Principal Investigator: Professor Robert Wynn Less <<
NCT00004990 Glomerulonephritis ... More >> Nephrotic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00801931 Leukemia Lymp... More >>homa Neuroblastoma Immunodeficiencies Anemia Less << Phase 1 Phase 2 Terminated(Poor accrual) - United States, New York ... More >> Columbia Presbyterian Medical Center New York, New York, United States, 10032 Less <<
NCT00079391 Hematologic Malignancies ... More >> Bone Marrow Transplant Rejection Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01724879 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Less << Phase 2 Completed - Germany ... More >> Robert Bosch Krankenhaus Stuttgart, Baden-Württemberg, Germany, 70376 Klinikum der Universität Regensburg Regensburg, Bayern, Germany, 93042 University Hospital of Frankfurt, Medical Dept. II Frankfurt, Hessen, Germany, 60590 Medizinische Hochschule Hannover Hannover, Niedersachsen, Germany, 30625 Universitätsklinikum Essen Essen, NRW, Germany, 45147 Universitätsklinik Münster Münster, NRW, Germany, 48149 Universitätsklinik Dresden Dresden, Sachsen, Germany, 01307 Uniklinik Aachen Aachen, Germany, 52074 Charité Universitätsmedizin Berlin Berlin, Germany, 13353 University Hospital Düsseldorf Düsseldorf, Germany, 40225 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Universitätsklinik Köln Köln, Germany, 50937 Universität Leipzig, José-Carreras-Haus Leipzig, Germany, 04103 Universitätskliniken Mainz Mainz, Germany, 55101 Klinikum Mannheim Mannheim, Germany, 68167 Universitätsklinikum Großhadern München, Germany, 81377 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Klinikum Oldenburg Oldenburg, Germany, 26133 Universität Rostock Rostock, Germany, 18055 Medizinische Universitätsklinik Ulm Ulm, Germany, 89070 Medizinische Poliklinik der Universität Würzburg Würzburg, Germany, 97070 Less <<
NCT02495454 CD20 Positive Diffuse Large B-... More >>cell Lymphoma Elderly Unfit Patients Less << Phase 2 Suspended(Primary objective no... More >>t obtained after interim analysis) Less << June 2020 Italy ... More >> A.O. Spedali Civili Brescia, BS, Italy, 25100 AUSL di Ravenna Ravenna, RA, Italy, 48100 Asmn-Irccs Reggio Emilia, RE, Italy, 43123 Ematologia 1U - AO Città della Salute e della Scienza Torino, TO, Italy, 10126 A.O. S. Maria di Terni Terni, TR, Italy, 05100 A.O. SS. Antonio e Biagio e C. Arrigo Alessandria, Italy, 15121 A.O. Universitaria Ospedali Riuniti - Ospedale Umberto I Di Ancona Ancona, Italy, 60126 A.O. Ospedale Degli Infermi Biella, Italy, 13900 Area Vasta Romagna e IRST Meldola (FC), Italy IRCCS, Istituto Nazionale dei Tumori Milano, Italy A.O. Universitaria Policlinico Di Modena Modena, Italy, 41124 SCDU Ematologia - Università del Piemonte Orientale Novara, Italy, 28100 Oncoematologia e TMO Dopartimento Oncologia La Maddalena Palermo, Italy Ausl Di Piacenza Piacenza, Italy, 29121 Ausl Di Rimini Rimini, Italy, 47924 UOC Ematologia - A.O. Sant'Andrea Roma, Italy A.O. Universitaria Senese Siena, Italy, 53100 Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI Varese, Italy, 21100 Less <<
NCT01087424 Diffuse Large B-Cell Lymphoma Phase 2 Completed - -
NCT01799460 - Unknown August 2013 China, Shanghai ... More >> Shanghai University of Traditional Chinese Medicine Recruiting Shanghai, Shanghai, China, 200032 Contact: Wang Lin, PHD    86-13816583673    happytlynn@163.com Less <<
NCT01528085 Philadelphia Chromsome Positiv... More >>e Acute Lymphoblastic Leukemia Less << Phase 2 Unknown November 2018 -
NCT00004853 Ewing's Sarcoma ... More >> Rhabdomyosarcoma MPNST Synovial Sarcoma High-risk Sarcoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00007345 Cutaneous T Cell Lymphoma ... More >> Peripheral T Cell Lymphoma Less << Phase 2 Completed - United States, Arizona ... More >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259 United States, Arkansas University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope National Cancer Center Duarte, California, United States, 91010 Mercy General Hospital Sacramento, California, United States, 95819 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007-2197 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New York North Shore University Hospital Manhasset, New York, United States, 11030 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 Australia Royal Adelaide Hospital Adelaide, Australia Peter MacCallum Cancer Centre Melbourne, Australia Sir Charles Gairdner Hospital Perth, Australia Less <<
NCT00001959 - Completed - -
NCT00079391 - Completed - -
NCT00131612 - Terminated(did not apply for e... More >>thics renewal) Less << - Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00001959 Fibrosis Foca... More >>l Glomerulosclerosis Kidney Failure Nephrotic Syndrome Proteinuria Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02115984 Breast Cancer Phase 2 Completed - -
NCT03236129 Hematological Malignancies ... More >> Regulatory T Cell Depletion Relapse Less << Phase 3 Not yet recruiting September 2021 France ... More >> Henri Mondor Hospital Not yet recruiting Creteil, France, 94010 Contact: Damien VANHOYE, PhD    (0)1 44 84 17 93 ext +33    damien.vanhoye@drc.aphp.fr    Contact: Laetitia GREGOIRE, M. Sc    (0)1 49 81 41 64 ext +33    Laetitia.gregoire@aphp.fr Less <<
NCT00477906 Melanoma Phase 3 Not yet recruiting January 2021 -
NCT00007345 - Completed - -
NCT02605694 Lymphoma Phase 2 Withdrawn(Sponsor is focusing ... More >>on studies which can enable registration of duvelisib) Less << - United States, Florida ... More >> Miami, Florida, United States, 33133 Less <<
NCT01430013 T Cell Lymphoma Phase 2 Unknown December 2015 China, Tianjin ... More >> Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin, China, 300060 Less <<
NCT03586297 - Recruiting May 1, 2021 United States, District of Col... More >>umbia Georgetown University Recruiting Washington, District of Columbia, United States, 20057 Contact: Caroline Jackman    202-687-8469    cj514@georgetown.edu    Principal Investigator: Eleni Tousimis, MD          United States, New Jersey Hackensack UMC Recruiting Hackensack, New Jersey, United States, 07601 Contact: Sara Hyman, BA    551-996-4381    Sara.Hyman@hackensackmeridian.org    Principal Investigator: Leslie Montgomery, MD          Sub-Investigator: Rena Feinman, PhD          Sub-Investigator: Robert Korngold, PhD          Sub-Investigator: Mary-Jane Warden, MD          Sub-Investigator: Tara Balija, MD          Sub-Investigator: Marson Davidson, MD          Sub-Investigator: Deena Graham, MD          Sub-Investigator: Gail Starr, MD          Sub-Investigator: Ciaran Mannion, MD          Sub-Investigator: Christopher Koenig, MD Less <<
NCT00001865 Behcet's Syndrome ... More >> Retinal Disease Uveitis Less << Phase 2 Completed - United States, Maryland ... More >> National Eye Institute (NEI) Bethesda, Maryland, United States, 20892 Less <<
NCT00280826 Uveitis Macul... More >>ar Edema Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02115984 - Completed - -
NCT00054327 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00054327 - Completed - -
NCT00005596 Leukemia Phase 3 Completed - -
NCT01764230 Hodgkin Lymphoma ... More >> Hodgkin Disease Less << Not Applicable Completed - Czech Republic ... More >> Brno University Hospital and Masaryk University School of Medicine Brno, Czech Republic, 62500 Less <<
NCT00006436 Lymphoma, AIDS-related ... More >> Lymphoma, Large B-Cell, Diffuse Less << Phase 2 Recruiting March 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT03123718 DLBCL Phase 3 Not yet recruiting June 30, 2021 Korea, Republic of ... More >> Chonnam National University Hwasun Hospital Hwasun-gun, Jeollanam-do, Korea, Republic of, 519-809 Less <<
NCT00531973 Breast Cancer Phase 4 Unknown December 2009 Italy ... More >> Catholic University Recruiting Rome, RM, Italy, 00168 Contact: Marzia Lotrionte, MD    +39-3470717591    marzial76@yahoo.it    Principal Investigator: Marzia Lotrionte, MD Less <<
NCT00280826 - Completed - -
NCT00869284 Lymphoma Phase 2 Completed - France ... More >> Emmanuel Gyan Tours, France, 37000 Less <<
NCT01174108 Severe Aplastic Anemia ... More >> MDS (Myelodysplastic Syndrome) Less << Phase 2 Recruiting June 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov    University of Maryland at Baltimore/MPRC Recruiting Catonsville, Maryland, United States, 21228 Contact: Nancy Hardy, M.D.    410-328-1230    nhardy12@umm.edu Less <<
NCT00074490 Lymphoma Leuk... More >>emia Myeloproliferative Disorders Multiple Myleoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States Less <<
NCT00206453 Breast Cancer Phase 2 Terminated(accrual too difficu... More >>lt to meet) Less << - United States, Texas ... More >> Baylor Breast Center Houston, Texas, United States, 77030 Less <<
NCT03638206 B-cell Acute Lymphoblastic Leu... More >>kemia Lymphoma Myeloid Leukemia Multiple Myeloma Hepatoma Gastric Cancer Pancreatic Cancer Mesothelioma Colorectal Cancer Esophagus Cancer Lung Cancer Glioma Melanoma Synovial Sarcoma Ovarian Cancer Renal Carcinoma Less << Phase 1 Phase 2 Recruiting March 1, 2023 China, Henan ... More >> The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Yi Zhang, MD, PhD    86-15138928971    yizhang@zzu.edu.cn Less <<
NCT01701674 - Active, not recruiting - -
NCT01553981 Lung Diseases, Interstitial Phase 3 Completed - India ... More >> SGPGIMS Lucknow, UP, India, 226014 Less <<
NCT01092182 Burkitt Lymphoma ... More >> Diffuse Large B-cell Lymphoma, c-MYC Positive Plasmablastic Lymphoma Less << Phase 2 Active, not recruiting February 28, 2023 United States, Iowa ... More >> Mercy Medical Center-Sioux City Sioux City, Iowa, United States Saint Luke's Regional Medical Center Sioux City, Iowa, United States Siouxland Hematology Oncology Associates LLP Sioux City, Iowa, United States United States, Kansas Providence Medical Center Kansas City, Kansas, United States Menorah Medical Center Overland Park, Kansas, United States Saint Luke's South Hospital Overland Park, Kansas, United States Kansas City CCOP Prairie Village, Kansas, United States Shawnee Mission Medical Center-KCCC Shawnee Mission, Kansas, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Massachusetts Massachusetts General Dana Farber and Beth Israel Cancer Centers Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States United States, Missouri Heartland Hematology and Oncology Associates Incorporated Kansas City, Missouri, United States Liberty Radiation Oncology Clinic Kansas City, Missouri, United States North Kansas City Hospital Kansas City, Missouri, United States Research Medical Center Kansas City, Missouri, United States Saint Luke's Hospital of Kansas City Kansas City, Missouri, United States Saint Luke's East - Lee's Summit Lee's Summit, Missouri, United States Heartland Regional Medical Center Saint Joseph, Missouri, United States Saint Joseph Oncology Inc Saint Joseph, Missouri, United States Washington University School of Medicine Saint Louis, Missouri, United States United States, Ohio Cleveland Clinic Beachwood Beachwood, Ohio, United States Cleveland Clinic Transplantation Clinic Cleveland, Ohio, United States Cleveland Clinic Cleveland, Ohio, United States Fairview Hospital Cleveland, Ohio, United States Cleveland Clinic Independence Independence, Ohio, United States Hillcrest Hospital Mayfield Heights, Ohio, United States Parma Community General Hospital Parma, Ohio, United States North Coast Cancer Care Sandusky, Ohio, United States Cleveland Clinic Strongsville Strongsville, Ohio, United States Cleveland Clinic Wooster Wooster, Ohio, United States United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-4096 Less <<
NCT02616848 Triple Negative Breast Cancer Phase 1 Unknown - Italy ... More >> AO Cremona Recruiting Cremona, Lombardia, Italy, 26100 Contact: Daniele Generali, Prof    daniele.genrali@gmail.com    daniele.generali@gmail.com Less <<
NCT00001561 Graft vs Host Disease ... More >> Multiple Myeloma Less << Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00604201 Myelodysplastic Syndrome (MDS)... More >> Severe Aplastic Anemia (SAA) Less << Phase 2 Recruiting December 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT01270373 Breast Cancer Phase 2 Active, not recruiting December 2018 Brazil ... More >> Hospital do Cancer III Rio de Janeiro, Brazil, 20560-120 Less <<
NCT01022021 Lymphoma Early Phase 1 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66205 Less <<
NCT01304849 Hodgkin's Lymphoma Not Applicable Completed - India ... More >> Department of Medical Oncology, Cancer Institute (WIA), Adyar Chennai, Tamil Nadu, India, 600020 Less <<
NCT00507780 Ovarian Function ... More >> Preservation of Ovarian Function Less << Phase 4 Withdrawn - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01867229 - Unknown December 2014 Belgium ... More >> Clinique Saint Vincent Not yet recruiting Rocourt, Liège, Belgium, 4000 Contact: Michel Masson          Principal Investigator: Michel Masson          Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Martine Berlière    +32 2 7641075    martine.berlière@uclouvain.be    Contact: Nathalie Blondeel    +32 2 764 42 14    nathalie.blondeel@uclouvain.be    Principal Investigator: Martine Berlière          Centre Hospitalier Université de Liège Not yet recruiting Liège, Belgium, 4000 Contact: Eric Lifrange       elifrange@chu.ulg.ac.be    Principal Investigator: Eric Lifrange          CHR Citadelle Not yet recruiting Liège, Belgium, 4000 Contact: Annelore Barbeaux       annelore.barbeaux@chrcitadelle.be    Principal Investigator: Annelore Barbeaux          Centre hospitalier Peltzer La Tourelle Recruiting Verviers, Belgium, 4800 Contact: Anne-Lore Barbeaux, MD       annelore.barbeaux@chrcitadelle.be    Principal Investigator: Anne-Lore Barbeaux, MD          France Institut Claudius Renaud Recruiting Toulouse, France, 31059 Contact: Henri Roche       roche.henri@claudiusregaud.fr    Principal Investigator: Henri Roche          Principal Investigator: Florence Dalenc Less <<
NCT00311246 Sarcoidosis Phase 2 Terminated(Difficulty in recru... More >>iting subjects) Less << - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT02879513 Invasive Ductal Breast Cancer ... More >> Tubular Breast Cancer Mucinous Breast Cancer Inflammatory Breast Cancer Less << Phase 3 Recruiting December 2022 China, Shanghai ... More >> Shanghai Jiaotong University School of Medicine, Renji Hospital Recruiting Shanghai, Shanghai, China, 200127 Contact: Jinsong Lu, MD       lujjss@163.com Less <<
NCT03553238 Leukemia, Acute ... More >> Leukemia, T Cell Leukemia, Lymphoblastic Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, MD, PhD    +862062787349    zhs1@i.smu.edu.cn Less <<
NCT00004567 Vasculitis We... More >>gener's Granulomatosis Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00013650 Alzheimer's Disease Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01701674 Metastatic Melanoma Not Applicable Active, not recruiting February 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02298283 Hodgkin Lymphoma Phase 2 Recruiting February 2021 France ... More >> CH Victor Dupouy Recruiting Argenteuil, France, 95100 Contact: Driss CHAOUI, MD       driss.chaoui@ch-argenteuil.fr    Principal Investigator: Driss CHAOUI, MD          Polyclinique Bordeaux Nord Recruiting Bordeaux, France, 33300 Contact: Olivier FITOUSSI, MD       o.fitoussi@bordeauxnord.com    Contact: Olivier          Principal Investigator: FITOUSSI, MD          Centre François Baclesse Recruiting Caen, France, 14076 Contact: Christophe FRUCHART, MD       c.fruchart@baclesse.unicancer.fr    Principal Investigator: Christophe FRUCHART, MD          CH de Chambéry Recruiting Chambéry, France, 73011 Contact: Gian Mathéo PICA, MD       gian-matteo.pica@ch-chambery.fr    Principal Investigator: Gian Mathéo PICA, MD          CH Sud Francilien Recruiting Corbeil-Essonnes, France, 91108 Contact: Bertrand JOLY, MD       bertrand.joly@ch-sud-francilien.fr    Principal Investigator: Bertrand JOLY, MD          Hôpital Henri Mondor Recruiting Creteil, France, 94010 Contact: Corinne HAIOUN, Prof       corinne.haioun@hmn.aphp.fr    Principal Investigator: Corinne HAIOUN, Prof          CHU de Dijon - Hôpital le Bocage Recruiting Dijon, France, 21034 Contact: Olivier CASASNOVAS, MD       olivier.casasnovas@chu-dijon.fr    Principal Investigator: Olivier CASASNOVAS, MD          Hôpital André Mignot Recruiting Le Chesnay, France, 78157 Contact: Hassan FARHAT, MD       hfarhat@ch-versailles.fr    Principal Investigator: Hassan FARHAT, MD          Clinique Victor Hugo Recruiting Le Mans, France, 72000 Contact: Katell LE DÛ, MD       k.ledu@cjb72.org    Principal Investigator: Katell LE DÛ, MD          CHRU Lille - Hôpital Claude Huriez Recruiting Lille, France, 59037 Contact: Franck MORSCHHAUSER, Prof       franck.morschhauser@chru-lille.fr    Principal Investigator: Franck MORSCHHAUSER, Prof          CHU de Limoges Recruiting Limoges, France, 87042 Contact: Mohamed TOUATI, MD       mohamed.touati@chu-limoges.fr    Principal Investigator: Mohamed TOUATI, MD          Centre Léon Bérard Recruiting Lyon, France, 69008 Contact: Emmanuelle NICOLAS- VIRELIZIER, MD       emmanuelle.nicolas@lyon.unicancer.fr    Principal Investigator: Emmanuelle NICOLAS- VIRELIZIER, MD          Institut Paoli Calmette Recruiting Marseille, France, 13273 Contact: Réda BOUABDALLAH, MD       bouabdallahr@ipc.unicancer.fr    Principal Investigator: Réda BOUABDALLAH, MD          Hôpital de la Conception Recruiting Marseille, France, 13385 Contact: Régis COSTELLO, Prof       regis.costello@free.fr    Principal Investigator: Régis COSTELLO, Prof          CHU Montpellier - Saint ELOI Recruiting Montpellier, France, 34295 Contact: Philippe QUITTET, MD       p-quittet@chu-montpellier.fr    Principal Investigator: Philippe QUITTET, MD          CHU de Nantes Recruiting Nantes, France, 44093 Contact: Thomas GASTINNE, MD       thomas.gastinne@chu-nantes.fr    Principal Investigator: Thomas GASTINNE, MD          Hôpital Saint Louis Recruiting Paris cedex 10, France, 75475 Contact: Pauline BRICE, MD       pauline.brice@sls.aphp.fr    Principal Investigator: Pauline BRICE, MD          Hôpital Cochin Recruiting Paris, France, 75004 Contact: Bénédicte DEAU-FISCHER, MD       benedicte.deau-fischer@cch.aphp.fr    Principal Investigator: Bénédicte DEAU-FISCHER, MD          Hôpital de la Pitié Salpétrière Recruiting Paris, France, 75651 Contact: Jean GABARRE, MD       jean.gabarre@psl.aphp.fr    Principal Investigator: Jean GABARRE, MD          CH Perpignan Recruiting Perpignan, France, 66046 Contact: Laurence SANHES, MD       laurence.sanhes@ch-perpignan.fr    Principal Investigator: Laurence SANHES, MD          Hôpital Haut Lévêque Recruiting Pessac, France, 33604 Contact: Krimo BOUABDALLAH, MD       krimo.bouabdallah@chu-bordeaux.fr    Principal Investigator: Krimo BOUABDALLAH, MD          CHU Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Contact: Gilles SALLES, Prof       gilles.salles@chu-lyon.fr    Principal Investigator: Gilles SALLES, Prof          CHU Robert Debre Recruiting Reims, France, 51092 Contact: Alain DELMER, MD       adelmer@chu-reims.fr    Principal Investigator: Alain DELMER, MD          CHU Pontchaillou Recruiting Rennes, France, 35033 Contact: Thierry LAMY de la CHAPELLE, Prof       thierry.lamy.de.la.chapelle@chu-rennes.fr    Principal Investigator: Thierry LAMY de la CHAPELLE, Prof          Centre Henri Becquerel Recruiting Rouen, France, 76000 Contact: Aspasia STAMATOULLAS, MD       aspasia.stamatoullas@chb.unicancer.fr    Principal Investigator: Aspasia STAMATOULLAS, MD          CHU de Strasbourg Recruiting Strasbourg, France, 67098 Contact: Luc-Matthieu FORNECKER, MD       luc-matthieu.fornecker@chru-strasbourg.fr    Principal Investigator: Luc-Matthieu FORNECKER, MD          I.U.C.T Oncopole Recruiting Toulouse, France, 31059 Contact: Cécile BOREL, MD       borel.c@chu-toulouse.fr    Principal Investigator: Cécile BOREL, MD          CHU Bretonneau Recruiting Tours, France, 37044 Contact: Marjan ERTAULT, MD       m.ertault@chu-tours.fr    Principal Investigator: Marjan ERTAULT, MD          CHU de Brabois Recruiting Vandœuvre-lès-Nancy, France, 54511 Contact: Serge BOLOGNA, MD       s.bologna@chu-nancy.fr    Principal Investigator: Serge BOLOGNA, MD          Gustave Roussy Cancer Campus Recruiting Villejuif, France, 94805 Contact: Vincent RIBRAG, MD       vincent.ribrag@gustaveroussy.fr    Principal Investigator: Vincent RIBRAG, MD Less <<
NCT03563144 Metastatic Pancreatic Cancer Phase 2 Not yet recruiting December 30, 2019 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00064337 - Completed - -
NCT01049854 Leukemia Lymp... More >>homa Bone Marrow Failure Immunodeficiencies Histiocytosis Sickle Cell Disease Beta Thalassemia Inborn Errors of Metabolism Less << Phase 2 Completed - United States, New York ... More >> New York Medical College Valhalla, New York, United States, 10595 Less <<
NCT00064337 Multiple Myeloma ... More >> Plasma Cell Myeloma Less << Phase 2 Completed - -
NCT02198248 Anti-Neutrophil Cytoplasmic An... More >>tibody-Associated Vasculitis Microscopic Polyangiitis Wegener Granulomatosis Less << Phase 4 Recruiting September 2020 Japan ... More >> Asahi General Hospital Recruiting Asahi, Chiba, Japan Contact: Shinichiro Kagami, M.D., Ph.D          Principal Investigator: Shinichiro Kagami, M.D., Ph.D          Teikyo University Medical Centre Not yet recruiting Ichihara, Chiba, Japan Contact: Noboru Hagino, M.D., Ph.D.          Principal Investigator: Noboru Hagino, M.D., Ph.D.          Kameda Medical Centre Recruiting Kamogawa, Chiba, Japan Contact: Shinji Motoshima, M.D., Ph.D.          Principal Investigator: Shinsji Motoshima, M.D., Ph.D.          Matsudo City Hospital Recruiting Matsudo, Chiba, Japan Contact: Tsuyoshi Umibe, M.D., Ph.D          Principal Investigator: Tsuyoshi Umibe, M.D., Ph.D          Saiseikai Narashino Hospital Recruiting Narashino, Chiba, Japan Contact: Yasushi Nawata, M.D., Ph.D          Principal Investigator: Yasushi Nawata, M.D., Ph.D          Japanese Red Cross Narita Hospital Recruiting Narita, Chiba, Japan Contact: Masaki Hiraguri, M.D., Ph.D          Principal Investigator: Masaki Hiraguri, M.D., Ph.D          Juntendo University Urayasu Hospital Recruiting Urayasu, Chiba, Japan Contact: Iwao Sekikawa, M.D., Ph.D          Principal Investigator: Iwao Sekikawa, M.D., Ph.D          Sub-Investigator: Shinji Morimoto, M.D., Ph.D          Tokyo Women's Medical University Yachiyo Medical Center Not yet recruiting Yachiyo, Chiba, Japan Contact: Yohei Seto, M.D., Ph.D          Principal Investigator: Yohei Seto, M.D., Ph.D          Shimoshizu Hospital Recruiting Yotsukaido, Chiba, Japan Contact: Takao Sugiyama, M.D., Ph.D          Principal Investigator: Takao Sugiyama, M.D., Ph.D          University of Occupational and Environmental Health Recruiting Kitakyushu, Fukuoka, Japan Contact: Yoshiya Tanaka, MD, PhD          Hokkaido University Recruiting Sapporo, Hokkaido, Japan Contact: Tatsuya Atsumi, MD, PhD          Hitachinaka General Hospital Recruiting Katsuta, Ibaragi, Japan Contact: Taichi Hayashi, M.D., Ph.D          Principal Investigator: Taichi Hayashi, M.D., Ph.D          University of Tsukuba Recruiting Tsukuba, Ibaragi, Japan Contact: Takayuki Sumida, M.D., Ph.D          Principal Investigator: Takayuki Sumida, M.D., Ph.D          Sub-Investigator: Atsuhiro Kondo, M.D., Ph.D          St. Marianna University School of Medicine Hospital Recruiting Kawasaki, Kanagawa, Japan Contact: Hidehiro Yamada, M.D., Ph.D.          Contact: Mamiko Shimizu          Yokohama City University Recruiting Yokohama, Kanagawa, Japan Contact: Yoshiaki Ishigatsubo, M.D., Ph.D          Principal Investigator: Yoshiaki Ishigatsubo, M.D., Ph.D          Sub-Investigator: Ryusuke Yoshimi, M.D., Ph.D          Yokohama Rosai Hospital Recruiting Yokohama, Kanagawa, Japan Contact: Yasuhiko Kita, M.D., Ph.D          Principal Investigator: Yasuhiko Kita, M.D., Ph.D          Tohoku Recruiting Sendai, Miyagi, Japan Contact: Tomonori Ishii, MD, PhD          Shinshu University Recruiting Matsumoto, Nagano, Japan Contact: Shuichi Ikeda, M.D., Ph.D.          Contact: Yasuhiro Shimojima, M.D., Ph.D.          Saitama Medical Center Recruiting Kawagoe, Saitama, Japan Contact: Kouichi Amano, M.D., Ph.D          Principal Investigator: Kouichi Amano, M.D., Ph.D          Sub-Investigator: Ryota Sakai, M.D., Ph.D          Dokkyo Medical University Recruiting Mibu, Tochigi, Japan Contact: Kazuhiro Kurasawa, M.D., Ph.D          Principal Investigator: Kazuhiro Kurasawa, M.D., Ph.D          Sub-Investigator: Takayoshi Owada, M.D., Ph.D          Teikyo University Recruiting Itabashi, Tokyo, Japan Contact: Hajime Kono, M.D., Ph.D          Principal Investigator: Hajime Kono, M.D., Ph.D          Sub-Investigator: Shunya Uchida, M.D., Ph.D          Keio University Hospital Recruiting Shinanomachi, Tokyo, Japan Contact: Tsutomu Takeuchi, MD, PhD          Akita University Recruiting Akita, Japan Contact: Atsushi Komatsuda, MD, PhD          Chiba University Hospital Recruiting Chiba, Japan, 260-8677 Contact: Shunsuke Furuta, M.D., Ph.D          Sub-Investigator: Shunsuke Furuta, M.D., Ph.D          Principal Investigator: Hiroshi Nakajima, M.D., Ph.D          Sub-Investigator: Kei Ikeda, M.D., Ph.D          Chiba Aoba Municipal Hospital Recruiting Chiba, Japan Contact: Yoshihisa Kobayashi, M.D., Ph.D          Principal Investigator: Yoshihisa Kobayashi, M.D., Ph.D          Chiba East Hospital Recruiting Chiba, Japan Contact: Ryutaro Matsumura, M.D., Ph.D          Principal Investigator: Ryutaro Matsumura, M.D., Ph.D          Fukushima Medical University Recruiting Fukushima, Japan Contact: Hiroshi Watanabe, M.D., Ph.D.          Principal Investigator: Hiroshi Watanabe, M.D., Ph.D.          Nagasaki University Recruiting Nagasaki, Japan Contact: Atsushi Kawakami, MD, PhD          Niigata University Recruiting Niigata, Japan Contact: Ichiei Narita, Prof          Principal Investigator: Ichiei Narita, M.D., Ph.D.          Osaka University Recruiting Osaka, Japan Contact: Atsushi Kumanogoh, MD, PhD          National Center for Global Health and Medicine Not yet recruiting Tokyo, Japan Contact: Akio Mimori, M.D., Ph.D          Principal Investigator: Akio Mimori, M.D., Ph.D          Sub-Investigator: Hiroshi Kaneko, M.D., Ph.D Less <<
NCT01883180 Hematopoietic Stem Cell Transp... More >>lantation Antithymocyte Globulin Viral Infection Less << Phase 4 Completed - China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China, 510515 Less <<
NCT03540303 Relapsed Non Hodgkin Lymphoma Phase 1 Recruiting April 30, 2020 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Quanli Gao, M.D    +86-15038171966    gaoquanli2015@126.com    Contact: Lu Han, M.D    +86-13838583031    luhan0377@163.com Less <<
NCT02553460 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2031 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Paul Gaynon, MD    323-361-4110    pgaynon@chla.usc.edu    Principal Investigator: Paul Gaynon, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92868 Contact: Ivan Kirov, MD    714-997-3000    ikirov@choc.org    Principal Investigator: Ivan Kirov, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Minnesota Children's Hospital and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55102 Contact: Michael Richards, MD    612-813-5193    Michael.richards@childrensmn.org    Principal Investigator: Michael Richards, MD          United States, North Carolina St. Jude Affiliate-Charlotte Recruiting Charlotte, North Carolina, United States, 28204 Contact: Christine Bolen, MD    704-384-1900    cybolen@novanthealth.org    Principal Investigator: Christine Bolen, MD          United States, Ohio Cincinnati Children's Hospital Recruiting Cincinnati, Ohio, United States, 45229 Contact: Erin Breese, MD, PhD    513-636-2799    erin.breese@cchmc.org    Principal Investigator: Erin Breese, MD, PhD          Rainbow Babies & Children's Hospital Recruiting Cleveland, Ohio, United States, 44106 Contact: Yousif Matloub, MD    216-844-5437    yousif.matloub@uhhospitals.org    Principal Investigator: Yousif Matloub, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: Bill Chang, MD    503-494-1080    changb@ohsu.edu    Principal Investigator: Bill Chang, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Virginia Children's Hospital of the King's Daughters (CHKD) Recruiting Norfolk, Virginia, United States, 23507 Contact: Eric Lowe, MD    757-668-7243    eric.lowe@chkd.org    Principal Investigator: Eric Lowe, MD          Canada, Alberta Alberta Children's Hospital Recruiting Calgary, Alberta, Canada, T3A 6A8 Contact: Victor A. Lewis, MD    403-220-6898    victor.lewis@ahs.ca    Principal Investigator: Victor A. Lewis, MD          Stollery Children's Hospital Recruiting Edmonton, Alberta, Canada, T6G 2B7 Contact: Sunil Desai, M.B.Ch.B., FRCP(c)    780-248-5415    sunil.desai@ahs.ca    Principal Investigator: Sunil Desai, M.B.Ch.B., FRCP(c)          Canada, British Columbia Children's & Women's Health Centre of British Columbia Recruiting Vancouver, British Columbia, Canada, V6H 3V4 Contact: Kirk R. Schultz, MD    604-875-2345 ext 6477    kschultz@mail.ubc.ca    Principal Investigator: Kirk R. Schultz, MD          Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Recruiting Hamilton, Ontario, Canada, L85 4J9 Contact: Uma Athale, MD    905-521-2100 ext 73376    athaleu@mcmaster.ca    Principal Investigator: Uma Athale, MD          Canada, Quebec The Montreal Children's Hospital (MUHC-McGill) Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Catherine Vezina, MD    514-412-4445    catherine.vezina@muhc.mcgill.ca    Principal Investigator: Catherine Vezina, MD          Centre Hospitalier Universitaire Sainte-Justine Recruiting Montreal, Quebec, Canada, HcT 1C5 Contact: Henrique Bittencourt, MD    514-345-4931    henrique.bittencourt.hsj@ssss.gouv.qc.ca    Contact: Yvan Samson       yvan.samson@umontreal.ca    Principal Investigator: Henrique Bittencourt, MD          Centre Hospitalier Universitaire de Quebec Recruiting Québec, Quebec, Canada, G1V 4G2 Contact: Bruno Michon, MD    418-525-4444    bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT00610311 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03074149 - Recruiting April 30, 2021 Greece ... More >> Gen. Hosp. of Chest Diseases "Sotiria", Univ. Resp. Med. Recruiting Athens, Greece, 11527 Contact: Demosthenes Bouros    +302107763559    debouros@gmail.com    Sotiria Hospital Athens, 7th Pulmonary Clinic Recruiting Athens, Greece, 11527 Contact: Likourgos Kolilekas    30-2107763306    lykol@yahoo.gr    University General Hospital Attikon Recruiting Athens, Greece, 124 62 Contact: Spyros Papiris    6932646673    papiris@otenet.gr    University Hospital of Heraklion, University Pulmonology Cl Recruiting Heraklion, Greece, 71100 Contact: Aikaterini Antoniou    +302810 371966    kantoniou@med.uoc.gr    Univ. Gen. Hosp. of Larissa Recruiting Larissa, Greece, 41110 Contact: Zoe Daniil    +302413502898    zdaniil@med.uth.gr    A Pulmonology Clinic "G.Papanikolaou" Hospital Thessaloniki Recruiting Thessaloniki, Greece, 57010 Contact: Aikaterini Markopoulou    +302313307706    markopoulouk@gmail.com    General Hospital of Thessaloniki "G. Papanikolaou" Recruiting Thessaloniki, Greece, 57010 Contact: Despoina Papakosta    +302313307179    depapako@gmail.com Less <<
NCT00610311 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT00630032 Breast Cancer Phase 3 Active, not recruiting September 2019 -
NCT03493854 Early Breast Cancer Phase 3 Recruiting April 4, 2024 -
NCT00025259 Childhood Lymphocyte-Depleted ... More >>Classical Hodgkin Lymphoma Childhood Mixed Cellularity Classical Hodgkin Lymphoma Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma Childhood Nodular Sclerosis Classical Hodgkin Lymphoma Stage I Childhood Hodgkin Lymphoma Stage II Childhood Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT02643589 Hematopoietic Stem Cell Transp... More >>lantation Less << Not Applicable Unknown December 2016 China, Guangdong ... More >> Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Ren Lin    +86-020-62787883    lansinglinren@hotmail.com Less <<
NCT00025259 - Completed - -
NCT00002995 Sarcoma Phase 3 Completed - -
NCT02677714 Breast Cancer ... More >> Doxorubicin Induced Cardiomyopathy Less << Phase 2 Recruiting December 2018 Canada, Ontario ... More >> University of Ottawa Heart Institute Recruiting Ottawa, Ontario, Canada, K1Y 4W7 Contact: Terrence Ruddy, MD, FRCPC, FACC    +1 613-761-4085    TRuddy@ottawaheart.ca    Contact: Marlie Poirier, Clinical Trial Coordinator       mpoirier@ottawaheart.ca    Principal Investigator: Terrence Ruddy, MD, FRCPC, FACC          Sub-Investigator: Kathryn Ascah, MD, FRCPC, FACC          Sub-Investigator: Girish Dwivedi, PhD, MD          Sub-Investigator: Glenn Wells, PhD          Sub-Investigator: Olexiy Aseyev, MD          Sub-Investigator: Susan Dent, MD          Sub-Investigator: John Hilton, MD          Sub-Investigator: Jeffrey Sulpher, MD Less <<
NCT00113919 Multiple Myeloma Phase 1 Phase 2 Terminated(Due to poor accrual... More >>) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States, 72205 University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT03664661 Relapsed/Refractory Myeloma Phase 1 Recruiting April 30, 2020 China, Henan ... More >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Yongping Song    +86-13521186987    ph200811@163.com    Principal Investigator: Yongping Song Less <<
NCT01275287 Anti-Neutrophil Cytoplasmic An... More >>tibody-Associated Vasculitis Less << Phase 2 Withdrawn(the study failed to ... More >>enroll any patient and sponsor wished to stop.) Less << - United States, North Carolina ... More >> UNC Kidney Center Chapel Hill, North Carolina, United States, 27510-7155 Less <<
NCT03344367 Non Hodgkin Lymphoma Phase 1 Recruiting March 2022 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD    +86-10-88196596    zj@bjcancer.org    Contact: Zhitao Ying, MD    +86-10-88196109    yingzhitao001@163.com    Principal Investigator: Jun Zhu, MD          Sub-Investigator: Zhitao Ying, MD Less <<
NCT01659151 Metastatic Melanoma Phase 2 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01854372 Newly Diagnosed Diffuse Large ... More >>B-Cell Lymphoma Intermediate (Burkitt-Like) Lymphoma Less << Phase 2 Withdrawn - -
NCT00113919 - Terminated(Due to poor accrual... More >>) Less << - -
NCT02393833 Breast Cancer Phase 3 Active, not recruiting - Italy ... More >> Istituto Europeo di Oncologia (IEO Milano, Italy Nigeria Ibadan, Nigeria Peru Lima, Peru Less <<
NCT00003396 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT03355859 Non Hodgkin Lymphoma Phase 1 Recruiting March 2022 China, Shanghai ... More >> Ruijin hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili ZHAO, MD, PhD    86-21-64370045 ext 610707    zhao.weili@yahoo.com    Contact: Shu CHENG, MD, PhD    86-21-64370045 ext 665251    orenge@medmail.com.cn    Principal Investigator: Weili ZHAO, MD, PhD          Sub-Investigator: Shu CHENG, MD, PhD Less <<
NCT01597778 Acute Lymphocytic Leukemia ... More >> Acute Myelogenous Leukemia Burkitt's Lymphoma Follicular Lymphoma Hodgkin Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma Less << Phase 3 Active, not recruiting June 2020 -
NCT00186966 Acute Myeloid Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01208896 Lymphoma, Follicular ... More >> Stem Cell Transplantation Less << Phase 2 Completed - France ... More >> University Hospital Angers Angers Cedex 01, Angers, France, 49033 Service Hématologie, Hôpital Minjoz Besançon, France, 25030 Service Hématologie, Hôpital Augustin Morvan Brest, France, 29609 University Hospital, Caen Caen, France Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand Clermont-Ferrand, France, 63000 CHU Grenoble Grenoble, France, 38043 CHRU Lille Lille, France, 59037 CHU Limoges Limoges, France, 87042 Hôpital Edouard Herriot Lyon, France, 69374 Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier Montpellier, France, 34295 CHU Nancy Nancy, France, 54511 Service Hématologie Clinique, CHU -Hôtel Dieu Nantes, France, 44093 Service Hématologie Clinique, Hôpital Archet 1 Nice, France, 06202 APHP Hôpital Necker-Enfants malades Paris, France, 75015 APHP Hôpital Saint Louis Paris, France, 75475 APHP Hôpital Pitié-Salpêtrière Paris, France, 75651 APHP Hôpital Henri-Mondor Paris, France, 94010 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Pessac, France, 33600 CHU Poitiers - La Milétrie Poitiers, France, 86000 Service Hématologie Clinique, Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France Institut de Cancérologie de la Loire Saint Etienne, France, 60008 Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre Strasbourg, France, 67098 Service Hématologie, Hôpital Purpan Toulouse, France, 31059 CHRU Tours Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00828009 Lung Cancer Phase 2 Active, not recruiting June 30, 2023 -
NCT01356680 Hodgkin Lymphoma Phase 3 Active, not recruiting December 2019 Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany Less <<
NCT02323867 Leukemia Lymp... More >>homa Myelodysplasia Less << Phase 2 Recruiting June 2020 United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19103 Contact: Margaret Tartaglione, RN    215-590-4029    tartaglione@email.chop.edu    Contact: Patricia Hankins, RN    215-590-5168    hankinsp@email.chop.edu    Principal Investigator: Nancy J Bunin, MD          Sub-Investigator: Stephan A Grupp, MD, PhD Less <<
NCT02633137 Mantle Cell Lymphoma ... More >> Untreated Less << Phase 2 Active, not recruiting December 2019 United States, New Jersey ... More >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 Memorial Sloan Kettering Bergen Montvale, New Jersey, United States, 07645 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 Less <<
NCT00842114 Non-Hodgkin's Lymphoma Phase 2 Completed - Spain ... More >> Hospital Universitario de La Princesa Madrid, Spain, 28006 Less <<
NCT01099930 Multiple Sclerosis Phase 2 Completed - Canada, Ontario ... More >> Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT03246178 Severe Aplastic Anemia Not Applicable Enrolling by invitation December 1, 2020 China ... More >> Department of Hematology, 304th Clinical Division, Chinese PLA General Hospital Beijing, China, 100048 Less <<
NCT00004224 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Argentina ... More >> Fundacion para la Lucha contra las Enfermedades Neurologicas de la Infancia Buenos Aires, Argentina, 1428 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Italy Fondazione Istituto Nazionale dei Tumori Milan, Italy, 20133 Netherlands Erasmus MC - Sophia Children's Hospital Rotterdam, Netherlands, 3015 GJ Spain Hospital Des Cruces Vizcaya, Spain, 48 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Less <<
NCT03758989 DLBCL Phase 2 Not yet recruiting January 1, 2024 -
NCT00698191 Refractory Systemic Lupus Eryt... More >>hematosus Less << Phase 1 Phase 2 Unknown December 2012 China, Jiangsu ... More >> Department of Rheumatology and Immunology, Nanjing University Medical College Affiliated Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Sun Lingyun, MD    +86 25 83105219    lingyunsun2001@yahoo.com.cn Less <<
NCT00974324 T Cell Lymphoma Phase 2 Unknown September 2011 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Haiyi Guo, MD    86(021)64175590 ext 5008    guohaiyi@csco.org.cn    Sub-Investigator: Haiyi Guo, MD          Principal Investigator: Junning Cao, MD Less <<
NCT00408005 T Acute Lymphoblastic Leukemia... More >> T Lymphoblastic Lymphoma Less << Phase 3 Completed - -
NCT00923364 MDS Immunodef... More >>iciency GATA2 Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01896102 Cerebral Adrenoleukodystrophy ... More >>(CALD) Less << Phase 2 Phase 3 Active, not recruiting December 2021 United States, California ... More >> Mattel Children's Hospital UCLA/Ronald Reagan UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 France Hôpital Bicêtre Le Kremlin-Bicêtre Cedex, France, 94275 United Kingdom Great Ormond Street Hospital for Children NHS Foundation Trust London, United Kingdom, WC1N3JH Less <<
NCT01130194 Follicular Lymphoma Phase 2 Completed - United States, Missouri ... More >> Saint Louis University Cancer Center Saint Louis, Missouri, United States, 63110 Less <<
NCT02339532 Breast Cancer Phase 2 Recruiting June 2023 France ... More >> Institut de Cancerologie de L'Ouest - Site Paul Papin Recruiting Angers, France Principal Investigator: Paule AUGEREAU          Centre Hospitalier Regional Universitaire de Brest - Hôpital Morvan Recruiting Brest, France Principal Investigator: Pierre-François DUPRE          Centre Francois Baclesse Recruiting Caen, France Principal Investigator: Christelle LEVY          Centre Jean Perrin Recruiting Clermont Ferrand, France Principal Investigator: Marie-Ange MOURET REYNIER          Centre Georges-Francois Leclerc Withdrawn Dijon, France Chu de Grenoble - Hopital Michallon Recruiting Grenoble, France Principal Investigator: Mireille MOUSSEAU          Centre Jean Bernard - Clinique Victor Hugo Withdrawn Le Mans, France Centre Oscar Lambret Withdrawn Lille, France Chu de Limoges - Hôpital Dupuytren Recruiting Limoges, France Principal Investigator: Laurence VENAT BOUVET          Centre Leon Berard Not yet recruiting Lyon, France Principal Investigator: Pierre-Etienne HEUDEL          Institut Regional Du Cancer Montpellier Val D'Aurelle Recruiting Montpellier, France Principal Investigator: Véronique D'HONDT          Institut de Cancerologie de L'Ouest - Site Rene Gauducheau Recruiting Nantes-Saint Herblain, France Principal Investigator: Mario CAMPONE          Groupe Hospitalier Les Diaconesses - Croix Saint Simon Withdrawn Paris, France Hôpital Tenon Withdrawn Paris, France Hopital D'Instructions Des Armees Not yet recruiting Saint-Mande, France Principal Investigator: Serge CREMADES          Institut de Cancerologie Lucien Neuwirth Withdrawn Saint-priest-en-jarez, France Centre Paul Strauss Recruiting Strasbourg, France Principal Investigator: Thierry PETIT          Institut de Cancerologie de Lorraine Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France Principal Investigator: Elisabeth LUPORSI Less <<
NCT03671018 B-cell Non-Hodgkin Lymphoma Phase 1 Recruiting September 28, 2023 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 United States, Florida University of Miami Miller School of Medicine Recruiting Miami, Florida, United States, 33136 Less <<
NCT02842138 B-cell Lymphoma Phase 1 Recruiting June 2019 China ... More >> Peking University Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD    +86-10-88196596    zj@bjcancer.org Less <<
NCT00578942 Lymphoma Myel... More >>oma Leukemia Myelodysplasia Solid Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health Systems Durham, North Carolina, United States, 27710 Less <<
NCT01639573 - Recruiting January 2020 United States, California ... More >> Childrens Hospitla Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Andreas O Reiff, MD    323-361-4178 ext 4178    areiff@chla.usc.edu    Contact: Ana A Cabrera, BA    323 361-4178 ext 4178    ancabrera@chla.usc.edu    Principal Investigator: Andreas O Reiff, MD Less <<
NCT00578942 - Completed - -
NCT00590941 Lymphoma Diff... More >>use Large Cell Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00104299 - Completed - -
NCT00104299 Vasculitis We... More >>gener's Granulomatosis Microscopic Polyangiitis Less << Phase 2 Phase 3 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, Massachusetts Boston University Boston, Massachusetts, United States, 02118 United States, Minnesota Mayo Clinic Foundation Rochester, Minnesota, United States, 55905 United States, New York Hospital for Special Surgery New York, New York, United States, 10128 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44195 Netherlands University Hospital Groningen Groningen, Netherlands, 9713 GZ Less <<
NCT01336712 Chronic Leukemia ... More >> Acute Leukemia Hodgkin's Disease Non-Hodgkin's Lymphoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT01190345 Breast Cancer Phase 2 Completed - France ... More >> Jean-Marc EXTRA, MD Marseille, France, 13009 Jean-Yves PIERGA Paris, France Hervé CURE Reims, France Less <<
NCT00923364 - Completed - -
NCT01336712 - Completed - -
NCT02789657 Breast Cancer Phase 2 Recruiting December 2019 United States, Rhode Island ... More >> Rhode Island Hospital and The Miriam Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: Mary Lopresti, MD          Women and Infants hospital of RI Recruiting Providence, Rhode Island, United States, 02905 Contact: Kayla Rosati    401-863-3000    kayla_rosati@brown.edu    Principal Investigator: William Sikov, MD Less <<
NCT02586025 Breast Cancer Phase 3 Active, not recruiting April 30, 2022 China ... More >> The Affiliated Hospital of Military Medical Sciences(The 307th Hospital of Chinese PLA) Beijing, China, 100071 Jilin Cancer Hospital Changchun, China, 130012 the First Hospital of Jilin University Changchun, China, 130021 Fujian Medical University Union Hospital Fujian, China, 350001 Sun Yet-sen University Cancer Center Guangzhou, China, 510060 Guangdong General Hospital Guangzhou, China, 510080 Zhejiang Cancer Hospital Hangzhou, China, 310022 Harbin Medical University Cancer Hospital Harbin, China, 150081 Shandong Cancer Hospital Jinan, China, 250117 The 1st Affiliated Hospital of Nanchang Unversity Nanchang, China, 330006 Jiangsu Province Hospital Nanjing, China, 210036 Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, China, 200025 Fudan University Shanghai Cancer Center Shanghai, China, 200032 Henan Cancer Hospital Zhengzhou, China, 450008 Korea, Republic of Kyungpook National University Medical Center Daegu, Korea, Republic of, 41404 Ajou University Medical Center Gyeonggi-do, Korea, Republic of, 16499 Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Taiwan Taipei Medical University -Shuang Ho Hospital New Taipei City, Taiwan, 23561 China Medical University Hospital; Surgery Taichung, Taiwan, 404 Mackay Memorial Hospital; Dept of Surgery Taipei, Taiwan, 104 Taipei Medical University Hospital Taipei, Taiwan, 110 Wanfang Hospital Taipei, Taiwan, 116 Thailand Bhumibol Adulyadej Hospital; Medicine Bangkok, Thailand, 10220 Srinagarind Hospital, Khon Kaen University; Surgery Khon Kaen, Thailand, 40002 Songklanagarind Hospital; Department of Surgery Songkla, Thailand, 90110 Less <<
NCT00517894 - - - -
NCT03085914 Solid Tumors ... More >>Colorectal Cancer (CRC) Adenocarcinoma (PDAC) Lung Cancer UC (Urothelial Cancer) Head and Neck Cancer Less << Phase 1 Phase 2 Active, not recruiting January 2020 United States, Arizona ... More >> Mayo Clinic Arizona Phoenix, Arizona, United States, 85054 United States, California University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States, 92093 The Angeles Clinic and Research Institute Los Angeles, California, United States, 90025 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Carolina Bio-Oncology Institute, PLLC Huntersville, North Carolina, United States, 28078 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania University of Pennsylvania Health System Philadelphia, Pennsylvania, United States, 19104 University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15237 United States, Tennessee Tennessee Oncology - Nashville; The Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Vanderbilt University; Henry Joyce Cancer Clinic Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT02277639 Bone Marrow Failure Syndromes ... More >> Immunodeficiencies Immune Dysregulation Syndromes Less << Phase 2 Completed - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02277639 - Completed - -
NCT00103285 B-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT01341899 Type 1 Diabetes Phase 2 Completed - China, Jiangsu ... More >> at Division of Endocrinology, the Affiliated Drum Tower Hospital of Nanjing University Nanjing, Jiangsu, China, 210008 Less <<
NCT03296137 Cancer Phase 1 Phase 2 Recruiting March 13, 2020 Denmark ... More >> Center for Cancer immune Therapy (CCIT), Dept. of Hematology and dept. of Oncology Recruiting Copenhagen, Denmark, 2730 Contact: Anders H Kverneland, MD       anders.kverneland@regionh.dk Less <<
NCT02066636 Non Small Cell Lung Cancer (NS... More >>CLC) Less << Phase 3 Active, not recruiting January 31, 2022 -
NCT03650933 Diffuse Large B-Cell Lymphoma,... More >> Unspecified Site Less << Phase 3 Not yet recruiting October 2021 -
NCT02128061 Diffuse Large B Cell Lymphoma Phase 3 Active, not recruiting February 2019 -
NCT03298828 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Less << Phase 1 Not yet recruiting October 2022 -
NCT00113932 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT02845882 Lymphoblastic Lymphoma Phase 2 Phase 3 Recruiting December 2025 China ... More >> West China Second University Hospital Recruiting Chengdu, China Contact: Xia Guo, M.D.       guoxkl@163.com    Shanghai Children's Medical Center Recruiting Shanghai, China, 200127 Contact: Yi-Jin Gao, M.D.    86-21-38626161 ext 82064    gaoyijin@scmc.com.cn    Contact: Jing-yan Gao, M.D. Less <<
NCT03393936 Renal Cell Carcinoma Phase 1 Phase 2 Recruiting March 30, 2035 China, Shanghai ... More >> Shanghai Public Health Clinical Center Recruiting Shanghai, Shanghai, China, 200000 Contact: Tongyu Zhu    13816002121    tyzhu@fudan.edu.cn    Contact: Hongliang Zong    +8613817903385    zonghl@PerHum.com    Principal Investigator: Tongyu Zhu Less <<
NCT01405924 Nausea Vomiti... More >>ng Less << Phase 2 Terminated(Low enrollment) - -
NCT02354313 MANTLE CELL LYMPHOMA Phase 3 Active, not recruiting January 2019 -
NCT03642626 Acute Lymphoblastic Leukemia ... More >> Large B-cell Lymphoma Less << Phase 2 Not yet recruiting July 2028 -
NCT02706405 BCL2 Gene Rearrangement ... More >> BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High-Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements MYC Gene Rearrangement Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Less << Phase 1 Recruiting December 1, 2033 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Cameron J. Turtle Less <<
NCT03672851 Acute Leukemia ... More >> Acute Leukemia in Relapse Acute Myeloid Leukemia Relapsed or Refractory Acute Leukemia Less << Phase 1 Recruiting December 31, 2020 China, Shaanxi ... More >> Second Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shaanxi, China, 710000 Contact: Aili He, MD, PhD    86-29-87679459    heaili@mail.xjtu.edu.cn    Contact: Jian-Li Wang, MD, PhD    86-29-87679457    wangjianli73@sina.cn    Principal Investigator: Aili He, MD, PhD Less <<
NCT01405924 - Terminated(Low enrollment) - -
NCT03671720 Advanced Cancer ... More >> Metastatic Cancer Less << Early Phase 1 Recruiting December 30, 2020 China, Beijing ... More >> Capital Medical University Cancer Center/Beijing Shijitan Hospital Recruiting Beijing, Beijing, China, 100038 Contact: Jun Ren, MD, PhD    86-10-63926317    renjun9688@yahoo.com Less <<
NCT00536601 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Nasal Type Extranodal NK/T-cell Lymphoma Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET) Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Plasma Cell Neoplasm Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Malignant Testicular Germ Cell Tumor Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Neuroblastoma Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Regional Neuroblastoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Not Applicable Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT03373071 CD19-ALL CD19... More >>-LNH Less << Phase 1 Phase 2 Recruiting December 2027 Italy ... More >> Ospedale Pediatrico Bambino Gesù Recruiting Roma, Italy Contact: Franco Locatelli, MD, PhD    066859 ext 2678    franco.locatelli@opbg.net    Principal Investigator: Franco Locatelli, MD, PhD Less <<
NCT03564470 Leukemia Leuk... More >>emia, Acute Leukemia, Lymphoblastic Leukemia, B-cell Less << Phase 2 Phase 3 Recruiting August 30, 2020 China, Guangdong ... More >> Department of Hematology, Nanfang Hospital Recruiting Guangzhou, Guangdong, China, 510515 Contact: Hongsheng Zhou, PhD, MD    86-20-62787349    zhs1@i.smu.edu.cn Less <<
NCT00274846 Leukemia Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00103285 - Completed - -
NCT00274846 - Completed - -
NCT02441933 Breast Cancer Phase 3 Recruiting March 2023 Korea, Republic of ... More >> Chungbuk university hospital Recruiting Cheonju, Chungchung Do, Korea, Republic of Contact: Ki Hyeong Lee, MD, PhD       kihlee@chungbuk.ac.kr    National Cancer Center Recruiting Goyang, Gyeonggido, Korea, Republic of Contact: Keun Seok Lee, MD, PhD       ksleemd@gmail.com    National Health Insurance Service Ilsan Hospital Recruiting Ilsan, Gyeonggido, Korea, Republic of Contact: Soo Jung Hong, Md, PhD       suzzy901@nhimc.or.kr    Bundang Cha Hospital Recruiting Seongnam, Gyeonggido, Korea, Republic of Contact: Yong Hwa Moon, MD, PhD       ymoon@cha.ac.kr    Ajou universwity Medical Center Recruiting Suwon, Gyeonggido, Korea, Republic of Contact: Seok Yun Kang, MD       kangsy01@ajou.ac.kr    Soonchunhyang university Cheonan hospital Recruiting Cheonan, Gyungkido, Korea, Republic of Contact: Han Jo Kim, MD       hzmd@schmc.ac.kr    Inje University Haeundae Paik Hospital Recruiting Busan, Korea, Republic of Contact: Sung Sook Lee, Md, PhD       H00285@paik.ac.kr    Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of Contact: Keon Uk Park, MD, PhD       kupark@dsmc.or.kr    Gachon University Gil Medical Center Recruiting Incheon, Korea, Republic of Contact: Eun Kyung Cho, MD, PhD       ekcho@gilhospital.com    Seoul national university Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: Se Hyun Kim, MD       sehyunkim@snubh.org    Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Kyung Hae Jung, Md, PhD       khjung@amc.seoul.kr    Boramae Medical Center Recruiting Seoul, Korea, Republic of Contact: Jin Hyun Park, MD       jinhyunpak@gmail.com    Catholic university of Korea, Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Ji Eun Lee, MD, PhD       befamiliar@naver.com    Chung Ang University Heaelthcare System Recruiting Seoul, Korea, Republic of Contact: Hee Jun Kim, MD, PhD       heejun.dino11@gmail.com    Gangnam Severance hospital Recruiting Seoul, Korea, Republic of Contact: Hei Cheul Jeung, Md, PhD       jeunghc1123@yuhs.ac    Korea University Anam hospital Recruiting Seoul, Korea, Republic of Contact: Kyong Hwa Park, MD, PhD       khpark@korea.ac.kr    Kyunghee University Healthcare System Recruiting Seoul, Korea, Republic of Contact: Sun Kyung Baek, MD       wkiki@naver.com    Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Young Hyuck Im, MD, PhD       imyh00@skku.edu    Yonsei Cancer Center at Yonsei University Medical Center Recruiting Seoul, Korea, Republic of Contact: Joo Hyuk Sohn, MD, PhD    82-2-2228-8130       Ulsan University Hospital Recruiting Ulsan, Korea, Republic of Contact: Su Jin Koh, MD, PhD       sujinkoh@daum.net    Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of Contact: Seung Taek Lim, MD       darksgtlim@naver.com Less <<
NCT02930993 Mesothelin Positive Tumors Phase 1 Recruiting August 2019 China ... More >> China Meitan General Hospital Recruiting Beijing, China, 100028 Contact: Shidong Wei, MD    +86-13146634751    liqinghe9644679@163.com Less <<
NCT00005977 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT01583426 Tubular Breast Cancer Stage II... More >> Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer Tubular Breast Cancer Stage III HER-2 Positive Breast Cancer Inflammatory Breast Cancer Stage IV Inflammatory Breast Cancer Less << Phase 3 Unknown December 2018 Germany ... More >> Helios-Klinikum Berlin-Buch Berlin, Germany, 13125 Less <<
NCT03558412 T-lymphoblastic Lymphoma Phase 4 Recruiting June 1, 2020 China, Henan ... More >> Oncology Department of The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Mingzhi Zhang, Pro,Dr    13838565629    mingzhi_zhang@126.com    Contact: Mingzhi Zhang, Pro,Drc    13838565629    mingzhi_zhang@126.com Less <<
NCT00315133 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Brazil ... More >> Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo Ribeirão Preto, Brazil, 14048-900 Less <<
NCT03590574 T Cell Non-Hodgkin Lymphoma ... More >> Peripheral T-Cell Lymphoma, Not Otherwise Specified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Recruiting December 2022 United Kingdom ... More >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dr Kate Cwynarski          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Contact: Professor John Radford          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Dr Tobias Menne Less <<
NCT03467516 Uveal Neoplasms ... More >> Melanoma, Uveal Less << Phase 2 Recruiting August 1, 2021 United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Krystle L Eaton, BSN    412-623-7957    mientkiewiczk@upmc.edu Less <<
NCT02619630 T-cell Adult Acute Lymphoblast... More >>ic Leukemia Less << Phase 2 Recruiting December 2025 France ... More >> Hematology Recruiting Paris, France, 75010 Contact: Hervé Dombret, MDPhD       herve.dombret@aphp.fr Less <<
NCT00004114 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 1 Withdrawn(Study never opened) - -
NCT01433562 Breast Cancer Phase 2 Phase 3 Completed - Indonesia ... More >> Surgery-Oncology Division, Department of Surgery, Faculty of Medicine, University of Airlangga / Dr. Soetomo Hospital Surabaya, East Java, Indonesia, 60286 Less <<
NCT01191060 Myeloma Phase 3 Active, not recruiting September 2020 -
NCT00002989 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 3 Unknown - Belgium ... More >> Institut Jules Bordet Brussels (Bruxelles), Belgium, 1000 France Hopital Edouard Herriot Lyon, France, 69437 Hotel Dieu de Paris Paris, France, 75181 Institut Gustave Roussy Villejuif, France, F-94805 Germany Eberhard Karls Universitaet Tuebingen, Germany, D-72076 Italy Ospedale San Eugenio Rome, Italy, 00144 Azienda Policlinico Umberto Primo Rome, Italy, 00161 Netherlands Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT00807196 Non-Hodgkins Lymphoma Phase 1 Phase 2 Unknown December 2012 Canada, Quebec ... More >> Hopital Maisonneuve-Rosemont Recruiting Montreal, Quebec, Canada, H2V 1W7 Contact: Thomas Kiss, MD    (514)252-3404    thomas.kiss@umontreal.ca    Contact: Dominique Beaupré, BSc nursing    (514)252-3400 ext 5605    dbeaupré.hmr@ssss.gouv.qc.ca    Principal Investigator: Thomas Kiss, M.D. Less <<
NCT02728271 Churg-Strauss Syndrome Early Phase 1 Terminated(PI left the institu... More >>tion) Less << - -
NCT02672501 Leukemia, B-Cell Phase 1 Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Changhai Hospital，The Second Military Medical University Recruiting Shanghai, Shanghai, China, 200090 Contact: Jianmin Yang, Doctor    18317172636    yangjianmin@csco.org.cn Less <<
NCT03444025 Breast Cancer Triple Negative Phase 2 Not yet recruiting March 2023 -
NCT02846584 Lymphoma, Large B-Cell, Diffus... More >>e Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma，Malignant Less << Phase 2 Active, not recruiting December 2019 China, Chongqing ... More >> Southwest Hospital of Third Millitary Medical University Chongqing, Chongqing, China, 400000 Less <<
NCT01188174 AML Phase 2 Completed - France ... More >> CHU de Bordeaux Bordeaux, France CHU Caen Caen, France CHRU lille Lille, France Hôpital Edouard Herriot Lyon, France Institut Paoli Calmette Marseille, France Nantes University hospital Nantes, France, 44200 Paris saint Louis Paris, France CHRU de Strasbourg Strasbourg, France CHU Toulouse Toulouse, France Less <<
NCT02926833 Refractory Diffuse Large B Cel... More >>l Lymphoma Less << Phase 1 Phase 2 Recruiting June 2023 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Hormoz Mirshkarlo       hmirshkarlo@coh.org    Stanford Cancer Center Recruiting Stanford, California, United States, 94305 Contact: Juliana K Craig       jkcraig@stanford.edu    United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Guadalupe De Maeyer       gdemaeyer@partners.org    United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sherry Adkins       sadkins@mdanderson.org Less <<
NCT00689845 Lymphoma Not Applicable Unknown - United Kingdom ... More >> Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Contact Person    44-113-206-6400       St. George's Hospital Recruiting London, England, United Kingdom, SW17 0QT Contact: Contact Person    44-208-725-2425    rpetteng@sghms.ac.uk    Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-845-226-3000       Mount Vernon Cancer Centre at Mount Vernon Hospital Recruiting Northwood, England, United Kingdom, HA6 2RN Contact: Contact Person    44-1923-826-111       Cancer Research Centre at Weston Park Hospital Recruiting Sheffield, England, United Kingdom, S1O 2SJ Contact: Contact Person    44-114-226-5007    b.w.hancock@sheffield.ac.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-238-079-6186    johnsonp@soton.ac.uk    Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Contact Person    44-208-661-3279    david.cunningham@rmh.nhs.uk    Saint Bartholomew's Hospital Recruiting London, United Kingdom Contact: Contact Person    44-207-796-3979    silvia.montoto@cancer.org.uk Less <<
NCT00003163 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Unknown - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00005585 Leukemia Phase 3 Completed - -
NCT00113828 Lymphoma Leuk... More >>emia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Insufficient accrua... More >>l) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01683279 B Cell Leukemia Phase 1 Active, not recruiting January 2031 United States, Washington ... More >> Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT02169791 Acute Leukemia ... More >> Chronic Leukemia Myelodysplastic Syndrome Lymphomas Multiple Myeloma Less << Phase 2 Active, not recruiting August 30, 2020 United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT01067300 Leukemia Phase 3 Unknown January 2016 France ... More >> Assistance Publique - Hôpitaux de Marseille Marseille, France Less <<
NCT00461747 Multiple Myeloma Phase 3 Completed - -
NCT02273856 - Terminated(The study was termi... More >>nated due to insufficient subject enrollment and very slow enrollment.) Less << - Jordan ... More >> Site JO96201 King Abdullah University Hospital Irbid, Jordan, 22110 Kuwait Site KW96501 Kuwait Cancer Control Center Shuwaikh, Kuwait, 70653 Lebanon Site Hammoud Hospital University Medical Center Beirut, Lebanon, 1600 Site Hotel Dieu De France Beirut, Lebanon, 166830 Oman Site OM96801 Sultan Qaboos University Hospital Muscat, Oman, 123 Qatar Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital Doha, Qatar, 3050 Saudi Arabia Site SA96601 Aseer Central Hospital Abha, Aseer, Saudi Arabia, 61421 United Arab Emirates Site AE97101 Sheikh Khalifa Medical City Abu Dhabi, United Arab Emirates, 51900 Less <<
NCT01026220 - Completed - -
NCT03290456 Granulomatosis With Polyangiti... More >>s Less << Not Applicable Not yet recruiting December 1, 2021 France ... More >> Centre Hospitalier Lyon Sud Not yet recruiting Pierre-Bénite, France, 69310 Contact: Jean-Christophe LEGA, Pr    04.78.86.19.79    jean-christophe.lega@chu-lyon.fr Less <<
NCT00084838 - Completed - -
NCT00008008 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, New Jersey ... More >> St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02066220 Brain Tumors Phase 2 Phase 3 Recruiting April 2024 -
NCT00084838 Central Nervous System Tumor, ... More >>Pediatric Less << Phase 2 Completed - United States, California ... More >> Stanford Cancer Center Stanford, California, United States, 94305-5826 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus Atlanta, Georgia, United States, 30342 United States, Illinois Children's Memorial Hospital - Chicago Chicago, Illinois, United States, 60614 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Children's Hospital Boston Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis, Minnesota, United States, 55404 United States, Nevada Sunrise Hospital and Medical Center Las Vegas, Nevada, United States, 89109 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT03287804 Multiple Myeloma Phase 1 Phase 2 Recruiting October 2020 Netherlands ... More >> VU University Medical Centre Amsterdam Recruiting Amsterdam, Netherlands Principal Investigator: Professor Sonja Zweegman          United Kingdom University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rakesh Popat          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Principal Investigator: Dr James Cavet          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Tobias Menne Less <<
NCT03384654 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Less << Phase 2 Recruiting August 10, 2021 -
NCT01026220 Childhood Nodular Lymphocyte P... More >>redominant Hodgkin Lymphoma Stage III Childhood Hodgkin Lymphoma Stage IV Childhood Hodgkin Lymphoma Less << Phase 3 Completed - -
NCT02799147 Leukemia, Acute Lymphoblastic ... More >> Acute Myeloid Leukemia Mixed-Lineage Acute Leukemias Less << Phase 1 Phase 2 Recruiting June 2020 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, PhD    +79217961951    moisiv@mail.ru    Contact: Olga A. Slesarchuk, PhD    +79111910003    olga.slesarchuk@gmail.com    Sub-Investigator: Olga V. Pirogova, M.S. Less <<
NCT01384513 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Aplastic Anemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Mastocytosis Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Waldenstr?m Macroglobulinemia Less << Phase 2 Recruiting July 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP    215-955-8874       Principal Investigator: Dolores Grosso, DNP, CRNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Ubaldo Martinez-Outschoorn, MD          Sub-Investigator: John L Wagner, MD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Maria Werner-Wasik, MD          Sub-Investigator: Wenyin Shi, MD, PhD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Manish Sharma, MD Less <<
NCT01858922 Hodgkin Disease Phase 2 Active, not recruiting March 2021 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00278590 Systemic Lupus Erythematosus Phase 1 Withdrawn(No participants enro... More >>lled) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00002565 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Brazil Faculdade de Medicina do ABC Sao Paulo, Brazil, 01224--010 Chile Clinica Alemana Santiago, Chile, 5951 Less <<
NCT00554788 Extraocular Retinoblastoma Phase 3 Active, not recruiting - -
NCT00612222 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03503864 Neuroblastoma Phase 2 Recruiting December 30, 2029 China, Guangdong ... More >> Sun Yat-sen Memorial Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Yang Li, Professor    +8602081332456    drliyang@126.com Less <<
NCT00612222 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT00006256 Breast Cancer Phase 2 Active, not recruiting February 2019 United States, Ohio ... More >> UH-CantonMercy Canton, Ohio, United States, 44708 UH-Geauga Chardon, Ohio, United States, 44024 Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5055 UH-Monarch Mayfield Heights, Ohio, United States, 44124 UH-LUICC Mentor, Ohio, United States, 44060 UH-Southwest Middleburg Heights, Ohio, United States, 44130 UH-Chagrin Highlands Orange Village, Ohio, United States, 44122 UH-Green Road South Euclid, Ohio, United States, 44121 UH-Westlake Westlake, Ohio, United States, 44145 Less <<
NCT00187122 Lymphoblastic Lymphoma Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01220128 Neoplasms, Breast Phase 2 Terminated(Study termination d... More >>ue to negative Ph III of another study product from same technology platform.) Less << - -
NCT00005964 Lymphoma Phase 2 Completed - -
NCT00025610 Neuroblastoma Phase 2 Completed - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Less <<
NCT01220128 - Terminated(Study termination d... More >>ue to negative Ph III of another study product from same technology platform.) Less << - -
NCT00335556 - Completed - -
NCT00179803 Glioblastoma ... More >>Astrocytoma Pineoblastoma Rhabdoid Tumor Supratentorial Neoplasms Less << Phase 2 Phase 3 Unknown - United States, Illinois ... More >> Children's Memorial Hospital Chicago, Illinois, United States, 60614 Less <<
NCT00113646 Lymphoma Leuk... More >>emia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Expiration of MEDI-... More >>507) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02116 Less <<
NCT03462316 Bone Sarcoma ... More >>Soft Tissue Sarcoma Less << Phase 1 Recruiting February 15, 2020 China, Guangdong ... More >> Sun Yat-Sen Univerisity Recruiting Guangzhou, Guangdong, China, 510000 Contact: Xing Zhang, PhD,MD    86-020-87343192    zhangxing@sysucc.org.cn    Principal Investigator: Xing Zhang Less <<
NCT01167192 Breast Neoplasms Phase 2 Terminated - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00335556 Childhood Renal Cell Carcinoma... More >> Clear Cell Renal Cell Carcinoma Clear Cell Sarcoma of the Kidney Papillary Renal Cell Carcinoma Rhabdoid Tumor of the Kidney Stage I Renal Cell Cancer Stage I Renal Wilms Tumor Stage II Renal Cell Cancer Stage II Renal Wilms Tumor Stage III Renal Cell Cancer Stage III Renal Wilms Tumor Stage IV Renal Cell Cancer Stage IV Renal Wilms Tumor Less << Phase 2 Completed - -
NCT00589602 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Malignant Plasma Cell Neoplasms Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Secondary Myelofibrosis Less << Phase 2 Terminated(slow accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01167192 - Terminated - -
NCT00042367 Brain Tumors Not Applicable Completed - United States, North Carolina ... More >> Brain Tumor Center at Duke University Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-0318 United States, Texas Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00589602 - Terminated(slow accrual) - -
NCT00003816 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Phase 3 Active, not recruiting December 1, 2019 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00025077 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00003309 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Illinois Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States, 60611-4494 Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 United States, Minnesota CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, New Hampshire Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756-0002 United States, Tennessee Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226-3596 Less <<
NCT01338987 Myelodysplastic Syndrome RAEB ... More >>2 Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome RAEB 1 Less << Phase 2 Active, not recruiting November 19, 2020 United States, District of Col... More >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT02706782 Pancreatic Cancer Phase 1 Unknown September 2018 China, Shanghai ... More >> Renji Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China Contact: Xu Aimin, Doctor    86-13918183196    xuarmy@163.com    Contact: Yu Xuejun, Master    86-18616108610    yuxuejun@genechem.com.cn Less <<
NCT01047072 Systemic Scleroderma Phase 2 Withdrawn - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00003398 Anemia Graft ... More >>Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 4 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00004061 Leukemia Lymp... More >>homa Oral Complications Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00004921 Ovarian Cancer Phase 3 Completed - Austria ... More >> Sozialmedizinisches Zentrum Ost - Donauspital Vienna, Austria, A-1220 Belgium Centre Hospitalier Notre Dame - Reine Fabiola Charleroi, Belgium, 6000 Czech Republic Charles University Prague 10, Czech Republic, 10034 Thomayer Memorial Teaching Hospital Prague 4, Czech Republic, 14000 Germany Staedt Klinikum Karlsruhe GGMBH Karlsruhe, Germany, 76133 Klinikum Nuernberg - Klinikum Nord Nuernberg, Germany, D-90419 Italy Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi Bologna, Italy, 40138 Ospedale Santa Chiara Pisa, Italy, 56100 S. Camillo Hospital Rome, Italy, 00152 Ospedale San Bortolo Vicenza, Italy, 36100 Slovakia National Cancer Institute - Bratislava Bratislava, Slovakia, 833 10 Spain Hospital Universitario San Carlos Madrid, Spain, 28040 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom, NW1 2ND Cancer Research Centre at Weston Park Hospital Manchester, England, United Kingdom, M20 9BX Less <<
NCT00003877 Breast Cancer Phase 1 Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02396043 Lymphoma, Lymphoblastic Phase 2 Recruiting March 2020 China, Guangdong ... More >> Sun Yat-sen University Cancer Center Recruiting GuangZhou, Guangdong, China, 510060 Contact: Zhongjun Xia, MD.    0086-02087342438    zhongjunxia_64@sina.com Less <<
NCT02715362 Carcinoma, Hepatocellular Phase 1 Phase 2 Recruiting March 2019 China, Shanghai ... More >> Renji Hospital, Shanghai Jiao Tong University School of Medicine Recruiting Shanghai, Shanghai, China Contact: Xu Aimin, Doctor    86-13918183196    xuarmy@163.com    Contact: Yu Xuejun, Master    86-18616108610    yuxuejun@genechem.com.cn    Principal Investigator: Xu Aimin, Doctor Less <<
NCT00912223 Lymphoma, Non-Hodgkin Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California, San Diego (UCSD) Medical Center La Jolla, California, United States, 92093 University of California, Davis Medical Center Sacramento, California, United States, 95817 Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610-0277 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Dana-Farber Cancer Institute (DFCI)/Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI)/Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 United States, North Carolina University of North Carolina Hospital at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7305 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio University Hospitals of Cleveland/Case Western Cleveland, Ohio, United States, 44106-5061 Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Oklahoma University of Oklahoma Medical Center Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas University of Texas, MD Anderson Cancer Research Center Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506-9162 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT00004907 Lymphoma Phase 1 Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT00912223 - Completed - -
NCT01110291 - Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20521 Less <<
NCT03213964 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 1 Recruiting April 1, 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Melissa Geller, MD    612-624-0123    gelle005@umn.edu    Principal Investigator: Melissa Geller, MD Less <<
NCT00003899 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT03615313 Advanced Solid Tumor Phase 1 Phase 2 Recruiting December 3, 2020 China, Shanghai ... More >> China Recruiting Shanghai, Shanghai, China, 200072 Contact: Xue Yang    0086-021-66301147    shsyiec@126.com    Contact: Juemin Fang    0086-021-39590256 Less <<
NCT01458548 Post-transplantation Lymphopro... More >>liferative Disorder Less << Phase 2 Terminated(This study had an m... More >>ajor amendment in 12/2006 introducing risk stratified sequential treatment (RSST). The modified protocol is registered with NCT00590447.) Less << - Australia ... More >> Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Qld 4102 Brisbane, Australia France Hôpital Pitié-Salpétrière, Department of Hematology, 47-83 Boulevard de l'Hopital Paris, France, 75651 Germany Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Department of Hematology and Oncology, Augustenburger Platz 1 Berlin, Germany, 13353 Sweden Sahlgrens hospital, Department of Hematology Göteborg, Sweden, 41345 Less <<
NCT00604136 Metastatic Melanoma Phase 2 Recruiting July 2020 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Recruiting Jerusalem, Israel, 91120 Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Sub-Investigator: Shoshana Frankenburg, PhD          Principal Investigator: Michal Lotem, MD Less <<
NCT00594308 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplasia Lymphoma, Non-Hodgkin's Mantle-Cell Lymphoma Hodgkin's Disease Multiple Myeloma Myelofibrosis Less << Not Applicable Terminated(Treatment ineffecti... More >>ve) Less << - United States, Indiana ... More >> Indiana Universtiy Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00594308 - Terminated(Treatment ineffecti... More >>ve) Less << - -
NCT02549586 Complication of Transplanted O... More >>rgan, Nos Less << Phase 2 Active, not recruiting January 2020 Canada, Ontario ... More >> The Ottawa Hopital Ottawa, Ontario, Canada, K1H 8L6 Multi-Organ Transplant Program, Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Less <<
NCT00881920 Lymphoma Myel... More >>oma Leukemia Less << Phase 1 Recruiting July 2034 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vxtorran@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vxtorran@txch.org Less <<
NCT02862704 Liver Metastases Phase 1 Phase 2 Unknown December 2017 China, Shaanxi ... More >> Xijing Hospital of Digestive Diseases Recruiting Xi'an, Shaanxi, China, 701032 Contact: Yongzhan Nie, Doctor       yongznie@fmmu.edu.cn    Contact: Xuejun Yu, Master    86-18616108610    yuxuejun@genechem.com.cn Less <<
NCT02468739 Breast Cancer Phase 3 Completed - China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less <<
NCT03244176 Lymphomas Non-Hodgkin's B-Cell Early Phase 1 Recruiting July 2025 Australia, Victoria ... More >> Austin Health Recruiting Heidelberg, Victoria, Australia, 3084 Contact: Eliza Hawkes, MD    +61 3 9496 5763 ext 5763    eliza.hawkes@onjcri.org.au    Contact: Joanne Hakanson, BSc    +61 3 9496 3352 ext 3352    joanne.hakanson@austin.org.au    Principal Investigator: Eliza Hawkes, MD          Principal Investigator: Geoff Chong, MD          Principal Investigator: Joseph McKendrick, MD Less <<
NCT01037764 Acute Lymphoid Leukemia Phase 2 Terminated(The PI resigned the... More >> institute, and the rest investigators at the institute decided to terminate the study.) Less << - Korea, Republic of ... More >> Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00946374 Mantle-Cell Lymphoma Phase 2 Unknown June 2011 Germany ... More >> University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Markus Munder, MD Less <<
NCT00027885 Breast Cancer Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5055 UH-Southwest Middleburgh Heights, Ohio, United States, 44130 UH-Chagrin Highlands Orange Village, Ohio, United States, 44122 UH-Green Road South Euclid, Ohio, United States, 44121 UH-Westlake Westlake, Ohio, United States, 44145 Less <<
NCT03321123 Precursor B-Lymphoblastic Lymp... More >>homa/Leukaemia Refractory Less << Phase 2 Not yet recruiting December 31, 2019 -
NCT03672318 Multiple Myeloma ... More >> Immune System Diseases Less << Phase 1 Recruiting October 2032 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Sacha Tuchman, MD, MPS Less <<
NCT01091168 Breast Cancer ... More >> Metastases Less << Phase 3 Completed - -
NCT01484470 Hematologic Malignancies Phase 2 Active, not recruiting September 2018 United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00002961 Leukemia Phase 3 Terminated(poor accrual) - United States, Alabama ... More >> University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States, 35294 United States, California Children's Hospital and Health Center San Diego, California, United States, 92123-4282 United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 All Children's Hospital St. Petersburg, Florida, United States, 33701 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Kentucky Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Louisiana Louisiana State University School of Medicine New Orleans, Louisiana, United States, 70112-2822 Tulane University School of Medicine New Orleans, Louisiana, United States, 70112 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Hospital Saint Louis, Missouri, United States, 63104 Washington University Medical Center Saint Louis, Missouri, United States, 63110 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Palmetto Richland Memorial Hospital Columbia, South Carolina, United States, 29203 United States, Texas South Texas Cancer Institute San Antonio, Texas, United States, 78229 University of Texas Health Science Center at San Antonio San Antonio, Texas, United States, 78284-7811 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132 Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T2T 5C7 Less <<
NCT00366275 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Division of Hematology, IRCCS Policlinico S. Matteo, University of Pavia Pavia, Italy, 27100 Less <<
NCT00324467 Lymphoma, Non-Hodgkin ... More >> Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Less << Phase 2 Active, not recruiting December 2018 Canada, British Columbia ... More >> BC Cancer Agency Vancouver, British Columbia, Canada, V5Z 4E6 Less <<
NCT00004228 - Unknown - -
NCT00054236 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00911911 Breast Cancer Not Applicable Completed - France ... More >> Intercommunal Hospital Annemasse, France, 74 107 Centre Oscar Lambret Lille, France, 59020 Hopital Saint Vincent Lille, France, 59020 Centre Henri Becquerel Rouen, France, 76038 Geroges PIANTA Hospital THONON Les BAINS, France, 74 203 Less <<
NCT00366275 - Completed - -
NCT00004228 Lymphoma Phase 3 Unknown - -
NCT02779855 Breast Cancer ... More >> Ductal Carcinoma Invasive Breast Carcinoma Invasive Ductal Breast Carcinoma Less << Phase 1 Phase 2 Recruiting August 31, 2022 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Deanna Hogue    813-745-8304    deanna.hogue@moffitt.org    Contact: Hatem Soliman, M.D.    813-745-4933    hatem.soliman@moffitt.org    Principal Investigator: Hatem Soliman, M.D. Less <<
NCT02706392 Estrogen Receptor Negative ... More >> HER2/Neu Negative Progesterone Receptor Negative Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage IV Breast Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Triple-Negative Breast Carcinoma Less << Phase 1 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: David G. Maloney Less <<
NCT00003715 Melanoma (Skin) Phase 2 Terminated(Terminated recruiti... More >>ng or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated) Less << - United States, California ... More >> Cancer and Blood Institute of the Desert Rancho Mirage, California, United States, 92270 United States, Connecticut Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 United States, Florida Columbia - HCA Cancer Research Network North Miami Beach, Florida, United States, 33180 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Georgia Georgia Cancer Specialists Decatur, Georgia, United States, 30033 United States, Illinois University of Illinois at Chicago Chicago, Illinois, United States, 60612 Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 United States, Kentucky James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Michigan Cancer and Hematology Centers of Western Michigan Grand Rapids, Michigan, United States, 49546 United States, Minnesota Hubert H. Humphrey Cancer Center Robbinsdale, Minnesota, United States, 55422 United States, Missouri Midwest Oncology Consortium Kansas City, Missouri, United States, 64111 United States, New Jersey Jersey Shore Cancer Center Neptune, New Jersey, United States, 07753 Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, New York Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 Kimmel Cancer Center of Thomas Jefferson University - Philadelphia Philadelphia, Pennsylvania, United States, 19107 United States, South Carolina Palmetto Hematology/Oncology Associates Spartanburg, South Carolina, United States, 29303 Less <<
NCT03259516 Myelodysplastic Syndromes Phase 1 Phase 2 Recruiting December 25, 2021 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, MD, PhD    +79217961951    moisiv@mail.ru    Contact: Elena V Morozova, MD, PhD    +79119278229    dr_morozova@mail.ru    Principal Investigator: Boris V Afanasyev, MD, Prof          Sub-Investigator: Elena V Morozova, MD, PhD          Sub-Investigator: Yulia V Rudnizkaya, MD, PhD          Sub-Investigator: Ivan S Moiseev, MD, PhD          Sub-Investigator: Nikolai Yu Tcvetkov, MD Less <<
NCT00567554 Breast Cancer Phase 3 Completed - Germany ... More >> Universitätsfrauenklinik Frankfurt / Main Frankfurt / Main, Germany Less <<
NCT02119715 Breast Cancer ... More >> Neutropenia Febrile Neutropenia Less << Phase 2 Completed - China ... More >> 307 Hospital Affiliated to Academy Military Medical Science Beijing, China Less <<
NCT00003093 Neuroblastoma Phase 3 Completed - -
NCT02014506 Haploidentical Hematopoietic S... More >>tem Cell Transplantation Malignant Disease Non-malignant Disease Less << Phase 1 Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD    82-2-3010-3371    hojim@amc.seoul.kr    Principal Investigator: Ho Joon Im, MD & PhD Less <<
NCT00577512 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00002757 Leukemia Lymp... More >>homa Less << Phase 3 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 United Kingdom Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Less <<
NCT00577512 - Completed - -
NCT00000703 Lymphoma, Non-Hodgkin ... More >> HIV Infections Less << Not Applicable Completed - United States, California ... More >> Los Angeles County - USC Med Ctr Los Angeles, California, United States, 90033 UCLA CARE Ctr Los Angeles, California, United States, 90095 San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States, 941102859 United States, District of Columbia George Washington Univ Med Ctr Washington, District of Columbia, United States, 20037 United States, Louisiana Charity Hosp / Tulane Univ Med School New Orleans, Louisiana, United States, 70112 Louisiana State Univ Med Ctr / Tulane Med School New Orleans, Louisiana, United States, 70112 Tulane Univ School of Medicine New Orleans, Louisiana, United States, 70112 United States, Massachusetts Univ of Massachusetts Med Ctr Worcester, Massachusetts, United States, 01655 United States, New York Bellevue Hosp / New York Univ Med Ctr New York, New York, United States, 10016 Saint Luke's - Roosevelt Hosp Ctr New York, New York, United States, 10025 Mount Sinai Med Ctr New York, New York, United States, 10029 Univ of Rochester Medical Center Rochester, New York, United States, 14642 United States, Pennsylvania Milton S Hershey Med Ctr Hershey, Pennsylvania, United States, 170330850 United States, South Carolina Julio Arroyo West Columbia, South Carolina, United States, 29169 Less <<
NCT00148681 Breast Cancer ... More >> Stage II Breast Cancer Stage III Breast Cancer Less << Phase 2 Unknown April 2010 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT02568839 Early-Stage Breast Carcinoma ... More >> HER-2 Positive Breast Cancer Less << Phase 2 Phase 3 Recruiting December 2022 Sweden ... More >> Dept. of Oncology, Örebro University Hospital Not yet recruiting Örebro, Närke, Sweden Principal Investigator: Johan Ahlgren, Assoc prof          Dept. of Oncology, Sahlgrenska University Hospital Recruiting Göteborg, Sweden, 413 45 Contact: Kajsa Holgersson, RN       kajsa.holgersson@vgregion.se    Principal Investigator: Zakaria Einbeigi, MD, PhD          Dept. of Oncology, Skåne University Hospital Recruiting Lund, Sweden Contact: Suzy Lindberg, RN       suzylindberg@skane.se    Principal Investigator: Eva Karlsson, MD, PhD          Dept. of Oncology, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Ingrid Lundin, RN       ingrid.lundin@karolinska.se    Contact: Gittan Nässén, RN       birgitta.nassen@karolinska.se    Principal Investigator: Theodoros Foukakis, Assoc prof          Sub-Investigator: Ellinor Elinder, MD          Dept. of Oncology, Sundsvall Hospital Recruiting Sundsvall, Sweden, 851 86 Contact: Christin Näslund, RN       christine.naslund@lvn.se    Principal Investigator: Lena Carlsson, MD          Dept. of Oncology, University Hospital of Umeå Not yet recruiting Umeå, Sweden Contact: Lena Bylund, RN       lena.bylund@vll.se    Principal Investigator: Anne Andersson, MD          Dept. of Oncology, Uppsala University Hospital Not yet recruiting Uppsala, Sweden Contact: Camilla Taavo, RN       camilla.taavo@akademiska.se    Principal Investigator: Henrik Lindman, Assoc prof Less <<
NCT03242603 Neuroblastoma Recurrent Phase 1 Phase 2 Recruiting August 15, 2020 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Miriam Kimpo, MD    (+65) 8494 3914    miriam_kimpo@nuhs.edu.sg    Contact: Chetan Dhamne, MBBS, MS, MD    (+65) 6772 3361    chetan_dhamne@nuhs.edu.sg    Principal Investigator: Dr. Miriam Kimpo, MD          Principal Investigator: Dr.Chetan Dhamne, MBBS, MS. MD Less <<
NCT01974479 B-cell Acute Lymphoblastic Leu... More >>kemia Less << Phase 1 Suspended(Suspended for 12 mon... More >>ths - an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.) Less << February 2018 Singapore ... More >> Department of Paediatrics, National University Health System Singapore, Singapore, 119228 Department of Haematology, NCIS, National University Health System Singapore, Singapore Department of Hematology, Singapore General Hospital Singapore, Singapore Less <<
NCT03146234 Hepatocellular Carcinoma Not Applicable Recruiting June 15, 2020 China, Shanghai ... More >> Renji Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 20001 Contact: Bo Zhai, MD    +86-021-68383134    zhaiboshi@sina.com    Principal Investigator: Bo Zhai, MD          Sub-Investigator: Donghua Shi, MD Less <<
NCT01158118 - Completed - -
NCT00554164 Lymphoma, High-grade Phase 3 Completed - Germany ... More >> Department of Hematology, University Hospital Essen Essen, Germany, 45122 Less <<
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT02409576 Ewing Sarcoma ... More >> Osteosarcoma Rhabdomyosarcoma Less << Phase 1 Phase 2 Unknown September 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Chetan Dhamne    (65) 6772 3361    chetan_dhamne@nuhs.edu.sg    Contact: Clarice Chan    (65) 67726586    chan_zi_ying_clarice@nuhs.edu.sg    Principal Investigator: Chetan Dhamne          Sub-Investigator: Dario Campana          KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore Contact: Tan Ah Moy       tan.ah.moy@kkh.com.sg    Contact: Jillian Teo    +65 6394-5025    Jillian.Teo.CL@kkh.com.sg Less <<
NCT01665001 Precursor Lymphoid Neoplasms Phase 2 Unknown August 2018 Poland ... More >> Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch Not yet recruiting Gliwice, Poland, 44-101 Contact: Sebastian Giebel, MD    0048322788523    sgiebel@io.gliwice.pl Less <<
NCT01920737 Leukemia Phase 2 Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Jae Park, MD    212-639-4048       Contact: Martin Tallman, MD          Principal Investigator: Jae Park, MD          Weill Cornell Medical Center Recruiting New York, New York, United States Contact: Ellen Ritchie, MD          Principal Investigator: Ellen Ritchie, MD          United States, North Carolina Duke University Medical Center Active, not recruiting Durham, North Carolina, United States, 27701 United States, Pennsylvania Lehigh Valley Health Network Recruiting Allentown, Pennsylvania, United States, 18103 Contact: Brian Patson, MD    610-402-7880 Less <<
NCT01158118 Leukemia, Myeloid, Acute ... More >> Myelodysplastic Syndromes Lymphoma, Non-Hodgkin Hodgkin Disease Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma Less << Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00049634 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00055640 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-7284 Less <<
NCT03081780 Refractory Acute Myelogenous L... More >>eukemia Relapsed Acute Myelogenous Leukemia Less << Phase 1 Recruiting January 1, 2021 United States, Minnesota ... More >> University of Minnesota, Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Sarah Cooley, MD Less <<
NCT03251768 Chemotherapy-induced Neutropen... More >>ia Less << Phase 2 Recruiting November 30, 2018 China, Beijing ... More >> Chinese Academy of Medical Sciences Cancer Hospital Recruiting Beijing, Beijing, China, 100021 Contact: Binghe Xu, MD    86 10 67781331    xubinghe@medmail.com.cn Less <<
NCT02991898 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndromes Large-cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Hodgkin Lymphoma Multiple Myeloma Acute Myelogenous Leukemia Biphenotypic Leukemia Undifferentiated Leukemia Less << Phase 2 Suspended(Considering new tech... More >>nology for product.) Less << January 2025 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00544115 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Less << Phase 2 Active, not recruiting - -
NCT03179007 Advanced Solid Tumor Phase 1 Phase 2 Recruiting April 20, 2019 China, Zhejiang ... More >> Ningbo No.5 Hospital (Ningbo Cancer Hospital) Recruiting Ningbo, Zhejiang, China, 315201 Contact: Bi Wang    0086-0574-86689113    biwang0217@126.com    Principal Investigator: Jiangtao Wang Less <<
NCT03247309 Solid Tumor C... More >>ancer Head and Neck Squamous Cell Carcinoma Non-small Cell Lung Cancer Less << Phase 1 Recruiting December 2033 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03441100 Solid Tumor, Adult ... More >> Cancer Hepatocellular Carcinoma Hepatocellular Cancer Nonsmall Cell Lung Cancer Liver Cancer Lung Cancer Less << Phase 1 Recruiting June 2033 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02265770 Childhood Ependymoma Phase 2 Phase 3 Recruiting August 2026 -
NCT03619954 Immunotherapy Phase 1 Recruiting July 1, 2020 China, Anhui ... More >> Anhui Provincial cancer center Recruiting Hefei, Anhui, China, 230001 Contact: Yue-Yin Pan, PhD    0086-551-62283411    yueyinpan1965@163.com    Contact: Wei Wang, MD    0086-551-62283411    whouwei@gmail.com    Principal Investigator: Yue-Yin Pan, PhD Less <<
NCT03182803 Advanced Solid Tumor Phase 1 Phase 2 Recruiting April 20, 2019 China, Zhejiang ... More >> Ningbo No.5 Hospital (Ningbo Cancer Hospital) Recruiting Ningbo, Zhejiang, China, 315201 Contact: Bi Wang    0086-0574-86689113    biwang0217@126.com    Principal Investigator: Jiangtao Wang Less <<
NCT02535364 Acute Lymphoblastic Leukemia Phase 2 Terminated(Safety reasons) - United States, Alabama ... More >> University of Alabama Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35295 United States, California City of Hope Duarte, California, United States, 91010 University of California San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver -- Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, Florida Sylvester Comprehensive Cancer Center/UMHC Miami, Florida, United States, 33136 United States, Georgia The Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Illinois Northwestern University Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01861106 GATA2 Immunod... More >>eficiency MDS Less << Phase 2 Recruiting December 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00342316 Acute Myeloid Leukemia Phase 3 Unknown December 2017 -
NCT03686124 Refractory Cancer ... More >> Recurrent Cancer Solid Tumor, Adult Cancer Less << Phase 1 Not yet recruiting January 2035 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Apostolia Tsimberidou, M.D., Ph.D. Less <<
NCT02535364 - Terminated(Safety reasons) - -
NCT03182816 Advanced Solid Tumor Phase 1 Phase 2 Recruiting April 20, 2019 China, Zhejiang ... More >> Ningbo No.5 Hospital (Ningbo Cancer Hospital) Recruiting Ningbo, Zhejiang, China, 315201 Contact: Bi Wang    0086-0574-86689113    biwang0217@126.com    Principal Investigator: Jiangtao Wang Less <<
NCT00791947 Peripheral T-Cell Lymphoma Phase 2 Completed - Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 Copenhagen Hospital Copenhagen, Denmark Vejle Hospital Vejle, Denmark Finland OULO University Hospital Oulu, Oulo, Finland Kuopio University Hospital Kuopio, Finland, 70211 Norway Oslo University Hospital Oslo, Norway, 0310 Ullevaal University Hospital Oslo, Norway, 0407 Rogaland Hospital Rogaland, Norway St.Olavs Hospital Trondheim, Norway, 7006 Less <<
NCT00429416 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University` Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00429416 - Completed - -
NCT00966810 Philadelphia Chromosome-positi... More >>ve Chronic Myelocytic Leukemia Less << Phase 2 Phase 3 Unknown January 2011 Israel ... More >> Rambam Health Care Campus Haifa, Israel, 31096 Less <<
NCT00820547 Breast Cancer Phase 2 Active, not recruiting December 2018 France ... More >> Centre Paul Papin Angers, France, 49036 Institut Sainte Catherine Avignon, France, 84000 Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lutte Contre le Cancer Georges-Francois Leclerc Dijon, France, 21079 CMC Les Ormeaux Le Havre, France, 76600 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Hospitalier General Andre Boulloche Montbeliard, France, 25209 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Catherine de Sienne Nantes, France, 02 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Hopital Paris, France, 75248 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35042 Centre Henri Becquerel Rouen, France, 76038 Clinique Armoricaine De Radiologie Saint Brieuc, France, F-22015 Centre Rene Huguenin Saint Cloud, France, 92211 CRLCC Nantes - Atlantique Saint-Herblain, France, 44805 Centre Paul Strauss Strasbourg, France, 67065 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT03586999 Peripheral T Cell Lymphoma Phase 1 Phase 2 Recruiting August 2021 United States, California ... More >> City of Hope Cancer Center Not yet recruiting Duarte, California, United States, 91010 Contact: Jasmine Zain, MD       jazain@coh.org    Principal Investigator: Jasmine Zain, MD          United States, Colorado University of Colorado Hospital Recruiting Aurora, Colorado, United States, 80045 Contact: Derek Schatz    720-848-0628    derek.schatz@ucdenver.edu    Principal Investigator: Brad Haverkos, MD          United States, Pennsylvania Thomas Jefferson University Not yet recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Pierluigi Porcu, MD       pierluigi.porcu@jefferson.edu    Principal Investigator: Pierluigi Porcu, MD Less <<
NCT00003113 Lymphoma Phase 2 Terminated - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00504491 Chronic Lymphocytic Leukaemia ... More >> Patients Resistant to a Purine Analogous Patients Relapsed With Purines Therapy Less << Phase 2 Withdrawn(IMP new owner decisi... More >>on) Less << June 2012 Spain ... More >> ICO Badalona Badalona, Barcelona, Spain, 08916 ICO Bellvitge Hospitalet de Llobregat, Barcelona, Spain, 08907 Althaia Manresa, Barcelona, Spain, 08243 Corporacion Sanitaria Parc Tauli Sabadell, Barcelona, Spain, 08208 Hospital Clinic i Provincial. Barcelona, Cataluña, Spain, 08036 Hospital Universitario de Canarias La Laguna, Gran Canaria, Spain, 38320 Hospital de Son Dureta Palma de Mallorca, Islas Baleares, Spain, 07014 Hospital Francisco de Borja Gandia, Valencia, Spain, 46700 Hospital del Mar Barcelona, Spain, 08003 Hospital Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Valle de Hebron Barcelona, Spain, 08035 Hospital de Basurto Bilbao, Spain, 48013 ICO Gerona Girona, Spain, 17007 Hospital Virgen de las Nieves Granada, Spain, 18014 Hospital Arnau de Vilanova Lleida, Spain, 25198 Hospital La Princesa Madrid, Spain, 28006 Hospital Gregorio Marañon Madrid, Spain, 28007 M.D.Anderson Internacional Madrid, Spain, 28033 Hospital Ramón y Cajal Madrid, Spain, 28034 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital 12 de octubre Madrid, Spain, 28041 Hospital Morales Meseguer Murcia, Spain, 30008 Hospital Clinico de Salamanca Salamanca, Spain, 37007 Hospital Marques de Valdecilla Santander, Spain, 39008 Hospital Clinico Universitario de Santiago Santiago de Compostela, Spain, 36680 Hospital Virgen del Rocio Sevilla, Spain, 41013 Hospital Joan XXIII Tarragona, Spain, 43005 Hospital La Fe Valencia, Spain, 46009 Hospital Clinico de Valencia Valencia, Spain, 46011 Hospital Doctor Peset Valencia, Spain, 46017 Hospital General de Valencia Valencia, Spain, 46018 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT01783535 Retinoblastoma Phase 2 Recruiting June 2022 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Rachel C. Brennan, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Rachel C. Brennan, MD Less <<
NCT00002829 Lymphoma Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03085368 HER2-positive Breast Cancer Phase 2 Phase 3 Recruiting March 1, 2021 China ... More >> PUMCH Recruiting Beijing, China, 100730 Contact: Sun Qiang, M.D.    0086-13001289600    1210548954@qq.com    Contact: Wang Xuefei Less <<
NCT01862965 Chronic Graft-versus-host Dise... More >>ase Less << Phase 2 Active, not recruiting June 2018 Germany ... More >> Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany, 20246 Universitätsklinikum Jena Jena, Germany, 07743 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany, 55101 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universitätsklinikum Ulm Ulm, Germany, 89081 Deutsche Klinik fuer Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT00362531 Idiopathic Membranous Nephropa... More >>thy Nephrotic Syndrome Less << Phase 2 Phase 3 Completed - -
NCT01621477 - Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - -
NCT00107614 - Terminated(Terminated due to p... More >>oor accrual.) Less << - -
NCT00107614 Waldenstrom Macroglobulinemia Phase 2 Terminated(Terminated due to p... More >>oor accrual.) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00382694 Multiple Myeloma Phase 2 Unknown - Denmark ... More >> Department of Haematology B, Aalborg Hospital, University of Aarhus Aalborg, Denmark, 9000 Department of Haematology, Herlev University Hospital Herlev, Denmark, 2730 Department of Haematology, Rigshospitalet København Ø, Denmark, 2100 Department of Haematology X, Odense University Hospital Odense, Denmark, 5000 Department of Haematology, Vejle Hospital Vejle, Denmark, 7100 Dept. of Haematology, Århus University Hospital Århus, Denmark, 8000 Less <<
NCT01621477 Acute Lymphoblastic Leukemia ... More >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid Less << Phase 2 Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00003573 Brain Tumors ... More >>Central Nervous System Tumors Less << Phase 2 Completed - -
NCT03167177 Melanoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT02259348 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myelogenous Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Less << Phase 2 Terminated(Investigator's deci... More >>sion.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03167164 Merkel Cell Carcinoma Phase 1 Phase 2 Not yet recruiting March 2019 -
NCT00697671 Acute Lymphoblastic Leukemia ... More >> Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00039195 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00039195 - Completed - -
NCT02259348 - Terminated(Investigator's deci... More >>sion.) Less << - -
NCT00040937 - Completed - -
NCT00024050 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00040937 Multiple Myeloma Phase 2 Completed - -
NCT00005962 Leukemia Phase 2 Completed - -
NCT00266136 Acute Myeloid Leukemia Phase 3 Completed - Germany ... More >> University of Muenster, Medical Center, Department of Medicine, Hematology and Oncology Muenster, Germany, 48129 Less <<
NCT00006126 Breast Cancer ... More >> Kidney Cancer Lung Cancer Melanoma (Skin) Testicular Germ Cell Tumor Less << Phase 1 Withdrawn(Unable to accrue sub... More >>jects.) Less << - -
NCT00559754 - Completed - -
NCT00004132 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Oral Complications Radiation Toxicity Less << Phase 2 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 Less <<
NCT00451178 Lymphoma Phase 2 Completed - -
NCT00056095 Kidney Cancer Phase 2 Unknown - France ... More >> Centre Hospitalier Regional et Universitaire d'Angers Recruiting Angers, France, 49033 Contact: Norbert Ifrah, MD    33-2-41-35-4472       Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact: Contact Person    33-81-668-240       Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Alain Ravaud, MD, PhD    33-5-5679-5808    alain.ravaud@chu-bordeaux.fr    Chu-Hopital Gabriel Montpied Recruiting Clermont-Ferrand, France, 63003 Contact: Laurent Guy, MD    33-0473-750-750    lguy@chu-clermontferrand.fr    Centre Jean Perrin Recruiting Clermont-Ferrand, France, 63011 Contact: Jean Olivier    33-73-278-080       CHU de Grenoble - Hopital Michallon Recruiting Grenoble, France, 38043 Contact: Frederic Garban, MD, PhD    33-4-7676-5028       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Hospital Universitaire Hop Huriez Recruiting Lille, France, 59037 Contact: J.P. Jouet, MD    33 3 20 444197    jpjouet@chru-lille.fr    Centre Hospital Regional Universitaire de Limoges Recruiting Limoges, France, 87042 Contact: Dominique Bordessoule, MD, PhD    33-5-5505-6642    bordessoule@unilim.fr    Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie Negrier, MD    33-4-7878-2751    negrier@lyon.fnclcc.fr    Hopital Edouard Herriot - Lyon Recruiting Lyon, France, 69437 Contact: Mauricette Michallet, MD    33-472117401       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Didier Blaise, MD    33-4-91-22-37-54    blaised@marseille.fnclcc.fr    Hopital Lapeyronie-CHU Montpellier Recruiting Montpellier, France, 34295 Contact: Eric Legouffe, MD    33-4-67-33-80-79    e-legouffe@chu-montpellier.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital de l'Archet CHU de Nice Recruiting Nice, France, F-06202 Contact: Contact Person    33-49-203-9267       Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Pierre T. Dorval, MD    33-1-44-324-679    thierry.dorval@curie.net    Hopital Haut Leveque Recruiting Pessac, France, 33604 Contact: Reza Tabrizi, MD    33-57-656-511       Hopital Jean Bernard Recruiting Poitiers, France, 86021 Contact: Jean-Marc Tourani, MD    33-549-444-534    jm.tourani@chu.poitiers.frs.fr    Centre Hospitalier Universitaire de Rennes Recruiting Rennes, France, 35033 Contact: Thiery Lamy, MD, PhD    33-2-99-28-42-91    thierry.lamy@univ-rennes1.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Brigitte Laguerre    33-2-9925-3000       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Nathalie Contentin    33-2-3208-2222       Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Hopitaux de Brabois Recruiting Vandoeuvre-Les-Nancy, France, 54511 Contact: Pierre Bordigoni    Not Available       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Jean-Henri Bourhis, MD, PhD    33-1-42-11-4507    jhb@igr.fr Less <<
NCT00002789 Leukemia Phase 3 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00003577 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University of Cambridge Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00003364 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Heatherwood Hospital Ascot, England, United Kingdom, SL5 8AA Royal Sussex County Hospital Brighton, England, United Kingdom, BN2 5BE Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Broomfield Hospital Chelmsford, Essex, England, United Kingdom, CM1 5ET Essex County Hospital Colchester, England, United Kingdom Royal Free Hospital Hampstead, London, England, United Kingdom, NW3 2QG Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Guy's and St. Thomas' Hospitals Trust London, England, United Kingdom, SE1 9RT Charing Cross Hospital London, England, United Kingdom, W6 8RF Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, WIT 3AA Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Peterborough Hospitals Trust Peterborough, England, United Kingdom, PE3 6DA Southend NHS Trust Hospital Westcliff-On-Sea, England, United Kingdom Less <<
NCT00998270 Multiple Myeloma Phase 2 Phase 3 Unknown October 2017 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of Contact: Ardeshir Ghavamzadeh, MD    84902635 ext +98-21    ghavamza@sina.tums.ac.ir    Principal Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Kamran Alimoghaddam, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT00559754 Breast Cancer Phase 2 Completed - Spain ... More >> Sabadell, Barcelona, Barcelona, Spain, 08208 Cordoba, Spain, 14004 Jaen, Spain, 23007 Lerida, Spain, 25198 Malaga, Spain, 29010 Zaragoza, Spain, 50009 Less <<
NCT00265889 Lymphoma Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00017095 Breast Cancer Phase 3 Completed - -
NCT00092222 Lymphoproliferative Disorder ... More >> HHV-8 Malignancy HIV Less << Phase 2 Recruiting October 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00287950 Neuroblastoma Not Applicable Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT02624973 Breast Cancer Phase 2 Active, not recruiting June 2030 Norway ... More >> Akershus University Hospital Lørenskog, Akershus, Norway Haukeland University Hospital Bergen, Hordaland, Norway, 5021 Helse Fonna Haugesund, Rogaland, Norway Helse Stavanger Stavanger, Rogaland, Norway Helse Førde Førde, Sogn Og Fjordande, Norway St. Olavs Hospital Trondheim, Sør Trøndelag, Norway Helse Nord/UNN Tromsø, Troms, Norway Less <<
NCT00276731 Neuroblastoma Phase 3 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01859819 Diffuse Large Cell Lymphoma ... More >> Burkitt's Lymphoma High Grade B-cell Lymphoma Less << Phase 2 Recruiting December 2019 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Matthew Barth, MD       Matthew.Barth@RoswellPark.org    New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu    Contact: Lauren Harrison, MSN       lauren_harrison@nymc.edu    United States, North Carolina Levine Children's Hospital Recruiting Charlotte, North Carolina, United States, 28204 Contact: Javier Oesterheld, MD       Javier.Oesterheld@carolinashealthcare.org    United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Contact: Kimble Frazer, MD       kimble-frazer@ouhsc.edu    United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Michael Pulsipher, MD       michael.pulsipher@hsc.utah.edu Less <<
NCT00544570 Lymphoma Not Applicable Completed - -
NCT00002579 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Leicester Royal Infirmary NHS Trust Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT00276705 Liver Cancer Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health at Royal Victoria Infirmary Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00325416 Multiple Myeloma Phase 1 Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00003392 Breast Cancer Phase 2 Completed - United States, California ... More >> Scripps Clinic La Jolla, California, United States, 92037 University of California San Diego La Jolla, California, United States, 92093 United States, District of Columbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307-5000 United States, Florida Bone Marrow Stem Cell Transplant Institute of Florida Fort Lauderdale, Florida, United States, 33313 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Lutheran General Cancer Care Center Park Ridge, Illinois, United States, 60068 United States, New York Stem Cell Sciences New York, New York, United States, 10016 University of Rochester School of Medicine Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 Temple University Cancer Center Philadelphia, Pennsylvania, United States, 19140 United States, Tennessee Methodist Hospital-Central Unit Memphis, Tennessee, United States, 38104 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01302392 Multiple Myeloma Phase 3 Completed - -
NCT01302392 - Completed - -
NCT00683319 - Active, not recruiting - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00110006 Lymphoma Not Applicable Withdrawn(No accrual) - -
NCT01865110 Mantle Cell Lymphoma Phase 3 Recruiting March 2024 -
NCT03517137 Advanced Hodgkin Lymphoma Phase 2 Not yet recruiting September 1, 2023 -
NCT00325416 - Completed - -
NCT00580034 - Completed - -
NCT00152139 Acute Lymphoblastic Leukemias ... More >> Acute Myelocytic Leukemia Chronic Myeloid Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hemoglobinuria, Paroxysmal Non-Hodgkin Lymphoma Less << Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00265889 - Completed - -
NCT00753103 Wegener's Granulomatosis ... More >> Renal Limited Vasculitis Microscopic Polyangiitis Less << Phase 2 Completed - United Kingdom ... More >> University Hospitals Birmingham NHS Foundation Trust Birmingham, West Midlands, United Kingdom, B15 2TT Less <<
NCT00580034 Lymphoma Myel... More >>oma Leukemia Myelodysplasia Solid Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health Systems Durham, North Carolina, United States, 27710 Less <<
NCT03570892 Non-Hodgkin Lymphoma Phase 3 Not yet recruiting May 26, 2025 -
NCT01914770 - Completed - -
NCT00068523 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Not Applicable Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00513474 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 Less <<
NCT00477035 Leukemia Mult... More >>iple Myeloma Less << Phase 1 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00940524 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00072007 Leukemia Phase 2 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital Bern Bern, Switzerland, CH-3010 Spitaeler Chur AG Chur, Switzerland, CH-7000 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital, Luzerne Luzerne, Switzerland, CH-6000 Hopital des Cadolles, Neuchatel Neuchatel, Switzerland, 2000 Praxis Dr. Beretta Rheinfelden, Switzerland, 4310 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Onkozentrum Zurich, Switzerland, 8038 UniversitaetsSpital Zuerich Zurich, Switzerland, CH-8091 Less <<
NCT01358253 Acute Lymphoblastic Leukemia Phase 4 Completed - China, Shanghai ... More >> Ruijin Hospital Shanghai, Shanghai, China, 200025 Less <<
NCT00112827 Refractory Multiple Myeloma ... More >> Smoldering Multiple Myeloma Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Phase 2 Active, not recruiting November 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT02179359 Sickle Cell Disease ... More >> Transfusion Dependent Alpha- or Beta- Thalassemia Diamond Blackfan Anemia Paroxysmal Nocturnal Hemoglobinuria Glanzmann Thrombasthenia Severe Congenital Neutropenia Shwachman-Diamond Syndrome Non-Malignant Hematologic Disorders Less << Not Applicable Recruiting August 2021 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT00050167 Breast Cancer Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00050167 - Completed - -
NCT01422603 Acute Myeloid Leukaemia ... More >> Myelodysplasia Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Wessex Blood and Marrow Transplant Unit, Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom, SO16 6YD Less <<
NCT00516685 Non-small-cell Lung Cancer (NS... More >>CLC) Stage IIIb/IV Less << Phase 2 Phase 3 Terminated(Due to inability of... More >> patient enrollment, decision taken to terminate in the interests of patients and later Malaysia is incorporated into global Phase 3 trial.) Less << - Malaysia ... More >> Local Institution Kubang Kerian, Kelantan, Malaysia, 16150 Local Institution Nilai, Negeri Sembilan, Malaysia, 71800 Local Institution Kuantan, Pahang, Malaysia, 25100 Local Institution Georgetown, Pulau Pinang, Malaysia, 11200 Local Institution Kota Kinabalu, Sabah, Malaysia, 88838 Local Institution Kota Kinabalu, Sabah, Malaysia, 88996 Local Institution Klang, Selangor, Malaysia, 41000 Local Institution Petaling Jaya, Selangor, Malaysia, 50603 Local Institution Kuala Lumpur, Malaysia, 51900 Local Institution Kuala Lumpur, Malaysia, 53000 Less <<
NCT00513474 - Completed - -
NCT02911142 Primary Effusion Lymphoma ... More >> B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting October 1, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01793844 - Unknown December 2017 China, Guangdong ... More >> Tumor center, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510060 Contact: Lin TongYu    86-20-87343356    tongyulin@hotmail.com    Contact: Huang Yan    86-20-87343565    ehuangyancn@yahoo.com.cn Less <<
NCT02457039 Chemo-brain D... More >>rug-Related Side Effects and Adverse Reactions Mild Cognitive Impairment Breast Cancer Less << Not Applicable Recruiting October 2019 China, Guangdong ... More >> Department of Chinese Medicine, The University of Hong Kong - Shenzhen Hospital Recruiting Shenzhen, Guangdong, China, 518053 Contact: Jun-Mei J WU, PhD, MS, MBA    +852 3917 6447    wujunmei@hku.hk    Contact: Xian-Hui X FANG    +86 159 200 918 65    fangxh@hku-szh.org    Principal Investigator: Jun-Mei J WU, PhD, MS, MBA          Department of Clinical Oncology, The University of Hong Kong - Shenzhen Hospital Recruiting Shenzhen, Guangdong, China, 518053 Contact: Victor Ho-fun V LEE, MBBS, FRCR    +852 2255 4352    vhflee@hku.hk    Contact: Hai-Man H JING    +86 136 329 979 07    jinghm@hku-szh.org    Principal Investigator: Victor Ho-fun V LEE, MBBS, FRCR          Hong Kong The Nethersole School of Nursing, The Chinese University of Hong Kong Not yet recruiting Sha Tin, N.t., Hong Kong Contact: Winnie Kwok-Wei SO, MHA, PhD    +852 3943 1072    winnieso@cuhk.edu.hk    Principal Investigator: Winnie Kwok-Wei SO, MHA, PhD          Department of Clinical Oncology, Queen Mary Hospital Recruiting Hong Kong, Hong Kong Contact: Tsz-Him SO, MBBS, BCM    +852 2255 4352    sth495@hku.hk    Sub-Investigator: Victor Ho-fun LEE, MBBS, FRCR          Principal Investigator: Tsz-Him SO, MBBS, BCM          Department of Surgery, Queen Mary Hospital Recruiting Hong kong, Hong Kong Contact: Ava KWONG, PhD, FCSHK    +852 2255 4773    avakwong@hku.hk    Principal Investigator: Ava KWONG, PhD, FCSHK          Department of Surgery, Tung Wah Hospital Recruiting Sai Ying Pun, Hong Kong Contact: Ava KWONG, PhD, FCSHK    +852 2255 4773    avakwong@hku.hk    Principal Investigator: Ava KWONG, PhD, FCSHK Less <<
NCT01563211 - Completed - United Kingdom ... More >> Charing Cross Hospital London, United Kingdom, W6 8RF Less <<
NCT00002611 Kidney Cancer Phase 3 Completed - -
NCT00075725 Leukemia Phase 3 Completed - -
NCT01247688 Lymphoid Hematological Maligna... More >>ncies Umbilical Cord Blood Transplant Less << Not Applicable Withdrawn(This study was withd... More >>rawn due to low accrual.) Less << - -
NCT02229266 Acute Myeloid Leukemia Phase 2 Recruiting September 2020 Germany ... More >> Klinikum Bayreuth Not yet recruiting Bayreuth, Germany Contact: Alexander Kiani, Prof. Dr. med.       alexander.kiani@klinikum-bayreuth.de    Principal Investigator: Alexander Kiani, Prof. Dr. med.          Klinikum Chemnitz Not yet recruiting Chemitz, Germany Contact: Regina Herbst, Dr. med.       r.herbst@skc.de    Principal Investigator: Mathias Hänel, PD Dr. med.          Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Malte von Bonin, Dr. med.       Malte.Bonin@uniklinikum-dresden.de    Principal Investigator: Malte von Bonin, Dr. med. Less <<
NCT00002835 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT03575351 Lymphoma, Non-Hodgkin Phase 3 Recruiting January 13, 2023 -
NCT00849758 - Completed - Belgium ... More >> Jules Bordet Institute Brussels, Belgium, 1000 University Hospitals Leuven Leuven, Belgium, 3000 Less <<
NCT02521441 Neutropenia Phase 2 Completed - China ... More >> Fudan University Shanghai Cancer Center Shanghai, China, 200032 Less <<
NCT00185523 - Terminated - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03758781 Metastatic Cancer ... More >> Recurrent Cancer Solid Tumor Renal Cell Carcinoma Urothelial Carcinoma NSCLC Squamous Cell Carcinoma Non-Small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck Less << Phase 1 Not yet recruiting February 2022 United States, Florida ... More >> H Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Nevena Ugrenovic    813-745-2025       Sub-Investigator: Christine Chung, MD          Sub-Investigator: Benjamin Creelan, MD          Sub-Investigator: Jhanelle Gray, MD          Sub-Investigator: Nikhil Khushalani, MD          Sub-Investigator: Michael Shafique, MD          Sub-Investigator: Jingsong Zhang, MD, PhD Less <<
NCT00075725 - Completed - -
NCT00914628 Acute Leukemia (Category) Phase 3 Recruiting March 2021 -
NCT00057005 Leukemia Phase 1 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00017654 Graft Versus Host Disease ... More >> Aplastic Anemia Less << Not Applicable Unknown - United States, Illinois ... More >> Northwestern Memorial Hospital Chicago, Illinois, United States, 60611 Less <<
NCT02800447 Advanced Hodgkin's Lymphoma Not Applicable Active, not recruiting December 2018 -
NCT00910650 Metastatic Melanoma Phase 2 Recruiting December 2019 United States, California ... More >> University of California Los Angeles, David Geffen School of Medicine Recruiting Los Angeles, California, United States, 90095 Less <<
NCT00600353 Myeloma, Plasma-Cell ... More >> Lymphoma, Malignant Less << Phase 2 Completed - United States, Kansas ... More >> University of Kansas Medical Center Kansas City, Kansas, United States, 66160 Less <<
NCT01033552 Epidermolysis Bullosa Phase 2 Recruiting October 2019 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org    Principal Investigator: Jakub Tolar, MD, PhD Less <<
NCT00664599 Behcet's Syndrome Phase 2 Completed - Iran, Islamic Republic of ... More >> Rheumatology Research Center, Shariati Hospital Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT00600353 - Completed - -
NCT00004221 Malignant Ovarian Mixed Epithe... More >>lial Tumor Ovarian Clear Cell Cystadenocarcinoma Ovarian Endometrioid Adenocarcinoma Ovarian Mucinous Cystadenocarcinoma Ovarian Serous Cystadenocarcinoma Primary Peritoneal Carcinoma Stage III Ovarian Cancer Undifferentiated Ovarian Carcinoma Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00002616 Breast Cancer Phase 1 Unknown - United States, Illinois ... More >> University of Illinois at Chicago Health Sciences Center Chicago, Illinois, United States, 60612 Less <<
NCT00433433 Lymphoma Phase 3 Completed - Netherlands ... More >> Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Less <<
NCT01173887 Adult T-cell Leukemia-Lymphoma Phase 2 Completed - Japan ... More >> Fukuoka University Hospital Fukuoka, Japan Kyushu University Hospital Fukuoka, Japan National Kyushu Cancer Center Fukuoka, Japan Imamura Bun-in Hospital Kagoshima, Japan Kagoshima University Hospital Kagoshima, Japan Kokura Memorial Hospital Kitakyushu, Japan Kumamoto University Hospital Kumamoto, Japan National Hospital Organization Kumamoto Medical Center Kumamoto, Japan NTT West Japan Kyushu Hospital Kumamoto, Japan Nagasaki University Hospital Nagasaki, Japan The Japanese Red Cross Nagasaki Genbaku Hospital Nagasaki, Japan Aichi Cancer Center Hospital Nagoya, Japan Nagoya City University Hospital Nagoya, Japan Oita Prefectural Hospital Oita, Japan Heartlife Hospital Okinawa, Japan National Hospital Organization Nagasaki Medical Center Omura, Japan Sasebo City General Hospital Sasebo, Japan National Cancer Center Hospital Tokyo, Japan Ehime University Hospital Toon, Japan Less <<
NCT00002744 Leukemia Phase 3 Completed - -
NCT00774826 Follicular Lymphoma Phase 3 Unknown March 2014 -
NCT01219816 B ALL CD22+ E... More >>xpression Refractory B-ALL Less << Phase 2 Completed - France ... More >> Angers University Hospital Angers, France, 49933 University Hospital Caen, France, 14000 HEnri Mondor Hospital Creteil, France, 94010 Edouard Herriot Hospital Lyon, France, 69437 Institut Paoli Calmette Marseille, France, 13373 Nantes University Hospital Nantes, France, 44000 Saint Louis Hospital Paris, France, 75010 St Antoine Paris, France, 75015 Haut-Leveque Hospital Pessac, France, 33604 CHU de Poitiers Poitiers, France, 86021 Purpan Hospital Toulouse, France, 37509 Less <<
NCT00281905 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Less << Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT00003214 Ovarian Cancer Phase 3 Completed - Switzerland ... More >> Kantonspital Aarau Aarau, Switzerland, 5001 Frauenspital, Basel Basel, Switzerland, 4031 Office of Walter Weber-Stadelman Basel, Switzerland, CH 4051 University Hospital Basel, Switzerland, CH-4031 Inselspital, Bern Bern, Switzerland, CH-3010 Hopital Cantonal Universitaire de Geneva Geneva, Switzerland, CH-1211 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Burgerspital, Solothurn Solothurn, Switzerland, 4500 City Hospital Triemli Zurich, Switzerland, 8063 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00002870 Breast Cancer Phase 3 Completed - France ... More >> Centre Paul Papin Angers, France, 49036 CHR de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Clinique Saint Vincent Besancon, France, 25044 Institut Bergonie Bordeaux, France, 33076 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 C.H.U. de Brest Brest, France, 29200 Centre Hospitalier General Brive, France Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Hopital Louis Pasteur Colmar, France, 68024 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 Institut Prive de Cancerologie Grenoble, France, 38100 Centre Oscar Lambret Lille, France, 59020 Centre Leon Berard Lyon, France, 69373 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Notre-Dame de Bon Secours Metz, France, 55038 Hopital Sainte Blandine Metz, France, 57045 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital Saint-Louis Paris, France, 75475 Federation Nationale des Centres de Lutte Contre le Cancer Paris, France, 75654 Hopital Tenon Paris, France, 75970 Hopital Haut Leveque Pessac, France, 33604 Hopital Jean Bernard Poitiers, France, 86021 Institut Jean Godinot Reims, France, 51056 Centre Eugene Marquis Rennes, France, 35062 C.H.U. Saint Etienne Hospital Nord Saint Etienne, France, 42055 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Claudius Regaud Toulouse, France, 31052 Centre Hospitalier Universitaire Bretonneau de Tours Tours, France, 37044 Centre Alexis Vautrin Vandoeuvre-les-Nancy, France, 54511 CHRU de Nancy - Hopitaux de Brabois Vandoeuvre-Les-Nancy, France, 54511 Less <<
NCT00309881 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Kreiskrankenhaus Bad Hersfeld, Germany, 36251 DIAKO Ev. Diakonie Krankenhaus gGmbH Bremen, Germany, 28239 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Universitaetsklinikum Essen Essen, Germany, D-45122 Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie Giessen, Germany, 35392 St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH Hagen, Germany, 58095 Allgemeines Krankenhaus Hagen Hagen, Germany, D-58095 Praxis fur Innere Medizin - Hamburg Hamburg, Germany, 22457 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Marienhospital at Ruhr University Bochum Herne, Germany, D-44625 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Internistische Gemeinschaftspraxis - Kassel Kassel, Germany, 34117 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Oldenburg Oldenburg, Germany, D-26133 Marienhospital Stuttgart Stuttgart, Germany, 70199 Haematologische Praxis Weiden, Germany, D-92637 Medizinische Poliklinik, Universitaet Wuerzburg Wuerzburg, Germany, D-97070 Less <<
NCT00003960 Leukemia Mult... More >>iple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, South Carolina Center for Cancer Treatment and Research Columbia, South Carolina, United States, 29203 Less <<
NCT00233987 Lymphoma Phase 2 Completed - -
NCT00233987 - Completed - -
NCT00024128 Lymphoma Phase 2 Withdrawn(Withdrawn prior to i... More >>nitiation.) Less << - -
NCT00705120 Osteogenesis Imperfecta Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03020030 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting December 2026 United States, Massachusetts ... More >> Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis Silverman, MD    617-632-6191    lewis_silverman@dfci.harvard.edu    Principal Investigator: Lewis Silverman, MD          United States, New York Montefiore Medical Center Recruiting Bronx, New York, United States, 104617 Contact: Lisa Gennarini, MD       lfigueir@montefiore.org    Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Kara Kelly, MD       Kara.Kelly@RoswellPark.org    Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian Recruiting New York, New York, United States, 10032 Contact: Justine Kahn, MD       jk2034@cumc.columbia.edu    Principal Investigator: Justine Kahn, MD          United States, Rhode Island Hasbro Children's Hospital / Rhode Island Hospital Recruiting Providence, Rhode Island, United States, 02903 Contact: Jennifer Welch, MD       jwelch@lifespan.org    Canada, Quebec Hospital Sainte Justine, University of Montreal Recruiting Montreal, Quebec, Canada Contact: Jean-Marie LeClerc, MD       jean-marie.leclerc@umontreal.ca    Principal Investigator: Jean-Marie LeClerc, MD          Centre Hospitalier U. de Quebec Recruiting Quebec City, Quebec, Canada Contact: Bruno Michon, MD       bruno.michon@mail.chuq.qc.ca    Principal Investigator: Bruno Michon, MD Less <<
NCT00005945 Leukemia Phase 3 Completed - -
NCT02963831 Colorectal Cancer ... More >> Platinum-resistant Ovarian Cancer Appendiceal Cancer Less << Phase 1 Phase 2 Recruiting October 2022 United States, Florida ... More >> Research Facility Recruiting Miami, Florida, United States, 33136 United States, New York Research Facility Recruiting Buffalo, New York, United States, 14263 Research Facility Recruiting New York, New York, United States, 10065 United States, Ohio Research Facility Not yet recruiting Toledo, Ohio, United States, 43614 Contact: Nadine Nemunaitis       NNadine.Nemunaitis@UToledo.Edu    United States, Virginia Research Facility Recruiting Charlottesville, Virginia, United States, 22903 Less <<
NCT00002581 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT03128996 Severe Sickle Cell Disease ... More >> Bone Marrow Failure Syndromes Metabolic Disorders Immunologic Disorders Hemoglobinopathies Non-malignant Disorders Less << Phase 1 Phase 2 Recruiting April 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD    314-454-6018    shalinishenoy@wustl.edu    Contact: Lisa Murray, MA, CCRP    314-454-4240    murraylm@wustl.edu    Principal Investigator: Shalini Shenoy, MD Less <<
NCT03236857 Malignancies ... More >>Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Non-Hodgkin's Lymphoma Neuroblastoma Less << Phase 1 Recruiting April 7, 2022 -
NCT01597414 Elderly Metastatic Breast Canc... More >>er Population Less << Phase 2 Active, not recruiting December 2018 Belgium ... More >> UZ Antwerpen Antwerpen, Belgium Cliniques Universitaires Saint-Luc Brussels, Belgium Institut Jules Bordet Brussels, Belgium Hopital De Jolimont Haine St Paul, Belgium AZ Groeninge Kortrijk Kortrijk, Belgium UZ Leuven Leuven, Belgium CHU Sart-Tilman Liège, Belgium Clinique et Maternité Sainte Elisabeth Namur, Belgium AZ Damiaan Oostende, Belgium AZ Nikolaas Sint-Niklaas, Belgium France Centre Georges-Francois-Leclerc Dijon, France Centre Oscar Lambret Lille, France Hopital Rene Huguenin - Institut Curie Saint-Cloud, France Centre Paul Strauss Strasbourg, France Italy Istituto Europeo Di Oncologia Milano, Italy Istituto Oncologico Veneto IRCCS - Ospedale Busonera Padova, Italy Netherlands Leiden University Medical Centre Leiden, Netherlands VieCuri - Medisch Centrum voor Noord-Limburg - Locatie Venlo Venlo, Netherlands Poland Maria Sklodowska-Curie Memorial Cancer Centre Warsaw, Poland Portugal Champalimaud Cancer Center Lisboa, Portugal Instituto Português de Oncologia de Lisboa Francisco Gentil, E.P.E. Lisboa, Portugal Sweden Sahlgrenska Universitetssjukhuet Goteborg, Sweden Ryhov County Hospital Jonkoping, Sweden Uppsala University Hospital - Akademiska Sjukhuset Uppsala, Sweden Vastmanland Centralsjukhuset Vasteras Vasteras, Sweden United Kingdom Velindre NHS Trust - Velindre Cancer Centre Cardiff, United Kingdom NHS Lothian - Western General Hospital Edinburgh, United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital Glasgow, United Kingdom Peterborough and Stamford Hospitals NHS Foundation Trust - Peterborough City Hospita Peterboroug, United Kingdom University Hospital Southampton NHS Foundation Trust - Southampton General Hospital Southampton, United Kingdom Less <<
NCT02539017 Triple Negative Breast Neoplas... More >>ms Less << Phase 2 Withdrawn(because of safety pr... More >>oblem, this trial was stopped in the hospital) Less << - China, Shaanxi ... More >> the First Affiliated Hospital of Xi 'an Jiaotong University Xi'an, Shaanxi, China, 710000 Less <<
NCT00632827 Peripheral T-Cell Lymphoma Phase 2 Unknown December 2014 United States, Missouri ... More >> Washington University St. Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10021 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00923195 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00923195 - Completed - -
NCT01593696 ALL B Cell Ly... More >>mphoma Leukemia Large Cell Lymphoma Non-Hodgkin Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03670173 Multiple Myeloma Phase 1 Phase 2 Not yet recruiting September 30, 2020 -
NCT00005854 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 United States, Massachusetts University of Massachusetts Memorial Medical Center Worcester, Massachusetts, United States, 01655 United States, South Carolina University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01611051 Breast Cancer ... More >> Neutropenia Febrile Neutropenia Less << Phase 3 Completed - China, Beijing ... More >> Hospital Affiliated to Academy Military Medical Science Beijing, Beijing, China, 100071 Less <<
NCT02546167 Multiple Myeloma Phase 1 Active, not recruiting September 2020 United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01646385 - Completed - -
NCT00003416 Lymphoma Phase 2 Completed - -
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT01646385 - Completed - -
NCT01788137 T-cell Lymphoma Adults ... More >> Previously Untreated High Risk Less << Phase 3 Unknown December 2017 China, Guangdong ... More >> Tumor center, Sun Yat-sen University Recruiting GuangZhou, Guangdong, China, 510080 Contact: Guan ZhongZhen    86-20-87343356    tongyulin@hotmail.com Less <<
NCT01760655 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Cytopenia With Multilineage Dysplasia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Recruiting January 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, RN, CRNP, DNP    215-955-8874       Principal Investigator: Dolores Grosso, RN, CRNP, DNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Ubaldo Outschoorn Martinez, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Mark Weiss, MD Less <<
NCT01385423 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00282425 Scleroderma Phase 1 Terminated(No subject enrolled... More >> since 2009) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00466258 HIV Infections ... More >> Diffuse Large B Cell Lymphoma Less << Phase 4 Completed - Spain ... More >> H. Son Llatzer Palma de Mallorca, Baleares, Spain Germans Trias i Pujol Badalona, Barcelona, Spain Consorci Sanitari de Mataró Mataro, Barcelona, Spain H. Parc Taulí Sabadell, Barcelona, Spain Consorci Sanitari de Terrassa Terrassa, Barcelona, Spain Hospital de Navarra Pamplona, Navarra, Spain H. Clínic i Provincial, Barcelona Barcelona, Spain H. Vall d'Hebron, Barcelona Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Sant Pau, Barcelona Barcelona, Spain ICO - Duran i Reynals, Hospitalet de Llobregat Barcelona, Spain ICO - Josep Trueta Girona, Spain H. Gregorio Marañón Madrid, Spain H. Joan XXIII Tarragona, Spain Hospital Universitario Dr. Peset Valencia, Spain Less <<
NCT00258427 Fanconi Anemia Phase 2 Recruiting January 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Margaret MacMillan, M.D. Less <<
NCT01946529 Desmoplastic Small Round Cell ... More >>Tumor Ewing Sarcoma of Bone or Soft Tissue Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Active, not recruiting July 2026 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01946529 - Active, not recruiting - -
NCT01700946 Recurrent B-Cell Childhood Acu... More >>te Lymphoblastic Leukemia Recurrent Childhood B-Lymphoblastic Lymphoma Less << Phase 2 Recruiting October 2021 United States, California ... More >> Rady Children's Hospital and Health Center Completed San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Sima Jeha, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Sima Jeha, MD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007       Principal Investigator: Kenneth M. Heym, MD Less <<
NCT02661503 Classical Hodgkin Lymphoma Phase 3 Recruiting September 2025 Germany ... More >> University Hospital of Cologne Recruiting Cologne, Germany Contact: Peter Borchmann, Prof. Less <<
NCT01464606 Pleuropulmonary Blastoma Not Applicable Recruiting December 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Gretchen M Williams, BS    612-813-7115    gretchen.williams@childrensmn.org    Contact: Kris Ann P Schultz, MD    612-813-7121    krisann.schultz@childrensmn.org    Principal Investigator: Kris Ann P Schultz, M.D. Less <<
NCT01093586 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Blastic Phase Chronic Myelogenous Leukemia Burkitt Lymphoma Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Minimally Differentiated Myeloid Leukemia (M0) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Secondary Myelofibrosis Splenic Marginal Zone Lymphoma Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia T-cell Large Granular Lymphocyte Leukemia Waldenstrom Macroglobulinemia Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00460421 - Completed - -
NCT00450385 - Terminated(Investigator Decisi... More >>on due to insufficient accrual.) Less << - -
NCT00393185 Primary Biliary Cirrhosis Phase 1 Withdrawn - -
NCT00450385 Lymphoma Phase 2 Terminated(Investigator Decisi... More >>on due to insufficient accrual.) Less << - United States, California ... More >> Stanford University Stanford, California, United States, 94305 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, New York University of Rochester Medical Center - Wilmot Cancer Institute Rochester, New York, United States, 14642 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 Less <<
NCT00559845 Breast Cancer Phase 2 Completed - Italy ... More >> Napoli, Campania, Italy, 80131 Reggio Emilia, Emilia-Romagna, Italy, 42100 Pordenone, Friuli-Venezia Giulia, Italy, 33170 Genova, Liguria, Italy, 16132 Mantova, Lombardia, Italy, 46100 Cuneo, Piemonte, Italy, 12100 Torino, Piemonte, Italy, 10126 Negrar, Veneto, Italy, 37024 Less <<
NCT01044745 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage I Small Lymphocytic Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Waldenstr?m Macroglobulinemia Less << Phase 2 Active, not recruiting March 2018 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7830 Less <<
NCT00897871 - Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Contact Person    353-1-409-6659       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B4 6NH Contact: Martin W. English, MD    44-121-333-8412    martin.english@bch.nhs.uk    Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8BJ Contact: Contact Person    44-117-342-0205       Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Amos Burke, MD    44-1223-348-151       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Adam Glaser, MD    44-113-206-4984    adam.glaser@leedsth.nhs.uk    Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Heather P. McDowell, MD    44-151-293-3679       University College Hospital Recruiting London, England, United Kingdom, NW1 2PCE Contact: Maria Michelagnoli, MD    44-20-7380-9064    maria.michelagnoli@uclh.nhs.uk    Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Gill Levitt, MD    44-20-7405-9200 ext. 0073       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Juliet Hale, MD    44-191-282-4101    j.p.hale@ncl.ac.uk    Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Martin Hewitt, MD, BSc, FRCP, FRCPCH    44-115-924-9924 ext. 63394    martin.hewitt@nuh.nhs.uk    Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Kate Wheeler, MD    44-186-522-1066       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Mary P. Gerrard, MBChB, FRCP, FRCPCH    44-114-271-7366    mary.gerrard@sch.nhs.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Janice A. Kohler, MD, FRCP    44-23-8079-6942       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Mary Taj, MD    44-20-8642-6011 ext. 3089       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Veronica Neefjes    44-1224-550-217       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Heidi Traunecker, MD, PhD    44-29-2074-2285    heidi.traunecker@cardiffandvale.wales.nhs.uk Less <<
NCT00559845 - Completed - -
NCT01871441 Malignant Neoplasm Phase 2 Terminated(Trial was closed du... More >>e to poor accrual.) Less << - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00185614 Blood Cancer ... More >>Multiple Myeloma Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00185614 - Completed - -
NCT03302403 B Cell Lymphoma ... More >> B Cell Leukemia Myeloma Hepatocellular Carcinoma Pancreatic Carcinoma Adenocarcinoma of Esophagogastric Junction Less << Not Applicable Not yet recruiting December 2020 China, Zhejiang ... More >> First Affiliated Hospital of Wenzhou Medical University Not yet recruiting Wenzhou, Zhejiang, China, 325000 Contact: Kang Yu, MD    +86-13806681379    yukang62@126.com    Principal Investigator: Mengtao Zhou, MD          Principal Investigator: Kang Yu, MD          Principal Investigator: Songfu Jiang, MD Less <<
NCT02487316 Systemic Anaplastic Large-Cell... More >> Lymphoma Less << Phase 4 Withdrawn December 2017 China, Beijing ... More >> Weiping Liu Beijing, Beijing, China, 100142 Less <<
NCT00333008 Diffuse Large B Cell Lymphoma ... More >> Lymphoma, Non-Hodgkin Less << Phase 2 Unknown - United States, Maryland ... More >> Sinai Hospital of Baltimore Recruiting Baltimore, Maryland, United States, 21215 Contact: Pam Nickoles, RN, BSN    410-601-0729    pnickole@lifebridgehealth.org    Contact: Judy Bosley, RN, BSN    410-601-4392    jbosley@lifebridgehealth.org    Principal Investigator: Stephen Noga, MD, PhD          Northwest Hospital Center Recruiting Randallstown, Maryland, United States, 21133 Contact: Pam Nickoles, RN, BSN    410-601-0729    pnickole@lifebridgehealth.org    Contact: Judy Bosley, RN, BSN    410-601-4392    jbosley@lifebridgehealth.org    Principal Investigator: Stephen Noga, MD, PhD Less <<
NCT00282412 Rheumatoid Arthritis Phase 1 Terminated(No participant enro... More >>lled for three years. No plan to continue study.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00003784 Lymphoma Phase 2 Completed - -
NCT00077116 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Institut Jules Bordet Brussels, Belgium, 1000 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 H. Hartziekenhuis - Roeselaere. Roeselare, Belgium, 8800 Germany Ruprecht - Karls - Universitaet Heidelberg Heidelberg, Germany, D-69117 Netherlands Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Switzerland Universitaetsspital-Basel Basel, Switzerland, CH-4031 Less <<
NCT01871441 - Terminated(Trial was closed du... More >>e to poor accrual.) Less << - -
NCT00365755 Neuroblastoma Phase 3 Completed - -
NCT01159288 Non Small Cell Lung Cancer Phase 2 Completed - France ... More >> Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00262067 Metastatic Breast Cancer Phase 3 Unknown December 2013 -
NCT00637832 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-845-226-3000       Mount Vernon Cancer Centre at Mount Vernon Hospital Recruiting Northwood, England, United Kingdom, HA6 2RN Contact: Contact Person    44-182-382-6111       Dorset Cancer Centre Recruiting Poole Dorset, England, United Kingdom, BH15 2JB Contact: Contact Person    44-120-266-5511       Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Contact Person    44-238-079-8934    kc8@soton.ac.uk    Saint Bartholomew's Hospital Recruiting London, United Kingdom, EC1A 7BE Contact: Contact Person    44-207-377-7000 Less <<
NCT00301925 Breast Cancer Phase 3 Active, not recruiting September 2024 -
NCT00533936 Breast Cancer Phase 2 Unknown - Mexico ... More >> Instituto Nacional de Cancerologia Recruiting Mexico City, Distrito Federal, Mexico, 14000 Contact: Claudia Arce-Salinas, MD    52-55-5628-0400       Hospital General de Mexico Recruiting Mexico City, Distrito Federal, Mexico, C.P. 06726 Contact: Contact Person    52-55-5999-6133 Less <<
NCT00003680 Breast Cancer Phase 3 Unknown - United Kingdom ... More >> C.R.C. Beatson Laboratories Glasgow, Scotland, United Kingdom, G61 1BD Less <<
NCT00047099 Breast Cancer Phase 3 Completed - Germany ... More >> I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-80337 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Less <<
NCT00284271 Hodgkin′s Lymphoma Phase 2 Completed - Germany ... More >> University of Cologne Cologne, Germany, 50931 Less <<
NCT01804127 Diffuse Large B-cell Lymphoma Phase 2 Unknown December 2017 China, Shanghai ... More >> Fudan University Cancer Hospital Recruiting Shanghai, Shanghai, China, 200032 Contact: Ye Guo, MS    +86 21 64175590 ext 8906    pattrick_guo@msn.com    Principal Investigator: Ye Guo, MD Less <<
NCT00262067 - Unknown - -
NCT01343043 Synovial Sarcoma Phase 1 Recruiting May 31, 2020 United States, Florida ... More >> GSK Investigational Site Recruiting Tampa, Florida, United States, 33612 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Maryland GSK Investigational Site Recruiting Bethesda, Maryland, United States, 20892 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Massachusetts GSK Investigational Site Recruiting Boston, Massachusetts, United States, 02114 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Missouri GSK Investigational Site Recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10065 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Texas GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT02370550 Sjogren's Syndrome Phase 4 Unknown March 2017 -
NCT02549534 - Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center (IUSCC) Indianapolis, Indiana, United States, 46202 Syndney & Lois Eskenazi Health Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00574080 - Terminated(low accrual) - -
NCT00704938 Kidney Cancer ... More >> Melanoma (Skin) Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Terminated(Terminated due to w... More >>ithdrawal of support from our collaborator.) Less << - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT03314805 Cancer-related Fatigue ... More >> Neutropenia, Malignant Less << Phase 2 Recruiting April 2019 Taiwan ... More >> Chang Gung Memorial Hospital, Kaohsiung Branch Recruiting Kaohsiung City, Taiwan, 833 Chang Gung Memorial Hospital, Lakeview Branch Recruiting Keelung City, Taiwan, 204 Chang Gung Memorial Hospital, Taipei Branch Not yet recruiting Taipei, Taiwan, 105 Chang Gung Memorial Hospital, Linkou Branch Recruiting Taoyuan, Taiwan, 333 Less <<
NCT00004179 Lymphoma Phase 3 Completed - -
NCT00574080 Multiple Myeloma Phase 3 Terminated(low accrual) - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT00704938 - Terminated(Terminated due to w... More >>ithdrawal of support from our collaborator.) Less << - -
NCT00005959 Lymphoma Phase 2 Unknown - -
NCT00005803 - Active, not recruiting - -
NCT00806182 - Completed - United States, Illinois ... More >> National Pediatric Myoclonus Center, Formerly at Dept. of Neurology, Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 Less <<
NCT00004112 Lymphoma Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT02297126 Adverse Drug Reaction Not Applicable Completed - United States, Indiana ... More >> Eskenazi Health System Indianapolis, Indiana, United States, 46250 Less <<
NCT03574649 Non Small Cell Lung Cancer Phase 2 Not yet recruiting December 30, 2020 United States, California ... More >> Chan Soon-Shiong Institute for Medicine El Segundo, California, United States, 90245 Less <<
NCT00014508 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Florida ... More >> Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207-8554 Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 United States, Ohio Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-5065 MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00025597 Neuroblastoma Phase 2 Completed - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Less <<
NCT00005803 Prolymphocytic Leukemia ... More >> Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Less << Phase 1 Phase 2 Active, not recruiting September 1, 2018 United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00458250 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Less << Phase 1 Completed - Iran, Islamic Republic of ... More >> Hematology-Oncology & BMT Research Center Tehran, Iran, Islamic Republic of, 14114 Less <<
NCT00025623 Neuroblastoma Phase 2 Completed - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Less <<
NCT01008462 B-Cell Prolymphocytic Leukemia... More >> Hypodiploidy Loss of Chromosome 17p Plasma Cell Leukemia Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Non-Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma t(14;16) t(4;14) T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mohamed L. Sorror    206-667-6298    msorror@fhcrc.org    Principal Investigator: Mohamed L. Sorror          United States, Wisconsin Froedtert and the Medical College of Wisconsin Completed Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00003050 Breast Cancer Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033-0800 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 Less <<
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01256398 Acute Lymphoblastic Leukemia ... More >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting - -
NCT02885610 Systemic Lupus Erythematosus Phase 2 Recruiting December 2019 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China Contact: Fengchun Zhang Less <<
NCT03650257 Glioma of Brain Phase 2 Not yet recruiting August 20, 2023 China, Beijing ... More >> Beijing Tiantan Hospital Affiliated to Capital Medical University Not yet recruiting Beijing, Beijing, China, 100050 Contact: hua Gao    18600678822    gh2004518@163.com Less <<
NCT00016302 T-cell Childhood Acute Lymphob... More >>lastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00381680 B-cell Childhood Acute Lymphob... More >>lastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT00152113 Sickle Cell Disease Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00039377 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Less << Phase 2 Completed - -
NCT00025038 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00039377 - Completed - -
NCT00309920 Breast Cancer Not Applicable Unknown - Germany ... More >> Kreiskrankenhaus Aurich Recruiting Aurich, Germany, D-26603 Contact: Contact Person    49-41-94-1802       Maria-Hilf-Krankenhaus Recruiting Bergheim, Germany, D-50126 Contact: Contact Person    49-2271-87-0       Evangelisches Krankenhaus - Bergisch Gladbach Recruiting Bergisch, Germany, D-51465 Contact: Contact Person    49-2202-122-497       Knappschaft Krankenhaus Recruiting Bochum-Langendreer, Germany, D-44892 Contact: Contact Person    49-234-299-3300       Praxis fuer Haematologie - Onkologie Recruiting Bonn-Duisdorf, Germany, D-53123 Contact: Contact Person    49-228-644-546       Johanniter-Krankenhaus Bonn Recruiting Bonn, Germany, D-53113 Contact: Contact Person    49-228-543-2401       Onkologische Gemeinschaftspraxis Recruiting Bonn, Germany, D-53119 Contact: Contact Person    49-228-908-1900       St. Rochus Hospital Recruiting Castrop-Rauxel, Germany, D-44575 Contact: Contact Person    49-2305-294-250       Praxis Fuer Haematologie Internistische Onkologie Recruiting Cologne, Germany, D-50677 Contact: Contact Person    49-221-931-8220       Medizinische Universitaetsklinik I at the University of Cologne Recruiting Cologne, Germany, D-50924 Contact: Contact Person    49-221-478-4940       St. Elisabeth-Krankenhaus - Koeln Recruiting Cologne, Germany, D-50935 Contact: Contact Person    49-221-4677-0-521       Klinikum Deggendorf Recruiting Deggendorf, Germany, D-94469 Contact: Contact Person    49-991-380-3172       Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-811-7550       Onkologische Schwerpunktpraxis Recruiting Duisburg, Germany, D-47055 Contact: Contact Person    49-211-811-7550       Alfried Krupp Krankenhaus Recruiting Essen, Germany, D-45117 Contact: Contact Person    49-201-434-2548       Universitaetsklinikum Essen Recruiting Essen, Germany, D-45122 Contact: Contact Person    49-201-723-2578       II Medizinische Klinik - Klinikum Fuerth Recruiting Fuerth, Germany, D-90766 Contact: Contact Person    49-911-976-1474       Evangelische Kliniken Gelsenkirchen GmbH Recruiting Gelsenkirchen, Germany, D-45879 Contact: Contact Person    49-209-160-1201       Wilhelm-Anton-Hospital gGmbH, Goch Recruiting Goch, Germany, D-47574 Contact: Contact Person    49-2823-891-105       Maria-Josef-Hospital Greven GmbH Recruiting Greven, Germany, D-48268 Contact: Contact Person    49-2571-502-203       Allgemeines Krankenhaus Hagen Recruiting Hagen, Germany, D-58095 Contact: Contact Person    49-2331-201-2622       Evangelisches Krankenhaus Hagen-Haspe GmbH Recruiting Hagen, Germany, D-58135 Contact: Contact Person    49-2331-476-3825       Henriettenstiftung Krankenhaus Recruiting Hannover, Germany, D-30171 Contact: Contact Person    49-511-289-3350       Praxisgemeinschaft fuer Gynaekologische Onkologie Recruiting Hildesheim, Germany, D-31134 Contact: Contact Person    49-5121-590-20       Universitaetsklinikum des Saarlandes Recruiting Homburg, Germany, D-66424 Contact: Contact Person    49-6841-162-8101       Klinikum Kaufbeuren Ostallgaeu Recruiting Kaufbeuren, Germany, D-87600 Contact: Contact Person    49-8341-421-001       Katholisches Klinikum Koblenz Marienhof Recruiting Koblenz, Germany, D-56073 Contact: Contact Person    49-261-496-3101       Frankenwald Klinik Recruiting Kronach, Germany, D-96317 Contact: Contact Person    49-9261-5977-10       Internistische Onkologische Praxis - Kronach Recruiting Kronach, Germany, D-96317 Contact: Contact Person    49-9261-624-8161       St. Marien Hospital - Luenen Recruiting Luenen, Germany, D-44534 Contact: Contact Person    49-2306-772-701       St. Vincenz und Elisabeth Hospital Recruiting Mainz, Germany, D-55131 Contact: Contact Person    49-6131-575-1400       Klinikum Memmingen Recruiting Memmingen, Germany, D-87700 Contact: Contact Person    49-8331-702-257       Klinikum Minden Recruiting Minden, Germany, D-32423 Contact: Contact Person    49-571-801-4101       Krankenhaus Bethanien Recruiting Moers, Germany, D-47441 Contact: Contact Person    49-2841-200-2600       Marienhaus Klinikum St. Elisabeth Neuwied Recruiting Neuwied, Germany, D-56564 Contact: Contact Person    49-2631-821-213       Evangelisches Krankenhaus Oberhausen Recruiting Oberhausen, Germany, D-46004 Contact: Contact Person    49-208-881-00       Internistische Gemeinschaftspraxis - Offenbach Recruiting Offenbach, Germany, D-63065 Contact: Contact Person    49-69-812-626       Praxis fuer Haematologie und Onkoligie Recruiting Rheine, Germany, D-48431 Contact: Contact Person    49-5971-914-142       Klinikum Suedstadt Rostock Recruiting Rostock, Germany, D-18059 Contact: Contact Person    49-381-4401-4590       Marienkrankenhaus Schwerte gem. GmbH Recruiting Schwerte, Germany, D-58239 Contact: Contact Person    49-2304-109-234       Staedtisches Klinikum Solingen Recruiting Solingen, Germany, D-42653 Contact: Contact Person    49-212-547-2371       Praxis Fuer Internistische Haematologie / Onkologie Recruiting Troisdorf, Germany, D-53840 Contact: Contact Person    49-2241-975-422       Katherinen-Hospital gGmbH Recruiting Unna, Germany, D-59423 Contact: Contact Person    49-2303-100-2842       Marien-Hospital Wesel gGmbH Recruiting Wesel, Germany, D-46483 Contact: Contact Person    49-281-104-1160       Marien-Hospital Witten Recruiting Witten, Germany, D-58452 Contact: Contact Person    49-2302-173-1328       Bethesda Krankenhaus Wuppertal gGmbH Recruiting Wuppertal, Germany, D-42109 Contact: Contact Person    49-202-290-2152       Haematologie / Onkologische Schwerpunktpraxis Recruiting Wuppertal, Germany, D-42275 Contact: Contact Person    49-202-254-1150 Less <<
NCT00381680 - Completed - -
NCT00671034 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - -
NCT02101853 B Acute Lymphoblastic Leukemia Phase 3 Recruiting - -
NCT01751997 Acute Myeloid Leukemia Phase 2 Phase 3 Recruiting December 2019 Korea, Republic of ... More >> Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Less <<
NCT00671034 - Completed - -
NCT03579875 Fanconi Anemia ... More >> Severe Aplastic Anemia Myelodysplastic Syndromes Less << Phase 2 Recruiting February 2029 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org Less <<
NCT00557193 Acute Lymphoblastic Leukemia ... More >> Acute Undifferentiated Leukemia Childhood T Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - -
NCT03456908 Myeloma Before MV-NIS Treatmen... More >>t Endometrial Cancer Before VSV-hINF-NIS Treatment Less << Phase 1 Phase 2 Enrolling by invitation March 2021 United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00792948 - Active, not recruiting - -
NCT00557193 - Completed - -
NCT01004991 Diffuse Large B Cell Lymphoma Phase 1 Phase 2 Completed - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10065 Less <<
NCT01004991 - Completed - -
NCT00792948 Acute Lymphoblastic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Remission Adult B Acute Lymphoblastic Leukemia Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Adult L1 Acute Lymphoblastic Leukemia Adult L2 Acute Lymphoblastic Leukemia Adult T Acute Lymphoblastic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting September 24, 2019 -
NCT01622439 Diffuse Large B-cell Lymphoma Phase 1 Phase 2 Completed - Sweden ... More >> Skåne University Hospital, Dept. of Oncology Lund, Sweden, 221 85 Less <<
NCT03126916 Childhood Ganglioneuroblastoma... More >> Childhood Neuroblastoma INRG Stage L2 INRG Stage M INRG Stage MS NMYC Gene Amplification Recurrent Neuroblastoma Less << Phase 3 Recruiting June 30, 2026 -
NCT00653068 - Active, not recruiting - -
NCT02003222 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative BCR/ABL1 Fusion Protein Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT00849147 - Completed - -
NCT00849147 Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Less << Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California San Diego Medical Center La Jolla, California, United States, 92093 United States, Florida University of Florida College of Medicine (Shands) Gainesville, Florida, United States, 32610-0277 United States, Georgia Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States, 30342 United States, Hawaii Kapi'olani Medical Center for Women and Children, University of Hawaii Honolulu, Hawaii, United States, 96826 United States, Maryland University of Maryland, Greenbaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC) Baltimore, Maryland, United States, 21231 United States, Massachusetts DFCI, Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute, Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Fox Chase, Temple University Philadelphia, Pennsylvania, United States, 19111-2442 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02063685 Follicular Non-Hodgkin's Lymph... More >>oma Less << Phase 3 Active, not recruiting December 2021 -
NCT00653068 Childhood Atypical Teratoid/Rh... More >>abdoid Tumor Less << Phase 3 Active, not recruiting - -
NCT01190930 Acute Lymphoblastic Leukemia ... More >> Adult B Lymphoblastic Lymphoma Ann Arbor Stage I B Lymphoblastic Lymphoma Ann Arbor Stage II B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic Leukemia Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Childhood B Lymphoblastic Lymphoma Down Syndrome Hypodiploid B Acute Lymphoblastic Leukemia Intrachromosomal Amplification of Chromosome 21 Philadelphia Chromosome Positive Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Active, not recruiting - -
NCT01371630 Acute Lymphoblastic Leukemia ... More >> B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting August 31, 2019 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Elias Jabbour    713-792-7026       Principal Investigator: Elias Jabbour Less <<
NCT00022737 Childhood Acute Lymphoblastic ... More >>Leukemia in Remission Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00057811 Childhood Burkitt Lymphoma ... More >> Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00554502 IgA Nephropathy Phase 3 Completed - Germany ... More >> Medical Clinic II, University Hospital Aachen Aachen, Germany 2. Medizinische Klinik, Nephrologie, Klinikum Augsburg Augsburg, Germany Campus Charité Mitte, Medizinische Klinik - Schwerpunkt Nephrologie, Centrum 13 Berlin, Germany Charité Campus Virchow-Klinikum, Medizinische Klinik / Nephrologie Berlin, Germany Helios-Klinikum Berlin-Buch, Nephrologie Charité CCB Berlin, Germany St. Joseph Krankenhaus Medizinische Klinik II Berlin, Germany Klinikum Bremen-Mitte, Medizinische Klinik III Bremen, Germany Universitätsklinikum Dresden, Medizinische Klinik III, Bereich Nephrologie Dresden, Germany Universitätsklinikum Düsseldorf, Klinik für Nephrologie Düsseldorf, Germany Universitätsklinikum Erlangen, Medizinische Klinik IV Erlangen, Germany Universitätsklinikum Essen, Klinik für Nieren- und Hochdruckkrankheiten Essen, Germany Universitätsklinikum Freiburg, Innere Medizin IV Freiburg, Germany Universitätsklinikum Gießen und Marburg GmbH, Medizinische Klinik und Poliklinik II Gießen, Germany Universitätsklinikum Göttingen, Zentrum Innere Medizin, Abteilung für Nephrologie und Rheumatologie Göttingen, Germany Universitätsklinikum Hamburg-Eppendorf, 3. Medizinische Klinik und Poliklinik Hamburg, Germany Medizinische Hochschule Hannover, Abteilung Nephrologie Hannover, Germany Med. Universitätsklinik Heidelberg, Nierenzentrum Heidelberg, Sektion Nephrologie Heidelberg, Germany Universitätsklinikum Jena, Medizinische Klinik III Jena, Germany Westpfalz-Klinikum GmbH, Abteilung für Nephrologie und Transplantationsmedizin Kaiserslautern, Germany Uniklinik Köln, Klinik IV für Innere Medizin, Nephrologie und Allgemeine Innere Medizin Köln, Germany Universitätsklinikum Magdeburg, Klinik für Nephrologie, Zentrum für Innere Medizin Magdeburg, Germany Dialysezentrum am Brand Mainz, Germany Universitätsklinikum Mannheim, V. Medizinische Klinik Mannheim, Germany Universitätsklinikum Marburg, Klinik für Innere Medizin, Schwerpunkt Nephrologie Marburg, Germany KfH Nierenzentrum München, Germany Klinikum der LMU, Nephrologisches Zentrum München, Germany Klinikum rechts der Isar, Medizinische Klinik II, Abteilung für Nephrologie München, Germany Universitätsklinikum Münster, Medizinische Klinik und Poliklinik D Münster, Germany Universitätsklinikum Regensburg, Klinik und Poliklinik für Innere Medizin II Regensburg, Germany Krankenhaus der Barmherzigen Brüder, Abteilung Innere Medizin II Trier, Germany Universitätsklinikum Tübingen, Medizinische Klinik IV, Sektion für Nieren- und Hochdruckkrankheiten Tübingen, Germany Dialyse-Zentrum Dres.med. PD H. Reichel, Th. Weinreich u. C. Villingen-Schwenningen, Germany Zentrum für Nieren- und Hochdruckkrankheiten Wiesbaden, Germany Universitätsklinik Würzburg, Medizinische Klinik und Poliklinik I Würzburg, Germany Less <<
NCT02251821 Primary Myelofibrosis ... More >> Secondary Myelofibrosis Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit    206-667-1317    rsalit@fredhutch.org    Principal Investigator: Rachel B. Salit Less <<
NCT03542266 Previously Untreated Periphera... More >>l T-cell Lymphoma Less << Phase 2 Recruiting May 30, 2022 United States, New York ... More >> Weill Cornell Medicine Recruiting New York, New York, United States, 10065 Contact: Amelyn Rodriguez, RN    212-746-1362    amr2017@med.cornell.edu    Contact: Rita Vaccaro, RN    212-746-0702    rig9021@med.cornell.edu Less <<
NCT00057811 - Completed - -
NCT02883049 B Acute Lymphoblastic Leukemia... More >> Central Nervous System Leukemia Ph-Like Acute Lymphoblastic Leukemia Testicular Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting - -
NCT00736450 Contiguous Stage II Adult Diff... More >>use Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Less << Not Applicable Terminated(Manufacturer is no ... More >>longer making the drug.) Less << - United States, Nebraska ... More >> Saint Francis Medical Center Grand Island, Nebraska, United States, 68803 UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6805 Less <<
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT00736450 - Terminated(Manufacturer is no ... More >>longer making the drug.) Less << - -
NCT00864227 Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Less << Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida University of Florida College of Medicine, Shands Gainesville, Florida, United States, 32610-3633 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242-1009 United States, Kansas University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, Massachusetts Dana-Farber Cancer Institute (DFCI), Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College, NY Presbyterian Hospital New York, New York, United States, 10065 United States, Ohio Ohio State, Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Virginia Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital Richmond, Virginia, United States, 23298 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 Less <<
NCT00864227 - Completed - -
NCT00049036 - Completed - -
NCT00187057 Ataxia-Telangiectasia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00590447 PTLD Posttran... More >>splant Lymphoproliferative Disorder Less << Phase 2 Completed - Australia ... More >> Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Qld 4102 Brisbane, Australia Belgium Catholic University of Leuven, Department of Hematology Leuven, Belgium France Hôpital Pitié-Salpétrière, Department of Hematology, 47-83 Boulevard de l'Hopital Paris, France, 75651 Germany Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Department of Hematology and Oncology, Augustenburger Platz 1 Berlin, Germany, 13353 Italy Div. Universitaria Ematologia e Terapie Cellulari, University of Torino Torino, Italy, 10128 Poland Zakład Propedeutyki Onkologii, Gdańskiego Uniwersytetu Medycznego Gdynia, Poland, 81519 Sweden Sahlgrens hospital, Department of Hematology Göteborg, Sweden, 41345 Less <<
NCT00720109 - Completed - -
NCT00914849 Hematologic Neoplasms Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00914849 - Completed - -
NCT00379340 Stage III Wilms Tumor With Los... More >>s of Heterozygosity (LOH) for 1p and 16q Stage IV Wilms Tumor Less << Phase 3 Completed - -
NCT00720109 Adult B Acute Lymphoblastic Le... More >>ukemia With t(9;22)(q34;q11.2); BCR-ABL1 Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Phase 3 Completed - -
NCT00379340 - Completed - -
NCT00049036 AIDS-related Diffuse Large Cel... More >>l Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Less << Phase 2 Completed - United States, Maryland ... More >> AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States, 20850 Less <<
NCT02386332 - Not yet recruiting March 2020 -
NCT00499018 Diffuse Large B-Cell Lymphoma ... More >> IPI≥2 Less << Phase 3 Unknown September 2013 -
NCT00846157 Diffuse Large B-cell Lymphoma Phase 3 Unknown September 2014 Korea, Republic of ... More >> The Catholic University of korea Banpo-Dong 505, Seoul, Korea, Republic of, 137-701 Less <<
NCT01175356 Disseminated Neuroblastoma ... More >> Ganglioneuroblastoma Localized Resectable Neuroblastoma Localized Unresectable Neuroblastoma Regional Neuroblastoma Stage 4S Neuroblastoma Less << Not Applicable Completed - -
NCT02317471 Gastric Carcinoma Phase 1 Phase 2 Unknown December 2017 China, Beijing ... More >> Chinese PLA General Hospital Recruiting Beijing, Beijing, China, 100853 Contact: Zheng Peng, MD    086-10-66938028    zihpeng@sina.com    Principal Investigator: Lin Chen, MD Less <<
NCT02112916 Adult T Acute Lymphoblastic Le... More >>ukemia Ann Arbor Stage II Adult Lymphoblastic Lymphoma Ann Arbor Stage II Childhood Lymphoblastic Lymphoma Ann Arbor Stage III Adult Lymphoblastic Lymphoma Ann Arbor Stage III Childhood Lymphoblastic Lymphoma Ann Arbor Stage IV Adult Lymphoblastic Lymphoma Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma Childhood T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Suspended(Other - Temporary cl... More >>osure) Less << - -
NCT00003943 Carcinoma of Unknown Primary ... More >> Lung Cancer Less << Phase 2 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21231 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00003243 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00003944 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01175356 - Completed - -
NCT00002596 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Testicular Germ Cell Tumor Less << Phase 3 Completed - -
NCT00429299 - Completed - -
NCT00003955 Sarcoma Phase 2 Completed - -
NCT00003386 Ovarian Cancer Phase 2 Terminated - -
NCT00020176 Breast Cancer Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00574730 Non-Hodgkins Lymphoma Not Applicable Completed - -
NCT00429299 Neoplasms, Breast Phase 2 Completed - Germany ... More >> GSK Investigational Site Berlin, Germany, 13125 Italy GSK Investigational Site Carpi (MO), Emilia-Romagna, Italy, 41012 GSK Investigational Site Forlì, Emilia-Romagna, Italy, 47100 GSK Investigational Site Modena, Emilia-Romagna, Italy, 41100 GSK Investigational Site Parma, Emilia-Romagna, Italy, 43100 GSK Investigational Site Piacenza, Emilia-Romagna, Italy, 29100 GSK Investigational Site Rimini, Emilia-Romagna, Italy, 47900 GSK Investigational Site Treviglio (BG), Lombardia, Italy, 24047 GSK Investigational Site Candiolo (TO), Piemonte, Italy, 10060 GSK Investigational Site Brindisi, Puglia, Italy, 72100 GSK Investigational Site Pisa, Toscana, Italy, 56126 GSK Investigational Site Cremona, Italy, 26100 GSK Investigational Site Pavia, Italy, 27100 GSK Investigational Site Perugia, Italy, 06156 GSK Investigational Site Reggio Emilia, Italy, 42100 GSK Investigational Site Varese, Italy, 21100 Poland GSK Investigational Site Warszawa, Poland, 00-909 Less <<
NCT03007147 B Acute Lymphoblastic Leukemia... More >> BCR-ABL1 Fusion Protein Expression Minimal Residual Disease Philadelphia Chromosome Positive T Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 3 Recruiting June 30, 2026 -
NCT00007982 Brain and Central Nervous Syst... More >>em Tumors Head and Neck Cancer Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02465801 Chemotherapy-induced Neutropen... More >>ia Less << Phase 2 Completed - China ... More >> Cancer Hospital, Chinese Academy of Medical Scienses Beijing, China, 100021 Less <<
NCT00052923 Lymphoma Phase 3 Completed - -
NCT00002638 Leukemia Phase 2 Completed - United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT00681993 Breast Cancer Not Applicable Unknown July 2017 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00002780 Breast Cancer Phase 1 Phase 2 Unknown - United States, Wisconsin ... More >> St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00002675 Retinoblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00029380 Hematologic Diseases ... More >> Anemia, Sickle Cell Beta-Thalassemia Hematopoietic Stem Cell Transplantation Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Oakland Oakland, California, United States, 94609 Children's Hospital, Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States United States, Florida Nemours Children's Clinic Jacksonville, Florida, United States, 32207 University of Miami Batchelor Children's Research Center Miami, Florida, United States, 33136 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Louisiana Louisiana State University Children's Medical Center New Orleans, Louisiana, United States United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Duke University Medical Center Children's Hospital Durham, North Carolina, United States United States, Pennsylvania Children's Hospital Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29403 United States, Texas University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75235 Texas Transplant Institute San Antonio, Texas, United States, 78229 Canada, Quebec Hopital Ste-Justine Montreal, Quebec, Canada Less <<
NCT01309789 Lymphoma, Large-Cell, Anaplast... More >>ic Lymphoma, NK-cell Lymphoma, T-cell Less << Phase 1 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3300 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 Stanford Cancer Center Stanford, California, United States, 94305 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina St. Francis Hospital Greenville, South Carolina, United States, 29601 United States, Texas MD Anderson Cancer Center / University of Texas Houston, Texas, United States, 77030-4000 United States, Washington Seattle Cancer Care Alliance / University of Washington Medical Center Seattle, Washington, United States, 98109 United Kingdom Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Southampton General Hospital Southampton, United Kingdom, SO16 6YD Less <<
NCT00025324 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Unknown - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 United States, Virginia Children's Hospital of the King's Daughters Norfolk, Virginia, United States, 23507 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT00003007 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Tennessee ... More >> William F. Bowld Hospital Memphis, Tennessee, United States, 38103 Methodist Healthcare - Hospital of Memphis Memphis, Tennessee, United States, 38104 Baptist Memorial Hospital Memphis, Tennessee, United States, 38146 University of Tennessee, Memphis Memphis, Tennessee, United States, 38163 Less <<
NCT00006258 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 United States, Pennsylvania Geisinger Medical Center Danville, Pennsylvania, United States, 17822-1320 Canada, Alberta Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Less <<
NCT00003060 Melanoma (Skin) Phase 1 Unknown - United States, Louisiana ... More >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00818961 - Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - -
NCT02250937 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00723125 Breast Cancer Phase 2 Completed - United States, Connecticut ... More >> Bridgeport Hospital Bridgeport, Connecticut, United States, 06610 Yale Smilow Cancer Center New Haven, Connecticut, United States, 06519 United States, Rhode Island Rhode Island Hsopital Providence, Rhode Island, United States, 02903 Women and Infants Providence, Rhode Island, United States, 02905 The Miriam Hospital Providence, Rhode Island, United States, 02906 Less <<
NCT00818961 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00288002 Breast Cancer Phase 3 Completed - Germany ... More >> Universitaetsfrauenklinik Frankfurt Neu-Isenburg, Germany, D-63263 Less <<
NCT01652261 Hodgkin Lymphoma Phase 3 Withdrawn(Study closed due to ... More >>lack of recruitment) Less << March 2022 Denmark ... More >> Rigshospitalet Copenhagen, Denmark, 2100 Less <<
NCT00924287 Metastatic Cancer Phase 1 Phase 2 Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02624258 Hodgkin Lymphoma Early Phase 1 Recruiting December 2019 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Mia Benson-Smith    267-426-0762    oncointake@email.chop.edu    Contact: Claire White    267-426-0762    whiteC3@email.chop.edu    Principal Investigator: Susan Rheingold, MD Less <<
NCT00924287 - Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - -
NCT00719849 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(A new protocol was ... More >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00282412 - Terminated(No participant enro... More >>lled for three years. No plan to continue study.) Less << - -
NCT00723125 - Completed - -
NCT00968253 Leukemia Acut... More >>e Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00719849 - Terminated(A new protocol was ... More >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) Less << - -
NCT00968253 - Completed - -
NCT00379574 Lymphoma, Large-Cell, Diffuse ... More >> Lymphoma, B-Cell Less << Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Asan Medical Cener Seoul, Korea, Republic of Less <<
NCT00379574 - Completed - -
NCT00365287 Breast Cancer ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Phase 2 Completed - -
NCT01027000 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting - -
NCT00131027 Lymphoblastic Leukemia, Acute Phase 3 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00199004 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital of Frankfurt, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00574496 Lymphoma Phase 2 Active, not recruiting November 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00198978 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)6963015194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)6963016365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT01020734 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Inje University - Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT01085617 Leukemia Muco... More >>sitis Oral Complications Less << Phase 3 Recruiting July 2023 United Kingdom ... More >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2833 Less <<
NCT00066417 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(Trial was withdrawn... More >> for drug availability issues.) Less << - United States, Maryland ... More >> NIH - Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01027000 - Active, not recruiting - -
NCT00002905 Lymphoma Phase 2 Unknown - Italy ... More >> Centro di Riferimento Oncologico - Aviano Aviano, Italy, 33081 Less <<
NCT00513188 Lymphoma Not Applicable Withdrawn - United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States, 33136 Less <<
NCT00558519 Leukemia Phase 2 Active, not recruiting - -
NCT00589563 - Completed - -
NCT00669812 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 2 Unknown - United Kingdom ... More >> Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Anne Lennard    44-191-282-4743    a.l.lennard@ncl.ac.uk Less <<
NCT01659099 Diffuse Large B Cell Lymphoma ... More >>CD20 Positive Less << Phase 3 Terminated(experimental treatm... More >>ent not Superior to standard - no need to continue the follow-up) Less << - -
NCT00589563 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00265031 Hodgkin′s Lymphoma Phase 3 Completed - -
NCT00137111 Lymphoblastic Leukemia, Acute Phase 3 Active, not recruiting November 2020 United States, Tennessee ... More >> St Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT01569204 Hodgkin Lymphoma Phase 2 Completed - Germany ... More >> 1st Dept. of Medicine, Cologne University Hospital Cologne, Germany Less <<
NCT00137111 - Active, not recruiting - -
NCT01005758 Leukemia Phase 2 Unknown - -
NCT00311636 Breast Cancer Phase 3 Completed - Italy ... More >> Ospedale Civile Castelfranco - TV, Italy, 31033 Ospedale Sant Anna Como, Italy, 22100 Ospedale Santa Croce Cuneo, Italy, 12100 Azienda Ospedaliera di Firenze Florence, Italy, 50011 Istituto Nazionale per la Ricerca sul Cancro Genoa, Italy, 16132 Presidio Ospedaliero di Livorno Livorno, Italy, 57100 Carlo Poma Hospital Mantova, Italy, 46100 Federico II University Medical School Naples, Italy, 80131 Seconda Universita di Napoli Naples, Italy, 80131 Istituto G. Pascale Naples, Italy, 81131 Ospedale Silvestrini Perugia, Italy, 06156 Ospedale Santa Chiara Pisa Pisa, Italy, 56126 Istituto Regina Elena Rome, Italy, 00128 Ospedale Civile ASL 1 Sassari, Italy, 07100 Ospedale SS Trinita Sora, Italy, 03039 Ospedale Treviglio Caravaggio Treviglio, Italy, 24047 Ospedale Maggiore dell' Universita Trieste, Italy, 34100 Universita di Torino Turin, Italy, 10126 Less <<
NCT01196052 Breast Cancer Phase 2 Completed - -
NCT00494897 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT02723994 Leukemia Phase 2 Recruiting May 2024 -
NCT02523976 Acute,Leukemia, Lymphoid Phase 2 Enrolling by invitation August 2019 China, Tianjin ... More >> Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin, China, 300020 Less <<
NCT01196052 - Completed - -
NCT03206671 Mature B-cell Non-Hodgkin Lymp... More >>homa Less << Phase 3 Recruiting August 2024 -
NCT00830544 Breast Cancer Phase 2 Unknown December 2012 Puerto Rico ... More >> Auxilio Mutuo Cancer Center San Juan, Puerto Rico, 00927 Less <<
NCT00398554 Lymphoma Phase 2 Completed - Germany ... More >> Klinikum Augsburg Augsburg, Germany, D-86156 Charite University Medical Center of Berlin Berlin, Germany, D-13347 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Universitaets - Kinderklinik Erlangen, Germany, 91054 Universitaetsfrauenklinik Frankfurt Frankfurt, Germany, D-60596 Universitaetsklinikum Halle Halle, Germany, D-06097 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitaets - Kinderklinik Leipzig, Germany, D-04317 Medizinische Klinik und Poliklinik A - Universitaetsklinikum Muenster Muenster, Germany, D-48149 Kinderklinik d. TU / Schwabing Munich, Germany, 80804 Klinikum Oldenburg Oldenburg, Germany, D-26133 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 Less <<
NCT02582775 Epidermolysis Bullosa Phase 2 Recruiting September 2022 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org    Principal Investigator: Jakub Tolar, MD, PhD Less <<
NCT00005589 Lymphoma Phase 3 Completed - -
NCT00416832 Lymphoma Phase 2 Completed - -
NCT00004903 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Unknown - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Less <<
NCT00003402 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00004128 Leukemia Phase 3 Unknown - -
NCT00298506 Lupus Nephritis Not Applicable Completed - China, Jiangsu ... More >> Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine Nanjing, Jiangsu, China, 210002 Research Institute of Nephrology, Jinling Hospital Nanjing, Jiangsu, China, 210002 Less <<
NCT03571321 Acute Lymphoblastic Leukemia ... More >> ALL, Childhood ALL Less << Phase 1 Not yet recruiting September 5, 2024 United States, Illinois ... More >> University of Chicago Medical Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Howie Weiner    773-702-2084    hweiner@medicine.bsd.uchicago.edu    Contact: Peggy Green, RN    (773) 702-0267    mgreen@medicine.bsd.uchicago.edu    Principal Investigator: Emily Currant, MD Less <<
NCT00285389 Mantle Cell Lymphoma Phase 2 Completed - France ... More >> Regional university hospital Besancon, France, 25000 Regional university hospital Rennes, France, 35033 REgional Hospital Tours, France, 37000 Less <<
NCT00004006 Retinoblastoma Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105-2794 Less <<
NCT00262886 Kidney Cancer Phase 2 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00003399 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00005998 Lymphoma Phase 2 Withdrawn(Withdrawn because st... More >>udy never enrolled patients) Less << - -
NCT00004905 Leukemia Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT00028600 Multiple Myeloma ... More >> Plasma Cell Neoplasm Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Maryland Union Hospital Cancer Program at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 Less <<
NCT00025428 Neuroblastoma Phase 3 Completed - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Odense University Hospital Odense, Denmark, DK-5000 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Germany Children's Hospital Cologne, Germany, D-50924 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Southampton University Hospital NHS Trust Southampton, England, United Kingdom, SO16 6YD Less <<
NCT01484496 Systemic Lupus Erythematosus Phase 3 Completed - -
NCT00003852 Childhood Germ Cell Tumor ... More >> Extragonadal Germ Cell Tumor Ovarian Cancer Testicular Germ Cell Tumor Less << Phase 2 Terminated(lack of patient inc... More >>lusion) Less << - France ... More >> Centre Paul Papin Angers, France, 49036 CHR de Besancon - Hopital Jean Minjoz Besancon, France, 25030 Institut Bergonie Bordeaux, France, 33076 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre de Lute Contre le Cancer,Georges-Francois Leclerc Dijon, France, 21079 CHR de Grenoble - La Tronche Grenoble, France, 38043 Clinique Saint Michel La Rochelle, France, 17000 Centre Leon Berard Lyon, France, 69373 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Antoine Lacassagne Nice, France, 06189 Hopital d'Instruction des Armees du Val de Grace Paris, France Institut Jean Godinot Reims, France, 51056 Centre Henri Becquerel Rouen, France, 76038 Centre Rene Huguenin Saint Cloud, France, 92211 Hopitaux Universitaire de Strasbourg Strasbourg, France, 67091 Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT01632241 Systemic Lupus Erythematosus Phase 4 Active, not recruiting January 28, 2019 -
NCT00361621 Non-Hodgkin's Lymphoma Phase 2 Terminated(Closed due to slow ... More >>accrual) Less << - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00002792 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00002680 Breast Cancer Phase 2 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center New Haven, Connecticut, United States, 06520-8028 Less <<
NCT01464359 Acute Myelogenous Leukemia ... More >> Refractory Acute Myelogenous Leukemia Less << Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00002580 Breast Cancer Phase 3 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Ninewells Hospital and Medical School Dundee, Scotland, United Kingdom, DD1 9SY Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 9NQ Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT University of Glasgow Glasgow, Scotland, United Kingdom, G61 1BD Raigmore Hospital Inverness, Scotland, United Kingdom, 1V2 3UJ Royal Alexandra Hospital Paisley, Scotland, United Kingdom Ayr Hospital Ayr, United Kingdom, KA6 6DX Falkirk Royal Infirmary Falkirk, United Kingdom, FK1 5RE Less <<
NCT02842931 Diffuse Large B-Cell Lymphoma Phase 3 Recruiting February 2023 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Aminat U Magomedova, MD, PhD    495-613-2446 ext 007    maminat@mail.ru    Contact: Sergay K Kravchenko, MD, PhD    495-613-2446 ext 007    krav-hsc-ramn@mail.ru    Principal Investigator: Aminat U Magomedova, MD, PhD          Sub-Investigator: Sergey K Kravchenko, MD, PhD          Sub-Investigator: Anna E Misurina, MD, PhD Less <<
NCT01484496 - Completed - -
NCT01415765 Lymphoma, Diffuse Large-Cell B... More >>-cell Diffuse, Large B-cell Lymphoma Lymphoma, Diffuse Large-Cell Large-Cell Lymphoma, Diffuse Less << Phase 1 Phase 2 Withdrawn - -
NCT00562068 Lymphoma Smal... More >>l Intestine Cancer Less << Phase 1 Unknown - United Kingdom ... More >> Leeds General Infirmary Recruiting Leeds, England, United Kingdom, LS1 3EX Contact: Contact Person    44-113-392-3766       King's College Hospital Recruiting London, England, United Kingdom, SE5 9RS Contact: Contact Person    44-20-3299-9000       Royal Marsden - London Recruiting London, England, United Kingdom, SW3 6JJ Contact: Contact Person    44-20-7352-8171       Christie Hospital Recruiting Manchester, England, United Kingdom, M20 4BX Contact: Contact Person    44-161-446-8565       Torbay Hospital Recruiting Torbay Devon, England, United Kingdom, TQ2 7AA Contact: Contact Person    44-180-365-5260 Less <<
NCT00031928 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Maryland Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Texas Texas Children's Cancer Center Houston, Texas, United States, 77030-2399 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 United States, Vermont Neurological Research Center, Inc. Bennington, Vermont, United States, 05201 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00433459 Lymphoma Phase 3 Completed - Germany ... More >> Universitaetsklinikum Giessen-Marburg Giessen, Germany, D-35385 United Kingdom Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Less <<
NCT01464359 - Terminated(Slow accrual) - -
NCT02573935 Multiple Myeloma Phase 2 Terminated(Suspected side effe... More >>cts to the combination of clarithromycin and VCD (bortezomib, cyclophosphamide and dexamethasone)) Less << - Denmark ... More >> Department of Hematology, Aalborg University Hospital Aalborg, Denmark, 9000 Department of Hematology, Aarhus University Hospital Aarhus, Denmark, 8000 Department of Hematology, Rigshospitalet Copenhagen, Denmark, 2100 Department of Hematology, Herlev Hospital Herlev, Denmark, 2730 Department of Hematology, Odense University Hospital Odense, Denmark, 5000 Department of Hematology, Roskilde Hospital Roskilde, Denmark, 4000 Department of Hematology, Vejle Hospital Vejle, Denmark, 7100 Less <<
NCT00128895 Vasculitis Phase 4 Terminated - Netherlands ... More >> VU University Medical Centre Amsterdam, Netherlands, 1081HV University Medical Centre Groningen Groningen, Netherlands, 9700 RB Martini Hospital Groningen Groningen, Netherlands, 9700RM Medical Centre Leeuwarden Leeuwarden, Netherlands, 8901BR University Hospital Maastricht Maastricht, Netherlands, 6229 HX UMC St Radboud Nijmegen, Netherlands, 6525GC Erasmus Medical Centre Rotterdam, Netherlands, 3000CA University Medical Centre Utrecht Utrecht, Netherlands, 3508GA Less <<
NCT00645593 Bladder Cancer Phase 2 Completed - United States, California ... More >> City of Hope Cancer Center Duarte, California, United States, 91010 Kenneth J. Norris Jr. Comprehensive Cancer Center, Keck School of Medicine, University of Southern California Los Angeles, California, United States, 90033 Stanford University Stanford, California, United States, 94305 United States, Illinois Robert H. Lurie Comprehensive Cancer Center, Center of Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston Medical Center Boston, Massachusetts, United States, 02118 Lahey Clinic Burlington, Massachusetts, United States, 01805 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-3721 United States, Utah University of Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 United States, Washington University of Washington Seattle, Washington, United States, 98109 Less <<
NCT00662233 Ovarian Cancer ... More >> Sarcoma Less << Early Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00062881 Malignant Meningeal Neoplasms Phase 1 Completed - United States, California ... More >> Children'sHospital Los Angeles Los Angeles, California, United States, 90027 United States, District of Columbia Children's Hospital National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30342 United States, Maryland Pediatric Branch, National Cancer Institute Bethesda, Maryland, United States, 20892 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 United States, Vermont Neurological Research Center Bennington, Vermont, United States, 05210 United States, Washington Children's Hospital and Medical Center Seattle, Washington, United States, 98105 Less <<
NCT00222612 Acute Lymphoblastic Leukemia Phase 4 Unknown August 2013 United Kingdom ... More >> Sheffield Children's Hospital Recruiting Sheffield, United Kingdom, S10 2TH Contact: Ajay Vora       ajay.vora@sch.nhs.uk Less <<
NCT00339118 Rhabdomyosarcoma Phase 4 Unknown - -
NCT02098512 Hodgkin Lymphoma Phase 1 Phase 2 Recruiting December 2019 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo    914-594-2150    mitchell_cairo@nymc.edu    Contact: Jessica Hochberg, MD    914-594-2132    jessica_hochberg@nymc.edu Less <<
NCT03283384 Breast Neoplasms Phase 2 Recruiting February 2025 Netherlands ... More >> Jeroen Bosch Ziekenhuis Not yet recruiting 's-Hertogenbosch, Netherlands Contact: J. Tol          Ziekenhuisgroep Twente (Twenteborg ZH Almelo) Not yet recruiting Almelo, Netherlands Contact: E. Siemerink          Ziekenhuis Amstelland Not yet recruiting Amstelveen, Netherlands Contact: A. van Zweeden          Nederlands Kanker Instituut - Antoni van Leeuwenhoek Not yet recruiting Amsterdam, Netherlands Contact: S. Linn          Onze Lieve Vrouwe Gasthuis (Oost) Not yet recruiting Amsterdam, Netherlands Contact: J. Meerum Terwogt          Stichting Reinier Haga Groep (Reinier de Graaf Gasthuis) Not yet recruiting Delft, Netherlands Contact: K. Beelen          Stichting Deventer Ziekenhuisgroep Rielerenk Not yet recruiting Deventer, Netherlands Contact: L. Kessels          Catharina Ziekenhuis Not yet recruiting Eindhoven, Netherlands Contact: B. Vriens          Maxima Medisch Centrum (Eindhoven) Not yet recruiting Eindhoven, Netherlands Contact: M. Dercksen          Groene Hart Ziekenhuis (Bleuland) Not yet recruiting Gouda, Netherlands Contact: J. Hokken          Spaarne Gasthuis (Haarlem-Zuid) Not yet recruiting Haarlem, Netherlands Contact: P. Kuijer          Ziekenhuis St. Jansdal Not yet recruiting Harderwijk, Netherlands Contact: J. Ropela          Tergooiziekenhuizen (Hilversum) Not yet recruiting Hilversum, Netherlands Contact: S. Luykx-de Bakker          Westfriesgasthuis Not yet recruiting Hoorn, Netherlands Contact: S. van den Heiligenberg          Leiden University Medical Center Recruiting Leiden, Netherlands Contact: Judith R Kroep, MD PhD          Academisch Ziekenhuis Maastricht Not yet recruiting Maastricht, Netherlands Contact: M. de Boer          Canisius-Wilhelmina Ziekenhuis Not yet recruiting Nijmegen, Netherlands Contact: C. Mandigers          Bravis Ziekenhuis (Roosendaal) Not yet recruiting Roosendaal, Netherlands Contact: H. Droogendijk          Antonius Ziekenhuis Sneek Not yet recruiting Sneek, Netherlands Contact: G. Veldhuis          Ziekenhuis Rivierenland Not yet recruiting Tiel, Netherlands Contact: C. Kruijtzer-Schimmel          VieCuri Medisch Centrum (Venlo) Not yet recruiting Venlo, Netherlands Contact: A. van de Wouw          Streekziekenhuis Koningin Beatrix Not yet recruiting Winterswijk, Netherlands Contact: P. Schiphorst          Isala (Zwolle) Not yet recruiting Zwolle, Netherlands Contact: A. Honkoop Less <<
NCT01239368 - Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - -
NCT00046852 Infection Mul... More >>tiple Myeloma and Plasma Cell Neoplasm Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00083538 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00645593 - Completed - -
NCT00085462 Melanoma (Skin) Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT01239368 Myeloma, Plasma-Cell ... More >> Myeloma-Multiple Myelomatosis Less << Phase 1 Phase 2 Terminated(Terminated due to i... More >>nsufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health (NIH) Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT01850108 Sickle Cell Disease ... More >> Hemoglobinopathies Less << Not Applicable Recruiting November 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Clinical Trials Information Program    800-811-8480       Principal Investigator: Adetola A Kassim, MD Less <<
NCT00027937 Lymphoma Unsp... More >>ecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT01917578 Breast Cancer Phase 3 Unknown July 2014 China, Shandong ... More >> Shandong Cancer Hospital Recruiting Jinan, Shandong, China, 250117 Contact: Yong-sheng Wang, MD    +8613505409989    wangysh2008@aliyun.com    Contact: Tao Yang, MD    +8618264190568    yangtao133252@aliyun.com    Principal Investigator: Yong-sheng Wang, MD          Principal Investigator: Tao Yang, MD Less <<
NCT00007995 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00446030 Breast Neoplasms Phase 2 Completed - United States, New Jersey ... More >> Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States, 08807 Less <<
NCT00006123 Breast Cancer Phase 1 Phase 2 Withdrawn(Never started) - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00052351 Breast Cancer Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00017290 Lymphoma Phase 3 Unknown - -
NCT01649856 Lymphoma, Large B-Cell, Diffus... More >>e Less << Phase 3 Completed - -
NCT00004900 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT01649856 - Completed - -
NCT00008190 Leukemia Phase 2 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT00028717 Lymphoma Phase 3 Unknown - Netherlands ... More >> HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Leiden University Medical Center Leiden, Netherlands, 2300 RC Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00003119 Neuroblastoma Phase 3 Completed - -
NCT00004039 Lymphoma Phase 2 Withdrawn(No patient accruals) - United States, California ... More >> Hoag Memorial Hospital Presbyterian Newport Beach, California, United States, 92658 Less <<
NCT00408408 Breast Cancer Phase 3 Active, not recruiting March 2018 -
NCT00408408 - Active, not recruiting - -
NCT01042379 Breast Neoplasms ... More >> Breast Cancer Breast Tumors Less << Phase 2 Recruiting - -
NCT00003150 Lymphoma Phase 3 Completed - -
NCT00003194 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Unknown - United States, Washington ... More >> Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00446030 - Completed - -
NCT03663933 Lymphoproliferative Disorders ... More >> Autoimmune Lymphoproliferative Primary T-cell Immunodeficiency Disorders Immune System Diseases Common Variable Immunodeficiency Less << Phase 2 Recruiting May 1, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00009997 Breast Cancer Phase 1 Completed - United States, New York ... More >> NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Less <<
NCT02844530 CD22+ Relapsed/Refractory B-AL... More >>L Less << Phase 2 Withdrawn - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63000 Less <<
NCT00003603 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - United Kingdom ... More >> Hammersmith Hospital London, England, United Kingdom, W12 ONN Less <<
NCT00003042 Breast Cancer Phase 2 Active, not recruiting March 2019 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00002566 Extragonadal Germ Cell Tumor ... More >> Testicular Germ Cell Tumor Less << Phase 3 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00376961 Lymphoma Phase 2 Completed - -
NCT00376961 - Completed - -
NCT00003152 Lymphoma Phase 3 Terminated(low accrual) - Netherlands ... More >> Academisch Ziekenhuis Utrecht Utrecht, Netherlands, 3508 GA United Kingdom Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT00003957 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00005612 Ovarian Cancer Phase 1 Phase 2 Terminated(Low accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00093587 Graft Versus Host Disease ... More >> Leukemia Less << Not Applicable Unknown - United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1678 Less <<
NCT03367546 Sickle Cell Disease ... More >> Thalassemia High Risk Hematologic Disorders Cerebral Adrenoleukodystrophy Inherited Metabolic Disorders Less << Phase 2 Recruiting November 2025 United States, Minnesota ... More >> Masonic Caner Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT00081055 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Withdrawn - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Less <<
NCT00048893 Breast Neoplasms ... More >> Metastases, Neoplasm Less << Phase 1 Phase 2 Terminated(The study was close... More >>d to accrual due to very poor enrollment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT01367288 Locally Advanced Breast Cancer... More >> Ductal Histologic Type Without Her2 Overexpression. Less << Phase 2 Completed - France ... More >> Hopital Femme Mère Enfant, Service de Gynécologie BRON Cedex, France, 69677 Less <<
NCT02761915 Relapsed or Refractory Neurobl... More >>astoma Less << Phase 1 Recruiting February 2023 United Kingdom ... More >> University College London (UCL), Not yet recruiting London, United Kingdom, WC1E 6BT Contact: Person       rachael.hough@uclh.nhs.uk;    Principal Investigator: Rachel Hough, Dr          Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) Recruiting London, United Kingdom, WC1N 3JH Contact: Person       j.anderson@ucl.ac.uk    Principal Investigator: John Anderson, Prof Less <<
NCT00004172 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03295058 Severe Aplastic Anemia Phase 2 Phase 3 Not yet recruiting June 2020 -
NCT00038610 - Completed - -
NCT00038610 Leukemia Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00064116 Lymphoma Phase 3 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Newfoundland and Labrador Dr. H. Bliss Murphy Cancer Centre St. John's, Newfoundland and Labrador, Canada, AIB 3V6 Canada, Nova Scotia QEII Health Sciences Center Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Cancer Centre of Southeastern Ontario at Kingston Kingston, Ontario, Canada, K7L 5P9 Grand River Regional Cancer Centre Kitchener, Ontario, Canada, N2G 1G3 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Health Research Institute - General Division Ottawa, Ontario, Canada, K1H 8L6 Niagara Health System St. Catharines, Ontario, Canada, L2R 7C6 Odette Cancer Centre Toronto, Ontario, Canada, M4N 3M5 Univ. Health Network-The Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Trillium Health Centre - West Toronto Toronto, Ontario, Canada, M9C 1A5 Canada, Prince Edward Island PEI Cancer Treatment Centre,Queen Elizabeth Hospital Charlottetown, Prince Edward Island, Canada, C1A 8T5 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve-Rosemont Montreal, Quebec, Canada, H1T 2M4 CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 Hopital du Sacre-Coeur de Montreal Montreal, Quebec, Canada, H4J 1C5 CHA-Hopital Du St-Sacrement Quebec City, Quebec, Canada, G1S 4L8 Centre hospitalier universitaire de Sherbrooke Sherbrooke, Quebec, Canada, J1H 5N4 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT00048893 - Terminated(The study was close... More >>d to accrual due to very poor enrollment.) Less << - -
NCT00690560 Lymphoma Phase 2 Completed - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT03624036 Relapsed/Refractory Chronic Ly... More >>mphocytic Leukemia Less << Phase 1 Phase 2 Recruiting September 2035 United States, Tennessee ... More >> Sarah Cannon Research Center Recruiting Nashville, Tennessee, United States, 37203 Contact: Renee Thompson       Renee.Thompson@sarahcannon.com    Principal Investigator: Ian Flinn Less <<
NCT00005804 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00002553 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01119066 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Multiple Myeloma Less << Phase 2 Recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Richard O'Reilly, MD    212-639-5957       Contact: Sergio Giralt, MD    212-639-3859       Principal Investigator: Richard O'Reilly, MD Less <<
NCT02439788 Neuroblastoma Phase 1 Withdrawn(Based on newly avail... More >>able preclinical data we changed the CAR construct to a more effective version and will now study that product on a different protocol.) Less << October 2030 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02548468 Cutaneous T-Cell Non-Hodgkin L... More >>ymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Stage IIB Mycosis Fungoides and Sezary Syndrome Stage IIIA Mycosis Fungoides and Sezary Syndrome Stage IIIB Mycosis Fungoides and Sezary Syndrome Stage IVA Mycosis Fungoides and Sezary Syndrome Stage IVB Mycosis Fungoides and Sezary Syndrome Less << Phase 1 Withdrawn(Slow accrual) - -
NCT00376519 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Secondary Myelofibrosis Less << Phase 1 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02950259 Breast Neoplasm ... More >> Breast Neoplasm, Male Triple Negative Breast Cancer Less << Phase 1 Active, not recruiting November 2018 United States, Oregon ... More >> Providence Portland Medical Center Portland, Oregon, United States, 97213 Less <<
NCT00002509 Breast Cancer Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Temple University Cancer Center Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT00303719 Kidney Cancer ... More >> Leukemia Lymphoma Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting December 2021 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02685059 Breast Cancer Phase 2 Active, not recruiting March 2018 Germany ... More >> Centrum für Hämatologie und Onkologie am Bethanien-Krankenhaus Frankfurt, Hessen, Germany, 60389 Less <<
NCT00005852 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Terminated(low accrual) - -
NCT03761056 B-cell Lymphoma Phase 2 Recruiting December 2034 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo       LNVallejo@mdanderson.org    Contact: Yiming Chen       Yichen@mdanderson.org    Principal Investigator: Sattva Neelapu Less <<
NCT00002489 Extragonadal Germ Cell Tumor ... More >> Ovarian Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00002634 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003783 Leukemia Phase 2 Completed - -
NCT00334672 Nonneoplastic Condition Phase 3 Unknown - United Kingdom ... More >> Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Watford General Hospital Herts, England, United Kingdom, WD18 0HB Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00425802 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00005985 Lymphoma Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00003437 Leukemia Phase 3 Unknown - United Kingdom ... More >> Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Less <<
NCT00916045 Leukemia, Myeloid, Acute ... More >> Myelodysplastic Syndromes Leukemia, Lymphoblastic, Acute Lymphoma, Non-Hodgkin Hodgkin Disease Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Recruitment issues) - United Kingdom ... More >> King's College Hosptial NHS Foundation Trust London, United Kingdom, SE5 9RS Less <<
NCT00526409 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Hospital materno Infantil vall d'Hebrón Barcelona, Spain Hospital Niño Jesús Madrid, Spain Hospital Virgen de la Arrixaca Murcia, Spain Hospital Infantil Carlos Haya Málaga, Spain Less <<
NCT00425802 - Completed - -
NCT00002756 Leukemia Phase 2 Completed - -
NCT00003215 Lymphoma Phase 3 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Greece Saint Savvas Cancer Hospital of Athens Athens, Greece, 11522 Italy European Institute of Oncology Milano, Italy, 20141 Switzerland Universitatsspital-Basel Basel, Switzerland, CH-4031 Oncology Institute of Southern Switzerland Bellinzona, Switzerland, CH-6500 Inselspital, Bern Bern, Switzerland, CH-3010 Ratisches Kantons und Regionalspital Chur, Switzerland, CH-7000 Hopital Cantonal Universitaire de Geneve Collonge-Bellerive, Switzerland, CH-1245 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, 1011 Kantonsspital - St. Gallen St. Gallen, Switzerland, CH-9007 Klinik Hirslanden Zurich, Switzerland, CH-8008 Less <<
NCT00003859 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 3 Completed - United Kingdom ... More >> St. James's Hospital Leeds, England, United Kingdom, LS9 7TF Less <<
NCT00025103 Kidney Cancer Phase 2 Unknown - Ireland ... More >> Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH University College of London Hospitals London, England, United Kingdom, WIT 3AA Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00526175 Acute Lymphoblastic Leukemia Phase 4 Completed - Spain ... More >> Complejo Hospitalario Universitario de Albacete Albacete, Spain Hospital General de Alicante Alicante, Spain Hospital de Badalona Germans Trias i Pujol Badalona, Spain Hospital de Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Valle Hebrón-Materno Infantil Barcelona, Spain Basurtuko Ospitalea Basurto, Spain Complejo Hospitalario Reina Sofía Córdoba, Spain Hospital General de Guadalajara Guadalajara, Spain Complejo Hospitalario León Leon, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain . Hospital Clínico Universitario Virgen de la Victoria Málaga, Spain Complejo Asistencial Son Dureta Palma de Mallorca, Spain Hospital Clinico Universitario Salamanca, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Complejo Hospitalario Universitario de Santiago Santiago de Compostela, Spain Hospital General de Segovia Segovia, Spain H.U. Virgen del Rocio Sevilla, Spain Hospital Joan XXIII Tarragona, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Clínic Valencia, Spain Hospital La Fe Valencia, Spain Hospital Universitario Dr. Peset Valencia, Spain Hospital Clínico de Valladolid Valladolid, Spain Hospital Clínico Lozano Blesa Zaragoza, Spain Less <<
NCT00002898 Childhood Malignant Fibrous Hi... More >>stiocytoma of Bone Sarcoma Less << Phase 3 Completed - United Kingdom ... More >> Institute of Child Health Bristol, England, United Kingdom, BS2 8AE Less <<
NCT00003815 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Less <<
NCT00032019 Lymphoma Phase 2 Completed - -
NCT00002524 Lymphoma Phase 2 Completed - United States, Florida ... More >> MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00047138 Kidney Cancer Phase 3 Unknown - France ... More >> Institut Gustave Roussy Recruiting Villejuif, France, 94805 CEDEX Contact: Francois Pein, MD    33-1-4211-4339    pein@igr.fr    Germany Universitaetsklinikum des Saarlandes Recruiting Homburg, Germany, 66421 Contact: Norbert Graf    49-6841-162-4000       Netherlands Academisch Medisch Centrum at University of Amsterdam Recruiting Amsterdam, Netherlands, 1100 DE Contact: Jan DeKraker, MD    31-20-566-9111    j.dekraker@amc.uva.nl    United Kingdom Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Kathy Pritchard-Jones, MD    44-20-8661-3452 ext 3498 Less <<
NCT00003336 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-7284 Less <<
NCT00002658 Leukemia Neut... More >>ropenia Less << Phase 3 Unknown - United Kingdom ... More >> University of Wales College of Medicine Cardiff, Wales, United Kingdom, CF14 4XN Less <<
NCT00002822 Lung Cancer Phase 3 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00005603 Leukemia Phase 3 Completed - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027-0700 Lucile Packard Children's Hospital at Stanford Palo Alto, California, United States, 94304 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0128 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010-2970 United States, Illinois Saint Jude Midwest Affiliate Peoria, Illinois, United States, 61637 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216-4505 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio Children's Hospital Medical Center - Cincinnati Cincinnati, Ohio, United States, 45229-3039 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 United States, Texas University of Texas Medical Branch Galveston, Texas, United States, 77555-0361 University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Children's Hospital and Regional Medical Center - Seattle Seattle, Washington, United States, 98105 Less <<
NCT00004255 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Phase 3 Completed - United States, California ... More >> University of California San Diego Cancer Center La Jolla, California, United States, 92093-0658 United States, Colorado Presbyterian-St Luke's Medical Center Denver, Colorado, United States, 80218 United States, District of Columbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Florida Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States, 32610-100277 United States, Indiana Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States, 46202 United States, Kentucky James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73190 United States, Oregon Oregon Cancer Center Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 South Texas Cancer Institute San Antonio, Texas, United States, 78229 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00060385 Lymphoma Phase 2 Phase 3 Terminated(low accrual) - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Less <<
NCT00002865 Leukemia Phase 2 Completed - United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 Less <<
NCT00003013 Breast Cancer Phase 3 Completed - Austria ... More >> Kaiser Franz Josef Hospital Vienna, Austria, A-1100 Czech Republic Radiotherapy Institute Ostrava-Poruba, Czech Republic, 70852 Estonia University of Tartu Tartu, Estonia, 51003 Germany Frauenklinik Vom Roten Kreuz Munich, Germany, 80637 Hungary Semmelweis University Budapest, Hungary, 1082 Uzsoki Hospital Budapest, Hungary, 1145 Italy Policlinico Monteluce Perugia, Italy, 06122 Ospedale St. Santa Chiara Pisa, Italy, 56100 Centro di Riferimento Oncologico - Aviano Trento, Italy, 38100 Universita Degli Studi di Udine Udine, Italy, 33100 Ospedale San Bortolo Vicenza, Italy, 36100 Latvia Latvian Cancer Center Riga, Latvia, 1079 Poland Regional Center of Oncology Bydgoszcz, Poland, 85-796 Jagiellonian University Krakow (Cracow), Poland, 31-826 Szpital Kliniczny NR 1 Poznan, Poland, PL-61-878 Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology Warsaw, Poland, 02-781 Russian Federation Russian Academy of Medical Sciences Cancer Research Center Moscow, Russian Federation, 115478 Moscow Clinical Dispenser Moscow, Russian Federation, 129128 N. A. Semashko Central Clinical Hospital Moscow, Russian Federation, 129128 Regional Oncology Clinic Murmansk, Russian Federation, 183047 Petrov Research Institute of Oncology Saint Petersburg, Russian Federation, 197758 Slovakia St. Elizabeth Cancer Institute Hospital Bratislava, Slovakia, SK-81250 Spain Hospital de la Santa Cruz I Sant Pau Barcelona, Spain, 08025 Hospital General Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Clinico Universitario - Malaga Malaga, Spain, 29010 Instituto Valenciano De Oncologia Valencia, Spain, 46009 Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT00002643 Neutropenia S... More >>arcoma Less << Phase 2 Completed - -
NCT00002691 Lymphoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00070174 Leukemia Phase 2 Completed - -
NCT00032149 Lymphoma Phase 1 Phase 2 Unknown - United Kingdom ... More >> Cheltenham General Hospital Cheltenham, England, United Kingdom, GL53 7AN St. Georges, University of London London, England, United Kingdom, SW17 ORE King's College Hospital London, England, United Kingdom, W1T 4TJ Edinburgh Cancer Centre at Western General Hospital Edinburgh, Scotland, United Kingdom, EH4 2XU Less <<
NCT00077285 Sarcoma Phase 2 Active, not recruiting October 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00002531 Leukemia Phase 2 Unknown - Germany ... More >> Klinikum der J.W. Goethe Universitaet Frankfurt, Germany, D-60590 Less <<
NCT00199186 Philadelphia Positive Acute Ly... More >>mphoblastic Leukemia Lymphoid Blastic Phase of Chronic Myeloid Leukemia Less << Phase 2 Unknown - Germany ... More >> Medizinische Klinik II, Johann Wolfgang Goethe Universität Recruiting Frankfurt/Main, Germany, 60590 Contact: Oliver G Ottmann, M.D.    ++49-69-6301-0 ext 6221    ottmann@em.uni-frankfurt.de Less <<
NCT00003578 Lymphoma Phase 3 Unknown - -
NCT00410631 Neuroblastoma Phase 3 Unknown - -
NCT00417053 Neuroblastoma Phase 3 Unknown - -
NCT00005641 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Terminated(low study accrual) - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00002471 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109-0752 United States, New York Kaplan Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00003700 Leukemia Phase 2 Completed - -
NCT00822120 Lymphoma Nonn... More >>eoplastic Condition Less << Phase 2 Active, not recruiting April 2020 -
NCT00061945 Acute Undifferentiated Leukemi... More >>a B-cell Adult Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia L1 Adult Acute Lymphoblastic Leukemia L1 Childhood Acute Lymphoblastic Leukemia L2 Adult Acute Lymphoblastic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia T-cell Adult Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT00002549 Leukemia Phase 3 Unknown - -
NCT00002802 Neuroblastoma Phase 3 Completed - Germany ... More >> University of Cologne Frechen, Germany, DOH-5-0226 Less <<
NCT00003662 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Thymic Carcinoma Less << Phase 2 Completed - United States, Florida ... More >> University of Florida Health Science Center Gainesville, Florida, United States, 32610-0296 Division of Pediatric Surgery Jacksonville, Florida, United States, 32207 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637 United States, Louisiana Children's Hospital of New Orleans New Orleans, Louisiana, United States, 70118 United States, Missouri Cardinal Glennon Children's Hospital Saint Louis, Missouri, United States, 63104 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 New York Blood Center New York, New York, United States, 10021 United States, North Carolina Lineberger Comprehensive Cancer Center, UNC Chapel Hill, North Carolina, United States, 27599-7295 Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Pennsylvania St. Christopher's Hospital for Children Philadelphia, Pennsylvania, United States, 19134-1095 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425-0721 University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 Less <<
NCT00002665 Leukemia Neut... More >>ropenia Thrombocytopenia Less << Phase 2 Completed - -
NCT00822120 - Active, not recruiting - -
NCT00275106 Lymphoma Phase 3 Terminated(Withdrawn due to an... More >> excess of toxic deaths) Less << - Germany ... More >> Kinderklinik Giessen, Germany, D-35385 Ireland Our Lady's Hospital for Sick Children Crumlin Dublin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Institute of Child Health at University of Bristol Bristol, England, United Kingdom, BS2 8AE Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Royal London Hospital London, England, United Kingdom, E1 1BB Great Ormond Street Hospital for Children London, England, United Kingdom, WC1N 3JH Royal Manchester Children's Hospital Manchester, England, United Kingdom, M27 4HA Sir James Spence Institute of Child Health Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Royal Aberdeen Children's Hospital Aberdeen, Scotland, United Kingdom, AB25 2ZG Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom, EH9 1LF Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Childrens Hospital for Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT01383759 Light Chain Deposition Disease... More >> (LCDD or MIDD) Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) Monoclonal Immunoglobulin Deposition Disease (MIDD) Amyloidosis Less << Not Applicable Active, not recruiting June 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT00006455 Lymphoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium U.Z. Gasthuisberg Leuven, Belgium, B-3000 France Institut Gustave Roussy Villejuif, France, F-94805 Germany Kinderklinik Giessen, Germany, D-35385 Italy Azienda Ospedaliera di Padova Padova, Italy, 35128 Netherlands Dutch Childhood Leukemia Study Group Den Haag, Netherlands, 2504 AM Spain Hospital Clinico Universitario de Valencia Valencia, Spain, 46010 Sweden Karolinska University Hospital - Huddinge Stockholm, Sweden, S-171 76 Switzerland University Children's Hospital Zurich, Switzerland, CH-8032 United Kingdom Addenbrooke's Hospital Cambridge, England, United Kingdom, CB2 2QQ Less <<
NCT01132807 Lymphoma Phase 2 Completed - -
NCT00550992 Leukemia Not Applicable Unknown - United States, Massachusetts ... More >> Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02215 Contact: Lewis B. Silverman, MD    617-632-5285       United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Clinical Trials Office - St. Jude Children's Research Hospital    901-595-4644       United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245       United States, Washington Children's Hospital and Regional Medical Center - Seattle Recruiting Seattle, Washington, United States, 98105 Contact: Blythe Thomson, MD    206-987-2106       Austria St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Georg Mann, MD    43-1-4017-1250       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Alice Ferster, MD    32-2-477-2678    aferster@ulb.ac.be    Czech Republic University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz    France CHR Hotel Dieu Recruiting Nantes, France, 44093 Contact: Francoise Mechinaud, MD    33-1-4249-9046       Germany University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Medizinische Hochschule Hannover Recruiting Hannover, Germany, D-30625 Contact: Martin Schrappe, MD, PhD    49-511-532-6713       Italy Nuovo Ospedale San Gerardo at University of Milano-Bicocca Recruiting Monza, Italy, 20052 Contact: Andrea Biondi, MD    39-039-233-3661    biondi@galactica.it    Netherlands Erasmus MC - Sophia Children's Hospital Recruiting Rotterdam, Netherlands, 3015 GJ Contact: Rob Pieters, MD, MSC, PhD    31-10-463-6691    rob.pieters@erasmusmc.nl    United Kingdom Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Phil Ancliff, MD    44-20-7829-8831 Less <<
NCT00005987 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Terminated(Withdrawn because t... More >>reatment guidelines changed) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03674411 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Biphenotypic/Undifferentiated Leukemia Chronic Myelogenous Leukemia Myelodysplasia Relapsed Large Cell Lymphoma Mantle Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma Relapsed T-Cell Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 2 Not yet recruiting July 2023 -
NCT00002676 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Colorado CCOP - Colorado Cancer Research Program, Inc. Denver, Colorado, United States, 80209-5031 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Michigan CCOP - Kalamazoo Kalamazoo, Michigan, United States, 49007-3731 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Columbus Columbus, Ohio, United States, 43206 CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00400946 Drug/Agent Toxicity by Tissue/... More >>Organ Leukemia Less << Phase 3 Active, not recruiting June 2019 United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Albert Einstein Cancer Center at Albert Einstein College of Medicine Bronx, New York, United States, 10461 Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Rhode Island Hasbro Children's Hospital Providence, Rhode Island, United States, 02903 United States, Virginia INOVA Fairfax Hospital Fairfax, Virginia, United States, 22031 Canada, Ontario McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 Canada, Quebec Hopital Sainte Justine Montreal, Quebec, Canada, H3T 1C5 Centre de Recherche du Centre Hospitalier de l'Universite Laval Sainte Foy, Quebec, Canada, GIV 4G2 Puerto Rico San Jorge Children's Hospital Santurce, Puerto Rico, 00912 Less <<
NCT00061945 - Completed - -
NCT00003423 Lymphoma Phase 3 Unknown - United Kingdom ... More >> Hospital for Sick Children NHS Trust London, England, United Kingdom, WC1N 3JH Less <<
NCT00400946 - Active, not recruiting - -
NCT00253552 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Sarcoma Less << Not Applicable Terminated(Terminated at reque... More >>st of PI as study was outdated.) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00556127 Diffuse Large B-Cell Lymphoma ... More >> POOR PROGNOSIS Less << Phase 2 Completed - Italy ... More >> Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Ospedale Regionale, Divisione di Oncologia, Aosta, Italy Azienda Ospedaliera Ospedale Policlinico Consorziale Bari, Italy Osp. degli Infermi Biella, Italy Spedali Civili Brescia, Italy Centro Trapianti Midollo Osseo, P.O. Businco Cagliari, Italy Ospedale S. Gerardo Monza, Italy Osp. maggiore della Carità Novara, Italy Università degli Studi Policlinico Monteluce Perugia, Italy Divisione di Medicina, Ospedale Generale E. Agnelli, Pinerolo Torino, Italy Istituto per la Ricerca e la Cura del Cancro, Candiolo Torino, Italy Osp. S. Giovanni Battista "Molinette" Torino, Italy Ospedale di Chivasso e Ivrea Torino, Italy Stabilimento Ospedaliero Ciriè - Torino, Italy Less <<
NCT00343369 Leukemia Not Applicable Unknown - Germany ... More >> Evangelisches Krankenhauus Bielfeld Recruiting Biefeld, Germany, 33617 Contact: N. Jorch, MD    49-52-177-278-050       Klinikum Bremen-Mitte Recruiting Bremen, Germany, D-28205 Contact: Arnulf Pekrun, MD, PhD    49-421-497-3656    arnulf.pekrun@klinikum-bremen-mitte.de    Universitaetsklinikum Duesseldorf Recruiting Duesseldorf, Germany, D-40225 Contact: Contact Person    49-211-311-7990       Universitats - Kinderklinik Recruiting Greiswald, Germany, 17487 Contact: James F. Beck, MD    49-383-486-6325    beck@uni-greifswald.de    University Medical Center Hamburg - Eppendorf Recruiting Hamburg, Germany, D-20246 Contact: Gritta Janka-Schaub    49-404-2803-2580       Kreskrankenhaus Kinderabteilung Recruiting Heide, Germany, 25746 Contact: Streitberger    49-481-785-911       Clinic for Bone Marrow Transplantation and Hematology and Oncology Recruiting Idar-Oberstein, Germany, D-55743 Contact: Wenzel Nuernberger, MD, PhD    49-6781-66-1582    wnuernberger@bmt-center-io.com    Klinikum Krefeld GmbH Recruiting Krefeld, Germany, D-47805 Contact: P. Thomas    49-2151-322-375       Universitaets - Kinderklinik Recruiting Leipzig, Germany, D-04317 Contact: Dieter Koerholz, MD    49-341-9726-246    koerd@medizin.uni-leipzig.de    Johannes Gutenberg University Recruiting Mainz, Germany, D-55101 Contact: P. Gutjahr, MD    49-6131-17-2112       Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Recruiting Moenchengladbach, Germany, D-41066 Contact: Wolfgang Mueller, MD    49-2161-668-2481       Dr. von Haunersches Kinderspital der Universitaet Muenchen Recruiting Munich, Germany, D-80337 Contact: Arndt Borkhardt    49-89-5160-4498       Staedtisches Krankenhaus Muenchen - Harlaching Recruiting Munich, Germany, D-81545 Contact: Papucek    49-89-6210-2710       Klinik St. Hedwig-Kinderklinik Recruiting Regensburg, Germany, 93049 Contact: Ove Peters    49-941-369-5404       Dr. Horst-Schmidt-Kliniken Recruiting Wiesbaden, Germany, D-65199 Contact: Gerhard Beron, MD    49-611-43-2564       Helios Kliniken Wuppertal University Hospital Recruiting Wuppertal, Germany, D-42283 Contact: B. Dohrn, MD    49-202-896-3823    bdohrn@wuppertal.helios-klinikum.de Less <<
NCT00755313 - Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00526318 Neuroblastoma Not Applicable Unknown - -
NCT00002494 Leukemia Lymp... More >>homa Less << Phase 2 Completed - -
NCT00303810 Brain and Central Nervous Syst... More >>em Tumors Less << Not Applicable Completed - Germany ... More >> University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Less <<
NCT00290628 Chronic Myeloproliferative Dis... More >>orders Diamond-blackfan Anemia Fanconi Anemia Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Not Applicable Terminated(Replaced with anoth... More >>er study) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00003893 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Queen Elizabeth Hospital at University of Birmingham Birmingham, England, United Kingdom, B15 2TH Less <<
NCT00040690 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United Kingdom ... More >> Medical Research Council Clinical Trials Unit London, England, United Kingdom, NW1 2DA Less <<
NCT00801632 Kidney Transplantation ... More >> Kidney Failure, Chronic Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01279616 Sickle Cell Disease Phase 2 Terminated(PI moving to a diff... More >>erent institution.) Less << - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT00002701 Leukemia Phase 3 Unknown - -
NCT00018954 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 Egypt National Cancer Institute of Egypt Cairo, Egypt India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 Less <<
NCT00801632 - Completed - -
NCT00379457 Sarcoma Phase 3 Unknown - Austria ... More >> St. Anna Children's Hospital Recruiting Vienna, Austria, A-1090 Contact: Ruth Ladenstein, MD    43-1-404-700       Belgium Hopital Universitaire Des Enfants Reine Fabiola Recruiting Brussels, Belgium, 1020 Contact: Christine Devalck, MD    32-2-477-2678       Denmark Rigshospitalet - Copenhagen University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Catherine Rechnitzer, MD, PhD    45-3545-1368    rechnitzer@rh.dk    Ireland Our Lady's Hospital for Sick Children Crumlin Recruiting Dublin, Ireland, 12 Contact: Fin Breatnach, MD, FRCPE    353-1-409-6659    fin.breatnach@olhsc.ie    Spain Vall d'Hebron University Hospital Recruiting Barcelona, Spain, 08035 Contact: Soledad Gallego, MD, PhD    34-93-489-3090    sgallego@vhebron.net    Sweden Uppsala University Hospital Recruiting Uppsala, Sweden, SE-75185 Contact: Gustaf Ljungman, MD    46-18-611-5586       Switzerland University Children's Hospital Recruiting Zurich, Switzerland, CH-8032 Contact: Felix Niggli, MD    41-44-266-7823       United Kingdom Birmingham Children's Hospital Recruiting Birmingham, England, United Kingdom, B16 8ET Contact: David Hobin, MD    44-121-454-4851       Institute of Child Health at University of Bristol Recruiting Bristol, England, United Kingdom, BS2 8AE Contact: M. C. G. Stevens, MD    44-117-342-0205    m.stevens@bristol.ac.uk    Addenbrooke's Hospital Recruiting Cambridge, England, United Kingdom, CB2 2QQ Contact: Denise Williams, MD    44-1223-256-298       Leeds Cancer Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS9 7TF Contact: Martin Elliott, MD    44-113-206-4988       Leicester Royal Infirmary Recruiting Leicester, England, United Kingdom, LE1 5WW Contact: Johann Visser, MD    44-116-258-5309    johannes.visser@uhl-tr.nhs.uk    Royal Liverpool Children's Hospital, Alder Hey Recruiting Liverpool, England, United Kingdom, L12 2AP Contact: Heather P. McDowell, MD    44-151-293-3679       Middlesex Hospital Recruiting London, England, United Kingdom, W1T 3AA Contact: Ananth Shankar, MD    44-20-7380-9300 ext. 9950       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Julia Chisholm, MD    44-20-7829-7924       Royal Manchester Children's Hospital Recruiting Manchester, England, United Kingdom, M27 4HA Contact: Bernadette Brennan, MD    44-161-922-2227    bernadette.brennan@cmmc.nhs.uk    Sir James Spence Institute of Child Health at Royal Victoria Infirmary Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE1 4LP Contact: Juliet Hale, MD    44-191-282-4101    j.p.hale@ncl.ac.uk    Queen's Medical Centre Recruiting Nottingham, England, United Kingdom, NG7 2UH Contact: Martin Hewitt, MD, BSc, FRCP, FRCPCH    44-115-924-9924 ext. 63394    martin.hewitt@nuh.nhs.uk    Oxford Radcliffe Hospital Recruiting Oxford, England, United Kingdom, 0X3 9DU Contact: Sheila Lane, MD    44-1865-234-205       Children's Hospital - Sheffield Recruiting Sheffield, England, United Kingdom, S10 2TH Contact: Mary P. Gerrard, MBChB, FRCP, FRCPCH    44-114-271-7366    mary.gerrard@sch.nhs.uk    Southampton General Hospital Recruiting Southampton, England, United Kingdom, SO16 6YD Contact: Janice A. Kohler, MD, FRCP    44-23-8079-6942       Royal Marsden - Surrey Recruiting Sutton, England, United Kingdom, SM2 5PT Contact: Kathy Pritchard-Jones, MD    44-20-8661-3452 ext 3498       Royal Belfast Hospital for Sick Children Recruiting Belfast, Northern Ireland, United Kingdom, BT12 6BE Contact: Anthony McCarthy, MD    44-289-063-3631    anthonymcarthy@royalhospital.n.i.nhs.uk    Royal Aberdeen Children's Hospital Recruiting Aberdeen, Scotland, United Kingdom, AB25 2ZG Contact: Derek King, MD    44-1224-681-818       Royal Hospital for Sick Children Recruiting Edinburgh, Scotland, United Kingdom, EH9 1LF Contact: W. Hamish Wallace, MD    44-131-536-0426       Royal Hospital for Sick Children Recruiting Glasgow, Scotland, United Kingdom, G3 8SJ Contact: Milind D. Ronghe, MD    44-141-201-9309       Childrens Hospital for Wales Recruiting Cardiff, Wales, United Kingdom, CF14 4XW Contact: Meriel Jenney, MD    44-292-074-2107 Less <<
NCT00130195 Acute Lymphoblastic Leukemia Phase 2 Completed - Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Nagoya, Japan, 466-8550 Less <<
NCT00199082 Burkitt's Lymphoma ... More >> Burkitt's Leukemia Mediastinal Neoplasms Lymphoblastic Lymphoma Large Cell Anaplastic Lymphoma Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00199017 Lymphoma, Lymphoblastic Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT00041288 Leukemia Lymp... More >>homa Less << Phase 2 Unknown - -
NCT03272477 Breast Neoplasms Phase 2 Recruiting November 15, 2024 Germany ... More >> Evangelisches Krankenhaus Bethesda Mönchengladbach Recruiting Mönchengladbach, Germany, 41061 Contact: Oleg Gluz, PD Dr. med.    00492161 ext 9812010    oleg.gluz@wsg-online.com Less <<
NCT00019409 Leukemia Phase 3 Withdrawn - United States, Maryland ... More >> Pediatric Oncology Branch Bethesda, Maryland, United States, 20892 United States, Texas Texas Tech University Health Sciences Center School of Medicine Amarillo, Texas, United States, 79106 India Kidwai Memorial Institute of Oncology Bangalore, India, 560029 Cancer Institute (W.I.A.) Madras, India, 600020 Tata Memorial Centre Mumbai, India, 400012 All-India Institute of Medical Sciences New Delhi, India, 110029 Less <<
NCT00053911 Breast Cancer Phase 3 Terminated - France ... More >> Clinique Claude Bernard Albi, France, 81000 Centre Paul Papin Angers, France, 49036 Centre Hospitalier d'Annecy Annecy, France, 74011 Cedex Institut Sainte Catherine Avignon, France, 84082 Institut Bergonie Bordeaux, France, 33076 C.H. Bourg En Bresse Bourg En Bresse, France, 01012 CHU Hopital A. Morvan Brest, France, 29609 Centre Hospitalier General Brive, France, 19101 Centre Regional Francois Baclesse Caen, France, 14076 Centre Jean Perrin Clermont-Ferrand, France, 63011 Centre Hospitalier Compiegne Compiegne, France, 60321 Clinique du Petit Colmouilins Harfleur, France, 76700 Centre Oscar Lambret Lille, France, 59020 Institut J. Paoli and I. Calmettes Marseille, France, 13273 Hopital Notre-Dame de Bon Secours Metz, France, 57038 C.H. General Andre Boulloche Montbeliard, France, 25209 Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France, 34298 Centre Hospitalier de Mulhouse Mulhouse, France, 68051 Centre Regional Rene Gauducheau Nantes-Saint Herblain, France, 44805 Clinique Saint - Pierre Perpignan, France Centre Eugene Marquis Rennes, France, 35042 Clinique Armoricaine De Radiologie Saint Brieux, France, F-22015 Polyclinique de L'Ormeau Tarbes, France, 65000 Institut Claudius Regaud Toulouse, France, 31052 Hopital J. Ducuing Toulouse, France Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00003671 Leukemia Phase 2 Completed - -
NCT00002534 Leukemia Phase 3 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00430118 Leukemia Phase 3 Completed - -
NCT00002590 Lymphoma Phase 2 Completed - -
NCT00002582 Breast Cancer Phase 3 Completed - United Kingdom ... More >> Cancer Research Campaign Trials Unit-Birmingham (CRCTU) Birmingham, England, United Kingdom, B15 2TT Beatson Oncology Centre Glasgow, Scotland, United Kingdom, G11 6NT Less <<
NCT00006451 Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << Phase 3 Withdrawn(Withdrawn due to no ... More >>accrual) Less << - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00002516 Sarcoma Phase 3 Unknown - United Kingdom ... More >> Royal Victoria Infirmary Newcastle-upon-Tyne, England, United Kingdom, NE1 4LP Less <<
NCT00003187 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Phase 3 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Kentucky Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States, 40536-0084 United States, Minnesota University of Minnesota Medical School Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 Comprehensive Cancer Center of Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157-1082 United States, Ohio Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210 United States, Pennsylvania Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224 United States, South Carolina University of South Carolina School of Medicine Columbia, South Carolina, United States, 29203 United States, Utah Huntsman Cancer Institute Salt Lake City, Utah, United States, 84132 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 United States, Wisconsin Midwest Children's Cancer Center Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02596035 Renal Cell Carcinoma Phase 4 Active, not recruiting December 1, 2021 -
NCT00199095 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00002987 Lymphoma Phase 3 Unknown - South Africa ... More >> Groote Schuur Hospital, Cape Town Cape Town, South Africa, 7925 United Kingdom University Birmingham Birmingham, England, United Kingdom, B15 2TT Bristol Royal Hospital for Sick Children Bristol, England, United Kingdom, BS2 8BJ Bristol Oncology Centre Bristol, England, United Kingdom, BS2 8ED Addenbrooke's NHS Trust Cambridge, England, United Kingdom, CB2 2QQ Derbyshire Royal Infirmary Derby, England, United Kingdom, DE1 2QY Cookridge Hospital Leeds, England, United Kingdom, LS16 6QB University Hospitals of Leicester Leicester, England, United Kingdom, LE1 5WW Middlesex Hospital- Meyerstein Institute London, England, United Kingdom, W1G 3AA Clatterbridge Centre for Oncology NHS Trust Merseyside, England, United Kingdom, L63 4JY Newcastle General Hospital Newcastle Upon Tyne, England, United Kingdom, NE4 6BE Mount Vernon Hospital Northwood, England, United Kingdom, HA6 2RN Norfolk & Norwich Hospital Norwich, England, United Kingdom, NR1 3SR Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Royal Marsden Hospital Sutton, England, United Kingdom, SM2 5PT Southend General Hospital Westcliff-On-Sea, England, United Kingdom Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom Royal Preston Hospital Preston, United Kingdom, PR2 9HT Less <<
NCT00165139 Neuroblastoma ... More >> Ewings Sarcoma Non-rhabdomyosarcoma Soft Tissue Sarcoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00764907 Leukemia Phase 3 Unknown - Czech Republic ... More >> University Hospital Motol Recruiting Prague, Czech Republic, 150 06 Contact: Jan Stary, MD    420-2-2443-6401    jan.stary@lfmotol.cuni.cz Less <<
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT00629278 Breast Cancer Phase 3 Unknown - Italy ... More >> Ospedale Santa Croce Recruiting Cuneo, Italy, 12100 Contact: Contact Person    39-0171-441-309       Ospedale Civile di Ivrea Recruiting Ivrea, Italy, 10015 Contact: Contact Person    39-0125-4141       Azienda Ospedaliera - Universitaria di Modena Recruiting Modena, Italy, 41100 Contact: Pier Franco Conte, MD    39-059-422-4538    conte.pierfranco@unimo.it    Piacenza Hospital Recruiting Piacenza, Italy, 29100 Contact: Contact Person    39-052-330-3123       Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Recruiting Turin, Italy, 10126 Contact: Contact Person    39-011-633-1633       Ospedal San Andrea Recruiting Vercelli, Italy, 13100 Contact: Contact Person    39-161-593-418 Less <<
NCT01156883 Leukemia Not Applicable Completed - Italy ... More >> Complesso Ospedaliero S. Giovanni Addolorata Roma, (rm), Italy, 00184 Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy USL 8 - Ospedale S.Donato Arezzo, Italy Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Az.Ospedaliera S.G.Moscati Avellino, Italy UO Ematologia con trapianto- AOU Policlinico Consorziale di Bari Bari, Italy Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Divisione di Ematologia Ospedale A. Perrino Brindisi, Italy Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy Azienda Ospedaliera Pugliese Ciaccio - Presidio Ospedaliero A.Pugliese - Unità Operativa di Ematologia Catanzaro, Italy Sezione di Ematologia e Fisiopatologia delle Emostasi - Azienda Ospedaliera - Arcispedale S. Anna Ferrara, Italy Divisione Ematologia 1 - Azienda Ospedaliera Universitaria "San Martino" Genova, Italy ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Ospedale Niguarda " Ca Granda" Milano, Italy Centro Oncologico Modenese - Dipartimento di Oncoematologia Modena, Italy Azienda Ospedaliera di Rilievo Nazionale "A. Cardarelli" Napoli, Italy UOSC di Ematologia Oncologica - Istituto Nazionale Tumori "Fondazione Senatore Giovanni Pascale" Napoli, Italy zienda Ospedaliera Universitaria - Università degli Studi di Napoli "Federico II" - Facoltà di Medicina e Chirurgia Napoli, Italy Inferiore U.O. Medicina Interna Ematologia ed Oncologia P.O. Umberto I Nocera Inferiore, Italy S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro Novara, Italy Divisione di Ematologia con trapianto di midollo - A.U. Policlinico "Paolo Giaccone" Palermo, Italy Ospedali Riuniti "Villa Sofia-Cervello" Palermo, Italy Cattedra di Ematologia CTMO Università degli Studi di Parma Parma, Italy S.C. Ematologia - Fondazione IRCCS Policlinico S. Matteo Pavia, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Università di Pisa - Azienda Ospedaliera Pisana - Dipartimento di Oncologia, dei Trapianti e delle nuove Tecnologie in Medicina - Divisione di Ematologia Pisa, Italy Dipartimento Oncologico - Ospedale S.Maria delle Croci Ravenna, Italy Dipartimento Emato-Oncologia A.O."Bianchi-Melacrino-Morelli" Reggio Calabria, Italy Unità Operativa Complessa di Ematologia - Arcispedale S. Maria Nuova Reggio Emilia, Italy Az. Ospedaliera "Sant' Andrea"-Università la Sapienza Seconda Facoltà di Medicina e Chirurgia Roma, Italy Divisione di Ematologia - Ospedale S. Camillo Divisione di Ematologia - Ospedale S. Camillo Roma, Italy Divisione Ematologia - Università Campus Bio-Medico Roma, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy U.O.C. Ematologia - Ospedale S.Eugenio Roma, Italy Università Cattolica del Sacro Cuore - Policlinico A. Gemelli Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Istituto di Ematologia - IRCCS Ospedale Casa Sollievo della Sofferenza S. G. Rotondo, Italy Serv. di Ematologia Ist. di Ematologia ed Endocrinologia Sassari, Italy Struttura Complessa Ematologia - Azienda Sanitaria Locale BAT1- Presidio Ospedaliero Bisceglie-Trani Trani, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Università degli Studi di Verona - A. O. - Istituti Ospitalieri di Verona- Div. di Ematologia - Policlinico G.B. Rossi Verona, Italy Less <<
NCT00974792 Lymphoma Phase 2 Unknown - United Kingdom ... More >> Nottingham City Hospital Recruiting Nottingham, England, United Kingdom, NG5 1PB Contact: A. McMillan    44-115-969-1169 Less <<
NCT00002542 Breast Cancer Phase 3 Completed - -
NCT00196872 Breast Cancer Phase 3 Completed - Germany ... More >> Städtische Kliniken Frankfurt a.M.-Höchst Frankfurt, Hessia, Germany, 65929 Less <<
NCT01593020 Breast Cancer Phase 2 Active, not recruiting August 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00581776 Mantle Cell Lymphoma Phase 2 Completed - United States, Wisconsin ... More >> University Of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT03150693 B Acute Lymphoblastic Leukemia Phase 3 Recruiting August 2024 -
NCT03045471 - Not yet recruiting December 31, 2021 -
NCT01952769 DIPG Phase 1 Phase 2 Active, not recruiting April 2019 Israel ... More >> Hadassah Hebrew University Hospital Jerusalem, Israel, 91120 Less <<
NCT02566304 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia in Remission Aplastic Anemia Chronic Myelomonocytic Leukemia Hodgkin Lymphoma Indolent Non-Hodgkin Lymphoma Malignant Neoplasm Myelodysplastic Syndrome Myeloproliferative Neoplasm Plasma Cell Myeloma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts Less << Phase 2 Recruiting January 2021 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP    215-955-8874       Principal Investigator: Dolores Grosso, DNP, CRNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Ubaldo Martinez Outschoorn, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Mark Weiss, MD Less <<
NCT03018223 Non-Hodgkin's Lymphoma ... More >> Acute Leukemia in Remission Chronic Myeloid Leukemia Primary Myelofibrosis Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Hodgkin Lymphoma Multiple Myeloma Less << Phase 2 Active, not recruiting January 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00002522 Lymphoma Phase 2 Completed - United States, Pennsylvania ... More >> Fox Chase - Temple Cancer Center Philadelphia, Pennsylvania, United States, 19111-2442 Less <<
NCT00581776 - Completed - -
NCT01597219 Hodgkin's Lymphoma ... More >> Non-Hodgkin's Lymphoma Acute Myeloid Leukaemia Acute Lymphoblastic Leukaemia Myelodysplastic Syndrome Chronic Myeloid Leukaemia Chronic Lymphocytic Leukaemia Acquired Bone Marrow Failure Syndromes Other Haematological Malignancies; Unrelated HSCT Indicated Less << Phase 2 Recruiting March 2020 United Kingdom ... More >> Birmingham Heartlands Recruiting Birmingham, United Kingdom Contact: Dr Shankara Paneesha          Bristol Royal Infirmary Recruiting Bristol, United Kingdom Principal Investigator: Dr Rachel Protheroe          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Dr Ben Uttenthal          Beatson Hospital Recruiting Glasgow, United Kingdom Principal Investigator: Dr Dave Irvine          St James' University Hospital Recruiting Leeds, United Kingdom Principal Investigator: Dr Maria Gilleece          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Dr Rahuman Salim          King's College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Kavita Raj          St Bartholomew's Hospital Active, not recruiting London, United Kingdom University College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Panagiotis Kottaridis          Manchester Royal Infirmary Recruiting Manchester, United Kingdom Principal Investigator: Dr Eleni Tholouli          Freeman Hospital Recruiting Newcastle, United Kingdom Principal Investigator: Prof Matthew Colin          Royal Hallamshire, Sheffield & Weston Park Recruiting Sheffield, United Kingdom Principal Investigator: Prof John Snowden Less <<
NCT00002784 Breast Cancer Phase 3 Completed - Australia, New South Wales ... More >> Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia, NSW 2310 Royal Prince Alfred Hospital, Sydney Sydney, New South Wales, Australia, 2050 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Queen Elizabeth Hospital Adelaide, South Australia, Australia, 5011 Australia, Victoria Royal Melbourne Hospital Parkville, Victoria, Australia, 3050 Switzerland Swiss Institute for Applied Cancer Research Bern, Switzerland, CH-3008 Inselspital, Bern Bern, Switzerland, CH-3010 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Istituto Oncologico della Svizzera Italiana Lugano, Switzerland, CH-6900 Kantonsspital - Saint Gallen Saint Gallen, Switzerland, CH-9007 Universitaetsspital Zurich, Switzerland, CH-8091 Less <<
NCT03129828 Diffuse Large B Cell Lymphoma Phase 1 Phase 2 Recruiting March 31, 2022 Germany ... More >> Charité - Universitätsmedizin Berlin, Hematology, Oncology and Tumor Immunology, Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Clemens Schmitt, Prof. Dr.    +49-30-450 553 896    clemens.schmitt@charite.de    Contact: Sophy Denker, Dr.    +49-30-450 653 569    sophy.denker@charite.de    Principal Investigator: Clemens Schmitt, Prof. Dr. Less <<
NCT03743246 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Lymphoma, Non-Hodgkin Less << Phase 1 Phase 2 Recruiting December 1, 2023 Spain ... More >> Hospital Infantil Universitario Niño Jesús Recruiting Madrid, Spain, 28009 Less <<
NCT00189488 Graft Versus Host Disease ... More >> Hematologic Malignancies Less << Phase 2 Completed - -
NCT03518242 Breast Cancer Female Phase 2 Recruiting January 30, 2022 Uganda ... More >> Uganda Cancer Institute Recruiting Kampala, Uganda Contact: Manoj Menon Less <<
NCT00189488 - Completed - -
NCT01928589 Breast Cancer ... More >> Adenocarcinoma of the Breast Less << Phase 1 Phase 2 Recruiting January 2020 United States, District of Col... More >>umbia Sibley Memorial Hospital Recruiting Washington, District of Columbia, United States, 20016 Contact: Ruth Chamberlain    202-660-6420    rchamb13@jhmi.edu    Principal Investigator: Victoria Croog, MD          United States, Indiana Parkview Regional Medical Center Recruiting Fort Wayne, Indiana, United States, 46845 Contact: Karen Kreiger    260-266-6622    karen.kreiger@parkview.com    Contact: Angel Hamman    260-266-7745    angela.hamman@parkview.com    Principal Investigator: Wesley Russell, MD          Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Amy Miller    317-944-1242    amym@iu.edu    Principal Investigator: Richard Zellars, MD          Indiana University Health Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Kathryn Lauer    317-962-3172    KLauer@iuhealth.org    Principal Investigator: Richard Zellars, MD          IU Health Arnett Recruiting Lafayette, Indiana, United States, 47905 Contact: Samuel Durham    765-838-6885    sdurham1@iuhealth.org    Principal Investigator: Matthew Orton, MD          United States, Maryland Suburban Hospital Active, not recruiting Bethesda, Maryland, United States, 20814 United States, Pennsylvania Reading Hospital Active, not recruiting West Reading, Pennsylvania, United States, 19611 York Cancer Center Recruiting York, Pennsylvania, United States, 17403 Contact: Debi Oxenberg, RN    717-741-8124    doxenberg@wellspan.org    Principal Investigator: Amit Shah, MD          United States, Texas University of Texas-San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Carol Jenkins    210-450-5924    jenkinsca@uthscsa.edu    Principal Investigator: Richard Crownover, MD Less <<
NCT01057069 Breast Cancer Phase 2 Phase 3 Active, not recruiting December 2029 Netherlands ... More >> Medisch Centrum Alkmaar Alkmaar, Netherlands, 1815 JD NKI-AVL Amsterdam, Netherlands, 1066 CX OLVG Amsterdam, Netherlands, 1090 HM Reinier de Graaf Groep Delft, Netherlands, 2625 AD Medisch Centrum Haaglanden Den Haag, Netherlands, 2501 CK Deventer Ziekenhuis Deventer, Netherlands, 7400 GC Albert Schweitzer ziekenhuis Dordrecht, Netherlands Ziekenhuis Gelderse Vallei Ede, Netherlands Kennemer Gasthuis Haarlem, Netherlands, 2000AK Atrium Medisch Centrum Parkstad Heerlen, Netherlands, 6401 CX Spaarne Ziekenhuis Hoofddorp, Netherlands, 2130 AT LUMC Leiden, Netherlands, 2300 RC Maasstad ziekenhuis Rotterdam, Netherlands, 3007 AC Isala Klinieken Zwolle, Netherlands, 8000 GK Less <<
NCT03144947 Cancer, Breast Phase 2 Recruiting January 2019 Italy ... More >> UO di Oncologia Ematologia, Azienda Ospedaliero Universitaria di Ferrara Not yet recruiting Cona, Ferrara, Italy, 44124 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Antonio Frassoldati, MD          UOC Oncologia Medica, Azienda ULSS21 di Legnago Not yet recruiting Legnago, Verona, Italy, 37045 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Andrea Bonetti, MD          Oncologia Medica, Ospedale Sacro Cuore - Don Calabria - Negrar (VR) Recruiting Negrar, Verona, Italy, 37024 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Stefania Gori, MD          UOC Oncologia-A.O. PAPA GIOVANNI XXIII Bergamo Recruiting Bergamo, Italy, 24127 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Alberto Zambelli, MD          SSD di Oncologia Medica Addarii, Policlinico S. Orsola-Malpighi, Not yet recruiting Bologna, Italy, 40138 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Claudio Zamagni, MD          UOC di Oncologia. Azienda USL di Bologna, Ospedale Bellaria, Not yet recruiting Bologna, Italy, 40139 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Alba Brandes, MD          Divisione di Oncologia Medica - Ospedale di Bolzano, Not yet recruiting Bolzano, Italy, 39100 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Claudio Graiff, MD          Breast Unit Spedali Civili di Brescia Not yet recruiting Brescia, Italy Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Edda Simoncini, MD          Investigational Clinical Oncology - INCOIRCCS-Fondazione del Piemonte per l'Oncologia (FPO) Not yet recruiting Candiolo (TO), Italy, 10060 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Filippo Montemurro, DM          Chirurgia generale ad indirizzo senologico-Breast Unit Azienda Istituti Ospitalieri di Cremona Not yet recruiting Cremona, Italy, 26100 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Daniele Generali, MD          Dipartimento di Medicina Interna e Specialità Mediche (DI.M.I.)-Università di Genova Clinica di Medicina Interna ad indirizzo oncologico Not yet recruiting Genova, Italy, 16132 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Alberto Ballestrieri, MD          Oncologia Medica, IRST. Istituto Scientifico Romagnolo per lo studio e la cura dei Tumori, IRCCS di Meldola Not yet recruiting Meldola (FC), Italy, 47014 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Andrea Rocca, MD          Dipartimento di Scienze Mediche e Chirurgiche, Materno Infantili e dell'adulto. Policlinico di Modena Not yet recruiting Modena, Italy, 41124 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Luca Moscetti, MD          SC di Oncologia Medica, A.O. San Gerardo Not yet recruiting Monza (MB), Italy, 20900 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Marina Cazzaniga, MD          Azienda Ospedaliero-Universitaria di Parma, UOC di Oncologia Medica Recruiting Parma, Italy, 43100 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Antonio Musolino, MD          Dipartimento di Oncologia e Ematologia, UO di Oncologia Medica Azienda USL di Piacenza Recruiting Piacenza, Italy, 29121 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Luigi Cavanna, MD          Struttura Complessa di OncologiaIRCCS- Istituto in Tecnologie Avanzate e Modelli Assistenziali in Oncologia Arcispedale Santa Maria Nuova Recruiting Reggio Emilia, Italy, 42123 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Giancarlo Bisagni, MD          UO di Oncologia. Azienda USL di Rimini Recruiting Rimini, Italy, 47923 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Lorenzo Gianni, MD          Day Hospital, Ospedale di Sassuolo Not yet recruiting Sassuolo (MO), Italy, 41049 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Giovanni Partesotti, MD          U.O. di Oncologia Medica PO "S. Chiara" Not yet recruiting Trento, Italy, 38122 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Antonella Ferro, MD          Oncologia Medica Az. Ospedaliera di Verona Recruiting Verona, Italy, 37126 Contact: Todeschini       infogoirc@libero.it    Principal Investigator: Emilio Bria, MD Less <<
NCT00176930 Leukemia, Myeloid, Chronic ... More >> AML Leukemia, Lymphocytic, Acute MDS Leukemia, Lymphocytic, Chronic JMML Hodgkin's Disease Non-hodgkin's Lymphoma Multiple Myeloma Less << Not Applicable Suspended(Trial re-written as ... More >>MT2015-29) Less << December 2018 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00132691 Uveitis Phase 4 Completed - -
NCT00132691 - Completed - -
NCT02315196 Estrogen Receptor-negative Bre... More >>ast Cancer HER2-negative Breast Cancer Progesterone Receptor-negative Breast Cancer Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Triple-negative Breast Cancer Less << Phase 2 Recruiting July 2020 United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey Recruiting New Brunswick, New Jersey, United States, 08903 Contact: Kim M. Hirshfield    732-235-6028    hirshfie@cinj.rutgers.edu    Principal Investigator: Kim M. Hirshfield Less <<
NCT00617890 - Terminated(The study was prema... More >>turely terminated for strategic reasons, not for a safety concern.) Less << - -
NCT03035422 Refractory Acute Myeloid Leuke... More >>mia Less << Not Applicable Recruiting January 2021 France ... More >> Service d'hématologie Clinique Hôpital Saint Antoine Recruiting Paris, France, 75012 Contact: Rémy DULERY, PH    01.49.28.26.20    remy.dulery@aphp.fr    Contact: Mohamad MOHTY, PUPH    01.49.28.26.20    mohamad.mohty@inserm.fr Less <<
NCT00577096 - Completed - -
NCT03057626 - Recruiting August 1, 2020 -
NCT00328237 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Non-Hodgkin Lymphoma Myelodysplastic Syndromes Less << Phase 2 Unknown - United States, Colorado ... More >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Sub-Investigator: Scott Bearman, MD          Sub-Investigator: Robert Rifkin, MD          Sub-Investigator: Mark Brunvand, MD          Sub-Investigator: Jeffrey Matous, MD          Sub-Investigator: Michael Maris, MD Less <<
NCT00647218 Breast Cancer Not Applicable Completed - United States, Tennessee ... More >> Williamson Medical Center Frankling, Tennessee, United States, 37067 Jackson-Madison Hospital Jackson, Tennessee, United States, 38301 Boston Baskin Cancer Center Memphis, Tennessee, United States, 38104 Methodist Lebonheur Healthcare Memphis, Tennessee, United States, 38104 Meharry Medical College Nashville, Tennessee, United States, 37208 Vanderbilt-Ingram Cancer Cetner Nashville, Tennessee, United States Less <<
NCT00617890 Osteosarcoma ... More >>Sarcoma, Ewing's Peripheral Neuroectodermal Tumor Less << Phase 2 Terminated(The study was prema... More >>turely terminated for strategic reasons, not for a safety concern.) Less << - -
NCT03079089 Refractory or Relapsed Lymphoi... More >>d Haemopathy Less << Not Applicable Recruiting June 15, 2022 France ... More >> Service d'hématologie clinique Hôpital Saint Antoine Recruiting Paris, France Contact: Rémy DULERY, PH    01.49.28.26.20    remy.dulery@aphp.fr    Contact: Mohamad MOHTY, PUPH    01.49.28.26.20    mohamad.mohty@inserm.fr Less <<
NCT02903381 Smoldering Multiple Myeloma Phase 2 Suspended(FDA Partial Clinical... More >> Hold) Less << February 2024 United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT02765243 Neuroblastoma ... More >> Effects of Immunotherapy Less << Phase 2 Recruiting December 30, 2019 China, Guangdong ... More >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Wu xiaoxiao    +86-13826084545    zjllwyh@sina.com    Contact: Wang liqing, MD    +86-15918421985    wliqing2014@163.com Less <<
NCT00577096 Multiple Myeloma Not Applicable Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT03114865 Acute Lymphoblastic Leukemia ... More >> B-cell Non Hodgkin Lymphoma Pre B-Cell Acute Lymphoblastic Leukaemia Less << Early Phase 1 Recruiting May 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Ivana Gojo, MD    410-502-8775    igojo1@jhmi.edu Less <<
NCT01238562 Chemotherapy Patients Phase 1 Completed - China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT00083551 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00083551 - Completed - -
NCT02995330 Prostate Cancer Phase 1 Recruiting January 2022 United States, Maryland ... More >> Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21205 Contact: Connie Collins, RN    410-955-1017    ccolli23@jhmi.edu Less <<
NCT02043587 Acute Lymphocytic Leukemia ... More >> Adult Lymphoblastic Lymphoma Less << Phase 2 Active, not recruiting January 2020 United States, California ... More >> UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center La Jolla, California, United States, 92093 Hematological Malignancies/Stem Cell Transplantation Unit, David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT01996410 Breast Cancer Stages I Through... More >> III Less << Not Applicable Terminated(Low enrollment.) - United States, Ohio ... More >> Columbus Oncology and Hematology Associates Columbus, Ohio, United States, 43214 Less <<
NCT02022202 - Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic campus in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01996410 - Terminated(Low enrollment.) - -
NCT02428517 - Terminated(The PI resigned the... More >> institute, and the rest investigators at the institute decided to terminate the study.) Less << - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae Paik Hospital Busan, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of Less <<
NCT01731886 Multiple Myeloma Phase 4 Completed - United States, New York ... More >> Columbia University New York, New York, United States, 10032 Less <<
NCT00592111 Pediatric Hod... More >>gkin's Disease Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00366834 Vomiting Naus... More >>ea Nausea and Vomiting, Chemotherapy-Induced Less << Phase 3 Completed - -
NCT00317096 Lymphoma, Follicular ... More >> Lymphoma, Low-Grade Lymphoma, Intermediate-Grade Less << Phase 3 Active, not recruiting June 2021 Germany ... More >> German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Less <<
NCT03434704 Transplant-Related Hematologic... More >> Malignancy Leukemia, Acute Myelodysplastic Syndromes Graft Vs Host Disease Fungal Infection Less << Phase 2 Recruiting September 15, 2022 Italy ... More >> Ospedale San Raffaele Recruiting Milano, Lombardia, Italy, 20132 Contact: Fabio Ciceri, MD    0039022643 ext 4289    ciceri.clinicaltrials@hsr.it    Sub-Investigator: Raffaella Greco, MD          Sub-Investigator: Jacopo Peccatori, MD          Sub-Investigator: Maria Teresa Lupo Stanghellini, MD          Sub-Investigator: Andrea Assanelli, MD          Sub-Investigator: Consuelo Corti, MD Less <<
NCT02858258 Mantle Cell Lymphoma Phase 3 Recruiting May 2026 -
NCT00117598 Lymphoma Phase 3 Completed - -
NCT03617731 Multiple Myeloma Phase 3 Recruiting December 2025 Germany ... More >> HELIOS Klinikum, Klinik für Hämatologie, Onkologie und Immunologie Not yet recruiting Berlin, Germany, 13125 Contact: Stephan Fuhrmann, Dr.    030 ext 940112151    stephan.fuhrmann@helios-kliniken.de    Contact: Judith Niederland, Dr.       judith.niederland@helios-kliniken.de    Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und Palliativmedizin Not yet recruiting Bielefeld, Germany, D-33604 Contact: Martin Görner, Dr. med.    0521-581-3601    martin.goerner@klinikumbielefeld.de    Contact: Ulrich Krümpelmann, Dr.       ulrich.kruempelmann@klinikumbielefeld.de    Medizinische Universitätsklinik, Knappschaftskrankenhaus Not yet recruiting Bochum, Germany, D-44892 Contact: Roland Schroers, Prof. Dr. med.    0234-2993447    roland.schroers@rub.de    Contact: Lars Petersen, Dr.          Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Schwerpunkt Onkologie, Hämatologie und Rheumatologie Not yet recruiting Bonn, Germany, 53105 Contact: Annkristin Heine, Dr.    0228 ext 28717232    annkristin.heine@ukb.uni-bonn.de;    Contact: Jai-Juen Shiue, Dr.          Klinikum Chemnitz GmbH, Innere Medizin III Not yet recruiting Chemnitz, Germany, D-09116 Contact: Mathias Hänel, PD Dr. med.    0371-333-43045    m.haenel@skc.de    Contact: Anke Morgner, Dr.          Onkologisches Studienzentrum Darmstadt Not yet recruiting Darmstadt, Germany, 64283 Contact: Gerrit Dingeldein          Contact: Georgi Kojouharoff, Dr.    06151-130480       Klinikum Darmstadt, Med. Klinik V, Hämatologie/Onkologie Not yet recruiting Darmstadt, Germany, D-64283 Contact: Helga Bernhard, Prof. Dr.    06151-107-6651    helga.bernhard@mail.klinikum-darmstadt.de    Contact: Tu-Anh Dang, Dr.       tu-anh.dang@mail.klinikum-darmstadt.de    HELIOS St. Johannes Klinik, Akademisches Krankenhaus der Heinrich-Heine-Universität Düsseldorf Not yet recruiting Duisburg, Germany, 47166 Contact: Michael n.a. Heinsch, Dr.    0203 ext 5462442    michael.heinsch@helios-kliniken.de    Universitätsklinikum Düsseldorf, Klinik für Hämatologie,Onkologie und Klin. Immunologie Not yet recruiting Düsseldorf, Germany, D-40225 Contact: Roland Fenk, Prof. Dr.    0211-811-7760    fenk@med.uni-duesseldorf.de    Contact: Amelie Boquoi, Dr.          Universitätsklinik Erlangen Not yet recruiting Erlangen, Germany, 91054 Contact: Barbara Ferstl, Dr.    09131 ext 8543104    Barbara.Ferstl@uk-erlangen.de    Contact: Andreas Mackensen, Prof.       Andreas.Mackensen@uk-erlangen.de    Universitätsklinikum Essen, Klinik für Hämatologie Not yet recruiting Essen, Germany, D-45147 Contact: Jan Dürig, Prof. Dr.    0201-72384621    jan.duerig@uni-essen.de    Contact: Karl Richard Maria Noppeney, Dr.    0201-72384215       Ev. Krankenhaus Essen-Werden gGmbH, Zentrum für Innere Medizin, Klinik für Hämatologie, Onkologie und Stammzelltransplantation Not yet recruiting Essen, Germany, D-45239 Contact: Mohammed Wattad, Dr.    0201-4089 2246    m.wattad@kliniken-essen-sued.de    Contact: Peter Reimer, Prof. Dr.    0201-4089-0    p.reimer@kliniken-essen-sued.de    Universitätsklinikum Frankfurt, Goethe-Universität Medizinische Klinik II Not yet recruiting Frankfurt am Main, Germany, 60590 Contact: Wilde Birgit    069-6301 ext 86708    Birgit.Wilde@kgu.de    Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie Not yet recruiting Hagen, Germany, D-58095 Contact: Hans-Walter Lindemann, Dr.    02331-129-0    w.lindemann@kkh-hagen.de    Contact: Cordula Maria Elisabeth Maciejewski       maciejewskic@kkh-hagen.de    Asklepios Klinik Hamburg Altona, II. Med. Klinik Not yet recruiting Hamburg, Germany, D-22763 Contact: Hans Salwender, Dr.    040-181881-1212    h.salwender@asklepios.com    KRH Klinikum Siloah, Klinik für Hämatologie und Onkologie Not yet recruiting Hannover, Germany, 30459 Contact: Martin Müller, PD Dr.          Contact: Kim Marienhagen          University Hospital Heidelberg, Med. Klinik V Recruiting Heidelberg, Germany, D-69120 Contact: GMMG Study Office       studiensekretariat.gmmg@med.uni-heidelberg.de    Principal Investigator: Hartmut Goldschmidt, Prof. Dr.          SLK Kliniken Heilbronn, Med. Klinik III Not yet recruiting Heilbronn, Germany, D-74078 Contact: Uwe Martens, Prof. Dr.       uwe.martens@slk-kliniken.de    Contact: Markus Lindauer, Dr.          Praxisklinik für Hämatologie und Onkologie Not yet recruiting Koblenz, Germany, D-56068 Contact: Jörg Thomalla, Dr. med.    0261-30493-0    thomalla@onkologie-koblenz.de    Contact: Rudolf Weide, Prof. Dr.          Med. Klinik A, Klinikum der Stadt Ludwigshafen am Rhein gGmbH Not yet recruiting Ludwigshafen am Rhein, Germany, 67063 Contact: Martin Hoffmann, Dr.    0621 ext 50340702    HoffmanM@klilu.de    Contact: Michael Uppenkamp, Prof. Dr.    0621 ext 50340702       Universitätsmedizin der Johannes Gutenberg-Universität Mainz, III. Med. Klinik Not yet recruiting Mainz, Germany, D-55131 Contact: Markus Munder, PD. Dr. med.    06131-17-5948    markus.munder@unimedizin-mainz.de    Contact: Georg Heß, PD Dr.          III. Medizinische Klinik Hämatologie und Internistische Onkologie Not yet recruiting Mannheim, Germany, 68167 Contact: Stefan Klein, PD Dr.    0621-383-4114    stefan.klein@umm.de    Mannheimer Onkologie Praxis Not yet recruiting Mannheim, Germany, D-68161 Contact: Manfred Hensel, Prof. Dr. med.       hensel@mannheimer-onkologie-praxis.de    Contact: Dieter Schuster, Dr. med.          Philipps-Universität Marburg, Hämatologie/Onkologie/Immunologie Not yet recruiting Marburg, Germany, 35032 Contact: Andreas Neubauer, Prof. Dr.       neubauer@med.uni-marburg.de    Contact: Ellen Wollmer, Dr.       wollmer@med.uni-marburg.de    Mühlenkreiskliniken (AöR) Johannes Wesling Klinikum Minden, Hämatologie/Onkologie, Hämostaseologie und Palliativmedizin Not yet recruiting Minden, Germany, 32429 Contact: Hans-Joachim Tischler, Dr.    0571 ext 7904202    hans-joachim.tischler@muehlenkreiskliniken.de    Contact: Kai Wille, Dr.    0571 ext 79051193    kai.wille@muehlenkreiskliniken.de    Krankenhaus Maria Hilf GmbH, Franziskuskrankenhaus, Med. Klinik I Not yet recruiting Mönchengladbach, Germany, D-41063 Contact: Ullrich Graeven, PD Dr.    02161-892-2201    Ullrich.Graeven@mariahilf.de    Contact: Heidi Herfert    02161-892-2372    heidi.herfert@mariahilf.de    Krankenhaus Barmherzige Brüder, Klinik für Onkologie und Hämatologie Not yet recruiting Regensburg, Germany, 93049 Contact: Bernhard Heilmeier, Dr.    0941 ext 36992152    bernhard.heilmeier@barmherzige-regensburg.de    Contact: Anke Schlenska-Lange, Dr.       anke.schlenska-lange@barmherzige-regensburg.de;    Diakonie-Klinikum Schwäbisch Hall gGmbH, Innere Medizin III Not yet recruiting Schwäbisch Hall, Germany, 74523 Contact: Sabine Kraft    0791-753-4018 ext 4486    sabine.kraft@dasdiak.de    Contact: Samiha Priwitzer       Samiha.priwitzer@dasdiak.de    ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg Not yet recruiting Siegburg, Germany, D-53721 Contact: Stefan Fronhoffs, Dr.       sfronhoffs@zaho-rheinland.de    Contact: Bettina Bürgel    02241-5954-23    studienbuero@zaho-rheinland.de    Onkologische Schwerpunktpraxis Speyer Not yet recruiting Speyer, Germany, D-67346 Contact: Joachim Behringer, Dr. med.       j.behringer@onkologie-speyer.de    Contact: Lars Scheuer, Dr.    06232-604460    onkologie-speyer@t-online.de    University Hospital Tübingen, Med. Klinik und Poliklinik, Abt. II Not yet recruiting Tübingen, Germany, D-72076 Contact: Katja Weisel, PD Dr.    07071-29-84321    katja.weisel@med.uni-tuebingen.de    Contact: Britta Besemer, Dr.       britta.besemer@med.uni-tuebingen.de Less <<
NCT00145587 Osteopetrosis Not Applicable Terminated(Due to the principa... More >>l investigator having left the institution.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00117598 - Completed - -
NCT01362452 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00145587 - Terminated(Due to the principa... More >>l investigator having left the institution.) Less << - -
NCT02626715 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Hematopoietic Stem Cell Transplant (HSCT) Less << Phase 2 Recruiting September 2021 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Randy Windreich, MD    412-692-5055 Less <<
NCT00734877 Multiple Myeloma Phase 3 Recruiting September 2020 United States, Arkansas ... More >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty    501-526-6990 ext 2435    pettynathanm@uams.edu    Sub-Investigator: Frits van Rhee, MD, PhD          Sub-Investigator: Michele Fox, MD          Sub-Investigator: Maurizio Zangari, MD          Sub-Investigator: Atul Kothari, MD          Sub-Investigator: Carolina Schinke, MD          Sub-Investigator: Faith Davies, MD          Sub-Investigator: Gareth Morgan, MD          Sub-Investigator: Juan Crescencio, MD          Sub-Investigator: Mary Burgess, MD          Sub-Investigator: Meera Mohan, MD          Sub-Investigator: Muthukumar Radhakrishnan, MD          Sub-Investigator: Pankaj Mathur, MD          Sub-Investigator: Sharmilan Thanendrajan, MD          Sub-Investigator: Shadiqul Hogue, MD          Sub-Investigator: Sandra Susanibar-Adaniya, MD Less <<
NCT02990819 Immunodeficiencies ... More >> Immune Dysregulation Syndromes Less << Phase 2 Recruiting December 2023 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn, RN, BSN       MCGLYNN@email.chop.edu Less <<
NCT01044069 Leukemia Acut... More >>e Lymphoblastic Leukemia Less << Phase 1 Active, not recruiting January 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01941680 - Active, not recruiting March 2021 Guadeloupe ... More >> CHU Pinteà Pitre/Abymes Pointe à Pitre, Guadeloupe Martinique CHU de Martinique Fort de France, Martinique Less <<
NCT02135380 Idiopathic Pulmonary Fibrosis Phase 1 Phase 2 Unknown - India ... More >> Kasiak Research Pvt Ltd Recruiting Thane, Maharashtra, India, 400 610 Contact: Dr. Pankaj A Thakur, PhD    +91-(022)-411 73463 ext 463    pankaj.thakur@kasiakresearch.com    Contact: Sainyukta S Medhekar, MSc    +91-(022)-411 73463 ext 463    sainyukta.medhekar@kasiakresearch.com    Principal Investigator: Dr.Pratibha Singhal, M.B.B.S.M.D.          Principal Investigator: Dr. Ashok Mahashur, M.B.B.S.M.D.          Principal Investigator: Dr. Sujeet Rajan, M.B.B.S.M.D.          Principal Investigator: Dr. Karthik Shah, M.B.B.S.M.D. Less <<
NCT00241358 Leukemia, Myeloid, Acute ... More >> Leukemia, Myelogenous, Chronic Leukemia, Lymphoblastic, Acute Lymphocytic Leukemia, Chronic Myelodysplastic Syndromes Multiple Myeloma Lymphoma, Non-Hodgkin Hodgkin Disease Less << Phase 1 Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03373019 Chidamide Lym... More >>phoma, B-Cell Lymphoma, Large B-Cell, Diffuse Neoplasm by Histology Neoplasms Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Lymphoma, Non-Hodgkin Cyclophosphamide Rituximab Gemcitabine Cisplatin Dexamethasone HDAC Inhibitor Less << Phase 2 Recruiting March 1, 2021 China, Shanghai ... More >> Kai Xue Recruiting Shanghai, Shanghai, China, 200032 Contact: Kai Xue, MD    13818659448    xuekaishanghai@126.com    China Kai Xue Recruiting Shanghai, China Contact: Kai Xue, MD    13818659448    xuekaishanghai@126.com    Contact: Junning Cao, MD    13818659448 Less <<
NCT02579967 Primary T-cell Immunodeficienc... More >>y Disorders Common Variable Immunodeficiency Immune System Diseases Autoimmune Lymphoproliferative Lymphoproliferative Disorders Less << Phase 2 Recruiting October 21, 2027 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00241358 - Completed - -
NCT00003727 Leukemia Phase 2 Completed - United States, Maryland ... More >> Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Less <<
NCT00401817 Untreated Mantle Cell Lymphoma Phase 2 Completed - United States, Illinois ... More >> Rush University Medical Center Chicago, Illinois, United States, 60612 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 Less <<
NCT00401817 - Completed - -
NCT00131053 Lymphoblastic Leukemia, Acute Phase 2 Unknown September 2011 Japan ... More >> Department of Hematology, Nagoya University Graduate School of Medicine Recruiting Nagoya, Japan, 466-8550 Contact: Fumihiko Hayakawa, MD       bun-hy@med.nagoya-u.ac.jp    Principal Investigator: Fumihiko Hayakawa, MD Less <<
NCT00526305 Acute Lymphoblastic Leukemia Phase 4 Completed - -
NCT00439296 Recurrent Pediatric ALL ... More >> Relapsed Pediatric ALL Acute Lymphoblastic Leukemia Refractory Pediatric ALL Less << Phase 1 Terminated(The study was stopp... More >>ed due to poor accrual and lack of funding.) Less << - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 Stanford University Medical Center Palo Alto, California, United States, 94304-1812 UCSF School of Medicine San Francisco, California, United States, 94143-0106 United States, Florida University of Miami Cancer Center Miami, Florida, United States, 33136 United States, Michigan C.S. Mott Children's Hospital Ann Arbor, Michigan, United States, 48109-0914 United States, Minnesota Childrens Hospital & Clinics of Minnesota Minneapolis, Minnesota, United States, 55404-4597 United States, New York New York University Medical Center New York, New York, United States, 10016 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Less <<
NCT00186823 Leukemia, Acute Lymphocytic (A... More >>LL) Leukemia, Myeloid, Acute(AML) Leukemia, Myeloid, Chronic(CML) Juvenile Myelomonocytic Leukemia(JMML) Hemoglobinuria, Paroxysmal Nocturnal (PNH) Lymphoma, Non-Hodgkin (NHL) Myelodysplastic Syndrome (MDS) Less << Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00040872 Neuroblastoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00003397 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00476190 Acute Lymphoblastic Leukemia Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Children's Hospital of Boston Boston, Massachusetts, United States, 02115 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 Canada, British Columbia Vancouver Cancer Center Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, New Brunswick The Moncton Hospital Moncton, New Brunswick, Canada Canada, Nova Scotia QEII, Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec Hopital Charles LeMoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Maisonneuve Rosemont Montreal, Quebec, Canada, H1T 2M4 Hopital Notre-Dame Montreal, Quebec, Canada McGill University Department of Oncology Montreal, Quebec, Canada Less <<
NCT00049595 Lymphoma Phase 3 Active, not recruiting - -
NCT00049569 L1 Childhood Acute Lymphoblast... More >>ic Leukemia L2 Childhood Acute Lymphoblastic Leukemia Non-T, Non-B Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia T-cell Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT00053989 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01639339 Lupus Nephritis Phase 3 Active, not recruiting February 5, 2020 -
NCT00017368 Neuroblastoma Phase 2 Completed - United States, Georgia ... More >> AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish RiteCampus Atlanta, Georgia, United States, 30342 United States, Massachusetts Floating Hospital for Children Boston, Massachusetts, United States, 02111 Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon CCOP - Columbia River Oncology Program Portland, Oregon, United States, 97225 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 CCOP - Scott and White Hospital Temple, Texas, United States, 76508 United States, Wisconsin CCOP - Marshfield Clinic Research Foundation Marshfield, Wisconsin, United States, 54449 Australia, Western Australia Princess Margaret Hospital for Children Perth, Western Australia, Australia, 6001 Less <<
NCT00025636 Lymphoma Phase 3 Unknown - -
NCT00003086 Breast Cancer Phase 1 Phase 2 Unknown - United States, Louisiana ... More >> Louisiana State University School of Medicine Shreveport, Louisiana, United States, 71130-3932 Less <<
NCT00080925 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00030719 Neuroblastoma Phase 3 Unknown - -
NCT00002599 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - United Kingdom ... More >> Leeds Teaching Hospital Trust Leeds, England, United Kingdom, LS1 3EX Less <<
NCT00028886 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 3 Unknown - Belgium ... More >> U.Z. Gasthuisberg Leuven, Belgium, B-3000 Netherlands HagaZiekenhuis - Locatie Leyenburg 's-Gravenhage, Netherlands, 2545 CH Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands, 5211 NL Meander Medisch Centrum Amersfoort, Netherlands, 3816 CP Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1081HV Academisch Medisch Centrum at University of Amsterdam Amsterdam, Netherlands, 1105 AZ Medisch Spectrum Twente Enschede, Netherlands, 7500 KA University Medical Center Groningen Groningen, Netherlands, 9713 EZ Medisch Centrum Leeuwarden - Zuid Leeuwarden, Netherlands, 8934 AD Leiden University Medical Center Leiden, Netherlands, 2300 RC Academisch Ziekenhuis Maastricht Maastricht, Netherlands, 6202 AZ Sint Antonius Ziekenhuis Nieuwegein, Netherlands, 3435 CM Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands, NL-6500 HB Daniel Den Hoed Cancer Center at Erasmus Medical Center Rotterdam, Netherlands, 3008 AE University Medical Center Utrecht Utrecht, Netherlands, 3584 CX Isala Klinieken - locatie Sophia Zwolle, Netherlands, 8000 GK Less <<
NCT00004906 Breast Cancer Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00004231 Lymphoma Phase 2 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 Less <<
NCT03381183 Squamous Cell Carcinoma ... More >> Squamous Cell Carcinoma of the Head and Neck Metastatic Squamous Cell Carcinoma Oral Cavity Squamous Cell Carcinoma Oropharynx Squamous Cell Carcinoma Paranasal Sinus Squamous Cell Carcinoma Hypopharynx Squamous Cell Carcinoma Larynx Squamous Cell Carcinoma Less << Phase 1 Phase 2 Not yet recruiting March 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Not yet recruiting Tampa, Florida, United States, 33612 Contact: Brian Trank    813-745-5269    brian.trank@moffitt.org    Contact: Christine Chung, M.D.    813-745-5431    christine.chung@moffitt.org    Principal Investigator: Christine Chung, M.D.          United States, Georgia Emory University School of Medicine Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Nabil Saba, M.D.    404-778-3126    nfsaba@emory.edu    Principal Investigator: Nabil Saba, M.D.          United States, Michigan University of Michigan Health System Not yet recruiting Ann Arbor, Michigan, United States, 48019 Contact: Paul Swiecicki, M.D.    248-613-5992    pswiecic@med.umich.edu Less <<
NCT00016887 Lymphoma Phase 3 Unknown - Belgium ... More >> AZ Sint-Jan Brugge, Belgium, 8000 Italy Ospedale Civile Alessandria Alessandria, Italy, I-15100 Less <<
NCT00002766 Leukemia Lymp... More >>homa Less << Phase 3 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1678 Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States, 94305-5750 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 New York Medical College Valhalla, New York, United States, 10595 United States, North Carolina Duke Comprehensive Cancer Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00002785 Leukemia Phase 2 Completed - -
NCT00002766 - Completed - -
NCT00295997 Chronic Myeloproliferative Dis... More >>orders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Not Applicable Unknown - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00003273 Brain and Central Nervous Syst... More >>em Tumors Neuroblastoma Retinoblastoma Sarcoma Less << Phase 2 Withdrawn - United States, Hawaii ... More >> Cancer Research Center of Hawaii Honolulu, Hawaii, United States, 96813 United States, Maine Maine Children's Cancer Program Scarborough, Maine, United States, 04074-9308 United States, Michigan Spectrum Health and DeVos Children's Hospital Grand Rapids, Michigan, United States, 49503 United States, Nebraska Children's Hospital of Omaha Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Albert Einstein Clinical Cancer Center Bronx, New York, United States, 10461 Winthrop University Hospital Mineola, New York, United States, 11501 NYU School of Medicine's Kaplan Comprehensive Cancer Center New York, New York, United States, 10016 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Beth Israel Hospital North New York, New York, United States, 10128 State University of New York Health Sciences Center - Stony Brook Stony Brook, New York, United States, 11790-7775 State University of New York - Upstate Medical University Syracuse, New York, United States, 13210 United States, Ohio St. Vincent Mercy Medical Center Toledo, Ohio, United States, 43608 United States, Pennsylvania Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Argentina Children's Hospital Buenos Aires, Argentina, 1425 Canada, British Columbia British Columbia Children's Hospital Vancouver, British Columbia, Canada, V6H 3V4 Less <<
NCT00020943 Lymphoma Phase 2 Completed - -
NCT00002704 Leukemia Phase 2 Completed - -
NCT00024193 Neuroblastoma Phase 2 Unknown - France ... More >> Institut Gustave Roussy Villejuif, France, F-94805 Less <<
NCT00025402 Leukemia Phase 3 Unknown - -
NCT00017225 Neuroblastoma Phase 2 Completed - -
NCT00041327 Lymphoma Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90089-9181 United States, Florida University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital Saint Louis, Missouri, United States, 63110 Less <<
NCT00003913 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - -
NCT00004197 Lymphoma Phase 2 Completed - United States, California ... More >> Stanford University Medical Center Stanford, California, United States, 94305-5408 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-3330 Less <<
NCT00025441 Ovarian Cancer ... More >> Sarcoma Small Intestine Cancer Less << Phase 2 Completed - France ... More >> Centre Leon Berard Lyon, France, 69373 Ireland Our Lady's Hospital for Sick Children Crumlin, Ireland, 12 United Kingdom Birmingham Children's Hospital Birmingham, England, United Kingdom, B4 6NH Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom, CB2 2QQ Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool Children's Hospital, Alder Hey Liverpool, England, United Kingdom, L12 2AP Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Leeds Cancer Centre at St. James's University Hospital London, England, United Kingdom, W6 8RF Great Ormond Street Hospital for Children NHS Trust London, England, United Kingdom, WC1N 3JH Meyerstein Institute of Oncology at University College of London Hospitals London, England, United Kingdom, WIT 3AA Central Manchester and Manchester Children's University Hospitals NHS Trust Manchester, England, United Kingdom, M27 4HA Newcastle Upon Tyne Hospitals NHS Trust Newcastle-Upon-Tyne, England, United Kingdom, NE7 7DN Queen's Medical Centre Nottingham, England, United Kingdom, NG7 2UH Oxford Radcliffe Hospital Oxford, England, United Kingdom, 0X3 9DU Children's Hospital - Sheffield Sheffield, England, United Kingdom, S10 2TH Southampton General Hospital Southampton, England, United Kingdom, SO16 6YD Royal Marsden NHS Foundation Trust - Surrey Sutton, England, United Kingdom, SM2 5PT Royal Belfast Hospital for Sick Children Belfast, Northern Ireland, United Kingdom, BT12 6BE Aberdeen Royal Infirmary Aberdeen, Scotland, United Kingdom, AB25 2ZN Royal Hospital for Sick Children Edinburgh, Scotland, United Kingdom Royal Hospital for Sick Children Glasgow, Scotland, United Kingdom, G3 8SJ Less <<
NCT00060255 Breast Cancer ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Testicular Germ Cell Tumor Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00025649 Neuroblastoma Phase 2 Completed - Austria ... More >> St. Anna Children's Hospital Vienna, Austria, A-1090 Belgium Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 Denmark Rigshospitalet Copenhagen, Denmark, 2100 France Centre Hospitalier Regional de Purpan Toulouse, France, 31026 Italy Istituto Giannina Gaslini Genoa, Italy, 16148 Norway Rikshospitalet University Hospital Oslo, Norway, 0027 Portugal Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, S.A. Lisboa, Portugal, 1099-023 Codex Spain Hospital Universitario LA FE Valencia, Spain, 46009 Sweden Ostra Sjukhuset Gothenburg, Sweden, 41685 Switzerland Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 United Kingdom Bristol Royal Hospital for Children Bristol, England, United Kingdom, BS2 8BJ Less <<
NCT00055653 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Less << Phase 2 Completed - -
NCT00199069 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany Less <<
NCT00008203 Breast Cancer Phase 3 Completed - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00613457 Leukemia Phase 3 Completed - -
NCT00006056 Chediak-Higashi Syndrome ... More >> Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis Virus-Associated Hemophagocytic Syndrome Less << Not Applicable Unknown - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00238368 Lymphoma Phase 2 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00002514 Leukemia Phase 3 Completed - -
NCT00003414 Graft Versus Host Disease ... More >> Lymphoma Less << Phase 3 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00003541 Lymphoma Phase 1 Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00006054 Immunologic Deficiency Syndrom... More >>es Chediak-Higashi Syndrome Common Variable Immunodeficiency Graft Versus Host Disease X-Linked Lymphoproliferative Syndrome Familial Erythrophagocytic Lymphohistiocytosis Hemophagocytic Lymphohistiocytosis X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Hyper IgM Syndrome Severe Combined Immunodeficiency Leukocyte Adhesion Deficiency Syndrome Virus-Associated Hemophagocytic Syndrome Less << Not Applicable Terminated - United States, Minnesota ... More >> Fairview University Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00003401 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Maryland ... More >> Marlene & Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 Less <<
NCT00012311 Breast Cancer Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center New York, New York, United States, 10032 Less <<
NCT00002761 Leukemia Phase 1 Phase 2 Withdrawn(PI left institution) - -
NCT00002700 Leukemia Lymp... More >>homa Less << Phase 3 Completed - -
NCT00003650 Lymphoma Phase 3 Unknown - France ... More >> Centre Leon Berard Lyon, France, 69373 Less <<
NCT00004904 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States, 60611-3013 Less <<
NCT00022126 Leukemia Phase 2 Completed - -
NCT00003728 Leukemia Lymp... More >>homa Less << Phase 3 Unknown - Belgium ... More >> Ziekenhuis Netwerk Antwerpen Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels, Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels, Belgium, 1090 Ghent University Ghent, Belgium, B-9000 Universitair Ziekenhuis Gent Ghent, Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege, Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHU de Grenoble - Hopital de la Tronche Grenoble, France, 38043 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34059 CHR Hotel Dieu Nantes, France, 44035 Hopital de l'Archet CHU de Nice Nice, France, F-06202 CHU - Hopital Robert Debre Paris, France, 75019 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Instituto Portugues de Oncologia Centro do Porto, SA Porto, Portugal, 4200 Less <<
NCT02688803 Breast Cancer Not Applicable Unknown October 2018 Canada, Ontario ... More >> The Ottawa Hospital Cancer Centre Recruiting Ottawa, Ontario, Canada, K2H 8L6 Less <<
NCT02661035 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Myeloproliferative Syndromes Hematological Diseases Less << Phase 2 Recruiting March 2023 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Erica Warlick, MD Less <<
NCT01015443 Non-Small Cell Lung Cancer Phase 3 Terminated(The study is termin... More >>ated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.) Less << - -
NCT00006669 Lymphoma Phase 2 Unknown - United States, District of Col... More >>umbia Washington Cancer Institute Washington, District of Columbia, United States, 20010 United States, Maryland Franklin Square Hospital Center Baltimore, Maryland, United States, 21237 Less <<
NCT01594177 Unilateral HER2 Positive Breas... More >>t Cancer Less << Phase 2 Completed - Germany ... More >> Rotkreuzklinikum München München, Germany, 80634 Less <<
NCT01015443 - Terminated(The study is termin... More >>ated prematurely as the sponsor decided to discontinue program with Tecemotide in NSCLC.) Less << - -
NCT01334502 Lymphoma Phase 1 Completed - United States, Minnesota ... More >> Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 Less <<
NCT03409198 Breast Cancer ... More >> Luminal B Less << Phase 2 Recruiting January 1, 2025 Norway ... More >> Soerlandet Hospital HF Kristiansand Not yet recruiting Kristiansand, Norway Contact: Christian Kersten, MD          Oslo University Hospital Recruiting Oslo, Norway Contact: Jon Amund Kyte, M.D.-Ph.D.    +4722934000    Jon.Amund.Kyte@rr-research.no    Principal Investigator: Jon Amund Kyte, M.D.-Ph.D.          Sub-Investigator: Bjørn Naume, M.D.-Ph.D.          Stavanger University Hospital Not yet recruiting Stavanger, Norway, 4011 Contact: Bjørnar Gilje, MD Less <<
NCT02017964 Untreated Childhood Medullobla... More >>stoma Less << Phase 2 Completed - -
NCT00002552 Lymphoma Mult... More >>iple Myeloma and Plasma Cell Neoplasm Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT00001212 Nephrotic Syndrome ... More >> Systemic Lupus Erythematosus Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT02343536 Lymphoma, Large B-Cell, Diffus... More >>e Lymphoma, Follicular Less << Phase 1 Active, not recruiting March 1, 2020 United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02117 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medicine New York, New York, United States, 10065 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT01097057 Non-Hodgkin Lymphoma Phase 2 Completed - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00134030 Localized Osteosarcoma ... More >> Metastatic Osteosarcoma Less << Phase 3 Active, not recruiting - -
NCT01145209 Small Lymphocytic Lymphoma ... More >> CLL (Chronic Lymphocytic Leukemia) Less << Phase 2 Active, not recruiting December 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00089544 Recurrent Adult Soft Tissue Sa... More >>rcoma Stage I Adult Soft Tissue Sarcoma AJCC v7 Stage II Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Less << Phase 2 Terminated - United States, Pennsylvania ... More >> Radiation Therapy Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00089544 - Terminated - -
NCT01959698 CD20 Positive ... More >> Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Stage I Diffuse Large B-Cell Lymphoma Stage II Diffuse Large B-Cell Lymphoma Stage III Diffuse Large B-Cell Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting July 15, 2023 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@RoswellPark.org    Principal Investigator: Francisco J. Hernandez-ILizaliturri Less <<
NCT03323944 Pancreatic Cancer ... More >> Cancer of the Pancreas Less << Phase 1 Recruiting September 2021 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Mark O'Hara, MD    800-789-7366    Mark.O'hara@uphs.upenn.edu Less <<
NCT02219737 CD20 Positive ... More >> Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01097057 - Completed - -
NCT01602666 Central Nervous System Nongerm... More >>inomatous Germ Cell Tumor Childhood Central Nervous System Germinoma Less << Phase 2 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT02628405 CD20 Positive ... More >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Transformed Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting January 20, 2023 United States, Florida ... More >> Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Kathleen M. Burke    904-953-2000    Burke.Kathleen@mayo.edu    Principal Investigator: Han W. Tun          United States, Illinois Illinois CancerCare-Peoria Withdrawn Peoria, Illinois, United States, 61615 Carle Cancer Center NCI Community Oncology Research Program Recruiting Urbana, Illinois, United States, 61801 Contact: Pauline Mbuvi    217-383-4085    Pauline.Mbuvi@Carle.com    Principal Investigator: Priyank P. Patel          United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Susan B. Butcher    319-467-5827    susan-butcher@uiowa.edu    Principal Investigator: Umar Farooq          United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mayo Clinic Clinical Trials Office    855-776-0015       Principal Investigator: Grzegorz S. Nowakowski          Coborn Cancer Center at Saint Cloud Hospital Recruiting Saint Cloud, Minnesota, United States, 56303 Contact: Stacy St. Onge    320-229-4907    stacy.stonge@centracare.com    Principal Investigator: Donald J. Jurgens          Metro Minnesota Community Oncology Research Consortium Recruiting Saint Louis Park, Minnesota, United States, 55416 Contact: Elizabeth J. Wagner    952-992-1555    Elizabeth.wagner@parknicollet.com    Principal Investigator: Daniel M. Anderson          United States, Nebraska University of Nebraska Medical Center Withdrawn Omaha, Nebraska, United States, 68198 United States, New Hampshire Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Julie Gurnsey    603-653-3640    Julie.d.gurnsey@hitchcock.org    Principal Investigator: Frederick Lansigan          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara M. Yannotti    551-996-5900    Kara.Yannotti@HackensackMeridian.org    Principal Investigator: Tatyana A. Feldman          United States, New York State University of New York Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Joanne M. Chilton    315-464-8240    chiltonj@upstate.edu    Principal Investigator: Teresa C. Gentile          United States, Pennsylvania Geisinger Medical Center Withdrawn Danville, Pennsylvania, United States, 17822 United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Wisconsin Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Sheryl L. Mandel    715-389-4457    Mandel.Sheryl@mcrf.mfldclin.edu    Principal Investigator: Ali W. Bseiso Less <<
NCT03440567 CCND1 Positive ... More >> CD20 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mantle Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mantle Cell Lymphoma Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma Less << Phase 1 Recruiting June 8, 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Liana Nikolaenko, MD    626-256-4673    lnikolaenko@coh.org    Principal Investigator: Liana Nikolaenko, MD Less <<
NCT02227199 Recurrent Adult Hodgkin Lympho... More >>ma Refractory Hodgkin Lymphoma TNFRSF8 Positive Less << Phase 1 Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-606-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT00467051 - Completed - -
NCT00467051 Childhood Extracranial Germ Ce... More >>ll Tumor Childhood Extragonadal Malignant Germ Cell Tumor Childhood Malignant Ovarian Germ Cell Tumor Childhood Malignant Testicular Germ Cell Tumor Ovarian Choriocarcinoma Ovarian Embryonal Carcinoma Ovarian Yolk Sac Tumor Recurrent Childhood Malignant Germ Cell Tumor Recurrent Malignant Testicular Germ Cell Tumor Recurrent Ovarian Germ Cell Tumor Testicular Choriocarcinoma Testicular Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Embryonal Carcinoma Testicular Mixed Choriocarcinoma and Yolk Sac Tumor Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor Testicular Yolk Sac Tumor Less << Phase 2 Completed - -
NCT03016871 CD (Cluster of Differentiation... More >>) 30-Positive Neoplastic Cells Present Recurrent Hodgkin Lymphoma Refractory Hodgkin Lymphoma TNFRSF8 Positive Less << Phase 2 Recruiting April 24, 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Robert W. Chen, MD    626-256-4673 ext 64762    rchen@coh.org    Principal Investigator: Robert W. Chen, MD          United States, Connecticut Yale University Not yet recruiting New Haven, Connecticut, United States, 06520 Contact: Gottfried von Keudell, MD    203-707-4257    gottfried.vonkeudell@yale.edu    Principal Investigator: Gottfried von Keudell, MD          United States, Texas M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Michelle A. Fanale, MD    713-792-2860    mfanale@mdanderson.org    Principal Investigator: Michelle A. Fanale, MD          United States, Washington Fred Hutchinson Cancer Research Center Not yet recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal, MD    206-288-2035    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal, MD Less <<
NCT02050919 Pleomorphic Rhabdomyosarcoma ... More >> Stage IIB Adult Soft Tissue Sarcoma AJCC v7 Stage III Adult Soft Tissue Sarcoma AJCC v7 Stage IV Adult Soft Tissue Sarcoma AJCC v7 Less << Phase 2 Active, not recruiting December 31, 2018 United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 Less <<
NCT01446809 Stage IIA Adult Soft Tissue Sa... More >>rcoma Stage III Adult Soft Tissue Sarcoma Stage IV Adult Soft Tissue Sarcoma Less << Not Applicable Unknown - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00083681 Multiple Myeloma Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT02180867 Adult Fibrosarcoma ... More >> Alveolar Soft Part Sarcoma Angiomatoid Fibrous Histiocytoma Atypical Fibroxanthoma Clear Cell Sarcoma of Soft Tissue Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Sarcoma Extraskeletal Myxoid Chondrosarcoma Extraskeletal Osteosarcoma Fibrohistiocytic Neoplasm Glomus Tumor of the Skin Inflammatory Myofibroblastic Tumor Intimal Sarcoma Leiomyosarcoma Liposarcoma Low Grade Fibromyxoid Sarcoma Low Grade Myofibroblastic Sarcoma Malignant Cutaneous Granular Cell Tumor Malignant Peripheral Nerve Sheath Tumor Malignant Triton Tumor Mesenchymal Chondrosarcoma Myxofibrosarcoma Myxoid Chondrosarcoma Myxoinflammatory Fibroblastic Sarcoma Nerve Sheath Neoplasm PEComa Pericytic Neoplasm Plexiform Fibrohistiocytic Tumor Sclerosing Epithelioid Fibrosarcoma Stage IB Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Synovial Sarcoma Undifferentiated (Embryonal) Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone Less << Phase 2 Phase 3 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT01590732 Mycosis Fungoides ... More >> Recurrent Anaplastic Large Cell Lymphoma Recurrent Angioimmunoblastic T-Cell Lymphoma Recurrent Enteropathy-Associated T-Cell Lymphoma Recurrent Hepatosplenic T-Cell Lymphoma Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified Refractory Anaplastic Large Cell Lymphoma Refractory Angioimmunoblastic T-Cell Lymphoma Refractory Enteropathy-Associated T-Cell Lymphoma Refractory Hepatosplenic T-Cell Lymphoma Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified Less << Phase 1 Completed - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00749723 Recurrent Brain Tumors ... More >> Supratentorial PNETs Medulloblastomas Ependymomas Less << Phase 2 Phase 3 Completed - -
NCT01614301 Advanced Melanoma Phase 1 Phase 2 Unknown May 2016 Germany ... More >> University of Regensburg Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Albrecht Reichle, Professor    +499419440    albrecht.reichle@UKR.de    Sub-Investigator: Martin Vogelhuber, MD          Sub-Investigator: Stephanie Mayer, MD          Sub-Investigator: Christina Hart, MD          Sub-Investigator: Matthias Grube, MD          Sub-Investigator: Susanne Gantner, MD Less <<
NCT00184041 Acute Lymphoblastic Leukemia Phase 2 Completed - United States, California ... More >> USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States, 90032 Less <<
NCT02969083 Upper Tract Urothelial Carcino... More >>ma Less << Phase 2 Recruiting October 2023 Netherlands ... More >> Leiden University Medical Centre Recruiting Leiden, South Holland, Netherlands Less <<
NCT01795872 Multiple Sclerosis Phase 4 Completed - -
NCT03077828 Lymphocyte-Rich Classical Hodg... More >>kin Lymphoma Recurrent Lymphocyte-Depleted Classical Hodgkin Lymphoma Recurrent Mixed Cellularity Classical Hodgkin Lymphoma Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma Refractory Lymphocyte-Depleted Classical Hodgkin Lymphoma Refractory Mixed Cellularity Classical Hodgkin Lymphoma Refractory Nodular Sclerosis Classical Hodgkin Lymphoma Less << Phase 2 Recruiting February 2020 United States, Georgia ... More >> Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Pamela Allen, MD, MSc    404-778-1900       Principal Investigator: Pamela Allen, MD, MSc          Augusta University Medical Center Recruiting Augusta, Georgia, United States, 30912 Contact: Locke J. Bryan, M.D.    706-721-2505    lbryan@augusta.edu    Principal Investigator: Locke J. Bryan, M.D.          United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Jane N. Winter, M.D.    312-695-4538       Principal Investigator: Jane N. Winter, M.D.          Sub-Investigator: Leo I. Gordon, M.D.          Sub-Investigator: Shuo Ma, M.D., Ph.D.          Sub-Investigator: Barbara Pro, M.D.          Sub-Investigator: Jason Kaplan, M.D.          Loyola University Medical Center Recruiting Maywood, Illinois, United States, 60153 Contact: Scott E. Smith, M.D.,Ph.D.    708-216-9000       Principal Investigator: Scott E. Smith, M.D.,Ph.D.          United States, New Jersey Hackensack University Medical Center Not yet recruiting Hackensack, New Jersey, United States, 07601 Contact: Andre H. Goy, M.D., M.S    210-996-4469    agoy@hackensackumc.org    Principal Investigator: Andre H. Goy, M.D., M.S          United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Carla Casulo, M.D.    585-273-3258    carla_casulo@urmc.rochester.edu    Principal Investigator: Carla Casulo, M.D. Less <<
NCT01362530 - Completed - -
NCT01203722 Hematologic Malignancies Phase 1 Phase 2 Recruiting December 2023 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce    410-955-8804    jhcccro@jhmi.edu Less <<
NCT03072238 Metastatic Prostate Cancer Phase 3 Recruiting November 18, 2023 -
NCT03141970 Nephrotic Syndrome Phase 3 Recruiting March 31, 2022 United States, California ... More >> Cedars-Sinai Medical Center, Pediatric IBD & Pediatric Nephrology Not yet recruiting Los Angeles, California, United States, 90048 Contact: Jessica Reece, MA    310-423-5314    jessica.reece@cshs.org    Principal Investigator: Elaine S Kamil, MD          Stanford University Medical Center, Department of Pediatrics, Division of Nephrology Not yet recruiting Stanford, California, United States, 94305 Contact: Maira Simas    650-725-8327    mnsimas@standford.edu    Principal Investigator: Gia J Oh, MD          United States, Michigan University of Michigan Department of Pedatric Nephrology Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Brenda S Buckle, MSN    734-232-4830    bbuckle@med.umich.edu    Contact: Hailey Desmond, MS    734 232 4830    heturner@med.umich.edu    Principal Investigator: Debbie Gipson, MD          United States, North Carolina Levine's Children/Carolinas HealthCare System Not yet recruiting Charlotte, North Carolina, United States, 28207 Contact: Jennifer Lamothe, RN,BSN,CCRC    704-347-4052    jennifer.lamothe@carolinas.org    Principal Investigator: Susan Massengill, MD          India All India Institute of Medical Sciences Recruiting New Delhi, Delhi, India, 110029 Contact: Arvind Bagga, MD    911126593472    arvindbagga@hotmail.com    Contact: Aditi Sinha, MD    919899145489    aditisinhaaiims@gmail.com    Principal Investigator: Arvind Bagga, MD          Sub-Investigator: Aditi Sinha, MD          Sub-Investigator: Pankaj Hari, MD Less <<
NCT03013335 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting January 2023 France ... More >> Centre Francois Baclesse Recruiting Caen, France, 14076 Contact: Florence JOLY    +33(0)2 31 45 50 02    f.joly@baclesse.fr    Centre Georges-Francois Leclerc Recruiting Dijon, France, 21079 Contact: Sylvain LADOIRE    +33(0)3 80 73 75 06    sladoire@cgfl.fr    Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie NEGRIER    +33(0)4 78 78 27 51    sylvie.negrier@lyon.unicancer.fr    Institut Paoli-Calmettes Recruiting Marseille, France, 13273 Cedex 9 Contact: Gwenaelle GRAVIS    +33 (0)4 91 22 37 40    gravisg@ipc.unicancer.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Cedex 2 Contact: Delphine BORCHIELLINI    +33(0)4 92 03 15 14       Contact       delphine.borchiellini@nice.unicancer.fr    Institut de Cancerologie de Lorraine Recruiting Vandoeuvre Les Nancy, France, 54500 Contact: Lionnel GEOFFROIS    +33(0)3 83 59 84 61    l.geoffrois@nancy.unicancer.fr    Gustave Roussy Cancer Campus Grand Paris Recruiting Villejuif, France, 94800 Contact: Laurence ALBIGES    +33(0) 1 42 11 62 64    laurence.albiges@gustaveroussy.fr    Sub-Investigator: Bernard ESCUDIER Less <<
NCT01834157 - Unknown November 2017 -
NCT00169143 Untreated CD20-positive Large ... More >>B-cell Lymphoma Less << Phase 2 Completed - France ... More >> Hôpital Henri Mondor Créteil, France Service d'Hématologie Clinique - CHU Le Bocage Dijon, France Hôpital Saint Louis Paris, France Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France Centre Henri Becquerel Rouen, France CHRU de Nancy Brabois Vandoeuvre-les-Nancy, France Less <<
NCT00430677 Systemic Lupus Erythematosus Phase 2 Phase 3 Terminated(Terminated due to f... More >>ailure to meet the primary efficacy endpoint in the Short-term Period) Less << - -
NCT01362530 Chemotherapy Induced Nausea an... More >>d Vomiting Less << Phase 3 Completed - -
NCT01178086 - Completed - Germany ... More >> PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany, 50226 Less <<
NCT00558220 Diffuse Large B-Cell Lymphoma.... More >> Primary Mediastinal B-Cell Lymphoma Follicular Lymphoma Grade III Less << Phase 2 Completed - Czech Republic ... More >> University Hospital Brno-Bohunice Brno, Czech Republic, 625 00 Hospital Chomutov Chomutov, Czech Republic, 430 12 University Hospital Hradec Králové Hradec Králové, Czech Republic, 500 05 University Hospital Královské Vinohrady Prague, Czech Republic, 100 34 General University Hospital Prague, Czech Republic, 128 08 University Hospital Motol Prague, Czech Republic, 150 00 Hospital Ústí nad Labem Usti nad Labem, Czech Republic, 401 13 Hospital České Budějovice České Budějovice, Czech Republic Less <<
NCT03390387 Childhood Acute Lymphoblastic ... More >>Leukemia Less << Not Applicable Recruiting November 2025 -
NCT02316613 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT02316613 - Completed - -
NCT03479918 Lymphoma, High-Grade Phase 3 Recruiting March 15, 2024 Russian Federation ... More >> National Research Center for Hematology Recruiting Moscow, Russian Federation, 125167 Contact: Elena Parovichnikova, MD, PhD       director@blood.ru    Sub-Investigator: Sergey Kravchenko, MD, PhD          Sub-Investigator: Anna Misyurina, MD, PhD          Sub-Investigator: Aminat Magomedova, MD, PhD          Sub-Investigator: Sergey Kulikov, PhD          Sub-Investigator: Alla Kovrigina, PhD          Sub-Investigator: Tatiana Obukhova, PhD Less <<
NCT00430677 - Terminated(Terminated due to f... More >>ailure to meet the primary efficacy endpoint in the Short-term Period) Less << - -
NCT01946880 Systemic Lupus Erythematosus ... More >> SLE Less << Phase 2 Active, not recruiting October 1, 2020 United States, California ... More >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 UCSD San Diego, California, United States, 92093-0943 UCSF School of Medicine San Francisco, California, United States, 94143-0633 United States, Colorado University of Colorado Denver, Colorado, United States, 80204 United States, Florida University of Miami Hospitals and Clinics Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30303 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1426 United States, Massachusetts Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States, 39216 United States, New York Feinstein Institute for Medical Research Manhasset, New York, United States, 11025 New York University, Langone Medical Center New York, New York, United States, 10016 Weill Cornell Medical College: Hospital for Special Surgery - Rheumatology Division New York, New York, United States, 10021 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio The Ohio State University Columbus, Ohio, United States, 43210 United States, Oklahoma Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States, 73104 United States, Pennsylvania Penn State University Hershey, Pennsylvania, United States, 17033 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29412 Less <<
NCT00482066 ANCA-associated Vasculitis Phase 2 Terminated(Funders withdrew fu... More >>nding due to slow recruitment) Less << - United Kingdom ... More >> Imperial College London, Hammersmith Hospital London, United Kingdom, W12 0NN Less <<
NCT02356159 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Recruiting January 1, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03610217 Scleroderma, Systemic ... More >> Sclerosis, Systemic Less << Not Applicable Not yet recruiting October 2021 Canada, Ontario ... More >> Saint Joseph's Health Care London Not yet recruiting London, Ontario, Canada, n6a 4v2 Contact: Janet E Pope, MD, MPH, FRCPSC    15196466332    Janet.Pope@sjhc.london.on.ca    Contact: Andreu Fernandez-Codina    151964661023    doccodina@gmail.com Less <<
NCT01178086 - Completed - -
NCT02520895 - Completed - France ... More >> Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69310 Less <<
NCT01516593 HIV Burkitt's... More >> Lymphoma Less << Phase 2 Unknown August 2015 Italy ... More >> Oncologia Medica A - Centro di Riferimento Oncologico Not yet recruiting Aviano (PN), Italy Contact: Michele Spina, MD    +300434659 ext 284    mspina@cro.it    Principal Investigator: Michele Spina, MD          Ematologia - A.O. Spedali Civili Not yet recruiting Brescia, Italy Contact: Alessandro Re, MD    +39030399 ext 5438    sandrore@aruba.it    Principal Investigator: Alessandro Re, MD          Dip. Oncoematologia - Fondazione Centro San Raffaele del Monte Tabor Recruiting Milano, Italy Contact: Andrés JM Ferreri, MD    +39022643 ext 7649    ferreri.andres@hsr.it    Contact: Marta Bruno Ventre, MD       brunoventre.marta@hsr.it    Principal Investigator: Andrés JM Ferreri, MD          S.C. Oncologia Medica - Ospedale San Paolo Not yet recruiting Milano, Italy Contact: Niccolò Frungillo, MD       niccolo.frungillo@ao.sanpaolo.it    Principal Investigator: Niccolò Frungillo, MD          S.C. Oncologia Medica 3 - IRCCS Istituto Nazionale Tumori (INT) Not yet recruiting Milano, Italy Contact: Massimo Di Nicola, MD    +39022390 ext 2360    massimo.dinicola@istitutotumori.mi.it    Principal Investigator: Massimo Di Nicola, MD          U.O.C. Immunodeficienze virali - I.N.M.I. L. Spallanzani Not yet recruiting Roma, Italy Contact: Andrea Antinori, MD    +390655170 ext 348    andrea.antinori@inmi.it    Principal Investigator: Andrea Antinori, MD          S.C. Oncoematologia - A.O. Santa Maria Not yet recruiting Terni, Italy Contact: Anna Marina Liberati, MD    +390744205 ext 971    marinal@unipg.it    Principal Investigator: Anna Marina Liberati, MD          U.O. Ematologia 2 - Ospedale San Giovanni Battista Not yet recruiting Torino, Italy Contact: Dino Allione, MD    +39011633 ext 6685    ballione@molinette.piemonte.it    Principal Investigator: Dino Allione, MD Less <<
NCT00560053 Multiple Myeloma Phase 3 Completed - -
NCT03213977 Diffuse Large B-cell Lymphoma Phase 3 Recruiting February 1, 2021 China, Fujian ... More >> Fujian Medical University Union Hospital Recruiting Fuzhou, Fujian, China, 350001 Contact: Jianda Hu, Prof.    86-13959169016    drjiandahu@163.com    Contact: Ting Yang, Prof.    86-13950210357    yang.hopeting@gmail.com    Principal Investigator: Jianda Hu, Prof. Less <<
NCT01370213 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting January 2019 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Minnesota University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT02620280 Invasive Ductal Breast Carcino... More >>ma Less << Phase 3 Recruiting October 2022 -
NCT00136539 Breast Cancer Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01134484 Multiple Myeloma Phase 3 Unknown December 2015 Italy ... More >> AOU di Bologna Policlinico S.Orsola-Malpighi, UO di Ematologia Bologna, Italy, 40138 Less <<
NCT01818323 Head and Neck Cancer Phase 1 Recruiting December 2019 United Kingdom ... More >> Clinical Research Facility, Guy's Hospital Recruiting London, United Kingdom, SE1 9RT Principal Investigator: John Maher Less <<
NCT00684970 Metastatic Castration Resistan... More >>t Prostate Cancer (CRPC) Less << Phase 2 Unknown - Israel ... More >> Bnei Tzion Medical Center Recruiting Haifa, Israel Contact: Prof. Ofer Nativ       ofer.nativ@b-zion.org.il    Principal Investigator: Prof. Ofer Nativ, MD          Rambam Medical Center Recruiting Haifa, Israel Contact: Avivit Peer, MD       a_peer@rambam.health.gov.il    Principal Investigator: Dr. Avivit Peer, MD          Sheba Medical Center Recruiting Tel Hashomer, Israel Contact: Dr. Raanan Berger, M.D.       Raanan.Berger@sheba.health.gov.il    Principal Investigator: Dr. Raanan Berger, MD, PhD          Sourasky Medical Center Recruiting Tel-Aviv, Israel Contact: Dr. Eliahu Gez, MD       eliahug@tasmc.health.gov.il    Principal Investigator: Dr. Eliahu Gez, MD          Asaf Harofe Medical Center Recruiting Tzrifin, Israel Contact: Prof. Avishay Sella, MD       Dr.AvishaySella@asaf.health.gov.il    Principal Investigator: Prof. Avishay Sella, MD Less <<
NCT01501487 Breast Cancer Phase 4 Completed - United States, Alabama ... More >> University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States, 36688 United States, Florida Morton Plant Mease Health Care Clearwater, Florida, United States, 33756 University of Miami Miami, Florida, United States, 33124 University of South Florida Breast Cancer Program Tampa, Florida, United States, 33613 Helen Ellis Memorial Hospital Tarpon Springs, Florida, United States, 34689 United States, New York Eastchester Center for Cancer Care Bronx, New York, United States, 10469 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43212 United States, Oklahoma University of Oklahoma, Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Texas Texas Health, Plano Cancer Institute Plano, Texas, United States, 75093 Less <<
NCT00204568 Sarcoma, Soft Tissue Phase 2 Unknown October 2013 Germany ... More >> University Medical Center , Comprehensive Cancer Center North, Christian-Albrechts-University Kiel, Germany, 24105 Less <<
NCT00001338 Breast Neoplasms ... More >> Fever Hematologic Diseases Neutropenia Sepsis Less << Phase 3 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00001269 Breast Neoplasms ... More >> Neoplasm Metastasis Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT02084563 Acute Myeloid Leukemia ... More >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm Less << Phase 2 Completed - Brazil ... More >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 Less <<
NCT00189644 Breast Cancer Phase 3 Unknown - -
NCT01576692 Neuroblastoma Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00827424 Obesity Not Applicable Completed - Israel ... More >> Clinical Research Unit, Clalit Health Services, Haifa and Western Galilee District . Haifa,, Israel, 35024 Less <<
NCT00992992 Lymphoma, Mantle-Cell Phase 2 Completed - -
NCT01175772 Ovarian Carcinoma Phase 2 Terminated(Due to change in th... More >>e national policy of medications) Less << - Israel ... More >> HaEmek Medical Center Afula, Israel, 18101 Less <<
NCT01645059 - Completed - Spain ... More >> Hospital de Denia Denia, Alicante, Spain, 03700 Hospital General de Elda Elda, Alicante, Spain, 03600 Hospital de Cabueñes Gijón, Asturias, Spain, 33203 Hospital don Benito Don Benito, Badajoz, Spain, 06400 Hospital de Llerena Llerena, Badajoz, Spain, 06900 Hospital de Mérida Mérida, Badajoz, Spain, 06800 ICO Badalona Badalona, Barcelona, Spain, 08916 Hospital General de l'Hospitalet Hospitalet de Llobregat, Barcelona, Spain, 08906 Hospital Virgen del Puerto Plasencia, Cáceres, Spain, 10600 Hospital de Jerez Jerez de la Frontera, Cádiz, Spain, 11404 Hospital Son Llàtzer Palma de Mallorca, Islas Baleares, Spain, 07198 Hospital de Getafe Getafe, Madrid, Spain, 28901 Hospital Severo Ochoa Leganés, Madrid, Spain, 28911 Hospital de Móstoles Móstoles, Madrid, Spain, 28935 Hospital Quirón Pozuelo de Alarcón, Madrid, Spain, 28223 Hospital Reina Sofía de Tudela Tudela, Navarra, Spain, 31500 Hospital do Meixoeiro Vigo, Pontevedra, Spain, 36214 Hospital Universitario de Canarias La Laguna, Tenerife, Spain, 38320 Hospital Universitario de la Candelaria Santa Cruz de Tenerife, Tenerife, Spain, 38010 Hospital de Alcañiz Alcañiz, Teruel, Spain, 44600 Hospital de Galdakao Galdakao, Vizcaya, Spain, 48960 Hospital de Torrecárdenas Almería, Spain, 04009 Hospital Infanta Cristina de Badajoz Badajoz, Spain, 06008 Clínica Corachan Barcelona, Spain, 08017 Complejo Hospitalario Ciudad Real Ciudad Real, Spain, 13005 Hospital San Pedro Alcántara Cáceres, Spain, 10003 Hospital de León León, Spain, 24008 Hospital Universitario Arnau de Vilanova Lleida, Spain, 25198 Hospital Lucus Augusti Lugo, Spain, 27003 Hospital La Princesa Madrid, Spain, 28006 Hospital Morales Messeguer Murcia, Spain, 30008 Hospital General de Segovia Segovia, Spain, 40002 Hospital Virgen de la Macarena Sevilla, Spain, 41009 Hospital General Universitario de Valencia Valencia, Spain, 46014 Hospital Dr.Peset Valencia, Spain, 46017 Hospital Clínico de Valladolid Valladolid, Spain, 47005 Hospital Universitario Rio Hortega Valladolid, Spain, 47012 Hospital de Zamora Zamora, Spain, 49021 Hospital de Txagorritxu Vitoria, Álava, Spain, 01009 Less <<
NCT00992992 - Completed - -
NCT03619993 Non Hodgkin Lymphoma ... More >> Breast Cancer Less << Not Applicable Recruiting November 2020 Germany ... More >> Research Site Not yet recruiting Aschaffenburg, Germany, 63739 Research Site Not yet recruiting Augsburg, Germany, 86150 Research Site Not yet recruiting Berlin, Germany, 10367 Research Site Not yet recruiting Bonn, Germany, 53111 Research Site Not yet recruiting Celle, Germany, 29223 Research Site Not yet recruiting Dresden, Germany, 01127 Research Site Not yet recruiting Dresden, Germany, 01307 Research Site Not yet recruiting Erfurt, Germany, 99084 Research Site Not yet recruiting Flensburg, Germany, 24939 Research Site Not yet recruiting Frankfurt an der Oder, Germany, 15236 Research Site Recruiting Freiburg, Germany, 79110 Research Site Recruiting Georgsmarienhütte, Germany, 49124 Research Site Not yet recruiting Goslar, Germany, 38642 Research Site Not yet recruiting Göttingen, Germany, 37073 Research Site Not yet recruiting Halberstadt, Germany, 38820 Research Site Not yet recruiting Heidelberg, Germany, 69120 Research Site Not yet recruiting Herne, Germany, 44623 Research Site Not yet recruiting Hildesheim, Germany, 31134 Research Site Not yet recruiting Kaiserslautern, Germany, 67655 Research Site Not yet recruiting Kassel, Germany, 34119 Research Site Not yet recruiting Köthen, Germany, 06366 Research Site Not yet recruiting Mannheim, Germany, 68165 Research Site Not yet recruiting Mayen, Germany, 56727 Research Site Not yet recruiting Mühlhausen, Germany, 99974 Research Site Not yet recruiting Mülheim an der Ruhr, Germany, 45468 Research Site Not yet recruiting München, Germany, 80639 Research Site Not yet recruiting Naunhof, Germany, 04683 Research Site Not yet recruiting Neunkirchen, Germany, 66538 Research Site Not yet recruiting Neustadt In Sachsen, Germany, 01844 Research Site Not yet recruiting Nordhorn, Germany, 48527 Research Site Not yet recruiting Offenbach am Main, Germany, 63069 Research Site Not yet recruiting Oldenburg, Germany, 26121 Research Site Not yet recruiting Ostfildern, Germany, 73760 Research Site Not yet recruiting Passau, Germany, 94036 Research Site Not yet recruiting Pirna, Germany, 01796 Research Site Not yet recruiting Ratingen, Germany, 40878 Research Site Not yet recruiting Rostock, Germany, 18107 Research Site Recruiting Singen, Germany, 78224 Research Site Not yet recruiting Spremberg, Germany, 03130 Research Site Not yet recruiting Stolberg, Germany, 52222 Research Site Not yet recruiting Stralsund, Germany, 18435 Research Site Not yet recruiting Sömmerda, Germany, 99610 Research Site Not yet recruiting Würselen, Germany, 52146 Less <<
NCT01478542 CD20+ Aggressive B-Cell Lympho... More >>ma Less << Phase 3 Recruiting October 2019 -
NCT00001623 Graft vs Host Disease ... More >> Hematologic Neoplasm Leukemia Multiple Myeloma Myelodysplastic Syndrome Less << Not Applicable Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00083876 Multiple Myeloma Phase 3 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00001637 Chronic Lymphocytic Leukemia ... More >> Graft vs Host Disease Leukemia Myelodysplastic Syndrome Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01361438 ALL Ph Positive Phase 2 Active, not recruiting December 2018 -
NCT01484093 Mantle Cell Lymphoma Phase 1 Phase 2 Active, not recruiting November 2019 United States, New Jersey ... More >> Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 Less <<
NCT01645059 - Completed - -
NCT03382158 - Recruiting December 6, 2026 United States, Minnesota ... More >> Children;s Minnesota Recruiting Minneapolis, Minnesota, United States, 55404 Contact: Gretchen Williams, BS    612-813-7115    gretchen.williams@childrensmn.org Less <<
NCT03114670 Adult Acute Myeloid Leukemia Phase 1 Recruiting March 18, 2021 China ... More >> Fengtai District Recruiting Beijing Shi, China Contact: Hu Chen, M.D., Ph.D.    +86-010-6694-7108    chenhu217@aliyun.com Less <<
NCT01370408 Chemotherapy-induced Nausea an... More >>d Vomiting Less << Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT00122005 Prostate Cancer Phase 1 Phase 2 Unknown July 2005 United States, Oregon ... More >> Providence Portland Medical Center Portland, Oregon, United States, 97213 Less <<
NCT00001748 Graft vs Host Disease ... More >> Hematologic Neoplasms Lymphoma Myelodysplastic Syndromes Myeloid Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT02005783 Grade 3/4 Neutropenia ... More >> Febrile Neutropenia Less << Phase 2 Completed - China, Shanghai ... More >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200025 Less <<
NCT01370408 - Completed - -
NCT03468972 Biopsy-proven IgA Nephropathy Phase 4 Not yet recruiting June 1, 2024 Korea, Republic of ... More >> Severance Hospital Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Seung Hyeok Han, MD, Ph.D    82-2-2228-1984    hansh@yuhs.ac Less <<
NCT00574587 Breast Cancer Phase 1 Phase 2 Unknown January 2016 United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10461 Less <<
NCT00162656 B-Cell Lymphoma Phase 3 Completed - United States, New York ... More >> Morgan Stanley Childrens Hospital of New York Presbyterian New York, New York, United States France Institut Gustave Roussy Villejuif, France, 94800 United Kingdom Sheffield Children's Hospital Sheffield, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.58mL

0.72mL

0.36mL

17.91mL

3.58mL

1.79mL

35.83mL

7.17mL

3.58mL

References

[1]Schwartz PS, et al. Cyclophosphamide induces caspase 9-dependent apoptosis in 9L tumor cells. Mol Pharmacol. 2001 Dec;60(6):1268-1279.

[2]Liu P, et al. Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. J Immunother. 2010 Jan;33(1):53-9.

[3]Harris RN, et al. Carbon tetrachloride-induced increase in the antitumor activity of cyclophosphamide in mice: a pharmacokineticstudy. Cancer Chemother Pharmacol. 1984;12(3):167-72.

 

Historical Records

Categories

Chemistry
Organic Building Blocks
Chlorides
Chloroethyl
Animal Modeling Reagents
Immune and Inflammatory Disease Models
Cystitis Model
Animal Modeling Reagents
Immune and Inflammatory Disease Models
Myocarditis Model
Animal Modeling Reagents
Urinary System Disease Models
Other Urinary System Disease Model
Pharmaceutical Research
Animal Modeling Agents
Inflammation Model
Pharmaceutical Research
Animal Modeling Agents
Nervous System Model
Pharmaceutical Research
Animal Modeling Agents
Other Modeling Agents
Pharmaceutical Research
Small Molecule Positive Drugs
Anti-rheumatoid Arthritis

Tags: Cyclophosphamide hydrate | Cyclophosphamide monohydrate | Inflammation Model | Nervous System Model | Other Modeling Agents | Anti-rheumatoid Arthritis | Chlorides | Other Urinary System Disease Model | Myocarditis Model | Cystitis Model | Organic Building Blocks | Animal Modeling Agents | Immune and Inflammatory Disease Models | Small Molecule Positive Drugs | Urinary System Disease Models | 6055-19-2